cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	FDR	beta	r	Traits	SNP_position	Gene_position
READ	cis	rs9322193	0.962	rs6899661	ENSG00000231760.4	RP11-350J20.5	11.97	3.46e-18	3.19e-12	1.16	0.83	Lung cancer;	chr6:149818093	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9766004	ENSG00000231760.4	RP11-350J20.5	11.9	4.37e-18	3.19e-12	1.09	0.83	Lung cancer;	chr6:149754363	chr6:149796151~149826294:-
READ	cis	rs9326248	0.906	rs171052	ENSG00000254851.1	RP11-109L13.1	11.86	5.25e-18	3.19e-12	1.23	0.82	Blood protein levels;	chr11:117211047	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs9767123	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149660323	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs62439836	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149669173	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4869812	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149669447	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4870267	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149671572	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4380763	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149678086	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4354168	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149696642	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4455682	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149700161	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4870529	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149716436	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9767309	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149716807	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs17745062	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149721079	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs62441279	ENSG00000231760.4	RP11-350J20.5	11.83	5.87e-18	3.19e-12	1.11	0.82	Lung cancer;	chr6:149721194	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs9766562	ENSG00000231760.4	RP11-350J20.5	11.76	7.6e-18	3.19e-12	1.13	0.82	Lung cancer;	chr6:149788709	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1934534	ENSG00000231760.4	RP11-350J20.5	11.72	8.89e-18	3.19e-12	1.12	0.82	Lung cancer;	chr6:149711896	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs17673294	ENSG00000231760.4	RP11-350J20.5	11.68	1.03e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149813857	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs6913486	ENSG00000231760.4	RP11-350J20.5	-11.66	1.1e-17	3.19e-12	-1.08	-0.82	Lung cancer;	chr6:149705060	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs14314	ENSG00000231760.4	RP11-350J20.5	11.65	1.17e-17	3.19e-12	1.16	0.82	Lung cancer;	chr6:149820395	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3763162	ENSG00000231760.4	RP11-350J20.5	-11.65	1.17e-17	3.19e-12	-1.16	-0.82	Lung cancer;	chr6:149819674	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12175504	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149664079	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs35443312	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149670625	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs62439843	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149676521	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs35031906	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149677438	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10872645	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149742840	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12211511	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149745206	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9479810	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149751359	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs12175575	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149763351	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4869966	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149763714	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs1112730	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149766383	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1112729	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149766491	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs10452626	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149767481	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs62441303	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149767547	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9765929	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149769680	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3805748	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149772542	chr6:149796151~149826294:-
READ	cis	rs9322193	0.736	rs10457851	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149775216	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs10872652	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149775303	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs12525871	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149775882	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs17672976	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149776207	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2184369	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149776681	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs2342861	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149777561	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs2342860	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149777641	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs10872653	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149778907	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs11155683	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149779341	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9372044	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149780867	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs11155685	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149781649	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9322220	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149782897	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs10214845	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149783124	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9767122	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149783553	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1413654	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149783956	chr6:149796151~149826294:-
READ	cis	rs9322193	0.683	rs113281309	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149787289	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9688809	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149787920	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9689242	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149787970	chr6:149796151~149826294:-
READ	cis	rs9322193	1	rs9767077	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149788479	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9688938	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149788941	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9688940	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149788977	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9689447	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149789350	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs3805751	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149791193	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9689269	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149791861	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs62441335	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149792658	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4816	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149793609	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3805753	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149795662	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs952166	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149798774	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs952165	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149798900	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs10872656	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149799444	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs9285525	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149801253	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9688412	ENSG00000231760.4	RP11-350J20.5	-11.64	1.18e-17	3.19e-12	-1.13	-0.82	Lung cancer;	chr6:149803147	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs6914319	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149806304	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs2095375	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149807037	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4869730	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149808187	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs11155689	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149808470	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2151913	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149809506	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs933055	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149809701	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4869731	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149810072	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs4552	ENSG00000231760.4	RP11-350J20.5	11.64	1.18e-17	3.19e-12	1.13	0.82	Lung cancer;	chr6:149811183	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs62439840	ENSG00000231760.4	RP11-350J20.5	11.63	1.24e-17	3.19e-12	1.1	0.82	Lung cancer;	chr6:149674639	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9393175	ENSG00000231760.4	RP11-350J20.5	11.63	1.24e-17	3.19e-12	1.1	0.82	Lung cancer;	chr6:149677587	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4870509	ENSG00000231760.4	RP11-350J20.5	11.63	1.24e-17	3.19e-12	1.1	0.82	Lung cancer;	chr6:149702212	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322214	ENSG00000231760.4	RP11-350J20.5	11.63	1.24e-17	3.19e-12	1.1	0.82	Lung cancer;	chr6:149703986	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782318	ENSG00000231760.4	RP11-350J20.5	11.63	1.24e-17	3.19e-12	1.1	0.82	Lung cancer;	chr6:149754137	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs12210605	ENSG00000231760.4	RP11-350J20.5	11.63	1.25e-17	3.19e-12	1.12	0.82	Lung cancer;	chr6:149817267	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9371199	ENSG00000231760.4	RP11-350J20.5	11.63	1.25e-17	3.19e-12	1.12	0.82	Lung cancer;	chr6:149817526	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9688517	ENSG00000231760.4	RP11-350J20.5	11.63	1.27e-17	3.2e-12	1.1	0.82	Lung cancer;	chr6:149740655	chr6:149796151~149826294:-
READ	cis	rs9322193	0.632	rs3828700	ENSG00000231760.4	RP11-350J20.5	11.56	1.66e-17	4.06e-12	1.12	0.82	Lung cancer;	chr6:149791033	chr6:149796151~149826294:-
READ	cis	rs9322193	0.736	rs3828701	ENSG00000231760.4	RP11-350J20.5	11.56	1.66e-17	4.06e-12	1.12	0.82	Lung cancer;	chr6:149791063	chr6:149796151~149826294:-
READ	cis	rs9322193	0.736	rs3805750	ENSG00000231760.4	RP11-350J20.5	11.56	1.66e-17	4.06e-12	1.12	0.82	Lung cancer;	chr6:149791065	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9505974	ENSG00000231760.4	RP11-350J20.5	11.51	1.96e-17	4.44e-12	1.1	0.82	Lung cancer;	chr6:149779294	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs9689036	ENSG00000231760.4	RP11-350J20.5	11.51	1.96e-17	4.44e-12	1.1	0.82	Lung cancer;	chr6:149780563	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9322218	ENSG00000231760.4	RP11-350J20.5	11.51	1.96e-17	4.44e-12	1.1	0.82	Lung cancer;	chr6:149782183	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9322219	ENSG00000231760.4	RP11-350J20.5	11.51	1.96e-17	4.44e-12	1.1	0.82	Lung cancer;	chr6:149782263	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10872644	ENSG00000231760.4	RP11-350J20.5	11.5	2.02e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149741819	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs11155675	ENSG00000231760.4	RP11-350J20.5	11.49	2.11e-17	4.44e-12	1.1	0.82	Lung cancer;	chr6:149742883	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9478291	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149729434	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9479494	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149739108	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800806	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149740350	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1572229	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149743841	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs10872646	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149746539	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs12528279	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149750892	chr6:149796151~149826294:-
READ	cis	rs9322193	0.809	rs9479808	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149751328	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs62441284	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149751542	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782316	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149752755	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs11155677	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149756953	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9480009	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149758502	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9480031	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149758875	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10872649	ENSG00000231760.4	RP11-350J20.5	11.48	2.22e-17	4.44e-12	1.09	0.82	Lung cancer;	chr6:149759454	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782317	ENSG00000231760.4	RP11-350J20.5	-11.48	2.22e-17	4.44e-12	-1.09	-0.82	Lung cancer;	chr6:149753911	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs7753812	ENSG00000231760.4	RP11-350J20.5	11.47	2.32e-17	4.53e-12	1.12	0.82	Lung cancer;	chr6:149690150	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12195866	ENSG00000231760.4	RP11-350J20.5	11.47	2.32e-17	4.53e-12	1.12	0.82	Lung cancer;	chr6:149693334	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9285524	ENSG00000231760.4	RP11-350J20.5	11.47	2.32e-17	4.53e-12	1.12	0.82	Lung cancer;	chr6:149694122	chr6:149796151~149826294:-
READ	cis	rs9322193	0.887	rs9767113	ENSG00000231760.4	RP11-350J20.5	11.41	2.86e-17	5.53e-12	1.11	0.81	Lung cancer;	chr6:149718157	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs62439837	ENSG00000231760.4	RP11-350J20.5	11.41	2.88e-17	5.54e-12	1.09	0.81	Lung cancer;	chr6:149670380	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs56103941	ENSG00000231760.4	RP11-350J20.5	11.37	3.33e-17	6.29e-12	1.12	0.81	Lung cancer;	chr6:149816095	chr6:149796151~149826294:-
READ	cis	rs916888	0.773	rs199447	ENSG00000262539.1	RP11-259G18.3	11.36	3.57e-17	6.59e-12	1.27	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46734822	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199445	ENSG00000262539.1	RP11-259G18.3	11.36	3.57e-17	6.59e-12	1.27	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46740042	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199443	ENSG00000262539.1	RP11-259G18.3	11.36	3.57e-17	6.59e-12	1.27	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46742199	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199448	ENSG00000262539.1	RP11-259G18.3	11.35	3.66e-17	6.63e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46731635	chr17:46259551~46260606:-
READ	cis	rs9322193	0.886	rs2065663	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149760331	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12205092	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149761375	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10872651	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149768273	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3805749	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149772546	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs9505972	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149775255	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3805752	ENSG00000231760.4	RP11-350J20.5	11.34	3.74e-17	6.63e-12	1.11	0.81	Lung cancer;	chr6:149795490	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9397022	ENSG00000231760.4	RP11-350J20.5	11.33	3.89e-17	6.82e-12	1.09	0.81	Lung cancer;	chr6:149812052	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9397357	ENSG00000231760.4	RP11-350J20.5	11.33	3.89e-17	6.82e-12	1.09	0.81	Lung cancer;	chr6:149812465	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9767105	ENSG00000231760.4	RP11-350J20.5	11.33	3.98e-17	6.94e-12	1.02	0.81	Lung cancer;	chr6:149659591	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs13215691	ENSG00000231760.4	RP11-350J20.5	11.32	4.18e-17	6.95e-12	1.09	0.81	Lung cancer;	chr6:149792666	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9322223	ENSG00000231760.4	RP11-350J20.5	11.32	4.18e-17	6.95e-12	1.09	0.81	Lung cancer;	chr6:149801509	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12174035	ENSG00000231760.4	RP11-350J20.5	11.29	4.58e-17	6.95e-12	1.11	0.81	Lung cancer;	chr6:149763311	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs11155671	ENSG00000231760.4	RP11-350J20.5	11.29	4.69e-17	6.95e-12	1.11	0.81	Lung cancer;	chr6:149650996	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9689723	ENSG00000231760.4	RP11-350J20.5	11.29	4.69e-17	6.95e-12	1.11	0.81	Lung cancer;	chr6:149655935	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs288016	ENSG00000253404.1	AC034243.1	-11.28	4.73e-17	6.95e-12	-0.92	-0.81	Age-related hearing impairment (SNP x SNP interaction);	chr5:138859299	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs3924871	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149662080	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs35961297	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149667929	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs35830138	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149668635	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs35967444	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149675588	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs62439842	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149675847	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs7767622	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149681766	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs4421206	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149682891	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs3798761	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149683643	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322209	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149691226	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9322210	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149695440	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs11155674	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149711111	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2185352	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149714640	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12174349	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149718012	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2297932	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149718225	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2297930	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149718360	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2297928	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149718584	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9479094	ENSG00000231760.4	RP11-350J20.5	11.28	4.74e-17	6.95e-12	1.06	0.81	Lung cancer;	chr6:149725083	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs825747	ENSG00000253404.1	AC034243.1	-11.27	4.99e-17	7.27e-12	-0.98	-0.81	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800896	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs10872650	ENSG00000231760.4	RP11-350J20.5	11.26	5.25e-17	7.54e-12	1.1	0.81	Lung cancer;	chr6:149760959	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs160405	ENSG00000253404.1	AC034243.1	11.25	5.37e-17	7.68e-12	0.98	0.81	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748387	chr5:138744434~138753309:-
READ	cis	rs9322193	0.884	rs10872647	ENSG00000231760.4	RP11-350J20.5	11.24	5.61e-17	7.78e-12	1.11	0.81	Lung cancer;	chr6:149758687	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs10872648	ENSG00000231760.4	RP11-350J20.5	11.24	5.61e-17	7.78e-12	1.11	0.81	Lung cancer;	chr6:149758699	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs11155679	ENSG00000231760.4	RP11-350J20.5	11.24	5.61e-17	7.78e-12	1.11	0.81	Lung cancer;	chr6:149758881	chr6:149796151~149826294:-
READ	cis	rs916888	0.773	rs199535	ENSG00000262539.1	RP11-259G18.3	11.24	5.64e-17	7.78e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46745296	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199534	ENSG00000262539.1	RP11-259G18.3	11.24	5.64e-17	7.78e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46746847	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199533	ENSG00000262539.1	RP11-259G18.3	11.24	5.64e-17	7.78e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46751565	chr17:46259551~46260606:-
READ	cis	rs9322193	0.962	rs3763163	ENSG00000231760.4	RP11-350J20.5	11.22	6.01e-17	8.27e-12	1.11	0.81	Lung cancer;	chr6:149819770	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9371486	ENSG00000231760.4	RP11-350J20.5	11.2	6.62e-17	9.07e-12	1.11	0.81	Lung cancer;	chr6:149832090	chr6:149796151~149826294:-
READ	cis	rs9326248	0.953	rs488962	ENSG00000254851.1	RP11-109L13.1	11.19	6.74e-17	9.14e-12	1.2	0.81	Blood protein levels;	chr11:117201809	chr11:117135528~117138582:+
READ	cis	rs9326248	0.953	rs634960	ENSG00000254851.1	RP11-109L13.1	11.19	6.74e-17	9.14e-12	1.2	0.81	Blood protein levels;	chr11:117202247	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs12174716	ENSG00000231760.4	RP11-350J20.5	11.18	7.04e-17	9.51e-12	1.12	0.81	Lung cancer;	chr6:149644487	chr6:149796151~149826294:-
READ	cis	rs916888	0.779	rs199528	ENSG00000262539.1	RP11-259G18.3	11.18	7.22e-17	9.65e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46765770	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs199525	ENSG00000262539.1	RP11-259G18.3	11.18	7.22e-17	9.65e-12	1.26	0.81	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46770468	chr17:46259551~46260606:-
READ	cis	rs9322193	0.884	rs9371201	ENSG00000231760.4	RP11-350J20.5	11.17	7.5e-17	9.76e-12	1.11	0.81	Lung cancer;	chr6:149823865	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800736	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149661281	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs66516768	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149671999	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs7450246	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149702517	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9383812	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149712355	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs9383844	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149716268	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs56397000	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149739347	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9689702	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149740720	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782315	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149743093	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10747276	ENSG00000231760.4	RP11-350J20.5	11.16	7.72e-17	9.76e-12	1.05	0.81	Lung cancer;	chr6:149758739	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9688350	ENSG00000231760.4	RP11-350J20.5	11.14	8.29e-17	1.03e-11	1.05	0.81	Lung cancer;	chr6:149730977	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9688699	ENSG00000231760.4	RP11-350J20.5	11.14	8.29e-17	1.03e-11	1.05	0.81	Lung cancer;	chr6:149733680	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9767652	ENSG00000231760.4	RP11-350J20.5	11.14	8.29e-17	1.03e-11	1.05	0.81	Lung cancer;	chr6:149734502	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782314	ENSG00000231760.4	RP11-350J20.5	11.14	8.29e-17	1.03e-11	1.05	0.81	Lung cancer;	chr6:149735527	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs57938011	ENSG00000231760.4	RP11-350J20.5	11.12	8.84e-17	1.08e-11	1.1	0.81	Lung cancer;	chr6:149642969	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs176382	ENSG00000253404.1	AC034243.1	11.1	9.73e-17	1.18e-11	0.93	0.81	Age-related hearing impairment (SNP x SNP interaction);	chr5:138891078	chr5:138744434~138753309:-
READ	cis	rs9322193	0.884	rs1125	ENSG00000231760.4	RP11-350J20.5	11.09	9.89e-17	1.19e-11	1.11	0.81	Lung cancer;	chr6:149658280	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs2342858	ENSG00000231760.4	RP11-350J20.5	11.09	1.01e-16	1.21e-11	1.13	0.81	Lung cancer;	chr6:149805967	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs7740784	ENSG00000231760.4	RP11-350J20.5	11.04	1.21e-16	1.45e-11	1.12	0.81	Lung cancer;	chr6:149833364	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs2065664	ENSG00000231760.4	RP11-350J20.5	11.04	1.22e-16	1.45e-11	1.13	0.81	Lung cancer;	chr6:149762485	chr6:149796151~149826294:-
READ	cis	rs2882667	0.654	rs6863054	ENSG00000253404.1	AC034243.1	-11.02	1.32e-16	1.56e-11	-0.95	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138853166	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs12660304	ENSG00000231760.4	RP11-350J20.5	11.02	1.33e-16	1.56e-11	1.04	0.8	Lung cancer;	chr6:149739647	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12176034	ENSG00000231760.4	RP11-350J20.5	11.01	1.37e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149800557	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs7745915	ENSG00000231760.4	RP11-350J20.5	11	1.43e-16	1.56e-11	1.17	0.8	Lung cancer;	chr6:149834111	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs311596	ENSG00000253404.1	AC034243.1	-11	1.46e-16	1.56e-11	-0.92	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138736393	chr5:138744434~138753309:-
READ	cis	rs9322193	0.847	rs12234128	ENSG00000231760.4	RP11-350J20.5	11	1.46e-16	1.56e-11	1.11	0.8	Lung cancer;	chr6:149627553	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs57012784	ENSG00000231760.4	RP11-350J20.5	11	1.46e-16	1.56e-11	1.11	0.8	Lung cancer;	chr6:149627691	chr6:149796151~149826294:-
READ	cis	rs9322193	1	rs9377228	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149600862	chr6:149796151~149826294:-
READ	cis	rs9322193	0.924	rs9498382	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149610982	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs9485408	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149618888	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1080670	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149620161	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs10782312	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149622669	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs9322198	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149623772	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9505823	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149628899	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9689599	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149631973	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800580	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149632845	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs11155669	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149633501	chr6:149796151~149826294:-
READ	cis	rs9322193	0.887	rs9505824	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149633663	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9505826	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149633912	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9766886	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149637048	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9688861	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149637924	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs7740278	ENSG00000231760.4	RP11-350J20.5	10.99	1.46e-16	1.56e-11	1.1	0.8	Lung cancer;	chr6:149640116	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs2064521	ENSG00000231760.4	RP11-350J20.5	-10.99	1.46e-16	1.56e-11	-1.1	-0.8	Lung cancer;	chr6:149625336	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9766037	ENSG00000231760.4	RP11-350J20.5	10.97	1.6e-16	1.69e-11	1.11	0.8	Lung cancer;	chr6:149616921	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800871	ENSG00000231760.4	RP11-350J20.5	10.97	1.6e-16	1.69e-11	1.1	0.8	Lung cancer;	chr6:149644540	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs10043478	ENSG00000253404.1	AC034243.1	10.96	1.7e-16	1.78e-11	0.94	0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138853022	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs10782310	ENSG00000231760.4	RP11-350J20.5	10.91	2.04e-16	2.06e-11	1.11	0.8	Lung cancer;	chr6:149622458	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10782311	ENSG00000231760.4	RP11-350J20.5	10.91	2.04e-16	2.06e-11	1.11	0.8	Lung cancer;	chr6:149622592	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs62439808	ENSG00000231760.4	RP11-350J20.5	10.91	2.04e-16	2.06e-11	1.11	0.8	Lung cancer;	chr6:149629690	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322200	ENSG00000231760.4	RP11-350J20.5	10.91	2.04e-16	2.06e-11	1.11	0.8	Lung cancer;	chr6:149630078	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs12526675	ENSG00000231760.4	RP11-350J20.5	-10.9	2.08e-16	2.09e-11	-1.05	-0.8	Lung cancer;	chr6:149729540	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322204	ENSG00000231760.4	RP11-350J20.5	10.89	2.21e-16	2.19e-11	1.11	0.8	Lung cancer;	chr6:149636047	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800614	ENSG00000231760.4	RP11-350J20.5	10.88	2.3e-16	2.27e-11	1.08	0.8	Lung cancer;	chr6:149644604	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs9767555	ENSG00000231760.4	RP11-350J20.5	10.82	2.85e-16	2.8e-11	1.11	0.8	Lung cancer;	chr6:149647022	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs10515504	ENSG00000253404.1	AC034243.1	-10.81	2.96e-16	2.89e-11	-0.93	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138887305	chr5:138744434~138753309:-
READ	cis	rs9326248	0.954	rs10790177	ENSG00000254851.1	RP11-109L13.1	-10.81	2.99e-16	2.91e-11	-1.09	-0.8	Blood protein levels;	chr11:117177701	chr11:117135528~117138582:+
READ	cis	rs2882667	0.69	rs160399	ENSG00000253404.1	AC034243.1	10.81	3e-16	2.91e-11	0.93	0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727552	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs9689716	ENSG00000231760.4	RP11-350J20.5	10.79	3.29e-16	3.15e-11	1.05	0.8	Lung cancer;	chr6:149655662	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322207	ENSG00000231760.4	RP11-350J20.5	10.79	3.29e-16	3.15e-11	1.05	0.8	Lung cancer;	chr6:149657185	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9968911	ENSG00000231760.4	RP11-350J20.5	10.79	3.29e-16	3.15e-11	1.05	0.8	Lung cancer;	chr6:149657419	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322208	ENSG00000231760.4	RP11-350J20.5	10.79	3.29e-16	3.15e-11	1.05	0.8	Lung cancer;	chr6:149658547	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs1413655	ENSG00000231760.4	RP11-350J20.5	10.78	3.44e-16	3.2e-11	1.16	0.8	Lung cancer;	chr6:149821815	chr6:149796151~149826294:-
READ	cis	rs9322193	0.926	rs9383546	ENSG00000231760.4	RP11-350J20.5	10.78	3.44e-16	3.2e-11	1.16	0.8	Lung cancer;	chr6:149822743	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs2151912	ENSG00000231760.4	RP11-350J20.5	10.78	3.44e-16	3.2e-11	1.16	0.8	Lung cancer;	chr6:149831772	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9377230	ENSG00000231760.4	RP11-350J20.5	10.77	3.55e-16	3.23e-11	1.1	0.8	Lung cancer;	chr6:149613607	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs1828187	ENSG00000253404.1	AC034243.1	10.76	3.66e-16	3.3e-11	0.93	0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138836531	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1039789	ENSG00000253404.1	AC034243.1	-10.76	3.66e-16	3.3e-11	-0.93	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138835734	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1039788	ENSG00000253404.1	AC034243.1	-10.76	3.66e-16	3.3e-11	-0.93	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138835812	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1828188	ENSG00000253404.1	AC034243.1	-10.76	3.66e-16	3.3e-11	-0.93	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138836307	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6421921	ENSG00000253404.1	AC034243.1	-10.76	3.68e-16	3.31e-11	-0.93	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831581	chr5:138744434~138753309:-
READ	cis	rs9322193	0.962	rs4870048	ENSG00000231760.4	RP11-350J20.5	10.75	3.88e-16	3.44e-11	1.17	0.8	Lung cancer;	chr6:149834324	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9800686	ENSG00000231760.4	RP11-350J20.5	10.74	3.94e-16	3.44e-11	1.09	0.8	Lung cancer;	chr6:149634464	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs55849538	ENSG00000231760.4	RP11-350J20.5	10.74	3.94e-16	3.44e-11	1.09	0.8	Lung cancer;	chr6:149635330	chr6:149796151~149826294:-
READ	cis	rs9322193	0.81	rs62439811	ENSG00000231760.4	RP11-350J20.5	10.74	3.94e-16	3.44e-11	1.09	0.8	Lung cancer;	chr6:149640416	chr6:149796151~149826294:-
READ	cis	rs2882667	0.619	rs6861556	ENSG00000253404.1	AC034243.1	-10.72	4.26e-16	3.56e-11	-0.97	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138852351	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs12529698	ENSG00000231760.4	RP11-350J20.5	10.69	4.87e-16	4.03e-11	1.05	0.8	Lung cancer;	chr6:149650951	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs6596456	ENSG00000253404.1	AC034243.1	-10.67	5.14e-16	4.24e-11	-0.92	-0.8	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831808	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs2342857	ENSG00000231760.4	RP11-350J20.5	10.64	5.94e-16	4.75e-11	1.09	0.79	Lung cancer;	chr6:149809537	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9478848	ENSG00000231760.4	RP11-350J20.5	10.64	6e-16	4.75e-11	1.16	0.79	Lung cancer;	chr6:149825080	chr6:149796151~149826294:-
READ	cis	rs9322193	1	rs9399693	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149612718	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9404048	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149616188	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9505982	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149618465	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322196	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149619645	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs10747275	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149622782	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9688794	ENSG00000231760.4	RP11-350J20.5	10.63	6.02e-16	4.75e-11	1.07	0.79	Lung cancer;	chr6:149632121	chr6:149796151~149826294:-
READ	cis	rs9322193	0.886	rs9718079	ENSG00000231760.4	RP11-350J20.5	10.57	7.71e-16	6.01e-11	1.1	0.79	Lung cancer;	chr6:149645947	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs2342764	ENSG00000231760.4	RP11-350J20.5	10.56	8.2e-16	6.36e-11	1.06	0.79	Lung cancer;	chr6:149835068	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs13177415	ENSG00000253404.1	AC034243.1	10.54	8.87e-16	6.87e-11	0.93	0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138914251	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs9689084	ENSG00000231760.4	RP11-350J20.5	10.53	8.96e-16	6.9e-11	1.06	0.79	Lung cancer;	chr6:149639648	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs288033	ENSG00000253404.1	AC034243.1	10.52	9.63e-16	7.4e-11	0.96	0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138878405	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs9767554	ENSG00000231760.4	RP11-350J20.5	10.51	9.71e-16	7.44e-11	1.05	0.79	Lung cancer;	chr6:149616860	chr6:149796151~149826294:-
READ	cis	rs2882667	0.654	rs700626	ENSG00000253404.1	AC034243.1	-10.49	1.06e-15	8.02e-11	-0.94	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138782249	chr5:138744434~138753309:-
READ	cis	rs916888	0.773	rs9896243	ENSG00000262539.1	RP11-259G18.3	10.49	1.06e-15	8.02e-11	1.32	0.79	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46748690	chr17:46259551~46260606:-
READ	cis	rs2882667	0.654	rs288019	ENSG00000253404.1	AC034243.1	-10.49	1.07e-15	8.06e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138855704	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700623	ENSG00000253404.1	AC034243.1	-10.49	1.08e-15	8.11e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762993	chr5:138744434~138753309:-
READ	cis	rs4853012	0.838	rs12619982	ENSG00000217702.2	RP11-287D1.4	10.47	1.16e-15	8.31e-11	1.05	0.79	Gestational age at birth (maternal effect);	chr2:74128895	chr2:74130583~74135395:+
READ	cis	rs4853012	0.838	rs72915068	ENSG00000217702.2	RP11-287D1.4	10.47	1.16e-15	8.31e-11	1.05	0.79	Gestational age at birth (maternal effect);	chr2:74129058	chr2:74130583~74135395:+
READ	cis	rs2882667	0.69	rs700629	ENSG00000253404.1	AC034243.1	-10.47	1.17e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138788305	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700624	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138763332	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700625	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138763908	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs2940595	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138765348	chr5:138744434~138753309:-
READ	cis	rs2882667	0.587	rs2174972	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138766229	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs851278	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138767577	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs2693963	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138770637	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1567313	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138775013	chr5:138744434~138753309:-
READ	cis	rs2882667	0.589	rs825770	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138779530	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825769	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138779666	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700627	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138783711	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825758	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138791288	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6596455	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831416	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs995177	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138833874	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs7710300	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138834793	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825748	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800378	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825746	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800930	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825762	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138801981	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825761	ENSG00000253404.1	AC034243.1	-10.46	1.2e-15	8.31e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138802318	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs1095374	ENSG00000253404.1	AC034243.1	-10.46	1.21e-15	8.31e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138759517	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700620	ENSG00000253404.1	AC034243.1	-10.46	1.21e-15	8.31e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762247	chr5:138744434~138753309:-
READ	cis	rs2882667	0.659	rs700621	ENSG00000253404.1	AC034243.1	-10.46	1.21e-15	8.31e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762741	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs1972072	ENSG00000253404.1	AC034243.1	-10.45	1.24e-15	8.5e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138849604	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825749	ENSG00000253404.1	AC034243.1	-10.44	1.31e-15	8.94e-11	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800232	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs9688452	ENSG00000231760.4	RP11-350J20.5	10.42	1.4e-15	9.5e-11	1.05	0.79	Lung cancer;	chr6:149658764	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs6873425	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138819556	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs884470	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138820236	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6860780	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138824367	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs4835705	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138827887	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6884198	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138828618	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs4835706	ENSG00000253404.1	AC034243.1	-10.41	1.44e-15	9.61e-11	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138829037	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs884469	ENSG00000253404.1	AC034243.1	-10.39	1.61e-15	1.06e-10	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138820270	chr5:138744434~138753309:-
READ	cis	rs2882667	0.722	rs2011462	ENSG00000253404.1	AC034243.1	-10.39	1.61e-15	1.06e-10	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138827083	chr5:138744434~138753309:-
READ	cis	rs9322193	0.961	rs4870144	ENSG00000231760.4	RP11-350J20.5	10.38	1.68e-15	1.11e-10	1.12	0.79	Lung cancer;	chr6:149575540	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs160404	ENSG00000253404.1	AC034243.1	10.36	1.82e-15	1.19e-10	0.96	0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748580	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6877187	ENSG00000253404.1	AC034243.1	-10.35	1.85e-15	1.2e-10	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138823655	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs3804199	ENSG00000253404.1	AC034243.1	-10.35	1.85e-15	1.2e-10	-0.93	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138826440	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs11749163	ENSG00000253404.1	AC034243.1	10.35	1.89e-15	1.23e-10	0.91	0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138926981	chr5:138744434~138753309:-
READ	cis	rs9326248	0.817	rs1242127	ENSG00000254851.1	RP11-109L13.1	10.34	1.97e-15	1.27e-10	1.1	0.79	Blood protein levels;	chr11:117205848	chr11:117135528~117138582:+
READ	cis	rs9322193	0.924	rs9322189	ENSG00000231760.4	RP11-350J20.5	10.31	2.22e-15	1.36e-10	1.12	0.79	Lung cancer;	chr6:149588797	chr6:149796151~149826294:-
READ	cis	rs4853012	0.941	rs4852329	ENSG00000217702.2	RP11-287D1.4	10.31	2.23e-15	1.36e-10	1.13	0.79	Gestational age at birth (maternal effect);	chr2:74127417	chr2:74130583~74135395:+
READ	cis	rs2882667	0.654	rs825760	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138804285	chr5:138744434~138753309:-
READ	cis	rs2882667	0.652	rs700622	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762862	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7722965	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138764766	chr5:138744434~138753309:-
READ	cis	rs2882667	0.587	rs825674	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138767031	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825677	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138769081	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1976562	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138774905	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825759	ENSG00000253404.1	AC034243.1	-10.31	2.23e-15	1.36e-10	-0.95	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138790250	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1651358	ENSG00000253404.1	AC034243.1	-10.3	2.25e-15	1.36e-10	-0.92	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138745318	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs160400	ENSG00000253404.1	AC034243.1	-10.3	2.3e-15	1.36e-10	-0.91	-0.79	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727330	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs664922	ENSG00000254851.1	RP11-109L13.1	-10.3	2.31e-15	1.36e-10	-1.13	-0.79	Blood protein levels;	chr11:117200179	chr11:117135528~117138582:+
READ	cis	rs9326248	1	rs664082	ENSG00000254851.1	RP11-109L13.1	-10.3	2.31e-15	1.36e-10	-1.13	-0.79	Blood protein levels;	chr11:117200354	chr11:117135528~117138582:+
READ	cis	rs4853012	0.838	rs4563249	ENSG00000217702.2	RP11-287D1.4	10.29	2.37e-15	1.36e-10	1.06	0.78	Gestational age at birth (maternal effect);	chr2:74126889	chr2:74130583~74135395:+
READ	cis	rs916888	0.773	rs199451	ENSG00000262539.1	RP11-259G18.3	10.28	2.43e-15	1.36e-10	1.22	0.78	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46724418	chr17:46259551~46260606:-
READ	cis	rs2882667	0.658	rs311592	ENSG00000253404.1	AC034243.1	10.28	2.5e-15	1.36e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138734506	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1627698	ENSG00000253404.1	AC034243.1	-10.28	2.5e-15	1.36e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138741777	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1725335	ENSG00000253404.1	AC034243.1	-10.28	2.5e-15	1.36e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138745541	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs160406	ENSG00000253404.1	AC034243.1	-10.27	2.52e-15	1.36e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748032	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs7946257	ENSG00000254851.1	RP11-109L13.1	-10.27	2.55e-15	1.36e-10	-1.09	-0.78	Blood protein levels;	chr11:117182449	chr11:117135528~117138582:+
READ	cis	rs9322193	0.962	rs7818	ENSG00000231760.4	RP11-350J20.5	10.27	2.6e-15	1.38e-10	1.07	0.78	Lung cancer;	chr6:149810956	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs17031	ENSG00000253404.1	AC034243.1	10.27	2.61e-15	1.39e-10	0.94	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138934853	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs1703211	ENSG00000253404.1	AC034243.1	-10.25	2.75e-15	1.45e-10	-0.9	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138740587	chr5:138744434~138753309:-
READ	cis	rs9322193	0.961	rs2064520	ENSG00000231760.4	RP11-350J20.5	10.24	2.87e-15	1.51e-10	1.11	0.78	Lung cancer;	chr6:149603650	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs55993747	ENSG00000231760.4	RP11-350J20.5	10.24	2.91e-15	1.52e-10	1.05	0.78	Lung cancer;	chr6:149622016	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs12191643	ENSG00000231760.4	RP11-350J20.5	10.24	2.91e-15	1.52e-10	1.05	0.78	Lung cancer;	chr6:149628912	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs1651032	ENSG00000253404.1	AC034243.1	-10.23	2.97e-15	1.52e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138743151	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288025	ENSG00000253404.1	AC034243.1	10.23	2.98e-15	1.52e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138887944	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288023	ENSG00000253404.1	AC034243.1	10.23	2.98e-15	1.52e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888359	chr5:138744434~138753309:-
READ	cis	rs2882667	0.599	rs288008	ENSG00000253404.1	AC034243.1	10.23	2.98e-15	1.52e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138893632	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs2662543	ENSG00000253404.1	AC034243.1	10.23	2.98e-15	1.52e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138898441	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs17207772	ENSG00000253404.1	AC034243.1	10.23	2.98e-15	1.52e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138906131	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6880786	ENSG00000253404.1	AC034243.1	-10.23	2.98e-15	1.52e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138845874	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs9327826	ENSG00000253404.1	AC034243.1	-10.23	2.98e-15	1.52e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846318	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825669	ENSG00000253404.1	AC034243.1	-10.23	2.98e-15	1.52e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138731258	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs906695	ENSG00000253404.1	AC034243.1	10.23	3.06e-15	1.56e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138803588	chr5:138744434~138753309:-
READ	cis	rs916888	0.687	rs199456	ENSG00000262539.1	RP11-259G18.3	10.22	3.14e-15	1.59e-10	1.24	0.78	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46720553	chr17:46259551~46260606:-
READ	cis	rs2882667	0.69	rs1703212	ENSG00000253404.1	AC034243.1	-10.21	3.21e-15	1.63e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138742863	chr5:138744434~138753309:-
READ	cis	rs2882667	0.659	rs311595	ENSG00000253404.1	AC034243.1	10.21	3.21e-15	1.63e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138736183	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs160401	ENSG00000253404.1	AC034243.1	-10.21	3.3e-15	1.67e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138725652	chr5:138744434~138753309:-
READ	cis	rs9322193	0.962	rs1889473	ENSG00000231760.4	RP11-350J20.5	10.2	3.44e-15	1.71e-10	1.11	0.78	Lung cancer;	chr6:149825485	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs6903998	ENSG00000231760.4	RP11-350J20.5	10.2	3.44e-15	1.71e-10	1.11	0.78	Lung cancer;	chr6:149831357	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs1984111	ENSG00000231760.4	RP11-350J20.5	10.2	3.44e-15	1.71e-10	1.11	0.78	Lung cancer;	chr6:149831720	chr6:149796151~149826294:-
READ	cis	rs2882667	0.587	rs288015	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138859528	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288013	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860128	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs176381	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138861042	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288011	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864250	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288010	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864340	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs495638	ENSG00000253404.1	AC034243.1	-10.19	3.47e-15	1.71e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138865253	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288042	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138867345	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288041	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138868322	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288039	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138870511	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288038	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138871844	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288031	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138880377	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288030	ENSG00000253404.1	AC034243.1	10.19	3.47e-15	1.71e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138880594	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7736925	ENSG00000253404.1	AC034243.1	-10.18	3.65e-15	1.78e-10	-0.95	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138818841	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs883333	ENSG00000253404.1	AC034243.1	-10.18	3.65e-15	1.78e-10	-0.95	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138819781	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7446631	ENSG00000253404.1	AC034243.1	10.15	4.13e-15	2e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138891376	chr5:138744434~138753309:-
READ	cis	rs2882667	0.659	rs12719515	ENSG00000253404.1	AC034243.1	10.15	4.13e-15	2e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138905629	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs13172507	ENSG00000253404.1	AC034243.1	10.15	4.13e-15	2e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138907409	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs12517514	ENSG00000253404.1	AC034243.1	-10.13	4.51e-15	2.09e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138814430	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs7107152	ENSG00000254851.1	RP11-109L13.1	10.12	4.61e-15	2.13e-10	1.09	0.78	Blood protein levels;	chr11:117185364	chr11:117135528~117138582:+
READ	cis	rs9326248	0.954	rs4938349	ENSG00000254851.1	RP11-109L13.1	-10.12	4.7e-15	2.17e-10	-1.09	-0.78	Blood protein levels;	chr11:117151207	chr11:117135528~117138582:+
READ	cis	rs2882667	0.69	rs288012	ENSG00000253404.1	AC034243.1	-10.12	4.73e-15	2.18e-10	-0.89	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860584	chr5:138744434~138753309:-
READ	cis	rs2882667	0.587	rs1848506	ENSG00000253404.1	AC034243.1	-10.11	4.79e-15	2.2e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846768	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1848505	ENSG00000253404.1	AC034243.1	-10.11	4.79e-15	2.2e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846841	chr5:138744434~138753309:-
READ	cis	rs2739330	0.929	rs5751775	ENSG00000218537.1	MIF-AS1	10.11	4.79e-15	2.2e-10	0.94	0.78	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23924539	chr22:23894426~23898930:-
READ	cis	rs9322193	0.651	rs9322188	ENSG00000231760.4	RP11-350J20.5	-10.11	4.84e-15	2.21e-10	-1.07	-0.78	Lung cancer;	chr6:149588355	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs288014	ENSG00000253404.1	AC034243.1	-10.11	4.85e-15	2.21e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860104	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs825754	ENSG00000253404.1	AC034243.1	-10.1	4.97e-15	2.24e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138796200	chr5:138744434~138753309:-
READ	cis	rs2882667	0.722	rs825751	ENSG00000253404.1	AC034243.1	-10.1	4.97e-15	2.24e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138798180	chr5:138744434~138753309:-
READ	cis	rs2882667	0.62	rs3789151	ENSG00000253404.1	AC034243.1	-10.1	4.97e-15	2.24e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138809771	chr5:138744434~138753309:-
READ	cis	rs2882667	0.722	rs4835649	ENSG00000253404.1	AC034243.1	-10.1	4.97e-15	2.24e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138810534	chr5:138744434~138753309:-
READ	cis	rs2882667	0.587	rs6596450	ENSG00000253404.1	AC034243.1	-10.1	4.97e-15	2.24e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138810831	chr5:138744434~138753309:-
READ	cis	rs9322193	0.887	rs4870139	ENSG00000231760.4	RP11-350J20.5	10.09	5.27e-15	2.35e-10	1.1	0.78	Lung cancer;	chr6:149575182	chr6:149796151~149826294:-
READ	cis	rs2882667	0.591	rs56322405	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138837693	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs4835707	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138838831	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6887841	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138840221	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs12656942	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138840769	chr5:138744434~138753309:-
READ	cis	rs2882667	0.686	rs62381196	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138841000	chr5:138744434~138753309:-
READ	cis	rs2882667	0.72	rs56044552	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138841265	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7710288	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844049	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1976568	ENSG00000253404.1	AC034243.1	-10.08	5.41e-15	2.38e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844627	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs2351247	ENSG00000253404.1	AC034243.1	-10.07	5.64e-15	2.47e-10	-0.95	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138849456	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs3763016	ENSG00000253404.1	AC034243.1	10.07	5.81e-15	2.53e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935043	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs4938354	ENSG00000254851.1	RP11-109L13.1	-10.05	6.26e-15	2.71e-10	-1.09	-0.78	Blood protein levels;	chr11:117180449	chr11:117135528~117138582:+
READ	cis	rs2882667	0.69	rs825672	ENSG00000253404.1	AC034243.1	-10.04	6.33e-15	2.73e-10	-0.93	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138759954	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs6872423	ENSG00000253404.1	AC034243.1	10.04	6.55e-15	2.81e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138911089	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs160403	ENSG00000253404.1	AC034243.1	10.02	7e-15	2.99e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138722793	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700616	ENSG00000253404.1	AC034243.1	-10.02	7.07e-15	3e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752184	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs700617	ENSG00000253404.1	AC034243.1	-10.02	7.07e-15	3e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752290	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs700618	ENSG00000253404.1	AC034243.1	-10.02	7.07e-15	3e-10	-0.92	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752429	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs160398	ENSG00000253404.1	AC034243.1	10.01	7.16e-15	3.03e-10	0.92	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727750	chr5:138744434~138753309:-
READ	cis	rs916888	0.773	rs199457	ENSG00000262539.1	RP11-259G18.3	10	7.55e-15	3.18e-10	1.23	0.78	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46718103	chr17:46259551~46260606:-
READ	cis	rs2882667	0.628	rs13171173	ENSG00000253404.1	AC034243.1	-10	7.57e-15	3.18e-10	-0.95	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138706775	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs11155670	ENSG00000231760.4	RP11-350J20.5	9.98	8.25e-15	3.46e-10	1.04	0.78	Lung cancer;	chr6:149644992	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs4835708	ENSG00000253404.1	AC034243.1	-9.98	8.28e-15	3.47e-10	-0.91	-0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844204	chr5:138744434~138753309:-
READ	cis	rs9322193	0.961	rs9767713	ENSG00000231760.4	RP11-350J20.5	9.98	8.34e-15	3.49e-10	1.09	0.78	Lung cancer;	chr6:149588241	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs274119	ENSG00000253404.1	AC034243.1	9.97	8.55e-15	3.54e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138728530	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs274118	ENSG00000253404.1	AC034243.1	9.97	8.55e-15	3.54e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138729198	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs274117	ENSG00000253404.1	AC034243.1	9.97	8.55e-15	3.54e-10	0.91	0.78	Age-related hearing impairment (SNP x SNP interaction);	chr5:138729359	chr5:138744434~138753309:-
READ	cis	rs4853012	0.941	rs78128123	ENSG00000217702.2	RP11-287D1.4	9.97	8.68e-15	3.59e-10	1.14	0.78	Gestational age at birth (maternal effect);	chr2:74120398	chr2:74130583~74135395:+
READ	cis	rs9322193	0.962	rs9322206	ENSG00000231760.4	RP11-350J20.5	9.96	8.78e-15	3.62e-10	1.09	0.77	Lung cancer;	chr6:149641481	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs9688750	ENSG00000231760.4	RP11-350J20.5	9.96	8.78e-15	3.62e-10	1.09	0.77	Lung cancer;	chr6:149657633	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs6890932	ENSG00000253404.1	AC034243.1	9.95	9.07e-15	3.74e-10	0.92	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138910639	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288018	ENSG00000253404.1	AC034243.1	-9.95	9.25e-15	3.76e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138856727	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288017	ENSG00000253404.1	AC034243.1	-9.95	9.25e-15	3.76e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138857826	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs167009	ENSG00000253404.1	AC034243.1	-9.95	9.25e-15	3.76e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864768	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288040	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138869205	chr5:138744434~138753309:-
READ	cis	rs2882667	0.659	rs288037	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138872752	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288036	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138875206	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288035	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138876728	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288032	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138879639	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288029	ENSG00000253404.1	AC034243.1	9.95	9.25e-15	3.76e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138881616	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs311597	ENSG00000253404.1	AC034243.1	9.95	9.32e-15	3.78e-10	0.92	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138720212	chr5:138744434~138753309:-
READ	cis	rs9326248	0.798	rs10892079	ENSG00000254851.1	RP11-109L13.1	-9.93	9.9e-15	3.98e-10	-1.08	-0.77	Blood protein levels;	chr11:117146108	chr11:117135528~117138582:+
READ	cis	rs2882667	0.69	rs288026	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138886905	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288024	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888103	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288009	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138892973	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs185956	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138894574	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10044401	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138901868	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10067361	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138905185	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs12186373	ENSG00000253404.1	AC034243.1	9.92	1.03e-14	4.08e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138912885	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288022	ENSG00000253404.1	AC034243.1	9.92	1.05e-14	4.13e-10	0.92	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888586	chr5:138744434~138753309:-
READ	cis	rs2882667	0.598	rs288020	ENSG00000253404.1	AC034243.1	9.92	1.05e-14	4.13e-10	0.92	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888609	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs664971	ENSG00000254851.1	RP11-109L13.1	9.9	1.11e-14	4.32e-10	1.04	0.77	Blood protein levels;	chr11:117200141	chr11:117135528~117138582:+
READ	cis	rs2882667	0.621	rs55901834	ENSG00000253404.1	AC034243.1	-9.9	1.12e-14	4.35e-10	-0.9	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844094	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs4835703	ENSG00000253404.1	AC034243.1	-9.9	1.14e-14	4.43e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138815048	chr5:138744434~138753309:-
READ	cis	rs2882667	0.654	rs7709770	ENSG00000253404.1	AC034243.1	-9.89	1.18e-14	4.57e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138813650	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs160402	ENSG00000253404.1	AC034243.1	9.88	1.21e-14	4.66e-10	0.92	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138723599	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288028	ENSG00000253404.1	AC034243.1	9.87	1.28e-14	4.93e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138886300	chr5:138744434~138753309:-
READ	cis	rs9322193	0.887	rs3777949	ENSG00000231760.4	RP11-350J20.5	9.85	1.38e-14	5.27e-10	1.09	0.77	Lung cancer;	chr6:149596021	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs700619	ENSG00000253404.1	AC034243.1	-9.81	1.59e-14	6.07e-10	-0.94	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138753060	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs585849	ENSG00000254851.1	RP11-109L13.1	-9.79	1.77e-14	6.74e-10	-1.11	-0.77	Blood protein levels;	chr11:117198345	chr11:117135528~117138582:+
READ	cis	rs2882667	0.628	rs3749663	ENSG00000253404.1	AC034243.1	9.78	1.84e-14	6.99e-10	0.89	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935498	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs9327830	ENSG00000253404.1	AC034243.1	9.77	1.87e-14	7.08e-10	0.9	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936560	chr5:138744434~138753309:-
READ	cis	rs916888	0.61	rs199529	ENSG00000262539.1	RP11-259G18.3	9.77	1.88e-14	7.13e-10	1.19	0.77	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46759851	chr17:46259551~46260606:-
READ	cis	rs9326248	1	rs3736120	ENSG00000254851.1	RP11-109L13.1	-9.77	1.93e-14	7.3e-10	-1.05	-0.77	Blood protein levels;	chr11:117161409	chr11:117135528~117138582:+
READ	cis	rs2882667	0.69	rs10071381	ENSG00000253404.1	AC034243.1	9.76	1.95e-14	7.36e-10	0.9	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138937159	chr5:138744434~138753309:-
READ	cis	rs2882667	0.728	rs13181830	ENSG00000253404.1	AC034243.1	-9.75	2.05e-14	7.69e-10	-0.89	-0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138944727	chr5:138744434~138753309:-
READ	cis	rs9322193	1	rs9322193	ENSG00000231760.4	RP11-350J20.5	9.74	2.12e-14	7.9e-10	1.09	0.77	Lung cancer;	chr6:149598007	chr6:149796151~149826294:-
READ	cis	rs9322193	1	rs9377229	ENSG00000231760.4	RP11-350J20.5	9.74	2.12e-14	7.9e-10	1.09	0.77	Lung cancer;	chr6:149607655	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9322197	ENSG00000231760.4	RP11-350J20.5	9.74	2.12e-14	7.9e-10	1.09	0.77	Lung cancer;	chr6:149622577	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9688858	ENSG00000231760.4	RP11-350J20.5	9.74	2.12e-14	7.9e-10	1.09	0.77	Lung cancer;	chr6:149637911	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs311601	ENSG00000253404.1	AC034243.1	9.74	2.12e-14	7.9e-10	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138717697	chr5:138744434~138753309:-
READ	cis	rs2739330	0.929	rs5751775	ENSG00000273295.1	AP000350.5	9.73	2.25e-14	8.36e-10	0.84	0.77	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23924539	chr22:23901432~23907068:-
READ	cis	rs9326248	0.911	rs474339	ENSG00000254851.1	RP11-109L13.1	-9.73	2.28e-14	8.47e-10	-1.02	-0.77	Blood protein levels;	chr11:117188836	chr11:117135528~117138582:+
READ	cis	rs916888	0.821	rs70600	ENSG00000262539.1	RP11-259G18.3	9.67	2.81e-14	1.04e-09	1.21	0.77	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782655	chr17:46259551~46260606:-
READ	cis	rs2882667	0.69	rs10045605	ENSG00000253404.1	AC034243.1	9.67	2.88e-14	1.06e-09	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936458	chr5:138744434~138753309:-
READ	cis	rs9322193	0.961	rs9285521	ENSG00000231760.4	RP11-350J20.5	9.66	2.94e-14	1.08e-09	1.06	0.77	Lung cancer;	chr6:149585576	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs11954103	ENSG00000253404.1	AC034243.1	9.66	3.02e-14	1.11e-09	0.94	0.77	Age-related hearing impairment (SNP x SNP interaction);	chr5:138933459	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288021	ENSG00000253404.1	AC034243.1	9.64	3.16e-14	1.12e-09	0.95	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888594	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs9942422	ENSG00000253404.1	AC034243.1	9.63	3.37e-14	1.19e-09	0.95	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936847	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10038162	ENSG00000253404.1	AC034243.1	-9.63	3.39e-14	1.2e-09	-0.91	-0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138901066	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs1059110	ENSG00000253404.1	AC034243.1	9.61	3.62e-14	1.26e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138930857	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs13178601	ENSG00000253404.1	AC034243.1	9.61	3.62e-14	1.26e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138931688	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7709789	ENSG00000253404.1	AC034243.1	9.58	4.15e-14	1.4e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138938762	chr5:138744434~138753309:-
READ	cis	rs9322193	0.887	rs11155662	ENSG00000231760.4	RP11-350J20.5	9.57	4.32e-14	1.45e-09	1.08	0.76	Lung cancer;	chr6:149592731	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs891996	ENSG00000253404.1	AC034243.1	9.56	4.49e-14	1.51e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138932127	chr5:138744434~138753309:-
READ	cis	rs916888	0.773	rs169201	ENSG00000262539.1	RP11-259G18.3	9.56	4.52e-14	1.52e-09	1.25	0.76	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46712837	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs199439	ENSG00000262539.1	RP11-259G18.3	9.56	4.52e-14	1.52e-09	1.25	0.76	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46716137	chr17:46259551~46260606:-
READ	cis	rs2882667	0.69	rs10068280	ENSG00000253404.1	AC034243.1	9.55	4.58e-14	1.53e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138931394	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs2016720	ENSG00000253404.1	AC034243.1	9.55	4.68e-14	1.56e-09	0.9	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138928369	chr5:138744434~138753309:-
READ	cis	rs2882667	0.728	rs10068766	ENSG00000253404.1	AC034243.1	9.55	4.68e-14	1.56e-09	0.9	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941095	chr5:138744434~138753309:-
READ	cis	rs2882667	0.728	rs10037071	ENSG00000253404.1	AC034243.1	9.52	5.13e-14	1.71e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138942158	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs9327831	ENSG00000253404.1	AC034243.1	9.52	5.29e-14	1.76e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936597	chr5:138744434~138753309:-
READ	cis	rs1577917	0.559	rs1173418	ENSG00000203875.9	SNHG5	9.51	5.43e-14	1.8e-09	0.99	0.76	Response to antipsychotic treatment;	chr6:85693198	chr6:85660950~85678736:-
READ	cis	rs2882667	0.654	rs6862845	ENSG00000253404.1	AC034243.1	9.49	5.86e-14	1.94e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138937456	chr5:138744434~138753309:-
READ	cis	rs2739330	0.828	rs4822454	ENSG00000218537.1	MIF-AS1	9.49	5.87e-14	1.94e-09	0.91	0.76	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23894426~23898930:-
READ	cis	rs2882667	0.654	rs10044432	ENSG00000253404.1	AC034243.1	9.42	7.76e-14	2.47e-09	0.93	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138939207	chr5:138744434~138753309:-
READ	cis	rs2882667	0.728	rs10068786	ENSG00000253404.1	AC034243.1	9.42	7.76e-14	2.47e-09	0.93	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941255	chr5:138744434~138753309:-
READ	cis	rs916888	0.773	rs1378358	ENSG00000262539.1	RP11-259G18.3	9.42	7.79e-14	2.47e-09	1.24	0.76	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46709946	chr17:46259551~46260606:-
READ	cis	rs916888	0.773	rs538628	ENSG00000262539.1	RP11-259G18.3	9.42	7.79e-14	2.47e-09	1.24	0.76	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46709947	chr17:46259551~46260606:-
READ	cis	rs2882667	0.659	rs10056014	ENSG00000253404.1	AC034243.1	9.42	8.01e-14	2.53e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920329	chr5:138744434~138753309:-
READ	cis	rs2882667	0.598	rs10078179	ENSG00000253404.1	AC034243.1	9.42	8.01e-14	2.53e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920410	chr5:138744434~138753309:-
READ	cis	rs2882667	0.728	rs7722413	ENSG00000253404.1	AC034243.1	9.41	8.04e-14	2.54e-09	0.88	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138942562	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs13158360	ENSG00000253404.1	AC034243.1	9.41	8.33e-14	2.59e-09	0.89	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138922488	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10155636	ENSG00000253404.1	AC034243.1	9.4	8.54e-14	2.65e-09	0.92	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138926301	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10463975	ENSG00000253404.1	AC034243.1	9.4	8.54e-14	2.65e-09	0.92	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138927560	chr5:138744434~138753309:-
READ	cis	rs4853012	0.838	rs4452177	ENSG00000217702.2	RP11-287D1.4	9.39	8.88e-14	2.75e-09	1.02	0.76	Gestational age at birth (maternal effect);	chr2:74118079	chr2:74130583~74135395:+
READ	cis	rs4853012	0.838	rs60705299	ENSG00000217702.2	RP11-287D1.4	9.39	8.88e-14	2.75e-09	1.02	0.76	Gestational age at birth (maternal effect);	chr2:74118243	chr2:74130583~74135395:+
READ	cis	rs2882667	0.69	rs13181762	ENSG00000253404.1	AC034243.1	9.39	8.9e-14	2.75e-09	0.91	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138914417	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288004	ENSG00000253404.1	AC034243.1	9.36	1.02e-13	3.15e-09	0.9	0.76	Age-related hearing impairment (SNP x SNP interaction);	chr5:138895956	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs7714455	ENSG00000253404.1	AC034243.1	-9.35	1.03e-13	3.16e-09	-0.9	-0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138818281	chr5:138744434~138753309:-
READ	cis	rs1577917	0.655	rs9342045	ENSG00000203875.9	SNHG5	9.34	1.08e-13	3.33e-09	0.98	0.75	Response to antipsychotic treatment;	chr6:85715430	chr6:85660950~85678736:-
READ	cis	rs2882667	0.69	rs423469	ENSG00000253404.1	AC034243.1	9.34	1.1e-13	3.38e-09	0.88	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138898427	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs2351463	ENSG00000253404.1	AC034243.1	9.33	1.14e-13	3.49e-09	0.89	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923113	chr5:138744434~138753309:-
READ	cis	rs2882667	0.658	rs10076442	ENSG00000253404.1	AC034243.1	9.32	1.19e-13	3.6e-09	0.88	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941090	chr5:138744434~138753309:-
READ	cis	rs9326248	1	rs9326248	ENSG00000254851.1	RP11-109L13.1	-9.3	1.28e-13	3.88e-09	-1.03	-0.75	Blood protein levels;	chr11:117128509	chr11:117135528~117138582:+
READ	cis	rs3814244	0.528	rs7962511	ENSG00000255733.4	IFNG-AS1	9.29	1.32e-13	3.97e-09	0.77	0.75	Itch intensity from mosquito bite adjusted by bite size;	chr12:68002854	chr12:67989445~68234686:+
READ	cis	rs2739330	0.828	rs2186366	ENSG00000218537.1	MIF-AS1	-9.29	1.34e-13	4.01e-09	-0.87	-0.75	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23894426~23898930:-
READ	cis	rs2882667	0.628	rs10076629	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920272	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10078079	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920450	chr5:138744434~138753309:-
READ	cis	rs2882667	0.659	rs11750067	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920589	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs10054682	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923754	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs11953339	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923853	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs9327828	ENSG00000253404.1	AC034243.1	9.29	1.34e-13	4.01e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138925859	chr5:138744434~138753309:-
READ	cis	rs9322193	0.887	rs3734295	ENSG00000231760.4	RP11-350J20.5	9.23	1.67e-13	4.94e-09	1.04	0.75	Lung cancer;	chr6:149593917	chr6:149796151~149826294:-
READ	cis	rs9322193	0.851	rs9322194	ENSG00000231760.4	RP11-350J20.5	9.23	1.67e-13	4.94e-09	1.04	0.75	Lung cancer;	chr6:149599113	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs9327827	ENSG00000253404.1	AC034243.1	9.22	1.75e-13	5.15e-09	0.9	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846639	chr5:138744434~138753309:-
READ	cis	rs9322193	0.847	rs880246	ENSG00000231760.4	RP11-350J20.5	9.2	1.9e-13	5.56e-09	0.99	0.75	Lung cancer;	chr6:149845972	chr6:149796151~149826294:-
READ	cis	rs2882667	0.658	rs288003	ENSG00000253404.1	AC034243.1	9.18	2.07e-13	6.03e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138896266	chr5:138744434~138753309:-
READ	cis	rs2882667	0.69	rs288002	ENSG00000253404.1	AC034243.1	9.18	2.07e-13	6.03e-09	0.93	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138896398	chr5:138744434~138753309:-
READ	cis	rs4853012	0.887	rs77148265	ENSG00000217702.2	RP11-287D1.4	9.18	2.11e-13	6.11e-09	1.05	0.75	Gestational age at birth (maternal effect);	chr2:74112392	chr2:74130583~74135395:+
READ	cis	rs4853012	0.941	rs2421752	ENSG00000217702.2	RP11-287D1.4	9.18	2.11e-13	6.11e-09	1.05	0.75	Gestational age at birth (maternal effect);	chr2:74114488	chr2:74130583~74135395:+
READ	cis	rs9322193	0.884	rs880245	ENSG00000231760.4	RP11-350J20.5	-9.17	2.14e-13	6.18e-09	-0.98	-0.75	Lung cancer;	chr6:149846262	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs1108889	ENSG00000231760.4	RP11-350J20.5	9.17	2.14e-13	6.18e-09	0.98	0.75	Lung cancer;	chr6:149845433	chr6:149796151~149826294:-
READ	cis	rs9326248	1	rs10790175	ENSG00000254851.1	RP11-109L13.1	-9.17	2.15e-13	6.19e-09	-1	-0.75	Blood protein levels;	chr11:117164013	chr11:117135528~117138582:+
READ	cis	rs2739330	0.828	rs5760108	ENSG00000218537.1	MIF-AS1	9.16	2.25e-13	6.45e-09	0.88	0.75	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910481	chr22:23894426~23898930:-
READ	cis	rs9322193	0.886	rs4039600	ENSG00000231760.4	RP11-350J20.5	9.16	2.27e-13	6.53e-09	1.09	0.75	Lung cancer;	chr6:149576319	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs13174008	ENSG00000253404.1	AC034243.1	9.11	2.76e-13	7.81e-09	0.88	0.75	Age-related hearing impairment (SNP x SNP interaction);	chr5:138922220	chr5:138744434~138753309:-
READ	cis	rs9322193	0.961	rs9027	ENSG00000231760.4	RP11-350J20.5	9.1	2.85e-13	8.07e-09	1.09	0.75	Lung cancer;	chr6:149594921	chr6:149796151~149826294:-
READ	cis	rs9322193	1	rs58189451	ENSG00000231760.4	RP11-350J20.5	9.08	3.19e-13	8.99e-09	1.07	0.75	Lung cancer;	chr6:149600252	chr6:149796151~149826294:-
READ	cis	rs2739330	0.828	rs4822454	ENSG00000273295.1	AP000350.5	9.07	3.24e-13	9.11e-09	0.8	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs5760098	ENSG00000218537.1	MIF-AS1	9.07	3.27e-13	9.19e-09	0.86	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906127	chr22:23894426~23898930:-
READ	cis	rs2739330	0.828	rs5760102	ENSG00000218537.1	MIF-AS1	9.07	3.27e-13	9.19e-09	0.86	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906574	chr22:23894426~23898930:-
READ	cis	rs9326248	0.911	rs11216284	ENSG00000254851.1	RP11-109L13.1	-9.06	3.41e-13	9.52e-09	-1.05	-0.74	Blood protein levels;	chr11:117132344	chr11:117135528~117138582:+
READ	cis	rs9326248	1	rs4938344	ENSG00000254851.1	RP11-109L13.1	-9.06	3.41e-13	9.52e-09	-1.05	-0.74	Blood protein levels;	chr11:117133033	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs9371207	ENSG00000231760.4	RP11-350J20.5	9.04	3.63e-13	1.01e-08	0.96	0.74	Lung cancer;	chr6:149858087	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs2880436	ENSG00000231760.4	RP11-350J20.5	9.04	3.63e-13	1.01e-08	0.96	0.74	Lung cancer;	chr6:149859123	chr6:149796151~149826294:-
READ	cis	rs9322193	0.772	rs7738696	ENSG00000231760.4	RP11-350J20.5	9.04	3.66e-13	1.01e-08	0.96	0.74	Lung cancer;	chr6:149848985	chr6:149796151~149826294:-
READ	cis	rs2739330	0.796	rs5760097	ENSG00000218537.1	MIF-AS1	9.04	3.73e-13	1.03e-08	0.87	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905607	chr22:23894426~23898930:-
READ	cis	rs9322193	0.884	rs9383864	ENSG00000231760.4	RP11-350J20.5	9.03	3.86e-13	1.07e-08	0.96	0.74	Lung cancer;	chr6:149851969	chr6:149796151~149826294:-
READ	cis	rs2739330	0.828	rs4820572	ENSG00000218537.1	MIF-AS1	9.02	4.04e-13	1.11e-08	0.87	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908168	chr22:23894426~23898930:-
READ	cis	rs801193	1	rs10234018	ENSG00000226824.5	RP4-756H11.3	8.99	4.49e-13	1.23e-08	0.85	0.74	Aortic root size;	chr7:66681297	chr7:66654538~66669855:+
READ	cis	rs9322193	0.81	rs4869923	ENSG00000231760.4	RP11-350J20.5	8.97	4.86e-13	1.33e-08	1.1	0.74	Lung cancer;	chr6:149553763	chr6:149796151~149826294:-
READ	cis	rs9322193	0.774	rs2144207	ENSG00000231760.4	RP11-350J20.5	8.97	4.86e-13	1.33e-08	1.1	0.74	Lung cancer;	chr6:149558971	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9397036	ENSG00000231760.4	RP11-350J20.5	8.96	5.16e-13	1.4e-08	0.95	0.74	Lung cancer;	chr6:149851787	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs9383865	ENSG00000231760.4	RP11-350J20.5	8.96	5.16e-13	1.4e-08	0.95	0.74	Lung cancer;	chr6:149852043	chr6:149796151~149826294:-
READ	cis	rs2882667	0.69	rs9327829	ENSG00000253404.1	AC034243.1	-8.93	5.81e-13	1.57e-08	-0.91	-0.74	Age-related hearing impairment (SNP x SNP interaction);	chr5:138925982	chr5:138744434~138753309:-
READ	cis	rs1577917	0.561	rs3087978	ENSG00000203875.9	SNHG5	8.92	6e-13	1.62e-08	0.96	0.74	Response to antipsychotic treatment;	chr6:85678505	chr6:85660950~85678736:-
READ	cis	rs2739330	0.828	rs2186366	ENSG00000273295.1	AP000350.5	-8.91	6.22e-13	1.65e-08	-0.77	-0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs4822451	ENSG00000218537.1	MIF-AS1	8.91	6.26e-13	1.66e-08	0.87	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905979	chr22:23894426~23898930:-
READ	cis	rs2739330	0.828	rs5760099	ENSG00000218537.1	MIF-AS1	8.91	6.26e-13	1.66e-08	0.87	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906227	chr22:23894426~23898930:-
READ	cis	rs9322193	0.884	rs7769115	ENSG00000231760.4	RP11-350J20.5	8.88	7.05e-13	1.86e-08	0.94	0.74	Lung cancer;	chr6:149848796	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs7744105	ENSG00000231760.4	RP11-350J20.5	8.88	7.05e-13	1.86e-08	0.94	0.74	Lung cancer;	chr6:149849308	chr6:149796151~149826294:-
READ	cis	rs9322193	0.884	rs7743823	ENSG00000231760.4	RP11-350J20.5	8.88	7.05e-13	1.86e-08	0.94	0.74	Lung cancer;	chr6:149849744	chr6:149796151~149826294:-
READ	cis	rs9322193	0.847	rs9498372	ENSG00000231760.4	RP11-350J20.5	8.87	7.27e-13	1.91e-08	1.08	0.74	Lung cancer;	chr6:149567128	chr6:149796151~149826294:-
READ	cis	rs916888	0.821	rs199512	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779986	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs199509	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781362	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs199507	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781489	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs199506	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781665	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs415430	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781778	chr17:46259551~46260606:-
READ	cis	rs916888	0.779	rs430685	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781782	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs199505	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782044	chr17:46259551~46260606:-
READ	cis	rs916888	0.821	rs70602	ENSG00000262539.1	RP11-259G18.3	-8.87	7.4e-13	1.93e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782349	chr17:46259551~46260606:-
READ	cis	rs2739330	0.789	rs5760109	ENSG00000218537.1	MIF-AS1	8.86	7.79e-13	2.03e-08	0.86	0.74	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910751	chr22:23894426~23898930:-
READ	cis	rs2882667	0.69	rs3749664	ENSG00000253404.1	AC034243.1	8.83	8.56e-13	2.21e-08	0.85	0.74	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935732	chr5:138744434~138753309:-
READ	cis	rs916888	0.697	rs199516	ENSG00000262539.1	RP11-259G18.3	-8.83	8.69e-13	2.24e-08	-1.08	-0.74	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779119	chr17:46259551~46260606:-
READ	cis	rs4853012	0.539	rs9789534	ENSG00000217702.2	RP11-287D1.4	8.82	9.21e-13	2.37e-08	1	0.74	Gestational age at birth (maternal effect);	chr2:74135863	chr2:74130583~74135395:+
READ	cis	rs4853012	0.775	rs12465641	ENSG00000217702.2	RP11-287D1.4	-8.79	1.02e-12	2.61e-08	-1.01	-0.73	Gestational age at birth (maternal effect);	chr2:74110588	chr2:74130583~74135395:+
READ	cis	rs12439619	0.693	rs9944185	ENSG00000278603.1	RP13-608F4.5	8.75	1.22e-12	3.1e-08	1.1	0.73	Intelligence (multi-trait analysis);	chr15:82157927	chr15:82472203~82472426:+
READ	cis	rs3814244	0.569	rs2051993	ENSG00000255733.4	IFNG-AS1	8.73	1.32e-12	3.34e-08	0.75	0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68019898	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs17104682	ENSG00000255733.4	IFNG-AS1	-8.73	1.32e-12	3.34e-08	-0.75	-0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68033256	chr12:67989445~68234686:+
READ	cis	rs9322193	0.847	rs868375	ENSG00000231760.4	RP11-350J20.5	8.7	1.49e-12	3.78e-08	0.97	0.73	Lung cancer;	chr6:149844905	chr6:149796151~149826294:-
READ	cis	rs916888	0.821	rs199514	ENSG00000262539.1	RP11-259G18.3	-8.69	1.53e-12	3.85e-08	-1.09	-0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779515	chr17:46259551~46260606:-
READ	cis	rs2882667	0.69	rs288007	ENSG00000253404.1	AC034243.1	8.67	1.71e-12	4.28e-08	0.91	0.73	Age-related hearing impairment (SNP x SNP interaction);	chr5:138894939	chr5:138744434~138753309:-
READ	cis	rs916888	0.773	rs199535	ENSG00000214401.4	KANSL1-AS1	8.64	1.9e-12	4.75e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46745296	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs199534	ENSG00000214401.4	KANSL1-AS1	8.64	1.9e-12	4.75e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46746847	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs199533	ENSG00000214401.4	KANSL1-AS1	8.64	1.9e-12	4.75e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46751565	chr17:46193576~46196723:+
READ	cis	rs3814244	0.528	rs10878723	ENSG00000255733.4	IFNG-AS1	8.61	2.18e-12	5.4e-08	0.76	0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68005493	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs12582272	ENSG00000255733.4	IFNG-AS1	8.61	2.18e-12	5.4e-08	0.76	0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68006298	chr12:67989445~68234686:+
READ	cis	rs9322193	0.886	rs4870055	ENSG00000231760.4	RP11-350J20.5	8.6	2.26e-12	5.6e-08	0.96	0.73	Lung cancer;	chr6:149848433	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs7769101	ENSG00000231760.4	RP11-350J20.5	8.6	2.26e-12	5.6e-08	0.96	0.73	Lung cancer;	chr6:149848768	chr6:149796151~149826294:-
READ	cis	rs2739330	0.796	rs5760106	ENSG00000218537.1	MIF-AS1	-8.59	2.3e-12	5.66e-08	-0.87	-0.73	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908458	chr22:23894426~23898930:-
READ	cis	rs3814244	0.528	rs11177002	ENSG00000255733.4	IFNG-AS1	8.59	2.37e-12	5.84e-08	0.76	0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68003377	chr12:67989445~68234686:+
READ	cis	rs2739330	0.828	rs4820572	ENSG00000273295.1	AP000350.5	8.59	2.37e-12	5.84e-08	0.77	0.73	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908168	chr22:23901432~23907068:-
READ	cis	rs4853012	0.838	rs60964317	ENSG00000217702.2	RP11-287D1.4	8.59	2.38e-12	5.84e-08	0.96	0.73	Gestational age at birth (maternal effect);	chr2:74116296	chr2:74130583~74135395:+
READ	cis	rs916888	0.773	rs199447	ENSG00000214401.4	KANSL1-AS1	8.58	2.47e-12	6.06e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46734822	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs199445	ENSG00000214401.4	KANSL1-AS1	8.58	2.47e-12	6.06e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46740042	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs199443	ENSG00000214401.4	KANSL1-AS1	8.58	2.47e-12	6.06e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46742199	chr17:46193576~46196723:+
READ	cis	rs3814244	0.528	rs7306466	ENSG00000255733.4	IFNG-AS1	8.58	2.48e-12	6.07e-08	0.75	0.73	Itch intensity from mosquito bite adjusted by bite size;	chr12:68014942	chr12:67989445~68234686:+
READ	cis	rs916888	0.779	rs199528	ENSG00000214401.4	KANSL1-AS1	8.57	2.56e-12	6.26e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46765770	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199525	ENSG00000214401.4	KANSL1-AS1	8.57	2.56e-12	6.26e-08	1.22	0.73	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46770468	chr17:46193576~46196723:+
READ	cis	rs4853012	0.838	rs61521879	ENSG00000217702.2	RP11-287D1.4	8.57	2.56e-12	6.26e-08	0.96	0.73	Gestational age at birth (maternal effect);	chr2:74119081	chr2:74130583~74135395:+
READ	cis	rs2739330	0.753	rs4822452	ENSG00000218537.1	MIF-AS1	8.55	2.71e-12	6.6e-08	0.84	0.73	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912176	chr22:23894426~23898930:-
READ	cis	rs3814244	0.569	rs11177008	ENSG00000255733.4	IFNG-AS1	8.54	2.88e-12	6.95e-08	0.74	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:68021024	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs12228471	ENSG00000255733.4	IFNG-AS1	8.54	2.88e-12	6.95e-08	0.74	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:68027842	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs56393928	ENSG00000255733.4	IFNG-AS1	8.54	2.88e-12	6.95e-08	0.74	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:68029927	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs2870960	ENSG00000255733.4	IFNG-AS1	8.54	2.88e-12	6.95e-08	0.74	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:68032848	chr12:67989445~68234686:+
READ	cis	rs4853012	0.838	rs6715351	ENSG00000217702.2	RP11-287D1.4	8.53	2.96e-12	7.16e-08	0.97	0.72	Gestational age at birth (maternal effect);	chr2:74118992	chr2:74130583~74135395:+
READ	cis	rs2739330	0.828	rs5751770	ENSG00000218537.1	MIF-AS1	8.53	3.04e-12	7.32e-08	0.85	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910655	chr22:23894426~23898930:-
READ	cis	rs9322193	0.923	rs2342765	ENSG00000231760.4	RP11-350J20.5	8.52	3.06e-12	7.36e-08	0.97	0.72	Lung cancer;	chr6:149858873	chr6:149796151~149826294:-
READ	cis	rs9326248	0.954	rs521171	ENSG00000254851.1	RP11-109L13.1	-8.52	3.17e-12	7.59e-08	-1.02	-0.72	Blood protein levels;	chr11:117193977	chr11:117135528~117138582:+
READ	cis	rs1577917	0.655	rs1059307	ENSG00000203875.9	SNHG5	8.51	3.25e-12	7.78e-08	0.96	0.72	Response to antipsychotic treatment;	chr6:85678170	chr6:85660950~85678736:-
READ	cis	rs2739330	0.796	rs5760106	ENSG00000273295.1	AP000350.5	-8.5	3.31e-12	7.92e-08	-0.78	-0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908458	chr22:23901432~23907068:-
READ	cis	rs916888	0.821	rs199504	ENSG00000262539.1	RP11-259G18.3	-8.5	3.38e-12	8.09e-08	-1.05	-0.72	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46783637	chr17:46259551~46260606:-
READ	cis	rs2739330	0.828	rs5760098	ENSG00000273295.1	AP000350.5	8.5	3.43e-12	8.15e-08	0.76	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906127	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs5760102	ENSG00000273295.1	AP000350.5	8.5	3.43e-12	8.15e-08	0.76	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906574	chr22:23901432~23907068:-
READ	cis	rs875971	0.66	rs801217	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66545590	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs801216	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66546680	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs801211	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66550702	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs801205	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66557157	chr7:66654538~66669855:+
READ	cis	rs875971	0.617	rs810400	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66557902	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs801193	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66565625	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs801192	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66566965	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs801190	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66568046	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs2013222	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66570949	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs3857686	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66571204	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs3898855	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66571411	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs10278816	ENSG00000226824.5	RP4-756H11.3	8.49	3.48e-12	8.15e-08	0.81	0.72	Aortic root size;	chr7:66572000	chr7:66654538~66669855:+
READ	cis	rs875971	0.619	rs12533585	ENSG00000226824.5	RP4-756H11.3	-8.49	3.48e-12	8.15e-08	-0.81	-0.72	Aortic root size;	chr7:66519618	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs12698534	ENSG00000226824.5	RP4-756H11.3	-8.49	3.48e-12	8.15e-08	-0.81	-0.72	Aortic root size;	chr7:66521858	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs28698552	ENSG00000226824.5	RP4-756H11.3	-8.49	3.48e-12	8.15e-08	-0.81	-0.72	Aortic root size;	chr7:66540031	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs62465434	ENSG00000226824.5	RP4-756H11.3	-8.49	3.48e-12	8.15e-08	-0.81	-0.72	Aortic root size;	chr7:66540165	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs13224319	ENSG00000226824.5	RP4-756H11.3	-8.49	3.48e-12	8.15e-08	-0.81	-0.72	Aortic root size;	chr7:66542376	chr7:66654538~66669855:+
READ	cis	rs916888	0.738	rs199515	ENSG00000262539.1	RP11-259G18.3	-8.49	3.56e-12	8.32e-08	-1.05	-0.72	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779275	chr17:46259551~46260606:-
READ	cis	rs2739330	0.828	rs2877178	ENSG00000218537.1	MIF-AS1	8.49	3.56e-12	8.32e-08	0.85	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909330	chr22:23894426~23898930:-
READ	cis	rs2739330	0.828	rs2154593	ENSG00000218537.1	MIF-AS1	8.49	3.56e-12	8.32e-08	0.85	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909898	chr22:23894426~23898930:-
READ	cis	rs3814244	0.528	rs61923060	ENSG00000255733.4	IFNG-AS1	8.47	3.85e-12	8.95e-08	0.76	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:67997341	chr12:67989445~68234686:+
READ	cis	rs4853012	0.838	rs4429500	ENSG00000217702.2	RP11-287D1.4	8.42	4.65e-12	1.07e-07	0.94	0.72	Gestational age at birth (maternal effect);	chr2:74118209	chr2:74130583~74135395:+
READ	cis	rs801193	0.967	rs34356500	ENSG00000226824.5	RP4-756H11.3	-8.4	5.05e-12	1.16e-07	-0.82	-0.72	Aortic root size;	chr7:66771620	chr7:66654538~66669855:+
READ	cis	rs801193	0.904	rs4718405	ENSG00000226824.5	RP4-756H11.3	-8.4	5.05e-12	1.16e-07	-0.82	-0.72	Aortic root size;	chr7:66789659	chr7:66654538~66669855:+
READ	cis	rs2739330	0.796	rs5760097	ENSG00000273295.1	AP000350.5	8.34	6.55e-12	1.49e-07	0.75	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905607	chr22:23901432~23907068:-
READ	cis	rs3814244	0.528	rs7952790	ENSG00000255733.4	IFNG-AS1	8.34	6.58e-12	1.49e-07	0.73	0.72	Itch intensity from mosquito bite adjusted by bite size;	chr12:68012672	chr12:67989445~68234686:+
READ	cis	rs2739330	0.627	rs9608219	ENSG00000218537.1	MIF-AS1	8.33	6.76e-12	1.5e-07	0.92	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23931932	chr22:23894426~23898930:-
READ	cis	rs2739330	0.627	rs9608219	ENSG00000273295.1	AP000350.5	8.33	6.86e-12	1.5e-07	0.83	0.72	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23931932	chr22:23901432~23907068:-
READ	cis	rs875971	0.66	rs1860468	ENSG00000226824.5	RP4-756H11.3	8.33	6.9e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66642265	chr7:66654538~66669855:+
READ	cis	rs875971	0.619	rs2302918	ENSG00000226824.5	RP4-756H11.3	-8.33	6.92e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66535945	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs3764903	ENSG00000226824.5	RP4-756H11.3	8.32	6.98e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66633495	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs1860470	ENSG00000226824.5	RP4-756H11.3	8.32	6.98e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66638707	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs6460305	ENSG00000226824.5	RP4-756H11.3	8.32	7e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66595421	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs10272357	ENSG00000226824.5	RP4-756H11.3	8.32	7e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66598087	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs79009421	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66603522	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs6960778	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66606610	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs6460308	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66619753	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs7807930	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66622178	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs7807944	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66622208	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs35986979	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66624003	chr7:66654538~66669855:+
READ	cis	rs875971	0.642	rs35526611	ENSG00000226824.5	RP4-756H11.3	8.32	7.01e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66629021	chr7:66654538~66669855:+
READ	cis	rs801193	0.967	rs2707841	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66692033	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2659912	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66693012	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2659909	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66695292	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2707836	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66695448	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs4717310	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66696020	chr7:66654538~66669855:+
READ	cis	rs801193	0.844	rs7779971	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66696803	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2659906	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66700323	chr7:66654538~66669855:+
READ	cis	rs801193	0.935	rs11772264	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66711400	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs7782320	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66712111	chr7:66654538~66669855:+
READ	cis	rs801193	0.935	rs2659899	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66721734	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs62466793	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66726530	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs62466794	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66726592	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs1553609	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66732152	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs1553610	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66732246	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2707845	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66733811	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2707850	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66738883	chr7:66654538~66669855:+
READ	cis	rs801193	0.967	rs1110414	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66740595	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs7783924	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66744070	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs7789184	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66745208	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2707856	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66746023	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2707854	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66747610	chr7:66654538~66669855:+
READ	cis	rs801193	0.967	rs2707853	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66749023	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2659889	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66752125	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs3800812	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66758474	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs4279493	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66761633	chr7:66654538~66669855:+
READ	cis	rs801193	0.761	rs2659888	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66765184	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs4717319	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66777606	chr7:66654538~66669855:+
READ	cis	rs801193	0.904	rs4718403	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66777742	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs3778909	ENSG00000226824.5	RP4-756H11.3	-8.32	7.11e-12	1.5e-07	-0.81	-0.72	Aortic root size;	chr7:66790659	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs7793569	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66651646	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs6975195	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66659787	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs3857688	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66662819	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2286684	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66664843	chr7:66654538~66669855:+
READ	cis	rs801193	0.935	rs2286683	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66664856	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2420824	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66666129	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs10274773	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66668591	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs7785213	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66673991	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs11773829	ENSG00000226824.5	RP4-756H11.3	8.32	7.11e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66676087	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs10281080	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66577454	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs10950044	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66577989	chr7:66654538~66669855:+
READ	cis	rs875971	0.638	rs10249404	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66581737	chr7:66654538~66669855:+
READ	cis	rs875971	0.619	rs10278371	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66586553	chr7:66654538~66669855:+
READ	cis	rs875971	0.66	rs10215132	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66589419	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs1968127	ENSG00000226824.5	RP4-756H11.3	8.32	7.12e-12	1.5e-07	0.81	0.72	Aortic root size;	chr7:66591816	chr7:66654538~66669855:+
READ	cis	rs2739330	0.789	rs5760109	ENSG00000273295.1	AP000350.5	8.3	7.67e-12	1.61e-07	0.75	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910751	chr22:23901432~23907068:-
READ	cis	rs916888	0.773	rs199448	ENSG00000214401.4	KANSL1-AS1	8.28	8.2e-12	1.72e-07	1.19	0.71	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46731635	chr17:46193576~46196723:+
READ	cis	rs8013143	1	rs11846575	ENSG00000279656.1	RP11-298I3.6	-8.27	8.58e-12	1.79e-07	-0.97	-0.71	Reticulocyte fraction of red cells;Reticulocyte count;Red cell distribution width;	chr14:23022075	chr14:23023083~23024217:-
READ	cis	rs2739330	0.791	rs4822458	ENSG00000273295.1	AP000350.5	8.26	9.05e-12	1.88e-07	0.84	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs2330635	ENSG00000218537.1	MIF-AS1	8.25	9.28e-12	1.93e-07	0.84	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909157	chr22:23894426~23898930:-
READ	cis	rs2739330	0.828	rs5760108	ENSG00000273295.1	AP000350.5	8.24	9.76e-12	2.03e-07	0.75	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910481	chr22:23901432~23907068:-
READ	cis	rs6952407	1	rs6952407	ENSG00000226824.5	RP4-756H11.3	8.21	1.1e-11	2.27e-07	0.81	0.71	Cotinine glucuronidation;	chr7:66580525	chr7:66654538~66669855:+
READ	cis	rs875971	0.54	rs35510581	ENSG00000226824.5	RP4-756H11.3	8.2	1.16e-11	2.4e-07	0.77	0.71	Aortic root size;	chr7:66113790	chr7:66654538~66669855:+
READ	cis	rs875971	0.577	rs35072105	ENSG00000226824.5	RP4-756H11.3	8.2	1.16e-11	2.4e-07	0.77	0.71	Aortic root size;	chr7:66144830	chr7:66654538~66669855:+
READ	cis	rs916888	0.61	rs199529	ENSG00000214401.4	KANSL1-AS1	8.19	1.21e-11	2.49e-07	1.18	0.71	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46759851	chr17:46193576~46196723:+
READ	cis	rs3814244	0.868	rs10878726	ENSG00000255733.4	IFNG-AS1	8.17	1.33e-11	2.74e-07	0.73	0.71	Itch intensity from mosquito bite adjusted by bite size;	chr12:68022865	chr12:67989445~68234686:+
READ	cis	rs2739330	0.828	rs5760107	ENSG00000218537.1	MIF-AS1	8.16	1.36e-11	2.8e-07	0.83	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910410	chr22:23894426~23898930:-
READ	cis	rs2739330	0.828	rs4822451	ENSG00000273295.1	AP000350.5	8.14	1.5e-11	3.07e-07	0.75	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905979	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs5760099	ENSG00000273295.1	AP000350.5	8.14	1.5e-11	3.07e-07	0.75	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906227	chr22:23901432~23907068:-
READ	cis	rs875971	0.66	rs10229345	ENSG00000226824.5	RP4-756H11.3	-8.14	1.51e-11	3.08e-07	-0.79	-0.71	Aortic root size;	chr7:66517181	chr7:66654538~66669855:+
READ	cis	rs2739330	0.76	rs1002286	ENSG00000273295.1	AP000350.5	-8.13	1.52e-11	3.12e-07	-0.81	-0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23901432~23907068:-
READ	cis	rs858239	0.602	rs6953996	ENSG00000230658.1	KLHL7-AS1	8.13	1.54e-11	3.14e-07	0.97	0.71	Cerebrospinal fluid biomarker levels;	chr7:23136327	chr7:23101228~23105703:-
READ	cis	rs2739330	0.703	rs5760112	ENSG00000273295.1	AP000350.5	8.12	1.61e-11	3.28e-07	0.81	0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23917585	chr22:23901432~23907068:-
READ	cis	rs62445005	1	rs62445005	ENSG00000211697.3	TRGV5	8.11	1.65e-11	3.36e-07	1	0.71	Shingles;	chr7:38346957	chr7:38343894~38350022:-
READ	cis	rs858239	0.601	rs7805206	ENSG00000230658.1	KLHL7-AS1	8.11	1.7e-11	3.45e-07	0.84	0.71	Cerebrospinal fluid biomarker levels;	chr7:23120591	chr7:23101228~23105703:-
READ	cis	rs9322193	0.923	rs4869750	ENSG00000231760.4	RP11-350J20.5	8.09	1.84e-11	3.72e-07	0.95	0.71	Lung cancer;	chr6:149855996	chr6:149796151~149826294:-
READ	cis	rs2739330	0.76	rs1002286	ENSG00000218537.1	MIF-AS1	-8.08	1.91e-11	3.86e-07	-0.9	-0.71	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23894426~23898930:-
READ	cis	rs801193	1	rs13239306	ENSG00000226824.5	RP4-756H11.3	8.08	1.92e-11	3.88e-07	0.83	0.71	Aortic root size;	chr7:66671030	chr7:66654538~66669855:+
READ	cis	rs2739330	0.703	rs5760112	ENSG00000218537.1	MIF-AS1	8.06	2.05e-11	4.12e-07	0.9	0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23917585	chr22:23894426~23898930:-
READ	cis	rs2739330	0.753	rs4822452	ENSG00000273295.1	AP000350.5	8.06	2.07e-11	4.16e-07	0.74	0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912176	chr22:23901432~23907068:-
READ	cis	rs2739330	0.796	rs2154594	ENSG00000218537.1	MIF-AS1	-8.05	2.16e-11	4.33e-07	-0.82	-0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911868	chr22:23894426~23898930:-
READ	cis	rs875971	0.577	rs34888281	ENSG00000226824.5	RP4-756H11.3	8.04	2.28e-11	4.53e-07	0.78	0.7	Aortic root size;	chr7:66120784	chr7:66654538~66669855:+
READ	cis	rs2739330	0.796	rs2154594	ENSG00000273295.1	AP000350.5	-8.03	2.31e-11	4.58e-07	-0.74	-0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911868	chr22:23901432~23907068:-
READ	cis	rs1930961	1	rs760555	ENSG00000100058.11	CRYBB2P1	8.03	2.34e-11	4.64e-07	1.46	0.7	Bipolar disorder with mood-incongruent psychosis;	chr22:25476870	chr22:25448105~25520854:+
READ	cis	rs2882667	0.964	rs11739351	ENSG00000253404.1	AC034243.1	8.03	2.36e-11	4.68e-07	0.87	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138976053	chr5:138744434~138753309:-
READ	cis	rs3814244	0.832	rs11177006	ENSG00000255733.4	IFNG-AS1	8.02	2.49e-11	4.92e-07	0.72	0.7	Itch intensity from mosquito bite adjusted by bite size;	chr12:68019317	chr12:67989445~68234686:+
READ	cis	rs11155671	0.53	rs1334510	ENSG00000216906.2	RP11-350J20.9	8.01	2.53e-11	4.99e-07	0.9	0.7	Testicular germ cell tumor;	chr6:149880043	chr6:149904243~149906418:+
READ	cis	rs858239	0.601	rs764534	ENSG00000230658.1	KLHL7-AS1	8.01	2.54e-11	5.01e-07	0.92	0.7	Cerebrospinal fluid biomarker levels;	chr7:23114316	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs2068459	ENSG00000230658.1	KLHL7-AS1	8.01	2.54e-11	5.01e-07	0.92	0.7	Cerebrospinal fluid biomarker levels;	chr7:23114694	chr7:23101228~23105703:-
READ	cis	rs875971	0.558	rs4433015	ENSG00000226824.5	RP4-756H11.3	8.01	2.55e-11	5.03e-07	0.78	0.7	Aortic root size;	chr7:66174736	chr7:66654538~66669855:+
READ	cis	rs801193	0.967	rs2420827	ENSG00000226824.5	RP4-756H11.3	7.98	2.89e-11	5.66e-07	0.78	0.7	Aortic root size;	chr7:66682114	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs10224327	ENSG00000230658.1	KLHL7-AS1	7.98	2.91e-11	5.68e-07	0.93	0.7	Cerebrospinal fluid biomarker levels;	chr7:23122201	chr7:23101228~23105703:-
READ	cis	rs801193	1	rs17566701	ENSG00000226824.5	RP4-756H11.3	-7.98	2.91e-11	5.69e-07	-0.78	-0.7	Aortic root size;	chr7:66728196	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2055682	ENSG00000226824.5	RP4-756H11.3	-7.98	2.91e-11	5.69e-07	-0.78	-0.7	Aortic root size;	chr7:66795302	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs12539331	ENSG00000230658.1	KLHL7-AS1	7.94	3.36e-11	6.53e-07	0.93	0.7	Cerebrospinal fluid biomarker levels;	chr7:23111711	chr7:23101228~23105703:-
READ	cis	rs2739330	0.828	rs2330635	ENSG00000273295.1	AP000350.5	7.94	3.44e-11	6.68e-07	0.74	0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909157	chr22:23901432~23907068:-
READ	cis	rs875971	0.66	rs10263935	ENSG00000226824.5	RP4-756H11.3	-7.91	3.85e-11	7.47e-07	-0.79	-0.7	Aortic root size;	chr7:66631041	chr7:66654538~66669855:+
READ	cis	rs916888	0.779	rs199526	ENSG00000262539.1	RP11-259G18.3	-7.91	3.87e-11	7.5e-07	-0.93	-0.7	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46770341	chr17:46259551~46260606:-
READ	cis	rs2739330	0.731	rs2000468	ENSG00000273295.1	AP000350.5	7.89	4.23e-11	8.19e-07	0.8	0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23901432~23907068:-
READ	cis	rs875971	0.666	rs13242072	ENSG00000226824.5	RP4-756H11.3	7.89	4.23e-11	8.19e-07	0.79	0.7	Aortic root size;	chr7:66301001	chr7:66654538~66669855:+
READ	cis	rs9322193	0.847	rs4870054	ENSG00000231760.4	RP11-350J20.5	7.88	4.38e-11	8.48e-07	0.93	0.7	Lung cancer;	chr6:149848402	chr6:149796151~149826294:-
READ	cis	rs3814244	0.868	rs11177007	ENSG00000255733.4	IFNG-AS1	7.87	4.58e-11	8.84e-07	0.72	0.7	Itch intensity from mosquito bite adjusted by bite size;	chr12:68020964	chr12:67989445~68234686:+
READ	cis	rs2739330	0.76	rs1007888	ENSG00000273295.1	AP000350.5	7.86	4.71e-11	9.09e-07	0.79	0.7	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23901432~23907068:-
READ	cis	rs801193	0.935	rs2659916	ENSG00000226824.5	RP4-756H11.3	-7.86	4.81e-11	9.22e-07	-0.8	-0.7	Aortic root size;	chr7:66686365	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs6958520	ENSG00000226824.5	RP4-756H11.3	-7.86	4.81e-11	9.22e-07	-0.8	-0.7	Aortic root size;	chr7:66686466	chr7:66654538~66669855:+
READ	cis	rs801193	0.967	rs2707849	ENSG00000226824.5	RP4-756H11.3	-7.86	4.81e-11	9.22e-07	-0.8	-0.7	Aortic root size;	chr7:66687725	chr7:66654538~66669855:+
READ	cis	rs801193	0.935	rs3800820	ENSG00000226824.5	RP4-756H11.3	7.86	4.81e-11	9.22e-07	0.8	0.7	Aortic root size;	chr7:66682191	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs2003301	ENSG00000226824.5	RP4-756H11.3	7.86	4.81e-11	9.22e-07	0.8	0.7	Aortic root size;	chr7:66682669	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs7788576	ENSG00000226824.5	RP4-756H11.3	7.86	4.81e-11	9.22e-07	0.8	0.7	Aortic root size;	chr7:66683315	chr7:66654538~66669855:+
READ	cis	rs2739330	0.76	rs5760095	ENSG00000218537.1	MIF-AS1	7.85	4.9e-11	9.39e-07	0.87	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905106	chr22:23894426~23898930:-
READ	cis	rs2739330	0.76	rs5760095	ENSG00000273295.1	AP000350.5	7.84	5.04e-11	9.64e-07	0.79	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905106	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs5751770	ENSG00000273295.1	AP000350.5	7.84	5.11e-11	9.77e-07	0.74	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910655	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs2877178	ENSG00000273295.1	AP000350.5	7.84	5.14e-11	9.82e-07	0.74	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909330	chr22:23901432~23907068:-
READ	cis	rs2739330	0.828	rs2154593	ENSG00000273295.1	AP000350.5	7.84	5.14e-11	9.82e-07	0.74	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909898	chr22:23901432~23907068:-
READ	cis	rs858239	0.601	rs6980224	ENSG00000230658.1	KLHL7-AS1	7.84	5.2e-11	9.94e-07	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23109518	chr7:23101228~23105703:-
READ	cis	rs2739330	0.828	rs5760107	ENSG00000273295.1	AP000350.5	7.83	5.28e-11	1.01e-06	0.73	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910410	chr22:23901432~23907068:-
READ	cis	rs2739330	0.791	rs4822458	ENSG00000218537.1	MIF-AS1	7.83	5.29e-11	1.01e-06	0.91	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23894426~23898930:-
READ	cis	rs3814244	0.528	rs2906854	ENSG00000255733.4	IFNG-AS1	-7.83	5.36e-11	1.02e-06	-0.71	-0.69	Itch intensity from mosquito bite adjusted by bite size;	chr12:67993566	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs1468487	ENSG00000255733.4	IFNG-AS1	-7.83	5.36e-11	1.02e-06	-0.71	-0.69	Itch intensity from mosquito bite adjusted by bite size;	chr12:67996602	chr12:67989445~68234686:+
READ	cis	rs3814244	0.528	rs2860609	ENSG00000255733.4	IFNG-AS1	-7.83	5.36e-11	1.02e-06	-0.71	-0.69	Itch intensity from mosquito bite adjusted by bite size;	chr12:67997215	chr12:67989445~68234686:+
READ	cis	rs858239	0.57	rs10271613	ENSG00000230658.1	KLHL7-AS1	7.82	5.63e-11	1.07e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23122967	chr7:23101228~23105703:-
READ	cis	rs858239	0.57	rs10242166	ENSG00000230658.1	KLHL7-AS1	7.82	5.63e-11	1.07e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23123180	chr7:23101228~23105703:-
READ	cis	rs2739330	0.731	rs2000468	ENSG00000218537.1	MIF-AS1	7.81	5.68e-11	1.08e-06	0.88	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23894426~23898930:-
READ	cis	rs858239	0.601	rs929507	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23127045	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs929508	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23127090	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs4599714	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23129182	chr7:23101228~23105703:-
READ	cis	rs858239	0.541	rs4624924	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23129224	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs10278776	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23130140	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs3735228	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23130808	chr7:23101228~23105703:-
READ	cis	rs858239	0.632	rs13438452	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23134563	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs6948469	ENSG00000230658.1	KLHL7-AS1	7.81	5.84e-11	1.1e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23135147	chr7:23101228~23105703:-
READ	cis	rs858239	0.57	rs6968242	ENSG00000230658.1	KLHL7-AS1	7.8	5.93e-11	1.12e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23127792	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs1981665	ENSG00000230658.1	KLHL7-AS1	7.8	5.93e-11	1.12e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23128350	chr7:23101228~23105703:-
READ	cis	rs1577917	0.839	rs6454492	ENSG00000203875.9	SNHG5	-7.79	6.36e-11	1.19e-06	-0.93	-0.69	Response to antipsychotic treatment;	chr6:85773496	chr6:85660950~85678736:-
READ	cis	rs1577917	0.727	rs9344539	ENSG00000203875.9	SNHG5	-7.78	6.58e-11	1.23e-06	-0.92	-0.69	Response to antipsychotic treatment;	chr6:85643903	chr6:85660950~85678736:-
READ	cis	rs1577917	0.771	rs9362232	ENSG00000203875.9	SNHG5	-7.78	6.58e-11	1.23e-06	-0.92	-0.69	Response to antipsychotic treatment;	chr6:85643904	chr6:85660950~85678736:-
READ	cis	rs2739330	0.76	rs1007888	ENSG00000218537.1	MIF-AS1	7.78	6.62e-11	1.23e-06	0.87	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23894426~23898930:-
READ	cis	rs858239	0.601	rs1558313	ENSG00000230658.1	KLHL7-AS1	7.77	6.82e-11	1.26e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23116460	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs6962526	ENSG00000230658.1	KLHL7-AS1	7.77	6.82e-11	1.26e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23118614	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6971673	ENSG00000230658.1	KLHL7-AS1	7.77	6.82e-11	1.26e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23119904	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs10278700	ENSG00000230658.1	KLHL7-AS1	7.77	6.82e-11	1.26e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23120910	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs10263110	ENSG00000230658.1	KLHL7-AS1	7.77	6.82e-11	1.26e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23120932	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs73272053	ENSG00000230658.1	KLHL7-AS1	7.77	6.86e-11	1.27e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23115906	chr7:23101228~23105703:-
READ	cis	rs801193	0.773	rs801207	ENSG00000226824.5	RP4-756H11.3	7.77	6.88e-11	1.27e-06	0.79	0.69	Aortic root size;	chr7:66555603	chr7:66654538~66669855:+
READ	cis	rs875971	0.543	rs801191	ENSG00000226824.5	RP4-756H11.3	7.77	6.88e-11	1.27e-06	0.79	0.69	Aortic root size;	chr7:66567968	chr7:66654538~66669855:+
READ	cis	rs801193	0.844	rs732465	ENSG00000226824.5	RP4-756H11.3	-7.77	6.88e-11	1.27e-06	-0.79	-0.69	Aortic root size;	chr7:66533463	chr7:66654538~66669855:+
READ	cis	rs858239	0.6	rs7787110	ENSG00000230658.1	KLHL7-AS1	7.76	7.11e-11	1.31e-06	0.86	0.69	Cerebrospinal fluid biomarker levels;	chr7:23098855	chr7:23101228~23105703:-
READ	cis	rs1577917	0.655	rs9450311	ENSG00000203875.9	SNHG5	7.75	7.48e-11	1.37e-06	0.93	0.69	Response to antipsychotic treatment;	chr6:85666868	chr6:85660950~85678736:-
READ	cis	rs3814244	1	rs3814244	ENSG00000255733.4	IFNG-AS1	-7.75	7.54e-11	1.38e-06	-0.74	-0.69	Itch intensity from mosquito bite adjusted by bite size;	chr12:68019691	chr12:67989445~68234686:+
READ	cis	rs858239	0.601	rs1034963	ENSG00000230658.1	KLHL7-AS1	7.74	7.63e-11	1.4e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23108854	chr7:23101228~23105703:-
READ	cis	rs858239	0.57	rs10235467	ENSG00000230658.1	KLHL7-AS1	7.74	7.63e-11	1.4e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23109189	chr7:23101228~23105703:-
READ	cis	rs801193	0.967	rs3800823	ENSG00000226824.5	RP4-756H11.3	7.74	7.64e-11	1.4e-06	0.78	0.69	Aortic root size;	chr7:66682123	chr7:66654538~66669855:+
READ	cis	rs2739330	0.731	rs4822450	ENSG00000273295.1	AP000350.5	7.71	8.66e-11	1.58e-06	0.78	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900700	chr22:23901432~23907068:-
READ	cis	rs858239	0.601	rs73272048	ENSG00000230658.1	KLHL7-AS1	7.7	9.25e-11	1.68e-06	0.9	0.69	Cerebrospinal fluid biomarker levels;	chr7:23113034	chr7:23101228~23105703:-
READ	cis	rs875971	0.628	rs6974355	ENSG00000226824.5	RP4-756H11.3	-7.7	9.26e-11	1.68e-06	-0.78	-0.69	Aortic root size;	chr7:66376994	chr7:66654538~66669855:+
READ	cis	rs875971	0.706	rs1643374	ENSG00000226824.5	RP4-756H11.3	-7.7	9.26e-11	1.68e-06	-0.78	-0.69	Aortic root size;	chr7:66407695	chr7:66654538~66669855:+
READ	cis	rs916888	0.821	rs70600	ENSG00000214401.4	KANSL1-AS1	7.69	9.55e-11	1.73e-06	1.17	0.69	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782655	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199513	ENSG00000262539.1	RP11-259G18.3	-7.68	9.84e-11	1.78e-06	-1	-0.69	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779566	chr17:46259551~46260606:-
READ	cis	rs3814244	0.54	rs2159064	ENSG00000255733.4	IFNG-AS1	-7.67	1.04e-10	1.88e-06	-0.71	-0.69	Itch intensity from mosquito bite adjusted by bite size;	chr12:68017126	chr12:67989445~68234686:+
READ	cis	rs858239	0.601	rs987257	ENSG00000230658.1	KLHL7-AS1	7.67	1.04e-10	1.89e-06	0.91	0.69	Cerebrospinal fluid biomarker levels;	chr7:23108221	chr7:23101228~23105703:-
READ	cis	rs7208859	0.673	rs9915139	ENSG00000263531.1	RP13-753N3.1	7.66	1.07e-10	1.93e-06	1.17	0.69	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30831497	chr17:30863921~30864940:-
READ	cis	rs858239	0.601	rs10255228	ENSG00000230658.1	KLHL7-AS1	7.65	1.11e-10	2e-06	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23119244	chr7:23101228~23105703:-
READ	cis	rs2739330	0.76	rs5751760	ENSG00000273295.1	AP000350.5	7.64	1.19e-10	2.14e-06	0.78	0.68	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901386	chr22:23901432~23907068:-
READ	cis	rs875971	0.522	rs1880556	ENSG00000226824.5	RP4-756H11.3	-7.63	1.21e-10	2.17e-06	-0.76	-0.68	Aortic root size;	chr7:65967557	chr7:66654538~66669855:+
READ	cis	rs17711722	0.727	rs1880555	ENSG00000226824.5	RP4-756H11.3	-7.63	1.21e-10	2.17e-06	-0.76	-0.68	Calcium levels;	chr7:65967580	chr7:66654538~66669855:+
READ	cis	rs17711722	0.701	rs781143	ENSG00000226824.5	RP4-756H11.3	-7.63	1.21e-10	2.17e-06	-0.76	-0.68	Calcium levels;	chr7:65974892	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs781144	ENSG00000226824.5	RP4-756H11.3	-7.63	1.21e-10	2.17e-06	-0.76	-0.68	Aortic root size;	chr7:65975357	chr7:66654538~66669855:+
READ	cis	rs17711722	0.701	rs781145	ENSG00000226824.5	RP4-756H11.3	-7.63	1.21e-10	2.17e-06	-0.76	-0.68	Calcium levels;	chr7:65975383	chr7:66654538~66669855:+
READ	cis	rs17711722	0.74	rs7809991	ENSG00000226824.5	RP4-756H11.3	-7.63	1.23e-10	2.2e-06	-0.76	-0.68	Calcium levels;	chr7:65941231	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs6960048	ENSG00000226824.5	RP4-756H11.3	-7.63	1.23e-10	2.2e-06	-0.76	-0.68	Aortic root size;	chr7:65943052	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs6971002	ENSG00000230658.1	KLHL7-AS1	7.62	1.25e-10	2.22e-06	0.89	0.68	Cerebrospinal fluid biomarker levels;	chr7:23132685	chr7:23101228~23105703:-
READ	cis	rs11763147	1	rs11763147	ENSG00000226824.5	RP4-756H11.3	7.62	1.26e-10	2.23e-06	0.76	0.68	Corneal structure;	chr7:65861834	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs10807697	ENSG00000226824.5	RP4-756H11.3	-7.62	1.26e-10	2.23e-06	-0.76	-0.68	Aortic root size;	chr7:65951183	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs2008188	ENSG00000226824.5	RP4-756H11.3	-7.62	1.26e-10	2.23e-06	-0.76	-0.68	Aortic root size;	chr7:65964026	chr7:66654538~66669855:+
READ	cis	rs875971	0.505	rs6955582	ENSG00000226824.5	RP4-756H11.3	-7.62	1.26e-10	2.23e-06	-0.76	-0.68	Aortic root size;	chr7:65966699	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs9530	ENSG00000226824.5	RP4-756H11.3	-7.62	1.26e-10	2.23e-06	-0.76	-0.68	Aortic root size;	chr7:65960907	chr7:66654538~66669855:+
READ	cis	rs11155671	0.53	rs6557133	ENSG00000216906.2	RP11-350J20.9	7.61	1.33e-10	2.35e-06	0.89	0.68	Testicular germ cell tumor;	chr6:149874248	chr6:149904243~149906418:+
READ	cis	rs2882667	1	rs10515505	ENSG00000253404.1	AC034243.1	7.61	1.34e-10	2.38e-06	0.84	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138977457	chr5:138744434~138753309:-
READ	cis	rs875971	0.508	rs6947808	ENSG00000226824.5	RP4-756H11.3	7.57	1.54e-10	2.72e-06	0.79	0.68	Aortic root size;	chr7:66580095	chr7:66654538~66669855:+
READ	cis	rs2882667	0.858	rs7724108	ENSG00000253404.1	AC034243.1	-7.57	1.57e-10	2.77e-06	-0.83	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:139075233	chr5:138744434~138753309:-
READ	cis	rs875971	0.508	rs10950045	ENSG00000226824.5	RP4-756H11.3	7.56	1.61e-10	2.81e-06	0.79	0.68	Aortic root size;	chr7:66601386	chr7:66654538~66669855:+
READ	cis	rs801193	0.839	rs6968619	ENSG00000226824.5	RP4-756H11.3	7.56	1.61e-10	2.81e-06	0.79	0.68	Aortic root size;	chr7:66603880	chr7:66654538~66669855:+
READ	cis	rs801193	0.839	rs12534943	ENSG00000226824.5	RP4-756H11.3	7.56	1.61e-10	2.81e-06	0.79	0.68	Aortic root size;	chr7:66605533	chr7:66654538~66669855:+
READ	cis	rs801193	0.805	rs12532355	ENSG00000226824.5	RP4-756H11.3	7.56	1.61e-10	2.81e-06	0.79	0.68	Aortic root size;	chr7:66605597	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs2141307	ENSG00000230658.1	KLHL7-AS1	7.56	1.62e-10	2.82e-06	0.89	0.68	Cerebrospinal fluid biomarker levels;	chr7:23151805	chr7:23101228~23105703:-
READ	cis	rs875971	0.508	rs10242423	ENSG00000226824.5	RP4-756H11.3	7.56	1.62e-10	2.83e-06	0.79	0.68	Aortic root size;	chr7:66594188	chr7:66654538~66669855:+
READ	cis	rs875971	0.508	rs10253883	ENSG00000226824.5	RP4-756H11.3	7.56	1.62e-10	2.83e-06	0.79	0.68	Aortic root size;	chr7:66596151	chr7:66654538~66669855:+
READ	cis	rs875971	0.508	rs10258739	ENSG00000226824.5	RP4-756H11.3	7.56	1.62e-10	2.83e-06	0.79	0.68	Aortic root size;	chr7:66597948	chr7:66654538~66669855:+
READ	cis	rs1577917	0.629	rs6927475	ENSG00000203875.9	SNHG5	7.55	1.69e-10	2.93e-06	0.91	0.68	Response to antipsychotic treatment;	chr6:85497055	chr6:85660950~85678736:-
READ	cis	rs1577917	0.629	rs9450285	ENSG00000203875.9	SNHG5	7.55	1.69e-10	2.93e-06	0.91	0.68	Response to antipsychotic treatment;	chr6:85498378	chr6:85660950~85678736:-
READ	cis	rs11155671	0.53	rs4870080	ENSG00000216906.2	RP11-350J20.9	7.55	1.69e-10	2.93e-06	0.87	0.68	Testicular germ cell tumor;	chr6:149881508	chr6:149904243~149906418:+
READ	cis	rs858239	0.601	rs11982002	ENSG00000230658.1	KLHL7-AS1	7.54	1.74e-10	3.01e-06	0.88	0.68	Cerebrospinal fluid biomarker levels;	chr7:23123651	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs15775	ENSG00000230658.1	KLHL7-AS1	7.54	1.74e-10	3.01e-06	0.88	0.68	Cerebrospinal fluid biomarker levels;	chr7:23125082	chr7:23101228~23105703:-
READ	cis	rs2906856	0.848	rs3015001	ENSG00000255733.4	IFNG-AS1	-7.54	1.78e-10	3.06e-06	-0.7	-0.68	Mosquito bite size;	chr12:68003593	chr12:67989445~68234686:+
READ	cis	rs1577917	0.655	rs9444352	ENSG00000203875.9	SNHG5	7.53	1.82e-10	3.12e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85547817	chr6:85660950~85678736:-
READ	cis	rs875971	0.522	rs1917563	ENSG00000226824.5	RP4-756H11.3	7.53	1.84e-10	3.16e-06	0.76	0.68	Aortic root size;	chr7:65950660	chr7:66654538~66669855:+
READ	cis	rs2739330	0.731	rs4822450	ENSG00000218537.1	MIF-AS1	7.52	1.92e-10	3.29e-06	0.86	0.68	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900700	chr22:23894426~23898930:-
READ	cis	rs858239	0.665	rs6964665	ENSG00000230658.1	KLHL7-AS1	7.52	1.95e-10	3.33e-06	0.89	0.68	Cerebrospinal fluid biomarker levels;	chr7:23171733	chr7:23101228~23105703:-
READ	cis	rs858239	0.699	rs858260	ENSG00000230658.1	KLHL7-AS1	7.52	1.95e-10	3.33e-06	0.89	0.68	Cerebrospinal fluid biomarker levels;	chr7:23173315	chr7:23101228~23105703:-
READ	cis	rs916888	0.602	rs199508	ENSG00000262539.1	RP11-259G18.3	-7.51	1.97e-10	3.35e-06	-0.98	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781472	chr17:46259551~46260606:-
READ	cis	rs801193	0.844	rs2244022	ENSG00000226824.5	RP4-756H11.3	-7.51	2e-10	3.41e-06	-0.78	-0.68	Aortic root size;	chr7:66737443	chr7:66654538~66669855:+
READ	cis	rs1577917	0.655	rs12203963	ENSG00000203875.9	SNHG5	7.5	2.08e-10	3.53e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85513598	chr6:85660950~85678736:-
READ	cis	rs858239	0.6	rs2072368	ENSG00000230658.1	KLHL7-AS1	7.49	2.16e-10	3.66e-06	0.88	0.68	Cerebrospinal fluid biomarker levels;	chr7:23106493	chr7:23101228~23105703:-
READ	cis	rs1577917	0.816	rs1838952	ENSG00000203875.9	SNHG5	-7.49	2.18e-10	3.68e-06	-0.89	-0.68	Response to antipsychotic treatment;	chr6:85891426	chr6:85660950~85678736:-
READ	cis	rs1577917	0.883	rs13212415	ENSG00000203875.9	SNHG5	-7.49	2.18e-10	3.68e-06	-0.89	-0.68	Response to antipsychotic treatment;	chr6:85898365	chr6:85660950~85678736:-
READ	cis	rs1577917	0.633	rs7770835	ENSG00000203875.9	SNHG5	-7.49	2.18e-10	3.68e-06	-0.89	-0.68	Response to antipsychotic treatment;	chr6:85899189	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs1447159	ENSG00000203875.9	SNHG5	-7.49	2.18e-10	3.68e-06	-0.89	-0.68	Response to antipsychotic treatment;	chr6:85899531	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs6454472	ENSG00000203875.9	SNHG5	7.49	2.2e-10	3.72e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85514335	chr6:85660950~85678736:-
READ	cis	rs1577917	0.681	rs4707211	ENSG00000203875.9	SNHG5	7.49	2.2e-10	3.72e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85522992	chr6:85660950~85678736:-
READ	cis	rs858239	0.6	rs28646184	ENSG00000230658.1	KLHL7-AS1	7.48	2.22e-10	3.73e-06	0.86	0.68	Cerebrospinal fluid biomarker levels;	chr7:23099976	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10256524	ENSG00000230658.1	KLHL7-AS1	7.48	2.22e-10	3.73e-06	0.86	0.68	Cerebrospinal fluid biomarker levels;	chr7:23105328	chr7:23101228~23105703:-
READ	cis	rs916888	0.647	rs199524	ENSG00000262539.1	RP11-259G18.3	-7.48	2.23e-10	3.73e-06	-0.93	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46771072	chr17:46259551~46260606:-
READ	cis	rs916888	0.647	rs199523	ENSG00000262539.1	RP11-259G18.3	-7.48	2.23e-10	3.73e-06	-0.93	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46771151	chr17:46259551~46260606:-
READ	cis	rs1577917	0.56	rs12193777	ENSG00000203875.9	SNHG5	7.48	2.24e-10	3.73e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85536991	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs9444351	ENSG00000203875.9	SNHG5	7.48	2.24e-10	3.73e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85538081	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs7766485	ENSG00000203875.9	SNHG5	7.48	2.24e-10	3.73e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85553837	chr6:85660950~85678736:-
READ	cis	rs1577917	0.61	rs11752795	ENSG00000203875.9	SNHG5	7.48	2.24e-10	3.73e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85577411	chr6:85660950~85678736:-
READ	cis	rs916888	0.773	rs199451	ENSG00000214401.4	KANSL1-AS1	7.48	2.28e-10	3.8e-06	1.14	0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46724418	chr17:46193576~46196723:+
READ	cis	rs7208859	0.673	rs11657270	ENSG00000263531.1	RP13-753N3.1	7.47	2.32e-10	3.86e-06	1.24	0.68	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887369	chr17:30863921~30864940:-
READ	cis	rs916888	0.558	rs199521	ENSG00000262539.1	RP11-259G18.3	-7.47	2.33e-10	3.87e-06	-0.95	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776090	chr17:46259551~46260606:-
READ	cis	rs2739330	0.76	rs5751760	ENSG00000218537.1	MIF-AS1	7.47	2.38e-10	3.96e-06	0.86	0.68	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901386	chr22:23894426~23898930:-
READ	cis	rs7208859	0.623	rs9906957	ENSG00000263531.1	RP13-753N3.1	7.46	2.48e-10	4.1e-06	1.16	0.68	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30830737	chr17:30863921~30864940:-
READ	cis	rs2882667	0.964	rs12719517	ENSG00000253404.1	AC034243.1	7.46	2.49e-10	4.12e-06	0.82	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138969813	chr5:138744434~138753309:-
READ	cis	rs2882667	1	rs2060222	ENSG00000253404.1	AC034243.1	7.45	2.53e-10	4.18e-06	0.82	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138972777	chr5:138744434~138753309:-
READ	cis	rs2882667	1	rs10064130	ENSG00000253404.1	AC034243.1	7.45	2.53e-10	4.18e-06	0.82	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138973618	chr5:138744434~138753309:-
READ	cis	rs2882667	1	rs10064201	ENSG00000253404.1	AC034243.1	7.45	2.53e-10	4.18e-06	0.82	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138973716	chr5:138744434~138753309:-
READ	cis	rs916888	0.687	rs199456	ENSG00000214401.4	KANSL1-AS1	7.45	2.54e-10	4.19e-06	1.16	0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46720553	chr17:46193576~46196723:+
READ	cis	rs858239	0.6	rs2072369	ENSG00000230658.1	KLHL7-AS1	7.45	2.54e-10	4.19e-06	0.89	0.68	Cerebrospinal fluid biomarker levels;	chr7:23106570	chr7:23101228~23105703:-
READ	cis	rs916888	0.647	rs199520	ENSG00000262539.1	RP11-259G18.3	-7.44	2.67e-10	4.38e-06	-0.95	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776506	chr17:46259551~46260606:-
READ	cis	rs916888	0.647	rs199519	ENSG00000262539.1	RP11-259G18.3	-7.44	2.67e-10	4.38e-06	-0.95	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776558	chr17:46259551~46260606:-
READ	cis	rs7224296	0.709	rs199518	ENSG00000262539.1	RP11-259G18.3	-7.44	2.67e-10	4.38e-06	-0.95	-0.68	Intelligence (multi-trait analysis);	chr17:46777214	chr17:46259551~46260606:-
READ	cis	rs916888	0.647	rs199517	ENSG00000262539.1	RP11-259G18.3	-7.44	2.67e-10	4.38e-06	-0.95	-0.68	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46777221	chr17:46259551~46260606:-
READ	cis	rs1577917	0.655	rs9444354	ENSG00000203875.9	SNHG5	7.44	2.68e-10	4.39e-06	0.9	0.68	Response to antipsychotic treatment;	chr6:85582217	chr6:85660950~85678736:-
READ	cis	rs1577917	0.566	rs2842611	ENSG00000203875.9	SNHG5	-7.44	2.68e-10	4.39e-06	-0.9	-0.68	Response to antipsychotic treatment;	chr6:85592316	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs2842600	ENSG00000203875.9	SNHG5	-7.44	2.68e-10	4.39e-06	-0.9	-0.68	Response to antipsychotic treatment;	chr6:85615914	chr6:85660950~85678736:-
READ	cis	rs2882667	0.964	rs12055237	ENSG00000253404.1	AC034243.1	7.42	2.89e-10	4.73e-06	0.83	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:138971617	chr5:138744434~138753309:-
READ	cis	rs858239	0.6	rs2014768	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23082821	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10256361	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23084266	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6978827	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23085925	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7790157	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23087379	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6960001	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23091257	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10237755	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23091945	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6961131	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23095171	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs1115941	ENSG00000230658.1	KLHL7-AS1	7.41	3.02e-10	4.91e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23097569	chr7:23101228~23105703:-
READ	cis	rs916888	0.531	rs183211	ENSG00000262539.1	RP11-259G18.3	7.41	3.06e-10	4.92e-06	0.99	0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46710944	chr17:46259551~46260606:-
READ	cis	rs1577917	0.839	rs6929514	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85816050	chr6:85660950~85678736:-
READ	cis	rs1577917	0.796	rs12661231	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85834753	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs12055653	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85836945	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs1596990	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85840974	chr6:85660950~85678736:-
READ	cis	rs1577917	0.916	rs12661611	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85844117	chr6:85660950~85678736:-
READ	cis	rs1577917	0.637	rs1838957	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85855338	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs1838956	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85855545	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs12216103	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85861410	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs12664634	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85869696	chr6:85660950~85678736:-
READ	cis	rs1577917	0.839	rs6454504	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85870612	chr6:85660950~85678736:-
READ	cis	rs1577917	0.883	rs2166664	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85886904	chr6:85660950~85678736:-
READ	cis	rs1577917	0.883	rs9450348	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85888318	chr6:85660950~85678736:-
READ	cis	rs1577917	0.959	rs2816822	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85948574	chr6:85660950~85678736:-
READ	cis	rs1577917	0.804	rs2786854	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85959022	chr6:85660950~85678736:-
READ	cis	rs1577917	0.92	rs1337842	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85965379	chr6:85660950~85678736:-
READ	cis	rs1577917	0.883	rs2660575	ENSG00000203875.9	SNHG5	-7.4	3.09e-10	4.92e-06	-0.88	-0.67	Response to antipsychotic treatment;	chr6:85975277	chr6:85660950~85678736:-
READ	cis	rs7208859	0.673	rs999798	ENSG00000263531.1	RP13-753N3.1	7.4	3.09e-10	4.92e-06	1.06	0.67	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30831822	chr17:30863921~30864940:-
READ	cis	rs858239	0.6	rs4409314	ENSG00000230658.1	KLHL7-AS1	7.4	3.2e-10	5.08e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23088333	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs4140959	ENSG00000230658.1	KLHL7-AS1	7.39	3.25e-10	5.16e-06	0.87	0.67	Cerebrospinal fluid biomarker levels;	chr7:23131157	chr7:23101228~23105703:-
READ	cis	rs9322193	0.504	rs7771014	ENSG00000216906.2	RP11-350J20.9	7.38	3.35e-10	5.18e-06	0.84	0.67	Lung cancer;	chr6:149884310	chr6:149904243~149906418:+
READ	cis	rs9309473	1	rs7594511	ENSG00000163016.8	ALMS1P	7.37	3.51e-10	5.24e-06	0.94	0.67	Metabolite levels;	chr2:73454512	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs62151652	ENSG00000163016.8	ALMS1P	7.37	3.51e-10	5.24e-06	0.94	0.67	Metabolite levels;	chr2:73473004	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6740223	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73426204	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6707722	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73427235	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs2421550	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73431558	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6546835	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73437587	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs2901438	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73438528	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7584575	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73439274	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10175180	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73445995	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10496191	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73446670	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6546836	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73450706	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6546837	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73450771	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6546838	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73452153	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6724782	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73452863	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6546839	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73453381	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6756987	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73459950	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs9807961	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73466916	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10186501	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73470717	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10189574	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73471391	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs2140195	ENSG00000163016.8	ALMS1P	7.36	3.75e-10	5.5e-06	0.95	0.67	Metabolite levels;	chr2:73475217	chr2:73644919~73685576:+
READ	cis	rs1577917	0.793	rs9362245	ENSG00000203875.9	SNHG5	-7.35	3.8e-10	5.56e-06	-0.87	-0.67	Response to antipsychotic treatment;	chr6:85786602	chr6:85660950~85678736:-
READ	cis	rs2882667	0.822	rs13187096	ENSG00000253404.1	AC034243.1	7.35	3.8e-10	5.56e-06	0.82	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:139068399	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11957527	ENSG00000253404.1	AC034243.1	7.35	3.8e-10	5.56e-06	0.82	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:139069206	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11242444	ENSG00000253404.1	AC034243.1	7.35	3.8e-10	5.56e-06	0.82	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:139070690	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11956159	ENSG00000253404.1	AC034243.1	7.35	3.8e-10	5.56e-06	0.82	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:139072879	chr5:138744434~138753309:-
READ	cis	rs3814244	0.528	rs2906859	ENSG00000255733.4	IFNG-AS1	7.35	3.86e-10	5.64e-06	0.69	0.67	Itch intensity from mosquito bite adjusted by bite size;	chr12:68002355	chr12:67989445~68234686:+
READ	cis	rs916888	0.773	rs199457	ENSG00000214401.4	KANSL1-AS1	7.34	4.02e-10	5.88e-06	1.15	0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46718103	chr17:46193576~46196723:+
READ	cis	rs875971	0.54	rs1723268	ENSG00000226824.5	RP4-756H11.3	-7.34	4.05e-10	5.91e-06	-0.75	-0.67	Aortic root size;	chr7:66008093	chr7:66654538~66669855:+
READ	cis	rs9309473	1	rs10190219	ENSG00000163016.8	ALMS1P	7.33	4.14e-10	6.03e-06	0.93	0.67	Metabolite levels;	chr2:73431203	chr2:73644919~73685576:+
READ	cis	rs875971	0.54	rs781152	ENSG00000226824.5	RP4-756H11.3	-7.33	4.2e-10	6.03e-06	-0.75	-0.67	Aortic root size;	chr7:66014585	chr7:66654538~66669855:+
READ	cis	rs17711722	0.727	rs781151	ENSG00000226824.5	RP4-756H11.3	-7.33	4.2e-10	6.03e-06	-0.75	-0.67	Calcium levels;	chr7:66014891	chr7:66654538~66669855:+
READ	cis	rs2882667	0.858	rs11959851	ENSG00000253404.1	AC034243.1	7.33	4.22e-10	6.05e-06	0.84	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:139085716	chr5:138744434~138753309:-
READ	cis	rs12439619	0.739	rs62012046	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82236824	chr15:82472203~82472426:+
READ	cis	rs12439619	0.774	rs62012047	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82236852	chr15:82472203~82472426:+
READ	cis	rs12439619	0.81	rs62012049	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82237722	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs62012056	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82247278	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs62012059	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82251669	chr15:82472203~82472426:+
READ	cis	rs12439619	0.774	rs2867649	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82262331	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs28697264	ENSG00000278603.1	RP13-608F4.5	7.33	4.25e-10	6.05e-06	1.04	0.67	Intelligence (multi-trait analysis);	chr15:82265559	chr15:82472203~82472426:+
READ	cis	rs858239	0.539	rs4559148	ENSG00000230658.1	KLHL7-AS1	7.33	4.25e-10	6.05e-06	0.89	0.67	Cerebrospinal fluid biomarker levels;	chr7:23146348	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs4377861	ENSG00000230658.1	KLHL7-AS1	7.33	4.25e-10	6.05e-06	0.89	0.67	Cerebrospinal fluid biomarker levels;	chr7:23146350	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs10247268	ENSG00000230658.1	KLHL7-AS1	7.33	4.25e-10	6.05e-06	0.89	0.67	Cerebrospinal fluid biomarker levels;	chr7:23147560	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6461694	ENSG00000230658.1	KLHL7-AS1	7.33	4.25e-10	6.05e-06	0.89	0.67	Cerebrospinal fluid biomarker levels;	chr7:23148160	chr7:23101228~23105703:-
READ	cis	rs9309473	0.95	rs1052162	ENSG00000163016.8	ALMS1P	-7.32	4.3e-10	6.12e-06	-0.93	-0.67	Metabolite levels;	chr2:73602245	chr2:73644919~73685576:+
READ	cis	rs858239	0.632	rs7811903	ENSG00000230658.1	KLHL7-AS1	7.32	4.32e-10	6.13e-06	0.84	0.67	Cerebrospinal fluid biomarker levels;	chr7:23079437	chr7:23101228~23105703:-
READ	cis	rs801193	0.742	rs9969300	ENSG00000226824.5	RP4-756H11.3	7.32	4.42e-10	6.24e-06	0.77	0.67	Aortic root size;	chr7:66316659	chr7:66654538~66669855:+
READ	cis	rs801193	1	rs10252765	ENSG00000226824.5	RP4-756H11.3	-7.31	4.63e-10	6.51e-06	-0.77	-0.67	Aortic root size;	chr7:66763745	chr7:66654538~66669855:+
READ	cis	rs1577917	0.883	rs1337854	ENSG00000203875.9	SNHG5	7.3	4.79e-10	6.73e-06	0.87	0.67	Response to antipsychotic treatment;	chr6:86014297	chr6:85660950~85678736:-
READ	cis	rs916888	0.61	rs199444	ENSG00000262539.1	RP11-259G18.3	7.29	4.87e-10	6.83e-06	0.93	0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46740910	chr17:46259551~46260606:-
READ	cis	rs916888	0.61	rs199442	ENSG00000262539.1	RP11-259G18.3	7.29	4.87e-10	6.83e-06	0.93	0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46742756	chr17:46259551~46260606:-
READ	cis	rs1930961	1	rs1930961	ENSG00000100058.11	CRYBB2P1	7.29	5.01e-10	7.03e-06	1.52	0.67	Bipolar disorder with mood-incongruent psychosis;	chr22:25479298	chr22:25448105~25520854:+
READ	cis	rs916888	0.773	rs9896243	ENSG00000214401.4	KANSL1-AS1	7.28	5.13e-10	7.2e-06	1.21	0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46748690	chr17:46193576~46196723:+
READ	cis	rs916888	0.61	rs199446	ENSG00000262539.1	RP11-259G18.3	-7.28	5.18e-10	7.26e-06	-0.9	-0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46735803	chr17:46259551~46260606:-
READ	cis	rs916888	0.61	rs199536	ENSG00000262539.1	RP11-259G18.3	-7.28	5.18e-10	7.26e-06	-0.9	-0.67	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46743059	chr17:46259551~46260606:-
READ	cis	rs11155671	0.53	rs9968871	ENSG00000216906.2	RP11-350J20.9	7.26	5.5e-10	7.67e-06	0.84	0.67	Testicular germ cell tumor;	chr6:149888060	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9969044	ENSG00000216906.2	RP11-350J20.9	7.26	5.5e-10	7.67e-06	0.84	0.67	Testicular germ cell tumor;	chr6:149888068	chr6:149904243~149906418:+
READ	cis	rs858239	0.601	rs6969733	ENSG00000230658.1	KLHL7-AS1	7.26	5.62e-10	7.81e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23128758	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs4440529	ENSG00000230658.1	KLHL7-AS1	7.26	5.62e-10	7.81e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23129132	chr7:23101228~23105703:-
READ	cis	rs858239	0.571	rs6953020	ENSG00000230658.1	KLHL7-AS1	7.26	5.62e-10	7.81e-06	0.85	0.67	Cerebrospinal fluid biomarker levels;	chr7:23132513	chr7:23101228~23105703:-
READ	cis	rs7208859	0.673	rs28588622	ENSG00000263531.1	RP13-753N3.1	7.26	5.62e-10	7.81e-06	1.14	0.67	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30918681	chr17:30863921~30864940:-
READ	cis	rs12439619	0.693	rs7165536	ENSG00000278603.1	RP13-608F4.5	7.25	5.7e-10	7.81e-06	0.99	0.67	Intelligence (multi-trait analysis);	chr15:82273743	chr15:82472203~82472426:+
READ	cis	rs858239	0.699	rs1881200	ENSG00000230658.1	KLHL7-AS1	-7.25	5.88e-10	7.93e-06	-0.88	-0.67	Cerebrospinal fluid biomarker levels;	chr7:23162018	chr7:23101228~23105703:-
READ	cis	rs1930961	1	rs9624834	ENSG00000100058.11	CRYBB2P1	7.25	5.9e-10	7.95e-06	1.43	0.67	Bipolar disorder with mood-incongruent psychosis;	chr22:25450048	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs9624835	ENSG00000100058.11	CRYBB2P1	7.25	5.9e-10	7.95e-06	1.43	0.67	Bipolar disorder with mood-incongruent psychosis;	chr22:25450054	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004657	ENSG00000100058.11	CRYBB2P1	7.25	5.9e-10	7.95e-06	1.43	0.67	Bipolar disorder with mood-incongruent psychosis;	chr22:25459747	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004659	ENSG00000100058.11	CRYBB2P1	7.25	5.9e-10	7.95e-06	1.43	0.67	Bipolar disorder with mood-incongruent psychosis;	chr22:25460444	chr22:25448105~25520854:+
READ	cis	rs3814244	0.515	rs3015002	ENSG00000255733.4	IFNG-AS1	-7.24	5.95e-10	8e-06	-0.66	-0.67	Itch intensity from mosquito bite adjusted by bite size;	chr12:68010853	chr12:67989445~68234686:+
READ	cis	rs9309473	1	rs6753344	ENSG00000163016.8	ALMS1P	-7.24	6.01e-10	8.08e-06	-0.91	-0.67	Metabolite levels;	chr2:73426010	chr2:73644919~73685576:+
READ	cis	rs17711722	0.727	rs2658585	ENSG00000226824.5	RP4-756H11.3	-7.24	6.02e-10	8.09e-06	-0.75	-0.67	Calcium levels;	chr7:65996954	chr7:66654538~66669855:+
READ	cis	rs9309473	0.95	rs6546854	ENSG00000163016.8	ALMS1P	7.24	6.05e-10	8.13e-06	0.91	0.67	Metabolite levels;	chr2:73606907	chr2:73644919~73685576:+
READ	cis	rs875971	0.522	rs7784623	ENSG00000226824.5	RP4-756H11.3	-7.24	6.08e-10	8.16e-06	-0.75	-0.67	Aortic root size;	chr7:65930047	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs34973832	ENSG00000226824.5	RP4-756H11.3	-7.24	6.08e-10	8.16e-06	-0.75	-0.67	Aortic root size;	chr7:65931217	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs4718285	ENSG00000226824.5	RP4-756H11.3	-7.24	6.16e-10	8.23e-06	-0.75	-0.67	Aortic root size;	chr7:65827018	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs4718286	ENSG00000226824.5	RP4-756H11.3	-7.24	6.16e-10	8.23e-06	-0.75	-0.67	Aortic root size;	chr7:65827777	chr7:66654538~66669855:+
READ	cis	rs17711722	0.585	rs6942660	ENSG00000226824.5	RP4-756H11.3	-7.24	6.16e-10	8.23e-06	-0.75	-0.67	Calcium levels;	chr7:65837419	chr7:66654538~66669855:+
READ	cis	rs17711722	0.64	rs13237956	ENSG00000226824.5	RP4-756H11.3	-7.24	6.16e-10	8.23e-06	-0.75	-0.67	Calcium levels;	chr7:65853042	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs2949690	ENSG00000226824.5	RP4-756H11.3	7.23	6.21e-10	8.28e-06	0.75	0.66	Aortic root size;	chr7:66018255	chr7:66654538~66669855:+
READ	cis	rs875971	0.522	rs709604	ENSG00000226824.5	RP4-756H11.3	7.23	6.21e-10	8.28e-06	0.75	0.66	Aortic root size;	chr7:66032447	chr7:66654538~66669855:+
READ	cis	rs858239	0.6	rs9691762	ENSG00000230658.1	KLHL7-AS1	7.23	6.26e-10	8.33e-06	0.83	0.66	Cerebrospinal fluid biomarker levels;	chr7:23086303	chr7:23101228~23105703:-
READ	cis	rs801193	1	rs2659915	ENSG00000226824.5	RP4-756H11.3	-7.23	6.3e-10	8.38e-06	-0.74	-0.66	Aortic root size;	chr7:66688114	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs1962050	ENSG00000226824.5	RP4-756H11.3	7.23	6.41e-10	8.52e-06	0.73	0.66	Aortic root size;	chr7:66775021	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs875971	ENSG00000226824.5	RP4-756H11.3	7.22	6.47e-10	8.57e-06	0.72	0.66	Aortic root size;	chr7:66152608	chr7:66654538~66669855:+
READ	cis	rs875971	0.516	rs6945322	ENSG00000226824.5	RP4-756H11.3	-7.22	6.47e-10	8.57e-06	-0.75	-0.66	Aortic root size;	chr7:65871069	chr7:66654538~66669855:+
READ	cis	rs17711722	0.701	rs55773927	ENSG00000226824.5	RP4-756H11.3	-7.22	6.47e-10	8.57e-06	-0.75	-0.66	Calcium levels;	chr7:65872915	chr7:66654538~66669855:+
READ	cis	rs17711722	0.727	rs35850374	ENSG00000226824.5	RP4-756H11.3	-7.22	6.47e-10	8.57e-06	-0.75	-0.66	Calcium levels;	chr7:65892789	chr7:66654538~66669855:+
READ	cis	rs17711722	0.701	rs4467826	ENSG00000226824.5	RP4-756H11.3	-7.22	6.47e-10	8.57e-06	-0.75	-0.66	Calcium levels;	chr7:65903721	chr7:66654538~66669855:+
READ	cis	rs858239	0.699	rs1881201	ENSG00000230658.1	KLHL7-AS1	-7.21	6.78e-10	8.94e-06	-0.87	-0.66	Cerebrospinal fluid biomarker levels;	chr7:23154394	chr7:23101228~23105703:-
READ	cis	rs9309473	1	rs6736866	ENSG00000163016.8	ALMS1P	7.21	6.82e-10	9e-06	0.92	0.66	Metabolite levels;	chr2:73434858	chr2:73644919~73685576:+
READ	cis	rs916888	0.773	rs1378358	ENSG00000214401.4	KANSL1-AS1	7.2	7.13e-10	9.38e-06	1.17	0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46709946	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs538628	ENSG00000214401.4	KANSL1-AS1	7.2	7.13e-10	9.38e-06	1.17	0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46709947	chr17:46193576~46196723:+
READ	cis	rs916888	0.647	rs199449	ENSG00000262539.1	RP11-259G18.3	7.2	7.27e-10	9.55e-06	0.91	0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46731536	chr17:46259551~46260606:-
READ	cis	rs858239	0.601	rs764533	ENSG00000230658.1	KLHL7-AS1	7.19	7.5e-10	9.85e-06	0.84	0.66	Cerebrospinal fluid biomarker levels;	chr7:23114256	chr7:23101228~23105703:-
READ	cis	rs916888	0.773	rs169201	ENSG00000214401.4	KANSL1-AS1	7.18	7.63e-10	1e-05	1.17	0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46712837	chr17:46193576~46196723:+
READ	cis	rs916888	0.773	rs199439	ENSG00000214401.4	KANSL1-AS1	7.18	7.63e-10	1e-05	1.17	0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46716137	chr17:46193576~46196723:+
READ	cis	rs875971	0.522	rs1701760	ENSG00000226824.5	RP4-756H11.3	-7.18	7.69e-10	1.01e-05	-0.75	-0.66	Aortic root size;	chr7:66008701	chr7:66654538~66669855:+
READ	cis	rs9309473	1	rs7576245	ENSG00000163016.8	ALMS1P	7.18	7.87e-10	1.03e-05	0.9	0.66	Metabolite levels;	chr2:73602551	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs1403284	ENSG00000163016.8	ALMS1P	-7.17	8.02e-10	1.04e-05	-0.9	-0.66	Metabolite levels;	chr2:73499535	chr2:73644919~73685576:+
READ	cis	rs858239	0.539	rs6975852	ENSG00000230658.1	KLHL7-AS1	7.16	8.3e-10	1.04e-05	0.88	0.66	Cerebrospinal fluid biomarker levels;	chr7:23147035	chr7:23101228~23105703:-
READ	cis	rs858239	0.508	rs7805071	ENSG00000230658.1	KLHL7-AS1	7.16	8.3e-10	1.04e-05	0.88	0.66	Cerebrospinal fluid biomarker levels;	chr7:23150593	chr7:23101228~23105703:-
READ	cis	rs858239	0.508	rs7805085	ENSG00000230658.1	KLHL7-AS1	7.16	8.3e-10	1.04e-05	0.88	0.66	Cerebrospinal fluid biomarker levels;	chr7:23150624	chr7:23101228~23105703:-
READ	cis	rs7208859	0.673	rs999797	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832311	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11651802	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832642	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs17826219	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30834827	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs61223749	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30836729	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs3764420	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30837136	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11654331	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30837999	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs3764421	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30840635	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11651858	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30843700	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs36056619	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30845266	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9909497	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30846210	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11080135	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30849463	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs73277960	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30850423	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73277964	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30852183	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9894876	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30855002	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11652409	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30855689	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73277967	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30857148	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs60020217	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30858036	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9896095	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30860479	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs73277974	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30862851	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73277978	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30864431	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs58920731	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30864728	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11657391	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30867269	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73277984	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869115	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73277986	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869179	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs58089675	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869746	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs12103588	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30870442	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73263755	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30871954	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9899349	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30873104	chr17:30863921~30864940:-
READ	cis	rs7208859	0.614	rs9914534	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30875646	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs4131618	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30877783	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11652358	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30878462	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11656845	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30879146	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11658344	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30880727	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9891179	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881142	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9891413	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881191	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9900144	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881371	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73263776	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30884313	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11650271	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30886925	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs11656121	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887025	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11650973	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887027	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73263785	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887790	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs78799101	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30888142	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs55904046	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30888373	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73263788	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30889472	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs56085216	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30890216	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9889968	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30893110	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs61348930	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30894745	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs12949860	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896014	chr17:30863921~30864940:-
READ	cis	rs7208859	0.614	rs28758251	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896294	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9899943	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896907	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11080138	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30897524	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73265612	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30898965	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs2433	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30899210	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11658435	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30901543	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11650305	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30902343	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11654914	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30902406	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73265624	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30905048	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9914271	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30905607	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs2269915	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30906326	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs2269916	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30906745	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11649765	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30906870	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs12103759	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30908669	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs59029591	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30908728	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73265633	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30909288	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9913782	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30910366	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs75142521	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30913519	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs79541516	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30913565	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9895684	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30915582	chr17:30863921~30864940:-
READ	cis	rs7208859	0.614	rs73265646	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30917005	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs58908911	ENSG00000263531.1	RP13-753N3.1	7.16	8.42e-10	1.04e-05	1.13	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30917540	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9911989	ENSG00000263531.1	RP13-753N3.1	-7.16	8.42e-10	1.04e-05	-1.13	-0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30910684	chr17:30863921~30864940:-
READ	cis	rs916888	0.61	rs199436	ENSG00000262539.1	RP11-259G18.3	-7.15	8.62e-10	1.06e-05	-0.95	-0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46711919	chr17:46259551~46260606:-
READ	cis	rs858239	0.508	rs2390754	ENSG00000230658.1	KLHL7-AS1	7.15	8.65e-10	1.07e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23150875	chr7:23101228~23105703:-
READ	cis	rs858239	0.601	rs11984129	ENSG00000230658.1	KLHL7-AS1	7.15	8.67e-10	1.07e-05	0.84	0.66	Cerebrospinal fluid biomarker levels;	chr7:23113058	chr7:23101228~23105703:-
READ	cis	rs7208859	0.623	rs3752019	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30824687	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73271869	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30825203	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73271872	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30825210	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55724095	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30826040	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs56146117	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30826307	chr17:30863921~30864940:-
READ	cis	rs17826219	0.568	rs9903854	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Body mass index;	chr17:30826980	chr17:30863921~30864940:-
READ	cis	rs17826219	0.568	rs9907834	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Body mass index;	chr17:30826995	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs80355557	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827403	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9911173	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827732	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs73271887	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827917	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9898858	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829193	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs55658077	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829501	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9899692	ENSG00000263531.1	RP13-753N3.1	7.15	8.83e-10	1.08e-05	1.21	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829921	chr17:30863921~30864940:-
READ	cis	rs1577917	0.883	rs6454505	ENSG00000203875.9	SNHG5	-7.15	8.83e-10	1.08e-05	-0.85	-0.66	Response to antipsychotic treatment;	chr6:85882644	chr6:85660950~85678736:-
READ	cis	rs1930961	1	rs6004667	ENSG00000100058.11	CRYBB2P1	-7.15	8.88e-10	1.09e-05	-1.39	-0.66	Bipolar disorder with mood-incongruent psychosis;	chr22:25478497	chr22:25448105~25520854:+
READ	cis	rs875971	0.522	rs4502988	ENSG00000226824.5	RP4-756H11.3	-7.15	8.93e-10	1.09e-05	-0.75	-0.66	Aortic root size;	chr7:65832759	chr7:66654538~66669855:+
READ	cis	rs858239	0.539	rs4294098	ENSG00000230658.1	KLHL7-AS1	7.14	9.05e-10	1.1e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23146376	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs4504540	ENSG00000230658.1	KLHL7-AS1	7.14	9.05e-10	1.1e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23146579	chr7:23101228~23105703:-
READ	cis	rs858239	0.509	rs6975524	ENSG00000230658.1	KLHL7-AS1	7.14	9.05e-10	1.1e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23146833	chr7:23101228~23105703:-
READ	cis	rs858239	0.509	rs6962213	ENSG00000230658.1	KLHL7-AS1	7.14	9.05e-10	1.1e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23148490	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs1358442	ENSG00000230658.1	KLHL7-AS1	7.14	9.05e-10	1.1e-05	0.87	0.66	Cerebrospinal fluid biomarker levels;	chr7:23150120	chr7:23101228~23105703:-
READ	cis	rs12439619	0.693	rs28689861	ENSG00000278603.1	RP13-608F4.5	7.14	9.24e-10	1.12e-05	0.97	0.66	Intelligence (multi-trait analysis);	chr15:82206369	chr15:82472203~82472426:+
READ	cis	rs12439619	0.693	rs4778989	ENSG00000278603.1	RP13-608F4.5	7.13	9.66e-10	1.17e-05	0.98	0.66	Intelligence (multi-trait analysis);	chr15:82276963	chr15:82472203~82472426:+
READ	cis	rs17711722	1	rs17711722	ENSG00000226824.5	RP4-756H11.3	7.09	1.12e-09	1.35e-05	0.75	0.66	Calcium levels;	chr7:65806210	chr7:66654538~66669855:+
READ	cis	rs17711722	0.675	rs6947132	ENSG00000226824.5	RP4-756H11.3	7.09	1.12e-09	1.35e-05	0.75	0.66	Calcium levels;	chr7:65808508	chr7:66654538~66669855:+
READ	cis	rs875971	0.54	rs4717275	ENSG00000226824.5	RP4-756H11.3	7.08	1.18e-09	1.41e-05	0.75	0.66	Aortic root size;	chr7:65800193	chr7:66654538~66669855:+
READ	cis	rs875971	0.505	rs1723275	ENSG00000226824.5	RP4-756H11.3	7.07	1.22e-09	1.45e-05	0.74	0.66	Aortic root size;	chr7:66039646	chr7:66654538~66669855:+
READ	cis	rs875971	0.505	rs2462573	ENSG00000226824.5	RP4-756H11.3	7.07	1.22e-09	1.45e-05	0.74	0.66	Aortic root size;	chr7:66042405	chr7:66654538~66669855:+
READ	cis	rs875971	0.505	rs1167386	ENSG00000226824.5	RP4-756H11.3	7.07	1.22e-09	1.45e-05	0.74	0.66	Aortic root size;	chr7:66048109	chr7:66654538~66669855:+
READ	cis	rs875971	0.505	rs1167385	ENSG00000226824.5	RP4-756H11.3	7.07	1.22e-09	1.45e-05	0.74	0.66	Aortic root size;	chr7:66048321	chr7:66654538~66669855:+
READ	cis	rs9309473	0.95	rs6546849	ENSG00000163016.8	ALMS1P	7.06	1.24e-09	1.48e-05	0.9	0.66	Metabolite levels;	chr2:73603910	chr2:73644919~73685576:+
READ	cis	rs9309473	0.851	rs6546850	ENSG00000163016.8	ALMS1P	7.06	1.24e-09	1.48e-05	0.9	0.66	Metabolite levels;	chr2:73604020	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs6546852	ENSG00000163016.8	ALMS1P	7.06	1.24e-09	1.48e-05	0.9	0.66	Metabolite levels;	chr2:73606304	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs6546853	ENSG00000163016.8	ALMS1P	7.06	1.24e-09	1.48e-05	0.9	0.66	Metabolite levels;	chr2:73606612	chr2:73644919~73685576:+
READ	cis	rs916888	0.61	rs142167	ENSG00000262539.1	RP11-259G18.3	-7.06	1.25e-09	1.49e-05	-0.93	-0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46717868	chr17:46259551~46260606:-
READ	cis	rs7208859	0.623	rs56325146	ENSG00000263531.1	RP13-753N3.1	7.06	1.28e-09	1.53e-05	1.15	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30824006	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11655623	ENSG00000263531.1	RP13-753N3.1	7.05	1.29e-09	1.54e-05	1.1	0.66	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30835155	chr17:30863921~30864940:-
READ	cis	rs9309473	0.95	rs6726694	ENSG00000163016.8	ALMS1P	7.05	1.33e-09	1.58e-05	0.9	0.66	Metabolite levels;	chr2:73620103	chr2:73644919~73685576:+
READ	cis	rs858239	0.539	rs6461695	ENSG00000230658.1	KLHL7-AS1	7.04	1.38e-09	1.64e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23158165	chr7:23101228~23105703:-
READ	cis	rs801193	0.901	rs4273746	ENSG00000226824.5	RP4-756H11.3	7.03	1.42e-09	1.68e-05	0.74	0.65	Aortic root size;	chr7:66836124	chr7:66654538~66669855:+
READ	cis	rs9309473	0.95	rs7566364	ENSG00000163016.8	ALMS1P	7.03	1.44e-09	1.7e-05	0.91	0.65	Metabolite levels;	chr2:73615762	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs13427832	ENSG00000163016.8	ALMS1P	7.03	1.44e-09	1.7e-05	0.91	0.65	Metabolite levels;	chr2:73617691	chr2:73644919~73685576:+
READ	cis	rs858239	0.6	rs6461692	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23100076	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10235786	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23100321	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7785842	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23102087	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7456915	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23103430	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10233039	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23103494	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs13438179	ENSG00000230658.1	KLHL7-AS1	7.02	1.51e-09	1.78e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23104232	chr7:23101228~23105703:-
READ	cis	rs916888	0.61	rs199530	ENSG00000262539.1	RP11-259G18.3	-7.01	1.55e-09	1.83e-05	-0.89	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46759287	chr17:46259551~46260606:-
READ	cis	rs9309473	0.898	rs6546851	ENSG00000163016.8	ALMS1P	7	1.59e-09	1.86e-05	0.9	0.65	Metabolite levels;	chr2:73606156	chr2:73644919~73685576:+
READ	cis	rs858239	0.539	rs7791200	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23142502	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs57864591	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23144805	chr7:23101228~23105703:-
READ	cis	rs858239	0.509	rs57611130	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23144933	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6955726	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23147072	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6955969	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23147080	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6976957	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23147714	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6956828	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23147728	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs10280815	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23148751	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs10225608	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23149289	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs28624974	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23149317	chr7:23101228~23105703:-
READ	cis	rs5850	0.557	rs10270788	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Blood protein levels;	chr7:23149381	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs28716381	ENSG00000230658.1	KLHL7-AS1	7	1.59e-09	1.86e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23149396	chr7:23101228~23105703:-
READ	cis	rs11155671	0.53	rs7742993	ENSG00000216906.2	RP11-350J20.9	7	1.6e-09	1.86e-05	0.82	0.65	Testicular germ cell tumor;	chr6:149883959	chr6:149904243~149906418:+
READ	cis	rs2882667	0.931	rs10074461	ENSG00000253404.1	AC034243.1	7	1.6e-09	1.87e-05	0.78	0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138984126	chr5:138744434~138753309:-
READ	cis	rs916888	0.821	rs199499	ENSG00000262539.1	RP11-259G18.3	6.99	1.72e-09	2e-05	1.03	0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46788132	chr17:46259551~46260606:-
READ	cis	rs12439619	0.846	rs62013464	ENSG00000278603.1	RP13-608F4.5	6.98	1.73e-09	2.01e-05	1.01	0.65	Intelligence (multi-trait analysis);	chr15:82288250	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs62010071	ENSG00000278603.1	RP13-608F4.5	6.98	1.73e-09	2.01e-05	1.01	0.65	Intelligence (multi-trait analysis);	chr15:82289442	chr15:82472203~82472426:+
READ	cis	rs9309473	0.861	rs6546857	ENSG00000163016.8	ALMS1P	6.97	1.81e-09	2.09e-05	0.92	0.65	Metabolite levels;	chr2:73610828	chr2:73644919~73685576:+
READ	cis	rs858239	0.6	rs7776649	ENSG00000230658.1	KLHL7-AS1	6.97	1.86e-09	2.15e-05	0.82	0.65	Cerebrospinal fluid biomarker levels;	chr7:23079698	chr7:23101228~23105703:-
READ	cis	rs9309473	1	rs7598396	ENSG00000163016.8	ALMS1P	6.96	1.87e-09	2.16e-05	0.92	0.65	Metabolite levels;	chr2:73425500	chr2:73644919~73685576:+
READ	cis	rs858239	0.6	rs2003555	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23083296	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10256359	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23084258	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7784929	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23084658	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs4321896	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23088437	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7799422	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23088794	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs28483572	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23092166	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs61292332	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23092243	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs59073109	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23093607	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7788821	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23094026	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6956595	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23094637	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6961406	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23095272	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6461690	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23095915	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6967419	ENSG00000230658.1	KLHL7-AS1	6.95	2.02e-09	2.32e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23096691	chr7:23101228~23105703:-
READ	cis	rs9309473	1	rs7585004	ENSG00000163016.8	ALMS1P	6.94	2.09e-09	2.4e-05	0.93	0.65	Metabolite levels;	chr2:73439517	chr2:73644919~73685576:+
READ	cis	rs858239	0.571	rs2390755	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23151097	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs4365988	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23151252	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs4295546	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23151402	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs10279194	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23151464	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs3950345	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23151495	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs2178140	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23152006	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs2178139	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23152017	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs2141306	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23152045	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs2141305	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23152280	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6945510	ENSG00000230658.1	KLHL7-AS1	6.93	2.12e-09	2.42e-05	0.86	0.65	Cerebrospinal fluid biomarker levels;	chr7:23152621	chr7:23101228~23105703:-
READ	cis	rs916888	0.61	rs199438	ENSG00000262539.1	RP11-259G18.3	6.93	2.14e-09	2.43e-05	0.95	0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46714277	chr17:46259551~46260606:-
READ	cis	rs12439619	0.846	rs7496227	ENSG00000278603.1	RP13-608F4.5	6.92	2.23e-09	2.53e-05	1.01	0.65	Intelligence (multi-trait analysis);	chr15:82275241	chr15:82472203~82472426:+
READ	cis	rs916888	0.821	rs199512	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779986	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199509	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781362	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199507	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781489	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199506	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781665	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs415430	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781778	chr17:46193576~46196723:+
READ	cis	rs916888	0.779	rs430685	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781782	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs199505	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782044	chr17:46193576~46196723:+
READ	cis	rs916888	0.821	rs70602	ENSG00000214401.4	KANSL1-AS1	-6.91	2.32e-09	2.62e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46782349	chr17:46193576~46196723:+
READ	cis	rs916888	0.61	rs199452	ENSG00000262539.1	RP11-259G18.3	6.91	2.34e-09	2.64e-05	0.87	0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46723974	chr17:46259551~46260606:-
READ	cis	rs9309473	0.95	rs6546859	ENSG00000163016.8	ALMS1P	6.91	2.34e-09	2.64e-05	0.89	0.65	Metabolite levels;	chr2:73614928	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs6546860	ENSG00000163016.8	ALMS1P	6.91	2.34e-09	2.64e-05	0.89	0.65	Metabolite levels;	chr2:73617122	chr2:73644919~73685576:+
READ	cis	rs9309473	0.797	rs6723247	ENSG00000163016.8	ALMS1P	6.91	2.34e-09	2.64e-05	0.89	0.65	Metabolite levels;	chr2:73619622	chr2:73644919~73685576:+
READ	cis	rs17826219	0.706	rs9905827	ENSG00000263531.1	RP13-753N3.1	6.91	2.35e-09	2.65e-05	1.12	0.65	Body mass index;	chr17:30865150	chr17:30863921~30864940:-
READ	cis	rs858239	0.539	rs2103281	ENSG00000230658.1	KLHL7-AS1	6.91	2.38e-09	2.68e-05	0.85	0.65	Cerebrospinal fluid biomarker levels;	chr7:23154612	chr7:23101228~23105703:-
READ	cis	rs7208859	0.673	rs999796	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832386	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs9910051	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30834184	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs7210904	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30843187	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs9915802	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30846040	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs7342938	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30862812	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs6505215	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30862885	chr17:30863921~30864940:-
READ	cis	rs7208859	0.725	rs9891656	ENSG00000263531.1	RP13-753N3.1	6.9	2.42e-09	2.72e-05	0.99	0.65	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30916337	chr17:30863921~30864940:-
READ	cis	rs858239	0.539	rs870476	ENSG00000230658.1	KLHL7-AS1	6.9	2.46e-09	2.77e-05	0.81	0.65	Cerebrospinal fluid biomarker levels;	chr7:23153652	chr7:23101228~23105703:-
READ	cis	rs875971	1	rs6958271	ENSG00000226824.5	RP4-756H11.3	-6.89	2.54e-09	2.84e-05	-0.72	-0.65	Aortic root size;	chr7:66514344	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6958277	ENSG00000226824.5	RP4-756H11.3	-6.89	2.54e-09	2.84e-05	-0.72	-0.65	Aortic root size;	chr7:66514362	chr7:66654538~66669855:+
READ	cis	rs1577917	0.839	rs9450333	ENSG00000203875.9	SNHG5	-6.88	2.64e-09	2.94e-05	-0.88	-0.65	Response to antipsychotic treatment;	chr6:85810037	chr6:85660950~85678736:-
READ	cis	rs916888	0.61	rs199454	ENSG00000262539.1	RP11-259G18.3	-6.88	2.65e-09	2.96e-05	-0.86	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46722744	chr17:46259551~46260606:-
READ	cis	rs1577917	0.883	rs1415749	ENSG00000203875.9	SNHG5	6.87	2.79e-09	3.1e-05	0.86	0.65	Response to antipsychotic treatment;	chr6:86069366	chr6:85660950~85678736:-
READ	cis	rs9309473	0.95	rs6546858	ENSG00000163016.8	ALMS1P	6.86	2.83e-09	3.14e-05	0.89	0.65	Metabolite levels;	chr2:73611486	chr2:73644919~73685576:+
READ	cis	rs916888	0.697	rs199516	ENSG00000214401.4	KANSL1-AS1	-6.86	2.87e-09	3.19e-05	-1.02	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779119	chr17:46193576~46196723:+
READ	cis	rs858239	0.73	rs858279	ENSG00000230658.1	KLHL7-AS1	6.85	3.01e-09	3.34e-05	0.82	0.64	Cerebrospinal fluid biomarker levels;	chr7:23211386	chr7:23101228~23105703:-
READ	cis	rs2739330	0.76	rs5751761	ENSG00000273295.1	AP000350.5	-6.85	3.02e-09	3.35e-05	-0.74	-0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901549	chr22:23901432~23907068:-
READ	cis	rs3814244	0.902	rs2870961	ENSG00000255733.4	IFNG-AS1	-6.85	3.04e-09	3.36e-05	-0.67	-0.64	Itch intensity from mosquito bite adjusted by bite size;	chr12:68024262	chr12:67989445~68234686:+
READ	cis	rs3814244	0.933	rs10748093	ENSG00000255733.4	IFNG-AS1	-6.85	3.04e-09	3.36e-05	-0.67	-0.64	Itch intensity from mosquito bite adjusted by bite size;	chr12:68024469	chr12:67989445~68234686:+
READ	cis	rs3814244	0.933	rs12423194	ENSG00000255733.4	IFNG-AS1	6.84	3.1e-09	3.43e-05	0.67	0.64	Itch intensity from mosquito bite adjusted by bite size;	chr12:68020387	chr12:67989445~68234686:+
READ	cis	rs875971	0.965	rs697968	ENSG00000226824.5	RP4-756H11.3	6.84	3.15e-09	3.47e-05	0.7	0.64	Aortic root size;	chr7:66070046	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1183245	ENSG00000226824.5	RP4-756H11.3	6.84	3.15e-09	3.47e-05	0.7	0.64	Aortic root size;	chr7:66076198	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1144895	ENSG00000226824.5	RP4-756H11.3	6.84	3.15e-09	3.47e-05	0.7	0.64	Aortic root size;	chr7:66076320	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1144894	ENSG00000226824.5	RP4-756H11.3	6.84	3.15e-09	3.47e-05	0.7	0.64	Aortic root size;	chr7:66077907	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2220626	ENSG00000226824.5	RP4-756H11.3	6.84	3.15e-09	3.47e-05	0.7	0.64	Aortic root size;	chr7:66081075	chr7:66654538~66669855:+
READ	cis	rs858239	0.632	rs1985769	ENSG00000230658.1	KLHL7-AS1	6.82	3.38e-09	3.69e-05	0.79	0.64	Cerebrospinal fluid biomarker levels;	chr7:23082887	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs28499396	ENSG00000230658.1	KLHL7-AS1	6.82	3.38e-09	3.69e-05	0.79	0.64	Cerebrospinal fluid biomarker levels;	chr7:23084479	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs7789237	ENSG00000230658.1	KLHL7-AS1	6.82	3.38e-09	3.69e-05	0.79	0.64	Cerebrospinal fluid biomarker levels;	chr7:23085094	chr7:23101228~23105703:-
READ	cis	rs3814244	0.933	rs11610126	ENSG00000255733.4	IFNG-AS1	-6.82	3.39e-09	3.69e-05	-0.66	-0.64	Itch intensity from mosquito bite adjusted by bite size;	chr12:68026493	chr12:67989445~68234686:+
READ	cis	rs875971	0.964	rs55748098	ENSG00000226824.5	RP4-756H11.3	6.82	3.45e-09	3.75e-05	0.72	0.64	Aortic root size;	chr7:66298631	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs709597	ENSG00000226824.5	RP4-756H11.3	6.82	3.45e-09	3.75e-05	0.72	0.64	Aortic root size;	chr7:66360996	chr7:66654538~66669855:+
READ	cis	rs12439619	0.846	rs62011975	ENSG00000278603.1	RP13-608F4.5	6.81	3.46e-09	3.75e-05	0.98	0.64	Intelligence (multi-trait analysis);	chr15:82159213	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs62012003	ENSG00000278603.1	RP13-608F4.5	6.81	3.46e-09	3.75e-05	0.98	0.64	Intelligence (multi-trait analysis);	chr15:82183236	chr15:82472203~82472426:+
READ	cis	rs12439619	0.846	rs62012004	ENSG00000278603.1	RP13-608F4.5	6.81	3.46e-09	3.75e-05	0.98	0.64	Intelligence (multi-trait analysis);	chr15:82183924	chr15:82472203~82472426:+
READ	cis	rs12439619	0.768	rs28694364	ENSG00000278603.1	RP13-608F4.5	6.81	3.46e-09	3.75e-05	0.98	0.64	Intelligence (multi-trait analysis);	chr15:82208119	chr15:82472203~82472426:+
READ	cis	rs12439619	0.81	rs28876157	ENSG00000278603.1	RP13-608F4.5	6.81	3.46e-09	3.75e-05	0.98	0.64	Intelligence (multi-trait analysis);	chr15:82216708	chr15:82472203~82472426:+
READ	cis	rs858239	0.539	rs2390757	ENSG00000230658.1	KLHL7-AS1	6.81	3.58e-09	3.88e-05	0.86	0.64	Cerebrospinal fluid biomarker levels;	chr7:23151873	chr7:23101228~23105703:-
READ	cis	rs9309473	0.948	rs2421577	ENSG00000163016.8	ALMS1P	6.8	3.61e-09	3.91e-05	0.89	0.64	Metabolite levels;	chr2:73613871	chr2:73644919~73685576:+
READ	cis	rs7208859	0.673	rs11656462	ENSG00000263531.1	RP13-753N3.1	6.8	3.7e-09	4e-05	1.1	0.64	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30833682	chr17:30863921~30864940:-
READ	cis	rs858239	0.636	rs7808488	ENSG00000230658.1	KLHL7-AS1	6.8	3.7e-09	4e-05	0.83	0.64	Cerebrospinal fluid biomarker levels;	chr7:23182251	chr7:23101228~23105703:-
READ	cis	rs9309473	0.861	rs6546856	ENSG00000163016.8	ALMS1P	6.79	3.79e-09	4.08e-05	0.91	0.64	Metabolite levels;	chr2:73610624	chr2:73644919~73685576:+
READ	cis	rs2739330	0.76	rs5751761	ENSG00000218537.1	MIF-AS1	-6.79	3.79e-09	4.08e-05	-0.82	-0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901549	chr22:23894426~23898930:-
READ	cis	rs12439619	0.846	rs28470877	ENSG00000278603.1	RP13-608F4.5	6.79	3.82e-09	4.11e-05	1.04	0.64	Intelligence (multi-trait analysis);	chr15:82245797	chr15:82472203~82472426:+
READ	cis	rs916888	0.821	rs199514	ENSG00000214401.4	KANSL1-AS1	-6.79	3.87e-09	4.16e-05	-1.03	-0.64	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779515	chr17:46193576~46196723:+
READ	cis	rs6964833	0.554	rs112506907	ENSG00000123965.13	PMS2P5	6.78	3.93e-09	4.21e-05	0.76	0.64	Menarche (age at onset);	chr7:74654407	chr7:74894116~74897835:+
READ	cis	rs6964833	0.554	rs2527366	ENSG00000123965.13	PMS2P5	-6.78	3.93e-09	4.21e-05	-0.76	-0.64	Menarche (age at onset);	chr7:74684615	chr7:74894116~74897835:+
READ	cis	rs6964833	0.554	rs2527367	ENSG00000123965.13	PMS2P5	-6.78	3.93e-09	4.21e-05	-0.76	-0.64	Menarche (age at onset);	chr7:74684804	chr7:74894116~74897835:+
READ	cis	rs6964833	0.554	rs2527380	ENSG00000123965.13	PMS2P5	-6.78	3.93e-09	4.21e-05	-0.76	-0.64	Menarche (age at onset);	chr7:74690372	chr7:74894116~74897835:+
READ	cis	rs875971	0.964	rs697969	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66093491	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1182882	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66097076	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1167612	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66102989	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6961717	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66122550	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2087647	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66128201	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6958484	ENSG00000226824.5	RP4-756H11.3	6.78	3.96e-09	4.23e-05	0.7	0.64	Aortic root size;	chr7:66134459	chr7:66654538~66669855:+
READ	cis	rs2882667	0.858	rs10900856	ENSG00000253404.1	AC034243.1	-6.78	3.96e-09	4.23e-05	-0.77	-0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:139082057	chr5:138744434~138753309:-
READ	cis	rs9309473	0.95	rs7596773	ENSG00000163016.8	ALMS1P	6.77	4.08e-09	4.33e-05	0.88	0.64	Metabolite levels;	chr2:73618873	chr2:73644919~73685576:+
READ	cis	rs858239	0.537	rs10279691	ENSG00000230658.1	KLHL7-AS1	6.77	4.08e-09	4.34e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23188768	chr7:23101228~23105703:-
READ	cis	rs858239	0.537	rs6942981	ENSG00000230658.1	KLHL7-AS1	6.77	4.08e-09	4.34e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23191929	chr7:23101228~23105703:-
READ	cis	rs875971	1	rs1167411	ENSG00000226824.5	RP4-756H11.3	6.76	4.3e-09	4.54e-05	0.7	0.64	Aortic root size;	chr7:66074277	chr7:66654538~66669855:+
READ	cis	rs2739330	0.796	rs1006771	ENSG00000273295.1	AP000350.5	6.75	4.46e-09	4.7e-05	0.71	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23971817	chr22:23901432~23907068:-
READ	cis	rs1577917	0.883	rs2782263	ENSG00000203875.9	SNHG5	-6.75	4.5e-09	4.74e-05	-0.87	-0.64	Response to antipsychotic treatment;	chr6:86081589	chr6:85660950~85678736:-
READ	cis	rs875971	0.965	rs10267430	ENSG00000226824.5	RP4-756H11.3	6.75	4.53e-09	4.76e-05	0.72	0.64	Aortic root size;	chr7:66278036	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs10257427	ENSG00000226824.5	RP4-756H11.3	6.75	4.53e-09	4.76e-05	0.72	0.64	Aortic root size;	chr7:66278221	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs10215948	ENSG00000226824.5	RP4-756H11.3	6.75	4.53e-09	4.76e-05	0.72	0.64	Aortic root size;	chr7:66282799	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4718307	ENSG00000226824.5	RP4-756H11.3	6.75	4.54e-09	4.76e-05	0.7	0.64	Aortic root size;	chr7:66146001	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs7801282	ENSG00000226824.5	RP4-756H11.3	6.75	4.54e-09	4.76e-05	0.7	0.64	Aortic root size;	chr7:66148700	chr7:66654538~66669855:+
READ	cis	rs1930961	1	rs760554	ENSG00000100058.11	CRYBB2P1	6.74	4.66e-09	4.89e-05	1.29	0.64	Bipolar disorder with mood-incongruent psychosis;	chr22:25476625	chr22:25448105~25520854:+
READ	cis	rs9399135	0.967	rs4896123	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134974272	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs35123050	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134981602	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6909975	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134994432	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7773126	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134997252	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs4475342	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134962210	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4895434	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134972227	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs4895435	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134972325	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4896120	ENSG00000232876.1	CTA-212D2.2	-6.74	4.71e-09	4.93e-05	-0.8	-0.64	Red blood cell count;	chr6:134972374	chr6:135055033~135060550:+
READ	cis	rs7208859	0.673	rs3816780	ENSG00000263531.1	RP13-753N3.1	6.74	4.78e-09	4.98e-05	1.11	0.64	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30834340	chr17:30863921~30864940:-
READ	cis	rs858239	0.6	rs13438188	ENSG00000230658.1	KLHL7-AS1	-6.73	4.9e-09	5.09e-05	-0.79	-0.64	Cerebrospinal fluid biomarker levels;	chr7:23104578	chr7:23101228~23105703:-
READ	cis	rs875971	0.964	rs6978429	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66494889	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4718357	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66495891	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs12535036	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66499076	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs12533997	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66500390	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs12698523	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66503126	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6970030	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66503692	chr7:66654538~66669855:+
READ	cis	rs875971	0.928	rs6970357	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66503891	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs3735148	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66506022	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs60193905	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66506273	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs10950041	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66508888	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs6970860	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66511647	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6957199	ENSG00000226824.5	RP4-756H11.3	-6.73	4.92e-09	5.09e-05	-0.7	-0.64	Aortic root size;	chr7:66513532	chr7:66654538~66669855:+
READ	cis	rs858239	0.539	rs10254544	ENSG00000230658.1	KLHL7-AS1	6.72	5.07e-09	5.23e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23180616	chr7:23101228~23105703:-
READ	cis	rs858239	0.508	rs10242104	ENSG00000230658.1	KLHL7-AS1	6.72	5.07e-09	5.23e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23180831	chr7:23101228~23105703:-
READ	cis	rs858239	0.537	rs2286272	ENSG00000230658.1	KLHL7-AS1	6.72	5.07e-09	5.23e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23184748	chr7:23101228~23105703:-
READ	cis	rs858239	0.537	rs6955115	ENSG00000230658.1	KLHL7-AS1	6.72	5.07e-09	5.23e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23187525	chr7:23101228~23105703:-
READ	cis	rs875971	1	rs12532998	ENSG00000226824.5	RP4-756H11.3	-6.72	5.1e-09	5.25e-05	-0.7	-0.64	Aortic root size;	chr7:66502472	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs10239760	ENSG00000230658.1	KLHL7-AS1	6.71	5.37e-09	5.53e-05	0.85	0.64	Cerebrospinal fluid biomarker levels;	chr7:23110331	chr7:23101228~23105703:-
READ	cis	rs2019137	0.56	rs7578633	ENSG00000274877.1	RP11-65I12.1	-6.7	5.42e-09	5.53e-05	-0.72	-0.64	Lymphocyte counts;	chr2:113221073	chr2:113237595~113240825:+
READ	cis	rs2019137	0.539	rs11123170	ENSG00000274877.1	RP11-65I12.1	-6.7	5.42e-09	5.53e-05	-0.72	-0.64	Lymphocyte counts;	chr2:113221363	chr2:113237595~113240825:+
READ	cis	rs2019137	0.56	rs6707386	ENSG00000274877.1	RP11-65I12.1	-6.7	5.42e-09	5.53e-05	-0.72	-0.64	Lymphocyte counts;	chr2:113223445	chr2:113237595~113240825:+
READ	cis	rs9309473	0.898	rs10209517	ENSG00000163016.8	ALMS1P	6.7	5.56e-09	5.67e-05	0.88	0.64	Metabolite levels;	chr2:73618265	chr2:73644919~73685576:+
READ	cis	rs858239	0.6	rs7341483	ENSG00000230658.1	KLHL7-AS1	-6.69	5.72e-09	5.83e-05	-0.8	-0.64	Cerebrospinal fluid biomarker levels;	chr7:23088038	chr7:23101228~23105703:-
READ	cis	rs875971	0.964	rs12668936	ENSG00000226824.5	RP4-756H11.3	-6.68	5.87e-09	5.98e-05	-0.72	-0.64	Aortic root size;	chr7:66449417	chr7:66654538~66669855:+
READ	cis	rs9309473	1	rs3813227	ENSG00000163016.8	ALMS1P	-6.68	5.99e-09	6.1e-05	-0.95	-0.64	Metabolite levels;	chr2:73424839	chr2:73644919~73685576:+
READ	cis	rs11155671	0.53	rs9383940	ENSG00000216906.2	RP11-350J20.9	6.68	6.01e-09	6.11e-05	0.83	0.64	Testicular germ cell tumor;	chr6:149904923	chr6:149904243~149906418:+
READ	cis	rs858239	0.698	rs858295	ENSG00000230658.1	KLHL7-AS1	6.67	6.15e-09	6.24e-05	0.8	0.63	Cerebrospinal fluid biomarker levels;	chr7:23205950	chr7:23101228~23105703:-
READ	cis	rs858239	0.73	rs858290	ENSG00000230658.1	KLHL7-AS1	6.67	6.15e-09	6.24e-05	0.8	0.63	Cerebrospinal fluid biomarker levels;	chr7:23208417	chr7:23101228~23105703:-
READ	cis	rs858239	0.73	rs858289	ENSG00000230658.1	KLHL7-AS1	6.67	6.15e-09	6.24e-05	0.8	0.63	Cerebrospinal fluid biomarker levels;	chr7:23208539	chr7:23101228~23105703:-
READ	cis	rs12439619	0.693	rs17269819	ENSG00000278603.1	RP13-608F4.5	6.67	6.26e-09	6.34e-05	0.92	0.63	Intelligence (multi-trait analysis);	chr15:82174660	chr15:82472203~82472426:+
READ	cis	rs12439619	0.693	rs8034801	ENSG00000278603.1	RP13-608F4.5	6.67	6.26e-09	6.34e-05	0.92	0.63	Intelligence (multi-trait analysis);	chr15:82183996	chr15:82472203~82472426:+
READ	cis	rs3814244	0.788	rs3741649	ENSG00000255733.4	IFNG-AS1	-6.67	6.27e-09	6.34e-05	-0.64	-0.63	Itch intensity from mosquito bite adjusted by bite size;	chr12:68028351	chr12:67989445~68234686:+
READ	cis	rs3814244	0.788	rs11177014	ENSG00000255733.4	IFNG-AS1	-6.67	6.27e-09	6.34e-05	-0.64	-0.63	Itch intensity from mosquito bite adjusted by bite size;	chr12:68031871	chr12:67989445~68234686:+
READ	cis	rs2739330	0.796	rs1006771	ENSG00000218537.1	MIF-AS1	6.67	6.3e-09	6.36e-05	0.78	0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23971817	chr22:23894426~23898930:-
READ	cis	rs2882667	0.929	rs34846849	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139024889	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11957633	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139028705	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11951899	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139038621	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs35812969	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139041861	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11242442	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139044800	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs17207870	ENSG00000253404.1	AC034243.1	6.67	6.31e-09	6.36e-05	0.78	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:139052048	chr5:138744434~138753309:-
READ	cis	rs1930961	1	rs6004662	ENSG00000100058.11	CRYBB2P1	6.67	6.35e-09	6.4e-05	1.39	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25466157	chr22:25448105~25520854:+
READ	cis	rs875971	1	rs6946143	ENSG00000226824.5	RP4-756H11.3	-6.66	6.56e-09	6.48e-05	-0.7	-0.63	Aortic root size;	chr7:66114735	chr7:66654538~66669855:+
READ	cis	rs9309473	0.904	rs78450880	ENSG00000163016.8	ALMS1P	6.66	6.6e-09	6.51e-05	0.86	0.63	Metabolite levels;	chr2:73594254	chr2:73644919~73685576:+
READ	cis	rs9309473	0.904	rs79145598	ENSG00000163016.8	ALMS1P	6.66	6.6e-09	6.51e-05	0.86	0.63	Metabolite levels;	chr2:73594255	chr2:73644919~73685576:+
READ	cis	rs9309473	0.904	rs62149783	ENSG00000163016.8	ALMS1P	6.66	6.6e-09	6.51e-05	0.86	0.63	Metabolite levels;	chr2:73594257	chr2:73644919~73685576:+
READ	cis	rs2882667	0.964	rs11958050	ENSG00000253404.1	AC034243.1	6.65	6.75e-09	6.66e-05	0.79	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138966139	chr5:138744434~138753309:-
READ	cis	rs3814244	0.788	rs3741647	ENSG00000255733.4	IFNG-AS1	-6.64	6.9e-09	6.79e-05	-0.63	-0.63	Itch intensity from mosquito bite adjusted by bite size;	chr12:68028249	chr12:67989445~68234686:+
READ	cis	rs6964833	0.935	rs35735900	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74651887	chr7:74894116~74897835:+
READ	cis	rs6964833	0.872	rs4717903	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74653827	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs13227433	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74680386	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs6967152	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74684983	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs6964833	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74687575	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs35203738	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74690864	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs2301907	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74700517	chr7:74894116~74897835:+
READ	cis	rs6964833	0.935	rs7795281	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74708523	chr7:74894116~74897835:+
READ	cis	rs6964833	0.935	rs7795282	ENSG00000123965.13	PMS2P5	6.63	7.23e-09	7.09e-05	0.85	0.63	Menarche (age at onset);	chr7:74708526	chr7:74894116~74897835:+
READ	cis	rs858239	0.6	rs6461691	ENSG00000230658.1	KLHL7-AS1	6.63	7.46e-09	7.27e-05	0.82	0.63	Cerebrospinal fluid biomarker levels;	chr7:23099726	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs4628176	ENSG00000230658.1	KLHL7-AS1	6.63	7.46e-09	7.27e-05	0.82	0.63	Cerebrospinal fluid biomarker levels;	chr7:23102947	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10488077	ENSG00000230658.1	KLHL7-AS1	6.63	7.46e-09	7.27e-05	0.82	0.63	Cerebrospinal fluid biomarker levels;	chr7:23104563	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs10241208	ENSG00000230658.1	KLHL7-AS1	6.63	7.46e-09	7.27e-05	0.82	0.63	Cerebrospinal fluid biomarker levels;	chr7:23105295	chr7:23101228~23105703:-
READ	cis	rs6964833	0.935	rs13238996	ENSG00000123965.13	PMS2P5	6.62	7.48e-09	7.27e-05	0.88	0.63	Menarche (age at onset);	chr7:74655318	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs36044436	ENSG00000123965.13	PMS2P5	6.62	7.48e-09	7.27e-05	0.88	0.63	Menarche (age at onset);	chr7:74675495	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs34324835	ENSG00000123965.13	PMS2P5	6.62	7.48e-09	7.27e-05	0.88	0.63	Menarche (age at onset);	chr7:74717986	chr7:74894116~74897835:+
READ	cis	rs916888	0.738	rs199515	ENSG00000214401.4	KANSL1-AS1	-6.62	7.53e-09	7.31e-05	-0.99	-0.63	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779275	chr17:46193576~46196723:+
READ	cis	rs875971	1	rs55962648	ENSG00000226824.5	RP4-756H11.3	6.62	7.58e-09	7.35e-05	0.7	0.63	Aortic root size;	chr7:66160764	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2420168	ENSG00000226824.5	RP4-756H11.3	6.62	7.58e-09	7.35e-05	0.7	0.63	Aortic root size;	chr7:66165644	chr7:66654538~66669855:+
READ	cis	rs875971	0.867	rs1002053	ENSG00000226824.5	RP4-756H11.3	6.61	8.07e-09	7.78e-05	0.7	0.63	Aortic root size;	chr7:66333558	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6956179	ENSG00000226824.5	RP4-756H11.3	6.61	8.07e-09	7.78e-05	0.7	0.63	Aortic root size;	chr7:66341672	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6460292	ENSG00000226824.5	RP4-756H11.3	6.61	8.07e-09	7.78e-05	0.7	0.63	Aortic root size;	chr7:66345088	chr7:66654538~66669855:+
READ	cis	rs9322193	0.576	rs7452592	ENSG00000231760.4	RP11-350J20.5	6.6	8.12e-09	7.82e-05	0.92	0.63	Lung cancer;	chr6:149875445	chr6:149796151~149826294:-
READ	cis	rs875971	0.522	rs1617484	ENSG00000226824.5	RP4-756H11.3	-6.6	8.13e-09	7.82e-05	-0.72	-0.63	Aortic root size;	chr7:65998108	chr7:66654538~66669855:+
READ	cis	rs9309473	1	rs11893881	ENSG00000163016.8	ALMS1P	6.6	8.13e-09	7.82e-05	0.86	0.63	Metabolite levels;	chr2:73597246	chr2:73644919~73685576:+
READ	cis	rs2882667	0.931	rs10044736	ENSG00000253404.1	AC034243.1	-6.6	8.32e-09	8e-05	-0.75	-0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138985120	chr5:138744434~138753309:-
READ	cis	rs2019137	0.56	rs7578633	ENSG00000189223.12	PAX8-AS1	-6.59	8.5e-09	8.15e-05	-0.77	-0.63	Lymphocyte counts;	chr2:113221073	chr2:113211522~113276581:+
READ	cis	rs2019137	0.539	rs11123170	ENSG00000189223.12	PAX8-AS1	-6.59	8.5e-09	8.15e-05	-0.77	-0.63	Lymphocyte counts;	chr2:113221363	chr2:113211522~113276581:+
READ	cis	rs2019137	0.56	rs6707386	ENSG00000189223.12	PAX8-AS1	-6.59	8.5e-09	8.15e-05	-0.77	-0.63	Lymphocyte counts;	chr2:113223445	chr2:113211522~113276581:+
READ	cis	rs875971	1	rs6945843	ENSG00000226824.5	RP4-756H11.3	6.59	8.58e-09	8.22e-05	0.7	0.63	Aortic root size;	chr7:66269796	chr7:66654538~66669855:+
READ	cis	rs858239	0.6	rs7776644	ENSG00000230658.1	KLHL7-AS1	6.59	8.63e-09	8.26e-05	0.78	0.63	Cerebrospinal fluid biomarker levels;	chr7:23079688	chr7:23101228~23105703:-
READ	cis	rs875971	1	rs7789554	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66481051	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4717300	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66482393	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs1974769	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66485627	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs6460300	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66487937	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7803416	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66489212	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1981799	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66490572	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs2277911	ENSG00000226824.5	RP4-756H11.3	-6.59	8.76e-09	8.36e-05	-0.7	-0.63	Aortic root size;	chr7:66493638	chr7:66654538~66669855:+
READ	cis	rs9399135	0.967	rs13199205	ENSG00000232876.1	CTA-212D2.2	-6.59	8.78e-09	8.37e-05	-0.79	-0.63	Red blood cell count;	chr6:134965367	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs4445070	ENSG00000232876.1	CTA-212D2.2	-6.59	8.78e-09	8.37e-05	-0.79	-0.63	Red blood cell count;	chr6:134988074	chr6:135055033~135060550:+
READ	cis	rs875971	1	rs11974219	ENSG00000226824.5	RP4-756H11.3	6.58	8.87e-09	8.43e-05	0.7	0.63	Aortic root size;	chr7:66182423	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1565531	ENSG00000226824.5	RP4-756H11.3	6.58	8.87e-09	8.43e-05	0.7	0.63	Aortic root size;	chr7:66198126	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6963646	ENSG00000226824.5	RP4-756H11.3	6.58	8.87e-09	8.43e-05	0.7	0.63	Aortic root size;	chr7:66220780	chr7:66654538~66669855:+
READ	cis	rs875971	0.965	rs28682868	ENSG00000226824.5	RP4-756H11.3	6.58	8.87e-09	8.43e-05	0.7	0.63	Aortic root size;	chr7:66224822	chr7:66654538~66669855:+
READ	cis	rs875971	0.965	rs9969301	ENSG00000226824.5	RP4-756H11.3	6.58	8.87e-09	8.43e-05	0.7	0.63	Aortic root size;	chr7:66316668	chr7:66654538~66669855:+
READ	cis	rs2019137	0.56	rs7421852	ENSG00000189223.12	PAX8-AS1	-6.57	9.23e-09	8.76e-05	-0.77	-0.63	Lymphocyte counts;	chr2:113232684	chr2:113211522~113276581:+
READ	cis	rs11155671	0.53	rs2342767	ENSG00000216906.2	RP11-350J20.9	6.57	9.33e-09	8.84e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149888581	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs7764376	ENSG00000216906.2	RP11-350J20.9	6.57	9.33e-09	8.84e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149889208	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs6933882	ENSG00000216906.2	RP11-350J20.9	6.57	9.33e-09	8.84e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149889666	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs6939761	ENSG00000216906.2	RP11-350J20.9	6.57	9.33e-09	8.84e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149889858	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs3823021	ENSG00000216906.2	RP11-350J20.9	6.57	9.33e-09	8.84e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149889863	chr6:149904243~149906418:+
READ	cis	rs9399135	0.967	rs9399129	ENSG00000232876.1	CTA-212D2.2	-6.57	9.36e-09	8.86e-05	-0.8	-0.63	Red blood cell count;	chr6:134964010	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4896119	ENSG00000232876.1	CTA-212D2.2	-6.57	9.36e-09	8.86e-05	-0.8	-0.63	Red blood cell count;	chr6:134972253	chr6:135055033~135060550:+
READ	cis	rs2882667	0.931	rs11955952	ENSG00000253404.1	AC034243.1	6.57	9.45e-09	8.89e-05	0.74	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138993430	chr5:138744434~138753309:-
READ	cis	rs9399135	0.933	rs7755680	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134973121	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9376077	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134978575	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6925424	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134992810	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7741626	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134993044	chr6:135055033~135060550:+
READ	cis	rs9399135	0.904	rs4895438	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134996527	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4895439	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134997716	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs17638970	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:134998925	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs11754504	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135000371	chr6:135055033~135060550:+
READ	cis	rs9402673	0.558	rs9688342	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	High light scatter reticulocyte count;Reticulocyte count;	chr6:135001888	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs45544135	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135002913	chr6:135055033~135060550:+
READ	cis	rs9399135	0.933	rs4559100	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135002947	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs12527707	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135003373	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389251	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135004579	chr6:135055033~135060550:+
READ	cis	rs9399135	0.869	rs9402675	ENSG00000232876.1	CTA-212D2.2	-6.57	9.45e-09	8.89e-05	-0.8	-0.63	Red blood cell count;	chr6:135004656	chr6:135055033~135060550:+
READ	cis	rs2739330	0.731	rs5751792	ENSG00000250470.1	AP000351.3	6.57	9.54e-09	8.97e-05	0.83	0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23976904~23977585:-
READ	cis	rs858239	0.6	rs10266123	ENSG00000230658.1	KLHL7-AS1	6.56	9.61e-09	9.03e-05	0.82	0.63	Cerebrospinal fluid biomarker levels;	chr7:23096868	chr7:23101228~23105703:-
READ	cis	rs2882667	0.964	rs67296915	ENSG00000253404.1	AC034243.1	6.56	9.64e-09	9.06e-05	0.77	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138965910	chr5:138744434~138753309:-
READ	cis	rs2739330	0.761	rs5760176	ENSG00000250470.1	AP000351.3	-6.56	9.7e-09	9.1e-05	-0.83	-0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23976904~23977585:-
READ	cis	rs875971	1	rs9986696	ENSG00000226824.5	RP4-756H11.3	6.56	9.73e-09	9.11e-05	0.7	0.63	Aortic root size;	chr7:66239589	chr7:66654538~66669855:+
READ	cis	rs1930961	1	rs6004669	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25479836	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs5996946	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25480021	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs997873	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25482315	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs997872	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25482647	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004671	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25483507	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004672	ENSG00000100058.11	CRYBB2P1	6.55	1e-08	9.34e-05	1.54	0.63	Bipolar disorder with mood-incongruent psychosis;	chr22:25485046	chr22:25448105~25520854:+
READ	cis	rs9309473	1	rs6710438	ENSG00000163016.8	ALMS1P	-6.55	1.01e-08	9.35e-05	-0.86	-0.63	Metabolite levels;	chr2:73592981	chr2:73644919~73685576:+
READ	cis	rs2019137	0.539	rs6755040	ENSG00000274877.1	RP11-65I12.1	-6.55	1.01e-08	9.35e-05	-0.7	-0.63	Lymphocyte counts;	chr2:113223560	chr2:113237595~113240825:+
READ	cis	rs11155671	0.53	rs9383912	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149885479	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9383577	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886059	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9383914	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886098	chr6:149904243~149906418:+
READ	cis	rs11155671	0.517	rs9397058	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886113	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs7768626	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886826	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs7768665	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886888	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs7758020	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149886975	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9322228	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149888173	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs7774787	ENSG00000216906.2	RP11-350J20.9	6.55	1.02e-08	9.35e-05	0.79	0.63	Testicular germ cell tumor;	chr6:149888296	chr6:149904243~149906418:+
READ	cis	rs875971	1	rs778726	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66363744	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs778723	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66364510	chr7:66654538~66669855:+
READ	cis	rs875971	0.767	rs1695815	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66366357	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778685	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66371189	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs778682	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66372947	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs11765965	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66377234	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs1643388	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66379575	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778722	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66379841	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs778721	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66380410	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs778712	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66384991	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778710	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66389847	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs778708	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66391332	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778706	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66395437	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs778700	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66401463	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778699	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66403303	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778696	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66405826	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs778694	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66406571	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs778692	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66407462	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4718343	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66409301	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4718344	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66409394	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1968225	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66409786	chr7:66654538~66669855:+
READ	cis	rs875971	0.737	rs7803424	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66415618	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs7799834	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66415707	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6460295	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66417741	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs6978721	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66418217	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2077593	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66427543	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6460296	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66430152	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs4717292	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66430611	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs4718349	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66444024	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2420591	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66447394	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs10755833	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66448930	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs12698520	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66453720	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs4122249	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66455949	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs1833495	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66456608	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs6945032	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66457499	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs12673810	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66458866	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs35149210	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66464938	chr7:66654538~66669855:+
READ	cis	rs875971	0.929	rs34406470	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66464969	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2042133	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66466935	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs2161065	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66467918	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6961155	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66468308	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs3857684	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66473171	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs7789768	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66473993	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs12698521	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66474502	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1363055	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66478288	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs9691480	ENSG00000226824.5	RP4-756H11.3	-6.55	1.02e-08	9.35e-05	-0.7	-0.63	Aortic root size;	chr7:66479319	chr7:66654538~66669855:+
READ	cis	rs916888	0.821	rs199504	ENSG00000214401.4	KANSL1-AS1	-6.55	1.03e-08	9.37e-05	-0.98	-0.63	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46783637	chr17:46193576~46196723:+
READ	cis	rs2019137	0.539	rs4849177	ENSG00000274877.1	RP11-65I12.1	-6.54	1.06e-08	9.62e-05	-0.7	-0.63	Lymphocyte counts;	chr2:113225007	chr2:113237595~113240825:+
READ	cis	rs2019137	0.56	rs4849179	ENSG00000274877.1	RP11-65I12.1	-6.54	1.06e-08	9.62e-05	-0.7	-0.63	Lymphocyte counts;	chr2:113227593	chr2:113237595~113240825:+
READ	cis	rs2019137	0.56	rs10175462	ENSG00000274877.1	RP11-65I12.1	-6.54	1.06e-08	9.62e-05	-0.7	-0.63	Lymphocyte counts;	chr2:113230915	chr2:113237595~113240825:+
READ	cis	rs2019137	0.56	rs11123172	ENSG00000274877.1	RP11-65I12.1	6.54	1.06e-08	9.62e-05	0.7	0.63	Lymphocyte counts;	chr2:113226726	chr2:113237595~113240825:+
READ	cis	rs2019137	0.56	rs10206269	ENSG00000189223.12	PAX8-AS1	-6.53	1.08e-08	9.84e-05	-0.77	-0.63	Lymphocyte counts;	chr2:113232816	chr2:113211522~113276581:+
READ	cis	rs9309473	1	rs56672945	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73395535	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs60844734	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73396077	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs11899902	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73404436	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs13383871	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73404651	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs13428235	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73406302	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7580825	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73408020	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10179134	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73410391	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6755241	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73414236	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7564890	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73414725	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6705489	ENSG00000163016.8	ALMS1P	6.53	1.09e-08	9.87e-05	0.92	0.63	Metabolite levels;	chr2:73421683	chr2:73644919~73685576:+
READ	cis	rs858239	0.699	rs955187	ENSG00000230658.1	KLHL7-AS1	-6.53	1.1e-08	9.94e-05	-0.81	-0.63	Cerebrospinal fluid biomarker levels;	chr7:23154986	chr7:23101228~23105703:-
READ	cis	rs858239	0.633	rs858300	ENSG00000230658.1	KLHL7-AS1	6.51	1.2e-08	0.000107	0.79	0.63	Cerebrospinal fluid biomarker levels;	chr7:23205012	chr7:23101228~23105703:-
READ	cis	rs9309473	0.95	rs11689588	ENSG00000163016.8	ALMS1P	6.5	1.22e-08	0.000109	0.89	0.62	Metabolite levels;	chr2:73546564	chr2:73644919~73685576:+
READ	cis	rs6964833	1	rs3846966	ENSG00000123965.13	PMS2P5	6.5	1.23e-08	0.00011	0.86	0.62	Menarche (age at onset);	chr7:74698811	chr7:74894116~74897835:+
READ	cis	rs6964833	1	rs17515241	ENSG00000123965.13	PMS2P5	-6.5	1.24e-08	0.00011	-0.87	-0.62	Menarche (age at onset);	chr7:74717695	chr7:74894116~74897835:+
READ	cis	rs7208859	0.725	rs9897673	ENSG00000263531.1	RP13-753N3.1	6.5	1.24e-08	0.000111	0.93	0.62	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30916348	chr17:30863921~30864940:-
READ	cis	rs2882667	0.858	rs6882112	ENSG00000253404.1	AC034243.1	-6.5	1.26e-08	0.000112	-0.75	-0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:139078046	chr5:138744434~138753309:-
READ	cis	rs1930961	1	rs6519611	ENSG00000100058.11	CRYBB2P1	6.49	1.29e-08	0.000114	1.37	0.62	Bipolar disorder with mood-incongruent psychosis;	chr22:25449888	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs9624836	ENSG00000100058.11	CRYBB2P1	6.49	1.29e-08	0.000114	1.37	0.62	Bipolar disorder with mood-incongruent psychosis;	chr22:25450120	chr22:25448105~25520854:+
READ	cis	rs1930961	0.867	rs6423498	ENSG00000100058.11	CRYBB2P1	6.49	1.29e-08	0.000114	1.37	0.62	Bipolar disorder with mood-incongruent psychosis;	chr22:25457401	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004654	ENSG00000100058.11	CRYBB2P1	6.49	1.29e-08	0.000114	1.37	0.62	Bipolar disorder with mood-incongruent psychosis;	chr22:25459237	chr22:25448105~25520854:+
READ	cis	rs1930961	1	rs6004658	ENSG00000100058.11	CRYBB2P1	6.49	1.29e-08	0.000114	1.37	0.62	Bipolar disorder with mood-incongruent psychosis;	chr22:25460264	chr22:25448105~25520854:+
READ	cis	rs858239	0.539	rs6965833	ENSG00000230658.1	KLHL7-AS1	6.49	1.3e-08	0.000116	0.81	0.62	Cerebrospinal fluid biomarker levels;	chr7:23152747	chr7:23101228~23105703:-
READ	cis	rs858239	0.539	rs6949363	ENSG00000230658.1	KLHL7-AS1	6.49	1.3e-08	0.000116	0.81	0.62	Cerebrospinal fluid biomarker levels;	chr7:23152775	chr7:23101228~23105703:-
READ	cis	rs875971	1	rs709595	ENSG00000226824.5	RP4-756H11.3	-6.49	1.31e-08	0.000116	-0.69	-0.62	Aortic root size;	chr7:66352346	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs811880	ENSG00000226824.5	RP4-756H11.3	-6.49	1.31e-08	0.000116	-0.69	-0.62	Aortic root size;	chr7:66353659	chr7:66654538~66669855:+
READ	cis	rs9309473	0.95	rs6745480	ENSG00000163016.8	ALMS1P	6.48	1.36e-08	0.00012	0.87	0.62	Metabolite levels;	chr2:73612928	chr2:73644919~73685576:+
READ	cis	rs9399135	0.967	rs6923827	ENSG00000232876.1	CTA-212D2.2	-6.47	1.4e-08	0.000122	-0.78	-0.62	Red blood cell count;	chr6:135014244	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs6569988	ENSG00000232876.1	CTA-212D2.2	-6.47	1.4e-08	0.000122	-0.78	-0.62	Red blood cell count;	chr6:135031165	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs4896130	ENSG00000232876.1	CTA-212D2.2	-6.47	1.4e-08	0.000122	-0.78	-0.62	Red blood cell count;	chr6:135033980	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs11754265	ENSG00000232876.1	CTA-212D2.2	-6.47	1.4e-08	0.000122	-0.78	-0.62	Red blood cell count;	chr6:135035078	chr6:135055033~135060550:+
READ	cis	rs9399135	1	rs9399135	ENSG00000232876.1	CTA-212D2.2	-6.47	1.4e-08	0.000122	-0.78	-0.62	Red blood cell count;	chr6:135047176	chr6:135055033~135060550:+
READ	cis	rs2882667	0.964	rs12108892	ENSG00000253404.1	AC034243.1	6.47	1.41e-08	0.000123	0.76	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138963941	chr5:138744434~138753309:-
READ	cis	rs2739330	0.734	rs2000467	ENSG00000218537.1	MIF-AS1	-6.47	1.41e-08	0.000123	-0.73	-0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899346	chr22:23894426~23898930:-
READ	cis	rs11155671	0.53	rs7757984	ENSG00000216906.2	RP11-350J20.9	6.47	1.41e-08	0.000123	0.78	0.62	Testicular germ cell tumor;	chr6:149887515	chr6:149904243~149906418:+
READ	cis	rs1577917	0.56	rs9450288	ENSG00000203875.9	SNHG5	6.47	1.42e-08	0.000124	0.77	0.62	Response to antipsychotic treatment;	chr6:85511868	chr6:85660950~85678736:-
READ	cis	rs7208859	0.573	rs8078182	ENSG00000263531.1	RP13-753N3.1	6.46	1.45e-08	0.000127	1.14	0.62	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822646	chr17:30863921~30864940:-
READ	cis	rs875971	0.862	rs6460302	ENSG00000226824.5	RP4-756H11.3	-6.46	1.47e-08	0.000128	-0.69	-0.62	Aortic root size;	chr7:66495270	chr7:66654538~66669855:+
READ	cis	rs9399135	1	rs1014021	ENSG00000232876.1	CTA-212D2.2	6.45	1.49e-08	0.000129	0.78	0.62	Red blood cell count;	chr6:135013462	chr6:135055033~135060550:+
READ	cis	rs858239	0.536	rs6956974	ENSG00000230658.1	KLHL7-AS1	-6.45	1.49e-08	0.000129	-0.79	-0.62	Cerebrospinal fluid biomarker levels;	chr7:23212699	chr7:23101228~23105703:-
READ	cis	rs2019137	0.56	rs11123172	ENSG00000189223.12	PAX8-AS1	6.45	1.5e-08	0.00013	0.75	0.62	Lymphocyte counts;	chr2:113226726	chr2:113211522~113276581:+
READ	cis	rs2019137	0.539	rs4849177	ENSG00000189223.12	PAX8-AS1	-6.45	1.5e-08	0.00013	-0.75	-0.62	Lymphocyte counts;	chr2:113225007	chr2:113211522~113276581:+
READ	cis	rs2019137	0.56	rs4849179	ENSG00000189223.12	PAX8-AS1	-6.45	1.5e-08	0.00013	-0.75	-0.62	Lymphocyte counts;	chr2:113227593	chr2:113211522~113276581:+
READ	cis	rs2019137	0.56	rs10175462	ENSG00000189223.12	PAX8-AS1	-6.45	1.5e-08	0.00013	-0.75	-0.62	Lymphocyte counts;	chr2:113230915	chr2:113211522~113276581:+
READ	cis	rs875971	1	rs3981131	ENSG00000226824.5	RP4-756H11.3	-6.45	1.51e-08	0.00013	-0.69	-0.62	Aortic root size;	chr7:66486690	chr7:66654538~66669855:+
READ	cis	rs875971	0.838	rs2173570	ENSG00000226824.5	RP4-756H11.3	6.45	1.54e-08	0.000133	0.69	0.62	Aortic root size;	chr7:66297976	chr7:66654538~66669855:+
READ	cis	rs9309473	1	rs11689392	ENSG00000163016.8	ALMS1P	6.44	1.55e-08	0.000134	0.92	0.62	Metabolite levels;	chr2:73394898	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10184268	ENSG00000163016.8	ALMS1P	6.44	1.55e-08	0.000134	0.92	0.62	Metabolite levels;	chr2:73399916	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs1534471	ENSG00000163016.8	ALMS1P	6.44	1.55e-08	0.000134	0.92	0.62	Metabolite levels;	chr2:73420380	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs1881245	ENSG00000163016.8	ALMS1P	6.44	1.55e-08	0.000134	0.92	0.62	Metabolite levels;	chr2:73422800	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs13391552	ENSG00000163016.8	ALMS1P	6.44	1.57e-08	0.000135	0.82	0.62	Metabolite levels;	chr2:73591809	chr2:73644919~73685576:+
READ	cis	rs2882667	0.858	rs11744972	ENSG00000253404.1	AC034243.1	6.44	1.57e-08	0.000135	0.77	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:139093100	chr5:138744434~138753309:-
READ	cis	rs858239	0.669	rs10950940	ENSG00000230658.1	KLHL7-AS1	-6.44	1.6e-08	0.000138	-0.81	-0.62	Cerebrospinal fluid biomarker levels;	chr7:23157197	chr7:23101228~23105703:-
READ	cis	rs1577917	0.816	rs12664099	ENSG00000203875.9	SNHG5	-6.43	1.63e-08	0.00014	-0.81	-0.62	Response to antipsychotic treatment;	chr6:85938854	chr6:85660950~85678736:-
READ	cis	rs2019137	0.539	rs6755040	ENSG00000189223.12	PAX8-AS1	-6.43	1.64e-08	0.00014	-0.75	-0.62	Lymphocyte counts;	chr2:113223560	chr2:113211522~113276581:+
READ	cis	rs11155671	0.53	rs7756850	ENSG00000216906.2	RP11-350J20.9	6.43	1.67e-08	0.000142	0.79	0.62	Testicular germ cell tumor;	chr6:149891460	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9371542	ENSG00000216906.2	RP11-350J20.9	6.43	1.67e-08	0.000142	0.79	0.62	Testicular germ cell tumor;	chr6:149891949	chr6:149904243~149906418:+
READ	cis	rs9322193	0.567	rs7747457	ENSG00000216906.2	RP11-350J20.9	6.43	1.67e-08	0.000142	0.79	0.62	Lung cancer;	chr6:149892366	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9371223	ENSG00000216906.2	RP11-350J20.9	6.43	1.67e-08	0.000142	0.79	0.62	Testicular germ cell tumor;	chr6:149893670	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs2342769	ENSG00000216906.2	RP11-350J20.9	6.43	1.67e-08	0.000142	0.79	0.62	Testicular germ cell tumor;	chr6:149895371	chr6:149904243~149906418:+
READ	cis	rs6964833	1	rs4717907	ENSG00000123965.13	PMS2P5	6.42	1.69e-08	0.000143	0.83	0.62	Menarche (age at onset);	chr7:74672169	chr7:74894116~74897835:+
READ	cis	rs875971	1	rs697970	ENSG00000226824.5	RP4-756H11.3	6.42	1.69e-08	0.000143	0.67	0.62	Aortic root size;	chr7:66095065	chr7:66654538~66669855:+
READ	cis	rs9326248	0.559	rs12808524	ENSG00000254851.1	RP11-109L13.1	-6.42	1.69e-08	0.000143	-0.79	-0.62	Blood protein levels;	chr11:117020277	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs9688517	ENSG00000216906.2	RP11-350J20.9	6.42	1.71e-08	0.000144	0.78	0.62	Lung cancer;	chr6:149740655	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12660304	ENSG00000216906.2	RP11-350J20.9	6.42	1.71e-08	0.000145	0.76	0.62	Lung cancer;	chr6:149739647	chr6:149904243~149906418:+
READ	cis	rs17264034	0.861	rs1508798	ENSG00000250786.1	SNHG18	-6.42	1.75e-08	0.000147	-0.84	-0.62	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9556582	chr5:9546200~9550609:+
READ	cis	rs9322193	0.923	rs9767105	ENSG00000216906.2	RP11-350J20.9	6.41	1.76e-08	0.000148	0.73	0.62	Lung cancer;	chr6:149659591	chr6:149904243~149906418:+
READ	cis	rs2882667	0.537	rs7701116	ENSG00000253404.1	AC034243.1	6.41	1.77e-08	0.000149	0.7	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:139070389	chr5:138744434~138753309:-
READ	cis	rs2882667	0.537	rs11743534	ENSG00000253404.1	AC034243.1	6.41	1.77e-08	0.000149	0.7	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:139073318	chr5:138744434~138753309:-
READ	cis	rs9309473	1	rs11899740	ENSG00000163016.8	ALMS1P	6.41	1.77e-08	0.000149	0.9	0.62	Metabolite levels;	chr2:73404084	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs6755217	ENSG00000163016.8	ALMS1P	6.41	1.77e-08	0.000149	0.9	0.62	Metabolite levels;	chr2:73414157	chr2:73644919~73685576:+
READ	cis	rs2739330	0.734	rs2000467	ENSG00000273295.1	AP000350.5	-6.41	1.77e-08	0.000149	-0.66	-0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899346	chr22:23901432~23907068:-
READ	cis	rs9399135	0.967	rs3756799	ENSG00000232876.1	CTA-212D2.2	-6.41	1.78e-08	0.000149	-0.78	-0.62	Red blood cell count;	chr6:135019873	chr6:135055033~135060550:+
READ	cis	rs4660456	0.871	rs669072	ENSG00000237899.1	RP4-739H11.3	6.4	1.83e-08	0.000153	0.99	0.62	Platelet count;	chr1:40679946	chr1:40669089~40687588:-
READ	cis	rs4660456	0.912	rs658806	ENSG00000237899.1	RP4-739H11.3	6.4	1.83e-08	0.000153	0.99	0.62	Platelet count;	chr1:40683312	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs489222	ENSG00000237899.1	RP4-739H11.3	6.4	1.83e-08	0.000153	0.99	0.62	Platelet count;	chr1:40683422	chr1:40669089~40687588:-
READ	cis	rs2882667	0.861	rs11242445	ENSG00000253404.1	AC034243.1	6.4	1.84e-08	0.000154	0.73	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:139081365	chr5:138744434~138753309:-
READ	cis	rs875971	0.83	rs4718358	ENSG00000226824.5	RP4-756H11.3	-6.4	1.84e-08	0.000154	-0.68	-0.62	Aortic root size;	chr7:66508681	chr7:66654538~66669855:+
READ	cis	rs858239	0.6	rs1468592	ENSG00000230658.1	KLHL7-AS1	-6.39	1.9e-08	0.000159	-0.78	-0.62	Cerebrospinal fluid biomarker levels;	chr7:23101028	chr7:23101228~23105703:-
READ	cis	rs858239	0.6	rs6967475	ENSG00000230658.1	KLHL7-AS1	6.39	1.92e-08	0.00016	0.76	0.62	Cerebrospinal fluid biomarker levels;	chr7:23089363	chr7:23101228~23105703:-
READ	cis	rs11155671	0.53	rs4869764	ENSG00000216906.2	RP11-350J20.9	6.39	1.93e-08	0.000161	0.79	0.62	Testicular germ cell tumor;	chr6:149890692	chr6:149904243~149906418:+
READ	cis	rs9322193	0.567	rs7742692	ENSG00000216906.2	RP11-350J20.9	6.39	1.93e-08	0.000161	0.79	0.62	Lung cancer;	chr6:149892363	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs4869763	ENSG00000216906.2	RP11-350J20.9	6.39	1.94e-08	0.000162	0.79	0.62	Testicular germ cell tumor;	chr6:149890548	chr6:149904243~149906418:+
READ	cis	rs11155671	0.546	rs1999633	ENSG00000231760.4	RP11-350J20.5	6.39	1.94e-08	0.000162	0.89	0.62	Testicular germ cell tumor;	chr6:149866576	chr6:149796151~149826294:-
READ	cis	rs2739330	0.761	rs5760176	ENSG00000218537.1	MIF-AS1	-6.39	1.95e-08	0.000162	-0.74	-0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23894426~23898930:-
READ	cis	rs875971	0.964	rs6945019	ENSG00000226824.5	RP4-756H11.3	-6.39	1.96e-08	0.000163	-0.7	-0.62	Aortic root size;	chr7:66457471	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs7792762	ENSG00000226824.5	RP4-756H11.3	-6.39	1.97e-08	0.000164	-0.7	-0.62	Aortic root size;	chr7:66539151	chr7:66654538~66669855:+
READ	cis	rs9399135	0.933	rs9389262	ENSG00000232876.1	CTA-212D2.2	-6.38	2.06e-08	0.00017	-0.79	-0.62	Red blood cell count;	chr6:135055271	chr6:135055033~135060550:+
READ	cis	rs11155671	0.53	rs7763849	ENSG00000216906.2	RP11-350J20.9	6.37	2.06e-08	0.00017	0.75	0.62	Testicular germ cell tumor;	chr6:149885244	chr6:149904243~149906418:+
READ	cis	rs858239	0.669	rs1618339	ENSG00000230658.1	KLHL7-AS1	6.37	2.08e-08	0.000172	0.8	0.62	Cerebrospinal fluid biomarker levels;	chr7:23190155	chr7:23101228~23105703:-
READ	cis	rs2906856	0.921	rs1019076	ENSG00000255733.4	IFNG-AS1	-6.37	2.09e-08	0.000172	-0.6	-0.62	Mosquito bite size;	chr12:68004338	chr12:67989445~68234686:+
READ	cis	rs3814244	0.515	rs2906862	ENSG00000255733.4	IFNG-AS1	-6.37	2.09e-08	0.000172	-0.6	-0.62	Itch intensity from mosquito bite adjusted by bite size;	chr12:68005371	chr12:67989445~68234686:+
READ	cis	rs858239	0.867	rs10250602	ENSG00000230658.1	KLHL7-AS1	6.37	2.12e-08	0.000175	0.84	0.62	Cerebrospinal fluid biomarker levels;	chr7:23264082	chr7:23101228~23105703:-
READ	cis	rs2739330	0.761	rs5760176	ENSG00000273295.1	AP000350.5	-6.37	2.13e-08	0.000175	-0.67	-0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23901432~23907068:-
READ	cis	rs6964833	1	rs4717906	ENSG00000123965.13	PMS2P5	6.36	2.21e-08	0.000182	0.87	0.62	Menarche (age at onset);	chr7:74671923	chr7:74894116~74897835:+
READ	cis	rs9309473	0.66	rs56131703	ENSG00000163016.8	ALMS1P	6.35	2.24e-08	0.000183	0.93	0.62	Metabolite levels;	chr2:73620133	chr2:73644919~73685576:+
READ	cis	rs9399135	0.967	rs2150681	ENSG00000232876.1	CTA-212D2.2	6.35	2.3e-08	0.000187	0.78	0.62	Red blood cell count;	chr6:135054094	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs1854865	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135039162	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7763836	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135041240	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6569990	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135044680	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs13191501	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135045742	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6908512	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135046619	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs34546690	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135048571	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs11755229	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135048775	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389261	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135050010	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9376085	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135050086	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9373122	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135052396	chr6:135055033~135060550:+
READ	cis	rs9399135	0.933	rs28384512	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135055094	chr6:135055033~135060550:+
READ	cis	rs9399135	0.933	rs41294852	ENSG00000232876.1	CTA-212D2.2	-6.35	2.3e-08	0.000187	-0.78	-0.62	Red blood cell count;	chr6:135055241	chr6:135055033~135060550:+
READ	cis	rs9322193	0.923	rs12529698	ENSG00000216906.2	RP11-350J20.9	6.35	2.32e-08	0.000188	0.76	0.62	Lung cancer;	chr6:149650951	chr6:149904243~149906418:+
READ	cis	rs2882667	0.929	rs17207828	ENSG00000253404.1	AC034243.1	6.34	2.33e-08	0.000189	0.76	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138964146	chr5:138744434~138753309:-
READ	cis	rs858239	0.72	rs10227559	ENSG00000230658.1	KLHL7-AS1	6.34	2.34e-08	0.00019	0.83	0.62	Cerebrospinal fluid biomarker levels;	chr7:23232525	chr7:23101228~23105703:-
READ	cis	rs2906856	0.524	rs56236103	ENSG00000255733.4	IFNG-AS1	6.34	2.37e-08	0.000192	0.74	0.62	Mosquito bite size;	chr12:67937437	chr12:67989445~68234686:+
READ	cis	rs9326248	0.581	rs10892063	ENSG00000254851.1	RP11-109L13.1	-6.34	2.39e-08	0.000193	-0.79	-0.62	Blood protein levels;	chr11:117025439	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs10892064	ENSG00000254851.1	RP11-109L13.1	-6.34	2.39e-08	0.000193	-0.79	-0.62	Blood protein levels;	chr11:117025837	chr11:117135528~117138582:+
READ	cis	rs9326248	0.539	rs10892065	ENSG00000254851.1	RP11-109L13.1	-6.34	2.39e-08	0.000193	-0.79	-0.62	Blood protein levels;	chr11:117026308	chr11:117135528~117138582:+
READ	cis	rs2019137	0.56	rs7421852	ENSG00000274877.1	RP11-65I12.1	-6.34	2.4e-08	0.000194	-0.7	-0.62	Lymphocyte counts;	chr2:113232684	chr2:113237595~113240825:+
READ	cis	rs4660456	1	rs4660456	ENSG00000237899.1	RP4-739H11.3	-6.34	2.42e-08	0.000195	-0.99	-0.61	Platelet count;	chr1:40773839	chr1:40669089~40687588:-
READ	cis	rs4660456	0.956	rs4660457	ENSG00000237899.1	RP4-739H11.3	-6.34	2.42e-08	0.000195	-0.99	-0.61	Platelet count;	chr1:40774121	chr1:40669089~40687588:-
READ	cis	rs7847628	0.55	rs12343516	ENSG00000226752.6	PSMD5-AS1	-6.33	2.43e-08	0.000196	-0.74	-0.61	Birth weight;	chr9:120841191	chr9:120824828~120854385:+
READ	cis	rs9399135	0.967	rs6929661	ENSG00000232876.1	CTA-212D2.2	-6.33	2.45e-08	0.000198	-0.79	-0.61	Red blood cell count;	chr6:135007654	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389253	ENSG00000232876.1	CTA-212D2.2	-6.33	2.45e-08	0.000198	-0.79	-0.61	Red blood cell count;	chr6:135008617	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs2327578	ENSG00000232876.1	CTA-212D2.2	-6.33	2.45e-08	0.000198	-0.79	-0.61	Red blood cell count;	chr6:135008831	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389254	ENSG00000232876.1	CTA-212D2.2	-6.33	2.45e-08	0.000198	-0.79	-0.61	Red blood cell count;	chr6:135009571	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389256	ENSG00000232876.1	CTA-212D2.2	-6.33	2.45e-08	0.000198	-0.79	-0.61	Red blood cell count;	chr6:135010116	chr6:135055033~135060550:+
READ	cis	rs858239	0.632	rs6952947	ENSG00000230658.1	KLHL7-AS1	-6.33	2.46e-08	0.000198	-0.74	-0.61	Cerebrospinal fluid biomarker levels;	chr7:23081423	chr7:23101228~23105703:-
READ	cis	rs9399135	0.967	rs12526055	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135004780	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs1014020	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135013288	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs1041481	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135013925	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6902438	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135015449	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs6908681	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135016595	chr6:135055033~135060550:+
READ	cis	rs9389248	0.5	rs116273677	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	High light scatter reticulocyte percentage of red cells;	chr6:135017997	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4896125	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135021431	chr6:135055033~135060550:+
READ	cis	rs9399135	0.838	rs4896126	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135021648	chr6:135055033~135060550:+
READ	cis	rs9402673	0.517	rs978036	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	High light scatter reticulocyte count;Reticulocyte count;	chr6:135021765	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs949547	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135022361	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs1023179	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135022691	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9376082	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135025251	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs2150680	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135025993	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs11756988	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135026457	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs11754783	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135026523	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs952674	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135028019	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs987690	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135029241	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7750300	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135029812	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6919862	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135031305	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs10872427	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135032314	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7766189	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135032713	chr6:135055033~135060550:+
READ	cis	rs9399135	0.816	rs4134030	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135032956	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9402676	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135034369	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9389258	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135040002	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs2327580	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135043279	chr6:135055033~135060550:+
READ	cis	rs9399135	0.844	rs13209789	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135046778	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6915770	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135048076	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs11759999	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135049357	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs11760000	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135049358	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs9376086	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135050191	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs1041480	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135051938	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs2297338	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135054624	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs2297340	ENSG00000232876.1	CTA-212D2.2	-6.33	2.5e-08	0.000199	-0.79	-0.61	Red blood cell count;	chr6:135054920	chr6:135055033~135060550:+
READ	cis	rs858239	0.601	rs6461702	ENSG00000230658.1	KLHL7-AS1	6.33	2.5e-08	0.000199	0.81	0.61	Cerebrospinal fluid biomarker levels;	chr7:23209654	chr7:23101228~23105703:-
READ	cis	rs2882667	0.858	rs11242447	ENSG00000253404.1	AC034243.1	6.33	2.51e-08	2e-04	0.76	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139090484	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11741150	ENSG00000253404.1	AC034243.1	6.33	2.51e-08	2e-04	0.76	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139095768	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs13177503	ENSG00000253404.1	AC034243.1	6.33	2.51e-08	2e-04	0.76	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139097070	chr5:138744434~138753309:-
READ	cis	rs3814244	0.966	rs10784666	ENSG00000255733.4	IFNG-AS1	-6.33	2.51e-08	2e-04	-0.64	-0.61	Itch intensity from mosquito bite adjusted by bite size;	chr12:68021923	chr12:67989445~68234686:+
READ	cis	rs3814244	0.966	rs10784667	ENSG00000255733.4	IFNG-AS1	-6.33	2.51e-08	2e-04	-0.64	-0.61	Itch intensity from mosquito bite adjusted by bite size;	chr12:68021996	chr12:67989445~68234686:+
READ	cis	rs3814244	0.515	rs2906856	ENSG00000255733.4	IFNG-AS1	-6.32	2.53e-08	0.000201	-0.59	-0.61	Itch intensity from mosquito bite adjusted by bite size;	chr12:67996421	chr12:67989445~68234686:+
READ	cis	rs858239	0.831	rs7796541	ENSG00000230658.1	KLHL7-AS1	6.32	2.54e-08	0.000202	0.75	0.61	Cerebrospinal fluid biomarker levels;	chr7:23349454	chr7:23101228~23105703:-
READ	cis	rs2882667	0.537	rs7701338	ENSG00000253404.1	AC034243.1	6.32	2.54e-08	0.000202	0.69	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139070305	chr5:138744434~138753309:-
READ	cis	rs9399135	0.967	rs1590975	ENSG00000232876.1	CTA-212D2.2	-6.32	2.55e-08	0.000202	-0.77	-0.61	Red blood cell count;	chr6:135030950	chr6:135055033~135060550:+
READ	cis	rs9326248	0.813	rs7115562	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117149754	chr11:117135528~117138582:+
READ	cis	rs9326248	0.727	rs4938347	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117151043	chr11:117135528~117138582:+
READ	cis	rs9326248	0.861	rs4938348	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117151161	chr11:117135528~117138582:+
READ	cis	rs9326248	0.813	rs4938350	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117151560	chr11:117135528~117138582:+
READ	cis	rs9326248	0.652	rs7128382	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117152771	chr11:117135528~117138582:+
READ	cis	rs9326248	0.768	rs4936366	ENSG00000254851.1	RP11-109L13.1	-6.32	2.55e-08	0.000202	-0.95	-0.61	Blood protein levels;	chr11:117156169	chr11:117135528~117138582:+
READ	cis	rs1577917	0.883	rs12214536	ENSG00000203875.9	SNHG5	-6.32	2.6e-08	0.000206	-0.86	-0.61	Response to antipsychotic treatment;	chr6:86080592	chr6:85660950~85678736:-
READ	cis	rs858239	0.665	rs858306	ENSG00000230658.1	KLHL7-AS1	6.32	2.61e-08	0.000206	0.78	0.61	Cerebrospinal fluid biomarker levels;	chr7:23203135	chr7:23101228~23105703:-
READ	cis	rs9399135	0.967	rs12527683	ENSG00000232876.1	CTA-212D2.2	-6.31	2.63e-08	0.000208	-0.79	-0.61	Red blood cell count;	chr6:135003396	chr6:135055033~135060550:+
READ	cis	rs11155671	0.53	rs7758033	ENSG00000216906.2	RP11-350J20.9	6.31	2.67e-08	0.000211	0.78	0.61	Testicular germ cell tumor;	chr6:149886999	chr6:149904243~149906418:+
READ	cis	rs1930961	1	rs6004673	ENSG00000100058.11	CRYBB2P1	6.31	2.68e-08	0.000211	1.4	0.61	Bipolar disorder with mood-incongruent psychosis;	chr22:25489386	chr22:25448105~25520854:+
READ	cis	rs2019137	0.56	rs10206269	ENSG00000274877.1	RP11-65I12.1	-6.3	2.81e-08	0.000221	-0.69	-0.61	Lymphocyte counts;	chr2:113232816	chr2:113237595~113240825:+
READ	cis	rs875971	0.862	rs1983372	ENSG00000226824.5	RP4-756H11.3	6.29	2.9e-08	0.000228	0.7	0.61	Aortic root size;	chr7:66146364	chr7:66654538~66669855:+
READ	cis	rs9399135	0.967	rs4451151	ENSG00000232876.1	CTA-212D2.2	-6.29	2.91e-08	0.000229	-0.76	-0.61	Red blood cell count;	chr6:134989408	chr6:135055033~135060550:+
READ	cis	rs17264034	0.861	rs414396	ENSG00000250786.1	SNHG18	6.29	2.93e-08	0.000231	0.84	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9550596	chr5:9546200~9550609:+
READ	cis	rs9326248	0.574	rs1263173	ENSG00000254851.1	RP11-109L13.1	-6.29	2.95e-08	0.000232	-0.76	-0.61	Blood protein levels;	chr11:116810292	chr11:117135528~117138582:+
READ	cis	rs9399135	0.967	rs4388304	ENSG00000232876.1	CTA-212D2.2	-6.28	2.96e-08	0.000233	-0.76	-0.61	Red blood cell count;	chr6:134988459	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs6902954	ENSG00000232876.1	CTA-212D2.2	-6.28	2.96e-08	0.000233	-0.76	-0.61	Red blood cell count;	chr6:134992856	chr6:135055033~135060550:+
READ	cis	rs2882667	0.867	rs11749045	ENSG00000253404.1	AC034243.1	6.28	2.96e-08	0.000233	0.74	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139085271	chr5:138744434~138753309:-
READ	cis	rs17264034	0.861	rs55713652	ENSG00000250786.1	SNHG18	6.28	2.97e-08	0.000233	0.83	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9557010	chr5:9546200~9550609:+
READ	cis	rs875971	0.898	rs6977501	ENSG00000226824.5	RP4-756H11.3	6.28	3e-08	0.000235	0.68	0.61	Aortic root size;	chr7:66228355	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs11971949	ENSG00000226824.5	RP4-756H11.3	6.28	3e-08	0.000235	0.67	0.61	Aortic root size;	chr7:66161027	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1981798	ENSG00000226824.5	RP4-756H11.3	-6.28	3e-08	0.000235	-0.67	-0.61	Aortic root size;	chr7:66489916	chr7:66654538~66669855:+
READ	cis	rs2882667	0.898	rs11749944	ENSG00000253404.1	AC034243.1	6.28	3.01e-08	0.000236	0.75	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139077090	chr5:138744434~138753309:-
READ	cis	rs858239	0.636	rs28706766	ENSG00000230658.1	KLHL7-AS1	6.28	3.01e-08	0.000236	0.79	0.61	Cerebrospinal fluid biomarker levels;	chr7:23130215	chr7:23101228~23105703:-
READ	cis	rs7208859	0.623	rs7220999	ENSG00000263531.1	RP13-753N3.1	6.28	3.02e-08	0.000237	1.14	0.61	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822280	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55638872	ENSG00000263531.1	RP13-753N3.1	6.28	3.02e-08	0.000237	1.14	0.61	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822534	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9899268	ENSG00000263531.1	RP13-753N3.1	6.28	3.02e-08	0.000237	1.14	0.61	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30823237	chr17:30863921~30864940:-
READ	cis	rs2882667	0.537	rs13181793	ENSG00000253404.1	AC034243.1	6.28	3.04e-08	0.000238	0.71	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139073267	chr5:138744434~138753309:-
READ	cis	rs875971	1	rs10244498	ENSG00000226824.5	RP4-756H11.3	-6.28	3.04e-08	0.000238	-0.69	-0.61	Aortic root size;	chr7:66651069	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs2659897	ENSG00000226824.5	RP4-756H11.3	6.28	3.04e-08	0.000238	0.69	0.61	Aortic root size;	chr7:66722728	chr7:66654538~66669855:+
READ	cis	rs9399135	0.967	rs13218642	ENSG00000232876.1	CTA-212D2.2	-6.28	3.05e-08	0.000239	-0.76	-0.61	Red blood cell count;	chr6:134988802	chr6:135055033~135060550:+
READ	cis	rs17264034	0.821	rs60322708	ENSG00000250786.1	SNHG18	6.27	3.12e-08	0.000243	0.83	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9555837	chr5:9546200~9550609:+
READ	cis	rs2882667	0.931	rs1433009	ENSG00000253404.1	AC034243.1	6.26	3.22e-08	0.00025	0.73	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:138998095	chr5:138744434~138753309:-
READ	cis	rs2882667	0.931	rs7720150	ENSG00000253404.1	AC034243.1	6.26	3.22e-08	0.00025	0.73	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:138998380	chr5:138744434~138753309:-
READ	cis	rs858239	0.67	rs6967526	ENSG00000230658.1	KLHL7-AS1	6.26	3.24e-08	0.000251	0.79	0.61	Cerebrospinal fluid biomarker levels;	chr7:23119622	chr7:23101228~23105703:-
READ	cis	rs916888	0.821	rs199499	ENSG00000214401.4	KANSL1-AS1	6.26	3.25e-08	0.000252	1.04	0.61	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46788132	chr17:46193576~46196723:+
READ	cis	rs801193	0.636	rs10233806	ENSG00000226824.5	RP4-756H11.3	6.26	3.26e-08	0.000252	0.7	0.61	Aortic root size;	chr7:66653261	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs28673077	ENSG00000230658.1	KLHL7-AS1	6.26	3.27e-08	0.000253	0.8	0.61	Cerebrospinal fluid biomarker levels;	chr7:23211235	chr7:23101228~23105703:-
READ	cis	rs2882667	0.931	rs7706391	ENSG00000253404.1	AC034243.1	6.26	3.33e-08	0.000257	0.74	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139013475	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs55993747	ENSG00000216906.2	RP11-350J20.9	6.26	3.33e-08	0.000257	0.77	0.61	Lung cancer;	chr6:149622016	chr6:149904243~149906418:+
READ	cis	rs9322193	0.847	rs12191643	ENSG00000216906.2	RP11-350J20.9	6.26	3.33e-08	0.000257	0.77	0.61	Lung cancer;	chr6:149628912	chr6:149904243~149906418:+
READ	cis	rs1577917	0.883	rs9450375	ENSG00000203875.9	SNHG5	6.25	3.35e-08	0.000259	0.85	0.61	Response to antipsychotic treatment;	chr6:86046911	chr6:85660950~85678736:-
READ	cis	rs3814244	0.933	rs10878725	ENSG00000255733.4	IFNG-AS1	-6.25	3.35e-08	0.000259	-0.64	-0.61	Itch intensity from mosquito bite adjusted by bite size;	chr12:68020930	chr12:67989445~68234686:+
READ	cis	rs9309473	1	rs9309473	ENSG00000163016.8	ALMS1P	6.25	3.36e-08	0.000259	0.87	0.61	Metabolite levels;	chr2:73516855	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs10178678	ENSG00000163016.8	ALMS1P	6.25	3.36e-08	0.000259	0.87	0.61	Metabolite levels;	chr2:73535109	chr2:73644919~73685576:+
READ	cis	rs875971	1	rs6979382	ENSG00000226824.5	RP4-756H11.3	-6.25	3.47e-08	0.000266	-0.67	-0.61	Aortic root size;	chr7:66421388	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs6961990	ENSG00000226824.5	RP4-756H11.3	-6.25	3.47e-08	0.000266	-0.67	-0.61	Aortic root size;	chr7:66423583	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs7788984	ENSG00000226824.5	RP4-756H11.3	-6.25	3.47e-08	0.000266	-0.67	-0.61	Aortic root size;	chr7:66450629	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs11974264	ENSG00000226824.5	RP4-756H11.3	6.25	3.47e-08	0.000266	0.67	0.61	Aortic root size;	chr7:66182595	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs1540651	ENSG00000226824.5	RP4-756H11.3	6.25	3.47e-08	0.000266	0.67	0.61	Aortic root size;	chr7:66185134	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs937495	ENSG00000226824.5	RP4-756H11.3	6.25	3.47e-08	0.000266	0.67	0.61	Aortic root size;	chr7:66314811	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs2036264	ENSG00000226824.5	RP4-756H11.3	6.25	3.47e-08	0.000266	0.67	0.61	Aortic root size;	chr7:66334917	chr7:66654538~66669855:+
READ	cis	rs875971	1	rs7783613	ENSG00000226824.5	RP4-756H11.3	6.25	3.47e-08	0.000266	0.67	0.61	Aortic root size;	chr7:66340274	chr7:66654538~66669855:+
READ	cis	rs2882667	0.898	rs10079634	ENSG00000253404.1	AC034243.1	6.24	3.48e-08	0.000267	0.75	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139077364	chr5:138744434~138753309:-
READ	cis	rs2882667	0.931	rs10070021	ENSG00000253404.1	AC034243.1	6.24	3.53e-08	0.00027	0.71	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:138989017	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11750382	ENSG00000253404.1	AC034243.1	-6.24	3.56e-08	0.000272	-0.74	-0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139121305	chr5:138744434~138753309:-
READ	cis	rs875971	1	rs1544549	ENSG00000226824.5	RP4-756H11.3	6.24	3.56e-08	0.000273	0.7	0.61	Aortic root size;	chr7:66625676	chr7:66654538~66669855:+
READ	cis	rs9399135	0.967	rs4896121	ENSG00000232876.1	CTA-212D2.2	-6.24	3.56e-08	0.000273	-0.76	-0.61	Red blood cell count;	chr6:134972507	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4895436	ENSG00000232876.1	CTA-212D2.2	-6.24	3.59e-08	0.000274	-0.76	-0.61	Red blood cell count;	chr6:134973863	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4896122	ENSG00000232876.1	CTA-212D2.2	-6.24	3.59e-08	0.000274	-0.76	-0.61	Red blood cell count;	chr6:134973943	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs9376075	ENSG00000232876.1	CTA-212D2.2	-6.24	3.59e-08	0.000274	-0.76	-0.61	Red blood cell count;	chr6:134975825	chr6:135055033~135060550:+
READ	cis	rs9399135	0.935	rs4273704	ENSG00000232876.1	CTA-212D2.2	-6.24	3.59e-08	0.000274	-0.76	-0.61	Red blood cell count;	chr6:134976382	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4637662	ENSG00000232876.1	CTA-212D2.2	-6.24	3.59e-08	0.000274	-0.76	-0.61	Red blood cell count;	chr6:134977020	chr6:135055033~135060550:+
READ	cis	rs801193	0.66	rs2659914	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66691927	chr7:66654538~66669855:+
READ	cis	rs801193	0.613	rs2659900	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66719456	chr7:66654538~66669855:+
READ	cis	rs801193	0.636	rs2659895	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66731484	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs974239	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66748504	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs1016265	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66749580	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs4610622	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66759510	chr7:66654538~66669855:+
READ	cis	rs801193	0.66	rs10950049	ENSG00000226824.5	RP4-756H11.3	-6.24	3.62e-08	0.000275	-0.7	-0.61	Aortic root size;	chr7:66765873	chr7:66654538~66669855:+
READ	cis	rs17264034	1	rs414829	ENSG00000250786.1	SNHG18	6.23	3.65e-08	0.000278	0.83	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9552413	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs11749803	ENSG00000250786.1	SNHG18	6.23	3.65e-08	0.000278	0.83	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9553456	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs56344213	ENSG00000250786.1	SNHG18	6.23	3.65e-08	0.000278	0.83	0.61	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9553756	chr5:9546200~9550609:+
READ	cis	rs9326248	0.581	rs10892053	ENSG00000254851.1	RP11-109L13.1	-6.23	3.68e-08	0.00028	-0.77	-0.61	Blood protein levels;	chr11:116986287	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs10892061	ENSG00000254851.1	RP11-109L13.1	-6.23	3.68e-08	0.00028	-0.77	-0.61	Blood protein levels;	chr11:117015398	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs11216242	ENSG00000254851.1	RP11-109L13.1	-6.23	3.68e-08	0.00028	-0.77	-0.61	Blood protein levels;	chr11:117030833	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs12804122	ENSG00000254851.1	RP11-109L13.1	-6.23	3.68e-08	0.00028	-0.77	-0.61	Blood protein levels;	chr11:117031900	chr11:117135528~117138582:+
READ	cis	rs9399135	0.967	rs4376365	ENSG00000232876.1	CTA-212D2.2	-6.23	3.7e-08	0.000281	-0.76	-0.61	Red blood cell count;	chr6:134986602	chr6:135055033~135060550:+
READ	cis	rs875971	0.862	rs10256544	ENSG00000226824.5	RP4-756H11.3	-6.23	3.72e-08	0.000282	-0.67	-0.61	Aortic root size;	chr7:66210141	chr7:66654538~66669855:+
READ	cis	rs9322193	0.516	rs1999632	ENSG00000231760.4	RP11-350J20.5	6.23	3.73e-08	0.000283	0.9	0.61	Lung cancer;	chr6:149866737	chr6:149796151~149826294:-
READ	cis	rs7937890	0.9	rs7118682	ENSG00000254418.1	RP11-21L19.1	-6.23	3.74e-08	0.000284	-0.76	-0.61	Mitochondrial DNA levels;	chr11:14253004	chr11:14262846~14273691:-
READ	cis	rs2882667	0.931	rs6596457	ENSG00000253404.1	AC034243.1	6.23	3.74e-08	0.000284	0.71	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:138987690	chr5:138744434~138753309:-
READ	cis	rs916888	0.821	rs199513	ENSG00000214401.4	KANSL1-AS1	-6.22	3.8e-08	0.000288	-0.96	-0.61	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779566	chr17:46193576~46196723:+
READ	cis	rs9660180	0.62	rs3817856	ENSG00000268575.1	RP1-283E3.8	6.22	3.8e-08	0.000288	0.68	0.61	Body mass index;	chr1:1732392	chr1:1702736~1737688:-
READ	cis	rs858239	0.669	rs1006709	ENSG00000230658.1	KLHL7-AS1	6.22	3.81e-08	0.000288	0.77	0.61	Cerebrospinal fluid biomarker levels;	chr7:23100480	chr7:23101228~23105703:-
READ	cis	rs858239	0.568	rs6970694	ENSG00000230658.1	KLHL7-AS1	6.22	3.89e-08	0.000294	0.8	0.61	Cerebrospinal fluid biomarker levels;	chr7:23211209	chr7:23101228~23105703:-
READ	cis	rs9660180	0.62	rs34298494	ENSG00000268575.1	RP1-283E3.8	6.21	4.02e-08	0.000302	0.68	0.61	Body mass index;	chr1:1731963	chr1:1702736~1737688:-
READ	cis	rs1930961	1	rs6004668	ENSG00000100058.11	CRYBB2P1	-6.21	4.02e-08	0.000303	-1.43	-0.61	Bipolar disorder with mood-incongruent psychosis;	chr22:25478535	chr22:25448105~25520854:+
READ	cis	rs2739330	0.76	rs1002286	ENSG00000250470.1	AP000351.3	-6.21	4.04e-08	0.000304	-0.85	-0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23976904~23977585:-
READ	cis	rs7208859	0.673	rs216409	ENSG00000263531.1	RP13-753N3.1	-6.2	4.1e-08	0.000308	-0.92	-0.61	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30579251	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9914242	ENSG00000263531.1	RP13-753N3.1	6.2	4.11e-08	0.000308	1.19	0.61	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30889227	chr17:30863921~30864940:-
READ	cis	rs9399135	0.967	rs9321481	ENSG00000232876.1	CTA-212D2.2	6.2	4.14e-08	0.000311	0.78	0.61	Red blood cell count;	chr6:135031510	chr6:135055033~135060550:+
READ	cis	rs858239	0.806	rs10268610	ENSG00000230658.1	KLHL7-AS1	6.2	4.15e-08	0.000311	0.82	0.61	Cerebrospinal fluid biomarker levels;	chr7:23235145	chr7:23101228~23105703:-
READ	cis	rs2882667	0.754	rs11746434	ENSG00000253404.1	AC034243.1	6.19	4.25e-08	0.000318	0.75	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139099614	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs13170388	ENSG00000253404.1	AC034243.1	6.19	4.25e-08	0.000318	0.75	0.61	Age-related hearing impairment (SNP x SNP interaction);	chr5:139101176	chr5:138744434~138753309:-
READ	cis	rs2739330	0.703	rs5760112	ENSG00000250470.1	AP000351.3	6.19	4.26e-08	0.000318	0.85	0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23917585	chr22:23976904~23977585:-
READ	cis	rs875971	1	rs2420820	ENSG00000226824.5	RP4-756H11.3	6.19	4.26e-08	0.000318	0.69	0.61	Aortic root size;	chr7:66626920	chr7:66654538~66669855:+
READ	cis	rs9309473	0.95	rs1918863	ENSG00000163016.8	ALMS1P	6.19	4.28e-08	0.00032	0.9	0.61	Metabolite levels;	chr2:73417353	chr2:73644919~73685576:+
READ	cis	rs858239	0.698	rs4265084	ENSG00000230658.1	KLHL7-AS1	6.19	4.31e-08	0.000322	0.76	0.61	Cerebrospinal fluid biomarker levels;	chr7:23367621	chr7:23101228~23105703:-
READ	cis	rs4660456	0.913	rs556875	ENSG00000237899.1	RP4-739H11.3	-6.19	4.42e-08	0.000325	-0.92	-0.61	Platelet count;	chr1:40688571	chr1:40669089~40687588:-
READ	cis	rs875971	0.964	rs778735	ENSG00000226824.5	RP4-756H11.3	-6.18	4.44e-08	0.000327	-0.67	-0.61	Aortic root size;	chr7:66349822	chr7:66654538~66669855:+
READ	cis	rs11155671	0.53	rs2342770	ENSG00000216906.2	RP11-350J20.9	6.18	4.52e-08	0.000332	0.77	0.61	Testicular germ cell tumor;	chr6:149895549	chr6:149904243~149906418:+
READ	cis	rs10129255	0.518	rs10150460	ENSG00000211972.2	IGHV3-66	-6.18	4.56e-08	0.000334	-0.59	-0.61	Kawasaki disease;	chr14:106677179	chr14:106675017~106675544:-
READ	cis	rs9309473	0.606	rs6759452	ENSG00000163016.8	ALMS1P	6.18	4.56e-08	0.000335	0.86	0.61	Metabolite levels;	chr2:73651225	chr2:73644919~73685576:+
READ	cis	rs9309473	0.606	rs62149804	ENSG00000163016.8	ALMS1P	6.17	4.62e-08	0.000338	0.92	0.61	Metabolite levels;	chr2:73609879	chr2:73644919~73685576:+
READ	cis	rs7208859	0.673	rs9889755	ENSG00000263531.1	RP13-753N3.1	-6.17	4.67e-08	0.000342	-1.05	-0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30907487	chr17:30863921~30864940:-
READ	cis	rs2739330	0.791	rs4822458	ENSG00000250470.1	AP000351.3	6.17	4.7e-08	0.000344	0.87	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23976904~23977585:-
READ	cis	rs10129255	0.5	rs7161740	ENSG00000211972.2	IGHV3-66	6.17	4.71e-08	0.000345	0.57	0.6	Kawasaki disease;	chr14:106776119	chr14:106675017~106675544:-
READ	cis	rs10129255	0.556	rs6576222	ENSG00000211972.2	IGHV3-66	6.17	4.71e-08	0.000345	0.57	0.6	Kawasaki disease;	chr14:106776442	chr14:106675017~106675544:-
READ	cis	rs10129255	0.536	rs6576223	ENSG00000211972.2	IGHV3-66	6.17	4.71e-08	0.000345	0.57	0.6	Kawasaki disease;	chr14:106776448	chr14:106675017~106675544:-
READ	cis	rs9322193	0.923	rs9800736	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149661281	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs66516768	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149671999	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs7450246	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149702517	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9383812	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149712355	chr6:149904243~149906418:+
READ	cis	rs9322193	0.847	rs9383844	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149716268	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs56397000	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149739347	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9689702	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149740720	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782315	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149743093	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10747276	ENSG00000216906.2	RP11-350J20.9	6.16	4.89e-08	0.000355	0.74	0.6	Lung cancer;	chr6:149758739	chr6:149904243~149906418:+
READ	cis	rs2739330	0.627	rs9608219	ENSG00000250470.1	AP000351.3	6.15	5.02e-08	0.000363	0.86	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23931932	chr22:23976904~23977585:-
READ	cis	rs12439619	0.705	rs4778665	ENSG00000278603.1	RP13-608F4.5	6.15	5.08e-08	0.000366	0.96	0.6	Intelligence (multi-trait analysis);	chr15:82144163	chr15:82472203~82472426:+
READ	cis	rs2906856	0.526	rs2906852	ENSG00000255733.4	IFNG-AS1	6.15	5.08e-08	0.000367	0.72	0.6	Mosquito bite size;	chr12:67985701	chr12:67989445~68234686:+
READ	cis	rs4660456	0.913	rs545218	ENSG00000237899.1	RP4-739H11.3	6.14	5.26e-08	0.000379	0.97	0.6	Platelet count;	chr1:40675313	chr1:40669089~40687588:-
READ	cis	rs858239	0.601	rs6966776	ENSG00000230658.1	KLHL7-AS1	6.14	5.29e-08	0.000381	0.79	0.6	Cerebrospinal fluid biomarker levels;	chr7:23126389	chr7:23101228~23105703:-
READ	cis	rs9322193	0.923	rs10872650	ENSG00000216906.2	RP11-350J20.9	6.14	5.3e-08	0.000381	0.77	0.6	Lung cancer;	chr6:149760959	chr6:149904243~149906418:+
READ	cis	rs9309473	1	rs6711033	ENSG00000163016.8	ALMS1P	6.14	5.35e-08	0.000384	0.86	0.6	Metabolite levels;	chr2:73519516	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs13398956	ENSG00000163016.8	ALMS1P	6.13	5.43e-08	0.000387	0.9	0.6	Metabolite levels;	chr2:73493131	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs11884776	ENSG00000163016.8	ALMS1P	6.13	5.43e-08	0.000387	0.85	0.6	Metabolite levels;	chr2:73519796	chr2:73644919~73685576:+
READ	cis	rs9309473	0.748	rs2421552	ENSG00000163016.8	ALMS1P	6.13	5.43e-08	0.000387	0.85	0.6	Metabolite levels;	chr2:73531676	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs10199224	ENSG00000163016.8	ALMS1P	6.13	5.43e-08	0.000387	0.85	0.6	Metabolite levels;	chr2:73534319	chr2:73644919~73685576:+
READ	cis	rs858239	0.899	rs10085838	ENSG00000230658.1	KLHL7-AS1	6.13	5.45e-08	0.000388	0.81	0.6	Cerebrospinal fluid biomarker levels;	chr7:23258796	chr7:23101228~23105703:-
READ	cis	rs858239	0.536	rs6961109	ENSG00000230658.1	KLHL7-AS1	6.13	5.48e-08	0.000389	0.79	0.6	Cerebrospinal fluid biomarker levels;	chr7:23212794	chr7:23101228~23105703:-
READ	cis	rs9309473	1	rs10187416	ENSG00000163016.8	ALMS1P	6.13	5.48e-08	0.000389	0.91	0.6	Metabolite levels;	chr2:73486614	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs10207264	ENSG00000163016.8	ALMS1P	6.13	5.48e-08	0.000389	0.91	0.6	Metabolite levels;	chr2:73486970	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs2056486	ENSG00000163016.8	ALMS1P	6.13	5.48e-08	0.000389	0.91	0.6	Metabolite levels;	chr2:73490440	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10193972	ENSG00000163016.8	ALMS1P	6.13	5.48e-08	0.000389	0.91	0.6	Metabolite levels;	chr2:73490529	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs11901272	ENSG00000163016.8	ALMS1P	6.13	5.48e-08	0.000389	0.91	0.6	Metabolite levels;	chr2:73493317	chr2:73644919~73685576:+
READ	cis	rs7208859	0.673	rs423151	ENSG00000263531.1	RP13-753N3.1	6.13	5.53e-08	0.000392	0.91	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30625268	chr17:30863921~30864940:-
READ	cis	rs9309473	0.948	rs13392691	ENSG00000163016.8	ALMS1P	6.12	5.63e-08	0.000398	0.86	0.6	Metabolite levels;	chr2:73521853	chr2:73644919~73685576:+
READ	cis	rs801193	0.613	rs2016325	ENSG00000226824.5	RP4-756H11.3	6.12	5.65e-08	4e-04	0.7	0.6	Aortic root size;	chr7:66858513	chr7:66654538~66669855:+
READ	cis	rs2739330	0.587	rs4820571	ENSG00000218537.1	MIF-AS1	6.12	5.65e-08	4e-04	0.74	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900786	chr22:23894426~23898930:-
READ	cis	rs801193	0.591	rs2707839	ENSG00000226824.5	RP4-756H11.3	-6.12	5.73e-08	0.000404	-0.69	-0.6	Aortic root size;	chr7:66728097	chr7:66654538~66669855:+
READ	cis	rs62229266	0.835	rs998384	ENSG00000231106.2	LINC01436	6.12	5.74e-08	0.000405	0.78	0.6	Mitral valve prolapse;	chr21:36073228	chr21:36005338~36007838:+
READ	cis	rs4660456	0.913	rs16827569	ENSG00000237899.1	RP4-739H11.3	-6.12	5.83e-08	0.000411	-0.96	-0.6	Platelet count;	chr1:40761655	chr1:40669089~40687588:-
READ	cis	rs916888	0.602	rs199508	ENSG00000214401.4	KANSL1-AS1	-6.11	5.92e-08	0.000417	-0.94	-0.6	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46781472	chr17:46193576~46196723:+
READ	cis	rs62229266	0.804	rs2835241	ENSG00000231106.2	LINC01436	-6.11	5.95e-08	0.000419	-0.76	-0.6	Mitral valve prolapse;	chr21:36039082	chr21:36005338~36007838:+
READ	cis	rs9326248	0.817	rs6589598	ENSG00000254851.1	RP11-109L13.1	-6.11	6.04e-08	0.000424	-0.87	-0.6	Blood protein levels;	chr11:117131687	chr11:117135528~117138582:+
READ	cis	rs9322193	0.887	rs3734295	ENSG00000216906.2	RP11-350J20.9	6.11	6.06e-08	0.000425	0.78	0.6	Lung cancer;	chr6:149593917	chr6:149904243~149906418:+
READ	cis	rs9322193	0.851	rs9322194	ENSG00000216906.2	RP11-350J20.9	6.11	6.06e-08	0.000425	0.78	0.6	Lung cancer;	chr6:149599113	chr6:149904243~149906418:+
READ	cis	rs10129255	0.556	rs9324093	ENSG00000211972.2	IGHV3-66	6.11	6.07e-08	0.000425	0.55	0.6	Kawasaki disease;	chr14:106683893	chr14:106675017~106675544:-
READ	cis	rs1577917	0.629	rs7761762	ENSG00000203875.9	SNHG5	6.1	6.13e-08	0.000429	0.77	0.6	Response to antipsychotic treatment;	chr6:85496250	chr6:85660950~85678736:-
READ	cis	rs2882667	0.627	rs1549203	ENSG00000253404.1	AC034243.1	-6.1	6.24e-08	0.000437	-0.72	-0.6	Age-related hearing impairment (SNP x SNP interaction);	chr5:139132655	chr5:138744434~138753309:-
READ	cis	rs10129255	0.536	rs8004835	ENSG00000211972.2	IGHV3-66	6.1	6.27e-08	0.000438	0.56	0.6	Kawasaki disease;	chr14:106686361	chr14:106675017~106675544:-
READ	cis	rs916888	0.61	rs199453	ENSG00000262539.1	RP11-259G18.3	6.09	6.38e-08	0.000446	0.83	0.6	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46723580	chr17:46259551~46260606:-
READ	cis	rs10129255	0.536	rs3944157	ENSG00000211972.2	IGHV3-66	6.09	6.5e-08	0.000453	0.57	0.6	Kawasaki disease;	chr14:106682286	chr14:106675017~106675544:-
READ	cis	rs9399135	0.967	rs6923765	ENSG00000232876.1	CTA-212D2.2	6.09	6.52e-08	0.000454	0.76	0.6	Red blood cell count;	chr6:135014038	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs59329760	ENSG00000232876.1	CTA-212D2.2	-6.09	6.53e-08	0.000455	-0.76	-0.6	Red blood cell count;	chr6:135021299	chr6:135055033~135060550:+
READ	cis	rs3814244	0.751	rs12832728	ENSG00000255733.4	IFNG-AS1	-6.09	6.57e-08	0.000457	-0.61	-0.6	Itch intensity from mosquito bite adjusted by bite size;	chr12:68026623	chr12:67989445~68234686:+
READ	cis	rs1577917	0.654	rs9450284	ENSG00000203875.9	SNHG5	6.08	6.64e-08	0.000461	0.77	0.6	Response to antipsychotic treatment;	chr6:85489611	chr6:85660950~85678736:-
READ	cis	rs858239	0.67	rs3807452	ENSG00000230658.1	KLHL7-AS1	-6.08	6.67e-08	0.000463	-0.78	-0.6	Cerebrospinal fluid biomarker levels;	chr7:23122462	chr7:23101228~23105703:-
READ	cis	rs2739330	0.731	rs5751792	ENSG00000273295.1	AP000350.5	6.08	6.7e-08	0.000465	0.64	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23901432~23907068:-
READ	cis	rs9309473	1	rs11674602	ENSG00000163016.8	ALMS1P	6.08	6.72e-08	0.000466	0.88	0.6	Metabolite levels;	chr2:73496058	chr2:73644919~73685576:+
READ	cis	rs9322193	0.961	rs9285521	ENSG00000216906.2	RP11-350J20.9	6.08	6.78e-08	0.000469	0.78	0.6	Lung cancer;	chr6:149585576	chr6:149904243~149906418:+
READ	cis	rs1891275	0.551	rs7908678	ENSG00000228701.1	TNKS2-AS1	6.08	6.79e-08	0.00047	0.77	0.6	Intelligence (multi-trait analysis);	chr10:91659253	chr10:91782839~91798291:-
READ	cis	rs4660456	0.542	rs850009	ENSG00000237899.1	RP4-739H11.3	6.08	6.8e-08	0.00047	0.95	0.6	Platelet count;	chr1:40643593	chr1:40669089~40687588:-
READ	cis	rs1891275	0.54	rs10732773	ENSG00000228701.1	TNKS2-AS1	-6.08	6.82e-08	0.000472	-0.8	-0.6	Intelligence (multi-trait analysis);	chr10:91656468	chr10:91782839~91798291:-
READ	cis	rs4660456	0.564	rs34320811	ENSG00000237899.1	RP4-739H11.3	-6.07	6.88e-08	0.000475	-0.96	-0.6	Platelet count;	chr1:40763288	chr1:40669089~40687588:-
READ	cis	rs10129255	0.5	rs6576226	ENSG00000211972.2	IGHV3-66	6.07	7.05e-08	0.000485	0.57	0.6	Kawasaki disease;	chr14:106778135	chr14:106675017~106675544:-
READ	cis	rs10129255	0.5	rs6576230	ENSG00000211972.2	IGHV3-66	6.07	7.05e-08	0.000485	0.57	0.6	Kawasaki disease;	chr14:106778539	chr14:106675017~106675544:-
READ	cis	rs4660456	0.913	rs569159	ENSG00000237899.1	RP4-739H11.3	-6.07	7.11e-08	0.00049	-0.91	-0.6	Platelet count;	chr1:40701862	chr1:40669089~40687588:-
READ	cis	rs875971	0.862	rs6460290	ENSG00000226824.5	RP4-756H11.3	6.06	7.2e-08	0.000495	0.68	0.6	Aortic root size;	chr7:66344119	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs709596	ENSG00000226824.5	RP4-756H11.3	-6.06	7.2e-08	0.000495	-0.68	-0.6	Aortic root size;	chr7:66360926	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778724	ENSG00000226824.5	RP4-756H11.3	-6.06	7.2e-08	0.000495	-0.68	-0.6	Aortic root size;	chr7:66364304	chr7:66654538~66669855:+
READ	cis	rs10129255	0.5	rs988134	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106776698	chr14:106675017~106675544:-
READ	cis	rs10129255	0.5	rs988133	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106776724	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs8009594	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106777494	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs8009612	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106777510	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs8010020	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106778016	chr14:106675017~106675544:-
READ	cis	rs10129255	0.5	rs6576225	ENSG00000211972.2	IGHV3-66	6.06	7.2e-08	0.000495	0.57	0.6	Kawasaki disease;	chr14:106778120	chr14:106675017~106675544:-
READ	cis	rs11155671	0.53	rs4458704	ENSG00000216906.2	RP11-350J20.9	6.06	7.4e-08	0.000505	0.8	0.6	Testicular germ cell tumor;	chr6:149911743	chr6:149904243~149906418:+
READ	cis	rs9309473	1	rs13421462	ENSG00000163016.8	ALMS1P	6.06	7.44e-08	0.000507	0.88	0.6	Metabolite levels;	chr2:73492748	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs56154726	ENSG00000163016.8	ALMS1P	6.06	7.44e-08	0.000507	0.88	0.6	Metabolite levels;	chr2:73494640	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7572722	ENSG00000163016.8	ALMS1P	6.06	7.44e-08	0.000507	0.88	0.6	Metabolite levels;	chr2:73497548	chr2:73644919~73685576:+
READ	cis	rs9309473	0.687	rs12465867	ENSG00000163016.8	ALMS1P	6.05	7.49e-08	0.00051	0.74	0.6	Metabolite levels;	chr2:73384974	chr2:73644919~73685576:+
READ	cis	rs9309473	0.583	rs35885918	ENSG00000163016.8	ALMS1P	6.05	7.49e-08	0.00051	0.74	0.6	Metabolite levels;	chr2:73385106	chr2:73644919~73685576:+
READ	cis	rs10178409	1	rs10178409	ENSG00000163016.8	ALMS1P	6.05	7.6e-08	0.000517	0.86	0.6	Urinary metabolites;	chr2:73628380	chr2:73644919~73685576:+
READ	cis	rs10129255	0.536	rs10139058	ENSG00000211972.2	IGHV3-66	6.05	7.63e-08	0.000519	0.55	0.6	Kawasaki disease;	chr14:106685899	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs10136903	ENSG00000211972.2	IGHV3-66	6.05	7.65e-08	0.00052	0.56	0.6	Kawasaki disease;	chr14:106778866	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs11847766	ENSG00000211972.2	IGHV3-66	6.05	7.65e-08	0.00052	0.56	0.6	Kawasaki disease;	chr14:106779186	chr14:106675017~106675544:-
READ	cis	rs10129255	0.518	rs12590732	ENSG00000211972.2	IGHV3-66	-6.04	7.86e-08	0.000532	-0.56	-0.6	Kawasaki disease;	chr14:106779612	chr14:106675017~106675544:-
READ	cis	rs875971	0.564	rs313804	ENSG00000226824.5	RP4-756H11.3	-6.04	8.06e-08	0.000545	-0.66	-0.6	Aortic root size;	chr7:66049635	chr7:66654538~66669855:+
READ	cis	rs858239	0.738	rs13225593	ENSG00000230658.1	KLHL7-AS1	6.03	8.11e-08	0.000548	0.8	0.6	Cerebrospinal fluid biomarker levels;	chr7:23220688	chr7:23101228~23105703:-
READ	cis	rs858239	0.738	rs7807879	ENSG00000230658.1	KLHL7-AS1	6.03	8.11e-08	0.000548	0.8	0.6	Cerebrospinal fluid biomarker levels;	chr7:23220969	chr7:23101228~23105703:-
READ	cis	rs9309473	1	rs7607014	ENSG00000163016.8	ALMS1P	-6.03	8.14e-08	0.000549	-0.82	-0.6	Metabolite levels;	chr2:73503047	chr2:73644919~73685576:+
READ	cis	rs2739330	0.731	rs5751792	ENSG00000218537.1	MIF-AS1	6.03	8.16e-08	0.00055	0.71	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23894426~23898930:-
READ	cis	rs3814244	0.897	rs4141135	ENSG00000255733.4	IFNG-AS1	6.03	8.17e-08	0.000551	0.61	0.6	Itch intensity from mosquito bite adjusted by bite size;	chr12:68025050	chr12:67989445~68234686:+
READ	cis	rs9309473	0.95	rs13431529	ENSG00000163016.8	ALMS1P	6.03	8.27e-08	0.000553	0.84	0.6	Metabolite levels;	chr2:73648914	chr2:73644919~73685576:+
READ	cis	rs858239	0.931	rs9690941	ENSG00000230658.1	KLHL7-AS1	6.02	8.43e-08	0.000561	0.79	0.6	Cerebrospinal fluid biomarker levels;	chr7:23242134	chr7:23101228~23105703:-
READ	cis	rs7937890	0.904	rs67623158	ENSG00000254418.1	RP11-21L19.1	-6.02	8.46e-08	0.000563	-0.72	-0.6	Mitochondrial DNA levels;	chr11:14273650	chr11:14262846~14273691:-
READ	cis	rs9399135	0.684	rs1135205	ENSG00000232876.1	CTA-212D2.2	-6.02	8.5e-08	0.000566	-0.78	-0.6	Red blood cell count;	chr6:134960657	chr6:135055033~135060550:+
READ	cis	rs7208859	0.614	rs216412	ENSG00000263531.1	RP13-753N3.1	-6.02	8.67e-08	0.000576	-0.88	-0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30576376	chr17:30863921~30864940:-
READ	cis	rs7847628	0.551	rs10818476	ENSG00000226752.6	PSMD5-AS1	-6.02	8.68e-08	0.000576	-0.74	-0.6	Birth weight;	chr9:120809760	chr9:120824828~120854385:+
READ	cis	rs7847628	0.587	rs1060817	ENSG00000226752.6	PSMD5-AS1	-6.02	8.68e-08	0.000576	-0.74	-0.6	Birth weight;	chr9:120820914	chr9:120824828~120854385:+
READ	cis	rs7847628	0.587	rs10760117	ENSG00000226752.6	PSMD5-AS1	-6.02	8.68e-08	0.000576	-0.74	-0.6	Birth weight;	chr9:120824459	chr9:120824828~120854385:+
READ	cis	rs9322193	0.923	rs9766004	ENSG00000216906.2	RP11-350J20.9	6.02	8.71e-08	0.000578	0.74	0.6	Lung cancer;	chr6:149754363	chr6:149904243~149906418:+
READ	cis	rs2739330	0.587	rs4820571	ENSG00000273295.1	AP000350.5	6.01	8.85e-08	0.000586	0.66	0.59	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900786	chr22:23901432~23907068:-
READ	cis	rs9399135	0.967	rs6910530	ENSG00000232876.1	CTA-212D2.2	-6.01	8.95e-08	0.000593	-0.76	-0.59	Red blood cell count;	chr6:135011632	chr6:135055033~135060550:+
READ	cis	rs875971	0.862	rs1612452	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66108909	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1167390	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66110906	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs35034167	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66115179	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs28470208	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66119713	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs4368860	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66143495	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11773628	ENSG00000226824.5	RP4-756H11.3	6.01	9.03e-08	0.000597	0.66	0.59	Aortic root size;	chr7:66517644	chr7:66654538~66669855:+
READ	cis	rs9326248	0.581	rs7120515	ENSG00000254851.1	RP11-109L13.1	-6.01	9.07e-08	0.000599	-0.76	-0.59	Blood protein levels;	chr11:117121210	chr11:117135528~117138582:+
READ	cis	rs875971	0.862	rs10224872	ENSG00000226824.5	RP4-756H11.3	6	9.1e-08	6e-04	0.68	0.59	Aortic root size;	chr7:66294786	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs949930	ENSG00000226824.5	RP4-756H11.3	6	9.1e-08	6e-04	0.68	0.59	Aortic root size;	chr7:66301835	chr7:66654538~66669855:+
READ	cis	rs7847628	0.587	rs3793638	ENSG00000226752.6	PSMD5-AS1	-6	9.36e-08	0.000613	-0.74	-0.59	Birth weight;	chr9:120820419	chr9:120824828~120854385:+
READ	cis	rs7847628	0.587	rs12684934	ENSG00000226752.6	PSMD5-AS1	-6	9.36e-08	0.000613	-0.74	-0.59	Birth weight;	chr9:120830881	chr9:120824828~120854385:+
READ	cis	rs9322193	0.923	rs9478291	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149729434	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9479494	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149739108	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9800806	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149740350	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs1572229	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149743841	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs10872646	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149746539	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs12528279	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149750892	chr6:149904243~149906418:+
READ	cis	rs9322193	0.809	rs9479808	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149751328	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs62441284	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149751542	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782316	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149752755	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs11155677	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149756953	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9480009	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149758502	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9480031	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149758875	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10872649	ENSG00000216906.2	RP11-350J20.9	6	9.38e-08	0.000613	0.75	0.59	Lung cancer;	chr6:149759454	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782317	ENSG00000216906.2	RP11-350J20.9	-6	9.38e-08	0.000613	-0.75	-0.59	Lung cancer;	chr6:149753911	chr6:149904243~149906418:+
READ	cis	rs875971	0.862	rs13232191	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66521661	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs35378740	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66522725	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10950043	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66523623	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs17747530	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66529742	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs13226170	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66534311	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2420611	ENSG00000226824.5	RP4-756H11.3	-6	9.4e-08	0.000613	-0.7	-0.59	Aortic root size;	chr7:66534333	chr7:66654538~66669855:+
READ	cis	rs875971	0.861	rs801215	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66546951	chr7:66654538~66669855:+
READ	cis	rs875971	0.756	rs2901210	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66552518	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs13536	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66554203	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801209	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66554403	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801206	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66556979	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801204	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66557934	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801203	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66558025	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2024192	ENSG00000226824.5	RP4-756H11.3	6	9.4e-08	0.000613	0.7	0.59	Aortic root size;	chr7:66576460	chr7:66654538~66669855:+
READ	cis	rs2882667	0.824	rs1560656	ENSG00000253404.1	AC034243.1	-5.99	9.49e-08	0.000617	-0.68	-0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139135100	chr5:138744434~138753309:-
READ	cis	rs875971	0.825	rs1129531	ENSG00000226824.5	RP4-756H11.3	5.99	9.57e-08	0.00062	0.67	0.59	Aortic root size;	chr7:66154117	chr7:66654538~66669855:+
READ	cis	rs875971	0.798	rs6460304	ENSG00000226824.5	RP4-756H11.3	-5.99	9.57e-08	0.00062	-0.67	-0.59	Aortic root size;	chr7:66499741	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6945775	ENSG00000226824.5	RP4-756H11.3	-5.99	9.57e-08	0.00062	-0.67	-0.59	Aortic root size;	chr7:66503987	chr7:66654538~66669855:+
READ	cis	rs875971	0.798	rs57739047	ENSG00000226824.5	RP4-756H11.3	-5.99	9.57e-08	0.00062	-0.67	-0.59	Aortic root size;	chr7:66507579	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs6950137	ENSG00000226824.5	RP4-756H11.3	-5.99	9.57e-08	0.00062	-0.67	-0.59	Aortic root size;	chr7:66511623	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11763189	ENSG00000226824.5	RP4-756H11.3	-5.99	9.57e-08	0.00062	-0.67	-0.59	Aortic root size;	chr7:66518542	chr7:66654538~66669855:+
READ	cis	rs11155671	0.53	rs1334510	ENSG00000231760.4	RP11-350J20.5	5.99	9.6e-08	0.000621	0.81	0.59	Testicular germ cell tumor;	chr6:149880043	chr6:149796151~149826294:-
READ	cis	rs6964833	0.786	rs35633336	ENSG00000123965.13	PMS2P5	5.99	9.72e-08	0.000628	0.82	0.59	Menarche (age at onset);	chr7:74643961	chr7:74894116~74897835:+
READ	cis	rs6964833	0.935	rs34630792	ENSG00000123965.13	PMS2P5	5.99	9.72e-08	0.000628	0.82	0.59	Menarche (age at onset);	chr7:74646869	chr7:74894116~74897835:+
READ	cis	rs7937890	0.904	rs7484197	ENSG00000254418.1	RP11-21L19.1	5.98	1e-07	0.000644	0.73	0.59	Mitochondrial DNA levels;	chr11:14262108	chr11:14262846~14273691:-
READ	cis	rs7301826	0.651	rs1554807	ENSG00000256299.1	RP11-989F5.3	5.98	1e-07	0.000645	0.61	0.59	Plasma plasminogen activator levels;	chr12:130795872	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs7957899	ENSG00000256299.1	RP11-989F5.3	-5.98	1e-07	0.000645	-0.61	-0.59	Plasma plasminogen activator levels;	chr12:130794531	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs1973834	ENSG00000256299.1	RP11-989F5.3	-5.98	1e-07	0.000645	-0.61	-0.59	Plasma plasminogen activator levels;	chr12:130795612	chr12:130810821~130812622:-
READ	cis	rs2882667	0.931	rs10075039	ENSG00000253404.1	AC034243.1	5.98	1.01e-07	0.000647	0.7	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139002165	chr5:138744434~138753309:-
READ	cis	rs2882667	0.931	rs10068237	ENSG00000253404.1	AC034243.1	5.98	1.01e-07	0.000647	0.7	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139002271	chr5:138744434~138753309:-
READ	cis	rs2882667	0.931	rs12719518	ENSG00000253404.1	AC034243.1	5.98	1.01e-07	0.000647	0.7	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139005287	chr5:138744434~138753309:-
READ	cis	rs10129255	0.5	rs8022547	ENSG00000211972.2	IGHV3-66	5.98	1.01e-07	0.000647	0.58	0.59	Kawasaki disease;	chr14:106781985	chr14:106675017~106675544:-
READ	cis	rs9309473	0.95	rs10198549	ENSG00000163016.8	ALMS1P	5.98	1.01e-07	0.000647	0.86	0.59	Metabolite levels;	chr2:73567277	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs9653557	ENSG00000163016.8	ALMS1P	5.98	1.01e-07	0.000647	0.86	0.59	Metabolite levels;	chr2:73568835	chr2:73644919~73685576:+
READ	cis	rs9309473	0.848	rs17009159	ENSG00000163016.8	ALMS1P	5.98	1.01e-07	0.000647	0.86	0.59	Metabolite levels;	chr2:73570635	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7583255	ENSG00000163016.8	ALMS1P	5.98	1.01e-07	0.000647	0.86	0.59	Metabolite levels;	chr2:73570869	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7586463	ENSG00000163016.8	ALMS1P	5.98	1.01e-07	0.000647	0.86	0.59	Metabolite levels;	chr2:73571349	chr2:73644919~73685576:+
READ	cis	rs875971	0.8	rs427557	ENSG00000226824.5	RP4-756H11.3	-5.97	1.03e-07	0.000648	-0.64	-0.59	Aortic root size;	chr7:66054263	chr7:66654538~66669855:+
READ	cis	rs875971	0.964	rs160635	ENSG00000226824.5	RP4-756H11.3	-5.97	1.04e-07	0.000655	-0.64	-0.59	Aortic root size;	chr7:66063931	chr7:66654538~66669855:+
READ	cis	rs2882667	0.894	rs1433008	ENSG00000253404.1	AC034243.1	5.97	1.05e-07	0.000659	0.7	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:138997975	chr5:138744434~138753309:-
READ	cis	rs9309473	1	rs10187192	ENSG00000163016.8	ALMS1P	5.97	1.06e-07	0.000666	0.87	0.59	Metabolite levels;	chr2:73486373	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs10183818	ENSG00000163016.8	ALMS1P	5.97	1.06e-07	0.000666	0.87	0.59	Metabolite levels;	chr2:73487429	chr2:73644919~73685576:+
READ	cis	rs9309473	0.687	rs10165862	ENSG00000163016.8	ALMS1P	5.97	1.06e-07	0.000667	0.74	0.59	Metabolite levels;	chr2:73383615	chr2:73644919~73685576:+
READ	cis	rs1930961	1	rs7285549	ENSG00000100058.11	CRYBB2P1	5.97	1.06e-07	0.000669	1.42	0.59	Bipolar disorder with mood-incongruent psychosis;	chr22:25478613	chr22:25448105~25520854:+
READ	cis	rs875971	0.862	rs908915	ENSG00000226824.5	RP4-756H11.3	5.96	1.07e-07	0.000674	0.67	0.59	Aortic root size;	chr7:66149664	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7809814	ENSG00000226824.5	RP4-756H11.3	5.96	1.07e-07	0.000674	0.67	0.59	Aortic root size;	chr7:66150410	chr7:66654538~66669855:+
READ	cis	rs4660456	0.871	rs671704	ENSG00000237899.1	RP4-739H11.3	5.96	1.07e-07	0.000674	0.94	0.59	Platelet count;	chr1:40683974	chr1:40669089~40687588:-
READ	cis	rs4660456	0.826	rs507914	ENSG00000237899.1	RP4-739H11.3	5.96	1.07e-07	0.000674	0.94	0.59	Platelet count;	chr1:40686529	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs2780950	ENSG00000237899.1	RP4-739H11.3	5.96	1.07e-07	0.000674	0.94	0.59	Platelet count;	chr1:40686937	chr1:40669089~40687588:-
READ	cis	rs4660456	0.826	rs2744802	ENSG00000237899.1	RP4-739H11.3	5.96	1.07e-07	0.000674	0.94	0.59	Platelet count;	chr1:40687577	chr1:40669089~40687588:-
READ	cis	rs875971	0.83	rs427575	ENSG00000226824.5	RP4-756H11.3	-5.96	1.08e-07	0.000677	-0.64	-0.59	Aortic root size;	chr7:66054232	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs587360	ENSG00000226824.5	RP4-756H11.3	-5.96	1.08e-07	0.000677	-0.64	-0.59	Aortic root size;	chr7:66057711	chr7:66654538~66669855:+
READ	cis	rs62229266	0.839	rs11088335	ENSG00000231106.2	LINC01436	5.96	1.08e-07	0.00068	0.76	0.59	Mitral valve prolapse;	chr21:36098037	chr21:36005338~36007838:+
READ	cis	rs7301826	0.651	rs10848206	ENSG00000256299.1	RP11-989F5.3	-5.96	1.09e-07	0.000683	-0.61	-0.59	Plasma plasminogen activator levels;	chr12:130796926	chr12:130810821~130812622:-
READ	cis	rs9309473	0.687	rs7576824	ENSG00000163016.8	ALMS1P	-5.96	1.09e-07	0.000683	-0.73	-0.59	Metabolite levels;	chr2:73384153	chr2:73644919~73685576:+
READ	cis	rs9309473	0.687	rs6706235	ENSG00000163016.8	ALMS1P	5.96	1.09e-07	0.000683	0.73	0.59	Metabolite levels;	chr2:73386430	chr2:73644919~73685576:+
READ	cis	rs9309473	0.718	rs6546829	ENSG00000163016.8	ALMS1P	5.96	1.09e-07	0.000683	0.73	0.59	Metabolite levels;	chr2:73386661	chr2:73644919~73685576:+
READ	cis	rs801193	0.548	rs6975044	ENSG00000226824.5	RP4-756H11.3	-5.96	1.09e-07	0.000684	-0.72	-0.59	Aortic root size;	chr7:66762495	chr7:66654538~66669855:+
READ	cis	rs9326248	0.861	rs7120309	ENSG00000254851.1	RP11-109L13.1	-5.96	1.1e-07	0.000685	-0.84	-0.59	Blood protein levels;	chr11:117172100	chr11:117135528~117138582:+
READ	cis	rs9326248	0.861	rs7120449	ENSG00000254851.1	RP11-109L13.1	-5.96	1.1e-07	0.000685	-0.84	-0.59	Blood protein levels;	chr11:117172183	chr11:117135528~117138582:+
READ	cis	rs9326248	0.861	rs4938353	ENSG00000254851.1	RP11-109L13.1	-5.96	1.1e-07	0.000685	-0.84	-0.59	Blood protein levels;	chr11:117175481	chr11:117135528~117138582:+
READ	cis	rs875971	0.965	rs7794930	ENSG00000226824.5	RP4-756H11.3	5.96	1.1e-07	0.000688	0.67	0.59	Aortic root size;	chr7:66313559	chr7:66654538~66669855:+
READ	cis	rs10129255	0.509	rs756583	ENSG00000211972.2	IGHV3-66	5.95	1.11e-07	0.000695	0.58	0.59	Kawasaki disease;	chr14:106680002	chr14:106675017~106675544:-
READ	cis	rs9309473	0.95	rs6546847	ENSG00000163016.8	ALMS1P	5.95	1.13e-07	0.000702	0.87	0.59	Metabolite levels;	chr2:73558231	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs7580750	ENSG00000163016.8	ALMS1P	5.95	1.13e-07	0.000702	0.87	0.59	Metabolite levels;	chr2:73560999	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs11126403	ENSG00000163016.8	ALMS1P	5.95	1.13e-07	0.000702	0.87	0.59	Metabolite levels;	chr2:73569796	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs11126404	ENSG00000163016.8	ALMS1P	5.95	1.13e-07	0.000702	0.87	0.59	Metabolite levels;	chr2:73569797	chr2:73644919~73685576:+
READ	cis	rs2882667	0.858	rs66839813	ENSG00000253404.1	AC034243.1	5.95	1.13e-07	0.000703	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139106633	chr5:138744434~138753309:-
READ	cis	rs9322193	0.651	rs9322188	ENSG00000268592.3	RAET1E-AS1	-5.95	1.13e-07	0.000703	-0.76	-0.59	Lung cancer;	chr6:149588355	chr6:149863494~149919507:+
READ	cis	rs9309473	0.95	rs11126412	ENSG00000163016.8	ALMS1P	5.95	1.14e-07	0.000708	0.85	0.59	Metabolite levels;	chr2:73660507	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs6740766	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73553786	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs13431267	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73555073	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10207220	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73557919	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs10169213	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73560107	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs6735946	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73562931	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs17009149	ENSG00000163016.8	ALMS1P	5.95	1.15e-07	0.000714	0.85	0.59	Metabolite levels;	chr2:73563241	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7598419	ENSG00000163016.8	ALMS1P	5.94	1.15e-07	0.000716	0.86	0.59	Metabolite levels;	chr2:73571096	chr2:73644919~73685576:+
READ	cis	rs875971	0.658	rs432667	ENSG00000226824.5	RP4-756H11.3	-5.94	1.18e-07	0.000724	-0.64	-0.59	Aortic root size;	chr7:66049646	chr7:66654538~66669855:+
READ	cis	rs875971	0.662	rs448725	ENSG00000226824.5	RP4-756H11.3	-5.93	1.2e-07	0.000737	-0.64	-0.59	Aortic root size;	chr7:66049641	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs427973	ENSG00000226824.5	RP4-756H11.3	-5.93	1.21e-07	0.000741	-0.65	-0.59	Aortic root size;	chr7:66061661	chr7:66654538~66669855:+
READ	cis	rs875971	0.793	rs460678	ENSG00000226824.5	RP4-756H11.3	-5.93	1.21e-07	0.000741	-0.65	-0.59	Aortic root size;	chr7:66062213	chr7:66654538~66669855:+
READ	cis	rs11155671	0.53	rs9371544	ENSG00000216906.2	RP11-350J20.9	5.93	1.22e-07	0.000743	0.76	0.59	Testicular germ cell tumor;	chr6:149896224	chr6:149904243~149906418:+
READ	cis	rs875971	0.862	rs4149461	ENSG00000226824.5	RP4-756H11.3	5.93	1.22e-07	0.000743	0.68	0.59	Aortic root size;	chr7:66279745	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs4236208	ENSG00000226824.5	RP4-756H11.3	5.93	1.22e-07	0.000743	0.68	0.59	Aortic root size;	chr7:66284091	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10261398	ENSG00000226824.5	RP4-756H11.3	5.93	1.22e-07	0.000743	0.68	0.59	Aortic root size;	chr7:66285177	chr7:66654538~66669855:+
READ	cis	rs2882667	0.898	rs11952020	ENSG00000253404.1	AC034243.1	5.93	1.23e-07	0.00075	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139059467	chr5:138744434~138753309:-
READ	cis	rs62229266	0.618	rs11088334	ENSG00000231106.2	LINC01436	5.92	1.26e-07	0.000768	0.77	0.59	Mitral valve prolapse;	chr21:36094531	chr21:36005338~36007838:+
READ	cis	rs17264034	0.861	rs1614229	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9546883	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs1651285	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9547829	chr5:9546200~9550609:+
READ	cis	rs17264034	0.808	rs1706987	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9547853	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs1398337	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9547986	chr5:9546200~9550609:+
READ	cis	rs17264034	0.821	rs374218	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9548331	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs431288	ENSG00000250786.1	SNHG18	5.92	1.27e-07	0.000772	0.82	0.59	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9549347	chr5:9546200~9550609:+
READ	cis	rs9309473	0.95	rs73947808	ENSG00000163016.8	ALMS1P	5.92	1.27e-07	0.000774	0.85	0.59	Metabolite levels;	chr2:73494123	chr2:73644919~73685576:+
READ	cis	rs9326248	0.581	rs10892076	ENSG00000254851.1	RP11-109L13.1	-5.92	1.28e-07	0.000776	-0.77	-0.59	Blood protein levels;	chr11:117118220	chr11:117135528~117138582:+
READ	cis	rs2882667	0.858	rs11242448	ENSG00000253404.1	AC034243.1	5.91	1.31e-07	0.000791	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139107465	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs13174479	ENSG00000253404.1	AC034243.1	5.91	1.31e-07	0.000791	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139108481	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs13176497	ENSG00000253404.1	AC034243.1	5.91	1.31e-07	0.000791	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139110385	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs11959803	ENSG00000253404.1	AC034243.1	5.91	1.31e-07	0.000791	0.73	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139115626	chr5:138744434~138753309:-
READ	cis	rs2946504	0.501	rs2977092	ENSG00000251468.2	RP11-369K16.1	-5.91	1.32e-07	0.000795	-0.73	-0.59	Type 2 diabetes;	chr8:12949867	chr8:12958387~12962200:+
READ	cis	rs9309473	0.898	rs10185080	ENSG00000163016.8	ALMS1P	5.91	1.33e-07	0.000799	0.86	0.59	Metabolite levels;	chr2:73570380	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs10197755	ENSG00000163016.8	ALMS1P	5.91	1.33e-07	0.000799	0.86	0.59	Metabolite levels;	chr2:73570496	chr2:73644919~73685576:+
READ	cis	rs4660456	0.913	rs2223486	ENSG00000237899.1	RP4-739H11.3	-5.91	1.34e-07	0.000804	-0.93	-0.59	Platelet count;	chr1:40693557	chr1:40669089~40687588:-
READ	cis	rs9322193	0.923	rs9688452	ENSG00000216906.2	RP11-350J20.9	5.91	1.34e-07	0.000805	0.74	0.59	Lung cancer;	chr6:149658764	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9767554	ENSG00000216906.2	RP11-350J20.9	5.9	1.35e-07	0.000813	0.73	0.59	Lung cancer;	chr6:149616860	chr6:149904243~149906418:+
READ	cis	rs9309473	1	rs58603761	ENSG00000163016.8	ALMS1P	5.9	1.36e-07	0.000817	0.86	0.59	Metabolite levels;	chr2:73499478	chr2:73644919~73685576:+
READ	cis	rs875971	0.893	rs62465470	ENSG00000226824.5	RP4-756H11.3	5.9	1.37e-07	0.000821	0.65	0.59	Aortic root size;	chr7:66136231	chr7:66654538~66669855:+
READ	cis	rs1799949	0.931	rs34410138	ENSG00000198496.9	NBR2	-5.9	1.37e-07	0.000826	-0.69	-0.59	Menopause (age at onset);	chr17:43127753	chr17:43125610~43153671:+
READ	cis	rs875971	0.862	rs2901152	ENSG00000226824.5	RP4-756H11.3	5.9	1.38e-07	0.000829	0.71	0.59	Aortic root size;	chr7:66300017	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10263690	ENSG00000226824.5	RP4-756H11.3	5.9	1.38e-07	0.000829	0.71	0.59	Aortic root size;	chr7:66301466	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10250544	ENSG00000226824.5	RP4-756H11.3	5.9	1.38e-07	0.000829	0.71	0.59	Aortic root size;	chr7:66301574	chr7:66654538~66669855:+
READ	cis	rs9399135	0.636	rs7749106	ENSG00000232876.1	CTA-212D2.2	-5.9	1.38e-07	0.00083	-0.76	-0.59	Red blood cell count;	chr6:134947004	chr6:135055033~135060550:+
READ	cis	rs1577917	0.74	rs2475792	ENSG00000203875.9	SNHG5	5.89	1.41e-07	0.000846	0.73	0.59	Response to antipsychotic treatment;	chr6:85682384	chr6:85660950~85678736:-
READ	cis	rs916888	0.558	rs199521	ENSG00000214401.4	KANSL1-AS1	-5.89	1.41e-07	0.000848	-0.89	-0.59	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776090	chr17:46193576~46196723:+
READ	cis	rs4660456	0.913	rs34212676	ENSG00000237899.1	RP4-739H11.3	-5.89	1.44e-07	0.000858	-0.94	-0.59	Platelet count;	chr1:40766522	chr1:40669089~40687588:-
READ	cis	rs875971	0.825	rs801202	ENSG00000226824.5	RP4-756H11.3	5.89	1.45e-07	0.000862	0.7	0.59	Aortic root size;	chr7:66558942	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801195	ENSG00000226824.5	RP4-756H11.3	5.89	1.45e-07	0.000862	0.7	0.59	Aortic root size;	chr7:66561128	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs801194	ENSG00000226824.5	RP4-756H11.3	5.89	1.45e-07	0.000862	0.7	0.59	Aortic root size;	chr7:66563508	chr7:66654538~66669855:+
READ	cis	rs875971	0.798	rs12698522	ENSG00000226824.5	RP4-756H11.3	-5.89	1.45e-07	0.000862	-0.7	-0.59	Aortic root size;	chr7:66502354	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs28714531	ENSG00000226824.5	RP4-756H11.3	-5.89	1.45e-07	0.000862	-0.7	-0.59	Aortic root size;	chr7:66503250	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs12698526	ENSG00000226824.5	RP4-756H11.3	-5.89	1.45e-07	0.000862	-0.7	-0.59	Aortic root size;	chr7:66504118	chr7:66654538~66669855:+
READ	cis	rs875971	0.767	rs61348003	ENSG00000226824.5	RP4-756H11.3	-5.89	1.45e-07	0.000862	-0.7	-0.59	Aortic root size;	chr7:66540947	chr7:66654538~66669855:+
READ	cis	rs9399135	0.66	rs9376072	ENSG00000232876.1	CTA-212D2.2	-5.88	1.46e-07	0.000871	-0.76	-0.59	Red blood cell count;	chr6:134959381	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs7741515	ENSG00000232876.1	CTA-212D2.2	5.88	1.47e-07	0.000875	0.73	0.59	Red blood cell count;	chr6:135053230	chr6:135055033~135060550:+
READ	cis	rs2739330	0.796	rs2154594	ENSG00000225282.1	AP000350.6	-5.88	1.47e-07	0.000876	-0.56	-0.59	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911868	chr22:23926900~23929574:+
READ	cis	rs4660456	0.913	rs4660449	ENSG00000237899.1	RP4-739H11.3	5.88	1.48e-07	0.00088	0.84	0.59	Platelet count;	chr1:40739780	chr1:40669089~40687588:-
READ	cis	rs9322193	0.924	rs9322189	ENSG00000216906.2	RP11-350J20.9	5.88	1.48e-07	0.000881	0.78	0.59	Lung cancer;	chr6:149588797	chr6:149904243~149906418:+
READ	cis	rs1577917	0.74	rs7752502	ENSG00000203875.9	SNHG5	5.88	1.5e-07	0.000893	0.75	0.59	Response to antipsychotic treatment;	chr6:85700933	chr6:85660950~85678736:-
READ	cis	rs2739330	0.828	rs4822454	ENSG00000225282.1	AP000350.6	5.88	1.51e-07	0.000897	0.57	0.59	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23926900~23929574:+
READ	cis	rs1891275	0.516	rs10881935	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91637944	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421621	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91640344	chr10:91782839~91798291:-
READ	cis	rs1891275	0.527	rs35812291	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91642584	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933681	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91643365	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs7071844	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91644092	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933684	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91647805	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933687	ENSG00000228701.1	TNKS2-AS1	-5.88	1.52e-07	0.000898	-0.77	-0.59	Intelligence (multi-trait analysis);	chr10:91650642	chr10:91782839~91798291:-
READ	cis	rs9326248	0.559	rs482371	ENSG00000254851.1	RP11-109L13.1	-5.88	1.52e-07	9e-04	-0.75	-0.59	Blood protein levels;	chr11:116881447	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs1269329	ENSG00000254851.1	RP11-109L13.1	-5.88	1.52e-07	9e-04	-0.75	-0.59	Blood protein levels;	chr11:116884325	chr11:117135528~117138582:+
READ	cis	rs9326248	0.539	rs660443	ENSG00000254851.1	RP11-109L13.1	-5.88	1.52e-07	9e-04	-0.75	-0.59	Blood protein levels;	chr11:116889977	chr11:117135528~117138582:+
READ	cis	rs7937890	0.904	rs11023169	ENSG00000254418.1	RP11-21L19.1	-5.87	1.52e-07	9e-04	-0.72	-0.59	Mitochondrial DNA levels;	chr11:14269439	chr11:14262846~14273691:-
READ	cis	rs1799949	1	rs16940	ENSG00000198496.9	NBR2	-5.87	1.54e-07	0.000906	-0.68	-0.59	Menopause (age at onset);	chr17:43093220	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs66499067	ENSG00000198496.9	NBR2	-5.87	1.54e-07	0.000906	-0.68	-0.59	Menopause (age at onset);	chr17:43096467	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176145	ENSG00000198496.9	NBR2	-5.87	1.54e-07	0.000906	-0.68	-0.59	Menopause (age at onset);	chr17:43097077	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs8176140	ENSG00000198496.9	NBR2	-5.87	1.54e-07	0.000906	-0.68	-0.59	Menopause (age at onset);	chr17:43099629	chr17:43125610~43153671:+
READ	cis	rs875971	0.862	rs4718377	ENSG00000226824.5	RP4-756H11.3	5.87	1.54e-07	0.000906	0.7	0.59	Aortic root size;	chr7:66584691	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10278014	ENSG00000226824.5	RP4-756H11.3	5.87	1.54e-07	0.000906	0.7	0.59	Aortic root size;	chr7:66586277	chr7:66654538~66669855:+
READ	cis	rs9322193	0.886	rs4870055	ENSG00000216906.2	RP11-350J20.9	5.87	1.54e-07	0.000909	0.73	0.59	Lung cancer;	chr6:149848433	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs7769101	ENSG00000216906.2	RP11-350J20.9	5.87	1.54e-07	0.000909	0.73	0.59	Lung cancer;	chr6:149848768	chr6:149904243~149906418:+
READ	cis	rs9309473	0.66	rs79370894	ENSG00000163016.8	ALMS1P	5.87	1.55e-07	0.00091	0.92	0.59	Metabolite levels;	chr2:73456388	chr2:73644919~73685576:+
READ	cis	rs9309473	0.66	rs11686541	ENSG00000163016.8	ALMS1P	5.87	1.55e-07	0.00091	0.92	0.59	Metabolite levels;	chr2:73477348	chr2:73644919~73685576:+
READ	cis	rs9309473	0.615	rs11680965	ENSG00000163016.8	ALMS1P	5.87	1.55e-07	0.00091	0.92	0.59	Metabolite levels;	chr2:73498789	chr2:73644919~73685576:+
READ	cis	rs9322193	0.847	rs9498372	ENSG00000268592.3	RAET1E-AS1	5.87	1.55e-07	0.000911	0.81	0.59	Lung cancer;	chr6:149567128	chr6:149863494~149919507:+
READ	cis	rs2946504	0.501	rs2946509	ENSG00000251468.2	RP11-369K16.1	-5.87	1.56e-07	0.000919	-0.73	-0.59	Type 2 diabetes;	chr8:12950782	chr8:12958387~12962200:+
READ	cis	rs9326248	0.581	rs11216267	ENSG00000254851.1	RP11-109L13.1	-5.87	1.56e-07	0.000919	-0.74	-0.59	Blood protein levels;	chr11:117081676	chr11:117135528~117138582:+
READ	cis	rs9322193	1	rs9322193	ENSG00000268592.3	RAET1E-AS1	5.87	1.57e-07	0.000919	0.78	0.59	Lung cancer;	chr6:149598007	chr6:149863494~149919507:+
READ	cis	rs9322193	1	rs9377229	ENSG00000268592.3	RAET1E-AS1	5.87	1.57e-07	0.000919	0.78	0.59	Lung cancer;	chr6:149607655	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322197	ENSG00000268592.3	RAET1E-AS1	5.87	1.57e-07	0.000919	0.78	0.59	Lung cancer;	chr6:149622577	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9688858	ENSG00000268592.3	RAET1E-AS1	5.87	1.57e-07	0.000919	0.78	0.59	Lung cancer;	chr6:149637911	chr6:149863494~149919507:+
READ	cis	rs9309473	0.653	rs6718843	ENSG00000163016.8	ALMS1P	5.87	1.57e-07	0.00092	0.84	0.59	Metabolite levels;	chr2:73625378	chr2:73644919~73685576:+
READ	cis	rs9326248	0.581	rs7106437	ENSG00000254851.1	RP11-109L13.1	-5.87	1.57e-07	0.000921	-0.75	-0.59	Blood protein levels;	chr11:117121360	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs9689716	ENSG00000216906.2	RP11-350J20.9	5.87	1.58e-07	0.000922	0.73	0.59	Lung cancer;	chr6:149655662	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322207	ENSG00000216906.2	RP11-350J20.9	5.87	1.58e-07	0.000922	0.73	0.59	Lung cancer;	chr6:149657185	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9968911	ENSG00000216906.2	RP11-350J20.9	5.87	1.58e-07	0.000922	0.73	0.59	Lung cancer;	chr6:149657419	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322208	ENSG00000216906.2	RP11-350J20.9	5.87	1.58e-07	0.000922	0.73	0.59	Lung cancer;	chr6:149658547	chr6:149904243~149906418:+
READ	cis	rs9322193	1	rs9399693	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149612718	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9404048	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149616188	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9505982	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149618465	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322196	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149619645	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10747275	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149622782	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9688794	ENSG00000216906.2	RP11-350J20.9	5.86	1.59e-07	0.000927	0.74	0.59	Lung cancer;	chr6:149632121	chr6:149904243~149906418:+
READ	cis	rs2882667	0.537	rs7704790	ENSG00000253404.1	AC034243.1	5.86	1.59e-07	0.000928	0.66	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:139074407	chr5:138744434~138753309:-
READ	cis	rs9322193	0.847	rs12210605	ENSG00000216906.2	RP11-350J20.9	5.86	1.6e-07	0.000929	0.76	0.59	Lung cancer;	chr6:149817267	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9371199	ENSG00000216906.2	RP11-350J20.9	5.86	1.6e-07	0.000929	0.76	0.59	Lung cancer;	chr6:149817526	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs1125	ENSG00000268592.3	RAET1E-AS1	5.86	1.61e-07	0.000937	0.75	0.59	Lung cancer;	chr6:149658280	chr6:149863494~149919507:+
READ	cis	rs9399135	0.967	rs2183709	ENSG00000232876.1	CTA-212D2.2	-5.86	1.61e-07	0.000937	-0.77	-0.59	Red blood cell count;	chr6:135055953	chr6:135055033~135060550:+
READ	cis	rs9399135	0.967	rs4142299	ENSG00000232876.1	CTA-212D2.2	-5.86	1.61e-07	0.000937	-0.77	-0.59	Red blood cell count;	chr6:135056048	chr6:135055033~135060550:+
READ	cis	rs2882667	0.638	rs6895690	ENSG00000253404.1	AC034243.1	5.86	1.62e-07	0.00094	0.72	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139130162	chr5:138744434~138753309:-
READ	cis	rs875971	0.862	rs2460432	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66089398	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1167408	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66091121	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs1167406	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66091949	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs709609	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66095574	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1167399	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66096890	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs59466412	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66100371	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs57866200	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.00094	0.66	0.58	Aortic root size;	chr7:66100405	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7786892	ENSG00000226824.5	RP4-756H11.3	5.86	1.62e-07	0.000941	0.67	0.58	Aortic root size;	chr7:66163889	chr7:66654538~66669855:+
READ	cis	rs10129255	0.536	rs6576201	ENSG00000211972.2	IGHV3-66	-5.86	1.64e-07	0.000949	-0.55	-0.58	Kawasaki disease;	chr14:106683696	chr14:106675017~106675544:-
READ	cis	rs875971	0.756	rs4718328	ENSG00000226824.5	RP4-756H11.3	5.85	1.65e-07	0.000952	0.67	0.58	Aortic root size;	chr7:66228350	chr7:66654538~66669855:+
READ	cis	rs9322193	0.847	rs56103941	ENSG00000216906.2	RP11-350J20.9	5.85	1.65e-07	0.000953	0.75	0.58	Lung cancer;	chr6:149816095	chr6:149904243~149906418:+
READ	cis	rs17507216	1	rs17356118	ENSG00000278603.1	RP13-608F4.5	5.85	1.66e-07	0.000954	0.82	0.58	Excessive daytime sleepiness;	chr15:82569149	chr15:82472203~82472426:+
READ	cis	rs11155671	0.53	rs6557133	ENSG00000231760.4	RP11-350J20.5	5.85	1.66e-07	0.000955	0.81	0.58	Testicular germ cell tumor;	chr6:149874248	chr6:149796151~149826294:-
READ	cis	rs858239	0.899	rs28458177	ENSG00000230658.1	KLHL7-AS1	5.85	1.66e-07	0.000955	0.79	0.58	Cerebrospinal fluid biomarker levels;	chr7:23255253	chr7:23101228~23105703:-
READ	cis	rs7937890	0.874	rs2303972	ENSG00000254418.1	RP11-21L19.1	-5.85	1.67e-07	0.00096	-0.73	-0.58	Mitochondrial DNA levels;	chr11:14281736	chr11:14262846~14273691:-
READ	cis	rs7208859	0.673	rs216418	ENSG00000263531.1	RP13-753N3.1	5.85	1.68e-07	0.000961	0.92	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30609519	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs216420	ENSG00000263531.1	RP13-753N3.1	5.85	1.68e-07	0.000961	0.92	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30611490	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs216423	ENSG00000263531.1	RP13-753N3.1	5.85	1.68e-07	0.000961	0.92	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30615091	chr17:30863921~30864940:-
READ	cis	rs2882667	0.755	rs55650316	ENSG00000253404.1	AC034243.1	5.85	1.71e-07	0.000976	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139131603	chr5:138744434~138753309:-
READ	cis	rs1799949	0.965	rs8176087	ENSG00000198496.9	NBR2	-5.84	1.72e-07	0.000986	-0.68	-0.58	Menopause (age at onset);	chr17:43118649	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs34942571	ENSG00000198496.9	NBR2	-5.84	1.72e-07	0.000986	-0.68	-0.58	Menopause (age at onset);	chr17:43121362	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs8176130	ENSG00000198496.9	NBR2	-5.84	1.73e-07	0.000987	-0.68	-0.58	Menopause (age at onset);	chr17:43106026	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176120	ENSG00000198496.9	NBR2	-5.84	1.73e-07	0.000987	-0.68	-0.58	Menopause (age at onset);	chr17:43109216	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176109	ENSG00000198496.9	NBR2	-5.84	1.73e-07	0.000987	-0.68	-0.58	Menopause (age at onset);	chr17:43113759	chr17:43125610~43153671:+
READ	cis	rs9309473	1	rs7604682	ENSG00000163016.8	ALMS1P	5.84	1.73e-07	0.000987	0.86	0.58	Metabolite levels;	chr2:73560899	chr2:73644919~73685576:+
READ	cis	rs9322193	0.923	rs9766037	ENSG00000216906.2	RP11-350J20.9	5.84	1.74e-07	0.000988	0.76	0.58	Lung cancer;	chr6:149616921	chr6:149904243~149906418:+
READ	cis	rs916888	0.647	rs199520	ENSG00000214401.4	KANSL1-AS1	-5.84	1.76e-07	0.000995	-0.89	-0.58	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776506	chr17:46193576~46196723:+
READ	cis	rs916888	0.647	rs199519	ENSG00000214401.4	KANSL1-AS1	-5.84	1.76e-07	0.000995	-0.89	-0.58	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46776558	chr17:46193576~46196723:+
READ	cis	rs7224296	0.709	rs199518	ENSG00000214401.4	KANSL1-AS1	-5.84	1.76e-07	0.000995	-0.89	-0.58	Intelligence (multi-trait analysis);	chr17:46777214	chr17:46193576~46196723:+
READ	cis	rs916888	0.647	rs199517	ENSG00000214401.4	KANSL1-AS1	-5.84	1.76e-07	0.000995	-0.89	-0.58	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46777221	chr17:46193576~46196723:+
READ	cis	rs17826219	0.561	rs562840	ENSG00000263531.1	RP13-753N3.1	5.84	1.77e-07	0.000999	0.92	0.58	Body mass index;	chr17:30622372	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs450585	ENSG00000263531.1	RP13-753N3.1	5.84	1.77e-07	0.000999	0.92	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30624021	chr17:30863921~30864940:-
READ	cis	rs9309473	0.898	rs10201159	ENSG00000163016.8	ALMS1P	5.84	1.77e-07	0.000999	0.84	0.58	Metabolite levels;	chr2:73631838	chr2:73644919~73685576:+
READ	cis	rs9309473	0.847	rs4547554	ENSG00000163016.8	ALMS1P	5.84	1.77e-07	0.000999	0.84	0.58	Metabolite levels;	chr2:73640735	chr2:73644919~73685576:+
READ	cis	rs9309473	0.847	rs13538	ENSG00000163016.8	ALMS1P	5.84	1.77e-07	0.000999	0.84	0.58	Metabolite levels;	chr2:73641201	chr2:73644919~73685576:+
READ	cis	rs9326248	0.539	rs10892058	ENSG00000254851.1	RP11-109L13.1	-5.83	1.79e-07	0.001	-0.77	-0.58	Blood protein levels;	chr11:117005905	chr11:117135528~117138582:+
READ	cis	rs9326248	0.52	rs7127881	ENSG00000254851.1	RP11-109L13.1	-5.83	1.79e-07	0.001	-0.77	-0.58	Blood protein levels;	chr11:117010082	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs9800686	ENSG00000216906.2	RP11-350J20.9	5.83	1.79e-07	0.001	0.75	0.58	Lung cancer;	chr6:149634464	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs55849538	ENSG00000216906.2	RP11-350J20.9	5.83	1.79e-07	0.001	0.75	0.58	Lung cancer;	chr6:149635330	chr6:149904243~149906418:+
READ	cis	rs9322193	0.81	rs62439811	ENSG00000216906.2	RP11-350J20.9	5.83	1.79e-07	0.001	0.75	0.58	Lung cancer;	chr6:149640416	chr6:149904243~149906418:+
READ	cis	rs11690935	0.959	rs12692973	ENSG00000228389.1	AC068039.4	-5.83	1.79e-07	0.00101	-0.77	-0.58	Schizophrenia;	chr2:171785547	chr2:171773482~171775844:+
READ	cis	rs1930961	1	rs59226697	ENSG00000100058.11	CRYBB2P1	5.83	1.8e-07	0.00101	1.57	0.58	Bipolar disorder with mood-incongruent psychosis;	chr22:25474070	chr22:25448105~25520854:+
READ	cis	rs2739330	0.753	rs4822452	ENSG00000225282.1	AP000350.6	5.83	1.8e-07	0.00101	0.55	0.58	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912176	chr22:23926900~23929574:+
READ	cis	rs9322193	0.961	rs2064520	ENSG00000268592.3	RAET1E-AS1	5.83	1.82e-07	0.00102	0.78	0.58	Lung cancer;	chr6:149603650	chr6:149863494~149919507:+
READ	cis	rs9326248	0.581	rs6589582	ENSG00000254851.1	RP11-109L13.1	-5.83	1.82e-07	0.00102	-0.72	-0.58	Blood protein levels;	chr11:116958484	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs10872644	ENSG00000216906.2	RP11-350J20.9	5.83	1.82e-07	0.00102	0.73	0.58	Lung cancer;	chr6:149741819	chr6:149904243~149906418:+
READ	cis	rs2739330	0.828	rs2186366	ENSG00000225282.1	AP000350.6	-5.83	1.83e-07	0.00103	-0.55	-0.58	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23926900~23929574:+
READ	cis	rs875971	0.862	rs6971059	ENSG00000226824.5	RP4-756H11.3	5.83	1.84e-07	0.00103	0.69	0.58	Aortic root size;	chr7:66602045	chr7:66654538~66669855:+
READ	cis	rs875971	0.755	rs76288834	ENSG00000226824.5	RP4-756H11.3	5.83	1.84e-07	0.00103	0.69	0.58	Aortic root size;	chr7:66604815	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs66981195	ENSG00000226824.5	RP4-756H11.3	5.83	1.84e-07	0.00103	0.69	0.58	Aortic root size;	chr7:66614048	chr7:66654538~66669855:+
READ	cis	rs9322193	0.923	rs9800686	ENSG00000268592.3	RAET1E-AS1	5.83	1.84e-07	0.00103	0.75	0.58	Lung cancer;	chr6:149634464	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs55849538	ENSG00000268592.3	RAET1E-AS1	5.83	1.84e-07	0.00103	0.75	0.58	Lung cancer;	chr6:149635330	chr6:149863494~149919507:+
READ	cis	rs9322193	0.81	rs62439811	ENSG00000268592.3	RAET1E-AS1	5.83	1.84e-07	0.00103	0.75	0.58	Lung cancer;	chr6:149640416	chr6:149863494~149919507:+
READ	cis	rs12439619	0.705	rs17354185	ENSG00000278603.1	RP13-608F4.5	-5.83	1.85e-07	0.00104	-0.9	-0.58	Intelligence (multi-trait analysis);	chr15:82133829	chr15:82472203~82472426:+
READ	cis	rs1799949	0.896	rs8176098	ENSG00000198496.9	NBR2	-5.82	1.86e-07	0.00104	-0.68	-0.58	Menopause (age at onset);	chr17:43116189	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs35668327	ENSG00000198496.9	NBR2	-5.82	1.86e-07	0.00104	-0.68	-0.58	Menopause (age at onset);	chr17:43121078	chr17:43125610~43153671:+
READ	cis	rs1799949	0.896	rs8176086	ENSG00000198496.9	NBR2	-5.82	1.86e-07	0.00104	-0.68	-0.58	Menopause (age at onset);	chr17:43122761	chr17:43125610~43153671:+
READ	cis	rs1577917	0.74	rs9353327	ENSG00000203875.9	SNHG5	-5.82	1.86e-07	0.00104	-0.75	-0.58	Response to antipsychotic treatment;	chr6:85684348	chr6:85660950~85678736:-
READ	cis	rs9322193	0.923	rs9767105	ENSG00000268592.3	RAET1E-AS1	5.82	1.87e-07	0.00104	0.68	0.58	Lung cancer;	chr6:149659591	chr6:149863494~149919507:+
READ	cis	rs9309473	1	rs6745368	ENSG00000163016.8	ALMS1P	5.82	1.88e-07	0.00105	0.85	0.58	Metabolite levels;	chr2:73582847	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs10173534	ENSG00000163016.8	ALMS1P	5.82	1.88e-07	0.00105	0.85	0.58	Metabolite levels;	chr2:73586305	chr2:73644919~73685576:+
READ	cis	rs2882667	0.898	rs11950819	ENSG00000253404.1	AC034243.1	5.82	1.89e-07	0.00105	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139061411	chr5:138744434~138753309:-
READ	cis	rs4660456	0.913	rs2780952	ENSG00000237899.1	RP4-739H11.3	5.82	1.89e-07	0.00105	0.92	0.58	Platelet count;	chr1:40689711	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs656230	ENSG00000237899.1	RP4-739H11.3	5.82	1.89e-07	0.00105	0.92	0.58	Platelet count;	chr1:40692701	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs2780953	ENSG00000237899.1	RP4-739H11.3	5.82	1.89e-07	0.00105	0.92	0.58	Platelet count;	chr1:40694105	chr1:40669089~40687588:-
READ	cis	rs6545883	0.811	rs778753	ENSG00000271707.1	ATP1B3P1	-5.82	1.91e-07	0.00106	-0.72	-0.58	Tuberculosis;	chr2:61553065	chr2:60734895~60735715:-
READ	cis	rs9309473	0.95	rs13408433	ENSG00000163016.8	ALMS1P	5.82	1.92e-07	0.00106	0.83	0.58	Metabolite levels;	chr2:73655945	chr2:73644919~73685576:+
READ	cis	rs9309473	0.95	rs10189885	ENSG00000163016.8	ALMS1P	5.82	1.92e-07	0.00106	0.82	0.58	Metabolite levels;	chr2:73649928	chr2:73644919~73685576:+
READ	cis	rs801193	0.569	rs35070132	ENSG00000226824.5	RP4-756H11.3	-5.82	1.93e-07	0.00107	-0.72	-0.58	Aortic root size;	chr7:66773096	chr7:66654538~66669855:+
READ	cis	rs9322193	0.772	rs7738696	ENSG00000216906.2	RP11-350J20.9	5.82	1.93e-07	0.00107	0.7	0.58	Lung cancer;	chr6:149848985	chr6:149904243~149906418:+
READ	cis	rs875971	0.862	rs1968126	ENSG00000226824.5	RP4-756H11.3	5.81	1.95e-07	0.00108	0.69	0.58	Aortic root size;	chr7:66592017	chr7:66654538~66669855:+
READ	cis	rs858239	0.896	rs1637192	ENSG00000230658.1	KLHL7-AS1	5.81	1.96e-07	0.00108	0.76	0.58	Cerebrospinal fluid biomarker levels;	chr7:23220895	chr7:23101228~23105703:-
READ	cis	rs7617773	0.963	rs12495221	ENSG00000229759.1	MRPS18AP1	-5.81	1.96e-07	0.00109	-0.71	-0.58	Coronary artery disease;	chr3:48137688	chr3:48256350~48256938:-
READ	cis	rs858239	1	rs199348	ENSG00000230658.1	KLHL7-AS1	5.81	1.97e-07	0.00109	0.8	0.58	Cerebrospinal fluid biomarker levels;	chr7:23253479	chr7:23101228~23105703:-
READ	cis	rs875971	0.862	rs778686	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66370923	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778684	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66371416	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778680	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66375427	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11769079	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66377141	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1695820	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66379576	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs778715	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66384222	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs809025	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66384832	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778702	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66399848	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1643375	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66407690	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6962717	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66418748	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs6976714	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66426474	chr7:66654538~66669855:+
READ	cis	rs875971	0.651	rs2420596	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66450996	chr7:66654538~66669855:+
READ	cis	rs875971	0.52	rs2420597	ENSG00000226824.5	RP4-756H11.3	-5.81	1.98e-07	0.00109	-0.66	-0.58	Aortic root size;	chr7:66450999	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2420174	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66180374	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2420173	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66180412	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs4718319	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66187797	chr7:66654538~66669855:+
READ	cis	rs875971	0.723	rs28391294	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66189328	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs6967708	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66192326	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs7782806	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66192910	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs880166	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66205775	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs1000464	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66312922	chr7:66654538~66669855:+
READ	cis	rs875971	0.928	rs2036263	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66335210	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10240949	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66339430	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7782704	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66340379	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6959268	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.66	0.58	Aortic root size;	chr7:66347979	chr7:66654538~66669855:+
READ	cis	rs875971	0.79	rs10257911	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.71	0.58	Aortic root size;	chr7:66278783	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7796162	ENSG00000226824.5	RP4-756H11.3	5.81	1.98e-07	0.00109	0.71	0.58	Aortic root size;	chr7:66280771	chr7:66654538~66669855:+
READ	cis	rs9322193	0.847	rs880246	ENSG00000216906.2	RP11-350J20.9	5.81	1.98e-07	0.00109	0.72	0.58	Lung cancer;	chr6:149845972	chr6:149904243~149906418:+
READ	cis	rs2882667	0.652	rs6596463	ENSG00000253404.1	AC034243.1	5.8	2.01e-07	0.0011	0.72	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139109237	chr5:138744434~138753309:-
READ	cis	rs9399135	0.66	rs4472368	ENSG00000232876.1	CTA-212D2.2	-5.8	2.03e-07	0.00111	-0.77	-0.58	Red blood cell count;	chr6:134953094	chr6:135055033~135060550:+
READ	cis	rs1891275	0.551	rs2421624	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91656659	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421625	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91656744	chr10:91782839~91798291:-
READ	cis	rs1891275	0.576	rs7900117	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91657530	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933213	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91657947	chr10:91782839~91798291:-
READ	cis	rs1891275	0.515	rs7358148	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91658775	chr10:91782839~91798291:-
READ	cis	rs1891275	0.601	rs7358034	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91659007	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs7908547	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91659230	chr10:91782839~91798291:-
READ	cis	rs1891275	0.515	rs7908980	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91659545	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933690	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91659810	chr10:91782839~91798291:-
READ	cis	rs1891275	0.576	rs4933216	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91659825	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933691	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91660200	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421626	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91661177	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421627	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91662226	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421628	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91662412	chr10:91782839~91798291:-
READ	cis	rs1891275	0.515	rs10881945	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91663826	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421629	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91664018	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs4933692	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91664876	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs7900863	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91665737	chr10:91782839~91798291:-
READ	cis	rs1891275	0.588	rs6583782	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91666022	chr10:91782839~91798291:-
READ	cis	rs1891275	0.576	rs1891272	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91666306	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs1891271	ENSG00000228701.1	TNKS2-AS1	-5.8	2.03e-07	0.00111	-0.77	-0.58	Intelligence (multi-trait analysis);	chr10:91666566	chr10:91782839~91798291:-
READ	cis	rs9326248	0.581	rs4938331	ENSG00000254851.1	RP11-109L13.1	-5.8	2.05e-07	0.00111	-0.73	-0.58	Blood protein levels;	chr11:117059966	chr11:117135528~117138582:+
READ	cis	rs9326248	0.51	rs4938332	ENSG00000254851.1	RP11-109L13.1	-5.8	2.05e-07	0.00111	-0.73	-0.58	Blood protein levels;	chr11:117060082	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs4938334	ENSG00000254851.1	RP11-109L13.1	-5.8	2.05e-07	0.00111	-0.73	-0.58	Blood protein levels;	chr11:117060326	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs6589590	ENSG00000254851.1	RP11-109L13.1	-5.8	2.05e-07	0.00111	-0.73	-0.58	Blood protein levels;	chr11:117065365	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs7120963	ENSG00000254851.1	RP11-109L13.1	5.8	2.05e-07	0.00111	0.73	0.58	Blood protein levels;	chr11:116959545	chr11:117135528~117138582:+
READ	cis	rs9322193	1	rs9377228	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149600862	chr6:149904243~149906418:+
READ	cis	rs9322193	0.924	rs9498382	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149610982	chr6:149904243~149906418:+
READ	cis	rs9322193	0.886	rs9485408	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149618888	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs1080670	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149620161	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs10782312	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149622669	chr6:149904243~149906418:+
READ	cis	rs9322193	0.886	rs9322198	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149623772	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9505823	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149628899	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9689599	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149631973	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9800580	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149632845	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs11155669	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149633501	chr6:149904243~149906418:+
READ	cis	rs9322193	0.887	rs9505824	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149633663	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9505826	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149633912	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9766886	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149637048	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9688861	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149637924	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs7740278	ENSG00000216906.2	RP11-350J20.9	5.8	2.06e-07	0.00111	0.75	0.58	Lung cancer;	chr6:149640116	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs2064521	ENSG00000216906.2	RP11-350J20.9	-5.8	2.06e-07	0.00111	-0.75	-0.58	Lung cancer;	chr6:149625336	chr6:149904243~149906418:+
READ	cis	rs1799949	1	rs8176083	ENSG00000198496.9	NBR2	-5.8	2.07e-07	0.00111	-0.68	-0.58	Menopause (age at onset);	chr17:43123134	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs16941	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43092418	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs67060599	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43103085	chr17:43125610~43153671:+
READ	cis	rs1799949	0.896	rs35908185	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43103094	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176133	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43105441	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs2175957	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43134805	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs33988650	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43135863	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs33961729	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43135907	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11656097	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43138596	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs2292595	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43138657	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11657835	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43139936	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1135214	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43140306	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11658754	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43140722	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11652332	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43143472	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs33968979	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43145975	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12952790	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43147590	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12950607	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43147911	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11079056	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43148782	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12936816	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43149692	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793212	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43150733	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs34534709	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43150923	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs34059614	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43151054	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs33926631	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43152446	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1960605	ENSG00000198496.9	NBR2	-5.8	2.08e-07	0.00111	-0.67	-0.58	Menopause (age at onset);	chr17:43153380	chr17:43125610~43153671:+
READ	cis	rs9322193	0.884	rs2342858	ENSG00000268592.3	RAET1E-AS1	5.79	2.1e-07	0.00112	0.76	0.58	Lung cancer;	chr6:149805967	chr6:149863494~149919507:+
READ	cis	rs1891275	0.506	rs4933214	ENSG00000228701.1	TNKS2-AS1	-5.79	2.1e-07	0.00112	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91658004	chr10:91782839~91798291:-
READ	cis	rs9326248	0.581	rs7120706	ENSG00000254851.1	RP11-109L13.1	5.79	2.1e-07	0.00112	0.69	0.58	Blood protein levels;	chr11:116959371	chr11:117135528~117138582:+
READ	cis	rs1577917	0.682	rs1173417	ENSG00000203875.9	SNHG5	5.79	2.1e-07	0.00112	0.74	0.58	Response to antipsychotic treatment;	chr6:85694223	chr6:85660950~85678736:-
READ	cis	rs1577917	0.771	rs7762321	ENSG00000203875.9	SNHG5	5.79	2.1e-07	0.00112	0.74	0.58	Response to antipsychotic treatment;	chr6:85702428	chr6:85660950~85678736:-
READ	cis	rs9326248	0.603	rs7396061	ENSG00000254851.1	RP11-109L13.1	-5.79	2.13e-07	0.00113	-0.72	-0.58	Blood protein levels;	chr11:116880158	chr11:117135528~117138582:+
READ	cis	rs9322193	0.923	rs57938011	ENSG00000216906.2	RP11-350J20.9	5.79	2.13e-07	0.00113	0.74	0.58	Lung cancer;	chr6:149642969	chr6:149904243~149906418:+
READ	cis	rs875971	0.767	rs1643394	ENSG00000226824.5	RP4-756H11.3	-5.79	2.15e-07	0.00114	-0.66	-0.58	Aortic root size;	chr7:66371107	chr7:66654538~66669855:+
READ	cis	rs17826219	0.706	rs609472	ENSG00000263531.1	RP13-753N3.1	5.78	2.17e-07	0.00115	0.92	0.58	Body mass index;	chr17:30624409	chr17:30863921~30864940:-
READ	cis	rs875971	0.965	rs6971509	ENSG00000226824.5	RP4-756H11.3	5.78	2.19e-07	0.00116	0.64	0.58	Aortic root size;	chr7:66249983	chr7:66654538~66669855:+
READ	cis	rs1799949	0.93	rs3765640	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43124230	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176077	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43124331	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11655505	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43126360	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs4793204	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43127281	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs12947782	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43127865	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs33945274	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43128056	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs33925201	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43128665	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11653069	ENSG00000198496.9	NBR2	-5.78	2.23e-07	0.00117	-0.67	-0.58	Menopause (age at onset);	chr17:43131360	chr17:43125610~43153671:+
READ	cis	rs9322193	0.607	rs4870078	ENSG00000231760.4	RP11-350J20.5	-5.78	2.23e-07	0.00117	-0.88	-0.58	Lung cancer;	chr6:149880676	chr6:149796151~149826294:-
READ	cis	rs801193	0.569	rs2707824	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66724256	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs2659893	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66735006	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs2659892	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66735318	chr7:66654538~66669855:+
READ	cis	rs801193	0.548	rs2659891	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66736127	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs2707847	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66737884	chr7:66654538~66669855:+
READ	cis	rs801193	0.548	rs7805152	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66744266	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs11772819	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66752983	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs11761542	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66753209	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs7800620	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66758701	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs13226966	ENSG00000226824.5	RP4-756H11.3	-5.78	2.23e-07	0.00117	-0.68	-0.58	Aortic root size;	chr7:66768636	chr7:66654538~66669855:+
READ	cis	rs6504950	0.72	rs9913784	ENSG00000275710.1	RP11-257O5.4	5.78	2.26e-07	0.00118	0.87	0.58	Breast cancer;	chr17:54911710	chr17:54964474~54964679:+
READ	cis	rs4660456	0.913	rs16827552	ENSG00000237899.1	RP4-739H11.3	-5.78	2.26e-07	0.00118	-0.92	-0.58	Platelet count;	chr1:40758336	chr1:40669089~40687588:-
READ	cis	rs4660456	0.871	rs7549789	ENSG00000237899.1	RP4-739H11.3	-5.78	2.26e-07	0.00118	-0.92	-0.58	Platelet count;	chr1:40759362	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs6661855	ENSG00000237899.1	RP4-739H11.3	5.78	2.26e-07	0.00118	0.92	0.58	Platelet count;	chr1:40703245	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs7542019	ENSG00000237899.1	RP4-739H11.3	5.78	2.26e-07	0.00118	0.92	0.58	Platelet count;	chr1:40704039	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs1494	ENSG00000237899.1	RP4-739H11.3	5.78	2.26e-07	0.00118	0.92	0.58	Platelet count;	chr1:40706176	chr1:40669089~40687588:-
READ	cis	rs4660456	0.869	rs7518344	ENSG00000237899.1	RP4-739H11.3	5.78	2.26e-07	0.00118	0.92	0.58	Platelet count;	chr1:40708327	chr1:40669089~40687588:-
READ	cis	rs4660456	0.827	rs10736404	ENSG00000237899.1	RP4-739H11.3	5.78	2.26e-07	0.00118	0.92	0.58	Platelet count;	chr1:40710331	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs7551747	ENSG00000237899.1	RP4-739H11.3	5.77	2.26e-07	0.00119	0.96	0.58	Platelet count;	chr1:40699407	chr1:40669089~40687588:-
READ	cis	rs9322193	0.923	rs9371207	ENSG00000216906.2	RP11-350J20.9	5.77	2.26e-07	0.00119	0.7	0.58	Lung cancer;	chr6:149858087	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2880436	ENSG00000216906.2	RP11-350J20.9	5.77	2.26e-07	0.00119	0.7	0.58	Lung cancer;	chr6:149859123	chr6:149904243~149906418:+
READ	cis	rs17264034	0.821	rs605126	ENSG00000250786.1	SNHG18	5.77	2.27e-07	0.00119	0.8	0.58	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9541754	chr5:9546200~9550609:+
READ	cis	rs17264034	0.821	rs460234	ENSG00000250786.1	SNHG18	5.77	2.27e-07	0.00119	0.8	0.58	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9543022	chr5:9546200~9550609:+
READ	cis	rs17264034	0.821	rs422309	ENSG00000250786.1	SNHG18	5.77	2.27e-07	0.00119	0.8	0.58	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9544284	chr5:9546200~9550609:+
READ	cis	rs9322193	0.886	rs4039600	ENSG00000268592.3	RAET1E-AS1	5.77	2.29e-07	0.0012	0.79	0.58	Lung cancer;	chr6:149576319	chr6:149863494~149919507:+
READ	cis	rs2739330	0.929	rs5751775	ENSG00000225282.1	AP000350.6	5.77	2.31e-07	0.00121	0.57	0.58	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23924539	chr22:23926900~23929574:+
READ	cis	rs9322193	0.962	rs9322206	ENSG00000268592.3	RAET1E-AS1	5.77	2.31e-07	0.00121	0.77	0.58	Lung cancer;	chr6:149641481	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9688750	ENSG00000268592.3	RAET1E-AS1	5.77	2.31e-07	0.00121	0.77	0.58	Lung cancer;	chr6:149657633	chr6:149863494~149919507:+
READ	cis	rs9322193	0.607	rs10457852	ENSG00000231760.4	RP11-350J20.5	5.77	2.32e-07	0.00121	0.87	0.58	Lung cancer;	chr6:149880584	chr6:149796151~149826294:-
READ	cis	rs875971	0.862	rs6955837	ENSG00000226824.5	RP4-756H11.3	5.77	2.33e-07	0.00121	0.7	0.58	Aortic root size;	chr7:66578155	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs10281499	ENSG00000226824.5	RP4-756H11.3	5.77	2.33e-07	0.00121	0.7	0.58	Aortic root size;	chr7:66583979	chr7:66654538~66669855:+
READ	cis	rs1891275	0.551	rs7088831	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91652695	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2000177	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91653237	chr10:91782839~91798291:-
READ	cis	rs1891275	0.576	rs2000178	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91653287	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2027486	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91654229	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs2421623	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91654700	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs10881941	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91655154	chr10:91782839~91798291:-
READ	cis	rs1891275	0.576	rs10881942	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91655263	chr10:91782839~91798291:-
READ	cis	rs1891275	0.516	rs10881943	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91655373	chr10:91782839~91798291:-
READ	cis	rs1891275	0.551	rs7087959	ENSG00000228701.1	TNKS2-AS1	-5.77	2.33e-07	0.00121	-0.79	-0.58	Intelligence (multi-trait analysis);	chr10:91656160	chr10:91782839~91798291:-
READ	cis	rs2882667	0.838	rs11958529	ENSG00000253404.1	AC034243.1	5.77	2.34e-07	0.00121	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139059379	chr5:138744434~138753309:-
READ	cis	rs4660456	0.913	rs6667368	ENSG00000237899.1	RP4-739H11.3	5.76	2.35e-07	0.00122	0.92	0.58	Platelet count;	chr1:40694887	chr1:40669089~40687588:-
READ	cis	rs9322193	0.962	rs9478848	ENSG00000268592.3	RAET1E-AS1	5.76	2.36e-07	0.00122	0.79	0.58	Lung cancer;	chr6:149825080	chr6:149863494~149919507:+
READ	cis	rs875971	0.54	rs736270	ENSG00000226824.5	RP4-756H11.3	-5.76	2.36e-07	0.00123	-0.69	-0.58	Aortic root size;	chr7:65963835	chr7:66654538~66669855:+
READ	cis	rs9322193	0.887	rs4870139	ENSG00000268592.3	RAET1E-AS1	5.76	2.38e-07	0.00124	0.77	0.58	Lung cancer;	chr6:149575182	chr6:149863494~149919507:+
READ	cis	rs875971	0.862	rs6460282	ENSG00000226824.5	RP4-756H11.3	5.76	2.38e-07	0.00124	0.7	0.58	Aortic root size;	chr7:66226259	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs12531677	ENSG00000226824.5	RP4-756H11.3	5.76	2.38e-07	0.00124	0.7	0.58	Aortic root size;	chr7:66304099	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7798630	ENSG00000226824.5	RP4-756H11.3	5.76	2.38e-07	0.00124	0.7	0.58	Aortic root size;	chr7:66306492	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11984115	ENSG00000226824.5	RP4-756H11.3	5.76	2.38e-07	0.00124	0.7	0.58	Aortic root size;	chr7:66308872	chr7:66654538~66669855:+
READ	cis	rs9322193	0.886	rs2065663	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149760331	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12205092	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149761375	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10872651	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149768273	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs3805749	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149772546	chr6:149904243~149906418:+
READ	cis	rs9322193	0.847	rs9505972	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149775255	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs3805752	ENSG00000216906.2	RP11-350J20.9	5.76	2.39e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149795490	chr6:149904243~149906418:+
READ	cis	rs9326248	0.581	rs10502222	ENSG00000254851.1	RP11-109L13.1	-5.76	2.4e-07	0.00124	-0.71	-0.58	Blood protein levels;	chr11:116963014	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs10892052	ENSG00000254851.1	RP11-109L13.1	-5.76	2.4e-07	0.00124	-0.71	-0.58	Blood protein levels;	chr11:116963597	chr11:117135528~117138582:+
READ	cis	rs2882667	0.861	rs13176902	ENSG00000253404.1	AC034243.1	5.76	2.4e-07	0.00124	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139057640	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs11155671	ENSG00000216906.2	RP11-350J20.9	5.76	2.4e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149650996	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9689723	ENSG00000216906.2	RP11-350J20.9	5.76	2.4e-07	0.00124	0.74	0.58	Lung cancer;	chr6:149655935	chr6:149904243~149906418:+
READ	cis	rs9326248	0.59	rs2542063	ENSG00000254851.1	RP11-109L13.1	-5.76	2.4e-07	0.00124	-0.74	-0.58	Blood protein levels;	chr11:116814051	chr11:117135528~117138582:+
READ	cis	rs1799949	1	rs8176126	ENSG00000198496.9	NBR2	5.76	2.44e-07	0.00126	0.69	0.58	Menopause (age at onset);	chr17:43107032	chr17:43125610~43153671:+
READ	cis	rs7301826	0.651	rs4759517	ENSG00000256299.1	RP11-989F5.3	-5.76	2.44e-07	0.00126	-0.6	-0.58	Plasma plasminogen activator levels;	chr12:130799153	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs7132657	ENSG00000256299.1	RP11-989F5.3	-5.76	2.44e-07	0.00126	-0.6	-0.58	Plasma plasminogen activator levels;	chr12:130800642	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs7971046	ENSG00000256299.1	RP11-989F5.3	-5.76	2.44e-07	0.00126	-0.6	-0.58	Plasma plasminogen activator levels;	chr12:130802262	chr12:130810821~130812622:-
READ	cis	rs62229266	0.804	rs2835263	ENSG00000231106.2	LINC01436	-5.75	2.45e-07	0.00126	-0.73	-0.58	Mitral valve prolapse;	chr21:36057947	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs62230822	ENSG00000231106.2	LINC01436	5.75	2.45e-07	0.00126	0.73	0.58	Mitral valve prolapse;	chr21:36057647	chr21:36005338~36007838:+
READ	cis	rs875971	0.862	rs12537823	ENSG00000226824.5	RP4-756H11.3	-5.75	2.49e-07	0.00127	-0.66	-0.58	Aortic root size;	chr7:66255897	chr7:66654538~66669855:+
READ	cis	rs9399135	0.967	rs12661423	ENSG00000232876.1	CTA-212D2.2	-5.75	2.49e-07	0.00127	-0.72	-0.58	Red blood cell count;	chr6:135028432	chr6:135055033~135060550:+
READ	cis	rs9309473	0.66	rs10496192	ENSG00000163016.8	ALMS1P	5.75	2.51e-07	0.00127	0.89	0.58	Metabolite levels;	chr2:73452739	chr2:73644919~73685576:+
READ	cis	rs858239	0.73	rs10255155	ENSG00000230658.1	KLHL7-AS1	-5.75	2.52e-07	0.00127	-0.72	-0.58	Cerebrospinal fluid biomarker levels;	chr7:23362528	chr7:23101228~23105703:-
READ	cis	rs9322193	0.607	rs12527391	ENSG00000231760.4	RP11-350J20.5	5.75	2.52e-07	0.00127	0.87	0.58	Lung cancer;	chr6:149882156	chr6:149796151~149826294:-
READ	cis	rs9322193	0.607	rs3798763	ENSG00000231760.4	RP11-350J20.5	5.75	2.52e-07	0.00127	0.87	0.58	Lung cancer;	chr6:149889964	chr6:149796151~149826294:-
READ	cis	rs9322193	0.607	rs12204653	ENSG00000231760.4	RP11-350J20.5	5.75	2.52e-07	0.00127	0.87	0.58	Lung cancer;	chr6:149891885	chr6:149796151~149826294:-
READ	cis	rs4660456	0.83	rs12742219	ENSG00000237899.1	RP4-739H11.3	-5.74	2.56e-07	0.00129	-0.88	-0.58	Platelet count;	chr1:40728665	chr1:40669089~40687588:-
READ	cis	rs11690935	0.959	rs10167419	ENSG00000228389.1	AC068039.4	5.74	2.56e-07	0.00129	0.75	0.58	Schizophrenia;	chr2:171793316	chr2:171773482~171775844:+
READ	cis	rs9322193	0.923	rs9377230	ENSG00000216906.2	RP11-350J20.9	5.74	2.58e-07	0.0013	0.75	0.58	Lung cancer;	chr6:149613607	chr6:149904243~149906418:+
READ	cis	rs875971	0.862	rs778734	ENSG00000226824.5	RP4-756H11.3	-5.74	2.59e-07	0.0013	-0.66	-0.58	Aortic root size;	chr7:66349862	chr7:66654538~66669855:+
READ	cis	rs9322193	0.847	rs12234128	ENSG00000216906.2	RP11-350J20.9	5.74	2.6e-07	0.00131	0.75	0.58	Lung cancer;	chr6:149627553	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs57012784	ENSG00000216906.2	RP11-350J20.9	5.74	2.6e-07	0.00131	0.75	0.58	Lung cancer;	chr6:149627691	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs4870080	ENSG00000231760.4	RP11-350J20.5	5.74	2.64e-07	0.00133	0.78	0.58	Testicular germ cell tumor;	chr6:149881508	chr6:149796151~149826294:-
READ	cis	rs453301	0.686	rs3989373	ENSG00000233609.3	RP11-62H7.2	-5.73	2.67e-07	0.00134	-0.66	-0.58	Joint mobility (Beighton score);	chr8:9053798	chr8:8961200~8979025:+
READ	cis	rs875971	0.767	rs12668005	ENSG00000226824.5	RP4-756H11.3	-5.73	2.74e-07	0.00137	-0.7	-0.58	Aortic root size;	chr7:66444034	chr7:66654538~66669855:+
READ	cis	rs2882667	0.858	rs11948429	ENSG00000253404.1	AC034243.1	5.73	2.74e-07	0.00137	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139122895	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs2043271	ENSG00000253404.1	AC034243.1	5.73	2.74e-07	0.00137	0.71	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139123419	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs4380651	ENSG00000253404.1	AC034243.1	5.72	2.78e-07	0.00139	0.72	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:139055383	chr5:138744434~138753309:-
READ	cis	rs1891275	0.513	rs1539041	ENSG00000228701.1	TNKS2-AS1	-5.72	2.79e-07	0.0014	-0.83	-0.58	Intelligence (multi-trait analysis);	chr10:91817384	chr10:91782839~91798291:-
READ	cis	rs9322193	0.961	rs4870144	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.77	0.58	Lung cancer;	chr6:149575540	chr6:149863494~149919507:+
READ	cis	rs9322193	1	rs9377228	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149600862	chr6:149863494~149919507:+
READ	cis	rs9322193	0.924	rs9498382	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149610982	chr6:149863494~149919507:+
READ	cis	rs9322193	0.886	rs9485408	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149618888	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs1080670	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149620161	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs10782312	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149622669	chr6:149863494~149919507:+
READ	cis	rs9322193	0.886	rs9322198	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149623772	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9505823	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149628899	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9689599	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149631973	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9800580	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149632845	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs11155669	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149633501	chr6:149863494~149919507:+
READ	cis	rs9322193	0.887	rs9505824	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149633663	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9505826	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149633912	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9766886	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149637048	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9688861	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149637924	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs7740278	ENSG00000268592.3	RAET1E-AS1	5.72	2.8e-07	0.0014	0.74	0.58	Lung cancer;	chr6:149640116	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs2064521	ENSG00000268592.3	RAET1E-AS1	-5.72	2.8e-07	0.0014	-0.74	-0.58	Lung cancer;	chr6:149625336	chr6:149863494~149919507:+
READ	cis	rs62229266	0.839	rs11702763	ENSG00000231106.2	LINC01436	5.72	2.8e-07	0.0014	0.77	0.58	Mitral valve prolapse;	chr21:36098406	chr21:36005338~36007838:+
READ	cis	rs9322193	0.924	rs9322189	ENSG00000268592.3	RAET1E-AS1	5.72	2.83e-07	0.00141	0.77	0.58	Lung cancer;	chr6:149588797	chr6:149863494~149919507:+
READ	cis	rs9399135	0.66	rs9389248	ENSG00000232876.1	CTA-212D2.2	-5.72	2.86e-07	0.00142	-0.79	-0.58	Red blood cell count;	chr6:134961518	chr6:135055033~135060550:+
READ	cis	rs9322193	0.607	rs4869755	ENSG00000231760.4	RP11-350J20.5	5.71	2.87e-07	0.00142	0.87	0.58	Lung cancer;	chr6:149886347	chr6:149796151~149826294:-
READ	cis	rs9322193	0.639	rs4869756	ENSG00000231760.4	RP11-350J20.5	5.71	2.87e-07	0.00142	0.87	0.58	Lung cancer;	chr6:149886360	chr6:149796151~149826294:-
READ	cis	rs9322193	0.923	rs9377230	ENSG00000268592.3	RAET1E-AS1	5.71	2.89e-07	0.00143	0.74	0.58	Lung cancer;	chr6:149613607	chr6:149863494~149919507:+
READ	cis	rs62229266	0.771	rs11701590	ENSG00000231106.2	LINC01436	5.71	2.89e-07	0.00143	0.72	0.58	Mitral valve prolapse;	chr21:36012432	chr21:36005338~36007838:+
READ	cis	rs62229266	0.74	rs4817759	ENSG00000231106.2	LINC01436	5.71	2.89e-07	0.00143	0.72	0.58	Mitral valve prolapse;	chr21:36017261	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs2835231	ENSG00000231106.2	LINC01436	5.71	2.89e-07	0.00143	0.72	0.58	Mitral valve prolapse;	chr21:36018300	chr21:36005338~36007838:+
READ	cis	rs62229266	0.771	rs2835232	ENSG00000231106.2	LINC01436	5.71	2.89e-07	0.00143	0.72	0.58	Mitral valve prolapse;	chr21:36021129	chr21:36005338~36007838:+
READ	cis	rs62229266	0.74	rs2835233	ENSG00000231106.2	LINC01436	5.71	2.89e-07	0.00143	0.72	0.58	Mitral valve prolapse;	chr21:36021284	chr21:36005338~36007838:+
READ	cis	rs12594515	1	rs12594515	ENSG00000273972.1	CTD-2306A12.1	5.71	2.91e-07	0.00144	0.7	0.58	Weight;Waist circumference;	chr15:45692873	chr15:45702640~45703183:+
READ	cis	rs9322193	0.923	rs10782310	ENSG00000268592.3	RAET1E-AS1	5.71	2.91e-07	0.00144	0.75	0.58	Lung cancer;	chr6:149622458	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782311	ENSG00000268592.3	RAET1E-AS1	5.71	2.91e-07	0.00144	0.75	0.58	Lung cancer;	chr6:149622592	chr6:149863494~149919507:+
READ	cis	rs9322193	0.847	rs62439808	ENSG00000268592.3	RAET1E-AS1	5.71	2.91e-07	0.00144	0.75	0.58	Lung cancer;	chr6:149629690	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322200	ENSG00000268592.3	RAET1E-AS1	5.71	2.91e-07	0.00144	0.75	0.58	Lung cancer;	chr6:149630078	chr6:149863494~149919507:+
READ	cis	rs9326248	0.581	rs10892072	ENSG00000254851.1	RP11-109L13.1	-5.71	2.91e-07	0.00144	-0.73	-0.58	Blood protein levels;	chr11:117089597	chr11:117135528~117138582:+
READ	cis	rs9322193	0.961	rs9027	ENSG00000268592.3	RAET1E-AS1	5.71	2.96e-07	0.00146	0.79	0.57	Lung cancer;	chr6:149594921	chr6:149863494~149919507:+
READ	cis	rs875971	0.862	rs778736	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66348861	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2909688	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66376625	chr7:66654538~66669855:+
READ	cis	rs875971	0.83	rs778711	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66386670	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs1083554	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66387354	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778707	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66392040	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778705	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66396128	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs778697	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66405439	chr7:66654538~66669855:+
READ	cis	rs875971	0.798	rs7789615	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66413674	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6978028	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66421313	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6947339	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66423483	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11765791	ENSG00000226824.5	RP4-756H11.3	-5.7	2.98e-07	0.00146	-0.69	-0.57	Aortic root size;	chr7:66471587	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs6460278	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66197749	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6460279	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66197774	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs28491091	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66204077	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6952182	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66218330	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6964437	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66221457	chr7:66654538~66669855:+
READ	cis	rs875971	0.755	rs10228885	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66315542	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs3893216	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66325720	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6958294	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66329809	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2088655	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66330724	chr7:66654538~66669855:+
READ	cis	rs875971	0.895	rs10447522	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66331087	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs7783779	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66331639	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs2088653	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66343621	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6460293	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66345205	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6460306	ENSG00000226824.5	RP4-756H11.3	5.7	2.98e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66595806	chr7:66654538~66669855:+
READ	cis	rs858239	0.601	rs6461693	ENSG00000230658.1	KLHL7-AS1	-5.7	2.98e-07	0.00146	-0.76	-0.57	Cerebrospinal fluid biomarker levels;	chr7:23120514	chr7:23101228~23105703:-
READ	cis	rs9399135	0.66	rs4646868	ENSG00000232876.1	CTA-212D2.2	-5.7	2.98e-07	0.00146	-0.76	-0.57	Red blood cell count;	chr6:134950808	chr6:135055033~135060550:+
READ	cis	rs801193	0.569	rs6978178	ENSG00000226824.5	RP4-756H11.3	5.7	3e-07	0.00146	0.69	0.57	Aortic root size;	chr7:66658097	chr7:66654538~66669855:+
READ	cis	rs9322193	0.847	rs12234128	ENSG00000268592.3	RAET1E-AS1	5.7	3.01e-07	0.00146	0.74	0.57	Lung cancer;	chr6:149627553	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs57012784	ENSG00000268592.3	RAET1E-AS1	5.7	3.01e-07	0.00146	0.74	0.57	Lung cancer;	chr6:149627691	chr6:149863494~149919507:+
READ	cis	rs9309473	0.95	rs6756885	ENSG00000163016.8	ALMS1P	5.7	3.06e-07	0.00148	0.84	0.57	Metabolite levels;	chr2:73578045	chr2:73644919~73685576:+
READ	cis	rs9322193	0.923	rs3924871	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149662080	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs35961297	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149667929	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs35830138	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149668635	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs35967444	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149675588	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs62439842	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149675847	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs7767622	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149681766	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4421206	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149682891	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs3798761	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149683643	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322209	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149691226	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9322210	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149695440	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs11155674	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149711111	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2185352	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149714640	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12174349	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149718012	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2297932	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149718225	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2297930	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149718360	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2297928	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149718584	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9479094	ENSG00000216906.2	RP11-350J20.9	5.7	3.07e-07	0.00148	0.7	0.57	Lung cancer;	chr6:149725083	chr6:149904243~149906418:+
READ	cis	rs7617773	0.925	rs6442105	ENSG00000229759.1	MRPS18AP1	-5.7	3.08e-07	0.00148	-0.69	-0.57	Coronary artery disease;	chr3:48140836	chr3:48256350~48256938:-
READ	cis	rs9322193	0.887	rs9767113	ENSG00000216906.2	RP11-350J20.9	5.7	3.08e-07	0.00148	0.74	0.57	Lung cancer;	chr6:149718157	chr6:149904243~149906418:+
READ	cis	rs9322193	0.961	rs4870144	ENSG00000216906.2	RP11-350J20.9	5.7	3.08e-07	0.00148	0.77	0.57	Lung cancer;	chr6:149575540	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9689084	ENSG00000216906.2	RP11-350J20.9	5.7	3.08e-07	0.00148	0.73	0.57	Lung cancer;	chr6:149639648	chr6:149904243~149906418:+
READ	cis	rs6504950	0.695	rs9904377	ENSG00000275710.1	RP11-257O5.4	5.7	3.09e-07	0.00149	0.86	0.57	Breast cancer;	chr17:54908621	chr17:54964474~54964679:+
READ	cis	rs7208859	0.673	rs216440	ENSG00000263531.1	RP13-753N3.1	5.7	3.09e-07	0.00149	0.91	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30601291	chr17:30863921~30864940:-
READ	cis	rs9322193	0.923	rs57938011	ENSG00000268592.3	RAET1E-AS1	5.69	3.11e-07	0.0015	0.73	0.57	Lung cancer;	chr6:149642969	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782310	ENSG00000216906.2	RP11-350J20.9	5.69	3.14e-07	0.00151	0.75	0.57	Lung cancer;	chr6:149622458	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782311	ENSG00000216906.2	RP11-350J20.9	5.69	3.14e-07	0.00151	0.75	0.57	Lung cancer;	chr6:149622592	chr6:149904243~149906418:+
READ	cis	rs9322193	0.847	rs62439808	ENSG00000216906.2	RP11-350J20.9	5.69	3.14e-07	0.00151	0.75	0.57	Lung cancer;	chr6:149629690	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322200	ENSG00000216906.2	RP11-350J20.9	5.69	3.14e-07	0.00151	0.75	0.57	Lung cancer;	chr6:149630078	chr6:149904243~149906418:+
READ	cis	rs9322193	0.887	rs11155662	ENSG00000268592.3	RAET1E-AS1	5.69	3.19e-07	0.00153	0.76	0.57	Lung cancer;	chr6:149592731	chr6:149863494~149919507:+
READ	cis	rs4660456	0.913	rs12727412	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40723243	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs4660448	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40724682	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs7532802	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40725528	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs2361648	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40726825	chr1:40669089~40687588:-
READ	cis	rs4660456	0.711	rs12409109	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40727216	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs6675886	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40727955	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs6668453	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40733299	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs35881320	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40733893	chr1:40669089~40687588:-
READ	cis	rs4660456	0.871	rs34512220	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40733912	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs6664044	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40735089	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs6702983	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40735585	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs12566733	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40736067	chr1:40669089~40687588:-
READ	cis	rs4660456	0.83	rs12566786	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40742709	chr1:40669089~40687588:-
READ	cis	rs4660456	0.871	rs2274957	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40747290	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs4660173	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40747876	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs4660452	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40748519	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs12567925	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40751428	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs12728776	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40751718	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs12567755	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40751813	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs16827532	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40755064	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs12729696	ENSG00000237899.1	RP4-739H11.3	-5.68	3.24e-07	0.00154	-0.87	-0.57	Platelet count;	chr1:40755099	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs2744799	ENSG00000237899.1	RP4-739H11.3	5.68	3.24e-07	0.00154	0.87	0.57	Platelet count;	chr1:40719862	chr1:40669089~40687588:-
READ	cis	rs2980436	1	rs2980436	ENSG00000253981.4	ALG1L13P	-5.68	3.24e-07	0.00154	-0.83	-0.57	Schizophrenia;	chr8:8234503	chr8:8236003~8244667:-
READ	cis	rs9322193	0.923	rs9800871	ENSG00000268592.3	RAET1E-AS1	5.68	3.26e-07	0.00155	0.73	0.57	Lung cancer;	chr6:149644540	chr6:149863494~149919507:+
READ	cis	rs1891275	0.601	rs1970506	ENSG00000228701.1	TNKS2-AS1	-5.68	3.28e-07	0.00156	-0.76	-0.57	Intelligence (multi-trait analysis);	chr10:91668529	chr10:91782839~91798291:-
READ	cis	rs9322193	0.962	rs7745915	ENSG00000268592.3	RAET1E-AS1	5.68	3.3e-07	0.00157	0.78	0.57	Lung cancer;	chr6:149834111	chr6:149863494~149919507:+
READ	cis	rs2739330	0.828	rs4820572	ENSG00000225282.1	AP000350.6	5.68	3.32e-07	0.00158	0.55	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908168	chr22:23926900~23929574:+
READ	cis	rs2739330	0.789	rs5760109	ENSG00000225282.1	AP000350.6	5.68	3.33e-07	0.00158	0.54	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910751	chr22:23926900~23929574:+
READ	cis	rs9309473	0.687	rs6748040	ENSG00000163016.8	ALMS1P	-5.67	3.36e-07	0.0016	-0.71	-0.57	Metabolite levels;	chr2:73382800	chr2:73644919~73685576:+
READ	cis	rs2882667	0.66	rs3088052	ENSG00000253404.1	AC034243.1	5.67	3.36e-07	0.0016	0.71	0.57	Age-related hearing impairment (SNP x SNP interaction);	chr5:139121126	chr5:138744434~138753309:-
READ	cis	rs875971	0.789	rs7808013	ENSG00000226824.5	RP4-756H11.3	5.67	3.4e-07	0.00161	0.69	0.57	Aortic root size;	chr7:66606209	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs7384021	ENSG00000226824.5	RP4-756H11.3	5.67	3.4e-07	0.00161	0.69	0.57	Aortic root size;	chr7:66612917	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs3926380	ENSG00000226824.5	RP4-756H11.3	5.67	3.4e-07	0.00161	0.69	0.57	Aortic root size;	chr7:66615658	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs1860472	ENSG00000226824.5	RP4-756H11.3	5.67	3.4e-07	0.00161	0.69	0.57	Aortic root size;	chr7:66617736	chr7:66654538~66669855:+
READ	cis	rs9326248	0.515	rs2727793	ENSG00000254851.1	RP11-109L13.1	-5.67	3.42e-07	0.00162	-0.73	-0.57	Blood protein levels;	chr11:116812658	chr11:117135528~117138582:+
READ	cis	rs9326248	0.861	rs4938352	ENSG00000254851.1	RP11-109L13.1	-5.67	3.43e-07	0.00162	-0.84	-0.57	Blood protein levels;	chr11:117156765	chr11:117135528~117138582:+
READ	cis	rs6964833	0.873	rs4717905	ENSG00000123965.13	PMS2P5	5.67	3.47e-07	0.00164	0.79	0.57	Menarche (age at onset);	chr7:74668903	chr7:74894116~74897835:+
READ	cis	rs4500972	1	rs4500972	ENSG00000163016.8	ALMS1P	5.67	3.47e-07	0.00164	0.84	0.57	Glomerular filtration rate (creatinine);	chr2:73540770	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10496193	ENSG00000163016.8	ALMS1P	5.67	3.47e-07	0.00164	0.84	0.57	Metabolite levels;	chr2:73546376	chr2:73644919~73685576:+
READ	cis	rs7847628	0.587	rs4837796	ENSG00000226752.6	PSMD5-AS1	5.66	3.49e-07	0.00165	0.73	0.57	Birth weight;	chr9:120848010	chr9:120824828~120854385:+
READ	cis	rs9322193	0.887	rs11155662	ENSG00000216906.2	RP11-350J20.9	5.66	3.51e-07	0.00165	0.76	0.57	Lung cancer;	chr6:149592731	chr6:149904243~149906418:+
READ	cis	rs9322193	1	rs58189451	ENSG00000268592.3	RAET1E-AS1	5.66	3.51e-07	0.00166	0.77	0.57	Lung cancer;	chr6:149600252	chr6:149863494~149919507:+
READ	cis	rs9322193	0.961	rs9767713	ENSG00000268592.3	RAET1E-AS1	5.66	3.52e-07	0.00166	0.76	0.57	Lung cancer;	chr6:149588241	chr6:149863494~149919507:+
READ	cis	rs11690935	0.918	rs11757	ENSG00000228389.1	AC068039.4	5.66	3.54e-07	0.00167	0.76	0.57	Schizophrenia;	chr2:171784535	chr2:171773482~171775844:+
READ	cis	rs9309473	1	rs2421555	ENSG00000163016.8	ALMS1P	5.66	3.56e-07	0.00167	0.84	0.57	Metabolite levels;	chr2:73589828	chr2:73644919~73685576:+
READ	cis	rs9322193	0.81	rs4869923	ENSG00000268592.3	RAET1E-AS1	5.66	3.57e-07	0.00168	0.79	0.57	Lung cancer;	chr6:149553763	chr6:149863494~149919507:+
READ	cis	rs9322193	0.774	rs2144207	ENSG00000268592.3	RAET1E-AS1	5.66	3.57e-07	0.00168	0.79	0.57	Lung cancer;	chr6:149558971	chr6:149863494~149919507:+
READ	cis	rs7208859	0.573	rs73267829	ENSG00000263531.1	RP13-753N3.1	5.66	3.57e-07	0.00168	0.98	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30676921	chr17:30863921~30864940:-
READ	cis	rs9322193	0.886	rs9767555	ENSG00000268592.3	RAET1E-AS1	5.66	3.57e-07	0.00168	0.75	0.57	Lung cancer;	chr6:149647022	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9397036	ENSG00000216906.2	RP11-350J20.9	5.66	3.61e-07	0.00169	0.69	0.57	Lung cancer;	chr6:149851787	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9383865	ENSG00000216906.2	RP11-350J20.9	5.66	3.61e-07	0.00169	0.69	0.57	Lung cancer;	chr6:149852043	chr6:149904243~149906418:+
READ	cis	rs7617773	0.823	rs9839446	ENSG00000229759.1	MRPS18AP1	-5.66	3.62e-07	0.0017	-0.69	-0.57	Coronary artery disease;	chr3:48153176	chr3:48256350~48256938:-
READ	cis	rs7617773	0.823	rs9839447	ENSG00000229759.1	MRPS18AP1	-5.66	3.62e-07	0.0017	-0.69	-0.57	Coronary artery disease;	chr3:48153177	chr3:48256350~48256938:-
READ	cis	rs2882667	0.898	rs11956089	ENSG00000253404.1	AC034243.1	-5.65	3.65e-07	0.00171	-0.7	-0.57	Age-related hearing impairment (SNP x SNP interaction);	chr5:139058915	chr5:138744434~138753309:-
READ	cis	rs875971	0.825	rs28480509	ENSG00000226824.5	RP4-756H11.3	5.65	3.66e-07	0.00172	0.69	0.57	Aortic root size;	chr7:66634237	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs9791712	ENSG00000226824.5	RP4-756H11.3	5.65	3.66e-07	0.00172	0.69	0.57	Aortic root size;	chr7:66640176	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs9791713	ENSG00000226824.5	RP4-756H11.3	5.65	3.66e-07	0.00172	0.69	0.57	Aortic root size;	chr7:66640211	chr7:66654538~66669855:+
READ	cis	rs881375	0.934	rs1468671	ENSG00000226752.6	PSMD5-AS1	-5.65	3.7e-07	0.00173	-0.73	-0.57	Rheumatoid arthritis;	chr9:120895224	chr9:120824828~120854385:+
READ	cis	rs875971	0.862	rs10274883	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66651104	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs881285	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66654433	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs3846973	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66655048	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs2013908	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66656082	chr7:66654538~66669855:+
READ	cis	rs801193	0.548	rs2109297	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66657397	chr7:66654538~66669855:+
READ	cis	rs801193	0.591	rs721717	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66665305	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs6951302	ENSG00000226824.5	RP4-756H11.3	5.65	3.7e-07	0.00173	0.69	0.57	Aortic root size;	chr7:66667525	chr7:66654538~66669855:+
READ	cis	rs858239	0.932	rs1637190	ENSG00000230658.1	KLHL7-AS1	5.65	3.72e-07	0.00174	0.77	0.57	Cerebrospinal fluid biomarker levels;	chr7:23229446	chr7:23101228~23105703:-
READ	cis	rs858239	0.932	rs1728313	ENSG00000230658.1	KLHL7-AS1	5.65	3.72e-07	0.00174	0.77	0.57	Cerebrospinal fluid biomarker levels;	chr7:23231412	chr7:23101228~23105703:-
READ	cis	rs9326248	0.539	rs7120565	ENSG00000254851.1	RP11-109L13.1	-5.65	3.72e-07	0.00174	-0.69	-0.57	Blood protein levels;	chr11:117172233	chr11:117135528~117138582:+
READ	cis	rs9322193	0.962	rs1413655	ENSG00000268592.3	RAET1E-AS1	5.64	3.78e-07	0.00176	0.78	0.57	Lung cancer;	chr6:149821815	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs9383546	ENSG00000268592.3	RAET1E-AS1	5.64	3.78e-07	0.00176	0.78	0.57	Lung cancer;	chr6:149822743	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs2151912	ENSG00000268592.3	RAET1E-AS1	5.64	3.78e-07	0.00176	0.78	0.57	Lung cancer;	chr6:149831772	chr6:149863494~149919507:+
READ	cis	rs9322193	0.887	rs4870139	ENSG00000216906.2	RP11-350J20.9	5.64	3.78e-07	0.00176	0.76	0.57	Lung cancer;	chr6:149575182	chr6:149904243~149906418:+
READ	cis	rs11155671	0.53	rs9397420	ENSG00000216906.2	RP11-350J20.9	-5.64	3.79e-07	0.00176	-0.71	-0.57	Testicular germ cell tumor;	chr6:149885645	chr6:149904243~149906418:+
READ	cis	rs9399135	0.66	rs4267967	ENSG00000232876.1	CTA-212D2.2	-5.64	3.8e-07	0.00177	-0.75	-0.57	Red blood cell count;	chr6:134951339	chr6:135055033~135060550:+
READ	cis	rs10129255	0.5	rs4774008	ENSG00000211972.2	IGHV3-66	5.64	3.82e-07	0.00178	0.55	0.57	Kawasaki disease;	chr14:106681273	chr14:106675017~106675544:-
READ	cis	rs3096299	0.719	rs12934708	ENSG00000274627.1	RP11-104N10.2	5.64	3.84e-07	0.00179	0.65	0.57	Multiple myeloma (IgH translocation);	chr16:89457382	chr16:89516797~89522217:+
READ	cis	rs9399135	0.66	rs4440481	ENSG00000232876.1	CTA-212D2.2	-5.64	3.85e-07	0.00179	-0.77	-0.57	Red blood cell count;	chr6:134955558	chr6:135055033~135060550:+
READ	cis	rs9322193	0.923	rs62439840	ENSG00000216906.2	RP11-350J20.9	5.64	3.86e-07	0.00179	0.72	0.57	Lung cancer;	chr6:149674639	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9393175	ENSG00000216906.2	RP11-350J20.9	5.64	3.86e-07	0.00179	0.72	0.57	Lung cancer;	chr6:149677587	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4870509	ENSG00000216906.2	RP11-350J20.9	5.64	3.86e-07	0.00179	0.72	0.57	Lung cancer;	chr6:149702212	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322214	ENSG00000216906.2	RP11-350J20.9	5.64	3.86e-07	0.00179	0.72	0.57	Lung cancer;	chr6:149703986	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782318	ENSG00000216906.2	RP11-350J20.9	5.64	3.86e-07	0.00179	0.72	0.57	Lung cancer;	chr6:149754137	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9800614	ENSG00000268592.3	RAET1E-AS1	5.64	3.89e-07	0.0018	0.72	0.57	Lung cancer;	chr6:149644604	chr6:149863494~149919507:+
READ	cis	rs11690935	0.851	rs9808259	ENSG00000228389.1	AC068039.4	5.63	3.94e-07	0.00182	0.73	0.57	Schizophrenia;	chr2:171792464	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6745143	ENSG00000228389.1	AC068039.4	5.63	3.94e-07	0.00182	0.73	0.57	Schizophrenia;	chr2:171793872	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6758704	ENSG00000228389.1	AC068039.4	5.63	3.94e-07	0.00182	0.73	0.57	Schizophrenia;	chr2:171798587	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs1474074	ENSG00000228389.1	AC068039.4	5.63	3.94e-07	0.00182	0.73	0.57	Schizophrenia;	chr2:171803342	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6433314	ENSG00000228389.1	AC068039.4	5.63	3.94e-07	0.00182	0.73	0.57	Schizophrenia;	chr2:171804461	chr2:171773482~171775844:+
READ	cis	rs9309473	0.898	rs28879089	ENSG00000163016.8	ALMS1P	5.63	3.95e-07	0.00182	0.82	0.57	Metabolite levels;	chr2:73585759	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs1114380	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73577581	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs10169714	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73581646	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7558944	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73583782	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs13432605	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73583854	chr2:73644919~73685576:+
READ	cis	rs9309473	0.848	rs9750915	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73584753	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs7582606	ENSG00000163016.8	ALMS1P	5.63	3.96e-07	0.00182	0.83	0.57	Metabolite levels;	chr2:73586818	chr2:73644919~73685576:+
READ	cis	rs875971	0.862	rs1860469	ENSG00000226824.5	RP4-756H11.3	5.63	4e-07	0.00184	0.69	0.57	Aortic root size;	chr7:66641888	chr7:66654538~66669855:+
READ	cis	rs9322193	0.884	rs1108889	ENSG00000216906.2	RP11-350J20.9	5.63	4.03e-07	0.00185	0.7	0.57	Lung cancer;	chr6:149845433	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs880245	ENSG00000216906.2	RP11-350J20.9	-5.63	4.03e-07	0.00185	-0.7	-0.57	Lung cancer;	chr6:149846262	chr6:149904243~149906418:+
READ	cis	rs2739330	0.929	rs5751775	ENSG00000250470.1	AP000351.3	5.62	4.08e-07	0.00187	0.76	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23924539	chr22:23976904~23977585:-
READ	cis	rs9322193	0.886	rs9718079	ENSG00000268592.3	RAET1E-AS1	5.62	4.11e-07	0.00188	0.74	0.57	Lung cancer;	chr6:149645947	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322204	ENSG00000268592.3	RAET1E-AS1	5.62	4.11e-07	0.00188	0.74	0.57	Lung cancer;	chr6:149636047	chr6:149863494~149919507:+
READ	cis	rs801193	0.569	rs2659908	ENSG00000226824.5	RP4-756H11.3	-5.62	4.14e-07	0.00189	-0.68	-0.57	Aortic root size;	chr7:66695835	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs2659907	ENSG00000226824.5	RP4-756H11.3	-5.62	4.14e-07	0.00189	-0.68	-0.57	Aortic root size;	chr7:66699045	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs7782587	ENSG00000226824.5	RP4-756H11.3	-5.62	4.14e-07	0.00189	-0.68	-0.57	Aortic root size;	chr7:66701485	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs4717315	ENSG00000226824.5	RP4-756H11.3	-5.62	4.14e-07	0.00189	-0.68	-0.57	Aortic root size;	chr7:66713338	chr7:66654538~66669855:+
READ	cis	rs801193	0.527	rs2707837	ENSG00000226824.5	RP4-756H11.3	-5.62	4.14e-07	0.00189	-0.68	-0.57	Aortic root size;	chr7:66716086	chr7:66654538~66669855:+
READ	cis	rs17507216	1	rs3850610	ENSG00000278603.1	RP13-608F4.5	-5.62	4.15e-07	0.00189	-0.81	-0.57	Excessive daytime sleepiness;	chr15:82552642	chr15:82472203~82472426:+
READ	cis	rs6545883	0.708	rs2518936	ENSG00000271707.1	ATP1B3P1	-5.62	4.17e-07	0.0019	-0.7	-0.57	Tuberculosis;	chr2:61565207	chr2:60734895~60735715:-
READ	cis	rs7208859	0.623	rs216439	ENSG00000263531.1	RP13-753N3.1	5.62	4.21e-07	0.00192	0.96	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30600866	chr17:30863921~30864940:-
READ	cis	rs9322193	0.923	rs11155671	ENSG00000268592.3	RAET1E-AS1	5.62	4.23e-07	0.00192	0.73	0.57	Lung cancer;	chr6:149650996	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9689723	ENSG00000268592.3	RAET1E-AS1	5.62	4.23e-07	0.00192	0.73	0.57	Lung cancer;	chr6:149655935	chr6:149863494~149919507:+
READ	cis	rs11690935	1	rs11678984	ENSG00000228389.1	AC068039.4	-5.61	4.24e-07	0.00193	-0.74	-0.57	Schizophrenia;	chr2:171679338	chr2:171773482~171775844:+
READ	cis	rs11690935	1	rs34542126	ENSG00000228389.1	AC068039.4	-5.61	4.24e-07	0.00193	-0.74	-0.57	Schizophrenia;	chr2:171686195	chr2:171773482~171775844:+
READ	cis	rs11690935	1	rs6433311	ENSG00000228389.1	AC068039.4	-5.61	4.24e-07	0.00193	-0.74	-0.57	Schizophrenia;	chr2:171692738	chr2:171773482~171775844:+
READ	cis	rs62229266	0.773	rs878606	ENSG00000231106.2	LINC01436	5.61	4.24e-07	0.00193	0.71	0.57	Mitral valve prolapse;	chr21:36034394	chr21:36005338~36007838:+
READ	cis	rs9322193	0.884	rs9383864	ENSG00000216906.2	RP11-350J20.9	5.61	4.26e-07	0.00194	0.69	0.57	Lung cancer;	chr6:149851969	chr6:149904243~149906418:+
READ	cis	rs2739330	0.828	rs5760108	ENSG00000225282.1	AP000350.6	5.61	4.3e-07	0.00195	0.54	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910481	chr22:23926900~23929574:+
READ	cis	rs875971	0.862	rs4718383	ENSG00000226824.5	RP4-756H11.3	5.61	4.32e-07	0.00196	0.69	0.57	Aortic root size;	chr7:66643422	chr7:66654538~66669855:+
READ	cis	rs7301826	0.61	rs7957899	ENSG00000256250.1	RP11-989F5.1	-5.61	4.32e-07	0.00196	-0.54	-0.57	Plasma plasminogen activator levels;	chr12:130794531	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs1973834	ENSG00000256250.1	RP11-989F5.1	-5.61	4.32e-07	0.00196	-0.54	-0.57	Plasma plasminogen activator levels;	chr12:130795612	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs1554807	ENSG00000256250.1	RP11-989F5.1	5.61	4.32e-07	0.00196	0.54	0.57	Plasma plasminogen activator levels;	chr12:130795872	chr12:130810606~130812438:+
READ	cis	rs977987	0.528	rs9926933	ENSG00000261783.1	RP11-252K23.2	5.61	4.32e-07	0.00196	0.92	0.57	Dupuytren's disease;	chr16:75467669	chr16:75379818~75381260:-
READ	cis	rs17507216	1	rs17507216	ENSG00000278603.1	RP13-608F4.5	-5.61	4.33e-07	0.00196	-0.77	-0.57	Excessive daytime sleepiness;	chr15:82558175	chr15:82472203~82472426:+
READ	cis	rs9322193	0.923	rs9371486	ENSG00000216906.2	RP11-350J20.9	5.61	4.36e-07	0.00198	0.74	0.57	Lung cancer;	chr6:149832090	chr6:149904243~149906418:+
READ	cis	rs7301826	0.651	rs2037789	ENSG00000256250.1	RP11-989F5.1	5.61	4.4e-07	0.00199	0.54	0.57	Plasma plasminogen activator levels;	chr12:130803747	chr12:130810606~130812438:+
READ	cis	rs9322193	0.887	rs3777949	ENSG00000216906.2	RP11-350J20.9	5.6	4.41e-07	0.002	0.76	0.57	Lung cancer;	chr6:149596021	chr6:149904243~149906418:+
READ	cis	rs7301826	0.557	rs7953184	ENSG00000256299.1	RP11-989F5.3	5.6	4.46e-07	0.00202	0.61	0.57	Plasma plasminogen activator levels;	chr12:130800307	chr12:130810821~130812622:-
READ	cis	rs62229266	0.804	rs998383	ENSG00000231106.2	LINC01436	5.6	4.48e-07	0.00202	0.71	0.57	Mitral valve prolapse;	chr21:36073441	chr21:36005338~36007838:+
READ	cis	rs9322193	0.923	rs9688350	ENSG00000216906.2	RP11-350J20.9	5.6	4.49e-07	0.00203	0.7	0.57	Lung cancer;	chr6:149730977	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9688699	ENSG00000216906.2	RP11-350J20.9	5.6	4.49e-07	0.00203	0.7	0.57	Lung cancer;	chr6:149733680	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9767652	ENSG00000216906.2	RP11-350J20.9	5.6	4.49e-07	0.00203	0.7	0.57	Lung cancer;	chr6:149734502	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782314	ENSG00000216906.2	RP11-350J20.9	5.6	4.49e-07	0.00203	0.7	0.57	Lung cancer;	chr6:149735527	chr6:149904243~149906418:+
READ	cis	rs10129255	0.785	rs10150044	ENSG00000211972.2	IGHV3-66	5.6	4.51e-07	0.00204	0.53	0.57	Kawasaki disease;	chr14:106775695	chr14:106675017~106675544:-
READ	cis	rs9322193	0.923	rs55993747	ENSG00000268592.3	RAET1E-AS1	5.6	4.51e-07	0.00204	0.71	0.57	Lung cancer;	chr6:149622016	chr6:149863494~149919507:+
READ	cis	rs9322193	0.847	rs12191643	ENSG00000268592.3	RAET1E-AS1	5.6	4.51e-07	0.00204	0.71	0.57	Lung cancer;	chr6:149628912	chr6:149863494~149919507:+
READ	cis	rs9309473	0.95	rs10206899	ENSG00000163016.8	ALMS1P	5.6	4.53e-07	0.00205	0.81	0.57	Metabolite levels;	chr2:73673773	chr2:73644919~73685576:+
READ	cis	rs7301826	0.651	rs10734979	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130804409	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs4759519	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130804963	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs10773823	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130809956	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs73162873	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130811468	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs12228957	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130811521	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs12228959	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130811523	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs4759791	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130811950	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs9668291	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130812363	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs4759521	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130812768	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs4759794	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130812803	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10734981	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130813350	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10744483	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130813661	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10744484	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130813961	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10744485	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130814005	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10773824	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130814306	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs10773825	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130814368	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs7295705	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130817340	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs7968675	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130818832	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs4325342	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130827937	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs4514465	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130829124	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs1077317	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130830432	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs4759525	ENSG00000256299.1	RP11-989F5.3	-5.59	4.6e-07	0.00207	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130831736	chr12:130810821~130812622:-
READ	cis	rs11155671	0.53	rs9383940	ENSG00000268592.3	RAET1E-AS1	5.59	4.62e-07	0.00207	0.74	0.57	Testicular germ cell tumor;	chr6:149904923	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs12176034	ENSG00000216906.2	RP11-350J20.9	5.59	4.63e-07	0.00208	0.73	0.57	Lung cancer;	chr6:149800557	chr6:149904243~149906418:+
READ	cis	rs7301826	0.651	rs10848206	ENSG00000256250.1	RP11-989F5.1	-5.59	4.65e-07	0.00208	-0.54	-0.57	Plasma plasminogen activator levels;	chr12:130796926	chr12:130810606~130812438:+
READ	cis	rs10129255	0.957	rs17113284	ENSG00000211972.2	IGHV3-66	-5.59	4.72e-07	0.00212	-0.51	-0.57	Kawasaki disease;	chr14:106684476	chr14:106675017~106675544:-
READ	cis	rs9322193	0.961	rs9767713	ENSG00000216906.2	RP11-350J20.9	5.59	4.74e-07	0.00212	0.75	0.57	Lung cancer;	chr6:149588241	chr6:149904243~149906418:+
READ	cis	rs9309473	0.615	rs62153183	ENSG00000163016.8	ALMS1P	5.59	4.76e-07	0.00213	0.89	0.57	Metabolite levels;	chr2:73536239	chr2:73644919~73685576:+
READ	cis	rs7208859	0.562	rs11650923	ENSG00000263531.1	RP13-753N3.1	5.58	4.77e-07	0.00213	0.97	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30681149	chr17:30863921~30864940:-
READ	cis	rs7301826	0.651	rs10848210	ENSG00000256299.1	RP11-989F5.3	-5.58	4.78e-07	0.00214	-0.57	-0.57	Plasma plasminogen activator levels;	chr12:130827475	chr12:130810821~130812622:-
READ	cis	rs801193	0.569	rs10950050	ENSG00000226824.5	RP4-756H11.3	-5.58	4.78e-07	0.00214	-0.65	-0.57	Aortic root size;	chr7:66774601	chr7:66654538~66669855:+
READ	cis	rs6504950	0.679	rs9897646	ENSG00000275710.1	RP11-257O5.4	5.58	4.79e-07	0.00214	0.86	0.57	Breast cancer;	chr17:54907990	chr17:54964474~54964679:+
READ	cis	rs9322193	0.923	rs9767123	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149660323	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs62439836	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149669173	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4869812	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149669447	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4870267	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149671572	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4380763	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149678086	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4354168	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149696642	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4455682	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149700161	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4870529	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149716436	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9767309	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149716807	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs17745062	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149721079	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs62441279	ENSG00000216906.2	RP11-350J20.9	5.58	4.82e-07	0.00215	0.72	0.57	Lung cancer;	chr6:149721194	chr6:149904243~149906418:+
READ	cis	rs7301826	0.58	rs12821464	ENSG00000256299.1	RP11-989F5.3	5.58	4.82e-07	0.00215	0.57	0.57	Plasma plasminogen activator levels;	chr12:130838174	chr12:130810821~130812622:-
READ	cis	rs9322193	0.962	rs7740784	ENSG00000216906.2	RP11-350J20.9	5.58	4.83e-07	0.00215	0.74	0.57	Lung cancer;	chr6:149833364	chr6:149904243~149906418:+
READ	cis	rs7208859	0.673	rs216411	ENSG00000263531.1	RP13-753N3.1	-5.58	4.86e-07	0.00217	-0.83	-0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30576475	chr17:30863921~30864940:-
READ	cis	rs9309473	0.95	rs2947860	ENSG00000163016.8	ALMS1P	5.58	4.87e-07	0.00217	0.81	0.57	Metabolite levels;	chr2:73628259	chr2:73644919~73685576:+
READ	cis	rs2882667	0.66	rs6894907	ENSG00000253404.1	AC034243.1	5.58	4.88e-07	0.00217	0.68	0.57	Age-related hearing impairment (SNP x SNP interaction);	chr5:139106815	chr5:138744434~138753309:-
READ	cis	rs9309473	1	rs11903916	ENSG00000163016.8	ALMS1P	5.58	4.9e-07	0.00217	0.81	0.57	Metabolite levels;	chr2:73588201	chr2:73644919~73685576:+
READ	cis	rs9322193	0.847	rs868375	ENSG00000216906.2	RP11-350J20.9	5.58	4.9e-07	0.00217	0.71	0.57	Lung cancer;	chr6:149844905	chr6:149904243~149906418:+
READ	cis	rs1799949	1	rs16942	ENSG00000198496.9	NBR2	-5.58	4.91e-07	0.00217	-0.65	-0.57	Menopause (age at onset);	chr17:43091983	chr17:43125610~43153671:+
READ	cis	rs9322193	0.884	rs7769115	ENSG00000216906.2	RP11-350J20.9	5.58	4.91e-07	0.00217	0.68	0.57	Lung cancer;	chr6:149848796	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs7744105	ENSG00000216906.2	RP11-350J20.9	5.58	4.91e-07	0.00217	0.68	0.57	Lung cancer;	chr6:149849308	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs7743823	ENSG00000216906.2	RP11-350J20.9	5.58	4.91e-07	0.00217	0.68	0.57	Lung cancer;	chr6:149849744	chr6:149904243~149906418:+
READ	cis	rs875971	0.862	rs6460307	ENSG00000226824.5	RP4-756H11.3	-5.57	4.95e-07	0.00219	-0.66	-0.57	Aortic root size;	chr7:66595884	chr7:66654538~66669855:+
READ	cis	rs62229266	0.682	rs2835224	ENSG00000231106.2	LINC01436	5.57	5e-07	0.00221	0.68	0.57	Mitral valve prolapse;	chr21:35997732	chr21:36005338~36007838:+
READ	cis	rs2882667	0.861	rs7703288	ENSG00000253404.1	AC034243.1	5.57	5e-07	0.00221	0.67	0.57	Age-related hearing impairment (SNP x SNP interaction);	chr5:139030850	chr5:138744434~138753309:-
READ	cis	rs7617773	1	rs7617773	ENSG00000229759.1	MRPS18AP1	-5.57	5.01e-07	0.00221	-0.68	-0.57	Coronary artery disease;	chr3:48152025	chr3:48256350~48256938:-
READ	cis	rs7617773	0.962	rs6797587	ENSG00000229759.1	MRPS18AP1	-5.57	5.01e-07	0.00221	-0.68	-0.57	Coronary artery disease;	chr3:48156124	chr3:48256350~48256938:-
READ	cis	rs6545883	0.931	rs778756	ENSG00000271707.1	ATP1B3P1	-5.57	5.01e-07	0.00221	-0.73	-0.57	Tuberculosis;	chr2:61554859	chr2:60734895~60735715:-
READ	cis	rs11690935	0.959	rs7608403	ENSG00000228389.1	AC068039.4	5.57	5.07e-07	0.00223	0.73	0.57	Schizophrenia;	chr2:171790255	chr2:171773482~171775844:+
READ	cis	rs7617773	1	rs11711766	ENSG00000229759.1	MRPS18AP1	-5.57	5.09e-07	0.00224	-0.68	-0.57	Coronary artery disease;	chr3:48151680	chr3:48256350~48256938:-
READ	cis	rs9309473	0.606	rs1589576	ENSG00000163016.8	ALMS1P	5.57	5.1e-07	0.00224	0.88	0.57	Metabolite levels;	chr2:73511677	chr2:73644919~73685576:+
READ	cis	rs858239	0.932	rs1624451	ENSG00000230658.1	KLHL7-AS1	-5.57	5.11e-07	0.00224	-0.74	-0.57	Cerebrospinal fluid biomarker levels;	chr7:23222816	chr7:23101228~23105703:-
READ	cis	rs801193	0.591	rs4506088	ENSG00000226824.5	RP4-756H11.3	5.57	5.11e-07	0.00225	0.68	0.57	Aortic root size;	chr7:66670470	chr7:66654538~66669855:+
READ	cis	rs2739330	0.828	rs5760098	ENSG00000225282.1	AP000350.6	5.57	5.13e-07	0.00225	0.54	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906127	chr22:23926900~23929574:+
READ	cis	rs2739330	0.828	rs5760102	ENSG00000225282.1	AP000350.6	5.57	5.13e-07	0.00225	0.54	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906574	chr22:23926900~23929574:+
READ	cis	rs12594515	1	rs12906442	ENSG00000273972.1	CTD-2306A12.1	-5.57	5.14e-07	0.00225	-0.64	-0.57	Weight;Waist circumference;	chr15:45693056	chr15:45702640~45703183:+
READ	cis	rs9322193	0.887	rs3777949	ENSG00000268592.3	RAET1E-AS1	5.56	5.15e-07	0.00226	0.75	0.57	Lung cancer;	chr6:149596021	chr6:149863494~149919507:+
READ	cis	rs9322193	1	rs9399693	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149612718	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9404048	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149616188	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9505982	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149618465	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322196	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149619645	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10747275	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149622782	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9688794	ENSG00000268592.3	RAET1E-AS1	5.56	5.17e-07	0.00226	0.72	0.57	Lung cancer;	chr6:149632121	chr6:149863494~149919507:+
READ	cis	rs11690935	1	rs6721680	ENSG00000228389.1	AC068039.4	-5.56	5.18e-07	0.00226	-0.74	-0.57	Schizophrenia;	chr2:171687403	chr2:171773482~171775844:+
READ	cis	rs875971	0.862	rs10282433	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66256452	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10276077	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66263424	chr7:66654538~66669855:+
READ	cis	rs875971	0.825	rs4587224	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66271195	chr7:66654538~66669855:+
READ	cis	rs875971	0.792	rs6971752	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66272999	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs10950033	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66274686	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs11760844	ENSG00000226824.5	RP4-756H11.3	5.56	5.19e-07	0.00227	0.65	0.57	Aortic root size;	chr7:66274896	chr7:66654538~66669855:+
READ	cis	rs11690935	1	rs312918	ENSG00000228389.1	AC068039.4	5.56	5.24e-07	0.00229	0.73	0.56	Schizophrenia;	chr2:171713077	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs7597387	ENSG00000228389.1	AC068039.4	5.56	5.24e-07	0.00229	0.73	0.56	Schizophrenia;	chr2:171720606	chr2:171773482~171775844:+
READ	cis	rs6504950	0.76	rs17745189	ENSG00000275710.1	RP11-257O5.4	5.56	5.26e-07	0.0023	0.86	0.56	Breast cancer;	chr17:54936619	chr17:54964474~54964679:+
READ	cis	rs1577917	0.739	rs9450318	ENSG00000203875.9	SNHG5	5.56	5.31e-07	0.00231	0.76	0.56	Response to antipsychotic treatment;	chr6:85717459	chr6:85660950~85678736:-
READ	cis	rs1577917	0.771	rs9450319	ENSG00000203875.9	SNHG5	5.56	5.31e-07	0.00231	0.76	0.56	Response to antipsychotic treatment;	chr6:85717607	chr6:85660950~85678736:-
READ	cis	rs1577917	0.771	rs4383777	ENSG00000203875.9	SNHG5	5.56	5.31e-07	0.00231	0.76	0.56	Response to antipsychotic treatment;	chr6:85726242	chr6:85660950~85678736:-
READ	cis	rs4660456	0.913	rs657149	ENSG00000237899.1	RP4-739H11.3	5.56	5.34e-07	0.00233	0.86	0.56	Platelet count;	chr1:40692486	chr1:40669089~40687588:-
READ	cis	rs12594515	1	rs11070464	ENSG00000273972.1	CTD-2306A12.1	-5.55	5.37e-07	0.00234	-0.64	-0.56	Weight;Waist circumference;	chr15:45692578	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs11070465	ENSG00000273972.1	CTD-2306A12.1	-5.55	5.37e-07	0.00234	-0.64	-0.56	Weight;Waist circumference;	chr15:45692701	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs11070466	ENSG00000273972.1	CTD-2306A12.1	-5.55	5.37e-07	0.00234	-0.64	-0.56	Weight;Waist circumference;	chr15:45692757	chr15:45702640~45703183:+
READ	cis	rs7617773	0.963	rs6766754	ENSG00000229759.1	MRPS18AP1	-5.55	5.4e-07	0.00235	-0.66	-0.56	Coronary artery disease;	chr3:48141099	chr3:48256350~48256938:-
READ	cis	rs7617773	0.832	rs6775114	ENSG00000229759.1	MRPS18AP1	-5.55	5.4e-07	0.00235	-0.66	-0.56	Coronary artery disease;	chr3:48141130	chr3:48256350~48256938:-
READ	cis	rs7208859	0.573	rs216442	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30604179	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs216445	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30606558	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs216446	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30606700	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs79607958	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607530	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs75136574	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607531	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs77544470	ENSG00000263531.1	RP13-753N3.1	5.55	5.41e-07	0.00235	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607532	chr17:30863921~30864940:-
READ	cis	rs9660180	0.875	rs4648727	ENSG00000231050.1	RP1-140A9.1	-5.55	5.44e-07	0.00236	-0.69	-0.56	Body mass index;	chr1:1844830	chr1:1891471~1892658:+
READ	cis	rs9309473	0.95	rs7567585	ENSG00000163016.8	ALMS1P	5.55	5.44e-07	0.00236	0.84	0.56	Metabolite levels;	chr2:73524839	chr2:73644919~73685576:+
READ	cis	rs7208859	0.573	rs216443	ENSG00000263531.1	RP13-753N3.1	5.55	5.46e-07	0.00237	1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30604853	chr17:30863921~30864940:-
READ	cis	rs9322193	0.923	rs9322204	ENSG00000216906.2	RP11-350J20.9	5.55	5.5e-07	0.00239	0.74	0.56	Lung cancer;	chr6:149636047	chr6:149904243~149906418:+
READ	cis	rs2882667	0.66	rs11951084	ENSG00000253404.1	AC034243.1	5.55	5.53e-07	0.0024	0.69	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139125858	chr5:138744434~138753309:-
READ	cis	rs6504950	0.8	rs17745183	ENSG00000275710.1	RP11-257O5.4	5.54	5.59e-07	0.00242	0.8	0.56	Breast cancer;	chr17:54936234	chr17:54964474~54964679:+
READ	cis	rs1577917	0.771	rs7742201	ENSG00000203875.9	SNHG5	-5.54	5.6e-07	0.00242	-0.77	-0.56	Response to antipsychotic treatment;	chr6:85723212	chr6:85660950~85678736:-
READ	cis	rs9322193	0.651	rs9322188	ENSG00000216906.2	RP11-350J20.9	-5.54	5.61e-07	0.00243	-0.73	-0.56	Lung cancer;	chr6:149588355	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs4869750	ENSG00000216906.2	RP11-350J20.9	5.54	5.62e-07	0.00243	0.71	0.56	Lung cancer;	chr6:149855996	chr6:149904243~149906418:+
READ	cis	rs2739330	0.796	rs5760106	ENSG00000225282.1	AP000350.6	-5.54	5.65e-07	0.00245	-0.55	-0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908458	chr22:23926900~23929574:+
READ	cis	rs6504950	0.76	rs7214573	ENSG00000275710.1	RP11-257O5.4	5.54	5.66e-07	0.00245	0.85	0.56	Breast cancer;	chr17:54929293	chr17:54964474~54964679:+
READ	cis	rs6504950	0.8	rs35647022	ENSG00000275710.1	RP11-257O5.4	5.54	5.66e-07	0.00245	0.85	0.56	Breast cancer;	chr17:54930710	chr17:54964474~54964679:+
READ	cis	rs3096299	0.719	rs2353581	ENSG00000274627.1	RP11-104N10.2	5.54	5.69e-07	0.00246	0.65	0.56	Multiple myeloma (IgH translocation);	chr16:89452500	chr16:89516797~89522217:+
READ	cis	rs12594515	1	rs6493167	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45694611	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs6493168	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45694613	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs6493170	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45694821	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs6493172	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45695015	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8025258	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45695356	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8027000	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45695597	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8026221	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45695712	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8031128	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45696330	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8032361	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45696355	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs71405295	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45696723	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs11856523	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45697297	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs6493175	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45697700	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs6493176	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45697828	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs8039088	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45697980	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8038320	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45698069	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8038058	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45698074	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs67854274	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45698320	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs58368732	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45698333	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs7172161	ENSG00000273972.1	CTD-2306A12.1	-5.54	5.7e-07	0.00246	-0.63	-0.56	Weight;Waist circumference;	chr15:45698582	chr15:45702640~45703183:+
READ	cis	rs7617773	0.963	rs12494304	ENSG00000229759.1	MRPS18AP1	-5.54	5.76e-07	0.00248	-0.66	-0.56	Coronary artery disease;	chr3:48136539	chr3:48256350~48256938:-
READ	cis	rs9322193	0.962	rs2342764	ENSG00000216906.2	RP11-350J20.9	5.54	5.78e-07	0.00249	0.71	0.56	Lung cancer;	chr6:149835068	chr6:149904243~149906418:+
READ	cis	rs9322193	0.961	rs9285521	ENSG00000268592.3	RAET1E-AS1	5.53	5.8e-07	0.00249	0.73	0.56	Lung cancer;	chr6:149585576	chr6:149863494~149919507:+
READ	cis	rs67180937	0.921	rs2291834	ENSG00000272750.1	RP11-378J18.8	-5.53	5.84e-07	0.00251	-0.8	-0.56	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222658953	chr1:222658867~222661512:-
READ	cis	rs62229266	0.804	rs56279140	ENSG00000231106.2	LINC01436	5.53	5.84e-07	0.00251	0.75	0.56	Mitral valve prolapse;	chr21:36052063	chr21:36005338~36007838:+
READ	cis	rs7208859	0.623	rs609063	ENSG00000263531.1	RP13-753N3.1	5.53	5.87e-07	0.00252	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30624495	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs383436	ENSG00000263531.1	RP13-753N3.1	5.53	5.87e-07	0.00252	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30632161	chr17:30863921~30864940:-
READ	cis	rs17826219	0.714	rs11650821	ENSG00000263531.1	RP13-753N3.1	5.53	5.87e-07	0.00252	0.95	0.56	Body mass index;	chr17:30641132	chr17:30863921~30864940:-
READ	cis	rs9322193	0.607	rs915140	ENSG00000231760.4	RP11-350J20.5	5.53	5.9e-07	0.00252	0.84	0.56	Lung cancer;	chr6:149899674	chr6:149796151~149826294:-
READ	cis	rs7208859	0.623	rs60890550	ENSG00000263531.1	RP13-753N3.1	5.53	5.92e-07	0.00253	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30703843	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs55661352	ENSG00000263531.1	RP13-753N3.1	5.53	5.92e-07	0.00253	0.95	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30718610	chr17:30863921~30864940:-
READ	cis	rs11690935	0.921	rs6710698	ENSG00000228389.1	AC068039.4	5.53	5.95e-07	0.00254	0.73	0.56	Schizophrenia;	chr2:171739568	chr2:171773482~171775844:+
READ	cis	rs9309473	0.898	rs10170786	ENSG00000163016.8	ALMS1P	5.53	6e-07	0.00256	0.81	0.56	Metabolite levels;	chr2:73585861	chr2:73644919~73685576:+
READ	cis	rs4660456	0.913	rs2744808	ENSG00000237899.1	RP4-739H11.3	-5.53	6.01e-07	0.00256	-0.86	-0.56	Platelet count;	chr1:40712271	chr1:40669089~40687588:-
READ	cis	rs9322193	0.923	rs12529698	ENSG00000268592.3	RAET1E-AS1	5.52	6.06e-07	0.00258	0.7	0.56	Lung cancer;	chr6:149650951	chr6:149863494~149919507:+
READ	cis	rs2882667	0.556	rs6873733	ENSG00000253404.1	AC034243.1	5.52	6.09e-07	0.00259	0.64	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139067628	chr5:138744434~138753309:-
READ	cis	rs7208859	0.623	rs56378576	ENSG00000263531.1	RP13-753N3.1	5.52	6.1e-07	0.00259	0.96	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30683102	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs35916850	ENSG00000263531.1	RP13-753N3.1	5.52	6.1e-07	0.00259	0.96	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30684155	chr17:30863921~30864940:-
READ	cis	rs453301	0.686	rs11787026	ENSG00000253981.4	ALG1L13P	5.52	6.14e-07	0.00261	0.63	0.56	Joint mobility (Beighton score);	chr8:9044861	chr8:8236003~8244667:-
READ	cis	rs9487094	0.689	rs7754650	ENSG00000260273.1	RP11-425D10.10	5.52	6.16e-07	0.00262	0.67	0.56	Height;	chr6:109405536	chr6:109382795~109383666:+
READ	cis	rs9322193	0.923	rs9767554	ENSG00000268592.3	RAET1E-AS1	5.52	6.19e-07	0.00263	0.7	0.56	Lung cancer;	chr6:149616860	chr6:149863494~149919507:+
READ	cis	rs1799949	0.931	rs9912203	ENSG00000198496.9	NBR2	5.52	6.22e-07	0.00264	0.65	0.56	Menopause (age at onset);	chr17:43367777	chr17:43125610~43153671:+
READ	cis	rs6504950	0.83	rs72831295	ENSG00000275710.1	RP11-257O5.4	5.51	6.26e-07	0.00265	0.82	0.56	Breast cancer;	chr17:54966443	chr17:54964474~54964679:+
READ	cis	rs9322193	0.962	rs1889473	ENSG00000268592.3	RAET1E-AS1	5.51	6.27e-07	0.00266	0.75	0.56	Lung cancer;	chr6:149825485	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs6903998	ENSG00000268592.3	RAET1E-AS1	5.51	6.27e-07	0.00266	0.75	0.56	Lung cancer;	chr6:149831357	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs1984111	ENSG00000268592.3	RAET1E-AS1	5.51	6.27e-07	0.00266	0.75	0.56	Lung cancer;	chr6:149831720	chr6:149863494~149919507:+
READ	cis	rs12594515	1	rs11070467	ENSG00000273972.1	CTD-2306A12.1	5.51	6.28e-07	0.00266	0.67	0.56	Weight;Waist circumference;	chr15:45692803	chr15:45702640~45703183:+
READ	cis	rs9309473	0.615	rs74523560	ENSG00000163016.8	ALMS1P	5.51	6.31e-07	0.00267	0.88	0.56	Metabolite levels;	chr2:73537058	chr2:73644919~73685576:+
READ	cis	rs858239	0.863	rs274054	ENSG00000230658.1	KLHL7-AS1	5.51	6.31e-07	0.00268	0.74	0.56	Cerebrospinal fluid biomarker levels;	chr7:23350848	chr7:23101228~23105703:-
READ	cis	rs7301826	0.651	rs7956851	ENSG00000256299.1	RP11-989F5.3	-5.51	6.34e-07	0.00269	-0.58	-0.56	Plasma plasminogen activator levels;	chr12:130834554	chr12:130810821~130812622:-
READ	cis	rs9322193	0.923	rs12174716	ENSG00000268592.3	RAET1E-AS1	5.51	6.35e-07	0.00269	0.73	0.56	Lung cancer;	chr6:149644487	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4870048	ENSG00000268592.3	RAET1E-AS1	5.51	6.37e-07	0.0027	0.77	0.56	Lung cancer;	chr6:149834324	chr6:149863494~149919507:+
READ	cis	rs5850	0.602	rs1005786	ENSG00000230658.1	KLHL7-AS1	5.51	6.38e-07	0.0027	0.65	0.56	Blood protein levels;	chr7:23106218	chr7:23101228~23105703:-
READ	cis	rs858239	0.511	rs10256996	ENSG00000230658.1	KLHL7-AS1	-5.51	6.41e-07	0.00271	-0.65	-0.56	Cerebrospinal fluid biomarker levels;	chr7:23105676	chr7:23101228~23105703:-
READ	cis	rs9322193	0.923	rs11155670	ENSG00000216906.2	RP11-350J20.9	5.51	6.41e-07	0.00271	0.7	0.56	Lung cancer;	chr6:149644992	chr6:149904243~149906418:+
READ	cis	rs7301826	0.651	rs10848209	ENSG00000256299.1	RP11-989F5.3	-5.51	6.42e-07	0.00272	-0.57	-0.56	Plasma plasminogen activator levels;	chr12:130826727	chr12:130810821~130812622:-
READ	cis	rs12594515	0.506	rs74199860	ENSG00000273972.1	CTD-2306A12.1	-5.51	6.43e-07	0.00272	-0.64	-0.56	Weight;Waist circumference;	chr15:45696992	chr15:45702640~45703183:+
READ	cis	rs7301826	0.651	rs7956851	ENSG00000256250.1	RP11-989F5.1	-5.51	6.44e-07	0.00272	-0.53	-0.56	Plasma plasminogen activator levels;	chr12:130834554	chr12:130810606~130812438:+
READ	cis	rs9322193	0.923	rs12174716	ENSG00000216906.2	RP11-350J20.9	5.51	6.45e-07	0.00273	0.73	0.56	Lung cancer;	chr6:149644487	chr6:149904243~149906418:+
READ	cis	rs6545883	0.839	rs778764	ENSG00000271707.1	ATP1B3P1	-5.51	6.48e-07	0.00274	-0.69	-0.56	Tuberculosis;	chr2:61558545	chr2:60734895~60735715:-
READ	cis	rs7617773	1	rs9832957	ENSG00000229759.1	MRPS18AP1	-5.51	6.49e-07	0.00274	-0.68	-0.56	Coronary artery disease;	chr3:48143776	chr3:48256350~48256938:-
READ	cis	rs7617773	1	rs6442108	ENSG00000229759.1	MRPS18AP1	-5.51	6.49e-07	0.00274	-0.68	-0.56	Coronary artery disease;	chr3:48151469	chr3:48256350~48256938:-
READ	cis	rs7617773	1	rs6442109	ENSG00000229759.1	MRPS18AP1	-5.51	6.49e-07	0.00274	-0.68	-0.56	Coronary artery disease;	chr3:48151491	chr3:48256350~48256938:-
READ	cis	rs7617773	0.963	rs6771787	ENSG00000229759.1	MRPS18AP1	-5.51	6.49e-07	0.00274	-0.68	-0.56	Coronary artery disease;	chr3:48152752	chr3:48256350~48256938:-
READ	cis	rs7617773	1	rs6771889	ENSG00000229759.1	MRPS18AP1	-5.51	6.49e-07	0.00274	-0.68	-0.56	Coronary artery disease;	chr3:48152836	chr3:48256350~48256938:-
READ	cis	rs12594515	1	rs12911309	ENSG00000273972.1	CTD-2306A12.1	-5.5	6.52e-07	0.00275	-0.64	-0.56	Weight;Waist circumference;	chr15:45693521	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs12595137	ENSG00000273972.1	CTD-2306A12.1	-5.5	6.52e-07	0.00275	-0.64	-0.56	Weight;Waist circumference;	chr15:45693907	chr15:45702640~45703183:+
READ	cis	rs12594515	0.967	rs12595138	ENSG00000273972.1	CTD-2306A12.1	-5.5	6.52e-07	0.00275	-0.64	-0.56	Weight;Waist circumference;	chr15:45693910	chr15:45702640~45703183:+
READ	cis	rs9326248	0.559	rs484646	ENSG00000254851.1	RP11-109L13.1	-5.5	6.54e-07	0.00276	-0.71	-0.56	Blood protein levels;	chr11:116862140	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs476399	ENSG00000254851.1	RP11-109L13.1	-5.5	6.54e-07	0.00276	-0.71	-0.56	Blood protein levels;	chr11:116863012	chr11:117135528~117138582:+
READ	cis	rs9326248	0.559	rs573549	ENSG00000254851.1	RP11-109L13.1	-5.5	6.54e-07	0.00276	-0.71	-0.56	Blood protein levels;	chr11:116865963	chr11:117135528~117138582:+
READ	cis	rs9326248	0.509	rs533556	ENSG00000254851.1	RP11-109L13.1	-5.5	6.54e-07	0.00276	-0.71	-0.56	Blood protein levels;	chr11:116870856	chr11:117135528~117138582:+
READ	cis	rs9322193	0.566	rs12528243	ENSG00000231760.4	RP11-350J20.5	5.5	6.58e-07	0.00276	0.82	0.56	Lung cancer;	chr6:149898491	chr6:149796151~149826294:-
READ	cis	rs1799949	1	rs2037076	ENSG00000198496.9	NBR2	-5.5	6.6e-07	0.00276	-0.64	-0.56	Menopause (age at onset);	chr17:43153866	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs12950779	ENSG00000198496.9	NBR2	-5.5	6.6e-07	0.00276	-0.64	-0.56	Menopause (age at onset);	chr17:43154506	chr17:43125610~43153671:+
READ	cis	rs1799949	0.929	rs12937015	ENSG00000198496.9	NBR2	-5.5	6.6e-07	0.00276	-0.64	-0.56	Menopause (age at onset);	chr17:43155456	chr17:43125610~43153671:+
READ	cis	rs6504950	0.83	rs12949538	ENSG00000275710.1	RP11-257O5.4	-5.5	6.62e-07	0.00276	-0.84	-0.56	Breast cancer;	chr17:54933309	chr17:54964474~54964679:+
READ	cis	rs6597981	0.592	rs10902218	ENSG00000279672.1	CMB9-55F22.1	-5.5	6.64e-07	0.00276	-0.57	-0.56	Breast cancer;	chr11:743813	chr11:779617~780755:+
READ	cis	rs1799949	0.965	rs8176323	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43043694	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs8176322	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43043756	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12516	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43044391	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793190	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43048092	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs3092988	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43049685	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176297	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43051308	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176296	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43051574	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793191	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43052360	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793192	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43052373	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176289	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43054039	chr17:43125610~43153671:+
READ	cis	rs1799949	0.501	rs2343819	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43332285	chr17:43125610~43153671:+
READ	cis	rs1799949	0.55	rs2343818	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43332406	chr17:43125610~43153671:+
READ	cis	rs1799949	0.501	rs35399157	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43334234	chr17:43125610~43153671:+
READ	cis	rs1799949	0.602	rs4600503	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43336956	chr17:43125610~43153671:+
READ	cis	rs1799949	0.526	rs4352088	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43337311	chr17:43125610~43153671:+
READ	cis	rs1799949	0.501	rs9675035	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43337648	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs34633610	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43342017	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11654051	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43342288	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11649954	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43342667	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1824889	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43344508	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs56729776	ENSG00000198496.9	NBR2	-5.5	6.64e-07	0.00276	-0.65	-0.56	Menopause (age at onset);	chr17:43344763	chr17:43125610~43153671:+
READ	cis	rs7617773	1	rs12496784	ENSG00000229759.1	MRPS18AP1	-5.5	6.67e-07	0.00276	-0.65	-0.56	Coronary artery disease;	chr3:48144777	chr3:48256350~48256938:-
READ	cis	rs6597981	0.675	rs4963120	ENSG00000279672.1	CMB9-55F22.1	-5.5	6.7e-07	0.00277	-0.61	-0.56	Breast cancer;	chr11:825777	chr11:779617~780755:+
READ	cis	rs1577917	0.785	rs1885607	ENSG00000203875.9	SNHG5	5.5	6.7e-07	0.00277	0.72	0.56	Response to antipsychotic treatment;	chr6:85685187	chr6:85660950~85678736:-
READ	cis	rs2739330	0.828	rs2330635	ENSG00000225282.1	AP000350.6	5.5	6.73e-07	0.00279	0.54	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909157	chr22:23926900~23929574:+
READ	cis	rs11155671	0.53	rs4458704	ENSG00000268592.3	RAET1E-AS1	5.49	6.77e-07	0.0028	0.74	0.56	Testicular germ cell tumor;	chr6:149911743	chr6:149863494~149919507:+
READ	cis	rs7208859	0.673	rs11653955	ENSG00000263531.1	RP13-753N3.1	5.49	6.82e-07	0.00281	0.97	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30706274	chr17:30863921~30864940:-
READ	cis	rs12594515	1	rs8039622	ENSG00000273972.1	CTD-2306A12.1	-5.49	6.86e-07	0.00282	-0.64	-0.56	Weight;Waist circumference;	chr15:45694233	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8039974	ENSG00000273972.1	CTD-2306A12.1	-5.49	6.86e-07	0.00282	-0.64	-0.56	Weight;Waist circumference;	chr15:45694467	chr15:45702640~45703183:+
READ	cis	rs67180937	0.961	rs2133189	ENSG00000272750.1	RP11-378J18.8	-5.49	6.88e-07	0.00283	-0.79	-0.56	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222641100	chr1:222658867~222661512:-
READ	cis	rs7617773	0.963	rs6800730	ENSG00000229759.1	MRPS18AP1	5.49	6.89e-07	0.00284	0.65	0.56	Coronary artery disease;	chr3:48132720	chr3:48256350~48256938:-
READ	cis	rs2739330	0.731	rs5751792	ENSG00000231271.1	AP000350.8	5.49	6.91e-07	0.00284	0.68	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23949918~23954042:+
READ	cis	rs11690935	1	rs6757773	ENSG00000228389.1	AC068039.4	-5.49	6.93e-07	0.00285	-0.74	-0.56	Schizophrenia;	chr2:171693120	chr2:171773482~171775844:+
READ	cis	rs7829975	0.536	rs2980439	ENSG00000253981.4	ALG1L13P	5.49	6.96e-07	0.00286	0.68	0.56	Mood instability;	chr8:8237348	chr8:8236003~8244667:-
READ	cis	rs62229266	0.682	rs11700546	ENSG00000231106.2	LINC01436	5.49	6.98e-07	0.00287	0.68	0.56	Mitral valve prolapse;	chr21:35998841	chr21:36005338~36007838:+
READ	cis	rs7208859	0.623	rs8082537	ENSG00000263531.1	RP13-753N3.1	5.49	7.02e-07	0.00288	0.86	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30688914	chr17:30863921~30864940:-
READ	cis	rs17826219	0.561	rs11655876	ENSG00000263531.1	RP13-753N3.1	5.49	7.02e-07	0.00288	0.86	0.56	Body mass index;	chr17:30690132	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9907197	ENSG00000263531.1	RP13-753N3.1	5.49	7.02e-07	0.00288	0.86	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30691245	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9915963	ENSG00000263531.1	RP13-753N3.1	5.49	7.02e-07	0.00288	0.86	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30692625	chr17:30863921~30864940:-
READ	cis	rs1799949	1	rs8176273	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43059636	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs35330014	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43060530	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176269	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43061609	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176265	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43061979	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs3092994	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43063808	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176242	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43065857	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793194	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43066316	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176234	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43067763	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176233	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43067787	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8176220	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43070445	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs3092987	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43070706	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1799966	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43071077	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs35956818	ENSG00000198496.9	NBR2	-5.48	7.08e-07	0.00289	-0.65	-0.56	Menopause (age at onset);	chr17:43345617	chr17:43125610~43153671:+
READ	cis	rs6504950	0.83	rs35097996	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54944562	chr17:54964474~54964679:+
READ	cis	rs6504950	0.79	rs8066833	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54948114	chr17:54964474~54964679:+
READ	cis	rs6504950	0.821	rs8066588	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54948328	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs8073158	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54951254	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs3087650	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54951967	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs12936860	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54952865	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs12937006	ENSG00000275710.1	RP11-257O5.4	5.48	7.09e-07	0.00289	0.81	0.56	Breast cancer;	chr17:54953100	chr17:54964474~54964679:+
READ	cis	rs9487094	0.689	rs699700	ENSG00000260273.1	RP11-425D10.10	5.48	7.12e-07	0.0029	0.67	0.56	Height;	chr6:109367528	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs11251	ENSG00000260273.1	RP11-425D10.10	5.48	7.12e-07	0.0029	0.67	0.56	Height;	chr6:109368704	chr6:109382795~109383666:+
READ	cis	rs9487094	0.517	rs3778474	ENSG00000260273.1	RP11-425D10.10	5.48	7.12e-07	0.0029	0.67	0.56	Height;	chr6:109374782	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs13219952	ENSG00000260273.1	RP11-425D10.10	5.48	7.12e-07	0.0029	0.67	0.56	Height;	chr6:109391084	chr6:109382795~109383666:+
READ	cis	rs9326248	0.861	rs1871757	ENSG00000254851.1	RP11-109L13.1	-5.48	7.26e-07	0.00296	-0.83	-0.56	Blood protein levels;	chr11:117159865	chr11:117135528~117138582:+
READ	cis	rs9601248	0.529	rs2783125	ENSG00000227676.3	LINC01068	5.48	7.28e-07	0.00296	0.63	0.56	Major depressive disorder;	chr13:79583755	chr13:79566727~79571436:+
READ	cis	rs9322193	0.887	rs3734295	ENSG00000268592.3	RAET1E-AS1	5.47	7.31e-07	0.00297	0.73	0.56	Lung cancer;	chr6:149593917	chr6:149863494~149919507:+
READ	cis	rs9322193	0.851	rs9322194	ENSG00000268592.3	RAET1E-AS1	5.47	7.31e-07	0.00297	0.73	0.56	Lung cancer;	chr6:149599113	chr6:149863494~149919507:+
READ	cis	rs7617773	0.963	rs9822496	ENSG00000229759.1	MRPS18AP1	5.47	7.38e-07	0.003	0.65	0.56	Coronary artery disease;	chr3:48139843	chr3:48256350~48256938:-
READ	cis	rs858239	0.896	rs1637193	ENSG00000230658.1	KLHL7-AS1	5.47	7.39e-07	0.003	0.73	0.56	Cerebrospinal fluid biomarker levels;	chr7:23220632	chr7:23101228~23105703:-
READ	cis	rs9322193	0.926	rs9766562	ENSG00000268592.3	RAET1E-AS1	5.47	7.43e-07	0.00301	0.72	0.56	Lung cancer;	chr6:149788709	chr6:149863494~149919507:+
READ	cis	rs11690935	1	rs35549875	ENSG00000228389.1	AC068039.4	-5.47	7.44e-07	0.00301	-0.72	-0.56	Schizophrenia;	chr2:171675882	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10803863	ENSG00000228389.1	AC068039.4	-5.47	7.44e-07	0.00301	-0.72	-0.56	Schizophrenia;	chr2:171678827	chr2:171773482~171775844:+
READ	cis	rs11690935	1	rs12053003	ENSG00000228389.1	AC068039.4	-5.47	7.44e-07	0.00301	-0.72	-0.56	Schizophrenia;	chr2:171680840	chr2:171773482~171775844:+
READ	cis	rs11690935	1	rs3795999	ENSG00000228389.1	AC068039.4	-5.47	7.44e-07	0.00301	-0.72	-0.56	Schizophrenia;	chr2:171687973	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs12185567	ENSG00000228389.1	AC068039.4	-5.47	7.44e-07	0.00301	-0.72	-0.56	Schizophrenia;	chr2:171704219	chr2:171773482~171775844:+
READ	cis	rs11690935	1	rs312925	ENSG00000228389.1	AC068039.4	5.47	7.44e-07	0.00301	0.72	0.56	Schizophrenia;	chr2:171707412	chr2:171773482~171775844:+
READ	cis	rs11690935	0.694	rs312921	ENSG00000228389.1	AC068039.4	5.47	7.44e-07	0.00301	0.72	0.56	Schizophrenia;	chr2:171710715	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs2674484	ENSG00000228389.1	AC068039.4	5.47	7.44e-07	0.00301	0.72	0.56	Schizophrenia;	chr2:171718102	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10206062	ENSG00000228389.1	AC068039.4	5.47	7.44e-07	0.00301	0.72	0.56	Schizophrenia;	chr2:171720766	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs973889	ENSG00000228389.1	AC068039.4	5.47	7.44e-07	0.00301	0.72	0.56	Schizophrenia;	chr2:171723444	chr2:171773482~171775844:+
READ	cis	rs1577917	0.74	rs9344542	ENSG00000203875.9	SNHG5	5.47	7.48e-07	0.00303	0.71	0.56	Response to antipsychotic treatment;	chr6:85684187	chr6:85660950~85678736:-
READ	cis	rs4660456	0.913	rs12743517	ENSG00000237899.1	RP4-739H11.3	5.47	7.52e-07	0.00304	0.86	0.56	Platelet count;	chr1:40759682	chr1:40669089~40687588:-
READ	cis	rs2882667	0.858	rs6596460	ENSG00000253404.1	AC034243.1	5.47	7.54e-07	0.00305	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139078491	chr5:138744434~138753309:-
READ	cis	rs9322193	0.962	rs17673294	ENSG00000268592.3	RAET1E-AS1	5.47	7.59e-07	0.00307	0.72	0.56	Lung cancer;	chr6:149813857	chr6:149863494~149919507:+
READ	cis	rs11690935	0.959	rs11897196	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171729085	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10207085	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171729375	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs2292815	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171730141	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs7604918	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171731584	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10204501	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171732355	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10204502	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171732356	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10204622	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171732472	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6709156	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171735434	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6722757	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171735453	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs12692970	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171737687	chr2:171773482~171775844:+
READ	cis	rs11690935	0.921	rs10200608	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171741419	chr2:171773482~171775844:+
READ	cis	rs11690935	0.798	rs13018768	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171742082	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs4667694	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171748889	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10166005	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171750784	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10184866	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171752446	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs4668412	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171763260	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs76324055	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171763640	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs77280952	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171763641	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs75922913	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171763642	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs13419987	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171767404	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10194102	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171769633	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs7562356	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171770101	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs11904009	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171770833	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs7572215	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171777718	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs35391289	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171778473	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs1113389	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171778855	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6705200	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171781090	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs7355594	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171782938	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs10497374	ENSG00000228389.1	AC068039.4	5.46	7.66e-07	0.00307	0.72	0.56	Schizophrenia;	chr2:171784113	chr2:171773482~171775844:+
READ	cis	rs1799949	0.93	rs8176194	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43079204	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1060915	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43082453	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11653460	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43179289	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11653231	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43179443	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11650913	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43179580	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12936831	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43179799	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1399323	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43180313	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs35954893	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43181769	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs35292991	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43181999	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11658499	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43182732	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs4445938	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43185883	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs8074136	ENSG00000198496.9	NBR2	-5.46	7.68e-07	0.00307	-0.64	-0.56	Menopause (age at onset);	chr17:43190296	chr17:43125610~43153671:+
READ	cis	rs12439619	0.508	rs17354842	ENSG00000278603.1	RP13-608F4.5	-5.46	7.75e-07	0.0031	-0.73	-0.56	Intelligence (multi-trait analysis);	chr15:82177259	chr15:82472203~82472426:+
READ	cis	rs2739330	0.828	rs5760107	ENSG00000225282.1	AP000350.6	5.46	7.77e-07	0.0031	0.53	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910410	chr22:23926900~23929574:+
READ	cis	rs9322193	0.923	rs9689084	ENSG00000268592.3	RAET1E-AS1	5.46	7.82e-07	0.00312	0.7	0.56	Lung cancer;	chr6:149639648	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs62439837	ENSG00000216906.2	RP11-350J20.9	5.46	7.85e-07	0.00313	0.7	0.56	Lung cancer;	chr6:149670380	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9371201	ENSG00000216906.2	RP11-350J20.9	5.46	7.86e-07	0.00313	0.72	0.56	Lung cancer;	chr6:149823865	chr6:149904243~149906418:+
READ	cis	rs9309473	0.95	rs6711001	ENSG00000163016.8	ALMS1P	5.46	7.86e-07	0.00314	0.82	0.56	Metabolite levels;	chr2:73623693	chr2:73644919~73685576:+
READ	cis	rs6504950	0.705	rs9899545	ENSG00000275710.1	RP11-257O5.4	5.45	7.92e-07	0.00316	0.85	0.56	Breast cancer;	chr17:54909484	chr17:54964474~54964679:+
READ	cis	rs875971	0.862	rs1875057	ENSG00000226824.5	RP4-756H11.3	5.45	8.01e-07	0.00319	0.68	0.56	Aortic root size;	chr7:66266868	chr7:66654538~66669855:+
READ	cis	rs875971	0.862	rs6960446	ENSG00000226824.5	RP4-756H11.3	5.45	8.01e-07	0.00319	0.68	0.56	Aortic root size;	chr7:66268272	chr7:66654538~66669855:+
READ	cis	rs875971	0.789	rs10260426	ENSG00000226824.5	RP4-756H11.3	5.45	8.01e-07	0.00319	0.68	0.56	Aortic root size;	chr7:66271055	chr7:66654538~66669855:+
READ	cis	rs9322193	0.961	rs2064520	ENSG00000216906.2	RP11-350J20.9	5.45	8.08e-07	0.00321	0.74	0.56	Lung cancer;	chr6:149603650	chr6:149904243~149906418:+
READ	cis	rs2882667	0.867	rs6868085	ENSG00000253404.1	AC034243.1	5.45	8.11e-07	0.00322	0.67	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139096757	chr5:138744434~138753309:-
READ	cis	rs9399135	0.967	rs11757577	ENSG00000232876.1	CTA-212D2.2	-5.44	8.21e-07	0.00326	-0.73	-0.56	Red blood cell count;	chr6:135070327	chr6:135055033~135060550:+
READ	cis	rs6504950	0.83	rs56175787	ENSG00000275710.1	RP11-257O5.4	5.44	8.26e-07	0.00328	0.85	0.56	Breast cancer;	chr17:54940386	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs17817847	ENSG00000275710.1	RP11-257O5.4	5.44	8.26e-07	0.00328	0.85	0.56	Breast cancer;	chr17:54940920	chr17:54964474~54964679:+
READ	cis	rs10129255	0.536	rs17113249	ENSG00000211972.2	IGHV3-66	5.44	8.28e-07	0.00328	0.55	0.56	Kawasaki disease;	chr14:106678273	chr14:106675017~106675544:-
READ	cis	rs9309473	0.948	rs10170849	ENSG00000163016.8	ALMS1P	5.44	8.35e-07	0.00331	0.82	0.56	Metabolite levels;	chr2:73520805	chr2:73644919~73685576:+
READ	cis	rs9309473	0.948	rs6719753	ENSG00000163016.8	ALMS1P	5.44	8.35e-07	0.00331	0.82	0.56	Metabolite levels;	chr2:73521927	chr2:73644919~73685576:+
READ	cis	rs9309473	1	rs3738848	ENSG00000163016.8	ALMS1P	5.44	8.35e-07	0.00331	0.82	0.56	Metabolite levels;	chr2:73534754	chr2:73644919~73685576:+
READ	cis	rs9322193	0.884	rs11155675	ENSG00000268592.3	RAET1E-AS1	5.44	8.36e-07	0.00331	0.7	0.56	Lung cancer;	chr6:149742883	chr6:149863494~149919507:+
READ	cis	rs7301826	0.571	rs4759788	ENSG00000256299.1	RP11-989F5.3	-5.44	8.36e-07	0.00331	-0.56	-0.56	Plasma plasminogen activator levels;	chr12:130811769	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs4759789	ENSG00000256299.1	RP11-989F5.3	-5.44	8.36e-07	0.00331	-0.56	-0.56	Plasma plasminogen activator levels;	chr12:130811835	chr12:130810821~130812622:-
READ	cis	rs9322193	0.566	rs4870118	ENSG00000231760.4	RP11-350J20.5	-5.44	8.45e-07	0.00334	-0.83	-0.56	Lung cancer;	chr6:149923877	chr6:149796151~149826294:-
READ	cis	rs9322193	0.566	rs4869767	ENSG00000231760.4	RP11-350J20.5	-5.44	8.45e-07	0.00334	-0.83	-0.56	Lung cancer;	chr6:149923974	chr6:149796151~149826294:-
READ	cis	rs9322193	0.566	rs4869768	ENSG00000231760.4	RP11-350J20.5	-5.44	8.45e-07	0.00334	-0.83	-0.56	Lung cancer;	chr6:149924067	chr6:149796151~149826294:-
READ	cis	rs2882667	0.898	rs2351465	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139028162	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6862393	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139029009	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6890272	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139035427	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs3925110	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139035676	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6882330	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139046493	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6882526	ENSG00000253404.1	AC034243.1	5.44	8.5e-07	0.00335	0.66	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:139046679	chr5:138744434~138753309:-
READ	cis	rs7617773	0.925	rs7374376	ENSG00000229759.1	MRPS18AP1	-5.44	8.53e-07	0.00337	-0.65	-0.56	Coronary artery disease;	chr3:48131197	chr3:48256350~48256938:-
READ	cis	rs7617773	0.963	rs12493256	ENSG00000229759.1	MRPS18AP1	-5.44	8.53e-07	0.00337	-0.65	-0.56	Coronary artery disease;	chr3:48135257	chr3:48256350~48256938:-
READ	cis	rs1799949	1	rs9646417	ENSG00000198496.9	NBR2	-5.43	8.56e-07	0.00337	-0.65	-0.56	Menopause (age at onset);	chr17:43346885	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1545764	ENSG00000198496.9	NBR2	-5.43	8.56e-07	0.00337	-0.65	-0.56	Menopause (age at onset);	chr17:43347197	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs4584865	ENSG00000198496.9	NBR2	-5.43	8.56e-07	0.00337	-0.65	-0.56	Menopause (age at onset);	chr17:43347551	chr17:43125610~43153671:+
READ	cis	rs9326248	0.52	rs74830	ENSG00000254851.1	RP11-109L13.1	5.43	8.57e-07	0.00338	0.69	0.56	Blood protein levels;	chr11:117219842	chr11:117135528~117138582:+
READ	cis	rs1577917	0.771	rs9362237	ENSG00000203875.9	SNHG5	5.43	8.59e-07	0.00338	0.73	0.56	Response to antipsychotic treatment;	chr6:85699346	chr6:85660950~85678736:-
READ	cis	rs858239	0.863	rs274058	ENSG00000230658.1	KLHL7-AS1	5.43	8.6e-07	0.00339	0.73	0.56	Cerebrospinal fluid biomarker levels;	chr7:23351890	chr7:23101228~23105703:-
READ	cis	rs7301826	0.651	rs4759517	ENSG00000256250.1	RP11-989F5.1	-5.43	8.64e-07	0.0034	-0.53	-0.56	Plasma plasminogen activator levels;	chr12:130799153	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs7132657	ENSG00000256250.1	RP11-989F5.1	-5.43	8.64e-07	0.0034	-0.53	-0.56	Plasma plasminogen activator levels;	chr12:130800642	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs7971046	ENSG00000256250.1	RP11-989F5.1	-5.43	8.64e-07	0.0034	-0.53	-0.56	Plasma plasminogen activator levels;	chr12:130802262	chr12:130810606~130812438:+
READ	cis	rs9322193	0.923	rs7753812	ENSG00000268592.3	RAET1E-AS1	5.43	8.65e-07	0.0034	0.72	0.56	Lung cancer;	chr6:149690150	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs12195866	ENSG00000268592.3	RAET1E-AS1	5.43	8.65e-07	0.0034	0.72	0.56	Lung cancer;	chr6:149693334	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9285524	ENSG00000268592.3	RAET1E-AS1	5.43	8.65e-07	0.0034	0.72	0.56	Lung cancer;	chr6:149694122	chr6:149863494~149919507:+
READ	cis	rs10129255	0.957	rs12590735	ENSG00000211972.2	IGHV3-66	5.43	8.79e-07	0.00345	0.54	0.56	Kawasaki disease;	chr14:106779660	chr14:106675017~106675544:-
READ	cis	rs111585420	0.59	rs73156558	ENSG00000239443.1	PABPC1P10	5.43	8.85e-07	0.00348	1.23	0.56	Neuroticism;	chr3:155663036	chr3:155309427~155309807:-
READ	cis	rs2739330	0.828	rs5751770	ENSG00000225282.1	AP000350.6	5.42	8.87e-07	0.00348	0.53	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910655	chr22:23926900~23929574:+
READ	cis	rs10129255	0.957	rs10140904	ENSG00000211972.2	IGHV3-66	5.42	8.98e-07	0.00351	0.54	0.56	Kawasaki disease;	chr14:106776558	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs11847726	ENSG00000211972.2	IGHV3-66	5.42	8.98e-07	0.00351	0.54	0.56	Kawasaki disease;	chr14:106779116	chr14:106675017~106675544:-
READ	cis	rs875971	0.862	rs4718330	ENSG00000226824.5	RP4-756H11.3	5.42	9e-07	0.00351	0.63	0.56	Aortic root size;	chr7:66250256	chr7:66654538~66669855:+
READ	cis	rs11690935	0.959	rs67204065	ENSG00000228389.1	AC068039.4	5.42	9.01e-07	0.00351	0.72	0.56	Schizophrenia;	chr2:171816114	chr2:171773482~171775844:+
READ	cis	rs7208859	0.673	rs216410	ENSG00000263531.1	RP13-753N3.1	-5.42	9.03e-07	0.00351	-0.8	-0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30576813	chr17:30863921~30864940:-
READ	cis	rs9309473	0.687	rs6710659	ENSG00000163016.8	ALMS1P	5.42	9.06e-07	0.00351	0.72	0.55	Metabolite levels;	chr2:73380382	chr2:73644919~73685576:+
READ	cis	rs9322193	0.923	rs12175504	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149664079	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs35443312	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149670625	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs62439843	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149676521	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs35031906	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149677438	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10872645	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149742840	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs12211511	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149745206	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9479810	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149751359	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs12175575	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149763351	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4869966	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149763714	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs1112730	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149766383	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs1112729	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149766491	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs10452626	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149767481	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs62441303	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149767547	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9765929	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149769680	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs3805748	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149772542	chr6:149863494~149919507:+
READ	cis	rs9322193	0.736	rs10457851	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149775216	chr6:149863494~149919507:+
READ	cis	rs9322193	0.886	rs10872652	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149775303	chr6:149863494~149919507:+
READ	cis	rs9322193	0.886	rs12525871	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149775882	chr6:149863494~149919507:+
READ	cis	rs9322193	0.886	rs17672976	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149776207	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2184369	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149776681	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs2342861	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149777561	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs2342860	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149777641	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs10872653	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149778907	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs11155683	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149779341	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9372044	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149780867	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs11155685	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149781649	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9322220	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149782897	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs10214845	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149783124	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9767122	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149783553	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs1413654	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149783956	chr6:149863494~149919507:+
READ	cis	rs9322193	0.683	rs113281309	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149787289	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9688809	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149787920	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9689242	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149787970	chr6:149863494~149919507:+
READ	cis	rs9322193	1	rs9767077	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149788479	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9688938	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149788941	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9688940	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149788977	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9689447	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149789350	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs3805751	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149791193	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9689269	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149791861	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs62441335	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149792658	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4816	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149793609	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs3805753	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149795662	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs952166	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149798774	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs952165	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149798900	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs10872656	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149799444	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs9285525	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149801253	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs6914319	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149806304	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs2095375	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149807037	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4869730	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149808187	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs11155689	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149808470	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2151913	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149809506	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs933055	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149809701	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4869731	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149810072	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4552	ENSG00000268592.3	RAET1E-AS1	5.42	9.07e-07	0.00351	0.71	0.55	Lung cancer;	chr6:149811183	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9688412	ENSG00000268592.3	RAET1E-AS1	-5.42	9.07e-07	0.00351	-0.71	-0.55	Lung cancer;	chr6:149803147	chr6:149863494~149919507:+
READ	cis	rs2882667	0.898	rs2043272	ENSG00000253404.1	AC034243.1	5.42	9.11e-07	0.00352	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139054942	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs9689716	ENSG00000268592.3	RAET1E-AS1	5.42	9.16e-07	0.00354	0.69	0.55	Lung cancer;	chr6:149655662	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322207	ENSG00000268592.3	RAET1E-AS1	5.42	9.16e-07	0.00354	0.69	0.55	Lung cancer;	chr6:149657185	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9968911	ENSG00000268592.3	RAET1E-AS1	5.42	9.16e-07	0.00354	0.69	0.55	Lung cancer;	chr6:149657419	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322208	ENSG00000268592.3	RAET1E-AS1	5.42	9.16e-07	0.00354	0.69	0.55	Lung cancer;	chr6:149658547	chr6:149863494~149919507:+
READ	cis	rs10129255	0.957	rs8005468	ENSG00000211972.2	IGHV3-66	5.42	9.19e-07	0.00355	0.53	0.55	Kawasaki disease;	chr14:106686431	chr14:106675017~106675544:-
READ	cis	rs1799949	1	rs9646412	ENSG00000198496.9	NBR2	-5.41	9.25e-07	0.00355	-0.64	-0.55	Menopause (age at onset);	chr17:43348525	chr17:43125610~43153671:+
READ	cis	rs1891275	0.551	rs11186640	ENSG00000228701.1	TNKS2-AS1	-5.41	9.26e-07	0.00356	-0.76	-0.55	Intelligence (multi-trait analysis);	chr10:91640674	chr10:91782839~91798291:-
READ	cis	rs2739330	0.828	rs2877178	ENSG00000225282.1	AP000350.6	5.41	9.28e-07	0.00356	0.53	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909330	chr22:23926900~23929574:+
READ	cis	rs2739330	0.828	rs2154593	ENSG00000225282.1	AP000350.6	5.41	9.28e-07	0.00356	0.53	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23909898	chr22:23926900~23929574:+
READ	cis	rs6504950	0.8	rs72829484	ENSG00000275710.1	RP11-257O5.4	5.41	9.33e-07	0.00358	0.78	0.55	Breast cancer;	chr17:54931919	chr17:54964474~54964679:+
READ	cis	rs9326248	0.861	rs7931335	ENSG00000254851.1	RP11-109L13.1	-5.41	9.35e-07	0.00359	-0.81	-0.55	Blood protein levels;	chr11:117166089	chr11:117135528~117138582:+
READ	cis	rs1577917	0.727	rs9444361	ENSG00000203875.9	SNHG5	5.41	9.4e-07	0.0036	0.73	0.55	Response to antipsychotic treatment;	chr6:85691182	chr6:85660950~85678736:-
READ	cis	rs7301826	0.651	rs12820597	ENSG00000256299.1	RP11-989F5.3	5.41	9.41e-07	0.00361	0.56	0.55	Plasma plasminogen activator levels;	chr12:130795640	chr12:130810821~130812622:-
READ	cis	rs6504950	0.83	rs17817877	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54957267	chr17:54964474~54964679:+
READ	cis	rs6504950	0.79	rs8076984	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54958067	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs17745231	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54959168	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs12938118	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54959998	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs1802212	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54961293	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs17817901	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54961384	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs12150038	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54964159	chr17:54964474~54964679:+
READ	cis	rs6504950	0.83	rs12951542	ENSG00000275710.1	RP11-257O5.4	5.41	9.46e-07	0.00362	0.81	0.55	Breast cancer;	chr17:54964604	chr17:54964474~54964679:+
READ	cis	rs62229266	0.804	rs2255858	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36040454	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs12483151	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36047280	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs880221	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36048487	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs11088331	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36049574	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs62230821	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36052818	chr21:36005338~36007838:+
READ	cis	rs62229266	0.804	rs2835259	ENSG00000231106.2	LINC01436	5.41	9.51e-07	0.00363	0.72	0.55	Mitral valve prolapse;	chr21:36053004	chr21:36005338~36007838:+
READ	cis	rs3096299	0.692	rs4785565	ENSG00000274627.1	RP11-104N10.2	5.41	9.58e-07	0.00364	0.6	0.55	Multiple myeloma (IgH translocation);	chr16:89449351	chr16:89516797~89522217:+
READ	cis	rs3096299	0.642	rs12934829	ENSG00000274627.1	RP11-104N10.2	5.4	9.59e-07	0.00365	0.6	0.55	Multiple myeloma (IgH translocation);	chr16:89456941	chr16:89516797~89522217:+
READ	cis	rs2739330	0.828	rs4822454	ENSG00000250470.1	AP000351.3	5.4	9.66e-07	0.00367	0.73	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23976904~23977585:-
READ	cis	rs7301826	0.651	rs2037789	ENSG00000256299.1	RP11-989F5.3	5.4	9.7e-07	0.00368	0.57	0.55	Plasma plasminogen activator levels;	chr12:130803747	chr12:130810821~130812622:-
READ	cis	rs2117029	0.586	rs6580701	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49163482	chr12:49127782~49147869:+
READ	cis	rs2117029	0.554	rs2334931	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49174130	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs10875929	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49174605	chr12:49127782~49147869:+
READ	cis	rs2117029	0.554	rs2334930	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49175528	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs11168904	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49177234	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs10875931	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49179513	chr12:49127782~49147869:+
READ	cis	rs2117029	0.554	rs7954530	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49179742	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs7957998	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49180240	chr12:49127782~49147869:+
READ	cis	rs2117029	0.553	rs11168909	ENSG00000258017.1	RP11-386G11.10	-5.4	9.72e-07	0.00368	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49183092	chr12:49127782~49147869:+
READ	cis	rs858239	0.614	rs10229956	ENSG00000230658.1	KLHL7-AS1	-5.4	9.78e-07	0.0037	-0.64	-0.55	Cerebrospinal fluid biomarker levels;	chr7:23363317	chr7:23101228~23105703:-
READ	cis	rs17507216	0.958	rs28648832	ENSG00000278603.1	RP13-608F4.5	5.4	9.87e-07	0.00374	0.77	0.55	Excessive daytime sleepiness;	chr15:82567642	chr15:82472203~82472426:+
READ	cis	rs2739330	0.76	rs1002286	ENSG00000231271.1	AP000350.8	-5.4	9.94e-07	0.00376	-0.73	-0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23949918~23954042:+
READ	cis	rs9309473	0.948	rs7603647	ENSG00000163016.8	ALMS1P	5.39	9.97e-07	0.00377	0.79	0.55	Metabolite levels;	chr2:73590111	chr2:73644919~73685576:+
READ	cis	rs11690935	0.959	rs12692974	ENSG00000228389.1	AC068039.4	5.39	1e-06	0.00378	0.71	0.55	Schizophrenia;	chr2:171806746	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6754817	ENSG00000228389.1	AC068039.4	5.39	1e-06	0.00378	0.71	0.55	Schizophrenia;	chr2:171806884	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs3770452	ENSG00000228389.1	AC068039.4	5.39	1e-06	0.00378	0.71	0.55	Schizophrenia;	chr2:171812172	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs3770451	ENSG00000228389.1	AC068039.4	5.39	1e-06	0.00378	0.71	0.55	Schizophrenia;	chr2:171812205	chr2:171773482~171775844:+
READ	cis	rs9322193	0.923	rs62439840	ENSG00000268592.3	RAET1E-AS1	5.39	1.02e-06	0.00384	0.7	0.55	Lung cancer;	chr6:149674639	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9393175	ENSG00000268592.3	RAET1E-AS1	5.39	1.02e-06	0.00384	0.7	0.55	Lung cancer;	chr6:149677587	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4870509	ENSG00000268592.3	RAET1E-AS1	5.39	1.02e-06	0.00384	0.7	0.55	Lung cancer;	chr6:149702212	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322214	ENSG00000268592.3	RAET1E-AS1	5.39	1.02e-06	0.00384	0.7	0.55	Lung cancer;	chr6:149703986	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782318	ENSG00000268592.3	RAET1E-AS1	5.39	1.02e-06	0.00384	0.7	0.55	Lung cancer;	chr6:149754137	chr6:149863494~149919507:+
READ	cis	rs12439619	0.883	rs62012045	ENSG00000278603.1	RP13-608F4.5	5.39	1.03e-06	0.00387	0.73	0.55	Intelligence (multi-trait analysis);	chr15:82229366	chr15:82472203~82472426:+
READ	cis	rs12439619	0.921	rs56042848	ENSG00000278603.1	RP13-608F4.5	5.39	1.03e-06	0.00387	0.73	0.55	Intelligence (multi-trait analysis);	chr15:82235244	chr15:82472203~82472426:+
READ	cis	rs12439619	0.921	rs4778672	ENSG00000278603.1	RP13-608F4.5	-5.39	1.03e-06	0.00387	-0.73	-0.55	Intelligence (multi-trait analysis);	chr15:82245013	chr15:82472203~82472426:+
READ	cis	rs9322193	0.566	rs9397070	ENSG00000231760.4	RP11-350J20.5	-5.39	1.03e-06	0.00388	-0.82	-0.55	Lung cancer;	chr6:149922073	chr6:149796151~149826294:-
READ	cis	rs17507216	0.958	rs72751643	ENSG00000278603.1	RP13-608F4.5	5.39	1.03e-06	0.00389	0.76	0.55	Excessive daytime sleepiness;	chr15:82559444	chr15:82472203~82472426:+
READ	cis	rs2739330	0.703	rs5760112	ENSG00000231271.1	AP000350.8	5.38	1.04e-06	0.0039	0.72	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23917585	chr22:23949918~23954042:+
READ	cis	rs2882667	0.824	rs13189485	ENSG00000253404.1	AC034243.1	5.38	1.04e-06	0.0039	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139139712	chr5:138744434~138753309:-
READ	cis	rs10129255	0.957	rs8009073	ENSG00000211972.2	IGHV3-66	5.38	1.04e-06	0.00391	0.54	0.55	Kawasaki disease;	chr14:106777278	chr14:106675017~106675544:-
READ	cis	rs9322193	0.923	rs1934534	ENSG00000268592.3	RAET1E-AS1	5.38	1.06e-06	0.00395	0.71	0.55	Lung cancer;	chr6:149711896	chr6:149863494~149919507:+
READ	cis	rs7301826	0.651	rs34749116	ENSG00000256299.1	RP11-989F5.3	5.38	1.06e-06	0.00398	0.56	0.55	Plasma plasminogen activator levels;	chr12:130796207	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs7978987	ENSG00000256299.1	RP11-989F5.3	5.38	1.06e-06	0.00398	0.56	0.55	Plasma plasminogen activator levels;	chr12:130796949	chr12:130810821~130812622:-
READ	cis	rs17711722	0.653	rs2460421	ENSG00000226824.5	RP4-756H11.3	5.38	1.07e-06	0.00402	0.66	0.55	Calcium levels;	chr7:66026136	chr7:66654538~66669855:+
READ	cis	rs9322193	0.962	rs9397022	ENSG00000268592.3	RAET1E-AS1	5.37	1.08e-06	0.00403	0.7	0.55	Lung cancer;	chr6:149812052	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9397357	ENSG00000268592.3	RAET1E-AS1	5.37	1.08e-06	0.00403	0.7	0.55	Lung cancer;	chr6:149812465	chr6:149863494~149919507:+
READ	cis	rs6844153	0.752	rs58968032	ENSG00000240005.4	RP11-293A21.1	-5.37	1.08e-06	0.00404	-0.7	-0.55	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26884674	chr4:26859806~26860599:-
READ	cis	rs9322193	0.962	rs7818	ENSG00000268592.3	RAET1E-AS1	5.37	1.1e-06	0.00411	0.71	0.55	Lung cancer;	chr6:149810956	chr6:149863494~149919507:+
READ	cis	rs2882667	0.898	rs6863347	ENSG00000253404.1	AC034243.1	5.37	1.1e-06	0.00411	0.73	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139025446	chr5:138744434~138753309:-
READ	cis	rs9326248	0.581	rs7121898	ENSG00000254851.1	RP11-109L13.1	-5.37	1.1e-06	0.00411	-0.68	-0.55	Blood protein levels;	chr11:116926130	chr11:117135528~117138582:+
READ	cis	rs9326248	0.52	rs1446105	ENSG00000254851.1	RP11-109L13.1	-5.37	1.1e-06	0.00411	-0.68	-0.55	Blood protein levels;	chr11:116927828	chr11:117135528~117138582:+
READ	cis	rs9326248	0.581	rs10790167	ENSG00000254851.1	RP11-109L13.1	-5.37	1.1e-06	0.00411	-0.68	-0.55	Blood protein levels;	chr11:116930227	chr11:117135528~117138582:+
READ	cis	rs1577917	0.682	rs1173419	ENSG00000203875.9	SNHG5	-5.37	1.1e-06	0.00412	-0.72	-0.55	Response to antipsychotic treatment;	chr6:85692445	chr6:85660950~85678736:-
READ	cis	rs1577917	0.696	rs10806334	ENSG00000203875.9	SNHG5	-5.37	1.1e-06	0.00412	-0.7	-0.55	Response to antipsychotic treatment;	chr6:85729611	chr6:85660950~85678736:-
READ	cis	rs9322193	0.923	rs1934534	ENSG00000216906.2	RP11-350J20.9	5.37	1.11e-06	0.00414	0.71	0.55	Lung cancer;	chr6:149711896	chr6:149904243~149906418:+
READ	cis	rs2739330	0.627	rs9608219	ENSG00000231271.1	AP000350.8	5.37	1.12e-06	0.00416	0.73	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23931932	chr22:23949918~23954042:+
READ	cis	rs9322193	0.923	rs9800614	ENSG00000216906.2	RP11-350J20.9	5.37	1.12e-06	0.00417	0.7	0.55	Lung cancer;	chr6:149644604	chr6:149904243~149906418:+
READ	cis	rs1577917	0.771	rs9362239	ENSG00000203875.9	SNHG5	5.36	1.12e-06	0.00418	0.74	0.55	Response to antipsychotic treatment;	chr6:85719545	chr6:85660950~85678736:-
READ	cis	rs6844153	0.68	rs6833053	ENSG00000240005.4	RP11-293A21.1	-5.36	1.12e-06	0.00418	-0.71	-0.55	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26870838	chr4:26859806~26860599:-
READ	cis	rs1799949	1	rs4793229	ENSG00000198496.9	NBR2	5.36	1.13e-06	0.00421	0.65	0.55	Menopause (age at onset);	chr17:43340966	chr17:43125610~43153671:+
READ	cis	rs881375	0.967	rs7046108	ENSG00000226752.6	PSMD5-AS1	5.36	1.13e-06	0.00422	0.73	0.55	Rheumatoid arthritis;	chr9:120898061	chr9:120824828~120854385:+
READ	cis	rs2882667	0.898	rs3828600	ENSG00000253404.1	AC034243.1	5.36	1.14e-06	0.00426	0.69	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139051170	chr5:138744434~138753309:-
READ	cis	rs7429990	0.965	rs4599334	ENSG00000229759.1	MRPS18AP1	-5.36	1.15e-06	0.00426	-0.64	-0.55	Educational attainment (years of education);	chr3:48024910	chr3:48256350~48256938:-
READ	cis	rs9322193	0.923	rs12526675	ENSG00000216906.2	RP11-350J20.9	-5.36	1.15e-06	0.00428	-0.68	-0.55	Lung cancer;	chr6:149729540	chr6:149904243~149906418:+
READ	cis	rs2117029	0.521	rs1056875	ENSG00000258017.1	RP11-386G11.10	-5.36	1.16e-06	0.00429	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49186397	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs1874908	ENSG00000258017.1	RP11-386G11.10	-5.36	1.16e-06	0.00429	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49190247	chr12:49127782~49147869:+
READ	cis	rs9309473	0.606	rs78941213	ENSG00000163016.8	ALMS1P	5.35	1.16e-06	0.00432	0.87	0.55	Metabolite levels;	chr2:73658010	chr2:73644919~73685576:+
READ	cis	rs9309473	0.606	rs77962988	ENSG00000163016.8	ALMS1P	5.35	1.16e-06	0.00432	0.87	0.55	Metabolite levels;	chr2:73658963	chr2:73644919~73685576:+
READ	cis	rs9322193	0.923	rs11155670	ENSG00000268592.3	RAET1E-AS1	5.35	1.17e-06	0.00432	0.69	0.55	Lung cancer;	chr6:149644992	chr6:149863494~149919507:+
READ	cis	rs9322193	0.632	rs3828700	ENSG00000268592.3	RAET1E-AS1	5.35	1.17e-06	0.00433	0.71	0.55	Lung cancer;	chr6:149791033	chr6:149863494~149919507:+
READ	cis	rs9322193	0.736	rs3828701	ENSG00000268592.3	RAET1E-AS1	5.35	1.17e-06	0.00433	0.71	0.55	Lung cancer;	chr6:149791063	chr6:149863494~149919507:+
READ	cis	rs9322193	0.736	rs3805750	ENSG00000268592.3	RAET1E-AS1	5.35	1.17e-06	0.00433	0.71	0.55	Lung cancer;	chr6:149791065	chr6:149863494~149919507:+
READ	cis	rs9309473	0.687	rs11693531	ENSG00000163016.8	ALMS1P	5.35	1.17e-06	0.00435	0.72	0.55	Metabolite levels;	chr2:73381486	chr2:73644919~73685576:+
READ	cis	rs9322193	0.923	rs6913486	ENSG00000216906.2	RP11-350J20.9	-5.35	1.18e-06	0.00438	-0.68	-0.55	Lung cancer;	chr6:149705060	chr6:149904243~149906418:+
READ	cis	rs2117029	0.619	rs9325145	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49132101	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs10783307	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49135822	chr12:49127782~49147869:+
READ	cis	rs2117029	0.554	rs12306494	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49136998	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs11168884	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49146109	chr12:49127782~49147869:+
READ	cis	rs11168854	0.719	rs11168890	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Body mass index;	chr12:49150130	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs7954521	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49151857	chr12:49127782~49147869:+
READ	cis	rs2117029	0.553	rs2162644	ENSG00000258017.1	RP11-386G11.10	-5.35	1.18e-06	0.00438	-0.74	-0.55	Intelligence (multi-trait analysis);	chr12:49154407	chr12:49127782~49147869:+
READ	cis	rs881375	0.933	rs4837799	ENSG00000226752.6	PSMD5-AS1	-5.35	1.19e-06	0.00439	-0.71	-0.55	Rheumatoid arthritis;	chr9:120906048	chr9:120824828~120854385:+
READ	cis	rs1799949	1	rs3950989	ENSG00000198496.9	NBR2	-5.35	1.19e-06	0.00441	-0.65	-0.55	Menopause (age at onset);	chr17:43085936	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs2070834	ENSG00000198496.9	NBR2	-5.35	1.19e-06	0.00441	-0.65	-0.55	Menopause (age at onset);	chr17:43090268	chr17:43125610~43153671:+
READ	cis	rs858239	1	rs199357	ENSG00000230658.1	KLHL7-AS1	-5.35	1.2e-06	0.00442	-0.74	-0.55	Cerebrospinal fluid biomarker levels;	chr7:23248690	chr7:23101228~23105703:-
READ	cis	rs11690935	0.959	rs7586207	ENSG00000228389.1	AC068039.4	5.35	1.2e-06	0.00442	0.68	0.55	Schizophrenia;	chr2:171814584	chr2:171773482~171775844:+
READ	cis	rs2739330	0.761	rs5760176	ENSG00000231271.1	AP000350.8	-5.35	1.2e-06	0.00442	-0.68	-0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23949918~23954042:+
READ	cis	rs1799949	0.965	rs35521261	ENSG00000198496.9	NBR2	-5.35	1.2e-06	0.00444	-0.65	-0.55	Menopause (age at onset);	chr17:43161595	chr17:43125610~43153671:+
READ	cis	rs1799949	0.896	rs33933393	ENSG00000198496.9	NBR2	-5.35	1.2e-06	0.00444	-0.65	-0.55	Menopause (age at onset);	chr17:43165415	chr17:43125610~43153671:+
READ	cis	rs9322193	0.923	rs2342765	ENSG00000216906.2	RP11-350J20.9	5.35	1.2e-06	0.00444	0.69	0.55	Lung cancer;	chr6:149858873	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12526675	ENSG00000268592.3	RAET1E-AS1	-5.35	1.21e-06	0.00445	-0.68	-0.55	Lung cancer;	chr6:149729540	chr6:149863494~149919507:+
READ	cis	rs9322193	0.847	rs4870054	ENSG00000216906.2	RP11-350J20.9	5.34	1.22e-06	0.00448	0.69	0.55	Lung cancer;	chr6:149848402	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10782317	ENSG00000268592.3	RAET1E-AS1	-5.34	1.23e-06	0.00451	-0.69	-0.55	Lung cancer;	chr6:149753911	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9478291	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149729434	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9479494	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149739108	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9800806	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149740350	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs1572229	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149743841	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs10872646	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149746539	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs12528279	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149750892	chr6:149863494~149919507:+
READ	cis	rs9322193	0.809	rs9479808	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149751328	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs62441284	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149751542	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782316	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149752755	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs11155677	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149756953	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9480009	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149758502	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9480031	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149758875	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10872649	ENSG00000268592.3	RAET1E-AS1	5.34	1.23e-06	0.00451	0.69	0.55	Lung cancer;	chr6:149759454	chr6:149863494~149919507:+
READ	cis	rs1799949	1	rs4793231	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43350101	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11651341	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43350693	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs34572725	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43351298	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4534897	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43354440	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs1842147	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43357824	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs4793233	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43358069	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs4793234	ENSG00000198496.9	NBR2	-5.34	1.23e-06	0.00452	-0.65	-0.55	Menopause (age at onset);	chr17:43358815	chr17:43125610~43153671:+
READ	cis	rs881375	1	rs6478486	ENSG00000226752.6	PSMD5-AS1	-5.34	1.24e-06	0.00454	-0.72	-0.55	Rheumatoid arthritis;	chr9:120893051	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs7037140	ENSG00000226752.6	PSMD5-AS1	-5.34	1.24e-06	0.00454	-0.72	-0.55	Rheumatoid arthritis;	chr9:120894049	chr9:120824828~120854385:+
READ	cis	rs7301826	0.651	rs12820597	ENSG00000256250.1	RP11-989F5.1	5.34	1.24e-06	0.00454	0.52	0.55	Plasma plasminogen activator levels;	chr12:130795640	chr12:130810606~130812438:+
READ	cis	rs11155671	0.53	rs6557133	ENSG00000268592.3	RAET1E-AS1	5.34	1.24e-06	0.00455	0.71	0.55	Testicular germ cell tumor;	chr6:149874248	chr6:149863494~149919507:+
READ	cis	rs10129255	0.957	rs10137980	ENSG00000211972.2	IGHV3-66	5.34	1.24e-06	0.00455	0.51	0.55	Kawasaki disease;	chr14:106775735	chr14:106675017~106675544:-
READ	cis	rs6504950	0.8	rs9916547	ENSG00000275710.1	RP11-257O5.4	5.34	1.24e-06	0.00455	0.77	0.55	Breast cancer;	chr17:54929529	chr17:54964474~54964679:+
READ	cis	rs11155671	0.53	rs1334510	ENSG00000268592.3	RAET1E-AS1	5.34	1.24e-06	0.00456	0.7	0.55	Testicular germ cell tumor;	chr6:149880043	chr6:149863494~149919507:+
READ	cis	rs916888	0.779	rs199498	ENSG00000262539.1	RP11-259G18.3	5.34	1.25e-06	0.00456	0.75	0.55	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46788237	chr17:46259551~46260606:-
READ	cis	rs10129255	0.957	rs10150241	ENSG00000211972.2	IGHV3-66	-5.34	1.25e-06	0.00457	-0.51	-0.55	Kawasaki disease;	chr14:106775945	chr14:106675017~106675544:-
READ	cis	rs9309473	0.948	rs7566385	ENSG00000163016.8	ALMS1P	5.34	1.25e-06	0.00457	0.8	0.55	Metabolite levels;	chr2:73529690	chr2:73644919~73685576:+
READ	cis	rs453301	0.686	rs6748	ENSG00000233609.3	RP11-62H7.2	-5.33	1.26e-06	0.00462	-0.64	-0.55	Joint mobility (Beighton score);	chr8:9033292	chr8:8961200~8979025:+
READ	cis	rs1045529	0.524	rs34251783	ENSG00000233609.3	RP11-62H7.2	-5.33	1.26e-06	0.00462	-0.64	-0.55	Myopia (pathological);Myopia;	chr8:9033866	chr8:8961200~8979025:+
READ	cis	rs453301	0.686	rs11785634	ENSG00000233609.3	RP11-62H7.2	-5.33	1.26e-06	0.00462	-0.64	-0.55	Joint mobility (Beighton score);	chr8:9035087	chr8:8961200~8979025:+
READ	cis	rs453301	0.719	rs34004903	ENSG00000233609.3	RP11-62H7.2	-5.33	1.26e-06	0.00462	-0.64	-0.55	Joint mobility (Beighton score);	chr8:9035094	chr8:8961200~8979025:+
READ	cis	rs453301	0.686	rs6987107	ENSG00000233609.3	RP11-62H7.2	-5.33	1.26e-06	0.00462	-0.64	-0.55	Joint mobility (Beighton score);	chr8:9036071	chr8:8961200~8979025:+
READ	cis	rs10129255	0.957	rs12589190	ENSG00000211972.2	IGHV3-66	5.33	1.26e-06	0.00462	0.53	0.55	Kawasaki disease;	chr14:106783079	chr14:106675017~106675544:-
READ	cis	rs453301	0.686	rs6601281	ENSG00000233609.3	RP11-62H7.2	-5.33	1.27e-06	0.00462	-0.66	-0.55	Joint mobility (Beighton score);	chr8:9053494	chr8:8961200~8979025:+
READ	cis	rs9322193	0.962	rs9505974	ENSG00000268592.3	RAET1E-AS1	5.33	1.27e-06	0.00463	0.69	0.55	Lung cancer;	chr6:149779294	chr6:149863494~149919507:+
READ	cis	rs9322193	0.926	rs9689036	ENSG00000268592.3	RAET1E-AS1	5.33	1.27e-06	0.00463	0.69	0.55	Lung cancer;	chr6:149780563	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9322218	ENSG00000268592.3	RAET1E-AS1	5.33	1.27e-06	0.00463	0.69	0.55	Lung cancer;	chr6:149782183	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9322219	ENSG00000268592.3	RAET1E-AS1	5.33	1.27e-06	0.00463	0.69	0.55	Lung cancer;	chr6:149782263	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs1125	ENSG00000216906.2	RP11-350J20.9	5.33	1.27e-06	0.00464	0.71	0.55	Lung cancer;	chr6:149658280	chr6:149904243~149906418:+
READ	cis	rs453301	0.686	rs1045527	ENSG00000233609.3	RP11-62H7.2	-5.33	1.28e-06	0.00466	-0.64	-0.55	Joint mobility (Beighton score);	chr8:9032531	chr8:8961200~8979025:+
READ	cis	rs858239	1	rs858239	ENSG00000230658.1	KLHL7-AS1	5.33	1.28e-06	0.00466	0.73	0.55	Cerebrospinal fluid biomarker levels;	chr7:23246696	chr7:23101228~23105703:-
READ	cis	rs9322193	0.962	rs13215691	ENSG00000268592.3	RAET1E-AS1	5.33	1.28e-06	0.00466	0.69	0.55	Lung cancer;	chr6:149792666	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs9322223	ENSG00000268592.3	RAET1E-AS1	5.33	1.28e-06	0.00466	0.69	0.55	Lung cancer;	chr6:149801509	chr6:149863494~149919507:+
READ	cis	rs1577917	0.71	rs1059306	ENSG00000203875.9	SNHG5	5.33	1.28e-06	0.00467	0.72	0.55	Response to antipsychotic treatment;	chr6:85678391	chr6:85660950~85678736:-
READ	cis	rs748404	0.518	rs2927085	ENSG00000249839.1	AC011330.5	-5.33	1.28e-06	0.00467	-0.71	-0.55	Lung cancer;	chr15:43697332	chr15:43663654~43684339:-
READ	cis	rs881375	0.967	rs1860823	ENSG00000226752.6	PSMD5-AS1	-5.33	1.28e-06	0.00467	-0.72	-0.55	Rheumatoid arthritis;	chr9:120897026	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs1860824	ENSG00000226752.6	PSMD5-AS1	-5.33	1.28e-06	0.00467	-0.72	-0.55	Rheumatoid arthritis;	chr9:120897061	chr9:120824828~120854385:+
READ	cis	rs6545883	0.868	rs778755	ENSG00000271707.1	ATP1B3P1	5.33	1.28e-06	0.00468	0.67	0.55	Tuberculosis;	chr2:61553902	chr2:60734895~60735715:-
READ	cis	rs881375	0.967	rs1008382	ENSG00000226752.6	PSMD5-AS1	-5.33	1.29e-06	0.00471	-0.71	-0.55	Rheumatoid arthritis;	chr9:120918977	chr9:120824828~120854385:+
READ	cis	rs858239	0.965	rs156429	ENSG00000230658.1	KLHL7-AS1	5.33	1.29e-06	0.00472	0.71	0.55	Cerebrospinal fluid biomarker levels;	chr7:23266401	chr7:23101228~23105703:-
READ	cis	rs9322193	0.923	rs9800871	ENSG00000216906.2	RP11-350J20.9	5.33	1.3e-06	0.00472	0.7	0.55	Lung cancer;	chr6:149644540	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9688517	ENSG00000268592.3	RAET1E-AS1	5.33	1.3e-06	0.00472	0.69	0.55	Lung cancer;	chr6:149740655	chr6:149863494~149919507:+
READ	cis	rs9425766	0.679	rs2049992	ENSG00000227373.4	RP11-160H22.5	5.33	1.3e-06	0.00472	0.73	0.55	Life satisfaction;	chr1:174356554	chr1:174115300~174160004:-
READ	cis	rs7617773	0.817	rs11720622	ENSG00000229759.1	MRPS18AP1	5.33	1.3e-06	0.00472	0.63	0.55	Coronary artery disease;	chr3:48205189	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6806112	ENSG00000229759.1	MRPS18AP1	5.33	1.3e-06	0.00472	0.63	0.55	Coronary artery disease;	chr3:48234587	chr3:48256350~48256938:-
READ	cis	rs9309473	0.687	rs6747145	ENSG00000163016.8	ALMS1P	5.33	1.3e-06	0.00472	0.71	0.55	Metabolite levels;	chr2:73382049	chr2:73644919~73685576:+
READ	cis	rs858239	0.932	rs858272	ENSG00000230658.1	KLHL7-AS1	5.32	1.31e-06	0.00475	0.73	0.55	Cerebrospinal fluid biomarker levels;	chr7:23237166	chr7:23101228~23105703:-
READ	cis	rs858239	0.899	rs858271	ENSG00000230658.1	KLHL7-AS1	5.32	1.31e-06	0.00475	0.73	0.55	Cerebrospinal fluid biomarker levels;	chr7:23238664	chr7:23101228~23105703:-
READ	cis	rs858239	1	rs858240	ENSG00000230658.1	KLHL7-AS1	5.32	1.31e-06	0.00475	0.73	0.55	Cerebrospinal fluid biomarker levels;	chr7:23244618	chr7:23101228~23105703:-
READ	cis	rs1799949	0.864	rs60309406	ENSG00000198496.9	NBR2	-5.32	1.31e-06	0.00477	-0.65	-0.55	Menopause (age at onset);	chr17:43358297	chr17:43125610~43153671:+
READ	cis	rs2882667	0.898	rs10058347	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139025669	chr5:138744434~138753309:-
READ	cis	rs2882667	0.931	rs10038799	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139026594	chr5:138744434~138753309:-
READ	cis	rs2882667	0.861	rs10037106	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139029801	chr5:138744434~138753309:-
READ	cis	rs2882667	0.858	rs4643949	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139036656	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6867343	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139038739	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs12719519	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139039998	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs13163536	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139041530	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs2882792	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139044791	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs6882583	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139050107	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs13182437	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139051460	chr5:138744434~138753309:-
READ	cis	rs2882667	0.861	rs10043676	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139053872	chr5:138744434~138753309:-
READ	cis	rs2882667	0.898	rs10038121	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139053913	chr5:138744434~138753309:-
READ	cis	rs2882667	0.861	rs10075541	ENSG00000253404.1	AC034243.1	5.32	1.32e-06	0.00477	0.66	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139054629	chr5:138744434~138753309:-
READ	cis	rs9322193	0.884	rs10872647	ENSG00000216906.2	RP11-350J20.9	5.32	1.32e-06	0.00479	0.71	0.55	Lung cancer;	chr6:149758687	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs10872648	ENSG00000216906.2	RP11-350J20.9	5.32	1.32e-06	0.00479	0.71	0.55	Lung cancer;	chr6:149758699	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs11155679	ENSG00000216906.2	RP11-350J20.9	5.32	1.32e-06	0.00479	0.71	0.55	Lung cancer;	chr6:149758881	chr6:149904243~149906418:+
READ	cis	rs6504950	0.8	rs8065361	ENSG00000275710.1	RP11-257O5.4	5.32	1.32e-06	0.00479	0.77	0.55	Breast cancer;	chr17:54931492	chr17:54964474~54964679:+
READ	cis	rs6504950	0.745	rs12603899	ENSG00000275710.1	RP11-257O5.4	5.32	1.32e-06	0.00479	0.77	0.55	Breast cancer;	chr17:54932737	chr17:54964474~54964679:+
READ	cis	rs6504950	0.8	rs9891704	ENSG00000275710.1	RP11-257O5.4	5.32	1.32e-06	0.00479	0.77	0.55	Breast cancer;	chr17:54933394	chr17:54964474~54964679:+
READ	cis	rs6504950	0.8	rs9900816	ENSG00000275710.1	RP11-257O5.4	5.32	1.32e-06	0.00479	0.77	0.55	Breast cancer;	chr17:54934696	chr17:54964474~54964679:+
READ	cis	rs6504950	0.8	rs9907961	ENSG00000275710.1	RP11-257O5.4	5.32	1.32e-06	0.00479	0.77	0.55	Breast cancer;	chr17:54935566	chr17:54964474~54964679:+
READ	cis	rs7617773	0.817	rs11130162	ENSG00000229759.1	MRPS18AP1	5.32	1.33e-06	0.0048	0.62	0.55	Coronary artery disease;	chr3:48256121	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6787500	ENSG00000229759.1	MRPS18AP1	5.32	1.33e-06	0.0048	0.62	0.55	Coronary artery disease;	chr3:48257949	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs11130163	ENSG00000229759.1	MRPS18AP1	5.32	1.33e-06	0.0048	0.62	0.55	Coronary artery disease;	chr3:48271168	chr3:48256350~48256938:-
READ	cis	rs3096299	0.582	rs12935119	ENSG00000274627.1	RP11-104N10.2	5.32	1.33e-06	0.00481	0.65	0.55	Multiple myeloma (IgH translocation);	chr16:89476466	chr16:89516797~89522217:+
READ	cis	rs7429990	0.965	rs7430913	ENSG00000229759.1	MRPS18AP1	-5.32	1.33e-06	0.00481	-0.62	-0.55	Educational attainment (years of education);	chr3:47990867	chr3:48256350~48256938:-
READ	cis	rs1799949	1	rs33946455	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43169829	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11650132	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43174070	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11654731	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43174923	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs2271574	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43175631	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs33994002	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43176801	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs33920795	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43176993	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs33918839	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43177155	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11651623	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43177830	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11657883	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43178007	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs11656945	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43178248	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12944430	ENSG00000198496.9	NBR2	-5.32	1.34e-06	0.00483	-0.64	-0.55	Menopause (age at onset);	chr17:43178803	chr17:43125610~43153671:+
READ	cis	rs9322193	0.962	rs7745915	ENSG00000216906.2	RP11-350J20.9	5.32	1.36e-06	0.00488	0.75	0.55	Lung cancer;	chr6:149834111	chr6:149904243~149906418:+
READ	cis	rs12594515	1	rs8032835	ENSG00000273972.1	CTD-2306A12.1	-5.31	1.38e-06	0.00496	-0.65	-0.55	Weight;Waist circumference;	chr15:45705699	chr15:45702640~45703183:+
READ	cis	rs12594515	1	rs8033148	ENSG00000273972.1	CTD-2306A12.1	-5.31	1.38e-06	0.00496	-0.65	-0.55	Weight;Waist circumference;	chr15:45705731	chr15:45702640~45703183:+
READ	cis	rs12594515	0.904	rs8032875	ENSG00000273972.1	CTD-2306A12.1	-5.31	1.38e-06	0.00496	-0.65	-0.55	Weight;Waist circumference;	chr15:45705812	chr15:45702640~45703183:+
READ	cis	rs7301826	0.651	rs34749116	ENSG00000256250.1	RP11-989F5.1	5.31	1.38e-06	0.00496	0.52	0.55	Plasma plasminogen activator levels;	chr12:130796207	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs7978987	ENSG00000256250.1	RP11-989F5.1	5.31	1.38e-06	0.00496	0.52	0.55	Plasma plasminogen activator levels;	chr12:130796949	chr12:130810606~130812438:+
READ	cis	rs10129255	0.5	rs1974468	ENSG00000211972.2	IGHV3-66	5.31	1.39e-06	0.00498	0.51	0.55	Kawasaki disease;	chr14:106686149	chr14:106675017~106675544:-
READ	cis	rs9322193	0.962	rs2065664	ENSG00000268592.3	RAET1E-AS1	5.31	1.4e-06	0.00501	0.72	0.55	Lung cancer;	chr6:149762485	chr6:149863494~149919507:+
READ	cis	rs2117029	0.586	rs10783308	ENSG00000258017.1	RP11-386G11.10	-5.31	1.4e-06	0.00501	-0.73	-0.55	Intelligence (multi-trait analysis);	chr12:49137675	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs2114846	ENSG00000258017.1	RP11-386G11.10	-5.31	1.4e-06	0.00501	-0.73	-0.55	Intelligence (multi-trait analysis);	chr12:49154493	chr12:49127782~49147869:+
READ	cis	rs7301826	0.651	rs10848209	ENSG00000256250.1	RP11-989F5.1	-5.31	1.4e-06	0.00501	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130826727	chr12:130810606~130812438:+
READ	cis	rs10542411	1	rs10542411	ENSG00000271707.1	ATP1B3P1	-5.3	1.42e-06	0.00506	-0.72	-0.55	Eosinophil counts;Sum eosinophil basophil counts;	chr2:61541109	chr2:60734895~60735715:-
READ	cis	rs10129255	0.957	rs8009638	ENSG00000211972.2	IGHV3-66	5.3	1.42e-06	0.00506	0.53	0.55	Kawasaki disease;	chr14:106777570	chr14:106675017~106675544:-
READ	cis	rs453301	0.686	rs10217044	ENSG00000233609.3	RP11-62H7.2	-5.3	1.42e-06	0.00506	-0.63	-0.55	Joint mobility (Beighton score);	chr8:9037242	chr8:8961200~8979025:+
READ	cis	rs8078472	0.881	rs3213687	ENSG00000277621.1	RP11-597M12.2	5.3	1.42e-06	0.00508	1.15	0.55	Joint mobility (Beighton score);	chr17:12958853	chr17:12982613~12983002:-
READ	cis	rs2470135	1	rs2470135	ENSG00000249839.1	AC011330.5	-5.3	1.44e-06	0.00513	-0.72	-0.55	Diastolic blood pressure;	chr15:43703591	chr15:43663654~43684339:-
READ	cis	rs881375	0.967	rs1008381	ENSG00000226752.6	PSMD5-AS1	-5.3	1.44e-06	0.00513	-0.71	-0.55	Rheumatoid arthritis;	chr9:120918838	chr9:120824828~120854385:+
READ	cis	rs1577917	0.771	rs2484355	ENSG00000203875.9	SNHG5	-5.3	1.45e-06	0.00515	-0.69	-0.55	Response to antipsychotic treatment;	chr6:85684685	chr6:85660950~85678736:-
READ	cis	rs17507216	1	rs17158413	ENSG00000278603.1	RP13-608F4.5	5.3	1.46e-06	0.00518	0.77	0.55	Excessive daytime sleepiness;	chr15:82566658	chr15:82472203~82472426:+
READ	cis	rs1799949	1	rs4340367	ENSG00000198496.9	NBR2	-5.29	1.47e-06	0.0052	-0.64	-0.55	Menopause (age at onset);	chr17:43155755	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4792981	ENSG00000198496.9	NBR2	-5.29	1.47e-06	0.0052	-0.64	-0.55	Menopause (age at onset);	chr17:43156257	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs1973646	ENSG00000198496.9	NBR2	-5.29	1.47e-06	0.0052	-0.64	-0.55	Menopause (age at onset);	chr17:43158478	chr17:43125610~43153671:+
READ	cis	rs9425766	0.679	rs10912761	ENSG00000227373.4	RP11-160H22.5	5.29	1.47e-06	0.00521	0.75	0.55	Life satisfaction;	chr1:174312466	chr1:174115300~174160004:-
READ	cis	rs2882667	0.638	rs2351905	ENSG00000253404.1	AC034243.1	5.29	1.47e-06	0.00522	0.65	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr5:139135641	chr5:138744434~138753309:-
READ	cis	rs7301826	0.651	rs10734979	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130804409	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs4759519	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130804963	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs10773823	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130809956	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs73162873	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130811468	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs12228957	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130811521	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs12228959	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130811523	chr12:130810606~130812438:+
READ	cis	rs7301826	0.61	rs4759791	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130811950	chr12:130810606~130812438:+
READ	cis	rs7301826	0.61	rs9668291	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130812363	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs4759521	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130812768	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs4759794	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130812803	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10734981	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130813350	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10744483	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130813661	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10744484	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130813961	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10744485	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130814005	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10773824	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130814306	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs10773825	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130814368	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs7295705	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130817340	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs7968675	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130818832	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs4325342	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130827937	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs4514465	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130829124	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs1077317	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130830432	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs4759525	ENSG00000256250.1	RP11-989F5.1	-5.29	1.48e-06	0.00523	-0.51	-0.55	Plasma plasminogen activator levels;	chr12:130831736	chr12:130810606~130812438:+
READ	cis	rs858239	1	rs199347	ENSG00000230658.1	KLHL7-AS1	5.29	1.49e-06	0.00526	0.72	0.55	Cerebrospinal fluid biomarker levels;	chr7:23254127	chr7:23101228~23105703:-
READ	cis	rs7429990	0.965	rs1060407	ENSG00000229759.1	MRPS18AP1	5.29	1.49e-06	0.00527	0.66	0.55	Educational attainment (years of education);	chr3:47916547	chr3:48256350~48256938:-
READ	cis	rs916888	0.61	rs199444	ENSG00000214401.4	KANSL1-AS1	5.29	1.5e-06	0.0053	0.82	0.55	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46740910	chr17:46193576~46196723:+
READ	cis	rs916888	0.61	rs199442	ENSG00000214401.4	KANSL1-AS1	5.29	1.5e-06	0.0053	0.82	0.55	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46742756	chr17:46193576~46196723:+
READ	cis	rs858239	0.899	rs28635122	ENSG00000230658.1	KLHL7-AS1	5.29	1.5e-06	0.00531	0.75	0.55	Cerebrospinal fluid biomarker levels;	chr7:23270562	chr7:23101228~23105703:-
READ	cis	rs858239	0.899	rs7794684	ENSG00000230658.1	KLHL7-AS1	5.29	1.5e-06	0.00531	0.75	0.55	Cerebrospinal fluid biomarker levels;	chr7:23271186	chr7:23101228~23105703:-
READ	cis	rs858239	0.899	rs2268747	ENSG00000230658.1	KLHL7-AS1	5.29	1.5e-06	0.00531	0.75	0.55	Cerebrospinal fluid biomarker levels;	chr7:23273843	chr7:23101228~23105703:-
READ	cis	rs9322193	0.566	rs3922947	ENSG00000231760.4	RP11-350J20.5	-5.29	1.5e-06	0.00531	-0.81	-0.55	Lung cancer;	chr6:149924856	chr6:149796151~149826294:-
READ	cis	rs2455601	0.638	rs2742485	ENSG00000254860.4	TMEM9B-AS1	5.29	1.51e-06	0.00532	0.84	0.55	Schizophrenia;	chr11:8965240	chr11:8964675~8977527:+
READ	cis	rs875971	0.862	rs778720	ENSG00000226824.5	RP4-756H11.3	5.29	1.51e-06	0.00533	0.61	0.55	Aortic root size;	chr7:66381288	chr7:66654538~66669855:+
READ	cis	rs10129255	0.957	rs12590799	ENSG00000211972.2	IGHV3-66	5.29	1.51e-06	0.00534	0.51	0.55	Kawasaki disease;	chr14:106779713	chr14:106675017~106675544:-
READ	cis	rs9322193	0.887	rs9767113	ENSG00000268592.3	RAET1E-AS1	5.29	1.52e-06	0.00535	0.7	0.55	Lung cancer;	chr6:149718157	chr6:149863494~149919507:+
READ	cis	rs10129255	0.957	rs10141052	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106776528	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs10141009	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106776695	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs8009464	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106777611	chr14:106675017~106675544:-
READ	cis	rs10129255	0.912	rs6576227	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106778202	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs6576228	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106778401	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs11846893	ENSG00000211972.2	IGHV3-66	5.28	1.52e-06	0.00537	0.51	0.55	Kawasaki disease;	chr14:106779068	chr14:106675017~106675544:-
READ	cis	rs9326248	0.581	rs10892048	ENSG00000254851.1	RP11-109L13.1	-5.28	1.53e-06	0.00539	-0.67	-0.55	Blood protein levels;	chr11:116943880	chr11:117135528~117138582:+
READ	cis	rs2739330	0.796	rs5760097	ENSG00000225282.1	AP000350.6	5.28	1.54e-06	0.0054	0.52	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905607	chr22:23926900~23929574:+
READ	cis	rs9326248	0.773	rs1060211	ENSG00000254851.1	RP11-109L13.1	-5.28	1.54e-06	0.00542	-0.79	-0.55	Blood protein levels;	chr11:117169081	chr11:117135528~117138582:+
READ	cis	rs9322193	0.607	rs6925151	ENSG00000231760.4	RP11-350J20.5	5.28	1.54e-06	0.00543	0.81	0.55	Lung cancer;	chr6:149889587	chr6:149796151~149826294:-
READ	cis	rs9322193	0.962	rs3763162	ENSG00000216906.2	RP11-350J20.9	-5.28	1.56e-06	0.00547	-0.72	-0.54	Lung cancer;	chr6:149819674	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs14314	ENSG00000216906.2	RP11-350J20.9	5.28	1.56e-06	0.00547	0.72	0.54	Lung cancer;	chr6:149820395	chr6:149904243~149906418:+
READ	cis	rs8078472	1	rs1981622	ENSG00000277621.1	RP11-597M12.2	5.28	1.56e-06	0.00547	1.14	0.54	Joint mobility (Beighton score);	chr17:12969324	chr17:12982613~12983002:-
READ	cis	rs9326248	0.501	rs4938351	ENSG00000254851.1	RP11-109L13.1	-5.28	1.56e-06	0.00547	-0.66	-0.54	Blood protein levels;	chr11:117151636	chr11:117135528~117138582:+
READ	cis	rs1799949	1	rs4793215	ENSG00000198496.9	NBR2	-5.28	1.58e-06	0.00552	-0.66	-0.54	Menopause (age at onset);	chr17:43166915	chr17:43125610~43153671:+
READ	cis	rs10129255	0.5	rs2105989	ENSG00000211972.2	IGHV3-66	5.28	1.58e-06	0.00552	0.52	0.54	Kawasaki disease;	chr14:106682199	chr14:106675017~106675544:-
READ	cis	rs9322193	0.923	rs9766037	ENSG00000268592.3	RAET1E-AS1	5.28	1.58e-06	0.00552	0.7	0.54	Lung cancer;	chr6:149616921	chr6:149863494~149919507:+
READ	cis	rs17264034	0.95	rs55970326	ENSG00000250786.1	SNHG18	5.27	1.59e-06	0.00556	0.8	0.54	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9557008	chr5:9546200~9550609:+
READ	cis	rs9322193	0.923	rs9688350	ENSG00000268592.3	RAET1E-AS1	5.27	1.6e-06	0.00558	0.67	0.54	Lung cancer;	chr6:149730977	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9688699	ENSG00000268592.3	RAET1E-AS1	5.27	1.6e-06	0.00558	0.67	0.54	Lung cancer;	chr6:149733680	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9767652	ENSG00000268592.3	RAET1E-AS1	5.27	1.6e-06	0.00558	0.67	0.54	Lung cancer;	chr6:149734502	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782314	ENSG00000268592.3	RAET1E-AS1	5.27	1.6e-06	0.00558	0.67	0.54	Lung cancer;	chr6:149735527	chr6:149863494~149919507:+
READ	cis	rs10129255	0.957	rs10142918	ENSG00000211972.2	IGHV3-66	5.27	1.6e-06	0.00558	0.53	0.54	Kawasaki disease;	chr14:106782206	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs10142859	ENSG00000211972.2	IGHV3-66	5.27	1.6e-06	0.00558	0.53	0.54	Kawasaki disease;	chr14:106782238	chr14:106675017~106675544:-
READ	cis	rs9322193	0.923	rs9767123	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149660323	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs62439836	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149669173	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4869812	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149669447	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4870267	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149671572	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs4380763	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149678086	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4354168	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149696642	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4455682	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149700161	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4870529	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149716436	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9767309	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149716807	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs17745062	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149721079	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs62441279	ENSG00000268592.3	RAET1E-AS1	5.27	1.61e-06	0.00561	0.69	0.54	Lung cancer;	chr6:149721194	chr6:149863494~149919507:+
READ	cis	rs12594515	0.874	rs8032878	ENSG00000273972.1	CTD-2306A12.1	-5.27	1.61e-06	0.00563	-0.64	-0.54	Weight;Waist circumference;	chr15:45705817	chr15:45702640~45703183:+
READ	cis	rs2882667	0.931	rs3749665	ENSG00000253404.1	AC034243.1	5.27	1.62e-06	0.00564	0.64	0.54	Age-related hearing impairment (SNP x SNP interaction);	chr5:139021522	chr5:138744434~138753309:-
READ	cis	rs6504950	0.72	rs9910653	ENSG00000275710.1	RP11-257O5.4	5.27	1.64e-06	0.0057	0.77	0.54	Breast cancer;	chr17:54914907	chr17:54964474~54964679:+
READ	cis	rs6504950	0.72	rs12602751	ENSG00000275710.1	RP11-257O5.4	5.27	1.64e-06	0.0057	0.77	0.54	Breast cancer;	chr17:54916813	chr17:54964474~54964679:+
READ	cis	rs6504950	0.72	rs7216138	ENSG00000275710.1	RP11-257O5.4	5.27	1.64e-06	0.0057	0.77	0.54	Breast cancer;	chr17:54918303	chr17:54964474~54964679:+
READ	cis	rs1799949	0.965	rs8176161	ENSG00000198496.9	NBR2	-5.27	1.64e-06	0.0057	-0.64	-0.54	Menopause (age at onset);	chr17:43089373	chr17:43125610~43153671:+
READ	cis	rs1799949	0.894	rs8176160	ENSG00000198496.9	NBR2	-5.27	1.64e-06	0.0057	-0.64	-0.54	Menopause (age at onset);	chr17:43089486	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs2271573	ENSG00000198496.9	NBR2	-5.27	1.64e-06	0.0057	-0.64	-0.54	Menopause (age at onset);	chr17:43175604	chr17:43125610~43153671:+
READ	cis	rs9322193	0.884	rs62439837	ENSG00000268592.3	RAET1E-AS1	5.27	1.64e-06	0.00571	0.68	0.54	Lung cancer;	chr6:149670380	chr6:149863494~149919507:+
READ	cis	rs2882667	0.898	rs2116789	ENSG00000253404.1	AC034243.1	5.27	1.64e-06	0.00571	0.66	0.54	Age-related hearing impairment (SNP x SNP interaction);	chr5:139058573	chr5:138744434~138753309:-
READ	cis	rs6504950	0.705	rs17745123	ENSG00000275710.1	RP11-257O5.4	5.26	1.66e-06	0.00577	0.84	0.54	Breast cancer;	chr17:54910871	chr17:54964474~54964679:+
READ	cis	rs2117029	0.653	rs1476137	ENSG00000258017.1	RP11-386G11.10	-5.26	1.66e-06	0.00577	-0.75	-0.54	Intelligence (multi-trait analysis);	chr12:49129930	chr12:49127782~49147869:+
READ	cis	rs2117029	0.553	rs731350	ENSG00000258017.1	RP11-386G11.10	-5.26	1.66e-06	0.00577	-0.75	-0.54	Intelligence (multi-trait analysis);	chr12:49130804	chr12:49127782~49147869:+
READ	cis	rs62229266	0.633	rs743420	ENSG00000231106.2	LINC01436	5.26	1.68e-06	0.00583	0.67	0.54	Mitral valve prolapse;	chr21:36015104	chr21:36005338~36007838:+
READ	cis	rs2739330	0.791	rs4822458	ENSG00000231271.1	AP000350.8	5.26	1.69e-06	0.00586	0.73	0.54	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23949918~23954042:+
READ	cis	rs9487094	0.689	rs9487069	ENSG00000260273.1	RP11-425D10.10	5.26	1.69e-06	0.00588	0.65	0.54	Height;	chr6:109358652	chr6:109382795~109383666:+
READ	cis	rs1799949	0.683	rs55737636	ENSG00000198496.9	NBR2	-5.26	1.7e-06	0.00589	-0.63	-0.54	Menopause (age at onset);	chr17:43112722	chr17:43125610~43153671:+
READ	cis	rs10129255	0.912	rs8009135	ENSG00000211972.2	IGHV3-66	5.25	1.72e-06	0.00596	0.51	0.54	Kawasaki disease;	chr14:106777528	chr14:106675017~106675544:-
READ	cis	rs9399135	0.636	rs4646871	ENSG00000232876.1	CTA-212D2.2	5.25	1.72e-06	0.00596	0.69	0.54	Red blood cell count;	chr6:134944479	chr6:135055033~135060550:+
READ	cis	rs2882667	0.683	rs13188935	ENSG00000253404.1	AC034243.1	5.25	1.73e-06	0.00599	0.66	0.54	Age-related hearing impairment (SNP x SNP interaction);	chr5:139116536	chr5:138744434~138753309:-
READ	cis	rs9322193	0.923	rs12174035	ENSG00000216906.2	RP11-350J20.9	5.25	1.73e-06	0.006	0.7	0.54	Lung cancer;	chr6:149763311	chr6:149904243~149906418:+
READ	cis	rs2739330	0.828	rs4822451	ENSG00000225282.1	AP000350.6	5.25	1.74e-06	0.00602	0.52	0.54	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905979	chr22:23926900~23929574:+
READ	cis	rs2739330	0.828	rs5760099	ENSG00000225282.1	AP000350.6	5.25	1.74e-06	0.00602	0.52	0.54	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23906227	chr22:23926900~23929574:+
READ	cis	rs9322193	0.923	rs12174035	ENSG00000268592.3	RAET1E-AS1	5.25	1.75e-06	0.00605	0.69	0.54	Lung cancer;	chr6:149763311	chr6:149863494~149919507:+
READ	cis	rs881375	0.967	rs7875829	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120898120	chr9:120824828~120854385:+
READ	cis	rs881375	0.867	rs10818484	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120898916	chr9:120824828~120854385:+
READ	cis	rs881375	0.933	rs7859805	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120901845	chr9:120824828~120854385:+
READ	cis	rs881375	0.933	rs10818485	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120905538	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs10435843	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120905755	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs10435844	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120905921	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs7848332	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120907218	chr9:120824828~120854385:+
READ	cis	rs881375	0.867	rs6478487	ENSG00000226752.6	PSMD5-AS1	-5.25	1.75e-06	0.00607	-0.7	-0.54	Rheumatoid arthritis;	chr9:120910499	chr9:120824828~120854385:+
READ	cis	rs9322193	0.962	rs9478848	ENSG00000216906.2	RP11-350J20.9	5.25	1.76e-06	0.00608	0.74	0.54	Lung cancer;	chr6:149825080	chr6:149904243~149906418:+
READ	cis	rs10129255	0.5	rs10143242	ENSG00000211972.2	IGHV3-66	5.24	1.79e-06	0.00615	0.5	0.54	Kawasaki disease;	chr14:106681814	chr14:106675017~106675544:-
READ	cis	rs7429990	0.965	rs4858881	ENSG00000229759.1	MRPS18AP1	-5.24	1.8e-06	0.00616	-0.6	-0.54	Educational attainment (years of education);	chr3:48082306	chr3:48256350~48256938:-
READ	cis	rs881375	0.967	rs2416805	ENSG00000226752.6	PSMD5-AS1	-5.24	1.82e-06	0.0062	-0.7	-0.54	Rheumatoid arthritis;	chr9:120914204	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs2109896	ENSG00000226752.6	PSMD5-AS1	-5.24	1.82e-06	0.0062	-0.7	-0.54	Rheumatoid arthritis;	chr9:120920828	chr9:120824828~120854385:+
READ	cis	rs881375	0.9	rs1008383	ENSG00000226752.6	PSMD5-AS1	-5.24	1.82e-06	0.0062	-0.7	-0.54	Rheumatoid arthritis;	chr9:120921301	chr9:120824828~120854385:+
READ	cis	rs9322193	0.607	rs9371228	ENSG00000231760.4	RP11-350J20.5	-5.24	1.82e-06	0.00621	-0.79	-0.54	Lung cancer;	chr6:149921977	chr6:149796151~149826294:-
READ	cis	rs9322193	0.607	rs12209310	ENSG00000231760.4	RP11-350J20.5	5.24	1.82e-06	0.00622	0.81	0.54	Lung cancer;	chr6:149904882	chr6:149796151~149826294:-
READ	cis	rs9322193	0.607	rs12210822	ENSG00000231760.4	RP11-350J20.5	5.24	1.82e-06	0.00622	0.81	0.54	Lung cancer;	chr6:149905356	chr6:149796151~149826294:-
READ	cis	rs9326248	0.52	rs6589602	ENSG00000254851.1	RP11-109L13.1	-5.24	1.82e-06	0.00622	-0.66	-0.54	Blood protein levels;	chr11:117166349	chr11:117135528~117138582:+
READ	cis	rs11155671	0.53	rs4870080	ENSG00000268592.3	RAET1E-AS1	5.24	1.82e-06	0.00622	0.69	0.54	Testicular germ cell tumor;	chr6:149881508	chr6:149863494~149919507:+
READ	cis	rs9322193	1	rs58189451	ENSG00000216906.2	RP11-350J20.9	5.24	1.83e-06	0.00626	0.73	0.54	Lung cancer;	chr6:149600252	chr6:149904243~149906418:+
READ	cis	rs9326248	0.813	rs588534	ENSG00000254851.1	RP11-109L13.1	-5.24	1.84e-06	0.00626	-0.83	-0.54	Blood protein levels;	chr11:117197788	chr11:117135528~117138582:+
READ	cis	rs9326248	0.813	rs474488	ENSG00000254851.1	RP11-109L13.1	-5.24	1.84e-06	0.00626	-0.83	-0.54	Blood protein levels;	chr11:117198261	chr11:117135528~117138582:+
READ	cis	rs1799949	0.93	rs1554063	ENSG00000198496.9	NBR2	-5.24	1.84e-06	0.00627	-0.63	-0.54	Menopause (age at onset);	chr17:43135128	chr17:43125610~43153671:+
READ	cis	rs10129255	0.957	rs10136781	ENSG00000211972.2	IGHV3-66	5.23	1.84e-06	0.00628	0.5	0.54	Kawasaki disease;	chr14:106780451	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs8022165	ENSG00000211972.2	IGHV3-66	5.23	1.84e-06	0.00628	0.5	0.54	Kawasaki disease;	chr14:106781682	chr14:106675017~106675544:-
READ	cis	rs10129255	0.917	rs8022493	ENSG00000211972.2	IGHV3-66	5.23	1.84e-06	0.00628	0.5	0.54	Kawasaki disease;	chr14:106781820	chr14:106675017~106675544:-
READ	cis	rs1799949	1	rs4793236	ENSG00000198496.9	NBR2	-5.23	1.85e-06	0.00631	-0.64	-0.54	Menopause (age at onset);	chr17:43359072	chr17:43125610~43153671:+
READ	cis	rs11690935	0.959	rs66835971	ENSG00000228389.1	AC068039.4	5.23	1.85e-06	0.00631	0.7	0.54	Schizophrenia;	chr2:171820949	chr2:171773482~171775844:+
READ	cis	rs11690935	0.959	rs6759575	ENSG00000228389.1	AC068039.4	5.23	1.85e-06	0.00631	0.7	0.54	Schizophrenia;	chr2:171832558	chr2:171773482~171775844:+
READ	cis	rs11690935	0.921	rs908670	ENSG00000228389.1	AC068039.4	5.23	1.85e-06	0.00631	0.7	0.54	Schizophrenia;	chr2:171833670	chr2:171773482~171775844:+
READ	cis	rs11690935	0.879	rs908671	ENSG00000228389.1	AC068039.4	5.23	1.85e-06	0.00631	0.7	0.54	Schizophrenia;	chr2:171833755	chr2:171773482~171775844:+
READ	cis	rs9326248	0.581	rs12225187	ENSG00000254851.1	RP11-109L13.1	-5.23	1.87e-06	0.00634	-0.65	-0.54	Blood protein levels;	chr11:116922515	chr11:117135528~117138582:+
READ	cis	rs9326248	0.52	rs2735183	ENSG00000254851.1	RP11-109L13.1	-5.23	1.87e-06	0.00635	-0.66	-0.54	Blood protein levels;	chr11:117144479	chr11:117135528~117138582:+
READ	cis	rs1799949	1	rs2037075	ENSG00000198496.9	NBR2	-5.23	1.87e-06	0.00636	-0.64	-0.54	Menopause (age at onset);	chr17:43153809	chr17:43125610~43153671:+
READ	cis	rs2882667	0.931	rs10075893	ENSG00000253404.1	AC034243.1	-5.23	1.87e-06	0.00636	-0.67	-0.54	Age-related hearing impairment (SNP x SNP interaction);	chr5:139020182	chr5:138744434~138753309:-
READ	cis	rs7208859	0.623	rs9912440	ENSG00000263531.1	RP13-753N3.1	5.23	1.89e-06	0.00643	0.89	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30821754	chr17:30863921~30864940:-
READ	cis	rs7429990	0.965	rs7430879	ENSG00000229759.1	MRPS18AP1	-5.23	1.9e-06	0.00644	-0.61	-0.54	Educational attainment (years of education);	chr3:47997224	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs11130154	ENSG00000229759.1	MRPS18AP1	-5.23	1.9e-06	0.00644	-0.61	-0.54	Educational attainment (years of education);	chr3:48027752	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs5012971	ENSG00000229759.1	MRPS18AP1	-5.23	1.9e-06	0.00644	-0.61	-0.54	Educational attainment (years of education);	chr3:48033057	chr3:48256350~48256938:-
READ	cis	rs7429990	0.813	rs7637622	ENSG00000229759.1	MRPS18AP1	-5.23	1.9e-06	0.00644	-0.61	-0.54	Educational attainment (years of education);	chr3:48051561	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7627645	ENSG00000229759.1	MRPS18AP1	-5.23	1.9e-06	0.00644	-0.61	-0.54	Educational attainment (years of education);	chr3:48051643	chr3:48256350~48256938:-
READ	cis	rs7617773	0.694	rs13099560	ENSG00000229759.1	MRPS18AP1	-5.22	1.93e-06	0.00652	-0.62	-0.54	Coronary artery disease;	chr3:48163278	chr3:48256350~48256938:-
READ	cis	rs1799949	0.929	rs799906	ENSG00000198496.9	NBR2	-5.22	1.94e-06	0.00656	-0.62	-0.54	Menopause (age at onset);	chr17:43126099	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs799908	ENSG00000198496.9	NBR2	-5.22	1.94e-06	0.00656	-0.62	-0.54	Menopause (age at onset);	chr17:43126899	chr17:43125610~43153671:+
READ	cis	rs9322193	0.566	rs6912330	ENSG00000231760.4	RP11-350J20.5	-5.22	1.95e-06	0.00658	-0.79	-0.54	Lung cancer;	chr6:149908811	chr6:149796151~149826294:-
READ	cis	rs9322193	0.607	rs7764677	ENSG00000231760.4	RP11-350J20.5	5.22	1.95e-06	0.00658	0.79	0.54	Lung cancer;	chr6:149906197	chr6:149796151~149826294:-
READ	cis	rs62229266	0.771	rs7280136	ENSG00000231106.2	LINC01436	-5.22	1.95e-06	0.00659	-0.67	-0.54	Mitral valve prolapse;	chr21:36060612	chr21:36005338~36007838:+
READ	cis	rs858239	0.932	rs858275	ENSG00000230658.1	KLHL7-AS1	5.22	1.95e-06	0.00659	0.71	0.54	Cerebrospinal fluid biomarker levels;	chr7:23254525	chr7:23101228~23105703:-
READ	cis	rs10129255	0.912	rs61997792	ENSG00000211972.2	IGHV3-66	5.22	1.96e-06	0.0066	0.54	0.54	Kawasaki disease;	chr14:106799304	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs10138532	ENSG00000211972.2	IGHV3-66	5.22	1.96e-06	0.0066	0.54	0.54	Kawasaki disease;	chr14:106803901	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs8009948	ENSG00000211972.2	IGHV3-66	5.22	1.96e-06	0.0066	0.54	0.54	Kawasaki disease;	chr14:106805607	chr14:106675017~106675544:-
READ	cis	rs5769707	0.967	rs763126	ENSG00000188511.11	C22orf34	-5.21	1.99e-06	0.00665	-0.66	-0.54	Monocyte percentage of white cells;Monocyte count;	chr22:49594926	chr22:49414524~49657542:-
READ	cis	rs9322193	0.923	rs9800736	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149661281	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs66516768	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149671999	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs7450246	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149702517	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9383812	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149712355	chr6:149863494~149919507:+
READ	cis	rs9322193	0.847	rs9383844	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149716268	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs56397000	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149739347	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9689702	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149740720	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10782315	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149743093	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10747276	ENSG00000268592.3	RAET1E-AS1	5.21	1.99e-06	0.00665	0.66	0.54	Lung cancer;	chr6:149758739	chr6:149863494~149919507:+
READ	cis	rs6504950	0.8	rs12952253	ENSG00000275710.1	RP11-257O5.4	5.21	2e-06	0.00667	0.74	0.54	Breast cancer;	chr17:54928355	chr17:54964474~54964679:+
READ	cis	rs6504950	0.8	rs7208123	ENSG00000275710.1	RP11-257O5.4	5.21	2e-06	0.00667	0.74	0.54	Breast cancer;	chr17:54928978	chr17:54964474~54964679:+
READ	cis	rs9322193	0.962	rs7740784	ENSG00000268592.3	RAET1E-AS1	5.21	2e-06	0.00667	0.7	0.54	Lung cancer;	chr6:149833364	chr6:149863494~149919507:+
READ	cis	rs5753037	0.754	rs4820824	ENSG00000279159.1	RP3-394A18.1	-5.21	2e-06	0.00668	-0.35	-0.54	Type 1 diabetes;	chr22:29964926	chr22:29978950~30028236:-
READ	cis	rs1799949	1	rs2298862	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43024671	chr17:43125610~43153671:+
READ	cis	rs1799949	0.93	rs2298861	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43024814	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs915945	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43027847	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12944458	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43028755	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs36036395	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43029280	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs72829113	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43029818	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11653253	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43030645	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12951869	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43035550	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12944597	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43035667	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs12942277	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43035957	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs34616041	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43036769	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11654452	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43037366	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs4793189	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43038698	chr17:43125610~43153671:+
READ	cis	rs1799949	1	rs11657053	ENSG00000198496.9	NBR2	-5.21	2.01e-06	0.00668	-0.64	-0.54	Menopause (age at onset);	chr17:43039112	chr17:43125610~43153671:+
READ	cis	rs7429990	0.965	rs7642590	ENSG00000229759.1	MRPS18AP1	-5.21	2.01e-06	0.00668	-0.63	-0.54	Educational attainment (years of education);	chr3:48058260	chr3:48256350~48256938:-
READ	cis	rs881375	0.935	rs7034390	ENSG00000226752.6	PSMD5-AS1	-5.21	2.01e-06	0.00669	-0.7	-0.54	Rheumatoid arthritis;	chr9:120884210	chr9:120824828~120854385:+
READ	cis	rs3096299	0.509	rs4785691	ENSG00000274627.1	RP11-104N10.2	5.21	2.02e-06	0.00672	0.59	0.54	Multiple myeloma (IgH translocation);	chr16:89530813	chr16:89516797~89522217:+
READ	cis	rs9487094	0.689	rs9480949	ENSG00000260273.1	RP11-425D10.10	5.21	2.03e-06	0.00674	0.66	0.54	Height;	chr6:109407238	chr6:109382795~109383666:+
READ	cis	rs875971	0.895	rs4145009	ENSG00000226824.5	RP4-756H11.3	5.21	2.04e-06	0.00676	0.63	0.54	Aortic root size;	chr7:66261628	chr7:66654538~66669855:+
READ	cis	rs6504950	0.72	rs9914836	ENSG00000275710.1	RP11-257O5.4	5.21	2.04e-06	0.00676	0.8	0.54	Breast cancer;	chr17:54920514	chr17:54964474~54964679:+
READ	cis	rs7429990	0.901	rs7433678	ENSG00000229759.1	MRPS18AP1	-5.21	2.04e-06	0.00676	-0.62	-0.54	Educational attainment (years of education);	chr3:47995588	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs2166772	ENSG00000229759.1	MRPS18AP1	-5.21	2.04e-06	0.00676	-0.62	-0.54	Educational attainment (years of education);	chr3:48006384	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs4392441	ENSG00000229759.1	MRPS18AP1	-5.21	2.04e-06	0.00676	-0.62	-0.54	Educational attainment (years of education);	chr3:48036211	chr3:48256350~48256938:-
READ	cis	rs9322193	0.923	rs6913486	ENSG00000268592.3	RAET1E-AS1	-5.21	2.06e-06	0.00678	-0.67	-0.54	Lung cancer;	chr6:149705060	chr6:149863494~149919507:+
READ	cis	rs7301826	0.651	rs10848210	ENSG00000256250.1	RP11-989F5.1	-5.21	2.07e-06	0.0068	-0.5	-0.54	Plasma plasminogen activator levels;	chr12:130827475	chr12:130810606~130812438:+
READ	cis	rs881375	0.933	rs1548784	ENSG00000226752.6	PSMD5-AS1	-5.2	2.07e-06	0.0068	-0.7	-0.54	Rheumatoid arthritis;	chr9:120923002	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs7034492	ENSG00000226752.6	PSMD5-AS1	-5.2	2.07e-06	0.0068	-0.7	-0.54	Rheumatoid arthritis;	chr9:120924933	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs7034653	ENSG00000226752.6	PSMD5-AS1	-5.2	2.07e-06	0.0068	-0.7	-0.54	Rheumatoid arthritis;	chr9:120925094	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs1930781	ENSG00000226752.6	PSMD5-AS1	-5.2	2.07e-06	0.0068	-0.7	-0.54	Rheumatoid arthritis;	chr9:120925556	chr9:120824828~120854385:+
READ	cis	rs7429990	0.901	rs6442091	ENSG00000229759.1	MRPS18AP1	-5.2	2.07e-06	0.0068	-0.63	-0.54	Educational attainment (years of education);	chr3:48001568	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs4858810	ENSG00000229759.1	MRPS18AP1	-5.2	2.07e-06	0.0068	-0.63	-0.54	Educational attainment (years of education);	chr3:48002247	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs4296617	ENSG00000229759.1	MRPS18AP1	-5.2	2.07e-06	0.0068	-0.63	-0.54	Educational attainment (years of education);	chr3:48026818	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs4858887	ENSG00000229759.1	MRPS18AP1	-5.2	2.07e-06	0.0068	-0.63	-0.54	Educational attainment (years of education);	chr3:48050527	chr3:48256350~48256938:-
READ	cis	rs2882667	0.931	rs10069528	ENSG00000253404.1	AC034243.1	5.2	2.07e-06	0.00681	0.64	0.54	Age-related hearing impairment (SNP x SNP interaction);	chr5:139018338	chr5:138744434~138753309:-
READ	cis	rs5769707	1	rs5769707	ENSG00000188511.11	C22orf34	5.2	2.08e-06	0.00683	0.64	0.54	Monocyte percentage of white cells;Monocyte count;	chr22:49619754	chr22:49414524~49657542:-
READ	cis	rs5769707	0.904	rs7288869	ENSG00000188511.11	C22orf34	5.2	2.08e-06	0.00683	0.64	0.54	Monocyte percentage of white cells;Monocyte count;	chr22:49621679	chr22:49414524~49657542:-
READ	cis	rs7301826	0.651	rs2277336	ENSG00000256299.1	RP11-989F5.3	5.2	2.08e-06	0.00684	0.55	0.54	Plasma plasminogen activator levels;	chr12:130801574	chr12:130810821~130812622:-
READ	cis	rs9322193	0.884	rs11155675	ENSG00000216906.2	RP11-350J20.9	5.2	2.08e-06	0.00684	0.68	0.54	Lung cancer;	chr6:149742883	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2342857	ENSG00000268592.3	RAET1E-AS1	5.2	2.09e-06	0.00687	0.7	0.54	Lung cancer;	chr6:149809537	chr6:149863494~149919507:+
READ	cis	rs9309473	0.95	rs13391258	ENSG00000163016.8	ALMS1P	5.2	2.12e-06	0.00693	0.79	0.54	Metabolite levels;	chr2:73621806	chr2:73644919~73685576:+
READ	cis	rs9309473	0.898	rs6546861	ENSG00000163016.8	ALMS1P	5.2	2.12e-06	0.00693	0.79	0.54	Metabolite levels;	chr2:73622734	chr2:73644919~73685576:+
READ	cis	rs875971	0.862	rs6944374	ENSG00000226824.5	RP4-756H11.3	5.2	2.14e-06	0.007	0.67	0.54	Aortic root size;	chr7:66221942	chr7:66654538~66669855:+
READ	cis	rs9322193	0.607	rs9383941	ENSG00000231760.4	RP11-350J20.5	-5.19	2.15e-06	0.00701	-0.8	-0.54	Lung cancer;	chr6:149912100	chr6:149796151~149826294:-
READ	cis	rs9322193	0.566	rs5024811	ENSG00000231760.4	RP11-350J20.5	-5.19	2.15e-06	0.00701	-0.8	-0.54	Lung cancer;	chr6:149924898	chr6:149796151~149826294:-
READ	cis	rs5769707	0.967	rs2187891	ENSG00000188511.11	C22orf34	5.19	2.15e-06	0.00701	0.66	0.54	Monocyte percentage of white cells;Monocyte count;	chr22:49600446	chr22:49414524~49657542:-
READ	cis	rs67180937	0.921	rs35700460	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222638065	chr1:222658867~222661512:-
READ	cis	rs67180937	0.885	rs2133187	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222640383	chr1:222658867~222661512:-
READ	cis	rs67180937	0.844	rs35626308	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222643014	chr1:222658867~222661512:-
READ	cis	rs67180937	0.921	rs17163360	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222647448	chr1:222658867~222661512:-
READ	cis	rs67180937	1	rs67180937	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222650401	chr1:222658867~222661512:-
READ	cis	rs67180937	0.961	rs17011681	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222651746	chr1:222658867~222661512:-
READ	cis	rs67180937	0.961	rs17163363	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222655362	chr1:222658867~222661512:-
READ	cis	rs67180937	0.849	rs4575092	ENSG00000272750.1	RP11-378J18.8	-5.19	2.15e-06	0.00701	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222661161	chr1:222658867~222661512:-
READ	cis	rs9326248	0.559	rs609177	ENSG00000254851.1	RP11-109L13.1	-5.19	2.16e-06	0.00705	-0.69	-0.54	Blood protein levels;	chr11:116899801	chr11:117135528~117138582:+
READ	cis	rs10129255	0.957	rs10132367	ENSG00000211972.2	IGHV3-66	5.19	2.18e-06	0.00708	0.52	0.54	Kawasaki disease;	chr14:106690981	chr14:106675017~106675544:-
READ	cis	rs13113518	0.783	rs11943206	ENSG00000223305.1	RN7SKP30	5.19	2.19e-06	0.0071	0.67	0.54	Height;	chr4:55570843	chr4:55540502~55540835:-
READ	cis	rs1577917	0.771	rs6454486	ENSG00000203875.9	SNHG5	5.19	2.19e-06	0.0071	0.73	0.54	Response to antipsychotic treatment;	chr6:85723869	chr6:85660950~85678736:-
READ	cis	rs9322193	0.923	rs9688452	ENSG00000268592.3	RAET1E-AS1	5.19	2.19e-06	0.00711	0.67	0.54	Lung cancer;	chr6:149658764	chr6:149863494~149919507:+
READ	cis	rs67180937	0.961	rs17465637	ENSG00000272750.1	RP11-378J18.8	5.19	2.2e-06	0.00713	0.76	0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222650187	chr1:222658867~222661512:-
READ	cis	rs67180937	0.922	rs10495198	ENSG00000272750.1	RP11-378J18.8	-5.19	2.2e-06	0.00713	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222652375	chr1:222658867~222661512:-
READ	cis	rs67180937	0.961	rs17465940	ENSG00000272750.1	RP11-378J18.8	-5.19	2.2e-06	0.00713	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222663654	chr1:222658867~222661512:-
READ	cis	rs67180937	0.922	rs17465982	ENSG00000272750.1	RP11-378J18.8	-5.19	2.2e-06	0.00713	-0.76	-0.54	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222664597	chr1:222658867~222661512:-
READ	cis	rs9322193	0.962	rs6899661	ENSG00000216906.2	RP11-350J20.9	5.19	2.22e-06	0.00719	0.71	0.54	Lung cancer;	chr6:149818093	chr6:149904243~149906418:+
READ	cis	rs2117029	0.586	rs10875928	ENSG00000258017.1	RP11-386G11.10	-5.19	2.22e-06	0.00721	-0.74	-0.54	Intelligence (multi-trait analysis);	chr12:49162520	chr12:49127782~49147869:+
READ	cis	rs9322193	0.962	rs3763162	ENSG00000268592.3	RAET1E-AS1	-5.19	2.22e-06	0.00721	-0.71	-0.54	Lung cancer;	chr6:149819674	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs14314	ENSG00000268592.3	RAET1E-AS1	5.19	2.22e-06	0.00721	0.71	0.54	Lung cancer;	chr6:149820395	chr6:149863494~149919507:+
READ	cis	rs3096299	0.719	rs2965817	ENSG00000274627.1	RP11-104N10.2	5.19	2.22e-06	0.00721	0.58	0.54	Multiple myeloma (IgH translocation);	chr16:89446826	chr16:89516797~89522217:+
READ	cis	rs13068223	0.607	rs184695	ENSG00000243926.1	TIPARP-AS1	-5.18	2.24e-06	0.00724	-0.64	-0.54	Age-related hearing impairment (SNP x SNP interaction);	chr3:156679600	chr3:156671862~156674378:-
READ	cis	rs9309473	0.66	rs11679594	ENSG00000163016.8	ALMS1P	5.18	2.26e-06	0.00732	0.86	0.54	Metabolite levels;	chr2:73552380	chr2:73644919~73685576:+
READ	cis	rs9309473	0.606	rs62149777	ENSG00000163016.8	ALMS1P	5.18	2.26e-06	0.00732	0.86	0.54	Metabolite levels;	chr2:73568237	chr2:73644919~73685576:+
READ	cis	rs10129255	0.5	rs2105991	ENSG00000211972.2	IGHV3-66	5.18	2.27e-06	0.00735	0.52	0.54	Kawasaki disease;	chr14:106682022	chr14:106675017~106675544:-
READ	cis	rs7429990	0.76	rs319694	ENSG00000229759.1	MRPS18AP1	5.18	2.29e-06	0.0074	0.65	0.54	Educational attainment (years of education);	chr3:47843463	chr3:48256350~48256938:-
READ	cis	rs9326248	0.52	rs236919	ENSG00000254851.1	RP11-109L13.1	-5.18	2.3e-06	0.00741	-0.67	-0.54	Blood protein levels;	chr11:117224645	chr11:117135528~117138582:+
READ	cis	rs9322193	0.886	rs9767555	ENSG00000216906.2	RP11-350J20.9	5.18	2.31e-06	0.00744	0.7	0.54	Lung cancer;	chr6:149647022	chr6:149904243~149906418:+
READ	cis	rs916888	0.531	rs183211	ENSG00000214401.4	KANSL1-AS1	5.17	2.33e-06	0.0075	0.86	0.54	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46710944	chr17:46193576~46196723:+
READ	cis	rs7429990	0.932	rs4293721	ENSG00000229759.1	MRPS18AP1	-5.17	2.36e-06	0.00759	-0.62	-0.54	Educational attainment (years of education);	chr3:48003647	chr3:48256350~48256938:-
READ	cis	rs9322193	0.962	rs9505974	ENSG00000216906.2	RP11-350J20.9	5.17	2.36e-06	0.00759	0.68	0.54	Lung cancer;	chr6:149779294	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs9689036	ENSG00000216906.2	RP11-350J20.9	5.17	2.36e-06	0.00759	0.68	0.54	Lung cancer;	chr6:149780563	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9322218	ENSG00000216906.2	RP11-350J20.9	5.17	2.36e-06	0.00759	0.68	0.54	Lung cancer;	chr6:149782183	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9322219	ENSG00000216906.2	RP11-350J20.9	5.17	2.36e-06	0.00759	0.68	0.54	Lung cancer;	chr6:149782263	chr6:149904243~149906418:+
READ	cis	rs12439619	0.508	rs8042665	ENSG00000278603.1	RP13-608F4.5	5.17	2.36e-06	0.00759	0.71	0.54	Intelligence (multi-trait analysis);	chr15:82189008	chr15:82472203~82472426:+
READ	cis	rs916888	0.647	rs199524	ENSG00000214401.4	KANSL1-AS1	-5.17	2.39e-06	0.00767	-0.79	-0.54	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46771072	chr17:46193576~46196723:+
READ	cis	rs916888	0.647	rs199523	ENSG00000214401.4	KANSL1-AS1	-5.17	2.39e-06	0.00767	-0.79	-0.54	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46771151	chr17:46193576~46196723:+
READ	cis	rs7301826	0.651	rs2277336	ENSG00000256250.1	RP11-989F5.1	5.17	2.4e-06	0.0077	0.51	0.54	Plasma plasminogen activator levels;	chr12:130801574	chr12:130810606~130812438:+
READ	cis	rs7617773	0.817	rs936427	ENSG00000229759.1	MRPS18AP1	-5.16	2.42e-06	0.00776	-0.7	-0.54	Coronary artery disease;	chr3:48259584	chr3:48256350~48256938:-
READ	cis	rs7301826	0.571	rs4759788	ENSG00000256250.1	RP11-989F5.1	-5.16	2.46e-06	0.0079	-0.5	-0.54	Plasma plasminogen activator levels;	chr12:130811769	chr12:130810606~130812438:+
READ	cis	rs7301826	0.61	rs4759789	ENSG00000256250.1	RP11-989F5.1	-5.16	2.46e-06	0.0079	-0.5	-0.54	Plasma plasminogen activator levels;	chr12:130811835	chr12:130810606~130812438:+
READ	cis	rs10129255	0.518	rs7143784	ENSG00000211972.2	IGHV3-66	5.16	2.5e-06	0.008	0.5	0.54	Kawasaki disease;	chr14:106687277	chr14:106675017~106675544:-
READ	cis	rs881375	0.933	rs7031096	ENSG00000226752.6	PSMD5-AS1	-5.15	2.5e-06	0.00802	-0.69	-0.54	Rheumatoid arthritis;	chr9:120932664	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs10739580	ENSG00000226752.6	PSMD5-AS1	-5.15	2.5e-06	0.00802	-0.69	-0.54	Rheumatoid arthritis;	chr9:120933004	chr9:120824828~120854385:+
READ	cis	rs9487094	0.643	rs730089	ENSG00000260273.1	RP11-425D10.10	5.15	2.5e-06	0.00802	0.65	0.54	Height;	chr6:109393881	chr6:109382795~109383666:+
READ	cis	rs10129255	0.957	rs1024349	ENSG00000211972.2	IGHV3-66	5.15	2.51e-06	0.00804	0.51	0.54	Kawasaki disease;	chr14:106689997	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs2013423	ENSG00000211972.2	IGHV3-66	5.15	2.51e-06	0.00804	0.51	0.54	Kawasaki disease;	chr14:106690675	chr14:106675017~106675544:-
READ	cis	rs10129255	0.957	rs56134540	ENSG00000211972.2	IGHV3-66	5.15	2.51e-06	0.00804	0.51	0.54	Kawasaki disease;	chr14:106691290	chr14:106675017~106675544:-
READ	cis	rs6504950	0.745	rs9915913	ENSG00000275710.1	RP11-257O5.4	5.15	2.53e-06	0.00811	0.79	0.54	Breast cancer;	chr17:54920807	chr17:54964474~54964679:+
READ	cis	rs881375	0.967	rs758959	ENSG00000226752.6	PSMD5-AS1	-5.15	2.54e-06	0.00813	-0.7	-0.54	Rheumatoid arthritis;	chr9:120914421	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs876445	ENSG00000226752.6	PSMD5-AS1	-5.15	2.54e-06	0.00813	-0.7	-0.54	Rheumatoid arthritis;	chr9:120914824	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs2109895	ENSG00000226752.6	PSMD5-AS1	-5.15	2.54e-06	0.00813	-0.7	-0.54	Rheumatoid arthritis;	chr9:120915549	chr9:120824828~120854385:+
READ	cis	rs1799949	0.859	rs11657004	ENSG00000198496.9	NBR2	-5.15	2.55e-06	0.00814	-0.61	-0.54	Menopause (age at onset);	chr17:43365383	chr17:43125610~43153671:+
READ	cis	rs1799949	0.931	rs34474989	ENSG00000198496.9	NBR2	-5.15	2.55e-06	0.00814	-0.61	-0.54	Menopause (age at onset);	chr17:43368042	chr17:43125610~43153671:+
READ	cis	rs7208859	0.673	rs2470251	ENSG00000263531.1	RP13-753N3.1	5.15	2.56e-06	0.00816	0.91	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30768043	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs11652370	ENSG00000263531.1	RP13-753N3.1	5.15	2.56e-06	0.00816	0.91	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30770205	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs56846352	ENSG00000263531.1	RP13-753N3.1	5.15	2.56e-06	0.00816	0.91	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792170	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs7211776	ENSG00000263531.1	RP13-753N3.1	5.15	2.56e-06	0.00816	0.91	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30793178	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9912122	ENSG00000263531.1	RP13-753N3.1	5.15	2.56e-06	0.00816	0.91	0.54	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813698	chr17:30863921~30864940:-
READ	cis	rs11155671	0.53	rs9968871	ENSG00000231760.4	RP11-350J20.5	5.15	2.56e-06	0.00816	0.72	0.54	Testicular germ cell tumor;	chr6:149888060	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9969044	ENSG00000231760.4	RP11-350J20.5	5.15	2.56e-06	0.00816	0.72	0.54	Testicular germ cell tumor;	chr6:149888068	chr6:149796151~149826294:-
READ	cis	rs17301013	0.606	rs727912	ENSG00000227373.4	RP11-160H22.5	5.15	2.57e-06	0.00819	0.81	0.54	Systemic lupus erythematosus;	chr1:174132729	chr1:174115300~174160004:-
READ	cis	rs9322193	0.962	rs7818	ENSG00000216906.2	RP11-350J20.9	5.15	2.59e-06	0.00825	0.69	0.54	Lung cancer;	chr6:149810956	chr6:149904243~149906418:+
READ	cis	rs7429990	0.965	rs4858880	ENSG00000229759.1	MRPS18AP1	-5.15	2.59e-06	0.00826	-0.61	-0.54	Educational attainment (years of education);	chr3:48062959	chr3:48256350~48256938:-
READ	cis	rs9322193	0.923	rs10872644	ENSG00000268592.3	RAET1E-AS1	5.14	2.6e-06	0.00828	0.67	0.53	Lung cancer;	chr6:149741819	chr6:149863494~149919507:+
READ	cis	rs977987	0.735	rs166013	ENSG00000261783.1	RP11-252K23.2	5.14	2.61e-06	0.0083	0.75	0.53	Dupuytren's disease;	chr16:75400248	chr16:75379818~75381260:-
READ	cis	rs7301826	0.58	rs12821464	ENSG00000256250.1	RP11-989F5.1	5.14	2.62e-06	0.00833	0.5	0.53	Plasma plasminogen activator levels;	chr12:130838174	chr12:130810606~130812438:+
READ	cis	rs9322193	0.884	rs9371201	ENSG00000268592.3	RAET1E-AS1	5.14	2.62e-06	0.00834	0.69	0.53	Lung cancer;	chr6:149823865	chr6:149863494~149919507:+
READ	cis	rs9487094	0.666	rs9480958	ENSG00000260273.1	RP11-425D10.10	-5.14	2.62e-06	0.00834	-0.65	-0.53	Height;	chr6:109432968	chr6:109382795~109383666:+
READ	cis	rs916888	0.61	rs199436	ENSG00000214401.4	KANSL1-AS1	-5.14	2.63e-06	0.00836	-0.83	-0.53	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46711919	chr17:46193576~46196723:+
READ	cis	rs10129255	0.5	rs1024350	ENSG00000211972.2	IGHV3-66	5.14	2.64e-06	0.0084	0.5	0.53	Kawasaki disease;	chr14:106685105	chr14:106675017~106675544:-
READ	cis	rs2006771	0.846	rs6518754	ENSG00000236132.1	CTA-440B3.1	-5.14	2.67e-06	0.00849	-0.64	-0.53	Nonsyndromic cleft lip with cleft palate;	chr22:31701789	chr22:31816379~31817491:-
READ	cis	rs6504950	0.8	rs7209926	ENSG00000275710.1	RP11-257O5.4	-5.14	2.68e-06	0.00852	-0.74	-0.53	Breast cancer;	chr17:54928963	chr17:54964474~54964679:+
READ	cis	rs9545047	0.901	rs1212082	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79552633	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs2760102	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79555193	chr13:79566727~79571436:+
READ	cis	rs9601248	0.508	rs9601240	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Major depressive disorder;	chr13:79558238	chr13:79566727~79571436:+
READ	cis	rs9545047	0.837	rs9601242	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79561543	chr13:79566727~79571436:+
READ	cis	rs9545047	0.901	rs73235963	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79562805	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs2484343	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79563587	chr13:79566727~79571436:+
READ	cis	rs9545047	0.868	rs2476173	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79565740	chr13:79566727~79571436:+
READ	cis	rs9545047	0.868	rs1208049	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Schizophrenia;	chr13:79570220	chr13:79566727~79571436:+
READ	cis	rs9601248	0.529	rs2783126	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Major depressive disorder;	chr13:79584566	chr13:79566727~79571436:+
READ	cis	rs9601248	0.529	rs9545142	ENSG00000227676.3	LINC01068	5.13	2.72e-06	0.00862	0.62	0.53	Major depressive disorder;	chr13:79588420	chr13:79566727~79571436:+
READ	cis	rs7208859	0.573	rs73267873	ENSG00000263531.1	RP13-753N3.1	5.13	2.73e-06	0.00862	0.87	0.53	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30741439	chr17:30863921~30864940:-
READ	cis	rs17826219	0.561	rs4085382	ENSG00000263531.1	RP13-753N3.1	5.13	2.73e-06	0.00862	0.87	0.53	Body mass index;	chr17:30744184	chr17:30863921~30864940:-
READ	cis	rs526231	0.667	rs187580	ENSG00000175749.11	EIF3KP1	5.13	2.74e-06	0.00866	0.76	0.53	Primary biliary cholangitis;	chr5:103291654	chr5:103032376~103033031:+
READ	cis	rs77204473	0.557	rs9971422	ENSG00000254851.1	RP11-109L13.1	5.13	2.75e-06	0.00867	1.02	0.53	Sum eosinophil basophil counts;Eosinophil counts;	chr11:116966657	chr11:117135528~117138582:+
READ	cis	rs148406912	1	rs148406912	ENSG00000254851.1	RP11-109L13.1	5.13	2.75e-06	0.00867	1.02	0.53	Lobe attachment (rater-scored or self-reported);	chr11:116967001	chr11:117135528~117138582:+
READ	cis	rs12280210	0.557	rs11216225	ENSG00000254851.1	RP11-109L13.1	5.13	2.75e-06	0.00867	1.02	0.53	Lobe attachment (rater-scored or self-reported);	chr11:117007298	chr11:117135528~117138582:+
READ	cis	rs12280210	0.557	rs7112937	ENSG00000254851.1	RP11-109L13.1	5.13	2.75e-06	0.00867	1.02	0.53	Lobe attachment (rater-scored or self-reported);	chr11:117009740	chr11:117135528~117138582:+
READ	cis	rs77204473	0.549	rs12280210	ENSG00000254851.1	RP11-109L13.1	5.13	2.75e-06	0.00867	1.02	0.53	Sum eosinophil basophil counts;Eosinophil counts;	chr11:117069733	chr11:117135528~117138582:+
READ	cis	rs35160687	0.901	rs12478653	ENSG00000273080.1	RP11-301O19.1	-5.13	2.76e-06	0.00869	-0.6	-0.53	Night sleep phenotypes;	chr2:86308271	chr2:86195590~86196049:+
READ	cis	rs858239	0.932	rs199355	ENSG00000230658.1	KLHL7-AS1	5.13	2.77e-06	0.00872	0.71	0.53	Cerebrospinal fluid biomarker levels;	chr7:23256914	chr7:23101228~23105703:-
READ	cis	rs9309473	0.95	rs6705977	ENSG00000163016.8	ALMS1P	5.13	2.78e-06	0.00875	0.79	0.53	Metabolite levels;	chr2:73622043	chr2:73644919~73685576:+
READ	cis	rs7208859	0.623	rs7214570	ENSG00000263531.1	RP13-753N3.1	5.13	2.78e-06	0.00875	0.86	0.53	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30820146	chr17:30863921~30864940:-
READ	cis	rs17264034	1	rs17263917	ENSG00000250786.1	SNHG18	5.13	2.78e-06	0.00875	0.79	0.53	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9552226	chr5:9546200~9550609:+
READ	cis	rs17264034	0.861	rs55891419	ENSG00000250786.1	SNHG18	5.13	2.78e-06	0.00875	0.79	0.53	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9553468	chr5:9546200~9550609:+
READ	cis	rs7429990	0.864	rs319693	ENSG00000229759.1	MRPS18AP1	5.13	2.79e-06	0.00877	0.61	0.53	Educational attainment (years of education);	chr3:47845090	chr3:48256350~48256938:-
READ	cis	rs997154	0.579	rs12889177	ENSG00000279656.1	RP11-298I3.6	-5.13	2.8e-06	0.00879	-0.83	-0.53	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);	chr14:23022120	chr14:23023083~23024217:-
READ	cis	rs881375	1	rs10117059	ENSG00000226752.6	PSMD5-AS1	-5.12	2.8e-06	0.0088	-0.7	-0.53	Rheumatoid arthritis;	chr9:120891199	chr9:120824828~120854385:+
READ	cis	rs9487094	0.689	rs1074766	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109360263	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs9487070	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109361200	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs8465	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109367335	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs974034	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109368228	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs3818933	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109370741	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs9487076	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109371524	chr6:109382795~109383666:+
READ	cis	rs9487094	0.696	rs1853330	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109375548	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs1885691	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109382188	chr6:109382795~109383666:+
READ	cis	rs9487094	0.644	rs3757230	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109383239	chr6:109382795~109383666:+
READ	cis	rs9487094	0.644	rs3757231	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109383248	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs4946970	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109384807	chr6:109382795~109383666:+
READ	cis	rs9487094	0.62	rs6939953	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109390116	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs3757235	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109390638	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs746794	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109391534	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs736830	ENSG00000260273.1	RP11-425D10.10	5.12	2.81e-06	0.0088	0.65	0.53	Height;	chr6:109392096	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs1074765	ENSG00000260273.1	RP11-425D10.10	-5.12	2.81e-06	0.0088	-0.65	-0.53	Height;	chr6:109360458	chr6:109382795~109383666:+
READ	cis	rs6504950	0.72	rs28564882	ENSG00000275710.1	RP11-257O5.4	5.12	2.82e-06	0.00884	0.81	0.53	Breast cancer;	chr17:54912237	chr17:54964474~54964679:+
READ	cis	rs3096299	0.719	rs2911262	ENSG00000274627.1	RP11-104N10.2	5.12	2.84e-06	0.00889	0.59	0.53	Multiple myeloma (IgH translocation);	chr16:89448633	chr16:89516797~89522217:+
READ	cis	rs3096299	0.685	rs12446145	ENSG00000274627.1	RP11-104N10.2	5.12	2.84e-06	0.00889	0.59	0.53	Multiple myeloma (IgH translocation);	chr16:89476287	chr16:89516797~89522217:+
READ	cis	rs12280210	0.557	rs12284696	ENSG00000254851.1	RP11-109L13.1	5.12	2.86e-06	0.00894	1.04	0.53	Lobe attachment (rater-scored or self-reported);	chr11:117008803	chr11:117135528~117138582:+
READ	cis	rs5769707	0.933	rs2157444	ENSG00000188511.11	C22orf34	5.12	2.86e-06	0.00895	0.65	0.53	Monocyte percentage of white cells;Monocyte count;	chr22:49600644	chr22:49414524~49657542:-
READ	cis	rs7429990	0.965	rs184388	ENSG00000229759.1	MRPS18AP1	5.12	2.87e-06	0.00896	0.61	0.53	Educational attainment (years of education);	chr3:47898136	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs319696	ENSG00000229759.1	MRPS18AP1	5.12	2.87e-06	0.00896	0.61	0.53	Educational attainment (years of education);	chr3:47902371	chr3:48256350~48256938:-
READ	cis	rs7429990	0.93	rs71323371	ENSG00000229759.1	MRPS18AP1	5.12	2.87e-06	0.00896	0.61	0.53	Educational attainment (years of education);	chr3:47904327	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs34025851	ENSG00000229759.1	MRPS18AP1	5.12	2.87e-06	0.00896	0.61	0.53	Educational attainment (years of education);	chr3:47912243	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs7620736	ENSG00000229759.1	MRPS18AP1	-5.12	2.88e-06	0.00898	-0.6	-0.53	Educational attainment (years of education);	chr3:48068479	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs6791834	ENSG00000229759.1	MRPS18AP1	-5.12	2.88e-06	0.00898	-0.6	-0.53	Educational attainment (years of education);	chr3:48073598	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs35689209	ENSG00000229759.1	MRPS18AP1	-5.12	2.88e-06	0.00898	-0.6	-0.53	Educational attainment (years of education);	chr3:48078273	chr3:48256350~48256938:-
READ	cis	rs992157	1	rs4674280	ENSG00000261338.2	RP11-378A13.1	-5.12	2.88e-06	0.00899	-0.65	-0.53	Colorectal cancer;	chr2:218276735	chr2:218255319~218257366:+
READ	cis	rs17301013	0.932	rs11804941	ENSG00000227373.4	RP11-160H22.5	-5.12	2.9e-06	0.00904	-0.71	-0.53	Systemic lupus erythematosus;	chr1:174624074	chr1:174115300~174160004:-
READ	cis	rs9322193	0.884	rs2342858	ENSG00000216906.2	RP11-350J20.9	5.12	2.91e-06	0.00907	0.7	0.53	Lung cancer;	chr6:149805967	chr6:149904243~149906418:+
READ	cis	rs916888	0.779	rs199526	ENSG00000214401.4	KANSL1-AS1	-5.12	2.91e-06	0.00907	-0.77	-0.53	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46770341	chr17:46193576~46196723:+
READ	cis	rs7637701	0.517	rs3851992	ENSG00000243926.1	TIPARP-AS1	5.11	2.91e-06	0.00908	0.59	0.53	Breast cancer;	chr3:156681391	chr3:156671862~156674378:-
READ	cis	rs13068223	0.503	rs34277251	ENSG00000243926.1	TIPARP-AS1	5.11	2.91e-06	0.00908	0.59	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr3:156703736	chr3:156671862~156674378:-
READ	cis	rs732716	0.785	rs11085073	ENSG00000267980.1	AC007292.6	5.11	2.91e-06	0.00908	0.87	0.53	Mean corpuscular volume;	chr19:4375165	chr19:4363789~4364640:+
READ	cis	rs881375	0.967	rs2416806	ENSG00000226752.6	PSMD5-AS1	-5.11	2.91e-06	0.00908	-0.69	-0.53	Rheumatoid arthritis;	chr9:120928014	chr9:120824828~120854385:+
READ	cis	rs881375	0.933	rs7028641	ENSG00000226752.6	PSMD5-AS1	-5.11	2.91e-06	0.00908	-0.69	-0.53	Rheumatoid arthritis;	chr9:120928863	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs7864019	ENSG00000226752.6	PSMD5-AS1	-5.11	2.91e-06	0.00908	-0.69	-0.53	Rheumatoid arthritis;	chr9:120930590	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs10739579	ENSG00000226752.6	PSMD5-AS1	-5.11	2.91e-06	0.00908	-0.69	-0.53	Rheumatoid arthritis;	chr9:120932510	chr9:120824828~120854385:+
READ	cis	rs9322193	0.962	rs1413655	ENSG00000216906.2	RP11-350J20.9	5.11	2.91e-06	0.00908	0.73	0.53	Lung cancer;	chr6:149821815	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs9383546	ENSG00000216906.2	RP11-350J20.9	5.11	2.91e-06	0.00908	0.73	0.53	Lung cancer;	chr6:149822743	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs2151912	ENSG00000216906.2	RP11-350J20.9	5.11	2.91e-06	0.00908	0.73	0.53	Lung cancer;	chr6:149831772	chr6:149904243~149906418:+
READ	cis	rs881375	0.9	rs1930786	ENSG00000226752.6	PSMD5-AS1	-5.11	2.92e-06	0.0091	-0.69	-0.53	Rheumatoid arthritis;	chr9:120929191	chr9:120824828~120854385:+
READ	cis	rs916888	0.647	rs199449	ENSG00000214401.4	KANSL1-AS1	5.11	2.93e-06	0.00912	0.79	0.53	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46731536	chr17:46193576~46196723:+
READ	cis	rs4660456	0.913	rs2361650	ENSG00000237899.1	RP4-739H11.3	-5.11	2.95e-06	0.00919	-0.8	-0.53	Platelet count;	chr1:40764678	chr1:40669089~40687588:-
READ	cis	rs4660456	0.913	rs954654	ENSG00000237899.1	RP4-739H11.3	-5.11	2.95e-06	0.00919	-0.8	-0.53	Platelet count;	chr1:40764979	chr1:40669089~40687588:-
READ	cis	rs12594515	1	rs6493169	ENSG00000273972.1	CTD-2306A12.1	5.11	2.96e-06	0.00919	0.6	0.53	Weight;Waist circumference;	chr15:45694796	chr15:45702640~45703183:+
READ	cis	rs62229266	0.625	rs2051395	ENSG00000231106.2	LINC01436	-5.11	2.96e-06	0.00919	-0.67	-0.53	Mitral valve prolapse;	chr21:36058967	chr21:36005338~36007838:+
READ	cis	rs2882667	0.894	rs10054478	ENSG00000253404.1	AC034243.1	5.11	2.97e-06	0.00922	0.63	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr5:139018386	chr5:138744434~138753309:-
READ	cis	rs10256972	0.616	rs7806746	ENSG00000229043.2	AC091729.9	-5.11	2.97e-06	0.00923	-0.56	-0.53	Endometriosis;Longevity;	chr7:1035937	chr7:1160374~1165267:+
READ	cis	rs1075265	0.633	rs7591431	ENSG00000233266.1	HMGB1P31	5.11	2.99e-06	0.00929	0.62	0.53	Chronotype;Morning vs. evening chronotype;	chr2:53995028	chr2:54051334~54051760:+
READ	cis	rs9322193	0.923	rs3924871	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149662080	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs35961297	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149667929	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs35830138	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149668635	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs35967444	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149675588	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs62439842	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149675847	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs7767622	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149681766	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs4421206	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149682891	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs3798761	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149683643	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9322209	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149691226	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9322210	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149695440	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs11155674	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149711111	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2185352	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149714640	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs12174349	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149718012	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2297932	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149718225	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2297930	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149718360	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2297928	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149718584	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9479094	ENSG00000268592.3	RAET1E-AS1	5.11	3.01e-06	0.00931	0.65	0.53	Lung cancer;	chr6:149725083	chr6:149863494~149919507:+
READ	cis	rs17507216	0.588	rs28864981	ENSG00000278603.1	RP13-608F4.5	5.1	3.04e-06	0.00934	0.9	0.53	Excessive daytime sleepiness;	chr15:82695420	chr15:82472203~82472426:+
READ	cis	rs17507216	0.628	rs8032321	ENSG00000278603.1	RP13-608F4.5	5.1	3.04e-06	0.00934	0.9	0.53	Excessive daytime sleepiness;	chr15:82698956	chr15:82472203~82472426:+
READ	cis	rs17507216	0.628	rs8040488	ENSG00000278603.1	RP13-608F4.5	5.1	3.04e-06	0.00934	0.9	0.53	Excessive daytime sleepiness;	chr15:82699081	chr15:82472203~82472426:+
READ	cis	rs7301826	0.603	rs7975825	ENSG00000256299.1	RP11-989F5.3	-5.1	3.04e-06	0.00934	-0.53	-0.53	Plasma plasminogen activator levels;	chr12:130803899	chr12:130810821~130812622:-
READ	cis	rs916888	0.61	rs199446	ENSG00000214401.4	KANSL1-AS1	-5.1	3.06e-06	0.00936	-0.77	-0.53	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46735803	chr17:46193576~46196723:+
READ	cis	rs916888	0.61	rs199536	ENSG00000214401.4	KANSL1-AS1	-5.1	3.06e-06	0.00936	-0.77	-0.53	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46743059	chr17:46193576~46196723:+
READ	cis	rs881375	0.967	rs2239658	ENSG00000226752.6	PSMD5-AS1	-5.1	3.07e-06	0.0094	-0.66	-0.53	Rheumatoid arthritis;	chr9:120909559	chr9:120824828~120854385:+
READ	cis	rs9309473	0.615	rs62149774	ENSG00000163016.8	ALMS1P	5.1	3.08e-06	0.00942	0.85	0.53	Metabolite levels;	chr2:73560525	chr2:73644919~73685576:+
READ	cis	rs9309473	0.528	rs79799178	ENSG00000163016.8	ALMS1P	5.1	3.08e-06	0.00942	0.85	0.53	Metabolite levels;	chr2:73564108	chr2:73644919~73685576:+
READ	cis	rs67180937	0.884	rs2291832	ENSG00000272750.1	RP11-378J18.8	-5.1	3.11e-06	0.00951	-0.75	-0.53	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222653139	chr1:222658867~222661512:-
READ	cis	rs35158675	1	rs35158675	ENSG00000272750.1	RP11-378J18.8	-5.1	3.11e-06	0.00951	-0.75	-0.53	Coronary artery disease;	chr1:222656208	chr1:222658867~222661512:-
READ	cis	rs67180937	0.922	rs1133220	ENSG00000272750.1	RP11-378J18.8	-5.1	3.11e-06	0.00951	-0.75	-0.53	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222661461	chr1:222658867~222661512:-
READ	cis	rs9309473	0.948	rs7607892	ENSG00000163016.8	ALMS1P	5.1	3.12e-06	0.00951	0.75	0.53	Metabolite levels;	chr2:73591580	chr2:73644919~73685576:+
READ	cis	rs9545047	0.904	rs2760105	ENSG00000227676.3	LINC01068	5.1	3.12e-06	0.00951	0.61	0.53	Schizophrenia;	chr13:79535732	chr13:79566727~79571436:+
READ	cis	rs9425766	0.679	rs4650989	ENSG00000227373.4	RP11-160H22.5	5.1	3.12e-06	0.00951	0.73	0.53	Life satisfaction;	chr1:174289739	chr1:174115300~174160004:-
READ	cis	rs12468226	0.938	rs12463937	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202246543	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs116601501	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202274567	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs80282360	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202275121	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs76658848	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202275548	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs57571703	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202281997	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs78928733	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202283787	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs77062060	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202285639	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs116109808	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202287356	chr2:202336739~202337200:+
READ	cis	rs12468226	0.873	rs78175596	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202287993	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs74454549	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202288044	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs56684065	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202289528	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs1474001	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202290230	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs3731700	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202291213	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs114177656	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202291596	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs76664732	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202296298	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs12464254	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202301641	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs16841867	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202303512	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs16839065	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202308774	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs12471060	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202309597	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs114922024	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202315958	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs77261109	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202316233	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs12466003	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202317317	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs76501067	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202318042	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs80315897	ENSG00000272966.1	RP11-686O6.1	5.1	3.13e-06	0.00951	0.77	0.53	Urate levels;	chr2:202318044	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs4675274	ENSG00000272966.1	RP11-686O6.1	-5.1	3.13e-06	0.00951	-0.77	-0.53	Urate levels;	chr2:202243145	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs3843338	ENSG00000272966.1	RP11-686O6.1	-5.1	3.13e-06	0.00951	-0.77	-0.53	Urate levels;	chr2:202246102	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs6435139	ENSG00000272966.1	RP11-686O6.1	-5.1	3.13e-06	0.00951	-0.77	-0.53	Urate levels;	chr2:202255145	chr2:202336739~202337200:+
READ	cis	rs11155671	0.53	rs7763849	ENSG00000231760.4	RP11-350J20.5	5.09	3.15e-06	0.00958	0.69	0.53	Testicular germ cell tumor;	chr6:149885244	chr6:149796151~149826294:-
READ	cis	rs2486288	0.656	rs8041702	ENSG00000259520.4	CTD-2651B20.3	5.09	3.16e-06	0.00959	0.65	0.53	Glomerular filtration rate;	chr15:45254895	chr15:45251580~45279251:-
READ	cis	rs9425766	0.679	rs6670617	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174277574	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs4650990	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174289943	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7555067	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174297504	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6695636	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174303087	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs7512930	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174319464	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7523460	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174319664	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7552830	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174321643	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7523938	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174327373	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs6681780	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174328980	chr1:174115300~174160004:-
READ	cis	rs9425766	0.55	rs57366619	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174334929	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs17301013	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174343675	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs6693423	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174364680	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs60363188	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174375959	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12084119	ENSG00000227373.4	RP11-160H22.5	5.09	3.19e-06	0.00968	0.73	0.53	Life satisfaction;	chr1:174377138	chr1:174115300~174160004:-
READ	cis	rs9322193	0.962	rs3763163	ENSG00000216906.2	RP11-350J20.9	5.09	3.2e-06	0.00969	0.68	0.53	Lung cancer;	chr6:149819770	chr6:149904243~149906418:+
READ	cis	rs3096299	0.754	rs2965816	ENSG00000274627.1	RP11-104N10.2	-5.09	3.21e-06	0.00971	-0.57	-0.53	Multiple myeloma (IgH translocation);	chr16:89447775	chr16:89516797~89522217:+
READ	cis	rs10463554	0.824	rs60588319	ENSG00000175749.11	EIF3KP1	5.09	3.21e-06	0.00971	0.66	0.53	Parkinson's disease;	chr5:102988656	chr5:103032376~103033031:+
READ	cis	rs9322193	0.962	rs2342764	ENSG00000268592.3	RAET1E-AS1	5.09	3.21e-06	0.00971	0.67	0.53	Lung cancer;	chr6:149835068	chr6:149863494~149919507:+
READ	cis	rs2882667	0.931	rs13153618	ENSG00000253404.1	AC034243.1	5.09	3.23e-06	0.00974	0.63	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr5:139017087	chr5:138744434~138753309:-
READ	cis	rs875971	0.825	rs6951503	ENSG00000226824.5	RP4-756H11.3	5.09	3.24e-06	0.00976	0.64	0.53	Aortic root size;	chr7:66253949	chr7:66654538~66669855:+
READ	cis	rs801193	0.569	rs13242290	ENSG00000226824.5	RP4-756H11.3	5.09	3.24e-06	0.00977	0.65	0.53	Aortic root size;	chr7:66656898	chr7:66654538~66669855:+
READ	cis	rs9322193	0.962	rs3763163	ENSG00000268592.3	RAET1E-AS1	5.09	3.25e-06	0.00981	0.68	0.53	Lung cancer;	chr6:149819770	chr6:149863494~149919507:+
READ	cis	rs17608059	1	rs17608059	ENSG00000141028.6	CDRT15P1	-5.08	3.26e-06	0.00982	-0.52	-0.53	Temperament;	chr17:14007232	chr17:14024514~14025488:+
READ	cis	rs12468226	1	rs112306637	ENSG00000272966.1	RP11-686O6.1	5.08	3.28e-06	0.00988	0.81	0.53	Urate levels;	chr2:202334195	chr2:202336739~202337200:+
READ	cis	rs12468226	1	rs111252524	ENSG00000272966.1	RP11-686O6.1	5.08	3.28e-06	0.00988	0.81	0.53	Urate levels;	chr2:202334465	chr2:202336739~202337200:+
READ	cis	rs12468226	1	rs112753638	ENSG00000272966.1	RP11-686O6.1	5.08	3.28e-06	0.00988	0.81	0.53	Urate levels;	chr2:202334496	chr2:202336739~202337200:+
READ	cis	rs12468226	0.935	rs113188021	ENSG00000272966.1	RP11-686O6.1	5.08	3.28e-06	0.00988	0.81	0.53	Urate levels;	chr2:202336237	chr2:202336739~202337200:+
READ	cis	rs12468226	1	rs6731027	ENSG00000272966.1	RP11-686O6.1	5.08	3.28e-06	0.00988	0.81	0.53	Urate levels;	chr2:202337443	chr2:202336739~202337200:+
READ	cis	rs11690935	0.686	rs10165126	ENSG00000228389.1	AC068039.4	5.08	3.3e-06	0.00992	0.64	0.53	Schizophrenia;	chr2:171963793	chr2:171773482~171775844:+
READ	cis	rs17507216	0.718	rs7161977	ENSG00000278603.1	RP13-608F4.5	5.08	3.3e-06	0.00992	0.89	0.53	Excessive daytime sleepiness;	chr15:82646782	chr15:82472203~82472426:+
READ	cis	rs17507216	0.681	rs28877110	ENSG00000278603.1	RP13-608F4.5	5.08	3.3e-06	0.00992	0.89	0.53	Excessive daytime sleepiness;	chr15:82672111	chr15:82472203~82472426:+
READ	cis	rs17507216	0.609	rs1431716	ENSG00000278603.1	RP13-608F4.5	5.08	3.3e-06	0.00992	0.89	0.53	Excessive daytime sleepiness;	chr15:82676180	chr15:82472203~82472426:+
READ	cis	rs7301826	0.603	rs7975825	ENSG00000256250.1	RP11-989F5.1	-5.08	3.3e-06	0.00992	-0.49	-0.53	Plasma plasminogen activator levels;	chr12:130803899	chr12:130810606~130812438:+
READ	cis	rs10256972	0.552	rs6978842	ENSG00000229043.2	AC091729.9	-5.08	3.32e-06	0.00992	-0.67	-0.53	Endometriosis;Longevity;	chr7:1164963	chr7:1160374~1165267:+
READ	cis	rs67180937	0.961	rs17163358	ENSG00000272750.1	RP11-378J18.8	-5.08	3.32e-06	0.00993	-0.76	-0.53	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222647297	chr1:222658867~222661512:-
READ	cis	rs7301826	0.585	rs6486600	ENSG00000256299.1	RP11-989F5.3	-5.08	3.33e-06	0.00995	-0.53	-0.53	Plasma plasminogen activator levels;	chr12:130808432	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs4334059	ENSG00000256299.1	RP11-989F5.3	-5.08	3.33e-06	0.00995	-0.53	-0.53	Plasma plasminogen activator levels;	chr12:130829669	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs34103763	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130805604	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs36051740	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130808177	chr12:130810821~130812622:-
READ	cis	rs7301826	0.61	rs7961690	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130812335	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs6486601	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130816692	chr12:130810821~130812622:-
READ	cis	rs7301826	0.627	rs61937256	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130818100	chr12:130810821~130812622:-
READ	cis	rs7301826	0.651	rs7299281	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130818587	chr12:130810821~130812622:-
READ	cis	rs7301826	0.56	rs12829294	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130825427	chr12:130810821~130812622:-
READ	cis	rs7301826	0.58	rs61938969	ENSG00000256299.1	RP11-989F5.3	5.08	3.33e-06	0.00995	0.53	0.53	Plasma plasminogen activator levels;	chr12:130831525	chr12:130810821~130812622:-
READ	cis	rs372883	0.564	rs766928	ENSG00000232118.2	BACH1-AS1	-5.08	3.33e-06	0.00995	-0.66	-0.53	Pancreatic cancer;	chr21:29381286	chr21:29370019~29376339:-
READ	cis	rs62229266	0.804	rs62230788	ENSG00000231106.2	LINC01436	5.08	3.33e-06	0.00996	0.68	0.53	Mitral valve prolapse;	chr21:36008039	chr21:36005338~36007838:+
READ	cis	rs11105298	0.891	rs11105318	ENSG00000258302.2	RP11-981P6.1	5.08	3.34e-06	0.00998	0.68	0.53	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89532881	chr12:89561129~89594878:+
READ	cis	rs6095360	1	rs2295027	ENSG00000278231.1	RP5-906C1.1	-5.08	3.36e-06	0.01	-0.77	-0.53	Intelligence (multi-trait analysis);	chr20:48966347	chr20:48821688~48849458:-
READ	cis	rs6095360	0.966	rs6019557	ENSG00000278231.1	RP5-906C1.1	-5.08	3.36e-06	0.01	-0.77	-0.53	Intelligence (multi-trait analysis);	chr20:48966835	chr20:48821688~48849458:-
READ	cis	rs6095360	1	rs6019558	ENSG00000278231.1	RP5-906C1.1	-5.08	3.36e-06	0.01	-0.77	-0.53	Intelligence (multi-trait analysis);	chr20:48966943	chr20:48821688~48849458:-
READ	cis	rs17301013	0.932	rs6425281	ENSG00000227373.4	RP11-160H22.5	5.08	3.38e-06	0.0101	0.72	0.53	Systemic lupus erythematosus;	chr1:174449784	chr1:174115300~174160004:-
READ	cis	rs79040073	0.765	rs7169304	ENSG00000259531.2	RP11-295H24.3	5.07	3.4e-06	0.0101	0.77	0.53	Lung cancer in ever smokers;	chr15:49186829	chr15:49365124~49366685:-
READ	cis	rs732716	0.785	rs34080966	ENSG00000267980.1	AC007292.6	5.07	3.41e-06	0.0102	0.85	0.53	Mean corpuscular volume;	chr19:4417848	chr19:4363789~4364640:+
READ	cis	rs9322193	0.847	rs12210605	ENSG00000268592.3	RAET1E-AS1	5.07	3.43e-06	0.0102	0.68	0.53	Lung cancer;	chr6:149817267	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9371199	ENSG00000268592.3	RAET1E-AS1	5.07	3.43e-06	0.0102	0.68	0.53	Lung cancer;	chr6:149817526	chr6:149863494~149919507:+
READ	cis	rs2486288	0.656	rs1706768	ENSG00000259520.4	CTD-2651B20.3	5.07	3.44e-06	0.0103	0.66	0.53	Glomerular filtration rate;	chr15:45277245	chr15:45251580~45279251:-
READ	cis	rs3096299	0.685	rs2911244	ENSG00000274627.1	RP11-104N10.2	5.07	3.45e-06	0.0103	0.58	0.53	Multiple myeloma (IgH translocation);	chr16:89455452	chr16:89516797~89522217:+
READ	cis	rs12468226	1	rs16839077	ENSG00000272966.1	RP11-686O6.1	5.07	3.47e-06	0.0103	0.81	0.53	Urate levels;	chr2:202343970	chr2:202336739~202337200:+
READ	cis	rs526231	0.697	rs253754	ENSG00000175749.11	EIF3KP1	5.07	3.47e-06	0.0103	0.71	0.53	Primary biliary cholangitis;	chr5:103296261	chr5:103032376~103033031:+
READ	cis	rs13068223	0.568	rs7636965	ENSG00000243926.1	TIPARP-AS1	5.07	3.49e-06	0.0104	0.63	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr3:156700615	chr3:156671862~156674378:-
READ	cis	rs2455601	0.671	rs2568091	ENSG00000254860.4	TMEM9B-AS1	5.07	3.5e-06	0.0104	0.82	0.53	Schizophrenia;	chr11:8964501	chr11:8964675~8977527:+
READ	cis	rs12468226	0.938	rs79117531	ENSG00000272966.1	RP11-686O6.1	5.07	3.5e-06	0.0104	0.77	0.53	Urate levels;	chr2:202307690	chr2:202336739~202337200:+
READ	cis	rs17301013	0.531	rs6678286	ENSG00000227373.4	RP11-160H22.5	5.07	3.5e-06	0.0104	0.8	0.53	Systemic lupus erythematosus;	chr1:174200481	chr1:174115300~174160004:-
READ	cis	rs12468226	0.882	rs116437099	ENSG00000272966.1	RP11-686O6.1	5.07	3.5e-06	0.0104	0.77	0.53	Urate levels;	chr2:202299250	chr2:202336739~202337200:+
READ	cis	rs17507216	0.718	rs4779033	ENSG00000278603.1	RP13-608F4.5	-5.06	3.55e-06	0.0105	-0.92	-0.53	Excessive daytime sleepiness;	chr15:82576634	chr15:82472203~82472426:+
READ	cis	rs10129255	0.957	rs12590667	ENSG00000211972.2	IGHV3-66	-5.06	3.58e-06	0.0106	-0.49	-0.53	Kawasaki disease;	chr14:106779223	chr14:106675017~106675544:-
READ	cis	rs17301013	0.606	rs72711443	ENSG00000227373.4	RP11-160H22.5	5.06	3.59e-06	0.0106	0.8	0.53	Systemic lupus erythematosus;	chr1:174090876	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912728	ENSG00000227373.4	RP11-160H22.5	5.06	3.59e-06	0.0106	0.8	0.53	Systemic lupus erythematosus;	chr1:174093234	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4652168	ENSG00000227373.4	RP11-160H22.5	5.06	3.59e-06	0.0106	0.8	0.53	Systemic lupus erythematosus;	chr1:174095077	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs28831202	ENSG00000227373.4	RP11-160H22.5	5.06	3.59e-06	0.0106	0.8	0.53	Systemic lupus erythematosus;	chr1:174099231	chr1:174115300~174160004:-
READ	cis	rs2882667	0.931	rs10075951	ENSG00000253404.1	AC034243.1	5.06	3.6e-06	0.0106	0.63	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr5:139020274	chr5:138744434~138753309:-
READ	cis	rs6095360	0.87	rs1569749	ENSG00000278231.1	RP5-906C1.1	-5.06	3.6e-06	0.0106	-0.76	-0.53	Intelligence (multi-trait analysis);	chr20:48984972	chr20:48821688~48849458:-
READ	cis	rs7637701	0.517	rs66538320	ENSG00000243926.1	TIPARP-AS1	5.05	3.65e-06	0.0108	0.6	0.53	Breast cancer;	chr3:156674346	chr3:156671862~156674378:-
READ	cis	rs7301826	0.585	rs6486600	ENSG00000256250.1	RP11-989F5.1	-5.05	3.71e-06	0.0109	-0.49	-0.53	Plasma plasminogen activator levels;	chr12:130808432	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs4334059	ENSG00000256250.1	RP11-989F5.1	-5.05	3.71e-06	0.0109	-0.49	-0.53	Plasma plasminogen activator levels;	chr12:130829669	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs34103763	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130805604	chr12:130810606~130812438:+
READ	cis	rs7301826	0.61	rs36051740	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130808177	chr12:130810606~130812438:+
READ	cis	rs7301826	0.61	rs7961690	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130812335	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs6486601	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130816692	chr12:130810606~130812438:+
READ	cis	rs7301826	0.627	rs61937256	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130818100	chr12:130810606~130812438:+
READ	cis	rs7301826	0.651	rs7299281	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130818587	chr12:130810606~130812438:+
READ	cis	rs7301826	0.56	rs12829294	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130825427	chr12:130810606~130812438:+
READ	cis	rs7301826	0.58	rs61938969	ENSG00000256250.1	RP11-989F5.1	5.05	3.71e-06	0.0109	0.49	0.53	Plasma plasminogen activator levels;	chr12:130831525	chr12:130810606~130812438:+
READ	cis	rs4718428	1	rs4718428	ENSG00000226824.5	RP4-756H11.3	-5.05	3.72e-06	0.0109	-0.7	-0.53	Corneal structure;	chr7:66956459	chr7:66654538~66669855:+
READ	cis	rs748404	0.56	rs689797	ENSG00000249839.1	AC011330.5	-5.05	3.72e-06	0.0109	-0.64	-0.53	Lung cancer;	chr15:43534359	chr15:43663654~43684339:-
READ	cis	rs11155671	0.53	rs9968871	ENSG00000268592.3	RAET1E-AS1	5.05	3.73e-06	0.0109	0.67	0.53	Testicular germ cell tumor;	chr6:149888060	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9969044	ENSG00000268592.3	RAET1E-AS1	5.05	3.73e-06	0.0109	0.67	0.53	Testicular germ cell tumor;	chr6:149888068	chr6:149863494~149919507:+
READ	cis	rs2882667	0.931	rs10077896	ENSG00000253404.1	AC034243.1	5.05	3.73e-06	0.0109	0.63	0.53	Age-related hearing impairment (SNP x SNP interaction);	chr5:139021067	chr5:138744434~138753309:-
READ	cis	rs13113518	0.812	rs12500456	ENSG00000223305.1	RN7SKP30	5.05	3.75e-06	0.0109	0.63	0.53	Height;	chr4:55561053	chr4:55540502~55540835:-
READ	cis	rs6504950	0.72	rs2877634	ENSG00000275710.1	RP11-257O5.4	5.05	3.76e-06	0.0109	0.75	0.53	Breast cancer;	chr17:54910184	chr17:54964474~54964679:+
READ	cis	rs6504950	0.705	rs9899602	ENSG00000275710.1	RP11-257O5.4	-5.05	3.76e-06	0.0109	-0.75	-0.53	Breast cancer;	chr17:54909547	chr17:54964474~54964679:+
READ	cis	rs2111504	0.583	rs2868082	ENSG00000267213.4	AC007773.2	5.05	3.77e-06	0.0109	0.67	0.53	Bipolar disorder;	chr19:32368475	chr19:32390050~32405560:-
READ	cis	rs17301013	0.932	rs6425280	ENSG00000227373.4	RP11-160H22.5	5.05	3.77e-06	0.0109	0.7	0.53	Systemic lupus erythematosus;	chr1:174422186	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6664764	ENSG00000227373.4	RP11-160H22.5	5.05	3.77e-06	0.0109	0.7	0.53	Systemic lupus erythematosus;	chr1:174443402	chr1:174115300~174160004:-
READ	cis	rs5760092	0.755	rs5760096	ENSG00000218537.1	MIF-AS1	5.05	3.77e-06	0.0109	0.64	0.53	Urinary 1,3-butadiene metabolite levels in smokers;	chr22:23905123	chr22:23894426~23898930:-
READ	cis	rs17507216	0.628	rs4627310	ENSG00000278603.1	RP13-608F4.5	5.05	3.77e-06	0.0109	0.89	0.53	Excessive daytime sleepiness;	chr15:82708330	chr15:82472203~82472426:+
READ	cis	rs17507216	0.628	rs4513065	ENSG00000278603.1	RP13-608F4.5	5.05	3.77e-06	0.0109	0.89	0.53	Excessive daytime sleepiness;	chr15:82712096	chr15:82472203~82472426:+
READ	cis	rs17507216	0.628	rs28371837	ENSG00000278603.1	RP13-608F4.5	5.05	3.77e-06	0.0109	0.89	0.53	Excessive daytime sleepiness;	chr15:82714435	chr15:82472203~82472426:+
READ	cis	rs17507216	0.628	rs28607761	ENSG00000278603.1	RP13-608F4.5	5.05	3.77e-06	0.0109	0.89	0.53	Excessive daytime sleepiness;	chr15:82715317	chr15:82472203~82472426:+
READ	cis	rs1577917	0.958	rs2225754	ENSG00000203875.9	SNHG5	-5.05	3.79e-06	0.011	-0.71	-0.53	Response to antipsychotic treatment;	chr6:85739980	chr6:85660950~85678736:-
READ	cis	rs10129255	0.912	rs67410411	ENSG00000211972.2	IGHV3-66	5.04	3.8e-06	0.011	0.5	0.53	Kawasaki disease;	chr14:106680324	chr14:106675017~106675544:-
READ	cis	rs11155671	0.53	rs9371544	ENSG00000268592.3	RAET1E-AS1	5.04	3.8e-06	0.011	0.68	0.53	Testicular germ cell tumor;	chr6:149896224	chr6:149863494~149919507:+
READ	cis	rs12439619	0.508	rs8023960	ENSG00000278603.1	RP13-608F4.5	5.04	3.8e-06	0.011	0.68	0.53	Intelligence (multi-trait analysis);	chr15:82206704	chr15:82472203~82472426:+
READ	cis	rs9425766	0.679	rs4652234	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174181712	chr1:174115300~174160004:-
READ	cis	rs9425766	0.732	rs6658543	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174183338	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs9787001	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174222556	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs972361	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174228270	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6667267	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174243623	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs2064149	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Life satisfaction;	chr1:174255856	chr1:174115300~174160004:-
READ	cis	rs17301013	0.965	rs7548540	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Systemic lupus erythematosus;	chr1:174411672	chr1:174115300~174160004:-
READ	cis	rs17301013	0.965	rs2179214	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Systemic lupus erythematosus;	chr1:174413954	chr1:174115300~174160004:-
READ	cis	rs17301013	0.93	rs7523263	ENSG00000227373.4	RP11-160H22.5	5.04	3.81e-06	0.011	0.7	0.53	Systemic lupus erythematosus;	chr1:174414542	chr1:174115300~174160004:-
READ	cis	rs11105298	1	rs11105298	ENSG00000258302.2	RP11-981P6.1	-5.04	3.82e-06	0.0111	-0.65	-0.53	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89482366	chr12:89561129~89594878:+
READ	cis	rs9322193	0.962	rs6899661	ENSG00000268592.3	RAET1E-AS1	5.04	3.83e-06	0.0111	0.7	0.53	Lung cancer;	chr6:149818093	chr6:149863494~149919507:+
READ	cis	rs2929278	0.617	rs524908	ENSG00000249839.1	AC011330.5	5.04	3.85e-06	0.0111	0.7	0.53	Schizophrenia;	chr15:43895793	chr15:43663654~43684339:-
READ	cis	rs9322193	0.926	rs9766562	ENSG00000216906.2	RP11-350J20.9	5.04	3.85e-06	0.0111	0.68	0.53	Lung cancer;	chr6:149788709	chr6:149904243~149906418:+
READ	cis	rs9309473	0.718	rs10175529	ENSG00000163016.8	ALMS1P	5.04	3.87e-06	0.0112	0.65	0.53	Metabolite levels;	chr2:73378965	chr2:73644919~73685576:+
READ	cis	rs12468226	0.873	rs60722019	ENSG00000272966.1	RP11-686O6.1	5.04	3.87e-06	0.0112	0.71	0.53	Urate levels;	chr2:202282060	chr2:202336739~202337200:+
READ	cis	rs1577917	0.958	rs10944136	ENSG00000203875.9	SNHG5	-5.04	3.88e-06	0.0112	-0.69	-0.53	Response to antipsychotic treatment;	chr6:85738781	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs9647601	ENSG00000203875.9	SNHG5	-5.04	3.88e-06	0.0112	-0.69	-0.53	Response to antipsychotic treatment;	chr6:85740109	chr6:85660950~85678736:-
READ	cis	rs9487094	0.666	rs7748669	ENSG00000260273.1	RP11-425D10.10	5.04	3.89e-06	0.0112	0.65	0.53	Height;	chr6:109424139	chr6:109382795~109383666:+
READ	cis	rs3931020	0.53	rs6668736	ENSG00000272864.1	RP11-17E13.2	-5.04	3.9e-06	0.0112	-0.64	-0.53	Resistin levels;	chr1:74768866	chr1:74698769~74699333:-
READ	cis	rs4660456	0.913	rs2361651	ENSG00000237899.1	RP4-739H11.3	5.04	3.91e-06	0.0113	0.83	0.53	Platelet count;	chr1:40764542	chr1:40669089~40687588:-
READ	cis	rs12594515	0.967	rs11857628	ENSG00000273972.1	CTD-2306A12.1	-5.04	3.92e-06	0.0113	-0.6	-0.53	Weight;Waist circumference;	chr15:45706008	chr15:45702640~45703183:+
READ	cis	rs17301013	0.581	rs1591944	ENSG00000227373.4	RP11-160H22.5	5.04	3.93e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174204917	chr1:174115300~174160004:-
READ	cis	rs9660180	0.846	rs10907195	ENSG00000231050.1	RP1-140A9.1	-5.03	3.94e-06	0.0113	-0.66	-0.53	Body mass index;	chr1:1781909	chr1:1891471~1892658:+
READ	cis	rs17301013	0.606	rs4233169	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174118986	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1853321	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174125295	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6694208	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174127631	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4650950	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174134264	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4650951	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174134368	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4652191	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174135473	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6676161	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174138555	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6670425	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174144204	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs6685499	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174144237	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4652193	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174144554	chr1:174115300~174160004:-
READ	cis	rs17301013	0.632	rs12079214	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174149572	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12065785	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174151296	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs16846717	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174152180	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs16846718	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174152782	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912735	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174159002	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12354141	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174166078	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs3086	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174167236	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12082461	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174169876	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912737	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174172999	chr1:174115300~174160004:-
READ	cis	rs17301013	0.531	rs12079687	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174175545	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12087808	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174178848	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912740	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174180224	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs724888	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174180403	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7547766	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174180977	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs72711487	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174189002	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912746	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174210205	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6692437	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174213771	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs2103640	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174219147	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs56338048	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174220266	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs11802158	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174223973	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs12081445	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174226923	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12079689	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174240514	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7535987	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174240840	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs7551605	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174245718	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs12080977	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174247026	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs72713503	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174247553	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs16846816	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174251602	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912750	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174253637	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs12083540	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174254096	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12085311	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174256097	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912751	ENSG00000227373.4	RP11-160H22.5	5.03	3.95e-06	0.0113	0.8	0.53	Systemic lupus erythematosus;	chr1:174262992	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs724889	ENSG00000227373.4	RP11-160H22.5	-5.03	3.95e-06	0.0113	-0.8	-0.53	Systemic lupus erythematosus;	chr1:174180326	chr1:174115300~174160004:-
READ	cis	rs6504950	0.745	rs35079296	ENSG00000275710.1	RP11-257O5.4	5.03	3.95e-06	0.0113	0.76	0.53	Breast cancer;	chr17:54916849	chr17:54964474~54964679:+
READ	cis	rs17507216	0.718	rs28587782	ENSG00000278603.1	RP13-608F4.5	5.03	3.97e-06	0.0114	0.91	0.53	Excessive daytime sleepiness;	chr15:82576881	chr15:82472203~82472426:+
READ	cis	rs7429990	0.864	rs11712464	ENSG00000229759.1	MRPS18AP1	5.03	3.97e-06	0.0114	0.61	0.53	Educational attainment (years of education);	chr3:47724057	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs56376646	ENSG00000229759.1	MRPS18AP1	5.03	3.97e-06	0.0114	0.61	0.53	Educational attainment (years of education);	chr3:47732588	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs11927129	ENSG00000229759.1	MRPS18AP1	5.03	3.97e-06	0.0114	0.61	0.53	Educational attainment (years of education);	chr3:47745413	chr3:48256350~48256938:-
READ	cis	rs7429990	0.828	rs55823596	ENSG00000229759.1	MRPS18AP1	5.03	3.97e-06	0.0114	0.61	0.53	Educational attainment (years of education);	chr3:47758541	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs4858853	ENSG00000229759.1	MRPS18AP1	5.03	3.97e-06	0.0114	0.61	0.53	Educational attainment (years of education);	chr3:47760605	chr3:48256350~48256938:-
READ	cis	rs7429990	0.803	rs6776963	ENSG00000229759.1	MRPS18AP1	-5.03	3.97e-06	0.0114	-0.61	-0.53	Educational attainment (years of education);	chr3:47789251	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs4858863	ENSG00000229759.1	MRPS18AP1	-5.03	3.97e-06	0.0114	-0.61	-0.53	Educational attainment (years of education);	chr3:47814143	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7629850	ENSG00000229759.1	MRPS18AP1	-5.03	3.97e-06	0.0114	-0.61	-0.53	Educational attainment (years of education);	chr3:47815592	chr3:48256350~48256938:-
READ	cis	rs12594515	0.967	rs11854477	ENSG00000273972.1	CTD-2306A12.1	-5.03	3.99e-06	0.0114	-0.6	-0.53	Weight;Waist circumference;	chr15:45706147	chr15:45702640~45703183:+
READ	cis	rs35160687	0.901	rs6714362	ENSG00000273080.1	RP11-301O19.1	-5.03	3.99e-06	0.0114	-0.62	-0.53	Night sleep phenotypes;	chr2:86249465	chr2:86195590~86196049:+
READ	cis	rs748404	0.56	rs1869258	ENSG00000249839.1	AC011330.5	-5.03	3.99e-06	0.0114	-0.65	-0.53	Lung cancer;	chr15:43511423	chr15:43663654~43684339:-
READ	cis	rs748404	0.56	rs529611	ENSG00000249839.1	AC011330.5	-5.03	3.99e-06	0.0114	-0.65	-0.53	Lung cancer;	chr15:43513790	chr15:43663654~43684339:-
READ	cis	rs17301013	0.606	rs4650939	ENSG00000227373.4	RP11-160H22.5	5.03	4e-06	0.0114	0.8	0.53	Systemic lupus erythematosus;	chr1:174096823	chr1:174115300~174160004:-
READ	cis	rs732716	0.785	rs56272533	ENSG00000267980.1	AC007292.6	-5.03	4e-06	0.0114	-0.84	-0.53	Mean corpuscular volume;	chr19:4420045	chr19:4363789~4364640:+
READ	cis	rs10256972	0.577	rs2949179	ENSG00000229043.2	AC091729.9	-5.03	4.01e-06	0.0114	-0.67	-0.53	Endometriosis;Longevity;	chr7:1170249	chr7:1160374~1165267:+
READ	cis	rs10256972	0.504	rs2949178	ENSG00000229043.2	AC091729.9	-5.03	4.01e-06	0.0114	-0.67	-0.53	Endometriosis;Longevity;	chr7:1170289	chr7:1160374~1165267:+
READ	cis	rs2929278	0.736	rs2412823	ENSG00000249839.1	AC011330.5	5.03	4.03e-06	0.0115	0.68	0.53	Schizophrenia;	chr15:43935072	chr15:43663654~43684339:-
READ	cis	rs9487094	0.67	rs12192268	ENSG00000260273.1	RP11-425D10.10	5.03	4.03e-06	0.0115	0.64	0.53	Height;	chr6:109690255	chr6:109382795~109383666:+
READ	cis	rs1799949	0.827	rs74252763	ENSG00000198496.9	NBR2	-5.03	4.05e-06	0.0115	-0.63	-0.53	Menopause (age at onset);	chr17:43324652	chr17:43125610~43153671:+
READ	cis	rs992157	1	rs2168704	ENSG00000261338.2	RP11-378A13.1	5.03	4.06e-06	0.0116	0.66	0.53	Colorectal cancer;	chr2:218277769	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs13429408	ENSG00000261338.2	RP11-378A13.1	5.03	4.06e-06	0.0116	0.66	0.53	Colorectal cancer;	chr2:218278137	chr2:218255319~218257366:+
READ	cis	rs7937890	1	rs2970335	ENSG00000254418.1	RP11-21L19.1	5.02	4.09e-06	0.0116	0.63	0.53	Mitochondrial DNA levels;	chr11:14303855	chr11:14262846~14273691:-
READ	cis	rs17301013	0.932	rs444678	ENSG00000227373.4	RP11-160H22.5	5.02	4.11e-06	0.0117	0.69	0.53	Systemic lupus erythematosus;	chr1:174706080	chr1:174115300~174160004:-
READ	cis	rs17301013	0.896	rs332791	ENSG00000227373.4	RP11-160H22.5	5.02	4.11e-06	0.0117	0.69	0.53	Systemic lupus erythematosus;	chr1:174709784	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs332795	ENSG00000227373.4	RP11-160H22.5	5.02	4.11e-06	0.0117	0.69	0.53	Systemic lupus erythematosus;	chr1:174726785	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs1653627	ENSG00000227373.4	RP11-160H22.5	-5.02	4.11e-06	0.0117	-0.69	-0.53	Systemic lupus erythematosus;	chr1:174771879	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs1793297	ENSG00000227373.4	RP11-160H22.5	-5.02	4.11e-06	0.0117	-0.69	-0.53	Systemic lupus erythematosus;	chr1:174784411	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs1754355	ENSG00000227373.4	RP11-160H22.5	-5.02	4.11e-06	0.0117	-0.69	-0.53	Systemic lupus erythematosus;	chr1:174807407	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs2987869	ENSG00000227373.4	RP11-160H22.5	-5.02	4.11e-06	0.0117	-0.69	-0.53	Systemic lupus erythematosus;	chr1:174820269	chr1:174115300~174160004:-
READ	cis	rs17301013	0.827	rs1793309	ENSG00000227373.4	RP11-160H22.5	-5.02	4.11e-06	0.0117	-0.69	-0.53	Systemic lupus erythematosus;	chr1:174826199	chr1:174115300~174160004:-
READ	cis	rs881375	1	rs1953126	ENSG00000226752.6	PSMD5-AS1	-5.02	4.11e-06	0.0117	-0.68	-0.53	Rheumatoid arthritis;	chr9:120878222	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs1609810	ENSG00000226752.6	PSMD5-AS1	-5.02	4.11e-06	0.0117	-0.68	-0.53	Rheumatoid arthritis;	chr9:120880073	chr9:120824828~120854385:+
READ	cis	rs6095360	0.934	rs6019582	ENSG00000278231.1	RP5-906C1.1	-5.02	4.15e-06	0.0118	-0.74	-0.53	Intelligence (multi-trait analysis);	chr20:49011068	chr20:48821688~48849458:-
READ	cis	rs992157	0.965	rs13419763	ENSG00000261338.2	RP11-378A13.1	5.02	4.18e-06	0.0119	0.66	0.53	Colorectal cancer;	chr2:218270227	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs4791	ENSG00000261338.2	RP11-378A13.1	5.02	4.18e-06	0.0119	0.66	0.53	Colorectal cancer;	chr2:218274217	chr2:218255319~218257366:+
READ	cis	rs12439619	0.53	rs7162177	ENSG00000278603.1	RP13-608F4.5	5.01	4.24e-06	0.012	0.69	0.53	Intelligence (multi-trait analysis);	chr15:82181728	chr15:82472203~82472426:+
READ	cis	rs2929278	0.588	rs1975364	ENSG00000249839.1	AC011330.5	-5.01	4.25e-06	0.012	-0.72	-0.53	Schizophrenia;	chr15:43857991	chr15:43663654~43684339:-
READ	cis	rs2929278	0.546	rs686666	ENSG00000249839.1	AC011330.5	-5.01	4.25e-06	0.012	-0.72	-0.53	Schizophrenia;	chr15:43869352	chr15:43663654~43684339:-
READ	cis	rs2455601	0.638	rs2568092	ENSG00000254860.4	TMEM9B-AS1	-5.01	4.25e-06	0.012	-0.81	-0.53	Schizophrenia;	chr11:8965891	chr11:8964675~8977527:+
READ	cis	rs9322193	0.962	rs17673294	ENSG00000216906.2	RP11-350J20.9	5.01	4.26e-06	0.0121	0.68	0.53	Lung cancer;	chr6:149813857	chr6:149904243~149906418:+
READ	cis	rs732716	0.785	rs11666453	ENSG00000267980.1	AC007292.6	-5.01	4.29e-06	0.0121	-0.86	-0.53	Mean corpuscular volume;	chr19:4368800	chr19:4363789~4364640:+
READ	cis	rs9322193	0.923	rs4869750	ENSG00000268592.3	RAET1E-AS1	5.01	4.31e-06	0.0122	0.66	0.52	Lung cancer;	chr6:149855996	chr6:149863494~149919507:+
READ	cis	rs6844153	0.752	rs12644073	ENSG00000240005.4	RP11-293A21.1	-5.01	4.32e-06	0.0122	-0.67	-0.52	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26895436	chr4:26859806~26860599:-
READ	cis	rs11155671	0.53	rs2342770	ENSG00000268592.3	RAET1E-AS1	5.01	4.33e-06	0.0122	0.67	0.52	Testicular germ cell tumor;	chr6:149895549	chr6:149863494~149919507:+
READ	cis	rs372883	0.53	rs2832305	ENSG00000232118.2	BACH1-AS1	-5.01	4.33e-06	0.0122	-0.61	-0.52	Pancreatic cancer;	chr21:29380644	chr21:29370019~29376339:-
READ	cis	rs17507216	0.718	rs4779034	ENSG00000278603.1	RP13-608F4.5	5.01	4.34e-06	0.0122	0.89	0.52	Excessive daytime sleepiness;	chr15:82576799	chr15:82472203~82472426:+
READ	cis	rs9322193	0.923	rs12660304	ENSG00000268592.3	RAET1E-AS1	5.01	4.34e-06	0.0122	0.64	0.52	Lung cancer;	chr6:149739647	chr6:149863494~149919507:+
READ	cis	rs5753037	0.547	rs140134	ENSG00000279159.1	RP3-394A18.1	-5.01	4.35e-06	0.0123	-0.34	-0.52	Type 1 diabetes;	chr22:29767343	chr22:29978950~30028236:-
READ	cis	rs5753037	0.547	rs140140	ENSG00000279159.1	RP3-394A18.1	-5.01	4.35e-06	0.0123	-0.34	-0.52	Type 1 diabetes;	chr22:29770448	chr22:29978950~30028236:-
READ	cis	rs17301013	0.932	rs10912804	ENSG00000227373.4	RP11-160H22.5	5.01	4.36e-06	0.0123	0.68	0.52	Systemic lupus erythematosus;	chr1:174527412	chr1:174115300~174160004:-
READ	cis	rs17301013	0.9	rs12088073	ENSG00000227373.4	RP11-160H22.5	5.01	4.36e-06	0.0123	0.68	0.52	Systemic lupus erythematosus;	chr1:174528504	chr1:174115300~174160004:-
READ	cis	rs9322193	0.504	rs7771014	ENSG00000231760.4	RP11-350J20.5	5.01	4.38e-06	0.0123	0.69	0.52	Lung cancer;	chr6:149884310	chr6:149796151~149826294:-
READ	cis	rs1799949	1	rs8176202	ENSG00000198496.9	NBR2	-5.01	4.39e-06	0.0123	-0.62	-0.52	Menopause (age at onset);	chr17:43078211	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs8176193	ENSG00000198496.9	NBR2	-5.01	4.39e-06	0.0123	-0.62	-0.52	Menopause (age at onset);	chr17:43079499	chr17:43125610~43153671:+
READ	cis	rs748404	0.56	rs570933	ENSG00000249839.1	AC011330.5	-5	4.41e-06	0.0124	-0.65	-0.52	Lung cancer;	chr15:43531832	chr15:43663654~43684339:-
READ	cis	rs2739330	0.796	rs1006771	ENSG00000225282.1	AP000350.6	5	4.42e-06	0.0124	0.53	0.52	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23971817	chr22:23926900~23929574:+
READ	cis	rs748404	0.578	rs2584701	ENSG00000249839.1	AC011330.5	-5	4.43e-06	0.0125	-0.68	-0.52	Lung cancer;	chr15:43392741	chr15:43663654~43684339:-
READ	cis	rs748404	0.578	rs2244746	ENSG00000249839.1	AC011330.5	-5	4.43e-06	0.0125	-0.68	-0.52	Lung cancer;	chr15:43402885	chr15:43663654~43684339:-
READ	cis	rs7429990	0.932	rs6442101	ENSG00000229759.1	MRPS18AP1	-5	4.43e-06	0.0125	-0.59	-0.52	Educational attainment (years of education);	chr3:48089403	chr3:48256350~48256938:-
READ	cis	rs5753037	0.543	rs131284	ENSG00000279159.1	RP3-394A18.1	-5	4.44e-06	0.0125	-0.36	-0.52	Type 1 diabetes;	chr22:29761600	chr22:29978950~30028236:-
READ	cis	rs5753037	0.543	rs131287	ENSG00000279159.1	RP3-394A18.1	-5	4.44e-06	0.0125	-0.36	-0.52	Type 1 diabetes;	chr22:29762474	chr22:29978950~30028236:-
READ	cis	rs10463554	0.963	rs154355	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.63	0.52	Parkinson's disease;	chr5:103163177	chr5:103032376~103033031:+
READ	cis	rs26232	0.517	rs154356	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.63	0.52	Rheumatoid arthritis;	chr5:103163440	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs187427	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.63	0.52	Parkinson's disease;	chr5:103177102	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs26821	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.63	0.52	Parkinson's disease;	chr5:103184699	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs26816	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.65	0.52	Parkinson's disease;	chr5:103204821	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs26262	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.65	0.52	Parkinson's disease;	chr5:103209462	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs26261	ENSG00000175749.11	EIF3KP1	5	4.44e-06	0.0125	0.65	0.52	Parkinson's disease;	chr5:103209992	chr5:103032376~103033031:+
READ	cis	rs11690935	0.921	rs7594711	ENSG00000228389.1	AC068039.4	5	4.46e-06	0.0125	0.68	0.52	Schizophrenia;	chr2:172030734	chr2:171773482~171775844:+
READ	cis	rs12468226	1	rs16824599	ENSG00000272966.1	RP11-686O6.1	5	4.47e-06	0.0125	0.82	0.52	Urate levels;	chr2:202358243	chr2:202336739~202337200:+
READ	cis	rs9326248	0.539	rs518181	ENSG00000254851.1	RP11-109L13.1	-5	4.47e-06	0.0125	-0.65	-0.52	Blood protein levels;	chr11:116902071	chr11:117135528~117138582:+
READ	cis	rs12468226	1	rs113877751	ENSG00000272966.1	RP11-686O6.1	5	4.49e-06	0.0126	0.79	0.52	Urate levels;	chr2:202329998	chr2:202336739~202337200:+
READ	cis	rs12468226	0.935	rs113021930	ENSG00000272966.1	RP11-686O6.1	5	4.49e-06	0.0126	0.79	0.52	Urate levels;	chr2:202330448	chr2:202336739~202337200:+
READ	cis	rs12468226	1	rs113491584	ENSG00000272966.1	RP11-686O6.1	5	4.49e-06	0.0126	0.79	0.52	Urate levels;	chr2:202331724	chr2:202336739~202337200:+
READ	cis	rs858239	0.899	rs2268745	ENSG00000230658.1	KLHL7-AS1	5	4.49e-06	0.0126	0.72	0.52	Cerebrospinal fluid biomarker levels;	chr7:23277981	chr7:23101228~23105703:-
READ	cis	rs9487094	0.666	rs9480956	ENSG00000260273.1	RP11-425D10.10	5	4.51e-06	0.0126	0.64	0.52	Height;	chr6:109424305	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs12214147	ENSG00000260273.1	RP11-425D10.10	5	4.51e-06	0.0126	0.64	0.52	Height;	chr6:109425054	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs17070591	ENSG00000260273.1	RP11-425D10.10	5	4.51e-06	0.0126	0.64	0.52	Height;	chr6:109426518	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs7751582	ENSG00000260273.1	RP11-425D10.10	5	4.51e-06	0.0126	0.64	0.52	Height;	chr6:109427644	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs9487103	ENSG00000260273.1	RP11-425D10.10	5	4.51e-06	0.0126	0.64	0.52	Height;	chr6:109430292	chr6:109382795~109383666:+
READ	cis	rs1263173	0.696	rs1263172	ENSG00000254851.1	RP11-109L13.1	-5	4.51e-06	0.0126	-0.69	-0.52	HDL cholesterol;	chr11:116810202	chr11:117135528~117138582:+
READ	cis	rs6504950	0.745	rs12949718	ENSG00000275710.1	RP11-257O5.4	-5	4.52e-06	0.0126	-0.73	-0.52	Breast cancer;	chr17:54904492	chr17:54964474~54964679:+
READ	cis	rs5760092	0.717	rs5760101	ENSG00000218537.1	MIF-AS1	5	4.53e-06	0.0127	0.64	0.52	Urinary 1,3-butadiene metabolite levels in smokers;	chr22:23906525	chr22:23894426~23898930:-
READ	cis	rs10129255	0.5	rs9324092	ENSG00000211972.2	IGHV3-66	-5	4.53e-06	0.0127	-0.5	-0.52	Kawasaki disease;	chr14:106683806	chr14:106675017~106675544:-
READ	cis	rs7429990	0.932	rs13085054	ENSG00000229759.1	MRPS18AP1	-5	4.55e-06	0.0127	-0.57	-0.52	Educational attainment (years of education);	chr3:48092647	chr3:48256350~48256938:-
READ	cis	rs7429990	0.87	rs13089844	ENSG00000229759.1	MRPS18AP1	-5	4.55e-06	0.0127	-0.57	-0.52	Educational attainment (years of education);	chr3:48098741	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs12493348	ENSG00000229759.1	MRPS18AP1	-5	4.55e-06	0.0127	-0.57	-0.52	Educational attainment (years of education);	chr3:48102048	chr3:48256350~48256938:-
READ	cis	rs13113518	0.812	rs12500686	ENSG00000223305.1	RN7SKP30	4.99	4.59e-06	0.0128	0.66	0.52	Height;	chr4:55457922	chr4:55540502~55540835:-
READ	cis	rs7586879	0.765	rs6545758	ENSG00000271936.1	RP11-443B20.1	-4.99	4.59e-06	0.0128	-0.64	-0.52	Body mass index;	chr2:24852005	chr2:24825610~24826717:+
READ	cis	rs4718428	1	rs12534637	ENSG00000226824.5	RP4-756H11.3	-4.99	4.59e-06	0.0128	-0.69	-0.52	Corneal structure;	chr7:66862667	chr7:66654538~66669855:+
READ	cis	rs1577917	0.958	rs72907388	ENSG00000203875.9	SNHG5	-4.99	4.6e-06	0.0128	-0.7	-0.52	Response to antipsychotic treatment;	chr6:85730489	chr6:85660950~85678736:-
READ	cis	rs9322193	0.504	rs7771014	ENSG00000268592.3	RAET1E-AS1	4.99	4.62e-06	0.0129	0.65	0.52	Lung cancer;	chr6:149884310	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs7753812	ENSG00000216906.2	RP11-350J20.9	4.99	4.62e-06	0.0129	0.68	0.52	Lung cancer;	chr6:149690150	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12195866	ENSG00000216906.2	RP11-350J20.9	4.99	4.62e-06	0.0129	0.68	0.52	Lung cancer;	chr6:149693334	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9285524	ENSG00000216906.2	RP11-350J20.9	4.99	4.62e-06	0.0129	0.68	0.52	Lung cancer;	chr6:149694122	chr6:149904243~149906418:+
READ	cis	rs1799949	0.86	rs8176279	ENSG00000198496.9	NBR2	-4.99	4.62e-06	0.0129	-0.61	-0.52	Menopause (age at onset);	chr17:43058379	chr17:43125610~43153671:+
READ	cis	rs11155671	0.53	rs7763849	ENSG00000268592.3	RAET1E-AS1	4.99	4.71e-06	0.0131	0.64	0.52	Testicular germ cell tumor;	chr6:149885244	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs9766004	ENSG00000268592.3	RAET1E-AS1	4.99	4.71e-06	0.0131	0.65	0.52	Lung cancer;	chr6:149754363	chr6:149863494~149919507:+
READ	cis	rs2882667	0.518	rs10041986	ENSG00000253404.1	AC034243.1	4.99	4.72e-06	0.0131	0.62	0.52	Age-related hearing impairment (SNP x SNP interaction);	chr5:139088748	chr5:138744434~138753309:-
READ	cis	rs1577917	0.958	rs66807489	ENSG00000203875.9	SNHG5	-4.99	4.73e-06	0.0131	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85730984	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12213343	ENSG00000203875.9	SNHG5	-4.99	4.73e-06	0.0131	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85733301	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12215265	ENSG00000203875.9	SNHG5	-4.99	4.73e-06	0.0131	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85734251	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12197463	ENSG00000203875.9	SNHG5	-4.99	4.73e-06	0.0131	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85735524	chr6:85660950~85678736:-
READ	cis	rs12594515	1	rs7173144	ENSG00000273972.1	CTD-2306A12.1	-4.98	4.77e-06	0.0132	-0.6	-0.52	Weight;Waist circumference;	chr15:45698998	chr15:45702640~45703183:+
READ	cis	rs9322193	0.962	rs4870048	ENSG00000216906.2	RP11-350J20.9	4.98	4.77e-06	0.0132	0.72	0.52	Lung cancer;	chr6:149834324	chr6:149904243~149906418:+
READ	cis	rs5769707	0.967	rs2051626	ENSG00000188511.11	C22orf34	4.98	4.78e-06	0.0132	0.63	0.52	Monocyte percentage of white cells;Monocyte count;	chr22:49615325	chr22:49414524~49657542:-
READ	cis	rs5769707	0.967	rs1018812	ENSG00000188511.11	C22orf34	4.98	4.78e-06	0.0132	0.63	0.52	Monocyte percentage of white cells;Monocyte count;	chr22:49616425	chr22:49414524~49657542:-
READ	cis	rs5769707	0.967	rs9616327	ENSG00000188511.11	C22orf34	4.98	4.78e-06	0.0132	0.63	0.52	Monocyte percentage of white cells;Monocyte count;	chr22:49617243	chr22:49414524~49657542:-
READ	cis	rs9487094	0.666	rs12529733	ENSG00000260273.1	RP11-425D10.10	4.98	4.79e-06	0.0133	0.65	0.52	Height;	chr6:109332929	chr6:109382795~109383666:+
READ	cis	rs732716	0.785	rs56033249	ENSG00000267980.1	AC007292.6	-4.98	4.79e-06	0.0133	-0.86	-0.52	Mean corpuscular volume;	chr19:4369450	chr19:4363789~4364640:+
READ	cis	rs732716	0.785	rs11667543	ENSG00000267980.1	AC007292.6	-4.98	4.79e-06	0.0133	-0.86	-0.52	Mean corpuscular volume;	chr19:4374853	chr19:4363789~4364640:+
READ	cis	rs17301013	0.581	rs11801385	ENSG00000227373.4	RP11-160H22.5	4.98	4.81e-06	0.0133	0.79	0.52	Systemic lupus erythematosus;	chr1:174089454	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs17350956	ENSG00000227373.4	RP11-160H22.5	4.98	4.81e-06	0.0133	0.79	0.52	Systemic lupus erythematosus;	chr1:174093863	chr1:174115300~174160004:-
READ	cis	rs10129255	0.5	rs4774189	ENSG00000211972.2	IGHV3-66	4.98	4.81e-06	0.0133	0.49	0.52	Kawasaki disease;	chr14:106768275	chr14:106675017~106675544:-
READ	cis	rs9487094	0.67	rs2024850	ENSG00000260273.1	RP11-425D10.10	-4.98	4.83e-06	0.0134	-0.62	-0.52	Height;	chr6:109497253	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs13199135	ENSG00000260273.1	RP11-425D10.10	4.98	4.83e-06	0.0134	0.62	0.52	Height;	chr6:109588639	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs12193719	ENSG00000260273.1	RP11-425D10.10	4.98	4.83e-06	0.0134	0.62	0.52	Height;	chr6:109589051	chr6:109382795~109383666:+
READ	cis	rs9487094	0.644	rs1960325	ENSG00000260273.1	RP11-425D10.10	4.98	4.83e-06	0.0134	0.62	0.52	Height;	chr6:109592105	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs12528781	ENSG00000260273.1	RP11-425D10.10	4.98	4.83e-06	0.0134	0.62	0.52	Height;	chr6:109608105	chr6:109382795~109383666:+
READ	cis	rs17301013	0.93	rs6425279	ENSG00000227373.4	RP11-160H22.5	-4.98	4.83e-06	0.0134	-0.69	-0.52	Systemic lupus erythematosus;	chr1:174418717	chr1:174115300~174160004:-
READ	cis	rs2929278	0.588	rs688009	ENSG00000249839.1	AC011330.5	-4.98	4.84e-06	0.0134	-0.72	-0.52	Schizophrenia;	chr15:43864104	chr15:43663654~43684339:-
READ	cis	rs728616	0.867	rs7080405	ENSG00000225484.5	NUTM2B-AS1	-4.98	4.84e-06	0.0134	-1.08	-0.52	Chronic obstructive pulmonary disease-related biomarkers;	chr10:80142187	chr10:79663088~79826594:-
READ	cis	rs748404	0.518	rs480108	ENSG00000249839.1	AC011330.5	-4.98	4.85e-06	0.0134	-0.65	-0.52	Lung cancer;	chr15:43525208	chr15:43663654~43684339:-
READ	cis	rs372883	0.554	rs10154065	ENSG00000232118.2	BACH1-AS1	-4.98	4.86e-06	0.0134	-0.63	-0.52	Pancreatic cancer;	chr21:29377160	chr21:29370019~29376339:-
READ	cis	rs2882667	0.537	rs6887866	ENSG00000253404.1	AC034243.1	4.98	4.89e-06	0.0135	0.62	0.52	Age-related hearing impairment (SNP x SNP interaction);	chr5:139102007	chr5:138744434~138753309:-
READ	cis	rs11123170	0.64	rs2863240	ENSG00000274877.1	RP11-65I12.1	4.98	4.9e-06	0.0135	0.69	0.52	Renal function-related traits (BUN);	chr2:113212539	chr2:113237595~113240825:+
READ	cis	rs12468226	1	rs7597469	ENSG00000272966.1	RP11-686O6.1	4.98	4.91e-06	0.0135	0.79	0.52	Urate levels;	chr2:202329547	chr2:202336739~202337200:+
READ	cis	rs7429990	0.932	rs7630685	ENSG00000229759.1	MRPS18AP1	-4.97	4.93e-06	0.0136	-0.58	-0.52	Educational attainment (years of education);	chr3:48089680	chr3:48256350~48256938:-
READ	cis	rs9309473	0.687	rs11126399	ENSG00000163016.8	ALMS1P	4.97	4.94e-06	0.0136	0.67	0.52	Metabolite levels;	chr2:73386213	chr2:73644919~73685576:+
READ	cis	rs1799949	0.965	rs7212284	ENSG00000198496.9	NBR2	-4.97	4.96e-06	0.0136	-0.6	-0.52	Menopause (age at onset);	chr17:43053924	chr17:43125610~43153671:+
READ	cis	rs1799949	0.894	rs71367985	ENSG00000198496.9	NBR2	-4.97	4.96e-06	0.0136	-0.6	-0.52	Menopause (age at onset);	chr17:43222443	chr17:43125610~43153671:+
READ	cis	rs1799949	0.536	rs4793227	ENSG00000198496.9	NBR2	-4.97	4.96e-06	0.0136	-0.6	-0.52	Menopause (age at onset);	chr17:43334882	chr17:43125610~43153671:+
READ	cis	rs9487094	0.67	rs12199154	ENSG00000260273.1	RP11-425D10.10	-4.97	4.99e-06	0.0137	-0.63	-0.52	Height;	chr6:109501793	chr6:109382795~109383666:+
READ	cis	rs9322193	0.607	rs9322229	ENSG00000231760.4	RP11-350J20.5	4.97	5e-06	0.0137	0.74	0.52	Lung cancer;	chr6:149908949	chr6:149796151~149826294:-
READ	cis	rs992157	0.835	rs7559416	ENSG00000261338.2	RP11-378A13.1	-4.97	5.03e-06	0.0138	-0.65	-0.52	Colorectal cancer;	chr2:218285488	chr2:218255319~218257366:+
READ	cis	rs992157	0.804	rs7559525	ENSG00000261338.2	RP11-378A13.1	-4.97	5.03e-06	0.0138	-0.65	-0.52	Colorectal cancer;	chr2:218285584	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs13005100	ENSG00000261338.2	RP11-378A13.1	-4.97	5.03e-06	0.0138	-0.65	-0.52	Colorectal cancer;	chr2:218287044	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs13031757	ENSG00000261338.2	RP11-378A13.1	-4.97	5.03e-06	0.0138	-0.65	-0.52	Colorectal cancer;	chr2:218287203	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs34353396	ENSG00000261338.2	RP11-378A13.1	-4.97	5.03e-06	0.0138	-0.65	-0.52	Colorectal cancer;	chr2:218289259	chr2:218255319~218257366:+
READ	cis	rs9322193	0.923	rs2342765	ENSG00000268592.3	RAET1E-AS1	4.97	5.04e-06	0.0138	0.65	0.52	Lung cancer;	chr6:149858873	chr6:149863494~149919507:+
READ	cis	rs2688482	0.512	rs3103953	ENSG00000224769.1	AC069213.1	-4.97	5.04e-06	0.0138	-0.91	-0.52	Lung disease severity in cystic fibrosis;	chr3:195793726	chr3:195614947~195620233:+
READ	cis	rs9309473	0.607	rs10196402	ENSG00000163016.8	ALMS1P	4.97	5.05e-06	0.0138	0.67	0.52	Metabolite levels;	chr2:73344953	chr2:73644919~73685576:+
READ	cis	rs7429990	0.965	rs35199727	ENSG00000229759.1	MRPS18AP1	4.97	5.08e-06	0.0139	0.61	0.52	Educational attainment (years of education);	chr3:47905218	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs11707679	ENSG00000229759.1	MRPS18AP1	4.97	5.08e-06	0.0139	0.61	0.52	Educational attainment (years of education);	chr3:47915016	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs34750113	ENSG00000229759.1	MRPS18AP1	4.97	5.08e-06	0.0139	0.61	0.52	Educational attainment (years of education);	chr3:47944902	chr3:48256350~48256938:-
READ	cis	rs2455601	0.529	rs2653569	ENSG00000254860.4	TMEM9B-AS1	4.97	5.08e-06	0.0139	0.72	0.52	Schizophrenia;	chr11:8965431	chr11:8964675~8977527:+
READ	cis	rs881375	1	rs10818480	ENSG00000226752.6	PSMD5-AS1	-4.97	5.09e-06	0.0139	-0.68	-0.52	Rheumatoid arthritis;	chr9:120880892	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs4323544	ENSG00000226752.6	PSMD5-AS1	-4.97	5.09e-06	0.0139	-0.68	-0.52	Rheumatoid arthritis;	chr9:120885099	chr9:120824828~120854385:+
READ	cis	rs9322193	1	rs9322193	ENSG00000216906.2	RP11-350J20.9	4.97	5.1e-06	0.0139	0.69	0.52	Lung cancer;	chr6:149598007	chr6:149904243~149906418:+
READ	cis	rs9322193	1	rs9377229	ENSG00000216906.2	RP11-350J20.9	4.97	5.1e-06	0.0139	0.69	0.52	Lung cancer;	chr6:149607655	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9322197	ENSG00000216906.2	RP11-350J20.9	4.97	5.1e-06	0.0139	0.69	0.52	Lung cancer;	chr6:149622577	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs9688858	ENSG00000216906.2	RP11-350J20.9	4.97	5.1e-06	0.0139	0.69	0.52	Lung cancer;	chr6:149637911	chr6:149904243~149906418:+
READ	cis	rs2882667	0.505	rs6596465	ENSG00000253404.1	AC034243.1	-4.97	5.1e-06	0.0139	-0.58	-0.52	Age-related hearing impairment (SNP x SNP interaction);	chr5:139147337	chr5:138744434~138753309:-
READ	cis	rs9938149	0.736	rs7501402	ENSG00000260630.5	SNAI3-AS1	4.97	5.11e-06	0.0139	0.8	0.52	Central corneal thickness;Corneal structure;	chr16:88287305	chr16:88663298~88687186:+
READ	cis	rs1799949	1	rs8077486	ENSG00000198496.9	NBR2	-4.96	5.14e-06	0.014	-0.6	-0.52	Menopause (age at onset);	chr17:43060788	chr17:43125610~43153671:+
READ	cis	rs6095360	1	rs6019573	ENSG00000278231.1	RP5-906C1.1	-4.96	5.21e-06	0.0141	-0.76	-0.52	Intelligence (multi-trait analysis);	chr20:48986295	chr20:48821688~48849458:-
READ	cis	rs6095360	1	rs1048590	ENSG00000278231.1	RP5-906C1.1	-4.96	5.21e-06	0.0141	-0.76	-0.52	Intelligence (multi-trait analysis);	chr20:48993760	chr20:48821688~48849458:-
READ	cis	rs6095360	1	rs2295033	ENSG00000278231.1	RP5-906C1.1	-4.96	5.21e-06	0.0141	-0.76	-0.52	Intelligence (multi-trait analysis);	chr20:48994359	chr20:48821688~48849458:-
READ	cis	rs2980439	0.818	rs2945249	ENSG00000253981.4	ALG1L13P	4.96	5.21e-06	0.0141	0.63	0.52	Neuroticism;	chr8:8237204	chr8:8236003~8244667:-
READ	cis	rs11155671	0.53	rs4869764	ENSG00000268592.3	RAET1E-AS1	4.96	5.22e-06	0.0141	0.67	0.52	Testicular germ cell tumor;	chr6:149890692	chr6:149863494~149919507:+
READ	cis	rs9322193	0.567	rs7742692	ENSG00000268592.3	RAET1E-AS1	4.96	5.22e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149892363	chr6:149863494~149919507:+
READ	cis	rs2613964	0.548	rs9870733	ENSG00000241889.1	RP11-435F17.3	4.96	5.25e-06	0.0141	0.6	0.52	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113130407	chr3:113885298~113886031:+
READ	cis	rs9322193	0.962	rs9688412	ENSG00000216906.2	RP11-350J20.9	-4.96	5.26e-06	0.0141	-0.67	-0.52	Lung cancer;	chr6:149803147	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12175504	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149664079	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs35443312	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149670625	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs62439843	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149676521	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs35031906	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149677438	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs10872645	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149742840	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs12211511	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149745206	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9479810	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149751359	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs12175575	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149763351	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4869966	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149763714	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs1112730	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149766383	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs1112729	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149766491	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs10452626	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149767481	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs62441303	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149767547	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9765929	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149769680	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs3805748	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149772542	chr6:149904243~149906418:+
READ	cis	rs9322193	0.736	rs10457851	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149775216	chr6:149904243~149906418:+
READ	cis	rs9322193	0.886	rs10872652	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149775303	chr6:149904243~149906418:+
READ	cis	rs9322193	0.886	rs12525871	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149775882	chr6:149904243~149906418:+
READ	cis	rs9322193	0.886	rs17672976	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149776207	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2184369	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149776681	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs2342861	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149777561	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs2342860	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149777641	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs10872653	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149778907	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs11155683	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149779341	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9372044	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149780867	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs11155685	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149781649	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9322220	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149782897	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs10214845	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149783124	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9767122	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149783553	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs1413654	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149783956	chr6:149904243~149906418:+
READ	cis	rs9322193	0.683	rs113281309	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149787289	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9688809	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149787920	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9689242	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149787970	chr6:149904243~149906418:+
READ	cis	rs9322193	1	rs9767077	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149788479	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs9688938	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149788941	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9688940	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149788977	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9689447	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149789350	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs3805751	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149791193	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9689269	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149791861	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs62441335	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149792658	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4816	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149793609	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs3805753	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149795662	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs952166	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149798774	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs952165	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149798900	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs10872656	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149799444	chr6:149904243~149906418:+
READ	cis	rs9322193	0.926	rs9285525	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149801253	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs6914319	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149806304	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs2095375	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149807037	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4869730	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149808187	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs11155689	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149808470	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs2151913	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149809506	chr6:149904243~149906418:+
READ	cis	rs9322193	0.884	rs933055	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149809701	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4869731	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149810072	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs4552	ENSG00000216906.2	RP11-350J20.9	4.96	5.26e-06	0.0141	0.67	0.52	Lung cancer;	chr6:149811183	chr6:149904243~149906418:+
READ	cis	rs77204473	0.557	rs7111854	ENSG00000254851.1	RP11-109L13.1	4.96	5.27e-06	0.0142	0.98	0.52	Sum eosinophil basophil counts;Eosinophil counts;	chr11:116906110	chr11:117135528~117138582:+
READ	cis	rs6504950	0.615	rs66898273	ENSG00000275710.1	RP11-257O5.4	4.96	5.28e-06	0.0142	0.75	0.52	Breast cancer;	chr17:54916595	chr17:54964474~54964679:+
READ	cis	rs6504950	0.745	rs1962045	ENSG00000275710.1	RP11-257O5.4	4.96	5.28e-06	0.0142	0.75	0.52	Breast cancer;	chr17:54918789	chr17:54964474~54964679:+
READ	cis	rs6504950	0.72	rs9914596	ENSG00000275710.1	RP11-257O5.4	4.96	5.28e-06	0.0142	0.75	0.52	Breast cancer;	chr17:54919190	chr17:54964474~54964679:+
READ	cis	rs881375	1	rs10760121	ENSG00000226752.6	PSMD5-AS1	-4.96	5.28e-06	0.0142	-0.68	-0.52	Rheumatoid arthritis;	chr9:120885637	chr9:120824828~120854385:+
READ	cis	rs10760123	1	rs10760123	ENSG00000226752.6	PSMD5-AS1	-4.96	5.28e-06	0.0142	-0.68	-0.52	Allergic disease (asthma, hay fever or eczema);	chr9:120888256	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs2270231	ENSG00000226752.6	PSMD5-AS1	-4.96	5.28e-06	0.0142	-0.68	-0.52	Rheumatoid arthritis;	chr9:120888704	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs6478484	ENSG00000226752.6	PSMD5-AS1	-4.96	5.28e-06	0.0142	-0.68	-0.52	Rheumatoid arthritis;	chr9:120890102	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs881375	ENSG00000226752.6	PSMD5-AS1	-4.96	5.28e-06	0.0142	-0.68	-0.52	Rheumatoid arthritis;	chr9:120890620	chr9:120824828~120854385:+
READ	cis	rs11155671	0.53	rs4869763	ENSG00000268592.3	RAET1E-AS1	4.96	5.31e-06	0.0142	0.66	0.52	Testicular germ cell tumor;	chr6:149890548	chr6:149863494~149919507:+
READ	cis	rs10463554	0.655	rs152138	ENSG00000175749.11	EIF3KP1	4.95	5.32e-06	0.0142	0.67	0.52	Parkinson's disease;	chr5:103223727	chr5:103032376~103033031:+
READ	cis	rs17301013	0.606	rs56152378	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174106480	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4652179	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174107185	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs17353198	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174107439	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs17350991	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174114330	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs57407575	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174115504	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1407127	ENSG00000227373.4	RP11-160H22.5	-4.95	5.33e-06	0.0142	-0.78	-0.52	Systemic lupus erythematosus;	chr1:174119548	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6656491	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174127524	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs72711457	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174135385	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6668008	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174138752	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs4652204	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174150682	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs56158362	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174166437	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs77379897	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174169373	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1417186	ENSG00000227373.4	RP11-160H22.5	-4.95	5.33e-06	0.0142	-0.78	-0.52	Systemic lupus erythematosus;	chr1:174171090	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs56375942	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174176206	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs56404641	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174176323	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs56239105	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174179346	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs17300775	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174191901	chr1:174115300~174160004:-
READ	cis	rs17301013	0.566	rs72711492	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174195464	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4650968	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174223322	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4650969	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174229622	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs72711501	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174233081	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6666588	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174248972	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs72713504	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174251916	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs72713505	ENSG00000227373.4	RP11-160H22.5	4.95	5.33e-06	0.0142	0.78	0.52	Systemic lupus erythematosus;	chr1:174255911	chr1:174115300~174160004:-
READ	cis	rs9322193	0.632	rs3828700	ENSG00000216906.2	RP11-350J20.9	4.95	5.33e-06	0.0142	0.67	0.52	Lung cancer;	chr6:149791033	chr6:149904243~149906418:+
READ	cis	rs9322193	0.736	rs3828701	ENSG00000216906.2	RP11-350J20.9	4.95	5.33e-06	0.0142	0.67	0.52	Lung cancer;	chr6:149791063	chr6:149904243~149906418:+
READ	cis	rs9322193	0.736	rs3805750	ENSG00000216906.2	RP11-350J20.9	4.95	5.33e-06	0.0142	0.67	0.52	Lung cancer;	chr6:149791065	chr6:149904243~149906418:+
READ	cis	rs34375054	0.525	rs7133006	ENSG00000279233.1	RP11-158L12.4	4.95	5.34e-06	0.0143	0.49	0.52	Post bronchodilator FEV1/FVC ratio;	chr12:125121577	chr12:125138245~125141711:+
READ	cis	rs34375054	0.525	rs7133864	ENSG00000279233.1	RP11-158L12.4	4.95	5.34e-06	0.0143	0.49	0.52	Post bronchodilator FEV1/FVC ratio;	chr12:125121634	chr12:125138245~125141711:+
READ	cis	rs17301013	0.502	rs6703836	ENSG00000227373.4	RP11-160H22.5	4.95	5.35e-06	0.0143	0.79	0.52	Systemic lupus erythematosus;	chr1:174099675	chr1:174115300~174160004:-
READ	cis	rs1799949	0.894	rs36062488	ENSG00000198496.9	NBR2	4.95	5.37e-06	0.0144	0.6	0.52	Menopause (age at onset);	chr17:43185455	chr17:43125610~43153671:+
READ	cis	rs11690935	0.885	rs6752812	ENSG00000228389.1	AC068039.4	4.95	5.39e-06	0.0144	0.66	0.52	Schizophrenia;	chr2:171986588	chr2:171773482~171775844:+
READ	cis	rs748404	0.66	rs690367	ENSG00000249839.1	AC011330.5	4.95	5.42e-06	0.0144	0.7	0.52	Lung cancer;	chr15:43456106	chr15:43663654~43684339:-
READ	cis	rs7208859	0.623	rs11657662	ENSG00000263531.1	RP13-753N3.1	-4.95	5.42e-06	0.0144	-0.91	-0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30749329	chr17:30863921~30864940:-
READ	cis	rs1577917	0.57	rs114854865	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85844518	chr6:85660950~85678736:-
READ	cis	rs1577917	0.916	rs4706252	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85845462	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs1838959	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85847086	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs1579886	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85847473	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1816937	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85847533	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2324840	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85847902	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs7382798	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85850116	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12202188	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85852982	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs36035797	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85853162	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1838958	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85854250	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs2084293	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85856284	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12209668	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85856799	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs11752180	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85863447	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs12665464	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85864415	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs16876529	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85881484	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12204015	ENSG00000203875.9	SNHG5	-4.95	5.44e-06	0.0144	-0.69	-0.52	Response to antipsychotic treatment;	chr6:85888616	chr6:85660950~85678736:-
READ	cis	rs11155671	0.53	rs7756850	ENSG00000268592.3	RAET1E-AS1	4.95	5.44e-06	0.0144	0.66	0.52	Testicular germ cell tumor;	chr6:149891460	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9371542	ENSG00000268592.3	RAET1E-AS1	4.95	5.44e-06	0.0144	0.66	0.52	Testicular germ cell tumor;	chr6:149891949	chr6:149863494~149919507:+
READ	cis	rs9322193	0.567	rs7747457	ENSG00000268592.3	RAET1E-AS1	4.95	5.44e-06	0.0144	0.66	0.52	Lung cancer;	chr6:149892366	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9371223	ENSG00000268592.3	RAET1E-AS1	4.95	5.44e-06	0.0144	0.66	0.52	Testicular germ cell tumor;	chr6:149893670	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs2342769	ENSG00000268592.3	RAET1E-AS1	4.95	5.44e-06	0.0144	0.66	0.52	Testicular germ cell tumor;	chr6:149895371	chr6:149863494~149919507:+
READ	cis	rs57677839	1	rs57677839	ENSG00000184669.7	OR7E14P	-4.95	5.45e-06	0.0144	-0.64	-0.52	Coronary artery disease;	chr11:17006642	chr11:17013998~17053024:+
READ	cis	rs732716	0.785	rs7769	ENSG00000267980.1	AC007292.6	-4.95	5.5e-06	0.0145	-0.86	-0.52	Mean corpuscular volume;	chr19:4360546	chr19:4363789~4364640:+
READ	cis	rs773506	0.72	rs3914139	ENSG00000233081.1	RP11-440G5.2	4.94	5.55e-06	0.0147	0.65	0.52	Type 2 diabetes nephropathy;	chr9:91200908	chr9:91426238~91427144:+
READ	cis	rs773506	0.72	rs7035931	ENSG00000233081.1	RP11-440G5.2	4.94	5.55e-06	0.0147	0.65	0.52	Type 2 diabetes nephropathy;	chr9:91203994	chr9:91426238~91427144:+
READ	cis	rs773506	0.72	rs7020997	ENSG00000233081.1	RP11-440G5.2	4.94	5.55e-06	0.0147	0.65	0.52	Type 2 diabetes nephropathy;	chr9:91204070	chr9:91426238~91427144:+
READ	cis	rs773506	0.72	rs3884186	ENSG00000233081.1	RP11-440G5.2	4.94	5.55e-06	0.0147	0.65	0.52	Type 2 diabetes nephropathy;	chr9:91204751	chr9:91426238~91427144:+
READ	cis	rs10129255	0.957	rs8014696	ENSG00000211972.2	IGHV3-66	-4.94	5.56e-06	0.0147	-0.49	-0.52	Kawasaki disease;	chr14:106769752	chr14:106675017~106675544:-
READ	cis	rs17826219	0.5	rs117560728	ENSG00000263531.1	RP13-753N3.1	4.94	5.57e-06	0.0147	1.08	0.52	Body mass index;	chr17:30743920	chr17:30863921~30864940:-
READ	cis	rs12468226	0.938	rs10931993	ENSG00000272966.1	RP11-686O6.1	4.94	5.57e-06	0.0147	0.76	0.52	Urate levels;	chr2:202243017	chr2:202336739~202337200:+
READ	cis	rs56104184	0.725	rs4347731	ENSG00000235191.1	NUCB1-AS1	4.94	5.6e-06	0.0148	0.95	0.52	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr19:48881897	chr19:48910930~48918891:-
READ	cis	rs748404	0.56	rs572837	ENSG00000249839.1	AC011330.5	-4.94	5.6e-06	0.0148	-0.65	-0.52	Lung cancer;	chr15:43531615	chr15:43663654~43684339:-
READ	cis	rs7617773	0.817	rs9830016	ENSG00000229759.1	MRPS18AP1	4.94	5.62e-06	0.0148	0.62	0.52	Coronary artery disease;	chr3:48241004	chr3:48256350~48256938:-
READ	cis	rs6842047	0.611	rs12186257	ENSG00000250971.1	RP11-696F12.1	-4.94	5.63e-06	0.0148	-1.24	-0.52	Blood protein levels;	chr4:186262344	chr4:187060099~187060930:+
READ	cis	rs7429990	0.965	rs319682	ENSG00000229759.1	MRPS18AP1	4.94	5.65e-06	0.0149	0.58	0.52	Educational attainment (years of education);	chr3:47873628	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs2631721	ENSG00000229759.1	MRPS18AP1	4.94	5.65e-06	0.0149	0.58	0.52	Educational attainment (years of education);	chr3:47881807	chr3:48256350~48256938:-
READ	cis	rs9322193	0.962	rs9322206	ENSG00000216906.2	RP11-350J20.9	4.94	5.66e-06	0.0149	0.69	0.52	Lung cancer;	chr6:149641481	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9688750	ENSG00000216906.2	RP11-350J20.9	4.94	5.66e-06	0.0149	0.69	0.52	Lung cancer;	chr6:149657633	chr6:149904243~149906418:+
READ	cis	rs12468226	1	rs58288071	ENSG00000272966.1	RP11-686O6.1	4.94	5.67e-06	0.0149	0.8	0.52	Urate levels;	chr2:202350016	chr2:202336739~202337200:+
READ	cis	rs9322193	0.923	rs9371486	ENSG00000268592.3	RAET1E-AS1	4.94	5.68e-06	0.0149	0.67	0.52	Lung cancer;	chr6:149832090	chr6:149863494~149919507:+
READ	cis	rs62229266	0.659	rs2026259	ENSG00000231106.2	LINC01436	4.94	5.68e-06	0.0149	0.67	0.52	Mitral valve prolapse;	chr21:36058329	chr21:36005338~36007838:+
READ	cis	rs79040073	0.911	rs17393193	ENSG00000259531.2	RP11-295H24.3	4.94	5.69e-06	0.015	0.72	0.52	Lung cancer in ever smokers;	chr15:49039882	chr15:49365124~49366685:-
READ	cis	rs7617773	0.779	rs77957078	ENSG00000229759.1	MRPS18AP1	4.94	5.71e-06	0.015	0.64	0.52	Coronary artery disease;	chr3:48289796	chr3:48256350~48256938:-
READ	cis	rs7208859	0.623	rs3794796	ENSG00000263531.1	RP13-753N3.1	4.94	5.71e-06	0.015	0.93	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30803862	chr17:30863921~30864940:-
READ	cis	rs858239	1	rs199351	ENSG00000230658.1	KLHL7-AS1	4.94	5.72e-06	0.015	0.69	0.52	Cerebrospinal fluid biomarker levels;	chr7:23260430	chr7:23101228~23105703:-
READ	cis	rs34375054	0.525	rs1080910	ENSG00000279233.1	RP11-158L12.4	4.94	5.73e-06	0.015	0.49	0.52	Post bronchodilator FEV1/FVC ratio;	chr12:125123946	chr12:125138245~125141711:+
READ	cis	rs10129255	0.913	rs10140943	ENSG00000211972.2	IGHV3-66	4.93	5.73e-06	0.015	0.52	0.52	Kawasaki disease;	chr14:106767441	chr14:106675017~106675544:-
READ	cis	rs10129255	1	rs10141557	ENSG00000211972.2	IGHV3-66	4.93	5.73e-06	0.015	0.52	0.52	Kawasaki disease;	chr14:106767990	chr14:106675017~106675544:-
READ	cis	rs17301013	0.794	rs6425283	ENSG00000227373.4	RP11-160H22.5	4.93	5.74e-06	0.0151	0.68	0.52	Systemic lupus erythematosus;	chr1:174499853	chr1:174115300~174160004:-
READ	cis	rs10129255	1	rs8012033	ENSG00000211972.2	IGHV3-66	4.93	5.75e-06	0.0151	0.49	0.52	Kawasaki disease;	chr14:106678854	chr14:106675017~106675544:-
READ	cis	rs10129255	0.912	rs8011090	ENSG00000211972.2	IGHV3-66	4.93	5.75e-06	0.0151	0.49	0.52	Kawasaki disease;	chr14:106678896	chr14:106675017~106675544:-
READ	cis	rs372883	0.53	rs2832302	ENSG00000232118.2	BACH1-AS1	4.93	5.79e-06	0.0151	0.58	0.52	Pancreatic cancer;	chr21:29377473	chr21:29370019~29376339:-
READ	cis	rs17301013	0.761	rs332805	ENSG00000227373.4	RP11-160H22.5	4.93	5.82e-06	0.0152	0.68	0.52	Systemic lupus erythematosus;	chr1:174652487	chr1:174115300~174160004:-
READ	cis	rs9938149	0.706	rs7403826	ENSG00000260630.5	SNAI3-AS1	4.93	5.83e-06	0.0152	0.85	0.52	Central corneal thickness;Corneal structure;	chr16:88287561	chr16:88663298~88687186:+
READ	cis	rs5769707	0.967	rs5770585	ENSG00000188511.11	C22orf34	4.93	5.83e-06	0.0152	0.63	0.52	Monocyte percentage of white cells;Monocyte count;	chr22:49614226	chr22:49414524~49657542:-
READ	cis	rs319690	1	rs319690	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Diastolic blood pressure;Systolic blood pressure;Blood pressure;	chr3:47885994	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs319685	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47890494	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs319684	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47890784	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs810334	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47893813	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs777015	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47895582	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs34380889	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47905692	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs4858871	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47911915	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs6772396	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47918280	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7619882	ENSG00000229759.1	MRPS18AP1	4.93	5.84e-06	0.0152	0.58	0.52	Educational attainment (years of education);	chr3:47943334	chr3:48256350~48256938:-
READ	cis	rs34375054	0.525	rs7133614	ENSG00000279233.1	RP11-158L12.4	4.93	5.84e-06	0.0152	0.49	0.52	Post bronchodilator FEV1/FVC ratio;	chr12:125121411	chr12:125138245~125141711:+
READ	cis	rs7208859	0.573	rs7222803	ENSG00000263531.1	RP13-753N3.1	4.93	5.86e-06	0.0153	0.88	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792879	chr17:30863921~30864940:-
READ	cis	rs9425766	0.679	rs7537517	ENSG00000227373.4	RP11-160H22.5	4.93	5.86e-06	0.0153	0.71	0.52	Life satisfaction;	chr1:174207225	chr1:174115300~174160004:-
READ	cis	rs61160187	0.51	rs4482855	ENSG00000215032.2	GNL3LP1	4.93	5.87e-06	0.0153	0.6	0.52	Educational attainment (years of education);Educational attainment (college completion);	chr5:60800670	chr5:60891935~60893577:-
READ	cis	rs9322193	0.886	rs4870055	ENSG00000268592.3	RAET1E-AS1	4.93	5.87e-06	0.0153	0.64	0.52	Lung cancer;	chr6:149848433	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs7769101	ENSG00000268592.3	RAET1E-AS1	4.93	5.87e-06	0.0153	0.64	0.52	Lung cancer;	chr6:149848768	chr6:149863494~149919507:+
READ	cis	rs7208859	0.623	rs122898	ENSG00000263531.1	RP13-753N3.1	-4.93	5.89e-06	0.0153	-0.82	-0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30578236	chr17:30863921~30864940:-
READ	cis	rs4660456	0.826	rs3767952	ENSG00000237899.1	RP4-739H11.3	-4.93	5.92e-06	0.0154	-0.75	-0.52	Platelet count;	chr1:40765360	chr1:40669089~40687588:-
READ	cis	rs17264034	1	rs17264034	ENSG00000250786.1	SNHG18	-4.93	5.92e-06	0.0154	-0.73	-0.52	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9557490	chr5:9546200~9550609:+
READ	cis	rs9545047	0.935	rs1475797	ENSG00000227676.3	LINC01068	-4.92	5.95e-06	0.0155	-0.61	-0.52	Schizophrenia;	chr13:79519690	chr13:79566727~79571436:+
READ	cis	rs17301013	0.932	rs3737651	ENSG00000227373.4	RP11-160H22.5	-4.92	5.97e-06	0.0155	-0.68	-0.52	Systemic lupus erythematosus;	chr1:174475414	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6425282	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174493387	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs727279	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174496026	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs2072760	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174510186	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs10912797	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174511225	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6668053	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174515139	chr1:174115300~174160004:-
READ	cis	rs17301013	0.896	rs13375788	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174524207	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs10912807	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174547228	chr1:174115300~174160004:-
READ	cis	rs17301013	0.9	rs56347239	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174564476	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs7542389	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174565104	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs12074753	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174565768	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs1016466	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174570652	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs10753086	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174580802	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs7555533	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174589983	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6671824	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174603721	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs6672148	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174604016	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs10912813	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174607342	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs67967476	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174616119	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6683602	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174617615	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6696197	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174617860	chr1:174115300~174160004:-
READ	cis	rs17301013	0.73	rs12060177	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174618545	chr1:174115300~174160004:-
READ	cis	rs17301013	0.612	rs56199565	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174640992	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs34819375	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174654958	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs332770	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174681511	chr1:174115300~174160004:-
READ	cis	rs17301013	0.896	rs332773	ENSG00000227373.4	RP11-160H22.5	4.92	5.97e-06	0.0155	0.68	0.52	Systemic lupus erythematosus;	chr1:174695711	chr1:174115300~174160004:-
READ	cis	rs881375	0.933	rs4837804	ENSG00000226752.6	PSMD5-AS1	-4.92	5.97e-06	0.0155	-0.67	-0.52	Rheumatoid arthritis;	chr9:120943026	chr9:120824828~120854385:+
READ	cis	rs881375	0.967	rs7039505	ENSG00000226752.6	PSMD5-AS1	-4.92	5.97e-06	0.0155	-0.67	-0.52	Rheumatoid arthritis;	chr9:120943667	chr9:120824828~120854385:+
READ	cis	rs881375	0.902	rs2900180	ENSG00000226752.6	PSMD5-AS1	-4.92	5.97e-06	0.0155	-0.67	-0.52	Rheumatoid arthritis;	chr9:120944104	chr9:120824828~120854385:+
READ	cis	rs7429990	0.932	rs60446735	ENSG00000229759.1	MRPS18AP1	4.92	5.97e-06	0.0155	0.59	0.52	Educational attainment (years of education);	chr3:47929958	chr3:48256350~48256938:-
READ	cis	rs7301826	0.557	rs7953184	ENSG00000256250.1	RP11-989F5.1	4.92	5.98e-06	0.0155	0.51	0.52	Plasma plasminogen activator levels;	chr12:130800307	chr12:130810606~130812438:+
READ	cis	rs6095360	0.966	rs6019545	ENSG00000278231.1	RP5-906C1.1	-4.92	5.99e-06	0.0155	-0.75	-0.52	Intelligence (multi-trait analysis);	chr20:48940477	chr20:48821688~48849458:-
READ	cis	rs453301	0.686	rs6601281	ENSG00000253981.4	ALG1L13P	-4.92	6e-06	0.0155	-0.61	-0.52	Joint mobility (Beighton score);	chr8:9053494	chr8:8236003~8244667:-
READ	cis	rs17826219	0.706	rs28469200	ENSG00000263531.1	RP13-753N3.1	4.92	6.03e-06	0.0156	0.88	0.52	Body mass index;	chr17:30806554	chr17:30863921~30864940:-
READ	cis	rs6095360	1	rs1569750	ENSG00000278231.1	RP5-906C1.1	-4.92	6.04e-06	0.0156	-0.78	-0.52	Intelligence (multi-trait analysis);	chr20:48986704	chr20:48821688~48849458:-
READ	cis	rs3096299	0.667	rs2965947	ENSG00000274627.1	RP11-104N10.2	4.92	6.05e-06	0.0156	0.57	0.52	Multiple myeloma (IgH translocation);	chr16:89452262	chr16:89516797~89522217:+
READ	cis	rs13068223	0.584	rs345986	ENSG00000243926.1	TIPARP-AS1	-4.92	6.05e-06	0.0156	-0.61	-0.52	Age-related hearing impairment (SNP x SNP interaction);	chr3:156677540	chr3:156671862~156674378:-
READ	cis	rs2929278	0.617	rs694461	ENSG00000249839.1	AC011330.5	4.92	6.05e-06	0.0156	0.67	0.52	Schizophrenia;	chr15:43803865	chr15:43663654~43684339:-
READ	cis	rs7429990	0.965	rs319692	ENSG00000229759.1	MRPS18AP1	4.92	6.07e-06	0.0157	0.59	0.52	Educational attainment (years of education);	chr3:47882827	chr3:48256350~48256938:-
READ	cis	rs9660180	0.967	rs6603803	ENSG00000231050.1	RP1-140A9.1	4.92	6.1e-06	0.0157	0.69	0.52	Body mass index;	chr1:1881249	chr1:1891471~1892658:+
READ	cis	rs858239	0.676	rs3807459	ENSG00000230658.1	KLHL7-AS1	4.92	6.12e-06	0.0157	0.66	0.52	Cerebrospinal fluid biomarker levels;	chr7:23350132	chr7:23101228~23105703:-
READ	cis	rs1577917	1	rs10498958	ENSG00000203875.9	SNHG5	4.92	6.14e-06	0.0158	0.72	0.52	Response to antipsychotic treatment;	chr6:85939987	chr6:85660950~85678736:-
READ	cis	rs4660456	0.913	rs552147	ENSG00000237899.1	RP4-739H11.3	-4.92	6.14e-06	0.0158	-0.88	-0.52	Platelet count;	chr1:40689141	chr1:40669089~40687588:-
READ	cis	rs992157	1	rs992157	ENSG00000261338.2	RP11-378A13.1	-4.92	6.14e-06	0.0158	-0.67	-0.52	Colorectal cancer;	chr2:218290058	chr2:218255319~218257366:+
READ	cis	rs9309473	0.687	rs6546827	ENSG00000163016.8	ALMS1P	4.92	6.14e-06	0.0158	0.64	0.52	Metabolite levels;	chr2:73379365	chr2:73644919~73685576:+
READ	cis	rs9309473	0.687	rs6706409	ENSG00000163016.8	ALMS1P	-4.92	6.14e-06	0.0158	-0.64	-0.52	Metabolite levels;	chr2:73379380	chr2:73644919~73685576:+
READ	cis	rs773506	0.692	rs12238485	ENSG00000233081.1	RP11-440G5.2	-4.92	6.15e-06	0.0158	-0.63	-0.52	Type 2 diabetes nephropathy;	chr9:91198670	chr9:91426238~91427144:+
READ	cis	rs5753037	0.754	rs41158	ENSG00000279159.1	RP3-394A18.1	-4.92	6.16e-06	0.0158	-0.34	-0.52	Type 1 diabetes;	chr22:30009994	chr22:29978950~30028236:-
READ	cis	rs2487048	0.725	rs2246293	ENSG00000226334.1	RP11-217B7.2	4.91	6.2e-06	0.0159	0.66	0.52	Intraocular pressure;	chr9:104928557	chr9:104927553~104928892:+
READ	cis	rs7617773	0.817	rs936426	ENSG00000229759.1	MRPS18AP1	4.91	6.2e-06	0.0159	0.63	0.52	Coronary artery disease;	chr3:48173763	chr3:48256350~48256938:-
READ	cis	rs62229266	0.563	rs6517325	ENSG00000231106.2	LINC01436	4.91	6.2e-06	0.0159	0.65	0.52	Mitral valve prolapse;	chr21:36062680	chr21:36005338~36007838:+
READ	cis	rs62229266	0.693	rs2835264	ENSG00000231106.2	LINC01436	4.91	6.2e-06	0.0159	0.65	0.52	Mitral valve prolapse;	chr21:36063667	chr21:36005338~36007838:+
READ	cis	rs1799949	0.794	rs116409325	ENSG00000198496.9	NBR2	-4.91	6.22e-06	0.016	-0.59	-0.52	Menopause (age at onset);	chr17:43368092	chr17:43125610~43153671:+
READ	cis	rs7617773	0.817	rs745116	ENSG00000229759.1	MRPS18AP1	4.91	6.22e-06	0.016	0.63	0.52	Coronary artery disease;	chr3:48231046	chr3:48256350~48256938:-
READ	cis	rs12468226	1	rs7587234	ENSG00000272966.1	RP11-686O6.1	4.91	6.23e-06	0.016	0.81	0.52	Urate levels;	chr2:202351699	chr2:202336739~202337200:+
READ	cis	rs7429990	1	rs1684942	ENSG00000229759.1	MRPS18AP1	4.91	6.26e-06	0.016	0.57	0.52	Educational attainment (years of education);	chr3:47859213	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs800762	ENSG00000229759.1	MRPS18AP1	4.91	6.26e-06	0.016	0.57	0.52	Educational attainment (years of education);	chr3:47864080	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7653368	ENSG00000229759.1	MRPS18AP1	4.91	6.26e-06	0.016	0.57	0.52	Educational attainment (years of education);	chr3:47943871	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs796566	ENSG00000229759.1	MRPS18AP1	4.91	6.27e-06	0.0161	0.59	0.52	Educational attainment (years of education);	chr3:47896864	chr3:48256350~48256938:-
READ	cis	rs7429990	0.866	rs3732529	ENSG00000229759.1	MRPS18AP1	4.91	6.27e-06	0.0161	0.59	0.52	Educational attainment (years of education);	chr3:47928619	chr3:48256350~48256938:-
READ	cis	rs35160687	0.64	rs13015186	ENSG00000273080.1	RP11-301O19.1	4.91	6.29e-06	0.0161	0.6	0.52	Night sleep phenotypes;	chr2:86258455	chr2:86195590~86196049:+
READ	cis	rs977987	0.732	rs999675	ENSG00000261783.1	RP11-252K23.2	-4.91	6.29e-06	0.0161	-0.75	-0.52	Dupuytren's disease;	chr16:75272504	chr16:75379818~75381260:-
READ	cis	rs5769707	0.967	rs5769698	ENSG00000188511.11	C22orf34	4.91	6.3e-06	0.0161	0.64	0.52	Monocyte percentage of white cells;Monocyte count;	chr22:49604058	chr22:49414524~49657542:-
READ	cis	rs881375	0.967	rs1014529	ENSG00000226752.6	PSMD5-AS1	-4.91	6.32e-06	0.0162	-0.64	-0.52	Rheumatoid arthritis;	chr9:120922665	chr9:120824828~120854385:+
READ	cis	rs732716	0.785	rs62129354	ENSG00000267980.1	AC007292.6	-4.91	6.32e-06	0.0162	-0.84	-0.52	Mean corpuscular volume;	chr19:4396508	chr19:4363789~4364640:+
READ	cis	rs732716	0.74	rs62129356	ENSG00000267980.1	AC007292.6	-4.91	6.32e-06	0.0162	-0.84	-0.52	Mean corpuscular volume;	chr19:4400317	chr19:4363789~4364640:+
READ	cis	rs2929278	0.589	rs11638972	ENSG00000249839.1	AC011330.5	4.91	6.33e-06	0.0162	0.68	0.52	Schizophrenia;	chr15:43782493	chr15:43663654~43684339:-
READ	cis	rs7103411	0.637	rs6416056	ENSG00000224411.3	HSP90AA2P	4.91	6.33e-06	0.0162	0.78	0.52	Body mass index;Menarche (age at onset);Body mass index (joint analysis main effects and physical activity interaction);Body mass index in physically active individuals;	chr11:27625198	chr11:27888838~27891033:-
READ	cis	rs2882667	0.931	rs10077796	ENSG00000253404.1	AC034243.1	-4.91	6.36e-06	0.0163	-0.64	-0.52	Age-related hearing impairment (SNP x SNP interaction);	chr5:139021086	chr5:138744434~138753309:-
READ	cis	rs10256972	0.552	rs2949195	ENSG00000229043.2	AC091729.9	-4.91	6.39e-06	0.0163	-0.65	-0.52	Endometriosis;Longevity;	chr7:1163069	chr7:1160374~1165267:+
READ	cis	rs2487048	0.761	rs1800976	ENSG00000226334.1	RP11-217B7.2	-4.9	6.42e-06	0.0164	-0.66	-0.52	Intraocular pressure;	chr9:104928428	chr9:104927553~104928892:+
READ	cis	rs2487048	0.725	rs2422493	ENSG00000226334.1	RP11-217B7.2	-4.9	6.42e-06	0.0164	-0.66	-0.52	Intraocular pressure;	chr9:104928714	chr9:104927553~104928892:+
READ	cis	rs11690935	1	rs2138348	ENSG00000228389.1	AC068039.4	-4.9	6.42e-06	0.0164	-0.69	-0.52	Schizophrenia;	chr2:171701662	chr2:171773482~171775844:+
READ	cis	rs858239	0.899	rs5850	ENSG00000230658.1	KLHL7-AS1	4.9	6.43e-06	0.0164	0.69	0.52	Cerebrospinal fluid biomarker levels;	chr7:23274928	chr7:23101228~23105703:-
READ	cis	rs7208859	0.623	rs73269916	ENSG00000263531.1	RP13-753N3.1	4.9	6.54e-06	0.0166	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30769308	chr17:30863921~30864940:-
READ	cis	rs2117029	0.586	rs11168874	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49133753	chr12:49127782~49147869:+
READ	cis	rs2117029	0.523	rs12227296	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49136712	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs10875925	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49142575	chr12:49127782~49147869:+
READ	cis	rs2117029	0.586	rs11168882	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49143560	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs11168885	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49146204	chr12:49127782~49147869:+
READ	cis	rs2117029	0.554	rs12579015	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49162648	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs58336603	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49163105	chr12:49127782~49147869:+
READ	cis	rs2117029	0.553	rs1991427	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49164175	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs2114845	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49164750	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs6580702	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49169483	chr12:49127782~49147869:+
READ	cis	rs11168854	0.651	rs12227770	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Body mass index;	chr12:49183065	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs7953169	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49184389	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs12229524	ENSG00000258017.1	RP11-386G11.10	-4.9	6.54e-06	0.0166	-0.67	-0.52	Intelligence (multi-trait analysis);	chr12:49191570	chr12:49127782~49147869:+
READ	cis	rs10463554	0.963	rs26253	ENSG00000175749.11	EIF3KP1	4.9	6.54e-06	0.0166	0.63	0.52	Parkinson's disease;	chr5:103221266	chr5:103032376~103033031:+
READ	cis	rs858239	0.799	rs10279941	ENSG00000230658.1	KLHL7-AS1	4.9	6.55e-06	0.0166	0.67	0.52	Cerebrospinal fluid biomarker levels;	chr7:23330889	chr7:23101228~23105703:-
READ	cis	rs9309473	0.66	rs62151564	ENSG00000163016.8	ALMS1P	4.9	6.59e-06	0.0167	0.82	0.52	Metabolite levels;	chr2:73388321	chr2:73644919~73685576:+
READ	cis	rs7617773	0.817	rs6796490	ENSG00000229759.1	MRPS18AP1	4.89	6.66e-06	0.0169	0.61	0.52	Coronary artery disease;	chr3:48195614	chr3:48256350~48256938:-
READ	cis	rs916888	0.61	rs142167	ENSG00000214401.4	KANSL1-AS1	-4.89	6.68e-06	0.0169	-0.79	-0.52	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46717868	chr17:46193576~46196723:+
READ	cis	rs2980439	0.818	rs2948300	ENSG00000253981.4	ALG1L13P	4.89	6.71e-06	0.017	0.63	0.52	Neuroticism;	chr8:8248986	chr8:8236003~8244667:-
READ	cis	rs11690935	0.885	rs7602037	ENSG00000228389.1	AC068039.4	4.89	6.72e-06	0.017	0.66	0.52	Schizophrenia;	chr2:171961268	chr2:171773482~171775844:+
READ	cis	rs4718428	0.672	rs4718412	ENSG00000273142.1	RP11-458F8.4	4.89	6.73e-06	0.017	0.59	0.52	Corneal structure;	chr7:66821880	chr7:66902857~66906297:+
READ	cis	rs7429990	0.965	rs6770467	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47977742	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs6770477	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47977768	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs28637561	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47979528	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7427418	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47981217	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7431572	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47986361	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs13074973	ENSG00000229759.1	MRPS18AP1	-4.89	6.74e-06	0.017	-0.56	-0.52	Educational attainment (years of education);	chr3:47986654	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs7649981	ENSG00000229759.1	MRPS18AP1	4.89	6.74e-06	0.017	0.56	0.52	Educational attainment (years of education);	chr3:47957847	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs2053767	ENSG00000229759.1	MRPS18AP1	4.89	6.74e-06	0.017	0.56	0.52	Educational attainment (years of education);	chr3:47958184	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs9811277	ENSG00000229759.1	MRPS18AP1	4.89	6.74e-06	0.017	0.56	0.52	Educational attainment (years of education);	chr3:47970148	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs9814961	ENSG00000229759.1	MRPS18AP1	4.89	6.74e-06	0.017	0.56	0.52	Educational attainment (years of education);	chr3:47976127	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs11928691	ENSG00000229759.1	MRPS18AP1	4.89	6.75e-06	0.0171	0.62	0.52	Coronary artery disease;	chr3:48245275	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs9311421	ENSG00000229759.1	MRPS18AP1	4.89	6.75e-06	0.0171	0.62	0.52	Coronary artery disease;	chr3:48251588	chr3:48256350~48256938:-
READ	cis	rs2980436	1	rs2980436	ENSG00000173295.6	FAM86B3P	-4.89	6.75e-06	0.0171	-0.78	-0.52	Schizophrenia;	chr8:8234503	chr8:8228595~8244865:+
READ	cis	rs858239	0.796	rs433395	ENSG00000230658.1	KLHL7-AS1	4.89	6.75e-06	0.0171	0.65	0.52	Cerebrospinal fluid biomarker levels;	chr7:23362336	chr7:23101228~23105703:-
READ	cis	rs7617773	0.817	rs17647717	ENSG00000229759.1	MRPS18AP1	4.89	6.78e-06	0.0171	0.69	0.52	Coronary artery disease;	chr3:48263966	chr3:48256350~48256938:-
READ	cis	rs11123170	0.64	rs1015754	ENSG00000274877.1	RP11-65I12.1	4.89	6.8e-06	0.0172	0.68	0.52	Renal function-related traits (BUN);	chr2:113210413	chr2:113237595~113240825:+
READ	cis	rs10463554	0.963	rs26817	ENSG00000175749.11	EIF3KP1	-4.89	6.81e-06	0.0172	-0.61	-0.52	Parkinson's disease;	chr5:103204665	chr5:103032376~103033031:+
READ	cis	rs7429990	0.864	rs883662	ENSG00000229759.1	MRPS18AP1	4.89	6.82e-06	0.0172	0.57	0.52	Educational attainment (years of education);	chr3:47619342	chr3:48256350~48256938:-
READ	cis	rs7429990	0.828	rs11712152	ENSG00000229759.1	MRPS18AP1	4.89	6.82e-06	0.0172	0.57	0.52	Educational attainment (years of education);	chr3:47655314	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs12635438	ENSG00000229759.1	MRPS18AP1	4.89	6.82e-06	0.0172	0.57	0.52	Educational attainment (years of education);	chr3:47693210	chr3:48256350~48256938:-
READ	cis	rs9322193	0.847	rs56103941	ENSG00000268592.3	RAET1E-AS1	4.89	6.82e-06	0.0172	0.66	0.52	Lung cancer;	chr6:149816095	chr6:149863494~149919507:+
READ	cis	rs80285556	1	rs17605685	ENSG00000161643.11	SIGLEC16	4.89	6.84e-06	0.0172	1.18	0.52	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:49983484	chr19:49969673~49975814:+
READ	cis	rs10463554	0.963	rs11955683	ENSG00000175749.11	EIF3KP1	4.89	6.86e-06	0.0172	0.6	0.52	Parkinson's disease;	chr5:102990992	chr5:103032376~103033031:+
READ	cis	rs7208859	0.623	rs34756112	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30785998	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs60724269	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30786255	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs76633166	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30786347	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs1061346	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787211	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs1061343	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787258	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs1061342	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787445	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55938328	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30789992	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73269988	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30791127	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55961983	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792268	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9899525	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30793278	chr17:30863921~30864940:-
READ	cis	rs17826219	0.568	rs7213925	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Body mass index;	chr17:30794616	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs11653098	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30795483	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11658945	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30795491	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11657990	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797182	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9911784	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797562	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9911997	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797630	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9890862	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30798432	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs78071511	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30801136	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11650982	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30802937	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs2035494	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30803375	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9915546	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30805126	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9915566	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30805140	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs8064686	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30807821	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11657369	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809450	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8075341	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809547	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73271842	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30810137	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs9895815	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30811015	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs7214313	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30811578	chr17:30863921~30864940:-
READ	cis	rs7208859	0.673	rs8077116	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813144	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs28760584	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813999	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs73271850	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Body mass index;	chr17:30815122	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs79565452	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Body mass index;	chr17:30815823	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7208088	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816649	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7212991	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816731	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7208441	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816845	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs28627615	ENSG00000263531.1	RP13-753N3.1	4.89	6.87e-06	0.0172	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30818799	chr17:30863921~30864940:-
READ	cis	rs11123170	0.64	rs931472	ENSG00000274877.1	RP11-65I12.1	4.89	6.88e-06	0.0173	0.68	0.52	Renal function-related traits (BUN);	chr2:113212371	chr2:113237595~113240825:+
READ	cis	rs10463554	0.889	rs246912	ENSG00000175749.11	EIF3KP1	4.89	6.89e-06	0.0173	0.66	0.52	Parkinson's disease;	chr5:103225140	chr5:103032376~103033031:+
READ	cis	rs10463554	0.889	rs246911	ENSG00000175749.11	EIF3KP1	4.89	6.89e-06	0.0173	0.66	0.52	Parkinson's disease;	chr5:103227502	chr5:103032376~103033031:+
READ	cis	rs7208859	0.623	rs9898084	ENSG00000263531.1	RP13-753N3.1	4.89	6.9e-06	0.0173	0.87	0.52	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30755316	chr17:30863921~30864940:-
READ	cis	rs2486288	0.656	rs12440356	ENSG00000259520.4	CTD-2651B20.3	-4.89	6.9e-06	0.0173	-0.64	-0.52	Glomerular filtration rate;	chr15:45275331	chr15:45251580~45279251:-
READ	cis	rs2486288	0.656	rs11639349	ENSG00000259520.4	CTD-2651B20.3	4.89	6.9e-06	0.0173	0.64	0.52	Glomerular filtration rate;	chr15:45276062	chr15:45251580~45279251:-
READ	cis	rs7617773	0.817	rs9837228	ENSG00000229759.1	MRPS18AP1	-4.89	6.9e-06	0.0173	-0.63	-0.52	Coronary artery disease;	chr3:48282976	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs9847953	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48241205	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs11710861	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48256070	chr3:48256350~48256938:-
READ	cis	rs7617773	0.784	rs9850672	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48259682	chr3:48256350~48256938:-
READ	cis	rs7617773	0.779	rs11718329	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48268338	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs6442111	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48270570	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs3937	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48270912	chr3:48256350~48256938:-
READ	cis	rs7617773	0.851	rs6775179	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48271928	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6800492	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48282400	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs9818937	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48283791	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6801801	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48284943	chr3:48256350~48256938:-
READ	cis	rs7617773	0.779	rs9833309	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48285960	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs9853804	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48286239	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs9834095	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48286261	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs4131361	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48287322	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs4131362	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48287546	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6791930	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48288410	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs6794644	ENSG00000229759.1	MRPS18AP1	4.89	6.9e-06	0.0173	0.63	0.52	Coronary artery disease;	chr3:48288547	chr3:48256350~48256938:-
READ	cis	rs2836754	0.625	rs2836759	ENSG00000235888.1	AF064858.8	4.88	6.91e-06	0.0173	0.7	0.52	Body mass index;Crohn's disease;	chr21:38923252	chr21:38988707~39006153:-
READ	cis	rs2455601	0.744	rs2163626	ENSG00000254860.4	TMEM9B-AS1	4.88	6.93e-06	0.0173	0.75	0.52	Schizophrenia;	chr11:8962000	chr11:8964675~8977527:+
READ	cis	rs1577917	0.916	rs4142546	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85795593	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs6900436	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85796570	chr6:85660950~85678736:-
READ	cis	rs1577917	0.687	rs1470531	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85797651	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs4707223	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85800084	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs4618490	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85808685	chr6:85660950~85678736:-
READ	cis	rs1577917	0.916	rs7759727	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85809160	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12196230	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85810242	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12216074	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85810284	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12191340	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85811682	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1414199	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85812652	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs34994386	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85814417	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs36042496	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85814496	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs1584273	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85814859	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12198971	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85815727	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs34230196	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85816304	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs4707226	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85818110	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs10455448	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85823893	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs12212808	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85824254	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs13196576	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85824348	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs13213603	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85825040	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs3857480	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85825431	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2324839	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85827224	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs3900313	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85827436	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs2218594	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85834048	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2197648	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85834169	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2100109	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85835208	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1447160	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85836405	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs4707229	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85836519	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12198061	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85841267	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1838955	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85855731	chr6:85660950~85678736:-
READ	cis	rs1577917	0.874	rs1838954	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85855760	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs11752223	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85863676	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12660846	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85864091	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs7739241	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85866078	chr6:85660950~85678736:-
READ	cis	rs1577917	0.837	rs10944157	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85867481	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12202712	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85868823	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs4707236	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85874249	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs2166663	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85884178	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs16876530	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85885923	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs4706254	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85893095	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs13199006	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85898990	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs4707239	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85900999	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs7766645	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85912520	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1911552	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85928306	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs9647603	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85929623	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs7747824	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85937388	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs35385043	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85938828	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs35760725	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85939267	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2660576	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85941885	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs6914463	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85943697	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs2816821	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85947366	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs2812972	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85960162	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1337843	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85965827	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs2816815	ENSG00000203875.9	SNHG5	-4.88	6.97e-06	0.0173	-0.68	-0.52	Response to antipsychotic treatment;	chr6:85981938	chr6:85660950~85678736:-
READ	cis	rs11155671	0.53	rs7742993	ENSG00000231760.4	RP11-350J20.5	4.88	6.97e-06	0.0173	0.68	0.52	Testicular germ cell tumor;	chr6:149883959	chr6:149796151~149826294:-
READ	cis	rs6095360	0.934	rs6019580	ENSG00000278231.1	RP5-906C1.1	-4.88	6.98e-06	0.0173	-0.74	-0.52	Intelligence (multi-trait analysis);	chr20:49009368	chr20:48821688~48849458:-
READ	cis	rs6095360	0.899	rs3818223	ENSG00000278231.1	RP5-906C1.1	-4.88	6.98e-06	0.0173	-0.74	-0.52	Intelligence (multi-trait analysis);	chr20:49009948	chr20:48821688~48849458:-
READ	cis	rs6095360	0.934	rs2295578	ENSG00000278231.1	RP5-906C1.1	-4.88	6.98e-06	0.0173	-0.74	-0.52	Intelligence (multi-trait analysis);	chr20:49010064	chr20:48821688~48849458:-
READ	cis	rs7617773	0.78	rs11706277	ENSG00000229759.1	MRPS18AP1	4.88	7.01e-06	0.0174	0.62	0.51	Coronary artery disease;	chr3:48318943	chr3:48256350~48256938:-
READ	cis	rs2455601	0.638	rs2742484	ENSG00000254860.4	TMEM9B-AS1	4.88	7.01e-06	0.0174	0.79	0.51	Schizophrenia;	chr11:8966536	chr11:8964675~8977527:+
READ	cis	rs2455601	0.638	rs2248245	ENSG00000254860.4	TMEM9B-AS1	4.88	7.01e-06	0.0174	0.79	0.51	Schizophrenia;	chr11:8966803	chr11:8964675~8977527:+
READ	cis	rs9322193	0.576	rs7452592	ENSG00000216906.2	RP11-350J20.9	4.88	7.03e-06	0.0174	0.7	0.51	Lung cancer;	chr6:149875445	chr6:149904243~149906418:+
READ	cis	rs10463554	0.963	rs26254	ENSG00000175749.11	EIF3KP1	4.88	7.06e-06	0.0175	0.64	0.51	Parkinson's disease;	chr5:103221158	chr5:103032376~103033031:+
READ	cis	rs13113518	0.812	rs7667741	ENSG00000223305.1	RN7SKP30	4.88	7.06e-06	0.0175	0.62	0.51	Height;	chr4:55544621	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs13140590	ENSG00000223305.1	RN7SKP30	4.88	7.06e-06	0.0175	0.62	0.51	Height;	chr4:55548666	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs13116035	ENSG00000223305.1	RN7SKP30	4.88	7.06e-06	0.0175	0.62	0.51	Height;	chr4:55561218	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs2171618	ENSG00000223305.1	RN7SKP30	4.88	7.06e-06	0.0175	0.62	0.51	Height;	chr4:55564241	chr4:55540502~55540835:-
READ	cis	rs9322193	0.923	rs2342857	ENSG00000216906.2	RP11-350J20.9	4.88	7.11e-06	0.0176	0.67	0.51	Lung cancer;	chr6:149809537	chr6:149904243~149906418:+
READ	cis	rs6095360	0.934	rs6095395	ENSG00000278231.1	RP5-906C1.1	-4.88	7.12e-06	0.0176	-0.78	-0.51	Intelligence (multi-trait analysis);	chr20:49010558	chr20:48821688~48849458:-
READ	cis	rs9545047	0.935	rs1577416	ENSG00000227676.3	LINC01068	-4.88	7.15e-06	0.0177	-0.6	-0.51	Schizophrenia;	chr13:79500646	chr13:79566727~79571436:+
READ	cis	rs9545047	0.905	rs9318644	ENSG00000227676.3	LINC01068	-4.88	7.15e-06	0.0177	-0.6	-0.51	Schizophrenia;	chr13:79510042	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs7339303	ENSG00000227676.3	LINC01068	-4.88	7.15e-06	0.0177	-0.6	-0.51	Schizophrenia;	chr13:79516730	chr13:79566727~79571436:+
READ	cis	rs9545047	0.905	rs7321953	ENSG00000227676.3	LINC01068	-4.88	7.15e-06	0.0177	-0.6	-0.51	Schizophrenia;	chr13:79517404	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs2783119	ENSG00000227676.3	LINC01068	4.88	7.15e-06	0.0177	0.6	0.51	Schizophrenia;	chr13:79524983	chr13:79566727~79571436:+
READ	cis	rs7429990	0.864	rs1403579	ENSG00000229759.1	MRPS18AP1	4.88	7.15e-06	0.0177	0.61	0.51	Educational attainment (years of education);	chr3:47617889	chr3:48256350~48256938:-
READ	cis	rs992157	0.835	rs2271543	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218277768	chr2:218255319~218257366:+
READ	cis	rs992157	0.717	rs3817266	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218277871	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs2292551	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218278506	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs12987180	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218279366	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs12987219	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218279426	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs4674283	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218279531	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs2045434	ENSG00000261338.2	RP11-378A13.1	-4.87	7.17e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218279775	chr2:218255319~218257366:+
READ	cis	rs992157	0.798	rs7587220	ENSG00000261338.2	RP11-378A13.1	-4.87	7.2e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218296141	chr2:218255319~218257366:+
READ	cis	rs992157	0.798	rs4674284	ENSG00000261338.2	RP11-378A13.1	-4.87	7.2e-06	0.0177	-0.63	-0.51	Colorectal cancer;	chr2:218296518	chr2:218255319~218257366:+
READ	cis	rs13068223	0.584	rs345985	ENSG00000243926.1	TIPARP-AS1	-4.87	7.23e-06	0.0178	-0.59	-0.51	Age-related hearing impairment (SNP x SNP interaction);	chr3:156679385	chr3:156671862~156674378:-
READ	cis	rs75920871	0.588	rs4548653	ENSG00000254851.1	RP11-109L13.1	4.87	7.25e-06	0.0178	0.78	0.51	Subjective well-being;	chr11:117032600	chr11:117135528~117138582:+
READ	cis	rs1577917	1	rs12200330	ENSG00000203875.9	SNHG5	-4.87	7.3e-06	0.0179	-0.69	-0.51	Response to antipsychotic treatment;	chr6:85946935	chr6:85660950~85678736:-
READ	cis	rs35160687	0.862	rs13023154	ENSG00000273080.1	RP11-301O19.1	-4.87	7.3e-06	0.0179	-0.59	-0.51	Night sleep phenotypes;	chr2:86289861	chr2:86195590~86196049:+
READ	cis	rs7429990	0.813	rs7627568	ENSG00000229759.1	MRPS18AP1	-4.87	7.31e-06	0.018	-0.59	-0.51	Educational attainment (years of education);	chr3:48051562	chr3:48256350~48256938:-
READ	cis	rs216303	0.841	rs2283333	ENSG00000224906.3	RP1-102E24.9	-4.87	7.31e-06	0.018	-0.87	-0.51	Low vWF levels;	chr12:6053686	chr12:6438498~6438852:+
READ	cis	rs3096299	0.632	rs4399533	ENSG00000274627.1	RP11-104N10.2	4.87	7.32e-06	0.018	0.57	0.51	Multiple myeloma (IgH translocation);	chr16:89472974	chr16:89516797~89522217:+
READ	cis	rs4938330	0.512	rs4938327	ENSG00000254851.1	RP11-109L13.1	4.87	7.34e-06	0.018	0.77	0.51	Blood protein levels;	chr11:117036012	chr11:117135528~117138582:+
READ	cis	rs75920871	0.588	rs3181	ENSG00000254851.1	RP11-109L13.1	4.87	7.34e-06	0.018	0.77	0.51	Subjective well-being;	chr11:117036327	chr11:117135528~117138582:+
READ	cis	rs75920871	0.588	rs721783	ENSG00000254851.1	RP11-109L13.1	4.87	7.34e-06	0.018	0.77	0.51	Subjective well-being;	chr11:117036733	chr11:117135528~117138582:+
READ	cis	rs75920871	0.588	rs7118591	ENSG00000254851.1	RP11-109L13.1	-4.87	7.34e-06	0.018	-0.77	-0.51	Subjective well-being;	chr11:117037741	chr11:117135528~117138582:+
READ	cis	rs1577917	1	rs6454513	ENSG00000203875.9	SNHG5	4.87	7.35e-06	0.018	0.68	0.51	Response to antipsychotic treatment;	chr6:86010331	chr6:85660950~85678736:-
READ	cis	rs9322193	0.962	rs9397022	ENSG00000216906.2	RP11-350J20.9	4.87	7.36e-06	0.0181	0.65	0.51	Lung cancer;	chr6:149812052	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9397357	ENSG00000216906.2	RP11-350J20.9	4.87	7.36e-06	0.0181	0.65	0.51	Lung cancer;	chr6:149812465	chr6:149904243~149906418:+
READ	cis	rs1799949	0.965	rs799917	ENSG00000198496.9	NBR2	-4.87	7.36e-06	0.0181	-0.58	-0.51	Menopause (age at onset);	chr17:43092919	chr17:43125610~43153671:+
READ	cis	rs9322193	0.884	rs10872647	ENSG00000268592.3	RAET1E-AS1	4.87	7.37e-06	0.0181	0.66	0.51	Lung cancer;	chr6:149758687	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs10872648	ENSG00000268592.3	RAET1E-AS1	4.87	7.37e-06	0.0181	0.66	0.51	Lung cancer;	chr6:149758699	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs11155679	ENSG00000268592.3	RAET1E-AS1	4.87	7.37e-06	0.0181	0.66	0.51	Lung cancer;	chr6:149758881	chr6:149863494~149919507:+
READ	cis	rs2739330	0.76	rs1007888	ENSG00000250470.1	AP000351.3	4.87	7.39e-06	0.0181	0.71	0.51	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23976904~23977585:-
READ	cis	rs2929278	0.617	rs3087657	ENSG00000249839.1	AC011330.5	-4.87	7.41e-06	0.0181	-0.68	-0.51	Schizophrenia;	chr15:43771661	chr15:43663654~43684339:-
READ	cis	rs9322193	0.847	rs868375	ENSG00000268592.3	RAET1E-AS1	4.87	7.43e-06	0.0182	0.64	0.51	Lung cancer;	chr6:149844905	chr6:149863494~149919507:+
READ	cis	rs12130219	0.5	rs1552991	ENSG00000237975.5	FLG-AS1	-4.86	7.47e-06	0.0183	-0.7	-0.51	Inflammatory skin disease;	chr1:152193402	chr1:152168125~152445456:+
READ	cis	rs55879323	1	rs55879323	ENSG00000237975.5	FLG-AS1	-4.86	7.47e-06	0.0183	-0.7	-0.51	Inflammatory skin disease;	chr1:152196264	chr1:152168125~152445456:+
READ	cis	rs12130219	0.5	rs4845737	ENSG00000237975.5	FLG-AS1	-4.86	7.47e-06	0.0183	-0.7	-0.51	Inflammatory skin disease;	chr1:152205063	chr1:152168125~152445456:+
READ	cis	rs7160336	0.628	rs12893501	ENSG00000259065.1	RP5-1021I20.1	4.86	7.49e-06	0.0183	0.71	0.51	Blood protein levels;	chr14:73990459	chr14:73787360~73803270:+
READ	cis	rs11690935	0.851	rs10930502	ENSG00000228389.1	AC068039.4	4.86	7.49e-06	0.0183	0.66	0.51	Schizophrenia;	chr2:172025679	chr2:171773482~171775844:+
READ	cis	rs748404	0.56	rs2255663	ENSG00000249839.1	AC011330.5	4.86	7.5e-06	0.0183	0.64	0.51	Lung cancer;	chr15:43536810	chr15:43663654~43684339:-
READ	cis	rs80285556	1	rs79633979	ENSG00000161643.11	SIGLEC16	4.86	7.59e-06	0.0185	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:49985355	chr19:49969673~49975814:+
READ	cis	rs80285556	0.51	rs75463146	ENSG00000161643.11	SIGLEC16	4.86	7.59e-06	0.0185	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:49989087	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs80202648	ENSG00000161643.11	SIGLEC16	4.86	7.59e-06	0.0185	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:49991129	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs111902838	ENSG00000161643.11	SIGLEC16	4.86	7.59e-06	0.0185	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:49993357	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs77187281	ENSG00000161643.11	SIGLEC16	4.86	7.59e-06	0.0185	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50004410	chr19:49969673~49975814:+
READ	cis	rs75920871	0.557	rs7123336	ENSG00000254851.1	RP11-109L13.1	4.86	7.63e-06	0.0186	0.75	0.51	Subjective well-being;	chr11:116912103	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs983567	ENSG00000254851.1	RP11-109L13.1	4.86	7.63e-06	0.0186	0.75	0.51	Subjective well-being;	chr11:116912884	chr11:117135528~117138582:+
READ	cis	rs17301013	0.932	rs4233195	ENSG00000227373.4	RP11-160H22.5	-4.86	7.63e-06	0.0186	-0.68	-0.51	Systemic lupus erythematosus;	chr1:174806736	chr1:174115300~174160004:-
READ	cis	rs1577917	0.74	rs2758843	ENSG00000203875.9	SNHG5	-4.86	7.64e-06	0.0186	-0.66	-0.51	Response to antipsychotic treatment;	chr6:85618713	chr6:85660950~85678736:-
READ	cis	rs7208859	0.573	rs11654035	ENSG00000263531.1	RP13-753N3.1	4.86	7.67e-06	0.0187	0.94	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809408	chr17:30863921~30864940:-
READ	cis	rs9487094	0.666	rs4946967	ENSG00000260273.1	RP11-425D10.10	4.86	7.68e-06	0.0187	0.62	0.51	Height;	chr6:109357369	chr6:109382795~109383666:+
READ	cis	rs7429990	0.833	rs869508	ENSG00000229759.1	MRPS18AP1	4.86	7.68e-06	0.0187	0.57	0.51	Educational attainment (years of education);	chr3:47571812	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13085978	ENSG00000229759.1	MRPS18AP1	4.86	7.68e-06	0.0187	0.57	0.51	Educational attainment (years of education);	chr3:47608585	chr3:48256350~48256938:-
READ	cis	rs7429990	0.727	rs61675361	ENSG00000229759.1	MRPS18AP1	4.86	7.68e-06	0.0187	0.57	0.51	Educational attainment (years of education);	chr3:47610630	chr3:48256350~48256938:-
READ	cis	rs11155671	0.53	rs7742993	ENSG00000268592.3	RAET1E-AS1	4.86	7.69e-06	0.0187	0.64	0.51	Testicular germ cell tumor;	chr6:149883959	chr6:149863494~149919507:+
READ	cis	rs17826219	0.568	rs2626985	ENSG00000263531.1	RP13-753N3.1	4.86	7.7e-06	0.0187	0.87	0.51	Body mass index;	chr17:30750419	chr17:30863921~30864940:-
READ	cis	rs2019137	0.868	rs3748916	ENSG00000274877.1	RP11-65I12.1	4.86	7.71e-06	0.0188	0.56	0.51	Lymphocyte counts;	chr2:113226456	chr2:113237595~113240825:+
READ	cis	rs12130219	0.5	rs4845743	ENSG00000237975.5	FLG-AS1	-4.85	7.72e-06	0.0188	-0.71	-0.51	Inflammatory skin disease;	chr1:152211673	chr1:152168125~152445456:+
READ	cis	rs453301	0.631	rs17700611	ENSG00000233609.3	RP11-62H7.2	-4.85	7.73e-06	0.0188	-0.63	-0.51	Joint mobility (Beighton score);	chr8:8936144	chr8:8961200~8979025:+
READ	cis	rs7617773	0.71	rs36064160	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48201611	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs17786132	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48207930	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs35456569	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48209409	chr3:48256350~48256938:-
READ	cis	rs7617773	0.784	rs11715799	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48213730	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs34728236	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48217618	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs79310258	ENSG00000229759.1	MRPS18AP1	4.85	7.76e-06	0.0189	0.64	0.51	Coronary artery disease;	chr3:48218177	chr3:48256350~48256938:-
READ	cis	rs732716	0.719	rs56088814	ENSG00000267980.1	AC007292.6	-4.85	7.76e-06	0.0189	-0.83	-0.51	Mean corpuscular volume;	chr19:4422181	chr19:4363789~4364640:+
READ	cis	rs9545047	0.935	rs8002042	ENSG00000227676.3	LINC01068	-4.85	7.77e-06	0.0189	-0.6	-0.51	Schizophrenia;	chr13:79486552	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs6563113	ENSG00000227676.3	LINC01068	-4.85	7.77e-06	0.0189	-0.6	-0.51	Schizophrenia;	chr13:79490000	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs9530925	ENSG00000227676.3	LINC01068	-4.85	7.77e-06	0.0189	-0.6	-0.51	Schizophrenia;	chr13:79492641	chr13:79566727~79571436:+
READ	cis	rs1799949	0.965	rs9897425	ENSG00000198496.9	NBR2	-4.85	7.78e-06	0.0189	-0.61	-0.51	Menopause (age at onset);	chr17:43352811	chr17:43125610~43153671:+
READ	cis	rs2111504	0.559	rs12460112	ENSG00000267213.4	AC007773.2	4.85	7.79e-06	0.0189	0.66	0.51	Bipolar disorder;	chr19:32363928	chr19:32390050~32405560:-
READ	cis	rs2111504	0.583	rs2111503	ENSG00000267213.4	AC007773.2	4.85	7.79e-06	0.0189	0.66	0.51	Bipolar disorder;	chr19:32383819	chr19:32390050~32405560:-
READ	cis	rs2111504	0.583	rs1015839	ENSG00000267213.4	AC007773.2	4.85	7.79e-06	0.0189	0.66	0.51	Bipolar disorder;	chr19:32390365	chr19:32390050~32405560:-
READ	cis	rs9545047	0.901	rs7982263	ENSG00000227676.3	LINC01068	-4.85	7.79e-06	0.0189	-0.62	-0.51	Schizophrenia;	chr13:79486939	chr13:79566727~79571436:+
READ	cis	rs11690935	1	rs312924	ENSG00000228389.1	AC068039.4	-4.85	7.8e-06	0.0189	-0.68	-0.51	Schizophrenia;	chr2:171707511	chr2:171773482~171775844:+
READ	cis	rs10256972	0.567	rs2949185	ENSG00000229043.2	AC091729.9	-4.85	7.83e-06	0.019	-0.64	-0.51	Endometriosis;Longevity;	chr7:1169377	chr7:1160374~1165267:+
READ	cis	rs10256972	0.552	rs7805591	ENSG00000229043.2	AC091729.9	-4.85	7.83e-06	0.019	-0.64	-0.51	Endometriosis;Longevity;	chr7:1171109	chr7:1160374~1165267:+
READ	cis	rs1577917	0.958	rs2084294	ENSG00000203875.9	SNHG5	-4.85	7.84e-06	0.019	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85856225	chr6:85660950~85678736:-
READ	cis	rs10463554	1	rs11949145	ENSG00000175749.11	EIF3KP1	4.85	7.84e-06	0.019	0.6	0.51	Parkinson's disease;	chr5:102994552	chr5:103032376~103033031:+
READ	cis	rs2929278	0.638	rs2016840	ENSG00000249839.1	AC011330.5	4.85	7.84e-06	0.019	0.7	0.51	Schizophrenia;	chr15:43919670	chr15:43663654~43684339:-
READ	cis	rs12439619	0.53	rs28883606	ENSG00000278603.1	RP13-608F4.5	4.85	7.85e-06	0.019	0.67	0.51	Intelligence (multi-trait analysis);	chr15:82216713	chr15:82472203~82472426:+
READ	cis	rs12439619	0.693	rs28665836	ENSG00000278603.1	RP13-608F4.5	4.85	7.85e-06	0.019	0.67	0.51	Intelligence (multi-trait analysis);	chr15:82218955	chr15:82472203~82472426:+
READ	cis	rs10463554	0.853	rs2432177	ENSG00000175749.11	EIF3KP1	4.85	7.85e-06	0.019	0.67	0.51	Parkinson's disease;	chr5:103236172	chr5:103032376~103033031:+
READ	cis	rs6095360	0.934	rs6012581	ENSG00000278231.1	RP5-906C1.1	-4.85	7.87e-06	0.0191	-0.74	-0.51	Intelligence (multi-trait analysis);	chr20:49011308	chr20:48821688~48849458:-
READ	cis	rs79040073	0.637	rs8027094	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49388639	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs8030457	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49392809	chr15:49365124~49366685:-
READ	cis	rs79040073	0.599	rs17477722	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49394220	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73398243	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49394344	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs79365293	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49402268	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs113885253	ENSG00000259531.2	RP11-295H24.3	4.85	7.95e-06	0.0192	0.78	0.51	Lung cancer in ever smokers;	chr15:49402615	chr15:49365124~49366685:-
READ	cis	rs2739330	0.731	rs2000468	ENSG00000250470.1	AP000351.3	4.84	8.01e-06	0.0194	0.72	0.51	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23976904~23977585:-
READ	cis	rs11155671	0.53	rs7758033	ENSG00000268592.3	RAET1E-AS1	4.84	8.05e-06	0.0195	0.65	0.51	Testicular germ cell tumor;	chr6:149886999	chr6:149863494~149919507:+
READ	cis	rs17301013	0.606	rs55698100	ENSG00000227373.4	RP11-160H22.5	4.84	8.06e-06	0.0195	0.77	0.51	Systemic lupus erythematosus;	chr1:174258295	chr1:174115300~174160004:-
READ	cis	rs9487094	0.689	rs4636056	ENSG00000260273.1	RP11-425D10.10	4.84	8.08e-06	0.0195	0.64	0.51	Height;	chr6:109409679	chr6:109382795~109383666:+
READ	cis	rs4700393	0.967	rs4700394	ENSG00000215032.2	GNL3LP1	-4.84	8.08e-06	0.0195	-0.58	-0.51	Intelligence (multi-trait analysis);	chr5:60821375	chr5:60891935~60893577:-
READ	cis	rs773506	0.655	rs9792456	ENSG00000233081.1	RP11-440G5.2	4.84	8.12e-06	0.0196	0.65	0.51	Type 2 diabetes nephropathy;	chr9:91206063	chr9:91426238~91427144:+
READ	cis	rs115769866	0.609	rs974334	ENSG00000218069.2	RSL24D1P1	-4.84	8.13e-06	0.0196	-0.98	-0.51	Bipolar disorder;	chr6:28506441	chr6:27780619~27781111:-
READ	cis	rs1577917	1	rs12664335	ENSG00000203875.9	SNHG5	4.84	8.13e-06	0.0196	0.68	0.51	Response to antipsychotic treatment;	chr6:85888056	chr6:85660950~85678736:-
READ	cis	rs9425766	0.679	rs2901785	ENSG00000227373.4	RP11-160H22.5	4.84	8.13e-06	0.0196	0.68	0.51	Life satisfaction;	chr1:174135605	chr1:174115300~174160004:-
READ	cis	rs2117029	0.556	rs1057725	ENSG00000258017.1	RP11-386G11.10	-4.84	8.16e-06	0.0197	-0.68	-0.51	Intelligence (multi-trait analysis);	chr12:49128795	chr12:49127782~49147869:+
READ	cis	rs7429990	0.93	rs11130152	ENSG00000229759.1	MRPS18AP1	-4.84	8.21e-06	0.0198	-0.58	-0.51	Educational attainment (years of education);	chr3:48014919	chr3:48256350~48256938:-
READ	cis	rs916888	0.61	rs199438	ENSG00000214401.4	KANSL1-AS1	4.84	8.21e-06	0.0198	0.8	0.51	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46714277	chr17:46193576~46196723:+
READ	cis	rs1577917	0.74	rs9450302	ENSG00000203875.9	SNHG5	4.84	8.21e-06	0.0198	0.67	0.51	Response to antipsychotic treatment;	chr6:85579955	chr6:85660950~85678736:-
READ	cis	rs2243480	1	rs10807702	ENSG00000273142.1	RP11-458F8.4	-4.84	8.27e-06	0.0199	-0.8	-0.51	Diabetic kidney disease;	chr7:66302856	chr7:66902857~66906297:+
READ	cis	rs12468226	1	rs13389798	ENSG00000272966.1	RP11-686O6.1	4.84	8.28e-06	0.0199	0.78	0.51	Urate levels;	chr2:202348370	chr2:202336739~202337200:+
READ	cis	rs9322193	0.886	rs2065663	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149760331	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs12205092	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149761375	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs10872651	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149768273	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs3805749	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149772546	chr6:149863494~149919507:+
READ	cis	rs9322193	0.847	rs9505972	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149775255	chr6:149863494~149919507:+
READ	cis	rs9322193	0.962	rs3805752	ENSG00000268592.3	RAET1E-AS1	4.84	8.3e-06	0.02	0.65	0.51	Lung cancer;	chr6:149795490	chr6:149863494~149919507:+
READ	cis	rs7429990	0.901	rs7431567	ENSG00000229759.1	MRPS18AP1	-4.83	8.34e-06	0.02	-0.58	-0.51	Educational attainment (years of education);	chr3:47986342	chr3:48256350~48256938:-
READ	cis	rs1577917	0.958	rs6454488	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85741124	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13207173	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85747804	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs34795473	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85752081	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs4098044	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85752348	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2324817	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85752936	chr6:85660950~85678736:-
READ	cis	rs1577917	0.837	rs806529	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85757403	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs6921315	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85761950	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12192033	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85762841	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12190603	ENSG00000203875.9	SNHG5	-4.83	8.35e-06	0.02	-0.65	-0.51	Response to antipsychotic treatment;	chr6:85766000	chr6:85660950~85678736:-
READ	cis	rs7617773	0.746	rs6796343	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48240531	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs13100815	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48245959	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs13059037	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48246389	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs35414021	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48252034	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs13068265	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48260124	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs11709691	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48262179	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs34225441	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48267401	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs13072018	ENSG00000229759.1	MRPS18AP1	4.83	8.36e-06	0.02	0.64	0.51	Coronary artery disease;	chr3:48278842	chr3:48256350~48256938:-
READ	cis	rs3096299	0.685	rs12935112	ENSG00000274627.1	RP11-104N10.2	-4.83	8.36e-06	0.02	-0.53	-0.51	Multiple myeloma (IgH translocation);	chr16:89476450	chr16:89516797~89522217:+
READ	cis	rs7429990	0.965	rs13075795	ENSG00000229759.1	MRPS18AP1	-4.83	8.37e-06	0.0201	-0.57	-0.51	Educational attainment (years of education);	chr3:47983139	chr3:48256350~48256938:-
READ	cis	rs17301013	0.531	rs4650958	ENSG00000227373.4	RP11-160H22.5	4.83	8.39e-06	0.0201	0.77	0.51	Systemic lupus erythematosus;	chr1:174178378	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs2860907	ENSG00000227373.4	RP11-160H22.5	4.83	8.39e-06	0.0201	0.77	0.51	Systemic lupus erythematosus;	chr1:174203246	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs4607949	ENSG00000227373.4	RP11-160H22.5	4.83	8.39e-06	0.0201	0.77	0.51	Systemic lupus erythematosus;	chr1:174212218	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912747	ENSG00000227373.4	RP11-160H22.5	-4.83	8.39e-06	0.0201	-0.77	-0.51	Systemic lupus erythematosus;	chr1:174224564	chr1:174115300~174160004:-
READ	cis	rs992157	0.731	rs1399132	ENSG00000261338.2	RP11-378A13.1	4.83	8.42e-06	0.0202	0.62	0.51	Colorectal cancer;	chr2:218295047	chr2:218255319~218257366:+
READ	cis	rs992157	0.796	rs55680399	ENSG00000261338.2	RP11-378A13.1	4.83	8.42e-06	0.0202	0.62	0.51	Colorectal cancer;	chr2:218295898	chr2:218255319~218257366:+
READ	cis	rs992157	0.798	rs4996257	ENSG00000261338.2	RP11-378A13.1	4.83	8.42e-06	0.0202	0.62	0.51	Colorectal cancer;	chr2:218298113	chr2:218255319~218257366:+
READ	cis	rs11155671	0.53	rs7758033	ENSG00000231760.4	RP11-350J20.5	4.83	8.42e-06	0.0202	0.69	0.51	Testicular germ cell tumor;	chr6:149886999	chr6:149796151~149826294:-
READ	cis	rs6095360	1	rs6019535	ENSG00000278231.1	RP5-906C1.1	-4.83	8.44e-06	0.0202	-0.73	-0.51	Intelligence (multi-trait analysis);	chr20:48924980	chr20:48821688~48849458:-
READ	cis	rs6095360	1	rs34984028	ENSG00000278231.1	RP5-906C1.1	-4.83	8.44e-06	0.0202	-0.73	-0.51	Intelligence (multi-trait analysis);	chr20:48932510	chr20:48821688~48849458:-
READ	cis	rs1799949	0.965	rs799912	ENSG00000198496.9	NBR2	-4.83	8.46e-06	0.0202	-0.58	-0.51	Menopause (age at onset);	chr17:43105117	chr17:43125610~43153671:+
READ	cis	rs992157	0.835	rs10932768	ENSG00000261338.2	RP11-378A13.1	-4.83	8.5e-06	0.0203	-0.62	-0.51	Colorectal cancer;	chr2:218281476	chr2:218255319~218257366:+
READ	cis	rs10129255	1	rs11627342	ENSG00000211972.2	IGHV3-66	4.83	8.5e-06	0.0203	0.48	0.51	Kawasaki disease;	chr14:106675823	chr14:106675017~106675544:-
READ	cis	rs10129255	1	rs9324091	ENSG00000211972.2	IGHV3-66	4.83	8.5e-06	0.0203	0.48	0.51	Kawasaki disease;	chr14:106676625	chr14:106675017~106675544:-
READ	cis	rs10129255	1	rs61997605	ENSG00000211972.2	IGHV3-66	4.83	8.5e-06	0.0203	0.48	0.51	Kawasaki disease;	chr14:106678368	chr14:106675017~106675544:-
READ	cis	rs3096299	0.754	rs2965942	ENSG00000274627.1	RP11-104N10.2	4.83	8.52e-06	0.0203	0.59	0.51	Multiple myeloma (IgH translocation);	chr16:89443919	chr16:89516797~89522217:+
READ	cis	rs7429990	0.965	rs1061003	ENSG00000229759.1	MRPS18AP1	4.83	8.52e-06	0.0203	0.56	0.51	Educational attainment (years of education);	chr3:47851089	chr3:48256350~48256938:-
READ	cis	rs9309473	0.66	rs17349321	ENSG00000163016.8	ALMS1P	4.83	8.52e-06	0.0204	0.82	0.51	Metabolite levels;	chr2:73416625	chr2:73644919~73685576:+
READ	cis	rs7617773	0.817	rs3731555	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48164612	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs3731550	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48165093	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs3731534	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48170287	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs3731513	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48178047	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs3731489	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48187416	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs3729577	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48187504	chr3:48256350~48256938:-
READ	cis	rs7617773	0.779	rs3731487	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48188134	chr3:48256350~48256938:-
READ	cis	rs7617773	0.851	rs7647817	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48195017	chr3:48256350~48256938:-
READ	cis	rs7617773	0.817	rs11707606	ENSG00000229759.1	MRPS18AP1	4.83	8.54e-06	0.0204	0.64	0.51	Coronary artery disease;	chr3:48195597	chr3:48256350~48256938:-
READ	cis	rs10463554	1	rs56372231	ENSG00000175749.11	EIF3KP1	4.83	8.56e-06	0.0204	0.59	0.51	Parkinson's disease;	chr5:102986201	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs11242483	ENSG00000175749.11	EIF3KP1	4.83	8.56e-06	0.0204	0.59	0.51	Parkinson's disease;	chr5:102988062	chr5:103032376~103033031:+
READ	cis	rs12468226	1	rs7597156	ENSG00000272966.1	RP11-686O6.1	4.83	8.58e-06	0.0204	0.77	0.51	Urate levels;	chr2:202329339	chr2:202336739~202337200:+
READ	cis	rs9938149	0.706	rs58657775	ENSG00000260630.5	SNAI3-AS1	-4.83	8.6e-06	0.0205	-0.82	-0.51	Central corneal thickness;Corneal structure;	chr16:88290223	chr16:88663298~88687186:+
READ	cis	rs6095360	1	rs6019547	ENSG00000278231.1	RP5-906C1.1	-4.83	8.6e-06	0.0205	-0.74	-0.51	Intelligence (multi-trait analysis);	chr20:48944554	chr20:48821688~48849458:-
READ	cis	rs2117029	0.619	rs2241727	ENSG00000258017.1	RP11-386G11.10	-4.83	8.62e-06	0.0205	-0.68	-0.51	Intelligence (multi-trait analysis);	chr12:49131225	chr12:49127782~49147869:+
READ	cis	rs9322193	0.923	rs10872650	ENSG00000268592.3	RAET1E-AS1	4.83	8.63e-06	0.0205	0.65	0.51	Lung cancer;	chr6:149760959	chr6:149863494~149919507:+
READ	cis	rs9660180	0.934	rs12729990	ENSG00000231050.1	RP1-140A9.1	4.82	8.63e-06	0.0205	0.68	0.51	Body mass index;	chr1:1880596	chr1:1891471~1892658:+
READ	cis	rs9660180	0.967	rs6603802	ENSG00000231050.1	RP1-140A9.1	4.82	8.63e-06	0.0205	0.68	0.51	Body mass index;	chr1:1881082	chr1:1891471~1892658:+
READ	cis	rs9660180	0.967	rs11260623	ENSG00000231050.1	RP1-140A9.1	4.82	8.71e-06	0.0207	0.68	0.51	Body mass index;	chr1:1850017	chr1:1891471~1892658:+
READ	cis	rs9660180	0.967	rs9660106	ENSG00000231050.1	RP1-140A9.1	4.82	8.71e-06	0.0207	0.68	0.51	Body mass index;	chr1:1866508	chr1:1891471~1892658:+
READ	cis	rs2117029	0.587	rs57853986	ENSG00000258017.1	RP11-386G11.10	-4.82	8.73e-06	0.0207	-0.68	-0.51	Intelligence (multi-trait analysis);	chr12:49124612	chr12:49127782~49147869:+
READ	cis	rs67180937	0.582	rs71524942	ENSG00000272750.1	RP11-378J18.8	-4.82	8.73e-06	0.0207	-0.74	-0.51	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222689650	chr1:222658867~222661512:-
READ	cis	rs2929278	0.561	rs62018952	ENSG00000249839.1	AC011330.5	4.82	8.73e-06	0.0207	0.69	0.51	Schizophrenia;	chr15:43788539	chr15:43663654~43684339:-
READ	cis	rs732716	0.785	rs62129354	ENSG00000267769.1	CTB-50L17.9	-4.82	8.73e-06	0.0207	-0.71	-0.51	Mean corpuscular volume;	chr19:4396508	chr19:4454014~4455286:+
READ	cis	rs732716	0.74	rs62129356	ENSG00000267769.1	CTB-50L17.9	-4.82	8.73e-06	0.0207	-0.71	-0.51	Mean corpuscular volume;	chr19:4400317	chr19:4454014~4455286:+
READ	cis	rs2117029	0.619	rs2753	ENSG00000258017.1	RP11-386G11.10	-4.82	8.74e-06	0.0208	-0.67	-0.51	Intelligence (multi-trait analysis);	chr12:49127889	chr12:49127782~49147869:+
READ	cis	rs1577917	0.958	rs10944137	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85744596	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs34622605	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85746801	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12212480	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85749059	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1335442	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85756974	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13213899	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85763422	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs10806337	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85764531	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12205492	ENSG00000203875.9	SNHG5	-4.82	8.75e-06	0.0208	-0.67	-0.51	Response to antipsychotic treatment;	chr6:85766258	chr6:85660950~85678736:-
READ	cis	rs1799949	0.773	rs2137990	ENSG00000198496.9	NBR2	4.82	8.75e-06	0.0208	0.59	0.51	Menopause (age at onset);	chr17:43165879	chr17:43125610~43153671:+
READ	cis	rs10129255	1	rs4612959	ENSG00000211972.2	IGHV3-66	4.82	8.76e-06	0.0208	0.49	0.51	Kawasaki disease;	chr14:106767055	chr14:106675017~106675544:-
READ	cis	rs10129255	1	rs10129407	ENSG00000211972.2	IGHV3-66	4.82	8.76e-06	0.0208	0.49	0.51	Kawasaki disease;	chr14:106767956	chr14:106675017~106675544:-
READ	cis	rs10463554	0.963	rs257115	ENSG00000175749.11	EIF3KP1	4.82	8.76e-06	0.0208	0.63	0.51	Parkinson's disease;	chr5:103196107	chr5:103032376~103033031:+
READ	cis	rs9660180	0.837	rs915292	ENSG00000231050.1	RP1-140A9.1	4.82	8.76e-06	0.0208	0.68	0.51	Body mass index;	chr1:1860718	chr1:1891471~1892658:+
READ	cis	rs3096299	0.503	rs4785677	ENSG00000274627.1	RP11-104N10.2	4.82	8.78e-06	0.0208	0.59	0.51	Multiple myeloma (IgH translocation);	chr16:89488693	chr16:89516797~89522217:+
READ	cis	rs3096299	0.503	rs9940093	ENSG00000274627.1	RP11-104N10.2	4.82	8.78e-06	0.0208	0.59	0.51	Multiple myeloma (IgH translocation);	chr16:89492297	chr16:89516797~89522217:+
READ	cis	rs80285556	1	rs10500303	ENSG00000161643.11	SIGLEC16	4.82	8.78e-06	0.0208	1.17	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50008776	chr19:49969673~49975814:+
READ	cis	rs7829975	0.688	rs7827182	ENSG00000253981.4	ALG1L13P	4.82	8.79e-06	0.0208	0.59	0.51	Mood instability;	chr8:8522961	chr8:8236003~8244667:-
READ	cis	rs1799949	0.965	rs799910	ENSG00000198496.9	NBR2	-4.82	8.79e-06	0.0208	-0.58	-0.51	Menopause (age at onset);	chr17:43127544	chr17:43125610~43153671:+
READ	cis	rs80285556	1	rs80285556	ENSG00000161643.11	SIGLEC16	4.82	8.81e-06	0.0209	1.16	0.51	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50036913	chr19:49969673~49975814:+
READ	cis	rs7617773	0.817	rs3731497	ENSG00000229759.1	MRPS18AP1	4.82	8.82e-06	0.0209	0.64	0.51	Coronary artery disease;	chr3:48185063	chr3:48256350~48256938:-
READ	cis	rs2117029	0.521	rs12227610	ENSG00000258017.1	RP11-386G11.10	-4.82	8.82e-06	0.0209	-0.67	-0.51	Intelligence (multi-trait analysis);	chr12:49146153	chr12:49127782~49147869:+
READ	cis	rs748404	0.631	rs7167882	ENSG00000249839.1	AC011330.5	-4.82	8.86e-06	0.021	-0.66	-0.51	Lung cancer;	chr15:43386465	chr15:43663654~43684339:-
READ	cis	rs748404	0.586	rs2584700	ENSG00000249839.1	AC011330.5	-4.82	8.86e-06	0.021	-0.66	-0.51	Lung cancer;	chr15:43393134	chr15:43663654~43684339:-
READ	cis	rs7429990	0.965	rs7426976	ENSG00000229759.1	MRPS18AP1	-4.81	8.96e-06	0.0212	-0.56	-0.51	Educational attainment (years of education);	chr3:47981083	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs1013431	ENSG00000229759.1	MRPS18AP1	-4.81	8.96e-06	0.0212	-0.56	-0.51	Educational attainment (years of education);	chr3:47987628	chr3:48256350~48256938:-
READ	cis	rs7429990	0.965	rs9846062	ENSG00000229759.1	MRPS18AP1	4.81	8.96e-06	0.0212	0.56	0.51	Educational attainment (years of education);	chr3:47957476	chr3:48256350~48256938:-
READ	cis	rs7429990	0.93	rs7374516	ENSG00000229759.1	MRPS18AP1	4.81	8.96e-06	0.0212	0.56	0.51	Educational attainment (years of education);	chr3:47961150	chr3:48256350~48256938:-
READ	cis	rs7429990	0.932	rs9862913	ENSG00000229759.1	MRPS18AP1	4.81	8.96e-06	0.0212	0.56	0.51	Educational attainment (years of education);	chr3:47974682	chr3:48256350~48256938:-
READ	cis	rs2929278	0.617	rs663214	ENSG00000249839.1	AC011330.5	4.81	8.96e-06	0.0212	0.7	0.51	Schizophrenia;	chr15:43821584	chr15:43663654~43684339:-
READ	cis	rs9322193	0.962	rs13215691	ENSG00000216906.2	RP11-350J20.9	4.81	8.99e-06	0.0212	0.64	0.51	Lung cancer;	chr6:149792666	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs9322223	ENSG00000216906.2	RP11-350J20.9	4.81	8.99e-06	0.0212	0.64	0.51	Lung cancer;	chr6:149801509	chr6:149904243~149906418:+
READ	cis	rs2117029	0.554	rs35884657	ENSG00000258017.1	RP11-386G11.10	-4.81	9.08e-06	0.0214	-0.67	-0.51	Intelligence (multi-trait analysis);	chr12:49137317	chr12:49127782~49147869:+
READ	cis	rs11168854	0.62	rs11168888	ENSG00000258017.1	RP11-386G11.10	-4.81	9.08e-06	0.0214	-0.67	-0.51	Body mass index;	chr12:49149614	chr12:49127782~49147869:+
READ	cis	rs11168854	0.719	rs11168902	ENSG00000258017.1	RP11-386G11.10	-4.81	9.08e-06	0.0214	-0.67	-0.51	Body mass index;	chr12:49174483	chr12:49127782~49147869:+
READ	cis	rs2117029	0.553	rs11168903	ENSG00000258017.1	RP11-386G11.10	-4.81	9.08e-06	0.0214	-0.67	-0.51	Intelligence (multi-trait analysis);	chr12:49174883	chr12:49127782~49147869:+
READ	cis	rs992157	0.835	rs4674282	ENSG00000261338.2	RP11-378A13.1	-4.81	9.09e-06	0.0214	-0.62	-0.51	Colorectal cancer;	chr2:218279507	chr2:218255319~218257366:+
READ	cis	rs1577917	0.771	rs2842613	ENSG00000203875.9	SNHG5	4.81	9.11e-06	0.0215	0.65	0.51	Response to antipsychotic treatment;	chr6:85595984	chr6:85660950~85678736:-
READ	cis	rs11155671	0.53	rs4869764	ENSG00000231760.4	RP11-350J20.5	4.81	9.15e-06	0.0216	0.69	0.51	Testicular germ cell tumor;	chr6:149890692	chr6:149796151~149826294:-
READ	cis	rs9322193	0.567	rs7742692	ENSG00000231760.4	RP11-350J20.5	4.81	9.15e-06	0.0216	0.69	0.51	Lung cancer;	chr6:149892363	chr6:149796151~149826294:-
READ	cis	rs3753275	0.628	rs6577531	ENSG00000207865.1	MIR34A	-4.81	9.18e-06	0.0216	-0.85	-0.51	Educational attainment;	chr1:8836658	chr1:9151668~9151777:-
READ	cis	rs748404	0.587	rs690276	ENSG00000249839.1	AC011330.5	-4.81	9.18e-06	0.0216	-0.69	-0.51	Lung cancer;	chr15:43412360	chr15:43663654~43684339:-
READ	cis	rs11155671	0.53	rs2342767	ENSG00000268592.3	RAET1E-AS1	4.81	9.22e-06	0.0217	0.64	0.51	Testicular germ cell tumor;	chr6:149888581	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs7764376	ENSG00000268592.3	RAET1E-AS1	4.81	9.22e-06	0.0217	0.64	0.51	Testicular germ cell tumor;	chr6:149889208	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs6933882	ENSG00000268592.3	RAET1E-AS1	4.81	9.22e-06	0.0217	0.64	0.51	Testicular germ cell tumor;	chr6:149889666	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs6939761	ENSG00000268592.3	RAET1E-AS1	4.81	9.22e-06	0.0217	0.64	0.51	Testicular germ cell tumor;	chr6:149889858	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs3823021	ENSG00000268592.3	RAET1E-AS1	4.81	9.22e-06	0.0217	0.64	0.51	Testicular germ cell tumor;	chr6:149889863	chr6:149863494~149919507:+
READ	cis	rs7429990	0.965	rs319689	ENSG00000229759.1	MRPS18AP1	4.81	9.27e-06	0.0218	0.56	0.51	Educational attainment (years of education);	chr3:47886677	chr3:48256350~48256938:-
READ	cis	rs10463554	1	rs3776862	ENSG00000175749.11	EIF3KP1	4.81	9.28e-06	0.0218	0.6	0.51	Parkinson's disease;	chr5:102996017	chr5:103032376~103033031:+
READ	cis	rs7429990	0.932	rs11720151	ENSG00000229759.1	MRPS18AP1	-4.8	9.3e-06	0.0218	-0.55	-0.51	Educational attainment (years of education);	chr3:48099144	chr3:48256350~48256938:-
READ	cis	rs11690935	0.851	rs10174055	ENSG00000228389.1	AC068039.4	4.8	9.31e-06	0.0219	0.65	0.51	Schizophrenia;	chr2:171993303	chr2:171773482~171775844:+
READ	cis	rs11155671	0.53	rs7756850	ENSG00000231760.4	RP11-350J20.5	4.8	9.32e-06	0.0219	0.69	0.51	Testicular germ cell tumor;	chr6:149891460	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9371542	ENSG00000231760.4	RP11-350J20.5	4.8	9.32e-06	0.0219	0.69	0.51	Testicular germ cell tumor;	chr6:149891949	chr6:149796151~149826294:-
READ	cis	rs9322193	0.567	rs7747457	ENSG00000231760.4	RP11-350J20.5	4.8	9.32e-06	0.0219	0.69	0.51	Lung cancer;	chr6:149892366	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9371223	ENSG00000231760.4	RP11-350J20.5	4.8	9.32e-06	0.0219	0.69	0.51	Testicular germ cell tumor;	chr6:149893670	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs2342769	ENSG00000231760.4	RP11-350J20.5	4.8	9.32e-06	0.0219	0.69	0.51	Testicular germ cell tumor;	chr6:149895371	chr6:149796151~149826294:-
READ	cis	rs7829975	0.623	rs10087493	ENSG00000253981.4	ALG1L13P	-4.8	9.35e-06	0.0219	-0.61	-0.51	Mood instability;	chr8:8516047	chr8:8236003~8244667:-
READ	cis	rs79040073	0.593	rs11632038	ENSG00000259531.2	RP11-295H24.3	4.8	9.38e-06	0.022	0.81	0.51	Lung cancer in ever smokers;	chr15:49314101	chr15:49365124~49366685:-
READ	cis	rs3096299	0.685	rs4329923	ENSG00000274627.1	RP11-104N10.2	4.8	9.38e-06	0.022	0.55	0.51	Multiple myeloma (IgH translocation);	chr16:89493770	chr16:89516797~89522217:+
READ	cis	rs3096299	0.738	rs9929606	ENSG00000274627.1	RP11-104N10.2	4.8	9.42e-06	0.022	0.6	0.51	Multiple myeloma (IgH translocation);	chr16:89461129	chr16:89516797~89522217:+
READ	cis	rs7429990	0.965	rs319686	ENSG00000229759.1	MRPS18AP1	4.8	9.42e-06	0.022	0.6	0.51	Educational attainment (years of education);	chr3:47888930	chr3:48256350~48256938:-
READ	cis	rs881375	0.967	rs10733648	ENSG00000226752.6	PSMD5-AS1	-4.8	9.44e-06	0.0221	-0.64	-0.51	Rheumatoid arthritis;	chr9:120938501	chr9:120824828~120854385:+
READ	cis	rs11155671	0.53	rs4458704	ENSG00000231760.4	RP11-350J20.5	4.8	9.44e-06	0.0221	0.72	0.51	Testicular germ cell tumor;	chr6:149911743	chr6:149796151~149826294:-
READ	cis	rs4877387	0.56	rs7866466	ENSG00000186940.6	CHCHD2P9	4.8	9.44e-06	0.0221	0.8	0.51	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;	chr9:79094587	chr9:79391304~79391759:+
READ	cis	rs2581828	0.632	rs891369	ENSG00000242142.1	SERBP1P3	-4.8	9.45e-06	0.0221	-0.55	-0.51	Crohn's disease;	chr3:53102535	chr3:53064283~53065091:-
READ	cis	rs9322193	0.607	rs10457852	ENSG00000216906.2	RP11-350J20.9	4.8	9.47e-06	0.0221	0.72	0.51	Lung cancer;	chr6:149880584	chr6:149904243~149906418:+
READ	cis	rs1799949	1	rs35070007	ENSG00000198496.9	NBR2	4.8	9.47e-06	0.0221	0.59	0.51	Menopause (age at onset);	chr17:43164730	chr17:43125610~43153671:+
READ	cis	rs10463554	1	rs1593842	ENSG00000175749.11	EIF3KP1	4.8	9.47e-06	0.0221	0.59	0.51	Parkinson's disease;	chr5:102999018	chr5:103032376~103033031:+
READ	cis	rs10463554	1	rs12659870	ENSG00000175749.11	EIF3KP1	4.8	9.47e-06	0.0221	0.59	0.51	Parkinson's disease;	chr5:103000867	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs1552916	ENSG00000175749.11	EIF3KP1	4.8	9.47e-06	0.0221	0.59	0.51	Parkinson's disease;	chr5:103002036	chr5:103032376~103033031:+
READ	cis	rs79040073	0.637	rs17476361	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49302255	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs11634636	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49315407	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs35692325	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49316062	chr15:49365124~49366685:-
READ	cis	rs79040073	0.636	rs74339964	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49329916	chr15:49365124~49366685:-
READ	cis	rs79040073	0.51	rs111307556	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49339858	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73396235	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49346956	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73396238	ENSG00000259531.2	RP11-295H24.3	4.8	9.49e-06	0.0221	0.81	0.51	Lung cancer in ever smokers;	chr15:49347146	chr15:49365124~49366685:-
READ	cis	rs1577917	0.958	rs12195776	ENSG00000203875.9	SNHG5	-4.8	9.49e-06	0.0221	-0.66	-0.51	Response to antipsychotic treatment;	chr6:85778881	chr6:85660950~85678736:-
READ	cis	rs17264034	0.95	rs17328408	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9538184	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs11951006	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9539123	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs11951779	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9539567	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs11958229	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9539877	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs78826326	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9539890	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs75336098	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9540744	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs17262778	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9541048	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs77836114	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9541339	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs17328904	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9543158	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs17328932	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9543337	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs74982463	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9543473	chr5:9546200~9550609:+
READ	cis	rs17264034	0.95	rs17263150	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9544166	chr5:9546200~9550609:+
READ	cis	rs17264034	0.948	rs112941079	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9545986	chr5:9546200~9550609:+
READ	cis	rs17264034	0.796	rs113140904	ENSG00000250786.1	SNHG18	4.8	9.5e-06	0.0221	0.76	0.51	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease;	chr5:9546023	chr5:9546200~9550609:+
READ	cis	rs9487094	0.689	rs9487064	ENSG00000260273.1	RP11-425D10.10	4.8	9.5e-06	0.0221	0.62	0.51	Height;	chr6:109346560	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs9487066	ENSG00000260273.1	RP11-425D10.10	4.8	9.5e-06	0.0221	0.62	0.51	Height;	chr6:109347707	chr6:109382795~109383666:+
READ	cis	rs11155671	0.53	rs9383912	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149885479	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9383577	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886059	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9383914	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886098	chr6:149863494~149919507:+
READ	cis	rs11155671	0.517	rs9397058	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886113	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs7768626	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886826	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs7768665	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886888	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs7758020	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149886975	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs9322228	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149888173	chr6:149863494~149919507:+
READ	cis	rs11155671	0.53	rs7774787	ENSG00000268592.3	RAET1E-AS1	4.8	9.51e-06	0.0221	0.64	0.51	Testicular germ cell tumor;	chr6:149888296	chr6:149863494~149919507:+
READ	cis	rs7829975	0.659	rs4382480	ENSG00000253893.2	FAM85B	-4.8	9.55e-06	0.0222	-0.63	-0.51	Mood instability;	chr8:8863963	chr8:8167819~8226614:-
READ	cis	rs9425766	0.631	rs10158289	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174081529	chr1:174115300~174160004:-
READ	cis	rs9425766	0.523	rs6668959	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174088488	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs6685314	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174089905	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12563301	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174090924	chr1:174115300~174160004:-
READ	cis	rs9425766	0.665	rs7553788	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174093773	chr1:174115300~174160004:-
READ	cis	rs9425766	0.655	rs4652169	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174095343	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6682017	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174097809	chr1:174115300~174160004:-
READ	cis	rs9425766	0.655	rs2145376	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174098911	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6663794	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174099791	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6691711	ENSG00000227373.4	RP11-160H22.5	4.8	9.55e-06	0.0222	0.68	0.51	Life satisfaction;	chr1:174100283	chr1:174115300~174160004:-
READ	cis	rs9322193	0.81	rs4869923	ENSG00000216906.2	RP11-350J20.9	4.8	9.58e-06	0.0223	0.71	0.51	Lung cancer;	chr6:149553763	chr6:149904243~149906418:+
READ	cis	rs9322193	0.774	rs2144207	ENSG00000216906.2	RP11-350J20.9	4.8	9.58e-06	0.0223	0.71	0.51	Lung cancer;	chr6:149558971	chr6:149904243~149906418:+
READ	cis	rs13068223	0.607	rs193197	ENSG00000243926.1	TIPARP-AS1	-4.8	9.6e-06	0.0223	-0.59	-0.51	Age-related hearing impairment (SNP x SNP interaction);	chr3:156693943	chr3:156671862~156674378:-
READ	cis	rs881375	0.967	rs3761849	ENSG00000226752.6	PSMD5-AS1	-4.8	9.62e-06	0.0223	-0.66	-0.51	Rheumatoid arthritis;	chr9:120928679	chr9:120824828~120854385:+
READ	cis	rs11155671	0.53	rs4869763	ENSG00000231760.4	RP11-350J20.5	4.79	9.67e-06	0.0225	0.69	0.51	Testicular germ cell tumor;	chr6:149890548	chr6:149796151~149826294:-
READ	cis	rs1577917	0.696	rs2842617	ENSG00000203875.9	SNHG5	-4.79	9.67e-06	0.0225	-0.66	-0.51	Response to antipsychotic treatment;	chr6:85599980	chr6:85660950~85678736:-
READ	cis	rs4388249	0.687	rs2301017	ENSG00000271849.1	CTC-332L22.1	-4.79	9.72e-06	0.0225	-0.62	-0.51	Schizophrenia;	chr5:109863696	chr5:109687802~109688329:-
READ	cis	rs216303	0.841	rs2239161	ENSG00000224906.3	RP1-102E24.9	-4.79	9.73e-06	0.0226	-0.84	-0.51	Low vWF levels;	chr12:6053495	chr12:6438498~6438852:+
READ	cis	rs9322193	0.607	rs4869755	ENSG00000216906.2	RP11-350J20.9	4.79	9.73e-06	0.0226	0.72	0.51	Lung cancer;	chr6:149886347	chr6:149904243~149906418:+
READ	cis	rs9322193	0.639	rs4869756	ENSG00000216906.2	RP11-350J20.9	4.79	9.73e-06	0.0226	0.72	0.51	Lung cancer;	chr6:149886360	chr6:149904243~149906418:+
READ	cis	rs1859156	0.767	rs17429196	ENSG00000271474.1	RP11-710C12.1	-4.79	9.74e-06	0.0226	-0.9	-0.51	Attention deficit hyperactivity disorder;	chr4:94895866	chr4:95549129~95552457:+
READ	cis	rs11105298	0.786	rs10858867	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89457389	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858869	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89463834	chr12:89561129~89594878:+
READ	cis	rs11105298	0.786	rs3803128	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89466542	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10506972	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89467752	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs12228177	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89468253	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858871	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89477836	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858872	ENSG00000258302.2	RP11-981P6.1	4.79	9.74e-06	0.0226	0.64	0.51	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89479155	chr12:89561129~89594878:+
READ	cis	rs79040073	0.637	rs73398276	ENSG00000259531.2	RP11-295H24.3	4.79	9.78e-06	0.0227	0.78	0.51	Lung cancer in ever smokers;	chr15:49418782	chr15:49365124~49366685:-
READ	cis	rs2251381	0.515	rs2832299	ENSG00000232118.2	BACH1-AS1	-4.79	9.79e-06	0.0227	-0.57	-0.51	Selective IgA deficiency;	chr21:29376917	chr21:29370019~29376339:-
READ	cis	rs372883	0.506	rs2832300	ENSG00000232118.2	BACH1-AS1	-4.79	9.79e-06	0.0227	-0.57	-0.51	Pancreatic cancer;	chr21:29376995	chr21:29370019~29376339:-
READ	cis	rs372883	0.506	rs2832301	ENSG00000232118.2	BACH1-AS1	-4.79	9.79e-06	0.0227	-0.57	-0.51	Pancreatic cancer;	chr21:29377392	chr21:29370019~29376339:-
READ	cis	rs372883	0.507	rs8132992	ENSG00000232118.2	BACH1-AS1	-4.79	9.79e-06	0.0227	-0.57	-0.51	Pancreatic cancer;	chr21:29378241	chr21:29370019~29376339:-
READ	cis	rs11690935	1	rs1554166	ENSG00000228389.1	AC068039.4	4.79	9.81e-06	0.0227	0.64	0.51	Schizophrenia;	chr2:171685099	chr2:171773482~171775844:+
READ	cis	rs7429990	0.93	rs13075457	ENSG00000229759.1	MRPS18AP1	-4.79	9.81e-06	0.0227	-0.58	-0.51	Educational attainment (years of education);	chr3:48013063	chr3:48256350~48256938:-
READ	cis	rs1859156	0.767	rs13114040	ENSG00000271474.1	RP11-710C12.1	-4.79	9.81e-06	0.0227	-0.9	-0.51	Attention deficit hyperactivity disorder;	chr4:94895680	chr4:95549129~95552457:+
READ	cis	rs9309473	0.583	rs6705203	ENSG00000163016.8	ALMS1P	4.79	9.83e-06	0.0227	0.64	0.51	Metabolite levels;	chr2:73347472	chr2:73644919~73685576:+
READ	cis	rs2019137	0.868	rs6755639	ENSG00000189223.12	PAX8-AS1	-4.79	9.85e-06	0.0228	-0.61	-0.51	Lymphocyte counts;	chr2:113224233	chr2:113211522~113276581:+
READ	cis	rs6844153	0.752	rs12650172	ENSG00000240005.4	RP11-293A21.1	-4.79	9.86e-06	0.0228	-0.61	-0.51	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26872784	chr4:26859806~26860599:-
READ	cis	rs6844153	0.752	rs12641261	ENSG00000240005.4	RP11-293A21.1	-4.79	9.86e-06	0.0228	-0.61	-0.51	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26872814	chr4:26859806~26860599:-
READ	cis	rs5753037	0.543	rs140128	ENSG00000279159.1	RP3-394A18.1	-4.79	9.88e-06	0.0228	-0.34	-0.51	Type 1 diabetes;	chr22:29754151	chr22:29978950~30028236:-
READ	cis	rs9322193	0.962	rs2065664	ENSG00000216906.2	RP11-350J20.9	4.79	9.88e-06	0.0228	0.67	0.51	Lung cancer;	chr6:149762485	chr6:149904243~149906418:+
READ	cis	rs10256972	0.552	rs2960830	ENSG00000229043.2	AC091729.9	-4.79	9.88e-06	0.0228	-0.65	-0.51	Endometriosis;Longevity;	chr7:1161005	chr7:1160374~1165267:+
READ	cis	rs10256972	0.552	rs2960831	ENSG00000229043.2	AC091729.9	-4.79	9.88e-06	0.0228	-0.65	-0.51	Endometriosis;Longevity;	chr7:1161556	chr7:1160374~1165267:+
READ	cis	rs5760092	0.755	rs5760096	ENSG00000273295.1	AP000350.5	4.79	9.88e-06	0.0228	0.56	0.51	Urinary 1,3-butadiene metabolite levels in smokers;	chr22:23905123	chr22:23901432~23907068:-
READ	cis	rs1577917	1	rs12190604	ENSG00000203875.9	SNHG5	-4.79	9.9e-06	0.0229	-0.68	-0.51	Response to antipsychotic treatment;	chr6:86006497	chr6:85660950~85678736:-
READ	cis	rs992157	0.798	rs12053514	ENSG00000261338.2	RP11-378A13.1	-4.79	9.99e-06	0.0231	-0.62	-0.51	Colorectal cancer;	chr2:218303242	chr2:218255319~218257366:+
READ	cis	rs7208859	0.623	rs7219361	ENSG00000263531.1	RP13-753N3.1	4.78	1e-05	0.0231	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30753375	chr17:30863921~30864940:-
READ	cis	rs1799949	1	rs8176318	ENSG00000198496.9	NBR2	-4.78	1e-05	0.0231	-0.55	-0.51	Menopause (age at onset);	chr17:43045257	chr17:43125610~43153671:+
READ	cis	rs62229266	0.659	rs62230814	ENSG00000231106.2	LINC01436	4.78	1.01e-05	0.0232	0.63	0.51	Mitral valve prolapse;	chr21:36031248	chr21:36005338~36007838:+
READ	cis	rs1947988	0.774	rs1018703	ENSG00000231233.1	CCDC147-AS1	4.78	1.01e-05	0.0232	0.7	0.51	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);	chr10:105184137	chr10:104351591~104353575:-
READ	cis	rs2929278	0.561	rs3099045	ENSG00000249839.1	AC011330.5	-4.78	1.01e-05	0.0233	-0.69	-0.51	Schizophrenia;	chr15:43631757	chr15:43663654~43684339:-
READ	cis	rs10463554	1	rs3776864	ENSG00000175749.11	EIF3KP1	4.78	1.01e-05	0.0233	0.6	0.51	Parkinson's disease;	chr5:102992164	chr5:103032376~103033031:+
READ	cis	rs7264396	0.887	rs224419	ENSG00000278367.1	RP11-42O4.2	-4.78	1.01e-05	0.0234	-0.72	-0.51	Total cholesterol levels;	chr20:35555321	chr20:35174355~35174919:-
READ	cis	rs9287719	0.649	rs12617968	ENSG00000234818.1	AC092687.5	4.78	1.02e-05	0.0234	1.06	0.51	Prostate cancer;	chr2:10581819	chr2:10589166~10604830:+
READ	cis	rs9322193	0.923	rs12176034	ENSG00000268592.3	RAET1E-AS1	4.78	1.02e-05	0.0234	0.65	0.51	Lung cancer;	chr6:149800557	chr6:149863494~149919507:+
READ	cis	rs79040073	0.637	rs73398250	ENSG00000259531.2	RP11-295H24.3	4.78	1.02e-05	0.0234	0.78	0.51	Lung cancer in ever smokers;	chr15:49404829	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73398272	ENSG00000259531.2	RP11-295H24.3	4.78	1.02e-05	0.0234	0.78	0.51	Lung cancer in ever smokers;	chr15:49416426	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs11635354	ENSG00000259531.2	RP11-295H24.3	4.78	1.02e-05	0.0234	0.78	0.51	Lung cancer in ever smokers;	chr15:49419413	chr15:49365124~49366685:-
READ	cis	rs2019137	1	rs2019137	ENSG00000274877.1	RP11-65I12.1	4.78	1.02e-05	0.0234	0.56	0.51	Lymphocyte counts;	chr2:113216055	chr2:113237595~113240825:+
READ	cis	rs2019137	0.967	rs895412	ENSG00000274877.1	RP11-65I12.1	4.78	1.02e-05	0.0234	0.56	0.51	Lymphocyte counts;	chr2:113216387	chr2:113237595~113240825:+
READ	cis	rs9487094	0.626	rs11153213	ENSG00000260273.1	RP11-425D10.10	4.78	1.03e-05	0.0234	0.63	0.51	Height;	chr6:109693890	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs12201356	ENSG00000260273.1	RP11-425D10.10	4.78	1.03e-05	0.0234	0.63	0.51	Height;	chr6:109694672	chr6:109382795~109383666:+
READ	cis	rs1577917	0.958	rs12213331	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85795079	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1591438	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85815496	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs1591437	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85815587	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs66986937	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85822473	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs10944144	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85828037	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12665542	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85834725	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs10944147	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85841068	chr6:85660950~85678736:-
READ	cis	rs1577917	0.916	rs12198730	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85845420	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13201730	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85846929	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13219504	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85847199	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12196377	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85857057	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2121594	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85867136	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs2875456	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85892566	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12201741	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85892901	chr6:85660950~85678736:-
READ	cis	rs1577917	0.916	rs12203358	ENSG00000203875.9	SNHG5	-4.78	1.03e-05	0.0234	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85893506	chr6:85660950~85678736:-
READ	cis	rs9487094	0.67	rs11754340	ENSG00000260273.1	RP11-425D10.10	4.78	1.03e-05	0.0234	0.61	0.51	Height;	chr6:109584789	chr6:109382795~109383666:+
READ	cis	rs10129255	1	rs8010605	ENSG00000211972.2	IGHV3-66	4.78	1.03e-05	0.0234	0.5	0.51	Kawasaki disease;	chr14:106678742	chr14:106675017~106675544:-
READ	cis	rs4388249	0.659	rs10065099	ENSG00000271849.1	CTC-332L22.1	-4.78	1.03e-05	0.0234	-0.57	-0.51	Schizophrenia;	chr5:109841677	chr5:109687802~109688329:-
READ	cis	rs7208859	0.623	rs59447372	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30730567	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs61643715	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30730744	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs8080829	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30731712	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8079891	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30731845	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73267858	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30732719	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs56095789	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30733152	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11656844	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30733579	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11652533	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30733583	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11652631	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30733748	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs79505916	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30735308	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs77498725	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30736968	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs73267865	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30737186	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs57005940	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30739311	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs73267872	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30740189	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs9893922	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30741407	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs56812022	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30741715	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs57670615	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30742480	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs2874724	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30745415	chr17:30863921~30864940:-
READ	cis	rs17826219	0.568	rs9898097	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30745654	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs9891256	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30745674	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9911490	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30745995	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7503542	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30746812	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7503335	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30746944	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs11656278	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30748170	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs56031503	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30748647	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs6505207	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30749553	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs7223803	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30750175	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55814012	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30750679	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs2449749	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30751280	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9894709	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30751436	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9896603	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30751494	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs4055314	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30752751	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs7221463	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30753533	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7219712	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30753552	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs8078656	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30753953	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8080882	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30754128	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs28556733	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30756927	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs28452421	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30756962	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs28433704	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30757267	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs28779471	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30757351	chr17:30863921~30864940:-
READ	cis	rs17826219	0.5	rs61685770	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30758695	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs57486336	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30758713	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs55764512	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30758740	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs73988172	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759314	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs12103440	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759639	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs12103508	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759763	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs11653605	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30761367	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs11657777	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30764767	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73269913	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30765165	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7217984	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30765748	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs60114476	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30770649	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs8065744	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30772431	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs8071236	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30772984	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs2449770	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30774046	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs59913838	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30774545	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs56163556	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30774850	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8067035	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775170	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8067338	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775327	chr17:30863921~30864940:-
READ	cis	rs7208859	0.573	rs4055105	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775532	chr17:30863921~30864940:-
READ	cis	rs17826219	0.636	rs12946563	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30776148	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8081299	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777278	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8068645	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777324	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs55811708	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777713	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs2322197	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30778787	chr17:30863921~30864940:-
READ	cis	rs7208859	0.562	rs8078897	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30779239	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs8075163	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30779292	chr17:30863921~30864940:-
READ	cis	rs17826219	0.706	rs8075107	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Body mass index;	chr17:30779631	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7223209	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780202	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs7223404	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780345	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9916725	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780453	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9916727	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780454	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9914499	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780570	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73269945	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30781741	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9897728	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30781786	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs1054400	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30782936	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs1054397	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783178	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9890558	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783337	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9912283	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783355	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs12006	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783634	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs3752021	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784025	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs3752020	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784107	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9890855	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784689	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9893422	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784697	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs9891166	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784884	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73269974	ENSG00000263531.1	RP13-753N3.1	4.77	1.04e-05	0.0234	0.86	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30785366	chr17:30863921~30864940:-
READ	cis	rs1577917	1	rs1577917	ENSG00000203875.9	SNHG5	-4.77	1.04e-05	0.0235	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85982222	chr6:85660950~85678736:-
READ	cis	rs12468226	1	rs16839077	ENSG00000226261.1	AC064836.3	4.77	1.05e-05	0.0236	0.85	0.51	Urate levels;	chr2:202343970	chr2:202336024~202336727:-
READ	cis	rs2739330	0.796	rs2154594	ENSG00000250470.1	AP000351.3	-4.77	1.05e-05	0.0236	-0.65	-0.51	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911868	chr22:23976904~23977585:-
READ	cis	rs9322193	0.516	rs1999632	ENSG00000216906.2	RP11-350J20.9	4.77	1.05e-05	0.0236	0.7	0.51	Lung cancer;	chr6:149866737	chr6:149904243~149906418:+
READ	cis	rs13113518	0.812	rs12500601	ENSG00000223305.1	RN7SKP30	4.77	1.05e-05	0.0236	0.62	0.51	Height;	chr4:55451489	chr4:55540502~55540835:-
READ	cis	rs1577917	0.958	rs34765423	ENSG00000203875.9	SNHG5	-4.77	1.05e-05	0.0237	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85774730	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs2197651	ENSG00000203875.9	SNHG5	-4.77	1.05e-05	0.0237	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85785724	chr6:85660950~85678736:-
READ	cis	rs1577917	0.74	rs2842614	ENSG00000203875.9	SNHG5	-4.77	1.05e-05	0.0237	-0.66	-0.51	Response to antipsychotic treatment;	chr6:85596351	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs9359658	ENSG00000203875.9	SNHG5	4.77	1.05e-05	0.0237	0.66	0.51	Response to antipsychotic treatment;	chr6:85596051	chr6:85660950~85678736:-
READ	cis	rs35160687	0.829	rs13017143	ENSG00000273080.1	RP11-301O19.1	-4.77	1.05e-05	0.0237	-0.58	-0.51	Night sleep phenotypes;	chr2:86239426	chr2:86195590~86196049:+
READ	cis	rs35160687	0.862	rs12476706	ENSG00000273080.1	RP11-301O19.1	4.77	1.05e-05	0.0237	0.58	0.51	Night sleep phenotypes;	chr2:86301247	chr2:86195590~86196049:+
READ	cis	rs1577917	0.958	rs11758508	ENSG00000203875.9	SNHG5	4.77	1.05e-05	0.0237	0.66	0.51	Response to antipsychotic treatment;	chr6:85797160	chr6:85660950~85678736:-
READ	cis	rs67180937	0.882	rs17163345	ENSG00000272750.1	RP11-378J18.8	-4.77	1.05e-05	0.0237	-0.69	-0.51	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222632876	chr1:222658867~222661512:-
READ	cis	rs6920372	0.799	rs9480947	ENSG00000260273.1	RP11-425D10.10	4.77	1.06e-05	0.0237	0.63	0.51	Height;	chr6:109397362	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs6920372	ENSG00000260273.1	RP11-425D10.10	4.77	1.06e-05	0.0237	0.63	0.51	Height;	chr6:109402736	chr6:109382795~109383666:+
READ	cis	rs9487094	0.644	rs9320286	ENSG00000260273.1	RP11-425D10.10	4.77	1.06e-05	0.0237	0.63	0.51	Height;	chr6:109403734	chr6:109382795~109383666:+
READ	cis	rs2019137	0.936	rs3811059	ENSG00000274877.1	RP11-65I12.1	4.77	1.06e-05	0.0238	0.56	0.51	Lymphocyte counts;	chr2:113204494	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs12620738	ENSG00000274877.1	RP11-65I12.1	4.77	1.06e-05	0.0238	0.56	0.51	Lymphocyte counts;	chr2:113206162	chr2:113237595~113240825:+
READ	cis	rs881375	0.967	rs1930778	ENSG00000226752.6	PSMD5-AS1	-4.77	1.06e-05	0.0238	-0.64	-0.51	Rheumatoid arthritis;	chr9:120879091	chr9:120824828~120854385:+
READ	cis	rs881375	1	rs10760118	ENSG00000226752.6	PSMD5-AS1	-4.77	1.06e-05	0.0238	-0.64	-0.51	Rheumatoid arthritis;	chr9:120879338	chr9:120824828~120854385:+
READ	cis	rs35160687	0.862	rs17737955	ENSG00000273080.1	RP11-301O19.1	4.77	1.06e-05	0.0238	0.58	0.51	Night sleep phenotypes;	chr2:86280891	chr2:86195590~86196049:+
READ	cis	rs35160687	0.862	rs13024964	ENSG00000273080.1	RP11-301O19.1	4.77	1.06e-05	0.0238	0.58	0.51	Night sleep phenotypes;	chr2:86284745	chr2:86195590~86196049:+
READ	cis	rs67180937	0.774	rs3748626	ENSG00000272750.1	RP11-378J18.8	-4.77	1.06e-05	0.0238	-0.7	-0.51	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222629461	chr1:222658867~222661512:-
READ	cis	rs1577917	0.958	rs12198876	ENSG00000203875.9	SNHG5	-4.77	1.06e-05	0.0238	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85815758	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs67024565	ENSG00000203875.9	SNHG5	-4.77	1.06e-05	0.0238	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85844279	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs36053156	ENSG00000203875.9	SNHG5	-4.77	1.06e-05	0.0238	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85865791	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs12202170	ENSG00000203875.9	SNHG5	-4.77	1.06e-05	0.0238	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85880668	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10455449	ENSG00000203875.9	SNHG5	-4.77	1.06e-05	0.0238	-0.68	-0.51	Response to antipsychotic treatment;	chr6:85882508	chr6:85660950~85678736:-
READ	cis	rs748404	0.66	rs2467738	ENSG00000249839.1	AC011330.5	-4.77	1.06e-05	0.0238	-0.66	-0.51	Lung cancer;	chr15:43447738	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs2439846	ENSG00000249839.1	AC011330.5	-4.77	1.06e-05	0.0238	-0.66	-0.51	Lung cancer;	chr15:43448772	chr15:43663654~43684339:-
READ	cis	rs2487048	0.761	rs2980083	ENSG00000226334.1	RP11-217B7.2	-4.77	1.06e-05	0.0238	-0.66	-0.51	Intraocular pressure;	chr9:104929081	chr9:104927553~104928892:+
READ	cis	rs2117029	0.587	rs1865157	ENSG00000258017.1	RP11-386G11.10	-4.77	1.07e-05	0.0238	-0.67	-0.51	Intelligence (multi-trait analysis);	chr12:49129003	chr12:49127782~49147869:+
READ	cis	rs7615952	0.512	rs4234285	ENSG00000272840.1	RP11-379B18.6	4.77	1.07e-05	0.0238	0.81	0.51	Blood pressure (smoking interaction);	chr3:125685633	chr3:125774714~125797953:+
READ	cis	rs7615952	0.546	rs2976733	ENSG00000272840.1	RP11-379B18.6	4.77	1.07e-05	0.0238	0.81	0.51	Blood pressure (smoking interaction);	chr3:125695294	chr3:125774714~125797953:+
READ	cis	rs7615952	0.543	rs4645102	ENSG00000272840.1	RP11-379B18.6	4.77	1.07e-05	0.0238	0.81	0.51	Blood pressure (smoking interaction);	chr3:125705597	chr3:125774714~125797953:+
READ	cis	rs10256972	0.552	rs2949192	ENSG00000229043.2	AC091729.9	-4.77	1.07e-05	0.0239	-0.63	-0.51	Endometriosis;Longevity;	chr7:1164205	chr7:1160374~1165267:+
READ	cis	rs2019137	0.901	rs4849176	ENSG00000274877.1	RP11-65I12.1	4.77	1.07e-05	0.0239	0.55	0.51	Lymphocyte counts;	chr2:113220359	chr2:113237595~113240825:+
READ	cis	rs10129255	0.828	rs10140989	ENSG00000211972.2	IGHV3-66	4.77	1.07e-05	0.0239	0.48	0.51	Kawasaki disease;	chr14:106668657	chr14:106675017~106675544:-
READ	cis	rs10129255	0.872	rs1858683	ENSG00000211972.2	IGHV3-66	4.77	1.07e-05	0.0239	0.48	0.51	Kawasaki disease;	chr14:106670217	chr14:106675017~106675544:-
READ	cis	rs10129255	0.872	rs8015406	ENSG00000211972.2	IGHV3-66	4.77	1.07e-05	0.0239	0.48	0.51	Kawasaki disease;	chr14:106670611	chr14:106675017~106675544:-
READ	cis	rs9601248	0.903	rs2783129	ENSG00000227676.3	LINC01068	4.77	1.07e-05	0.0239	0.58	0.51	Major depressive disorder;	chr13:79594585	chr13:79566727~79571436:+
READ	cis	rs9322193	0.886	rs4039600	ENSG00000216906.2	RP11-350J20.9	4.77	1.07e-05	0.0239	0.69	0.51	Lung cancer;	chr6:149576319	chr6:149904243~149906418:+
READ	cis	rs3096299	0.503	rs9925045	ENSG00000274627.1	RP11-104N10.2	4.76	1.08e-05	0.024	0.61	0.51	Multiple myeloma (IgH translocation);	chr16:89490068	chr16:89516797~89522217:+
READ	cis	rs7694725	0.75	rs666609	ENSG00000241002.1	RP11-119H12.1	4.76	1.08e-05	0.024	0.58	0.51	Prostate cancer (SNP x SNP interaction);	chr4:113079015	chr4:112738672~112739106:+
READ	cis	rs1859156	0.767	rs17429252	ENSG00000271474.1	RP11-710C12.1	-4.76	1.08e-05	0.024	-0.9	-0.51	Attention deficit hyperactivity disorder;	chr4:94900504	chr4:95549129~95552457:+
READ	cis	rs7264396	1	rs224440	ENSG00000278367.1	RP11-42O4.2	-4.76	1.08e-05	0.0241	-0.6	-0.51	Total cholesterol levels;	chr20:35571517	chr20:35174355~35174919:-
READ	cis	rs2941509	1	rs9901483	ENSG00000265178.1	MIR4728	4.76	1.09e-05	0.0242	1.12	0.51	Systemic lupus erythematosus;	chr17:39776521	chr17:39726495~39726561:+
READ	cis	rs9487094	0.961	rs12528822	ENSG00000260273.1	RP11-425D10.10	4.76	1.09e-05	0.0242	0.61	0.51	Height;	chr6:109340338	chr6:109382795~109383666:+
READ	cis	rs10129255	0.833	rs61997797	ENSG00000211972.2	IGHV3-66	4.76	1.09e-05	0.0242	0.49	0.51	Kawasaki disease;	chr14:106815190	chr14:106675017~106675544:-
READ	cis	rs1577917	1	rs791856	ENSG00000203875.9	SNHG5	4.76	1.09e-05	0.0243	0.68	0.51	Response to antipsychotic treatment;	chr6:85972123	chr6:85660950~85678736:-
READ	cis	rs75920871	0.528	rs11216240	ENSG00000254851.1	RP11-109L13.1	4.76	1.1e-05	0.0243	0.75	0.51	Subjective well-being;	chr11:117028532	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs11216241	ENSG00000254851.1	RP11-109L13.1	4.76	1.1e-05	0.0243	0.75	0.51	Subjective well-being;	chr11:117028533	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs11600552	ENSG00000254851.1	RP11-109L13.1	4.76	1.1e-05	0.0243	0.75	0.51	Subjective well-being;	chr11:117030231	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs7941428	ENSG00000254851.1	RP11-109L13.1	4.76	1.1e-05	0.0243	0.75	0.51	Subjective well-being;	chr11:117032668	chr11:117135528~117138582:+
READ	cis	rs79040073	0.637	rs11635005	ENSG00000259531.2	RP11-295H24.3	4.76	1.1e-05	0.0243	0.79	0.51	Lung cancer in ever smokers;	chr15:49309228	chr15:49365124~49366685:-
READ	cis	rs17301013	0.606	rs4652500	ENSG00000227373.4	RP11-160H22.5	4.76	1.1e-05	0.0244	0.78	0.51	Systemic lupus erythematosus;	chr1:174500656	chr1:174115300~174160004:-
READ	cis	rs17301013	0.507	rs12071794	ENSG00000227373.4	RP11-160H22.5	4.76	1.1e-05	0.0244	0.78	0.51	Systemic lupus erythematosus;	chr1:174500767	chr1:174115300~174160004:-
READ	cis	rs17301013	0.556	rs7535845	ENSG00000227373.4	RP11-160H22.5	4.76	1.1e-05	0.0244	0.78	0.51	Systemic lupus erythematosus;	chr1:174502672	chr1:174115300~174160004:-
READ	cis	rs10463554	0.927	rs34798	ENSG00000175749.11	EIF3KP1	4.76	1.1e-05	0.0245	0.73	0.51	Parkinson's disease;	chr5:103090047	chr5:103032376~103033031:+
READ	cis	rs9309473	0.558	rs11679042	ENSG00000163016.8	ALMS1P	4.76	1.1e-05	0.0245	0.76	0.51	Metabolite levels;	chr2:73680184	chr2:73644919~73685576:+
READ	cis	rs9425766	0.692	rs4652294	ENSG00000227373.4	RP11-160H22.5	4.76	1.11e-05	0.0246	0.69	0.51	Life satisfaction;	chr1:174272027	chr1:174115300~174160004:-
READ	cis	rs9425766	0.655	rs6666767	ENSG00000227373.4	RP11-160H22.5	4.76	1.11e-05	0.0246	0.69	0.51	Life satisfaction;	chr1:174357564	chr1:174115300~174160004:-
READ	cis	rs7208859	0.623	rs7220289	ENSG00000263531.1	RP13-753N3.1	4.76	1.11e-05	0.0246	0.87	0.51	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30776744	chr17:30863921~30864940:-
READ	cis	rs11123170	0.65	rs2289897	ENSG00000274877.1	RP11-65I12.1	-4.76	1.11e-05	0.0247	-0.7	-0.51	Renal function-related traits (BUN);	chr2:113219877	chr2:113237595~113240825:+
READ	cis	rs61160187	0.51	rs4700393	ENSG00000215032.2	GNL3LP1	4.76	1.12e-05	0.0247	0.58	0.51	Educational attainment (years of education);Educational attainment (college completion);	chr5:60802440	chr5:60891935~60893577:-
READ	cis	rs5769707	0.839	rs73176988	ENSG00000188511.11	C22orf34	4.75	1.12e-05	0.0247	0.62	0.51	Monocyte percentage of white cells;Monocyte count;	chr22:49596001	chr22:49414524~49657542:-
READ	cis	rs5769707	0.967	rs17182154	ENSG00000188511.11	C22orf34	4.75	1.12e-05	0.0247	0.62	0.51	Monocyte percentage of white cells;Monocyte count;	chr22:49596822	chr22:49414524~49657542:-
READ	cis	rs858239	0.665	rs858305	ENSG00000230658.1	KLHL7-AS1	-4.75	1.12e-05	0.0248	-0.69	-0.51	Cerebrospinal fluid biomarker levels;	chr7:23203211	chr7:23101228~23105703:-
READ	cis	rs992157	0.798	rs10932772	ENSG00000261338.2	RP11-378A13.1	4.75	1.12e-05	0.0248	0.6	0.51	Colorectal cancer;	chr2:218312425	chr2:218255319~218257366:+
READ	cis	rs6095360	0.932	rs7264180	ENSG00000278231.1	RP5-906C1.1	-4.75	1.13e-05	0.0249	-0.73	-0.5	Intelligence (multi-trait analysis);	chr20:48963243	chr20:48821688~48849458:-
READ	cis	rs6095360	0.934	rs2295031	ENSG00000278231.1	RP5-906C1.1	-4.75	1.13e-05	0.0249	-0.73	-0.5	Intelligence (multi-trait analysis);	chr20:48963810	chr20:48821688~48849458:-
READ	cis	rs11105298	0.891	rs10858889	ENSG00000258302.2	RP11-981P6.1	4.75	1.13e-05	0.0249	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89508827	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858890	ENSG00000258302.2	RP11-981P6.1	4.75	1.13e-05	0.0249	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89513389	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs11105309	ENSG00000258302.2	RP11-981P6.1	4.75	1.13e-05	0.0249	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89516073	chr12:89561129~89594878:+
READ	cis	rs11690935	0.851	rs6731562	ENSG00000228389.1	AC068039.4	4.75	1.13e-05	0.0249	0.62	0.5	Schizophrenia;	chr2:171941742	chr2:171773482~171775844:+
READ	cis	rs11690935	0.851	rs10201430	ENSG00000228389.1	AC068039.4	4.75	1.13e-05	0.0249	0.62	0.5	Schizophrenia;	chr2:171956715	chr2:171773482~171775844:+
READ	cis	rs1577917	0.916	rs12206726	ENSG00000203875.9	SNHG5	-4.75	1.13e-05	0.025	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85789998	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs1414201	ENSG00000203875.9	SNHG5	-4.75	1.13e-05	0.025	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85790598	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs7453105	ENSG00000203875.9	SNHG5	-4.75	1.13e-05	0.025	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85791043	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12209259	ENSG00000203875.9	SNHG5	-4.75	1.13e-05	0.025	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85792630	chr6:85660950~85678736:-
READ	cis	rs7208859	0.623	rs11658022	ENSG00000263531.1	RP13-753N3.1	4.75	1.13e-05	0.025	0.92	0.5	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30758341	chr17:30863921~30864940:-
READ	cis	rs7208859	0.623	rs73269923	ENSG00000263531.1	RP13-753N3.1	4.75	1.13e-05	0.025	0.92	0.5	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775553	chr17:30863921~30864940:-
READ	cis	rs13113518	0.812	rs13107810	ENSG00000223305.1	RN7SKP30	4.75	1.13e-05	0.025	0.61	0.5	Height;	chr4:55542243	chr4:55540502~55540835:-
READ	cis	rs2486288	0.656	rs11632920	ENSG00000259520.4	CTD-2651B20.3	4.75	1.14e-05	0.0251	0.63	0.5	Glomerular filtration rate;	chr15:45259066	chr15:45251580~45279251:-
READ	cis	rs1577917	0.958	rs12193904	ENSG00000203875.9	SNHG5	-4.75	1.14e-05	0.0251	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85742985	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs11754330	ENSG00000203875.9	SNHG5	-4.75	1.14e-05	0.0251	-0.66	-0.5	Response to antipsychotic treatment;	chr6:85745352	chr6:85660950~85678736:-
READ	cis	rs2019137	0.868	rs3748916	ENSG00000189223.12	PAX8-AS1	4.75	1.14e-05	0.0252	0.59	0.5	Lymphocyte counts;	chr2:113226456	chr2:113211522~113276581:+
READ	cis	rs6095360	0.934	rs2273531	ENSG00000278231.1	RP5-906C1.1	-4.75	1.15e-05	0.0253	-0.73	-0.5	Intelligence (multi-trait analysis);	chr20:49011897	chr20:48821688~48849458:-
READ	cis	rs748404	0.588	rs2255410	ENSG00000249839.1	AC011330.5	-4.75	1.15e-05	0.0253	-0.63	-0.5	Lung cancer;	chr15:43538899	chr15:43663654~43684339:-
READ	cis	rs2486288	0.656	rs1719236	ENSG00000259520.4	CTD-2651B20.3	4.75	1.16e-05	0.0254	0.63	0.5	Glomerular filtration rate;	chr15:45285585	chr15:45251580~45279251:-
READ	cis	rs881375	0.967	rs1930780	ENSG00000226752.6	PSMD5-AS1	-4.75	1.16e-05	0.0255	-0.64	-0.5	Rheumatoid arthritis;	chr9:120923941	chr9:120824828~120854385:+
READ	cis	rs9938149	0.767	rs28425635	ENSG00000260630.5	SNAI3-AS1	-4.75	1.16e-05	0.0255	-0.81	-0.5	Central corneal thickness;Corneal structure;	chr16:88289993	chr16:88663298~88687186:+
READ	cis	rs977987	0.735	rs11149831	ENSG00000261783.1	RP11-252K23.2	-4.74	1.16e-05	0.0255	-0.69	-0.5	Dupuytren's disease;	chr16:75417563	chr16:75379818~75381260:-
READ	cis	rs10256972	0.567	rs2960835	ENSG00000229043.2	AC091729.9	-4.74	1.17e-05	0.0256	-0.64	-0.5	Endometriosis;Longevity;	chr7:1163327	chr7:1160374~1165267:+
READ	cis	rs13113518	0.812	rs13140173	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55527164	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs2035692	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55528801	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs4507426	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55529387	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs2035691	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55529786	chr4:55540502~55540835:-
READ	cis	rs13113518	0.756	rs11939652	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55532542	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs56055342	ENSG00000223305.1	RN7SKP30	4.74	1.17e-05	0.0257	0.61	0.5	Height;	chr4:55540928	chr4:55540502~55540835:-
READ	cis	rs4718428	0.924	rs6971897	ENSG00000226824.5	RP4-756H11.3	-4.74	1.18e-05	0.0258	-0.66	-0.5	Corneal structure;	chr7:66947787	chr7:66654538~66669855:+
READ	cis	rs6095360	0.934	rs2295579	ENSG00000278231.1	RP5-906C1.1	4.74	1.18e-05	0.0258	0.73	0.5	Intelligence (multi-trait analysis);	chr20:49010199	chr20:48821688~48849458:-
READ	cis	rs11105306	1	rs11105306	ENSG00000258302.2	RP11-981P6.1	4.74	1.18e-05	0.0259	0.63	0.5	NT-proBNP levels in acute coronary syndrome;	chr12:89503611	chr12:89561129~89594878:+
READ	cis	rs17301013	0.794	rs1793293	ENSG00000227373.4	RP11-160H22.5	-4.74	1.19e-05	0.0259	-0.64	-0.5	Systemic lupus erythematosus;	chr1:174774451	chr1:174115300~174160004:-
READ	cis	rs6694545	0.607	rs16833076	ENSG00000233399.2	RP11-111I12.1	-4.74	1.19e-05	0.026	-0.91	-0.5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29941335	chr1:30013952~30037612:-
READ	cis	rs453301	0.686	rs13252797	ENSG00000233609.3	RP11-62H7.2	4.74	1.19e-05	0.026	0.6	0.5	Joint mobility (Beighton score);	chr8:9003920	chr8:8961200~8979025:+
READ	cis	rs3096299	0.658	rs4785679	ENSG00000274627.1	RP11-104N10.2	4.74	1.19e-05	0.026	0.54	0.5	Multiple myeloma (IgH translocation);	chr16:89499705	chr16:89516797~89522217:+
READ	cis	rs992157	1	rs736730	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218255532	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs736731	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218255865	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs10932766	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218257367	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs3731859	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218259499	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs13003334	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218260198	chr2:218255319~218257366:+
READ	cis	rs992157	1	rs11554825	ENSG00000261338.2	RP11-378A13.1	4.74	1.19e-05	0.026	0.64	0.5	Colorectal cancer;	chr2:218261086	chr2:218255319~218257366:+
READ	cis	rs453301	0.653	rs1045529	ENSG00000233609.3	RP11-62H7.2	-4.74	1.19e-05	0.026	-0.63	-0.5	Joint mobility (Beighton score);	chr8:9032588	chr8:8961200~8979025:+
READ	cis	rs17301013	0.932	rs1653632	ENSG00000227373.4	RP11-160H22.5	-4.74	1.2e-05	0.0261	-0.67	-0.5	Systemic lupus erythematosus;	chr1:174786459	chr1:174115300~174160004:-
READ	cis	rs11123170	0.65	rs2289897	ENSG00000189223.12	PAX8-AS1	-4.74	1.2e-05	0.0262	-0.76	-0.5	Renal function-related traits (BUN);	chr2:113219877	chr2:113211522~113276581:+
READ	cis	rs10256972	0.577	rs6962809	ENSG00000229043.2	AC091729.9	-4.74	1.2e-05	0.0262	-0.64	-0.5	Endometriosis;Longevity;	chr7:1169253	chr7:1160374~1165267:+
READ	cis	rs9322193	0.961	rs9027	ENSG00000216906.2	RP11-350J20.9	4.74	1.2e-05	0.0262	0.69	0.5	Lung cancer;	chr6:149594921	chr6:149904243~149906418:+
READ	cis	rs7429990	0.932	rs11130155	ENSG00000229759.1	MRPS18AP1	-4.73	1.2e-05	0.0262	-0.55	-0.5	Educational attainment (years of education);	chr3:48098938	chr3:48256350~48256938:-
READ	cis	rs2929278	0.561	rs2927071	ENSG00000249839.1	AC011330.5	-4.73	1.2e-05	0.0263	-0.68	-0.5	Schizophrenia;	chr15:43626883	chr15:43663654~43684339:-
READ	cis	rs2412819	0.599	rs2470120	ENSG00000249839.1	AC011330.5	-4.73	1.2e-05	0.0263	-0.68	-0.5	Lung cancer;	chr15:43636872	chr15:43663654~43684339:-
READ	cis	rs2688482	0.557	rs3103952	ENSG00000224769.1	AC069213.1	4.73	1.22e-05	0.0265	0.87	0.5	Lung disease severity in cystic fibrosis;	chr3:195795819	chr3:195614947~195620233:+
READ	cis	rs1799949	0.965	rs6503726	ENSG00000198496.9	NBR2	-4.73	1.22e-05	0.0266	-0.56	-0.5	Menopause (age at onset);	chr17:43132725	chr17:43125610~43153671:+
READ	cis	rs11690935	0.788	rs10201053	ENSG00000228389.1	AC068039.4	4.73	1.22e-05	0.0266	0.64	0.5	Schizophrenia;	chr2:172024653	chr2:171773482~171775844:+
READ	cis	rs881375	0.933	rs2239657	ENSG00000226752.6	PSMD5-AS1	4.73	1.22e-05	0.0266	0.64	0.5	Rheumatoid arthritis;	chr9:120909242	chr9:120824828~120854385:+
READ	cis	rs732716	0.719	rs56088814	ENSG00000267769.1	CTB-50L17.9	-4.73	1.23e-05	0.0267	-0.7	-0.5	Mean corpuscular volume;	chr19:4422181	chr19:4454014~4455286:+
READ	cis	rs9425766	0.64	rs6658769	ENSG00000227373.4	RP11-160H22.5	4.73	1.23e-05	0.0267	0.67	0.5	Life satisfaction;	chr1:174100843	chr1:174115300~174160004:-
READ	cis	rs11105298	0.891	rs10858900	ENSG00000258302.2	RP11-981P6.1	4.73	1.23e-05	0.0267	0.66	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89531304	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs11105316	ENSG00000258302.2	RP11-981P6.1	4.73	1.23e-05	0.0267	0.66	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89531423	chr12:89561129~89594878:+
READ	cis	rs210138	0.882	rs407710	ENSG00000197251.3	LINC00336	4.73	1.23e-05	0.0267	0.74	0.5	Testicular germ cell tumor;	chr6:33586480	chr6:33586106~33593338:-
READ	cis	rs1577917	0.74	rs9353320	ENSG00000203875.9	SNHG5	4.73	1.23e-05	0.0268	0.66	0.5	Response to antipsychotic treatment;	chr6:85535130	chr6:85660950~85678736:-
READ	cis	rs2581828	0.632	rs73088322	ENSG00000242142.1	SERBP1P3	-4.73	1.24e-05	0.0269	-0.56	-0.5	Crohn's disease;	chr3:53107500	chr3:53064283~53065091:-
READ	cis	rs2581828	0.659	rs73088327	ENSG00000242142.1	SERBP1P3	-4.73	1.24e-05	0.0269	-0.56	-0.5	Crohn's disease;	chr3:53107533	chr3:53064283~53065091:-
READ	cis	rs2581828	0.659	rs4282053	ENSG00000242142.1	SERBP1P3	-4.73	1.24e-05	0.0269	-0.56	-0.5	Crohn's disease;	chr3:53107949	chr3:53064283~53065091:-
READ	cis	rs992157	0.798	rs10193383	ENSG00000261338.2	RP11-378A13.1	4.73	1.24e-05	0.0269	0.61	0.5	Colorectal cancer;	chr2:218292969	chr2:218255319~218257366:+
READ	cis	rs992157	0.798	rs10206064	ENSG00000261338.2	RP11-378A13.1	4.73	1.24e-05	0.0269	0.61	0.5	Colorectal cancer;	chr2:218293236	chr2:218255319~218257366:+
READ	cis	rs992157	0.7	rs10165153	ENSG00000261338.2	RP11-378A13.1	4.73	1.24e-05	0.0269	0.61	0.5	Colorectal cancer;	chr2:218294906	chr2:218255319~218257366:+
READ	cis	rs9322193	0.607	rs12527391	ENSG00000216906.2	RP11-350J20.9	4.72	1.25e-05	0.027	0.71	0.5	Lung cancer;	chr6:149882156	chr6:149904243~149906418:+
READ	cis	rs9322193	0.607	rs3798763	ENSG00000216906.2	RP11-350J20.9	4.72	1.25e-05	0.027	0.71	0.5	Lung cancer;	chr6:149889964	chr6:149904243~149906418:+
READ	cis	rs9322193	0.607	rs12204653	ENSG00000216906.2	RP11-350J20.9	4.72	1.25e-05	0.027	0.71	0.5	Lung cancer;	chr6:149891885	chr6:149904243~149906418:+
READ	cis	rs9425766	0.541	rs12691474	ENSG00000227373.4	RP11-160H22.5	4.72	1.25e-05	0.027	0.64	0.5	Life satisfaction;	chr1:174200867	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs12077622	ENSG00000227373.4	RP11-160H22.5	4.72	1.25e-05	0.027	0.67	0.5	Systemic lupus erythematosus;	chr1:174442507	chr1:174115300~174160004:-
READ	cis	rs748404	0.66	rs693510	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43422427	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs509306	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43422973	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs690512	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43425480	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs542898	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43427194	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs690012	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43427557	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs2249952	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43428335	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs689767	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43429879	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs2439845	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43430412	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs2467745	ENSG00000249839.1	AC011330.5	-4.72	1.25e-05	0.027	-0.67	-0.5	Lung cancer;	chr15:43430544	chr15:43663654~43684339:-
READ	cis	rs35681285	0.59	rs76507827	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16128876	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs2240856	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16130052	chr7:16695871~16719898:-
READ	cis	rs35681285	0.744	rs57179130	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16223536	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs76563131	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16244626	chr7:16695871~16719898:-
READ	cis	rs35681285	0.744	rs73293103	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16248069	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs79184364	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16270779	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs10247201	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16271263	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs59789077	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16271294	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs80269579	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16272046	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs10280613	ENSG00000235837.1	AC073333.8	4.72	1.25e-05	0.0271	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16272371	chr7:16695871~16719898:-
READ	cis	rs17301013	0.861	rs332796	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0271	0.64	0.5	Systemic lupus erythematosus;	chr1:174727142	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs332799	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0271	0.64	0.5	Systemic lupus erythematosus;	chr1:174731110	chr1:174115300~174160004:-
READ	cis	rs17826219	0.706	rs57698184	ENSG00000263531.1	RP13-753N3.1	4.72	1.26e-05	0.0272	0.87	0.5	Body mass index;	chr17:30737900	chr17:30863921~30864940:-
READ	cis	rs7208859	0.524	rs59923796	ENSG00000263531.1	RP13-753N3.1	4.72	1.26e-05	0.0272	0.87	0.5	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30737901	chr17:30863921~30864940:-
READ	cis	rs9425766	0.679	rs4650945	ENSG00000227373.4	RP11-160H22.5	-4.72	1.26e-05	0.0272	-0.67	-0.5	Life satisfaction;	chr1:174114966	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs2860846	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174106786	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs2860847	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174106787	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6672986	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174107726	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7533430	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174109279	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs7526024	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174109722	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12079062	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174110446	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12079063	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174110447	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12094341	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174110562	chr1:174115300~174160004:-
READ	cis	rs9425766	0.64	rs10912734	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174141977	chr1:174115300~174160004:-
READ	cis	rs9425766	0.628	rs6425274	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174144270	chr1:174115300~174160004:-
READ	cis	rs9425766	0.566	rs6696076	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174149900	chr1:174115300~174160004:-
READ	cis	rs9425766	0.54	rs2294492	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174157884	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6656188	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174183550	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs12087441	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174188696	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs4652237	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174189718	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs2143114	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174192292	chr1:174115300~174160004:-
READ	cis	rs9425766	0.679	rs6681390	ENSG00000227373.4	RP11-160H22.5	4.72	1.26e-05	0.0272	0.67	0.5	Life satisfaction;	chr1:174261331	chr1:174115300~174160004:-
READ	cis	rs10426930	0.816	rs2009654	ENSG00000269425.1	AC007292.7	-4.72	1.27e-05	0.0272	-0.69	-0.5	Monocyte percentage of white cells;	chr19:5061334	chr19:4339577~4343491:+
READ	cis	rs17301013	0.606	rs12076453	ENSG00000227373.4	RP11-160H22.5	4.72	1.27e-05	0.0272	0.73	0.5	Systemic lupus erythematosus;	chr1:174230438	chr1:174115300~174160004:-
READ	cis	rs2019137	0.936	rs4849169	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113196080	chr2:113237595~113240825:+
READ	cis	rs2019137	0.836	rs4848318	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113196375	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs2241978	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113196429	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs3828188	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113196670	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs3828189	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113196919	chr2:113237595~113240825:+
READ	cis	rs2019137	0.967	rs902695	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113197497	chr2:113237595~113240825:+
READ	cis	rs2019137	0.905	rs2276561	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113198794	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs2305133	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113199244	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs12612729	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113199471	chr2:113237595~113240825:+
READ	cis	rs2019137	0.936	rs731834	ENSG00000274877.1	RP11-65I12.1	4.72	1.27e-05	0.0273	0.56	0.5	Lymphocyte counts;	chr2:113199621	chr2:113237595~113240825:+
READ	cis	rs2882667	0.505	rs7721110	ENSG00000253404.1	AC034243.1	4.72	1.27e-05	0.0273	0.57	0.5	Age-related hearing impairment (SNP x SNP interaction);	chr5:139146817	chr5:138744434~138753309:-
READ	cis	rs3096299	0.658	rs12443705	ENSG00000274627.1	RP11-104N10.2	4.72	1.27e-05	0.0273	0.55	0.5	Multiple myeloma (IgH translocation);	chr16:89480646	chr16:89516797~89522217:+
READ	cis	rs3096299	0.685	rs4785675	ENSG00000274627.1	RP11-104N10.2	4.72	1.27e-05	0.0274	0.55	0.5	Multiple myeloma (IgH translocation);	chr16:89473566	chr16:89516797~89522217:+
READ	cis	rs3096299	0.685	rs4238830	ENSG00000274627.1	RP11-104N10.2	4.72	1.27e-05	0.0274	0.55	0.5	Multiple myeloma (IgH translocation);	chr16:89473833	chr16:89516797~89522217:+
READ	cis	rs9487094	0.62	rs7768973	ENSG00000260273.1	RP11-425D10.10	4.72	1.28e-05	0.0274	0.63	0.5	Height;	chr6:109424122	chr6:109382795~109383666:+
READ	cis	rs2739330	0.731	rs2000468	ENSG00000225282.1	AP000350.6	4.72	1.28e-05	0.0274	0.52	0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23926900~23929574:+
READ	cis	rs7208859	0.614	rs7216394	ENSG00000263531.1	RP13-753N3.1	-4.71	1.3e-05	0.0277	-0.75	-0.5	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30498738	chr17:30863921~30864940:-
READ	cis	rs4660456	0.619	rs753753	ENSG00000237899.1	RP4-739H11.3	-4.71	1.3e-05	0.0278	-0.69	-0.5	Platelet count;	chr1:40771716	chr1:40669089~40687588:-
READ	cis	rs10460009	0.803	rs10502310	ENSG00000266783.1	RP11-715F3.2	-4.71	1.3e-05	0.0278	-0.96	-0.5	Type 2 diabetes;	chr18:2995375	chr18:2561172~2562220:-
READ	cis	rs1799949	0.965	rs9646418	ENSG00000198496.9	NBR2	-4.71	1.3e-05	0.0278	-0.56	-0.5	Menopause (age at onset);	chr17:43348533	chr17:43125610~43153671:+
READ	cis	rs1577917	0.682	rs6909767	ENSG00000203875.9	SNHG5	4.71	1.3e-05	0.0278	0.66	0.5	Response to antipsychotic treatment;	chr6:85518391	chr6:85660950~85678736:-
READ	cis	rs10851478	0.529	rs12901929	ENSG00000259531.2	RP11-295H24.3	-4.71	1.3e-05	0.0278	-0.67	-0.5	Oral cavity cancer;	chr15:49383111	chr15:49365124~49366685:-
READ	cis	rs9545047	0.901	rs314688	ENSG00000227676.3	LINC01068	4.71	1.3e-05	0.0278	0.59	0.5	Schizophrenia;	chr13:79449171	chr13:79566727~79571436:+
READ	cis	rs35681285	0.59	rs10269890	ENSG00000235837.1	AC073333.8	4.71	1.31e-05	0.0279	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16128877	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs10240830	ENSG00000235837.1	AC073333.8	4.71	1.31e-05	0.0279	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16129061	chr7:16695871~16719898:-
READ	cis	rs11155671	0.53	rs9383912	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149885479	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9383577	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886059	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9383914	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886098	chr6:149796151~149826294:-
READ	cis	rs11155671	0.517	rs9397058	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886113	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs7768626	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886826	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs7768665	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886888	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs7758020	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149886975	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs9322228	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149888173	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs7774787	ENSG00000231760.4	RP11-350J20.5	4.71	1.31e-05	0.0279	0.67	0.5	Testicular germ cell tumor;	chr6:149888296	chr6:149796151~149826294:-
READ	cis	rs2919009	0.544	rs12267610	ENSG00000271670.1	RP11-95I16.4	4.71	1.31e-05	0.0279	0.66	0.5	Obesity-related traits;	chr10:120851275	chr10:120879256~120880667:-
READ	cis	rs7429990	0.833	rs35582375	ENSG00000229759.1	MRPS18AP1	-4.71	1.31e-05	0.0279	-0.56	-0.5	Educational attainment (years of education);	chr3:47829639	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13077230	ENSG00000229759.1	MRPS18AP1	-4.71	1.31e-05	0.0279	-0.56	-0.5	Educational attainment (years of education);	chr3:47832232	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs11130150	ENSG00000229759.1	MRPS18AP1	-4.71	1.31e-05	0.0279	-0.56	-0.5	Educational attainment (years of education);	chr3:47832449	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs11710199	ENSG00000229759.1	MRPS18AP1	-4.71	1.31e-05	0.0279	-0.56	-0.5	Educational attainment (years of education);	chr3:47836588	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs17290490	ENSG00000229759.1	MRPS18AP1	-4.71	1.31e-05	0.0279	-0.56	-0.5	Educational attainment (years of education);	chr3:47841237	chr3:48256350~48256938:-
READ	cis	rs4718428	1	rs1830070	ENSG00000226824.5	RP4-756H11.3	-4.71	1.31e-05	0.0279	-0.67	-0.5	Corneal structure;	chr7:66884684	chr7:66654538~66669855:+
READ	cis	rs10129255	1	rs10129255	ENSG00000211972.2	IGHV3-66	-4.71	1.31e-05	0.0279	-0.49	-0.5	Kawasaki disease;	chr14:106767970	chr14:106675017~106675544:-
READ	cis	rs9309473	0.583	rs6718864	ENSG00000163016.8	ALMS1P	4.71	1.32e-05	0.0279	0.63	0.5	Metabolite levels;	chr2:73347463	chr2:73644919~73685576:+
READ	cis	rs9425766	0.566	rs4442420	ENSG00000227373.4	RP11-160H22.5	4.71	1.32e-05	0.0279	0.64	0.5	Life satisfaction;	chr1:174199667	chr1:174115300~174160004:-
READ	cis	rs9425766	0.566	rs4447042	ENSG00000227373.4	RP11-160H22.5	4.71	1.32e-05	0.0279	0.64	0.5	Life satisfaction;	chr1:174212747	chr1:174115300~174160004:-
READ	cis	rs916888	0.61	rs199454	ENSG00000214401.4	KANSL1-AS1	-4.71	1.32e-05	0.0279	-0.72	-0.5	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46722744	chr17:46193576~46196723:+
READ	cis	rs1577917	1	rs1018184	ENSG00000203875.9	SNHG5	4.71	1.32e-05	0.0279	0.67	0.5	Response to antipsychotic treatment;	chr6:85938757	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13213551	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85898983	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12201571	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85900032	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12192992	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85900197	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs11759855	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85901123	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs2324843	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85907783	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs12201992	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85908501	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12201880	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85917289	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs7756203	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85917989	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10944161	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85920658	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1857965	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85921058	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs34622557	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85921134	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1911553	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85921174	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs7771342	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85922218	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1995688	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85922601	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12154056	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85924376	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1857964	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85926276	chr6:85660950~85678736:-
READ	cis	rs1577917	0.798	rs7772384	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85929962	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs6940458	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85935274	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs35738006	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85936591	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs13194429	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85936987	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs7747897	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85937631	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs13196930	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85942527	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12199832	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85943030	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12207374	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85946927	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12213740	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85947015	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12201735	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85947221	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12208493	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85952549	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12213149	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85958926	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10455455	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85960496	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10455456	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85960604	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10455158	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85963107	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12215903	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85965310	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12216203	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85965583	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs34106666	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85966540	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1337844	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85967555	chr6:85660950~85678736:-
READ	cis	rs1577917	0.959	rs34258068	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85969731	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs11756615	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85970117	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs10944168	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85970438	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs884841	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85970582	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs884842	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85970679	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10944170	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85975751	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12207610	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85978298	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12203457	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85979559	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs35283633	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85981069	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs11755864	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85982073	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs36096931	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85983416	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs1582127	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85987486	chr6:85660950~85678736:-
READ	cis	rs1577917	0.876	rs1582126	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85987487	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs11756510	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85990076	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs13207354	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85990545	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12204365	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85990814	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12663651	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85991937	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs34281561	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85992154	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs35419329	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85992573	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs34852683	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85992612	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs6936048	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85992890	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12216328	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85993700	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1999852	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85996020	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs34581302	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85996230	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs35797755	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85996836	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs68171315	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:85997682	chr6:85660950~85678736:-
READ	cis	rs1577917	0.652	rs75593931	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86009821	chr6:85660950~85678736:-
READ	cis	rs1577917	0.959	rs12201739	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86011021	chr6:85660950~85678736:-
READ	cis	rs1577917	0.917	rs35038582	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86011587	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs7760207	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86011982	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12205336	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86012649	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12207305	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86013784	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12209127	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86014709	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12212733	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86016295	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12199516	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86016503	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12199784	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86017090	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12215037	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86017913	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1337850	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86019385	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs955197	ENSG00000203875.9	SNHG5	-4.71	1.32e-05	0.0279	-0.67	-0.5	Response to antipsychotic treatment;	chr6:86019957	chr6:85660950~85678736:-
READ	cis	rs2929278	0.617	rs575082	ENSG00000249839.1	AC011330.5	4.71	1.32e-05	0.028	0.69	0.5	Schizophrenia;	chr15:43817944	chr15:43663654~43684339:-
READ	cis	rs2929278	0.617	rs2955969	ENSG00000249839.1	AC011330.5	4.71	1.32e-05	0.028	0.69	0.5	Schizophrenia;	chr15:43822329	chr15:43663654~43684339:-
READ	cis	rs80285556	1	rs17311679	ENSG00000161643.11	SIGLEC16	-4.71	1.33e-05	0.0281	-0.95	-0.5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50018074	chr19:49969673~49975814:+
READ	cis	rs61160187	0.51	rs10077663	ENSG00000215032.2	GNL3LP1	4.71	1.34e-05	0.0282	0.57	0.5	Educational attainment (years of education);Educational attainment (college completion);	chr5:60807665	chr5:60891935~60893577:-
READ	cis	rs1577917	0.74	rs9344533	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85526470	chr6:85660950~85678736:-
READ	cis	rs1577917	0.74	rs7775864	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85538041	chr6:85660950~85678736:-
READ	cis	rs1577917	0.74	rs7771612	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85554656	chr6:85660950~85678736:-
READ	cis	rs1577917	0.655	rs7742691	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85568973	chr6:85660950~85678736:-
READ	cis	rs1577917	0.71	rs9342041	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85571157	chr6:85660950~85678736:-
READ	cis	rs1577917	0.682	rs6935918	ENSG00000203875.9	SNHG5	4.71	1.34e-05	0.0282	0.66	0.5	Response to antipsychotic treatment;	chr6:85573857	chr6:85660950~85678736:-
READ	cis	rs2117029	0.521	rs1039225	ENSG00000258017.1	RP11-386G11.10	-4.7	1.34e-05	0.0283	-0.65	-0.5	Intelligence (multi-trait analysis);	chr12:49188909	chr12:49127782~49147869:+
READ	cis	rs2117029	0.521	rs11168910	ENSG00000258017.1	RP11-386G11.10	-4.7	1.34e-05	0.0283	-0.65	-0.5	Intelligence (multi-trait analysis);	chr12:49192707	chr12:49127782~49147869:+
READ	cis	rs896322	0.843	rs1172134	ENSG00000271580.1	RP11-536L3.4	4.7	1.35e-05	0.0284	0.88	0.5	Mean platelet volume;	chr1:205278904	chr1:205091163~205091946:+
READ	cis	rs9487094	0.666	rs2211288	ENSG00000260273.1	RP11-425D10.10	4.7	1.35e-05	0.0285	0.61	0.5	Height;	chr6:109383848	chr6:109382795~109383666:+
READ	cis	rs9322193	0.847	rs4870054	ENSG00000268592.3	RAET1E-AS1	4.7	1.35e-05	0.0285	0.63	0.5	Lung cancer;	chr6:149848402	chr6:149863494~149919507:+
READ	cis	rs7429990	0.932	rs6766641	ENSG00000229759.1	MRPS18AP1	-4.7	1.36e-05	0.0286	-0.54	-0.5	Educational attainment (years of education);	chr3:48103734	chr3:48256350~48256938:-
READ	cis	rs17301013	0.932	rs332771	ENSG00000227373.4	RP11-160H22.5	4.7	1.36e-05	0.0287	0.65	0.5	Systemic lupus erythematosus;	chr1:174704141	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs332789	ENSG00000227373.4	RP11-160H22.5	4.7	1.36e-05	0.0287	0.65	0.5	Systemic lupus erythematosus;	chr1:174735754	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs461910	ENSG00000227373.4	RP11-160H22.5	4.7	1.36e-05	0.0287	0.65	0.5	Systemic lupus erythematosus;	chr1:174736351	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs1754349	ENSG00000227373.4	RP11-160H22.5	-4.7	1.36e-05	0.0287	-0.65	-0.5	Systemic lupus erythematosus;	chr1:174837663	chr1:174115300~174160004:-
READ	cis	rs992157	0.732	rs10932771	ENSG00000261338.2	RP11-378A13.1	4.7	1.37e-05	0.0287	0.6	0.5	Colorectal cancer;	chr2:218305513	chr2:218255319~218257366:+
READ	cis	rs10129255	0.83	rs61997609	ENSG00000211972.2	IGHV3-66	4.7	1.37e-05	0.0287	0.48	0.5	Kawasaki disease;	chr14:106692376	chr14:106675017~106675544:-
READ	cis	rs9487094	0.961	rs9480957	ENSG00000260273.1	RP11-425D10.10	4.7	1.37e-05	0.0287	0.59	0.5	Height;	chr6:109430398	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs12524502	ENSG00000260273.1	RP11-425D10.10	4.7	1.37e-05	0.0288	0.63	0.5	Height;	chr6:109333018	chr6:109382795~109383666:+
READ	cis	rs11155671	0.53	rs2342767	ENSG00000231760.4	RP11-350J20.5	4.7	1.37e-05	0.0288	0.67	0.5	Testicular germ cell tumor;	chr6:149888581	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs7764376	ENSG00000231760.4	RP11-350J20.5	4.7	1.37e-05	0.0288	0.67	0.5	Testicular germ cell tumor;	chr6:149889208	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs6933882	ENSG00000231760.4	RP11-350J20.5	4.7	1.37e-05	0.0288	0.67	0.5	Testicular germ cell tumor;	chr6:149889666	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs6939761	ENSG00000231760.4	RP11-350J20.5	4.7	1.37e-05	0.0288	0.67	0.5	Testicular germ cell tumor;	chr6:149889858	chr6:149796151~149826294:-
READ	cis	rs11155671	0.53	rs3823021	ENSG00000231760.4	RP11-350J20.5	4.7	1.37e-05	0.0288	0.67	0.5	Testicular germ cell tumor;	chr6:149889863	chr6:149796151~149826294:-
READ	cis	rs2739330	0.76	rs1007888	ENSG00000225282.1	AP000350.6	4.7	1.37e-05	0.0288	0.51	0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23926900~23929574:+
READ	cis	rs10851478	0.802	rs7178146	ENSG00000259531.2	RP11-295H24.3	-4.7	1.38e-05	0.0289	-0.66	-0.5	Oral cavity cancer;	chr15:49712620	chr15:49365124~49366685:-
READ	cis	rs1577917	0.959	rs16876540	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85902801	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs35761942	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85919786	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs955227	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85941314	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs10944163	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85948975	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12661204	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85968868	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12196037	ENSG00000203875.9	SNHG5	-4.7	1.38e-05	0.0289	-0.68	-0.5	Response to antipsychotic treatment;	chr6:85984913	chr6:85660950~85678736:-
READ	cis	rs992157	0.717	rs11692780	ENSG00000261338.2	RP11-378A13.1	-4.7	1.38e-05	0.0289	-0.61	-0.5	Colorectal cancer;	chr2:218284440	chr2:218255319~218257366:+
READ	cis	rs453301	0.658	rs9329175	ENSG00000233609.3	RP11-62H7.2	-4.7	1.38e-05	0.0289	-0.63	-0.5	Joint mobility (Beighton score);	chr8:9009151	chr8:8961200~8979025:+
READ	cis	rs2486288	0.656	rs1719232	ENSG00000259520.4	CTD-2651B20.3	4.7	1.39e-05	0.029	0.63	0.5	Glomerular filtration rate;	chr15:45279874	chr15:45251580~45279251:-
READ	cis	rs5769707	0.935	rs1109320	ENSG00000188511.11	C22orf34	4.7	1.39e-05	0.029	0.6	0.5	Monocyte percentage of white cells;Monocyte count;	chr22:49595458	chr22:49414524~49657542:-
READ	cis	rs2688482	0.557	rs2550236	ENSG00000224769.1	AC069213.1	4.69	1.39e-05	0.0291	0.87	0.5	Lung disease severity in cystic fibrosis;	chr3:195795450	chr3:195614947~195620233:+
READ	cis	rs7694725	1	rs7694725	ENSG00000241002.1	RP11-119H12.1	-4.69	1.4e-05	0.0291	-0.55	-0.5	Prostate cancer (SNP x SNP interaction);	chr4:113079800	chr4:112738672~112739106:+
READ	cis	rs17826219	0.706	rs8075357	ENSG00000263531.1	RP13-753N3.1	4.69	1.4e-05	0.0292	0.86	0.5	Body mass index;	chr17:30730179	chr17:30863921~30864940:-
READ	cis	rs9425766	0.566	rs12079820	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Life satisfaction;	chr1:174240771	chr1:174115300~174160004:-
READ	cis	rs9425766	0.541	rs4652274	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Life satisfaction;	chr1:174249434	chr1:174115300~174160004:-
READ	cis	rs9425766	0.591	rs2049991	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Life satisfaction;	chr1:174356428	chr1:174115300~174160004:-
READ	cis	rs9425766	0.566	rs10912773	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Life satisfaction;	chr1:174374567	chr1:174115300~174160004:-
READ	cis	rs17301013	0.829	rs2006197	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Systemic lupus erythematosus;	chr1:174432825	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs12568655	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Systemic lupus erythematosus;	chr1:174465194	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs2038025	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Systemic lupus erythematosus;	chr1:174574712	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs61826916	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Systemic lupus erythematosus;	chr1:174616048	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs10912824	ENSG00000227373.4	RP11-160H22.5	4.69	1.4e-05	0.0292	0.64	0.5	Systemic lupus erythematosus;	chr1:174625846	chr1:174115300~174160004:-
READ	cis	rs3096299	0.719	rs2965945	ENSG00000274627.1	RP11-104N10.2	4.69	1.41e-05	0.0293	0.52	0.5	Multiple myeloma (IgH translocation);	chr16:89447609	chr16:89516797~89522217:+
READ	cis	rs11920570	0.526	rs3828362	ENSG00000272758.4	RP11-299J3.8	4.69	1.41e-05	0.0293	0.48	0.5	Resting heart rate;	chr3:122412930	chr3:122416207~122443180:+
READ	cis	rs992157	0.804	rs6758540	ENSG00000261338.2	RP11-378A13.1	-4.69	1.41e-05	0.0294	-0.62	-0.5	Colorectal cancer;	chr2:218273902	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs2292550	ENSG00000261338.2	RP11-378A13.1	-4.69	1.41e-05	0.0294	-0.62	-0.5	Colorectal cancer;	chr2:218275565	chr2:218255319~218257366:+
READ	cis	rs2739330	0.731	rs4822450	ENSG00000225282.1	AP000350.6	4.69	1.42e-05	0.0295	0.51	0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900700	chr22:23926900~23929574:+
READ	cis	rs9487094	0.626	rs1980591	ENSG00000260273.1	RP11-425D10.10	4.69	1.42e-05	0.0295	0.6	0.5	Height;	chr6:109618620	chr6:109382795~109383666:+
READ	cis	rs9487094	0.696	rs12191353	ENSG00000260273.1	RP11-425D10.10	4.69	1.42e-05	0.0295	0.6	0.5	Height;	chr6:109620772	chr6:109382795~109383666:+
READ	cis	rs9309473	0.607	rs7604588	ENSG00000163016.8	ALMS1P	4.69	1.42e-05	0.0296	0.63	0.5	Metabolite levels;	chr2:73344289	chr2:73644919~73685576:+
READ	cis	rs2739330	0.929	rs5751775	ENSG00000231271.1	AP000350.8	4.69	1.43e-05	0.0296	0.62	0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23924539	chr22:23949918~23954042:+
READ	cis	rs35681285	0.59	rs1405589	ENSG00000235837.1	AC073333.8	4.69	1.43e-05	0.0296	0.99	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16113562	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs10279326	ENSG00000235837.1	AC073333.8	4.69	1.43e-05	0.0296	0.99	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16115295	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs17169279	ENSG00000235837.1	AC073333.8	4.69	1.43e-05	0.0296	0.99	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16127706	chr7:16695871~16719898:-
READ	cis	rs35160687	0.901	rs6713456	ENSG00000273080.1	RP11-301O19.1	4.69	1.43e-05	0.0297	0.59	0.5	Night sleep phenotypes;	chr2:86280530	chr2:86195590~86196049:+
READ	cis	rs9545047	0.935	rs4885634	ENSG00000227676.3	LINC01068	-4.69	1.43e-05	0.0297	-0.6	-0.5	Schizophrenia;	chr13:79482772	chr13:79566727~79571436:+
READ	cis	rs17301013	0.606	rs10912754	ENSG00000227373.4	RP11-160H22.5	4.69	1.44e-05	0.0297	0.78	0.5	Systemic lupus erythematosus;	chr1:174273667	chr1:174115300~174160004:-
READ	cis	rs2581828	0.646	rs12630819	ENSG00000242142.1	SERBP1P3	-4.69	1.44e-05	0.0297	-0.55	-0.5	Crohn's disease;	chr3:53123286	chr3:53064283~53065091:-
READ	cis	rs2581828	0.646	rs12638996	ENSG00000242142.1	SERBP1P3	-4.69	1.44e-05	0.0297	-0.55	-0.5	Crohn's disease;	chr3:53123530	chr3:53064283~53065091:-
READ	cis	rs75920871	0.528	rs11216244	ENSG00000254851.1	RP11-109L13.1	4.69	1.44e-05	0.0297	0.73	0.5	Subjective well-being;	chr11:117042014	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs11216245	ENSG00000254851.1	RP11-109L13.1	4.69	1.44e-05	0.0297	0.73	0.5	Subjective well-being;	chr11:117042486	chr11:117135528~117138582:+
READ	cis	rs9487094	0.601	rs4945831	ENSG00000260273.1	RP11-425D10.10	4.68	1.45e-05	0.0299	0.61	0.5	Height;	chr6:109440234	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs1476387	ENSG00000260273.1	RP11-425D10.10	4.68	1.45e-05	0.0299	0.61	0.5	Height;	chr6:109443332	chr6:109382795~109383666:+
READ	cis	rs79040073	0.53	rs2078024	ENSG00000259531.2	RP11-295H24.3	4.68	1.46e-05	0.03	0.76	0.5	Lung cancer in ever smokers;	chr15:49329413	chr15:49365124~49366685:-
READ	cis	rs12468226	0.938	rs55681656	ENSG00000272966.1	RP11-686O6.1	4.68	1.46e-05	0.03	0.72	0.5	Urate levels;	chr2:202319041	chr2:202336739~202337200:+
READ	cis	rs1799949	1	rs8070085	ENSG00000198496.9	NBR2	4.68	1.46e-05	0.0301	0.56	0.5	Menopause (age at onset);	chr17:43189967	chr17:43125610~43153671:+
READ	cis	rs1577917	0.958	rs12215232	ENSG00000203875.9	SNHG5	-4.68	1.47e-05	0.0301	-0.69	-0.5	Response to antipsychotic treatment;	chr6:86075712	chr6:85660950~85678736:-
READ	cis	rs35681285	0.59	rs7799529	ENSG00000235837.1	AC073333.8	4.68	1.47e-05	0.0303	0.98	0.5	Serum tamsulosin hydrochloride concentration;	chr7:16111052	chr7:16695871~16719898:-
READ	cis	rs75920871	0.588	rs1940626	ENSG00000254851.1	RP11-109L13.1	4.68	1.48e-05	0.0303	0.71	0.5	Subjective well-being;	chr11:116957405	chr11:117135528~117138582:+
READ	cis	rs79040073	0.637	rs11635308	ENSG00000259531.2	RP11-295H24.3	4.68	1.48e-05	0.0303	0.77	0.5	Lung cancer in ever smokers;	chr15:49426531	chr15:49365124~49366685:-
READ	cis	rs34375054	0.525	rs7136220	ENSG00000279233.1	RP11-158L12.4	4.68	1.48e-05	0.0304	0.47	0.5	Post bronchodilator FEV1/FVC ratio;	chr12:125118138	chr12:125138245~125141711:+
READ	cis	rs2581828	0.656	rs1864367	ENSG00000242142.1	SERBP1P3	4.68	1.49e-05	0.0305	0.54	0.5	Crohn's disease;	chr3:53077688	chr3:53064283~53065091:-
READ	cis	rs1286150	0.738	rs3783835	ENSG00000260711.2	RP11-747H7.3	4.68	1.49e-05	0.0305	0.67	0.5	Total body bone mineral density;	chr14:90891310	chr14:91752856~91759798:-
READ	cis	rs1286150	0.704	rs8008667	ENSG00000260711.2	RP11-747H7.3	4.68	1.49e-05	0.0305	0.67	0.5	Total body bone mineral density;	chr14:90893313	chr14:91752856~91759798:-
READ	cis	rs992157	0.835	rs7585702	ENSG00000261338.2	RP11-378A13.1	-4.67	1.5e-05	0.0307	-0.61	-0.5	Colorectal cancer;	chr2:218281884	chr2:218255319~218257366:+
READ	cis	rs992157	0.866	rs2292554	ENSG00000261338.2	RP11-378A13.1	-4.67	1.5e-05	0.0307	-0.61	-0.5	Colorectal cancer;	chr2:218282145	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs2292555	ENSG00000261338.2	RP11-378A13.1	-4.67	1.5e-05	0.0307	-0.61	-0.5	Colorectal cancer;	chr2:218282159	chr2:218255319~218257366:+
READ	cis	rs992157	0.835	rs10932769	ENSG00000261338.2	RP11-378A13.1	-4.67	1.5e-05	0.0307	-0.61	-0.5	Colorectal cancer;	chr2:218282522	chr2:218255319~218257366:+
READ	cis	rs5769707	0.967	rs763127	ENSG00000188511.11	C22orf34	4.67	1.5e-05	0.0308	0.59	0.5	Monocyte percentage of white cells;Monocyte count;	chr22:49612430	chr22:49414524~49657542:-
READ	cis	rs748404	0.69	rs2467737	ENSG00000249839.1	AC011330.5	-4.67	1.5e-05	0.0308	-0.67	-0.5	Lung cancer;	chr15:43444990	chr15:43663654~43684339:-
READ	cis	rs2581828	0.646	rs13433700	ENSG00000242142.1	SERBP1P3	-4.67	1.5e-05	0.0308	-0.55	-0.5	Crohn's disease;	chr3:53113870	chr3:53064283~53065091:-
READ	cis	rs2581828	0.646	rs6783748	ENSG00000242142.1	SERBP1P3	-4.67	1.5e-05	0.0308	-0.55	-0.5	Crohn's disease;	chr3:53119415	chr3:53064283~53065091:-
READ	cis	rs2581828	0.646	rs9757079	ENSG00000242142.1	SERBP1P3	-4.67	1.5e-05	0.0308	-0.55	-0.5	Crohn's disease;	chr3:53121142	chr3:53064283~53065091:-
READ	cis	rs17301013	0.861	rs7521870	ENSG00000227373.4	RP11-160H22.5	-4.67	1.5e-05	0.0308	-0.63	-0.5	Systemic lupus erythematosus;	chr1:174497239	chr1:174115300~174160004:-
READ	cis	rs9487094	0.813	rs3799840	ENSG00000260273.1	RP11-425D10.10	4.67	1.5e-05	0.0308	0.63	0.5	Height;	chr6:109381443	chr6:109382795~109383666:+
READ	cis	rs9487094	0.744	rs2275652	ENSG00000260273.1	RP11-425D10.10	4.67	1.5e-05	0.0308	0.63	0.5	Height;	chr6:109382480	chr6:109382795~109383666:+
READ	cis	rs9487094	0.744	rs13199519	ENSG00000260273.1	RP11-425D10.10	4.67	1.5e-05	0.0308	0.63	0.5	Height;	chr6:109387972	chr6:109382795~109383666:+
READ	cis	rs11123170	0.64	rs1015754	ENSG00000189223.12	PAX8-AS1	4.67	1.51e-05	0.0308	0.71	0.5	Renal function-related traits (BUN);	chr2:113210413	chr2:113211522~113276581:+
READ	cis	rs10426930	0.816	rs858414	ENSG00000269425.1	AC007292.7	-4.67	1.51e-05	0.0308	-0.66	-0.5	Monocyte percentage of white cells;	chr19:5055185	chr19:4339577~4343491:+
READ	cis	rs9322193	0.923	rs9371207	ENSG00000268592.3	RAET1E-AS1	4.67	1.51e-05	0.0309	0.6	0.5	Lung cancer;	chr6:149858087	chr6:149863494~149919507:+
READ	cis	rs9322193	0.923	rs2880436	ENSG00000268592.3	RAET1E-AS1	4.67	1.51e-05	0.0309	0.6	0.5	Lung cancer;	chr6:149859123	chr6:149863494~149919507:+
READ	cis	rs17301013	0.606	rs10798307	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174264172	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6425277	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174296153	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12074276	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174302167	chr1:174115300~174160004:-
READ	cis	rs17301013	0.659	rs59649440	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174332024	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7536987	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174367978	chr1:174115300~174160004:-
READ	cis	rs17301013	0.556	rs10912774	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174387706	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs16846938	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174400537	chr1:174115300~174160004:-
READ	cis	rs17301013	0.632	rs10912782	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174418758	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs5015737	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174452857	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12089182	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174463816	chr1:174115300~174160004:-
READ	cis	rs17301013	0.54	rs72713601	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174482987	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs9729907	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174483607	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs2901818	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174486239	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6658315	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174489961	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12064743	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174496646	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7536102	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174496801	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7522253	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174496980	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912798	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174511420	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs10912799	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174511422	chr1:174115300~174160004:-
READ	cis	rs17301013	0.556	rs10912800	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174513939	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs56213002	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174516512	chr1:174115300~174160004:-
READ	cis	rs17301013	0.541	rs10798319	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174516983	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs9730220	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174519092	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs11487399	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174527129	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12086693	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174527651	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12062170	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174528420	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12062483	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174529089	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6681970	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174532698	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6668096	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174537343	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6692173	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174544474	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12077529	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174549874	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs7530265	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174564603	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12080535	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174569832	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12083628	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174572097	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6691118	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174577798	chr1:174115300~174160004:-
READ	cis	rs17301013	0.54	rs61624206	ENSG00000227373.4	RP11-160H22.5	4.67	1.52e-05	0.0309	0.77	0.5	Systemic lupus erythematosus;	chr1:174578374	chr1:174115300~174160004:-
READ	cis	rs7264396	1	rs6060479	ENSG00000278367.1	RP11-42O4.2	4.67	1.52e-05	0.0309	0.65	0.5	Total cholesterol levels;	chr20:35577801	chr20:35174355~35174919:-
READ	cis	rs12468226	1	rs77435512	ENSG00000272966.1	RP11-686O6.1	4.67	1.52e-05	0.031	0.75	0.5	Urate levels;	chr2:202334165	chr2:202336739~202337200:+
READ	cis	rs748404	0.69	rs2924369	ENSG00000249839.1	AC011330.5	4.67	1.53e-05	0.0311	0.65	0.5	Lung cancer;	chr15:43485787	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs2467742	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43458039	chr15:43663654~43684339:-
READ	cis	rs748404	0.69	rs2244981	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43460553	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs694725	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43464012	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs690446	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43469066	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs518288	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43471801	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs690472	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43472170	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs560191	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43475576	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs493377	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43481269	chr15:43663654~43684339:-
READ	cis	rs748404	0.69	rs1079309	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43490966	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs2444251	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43496397	chr15:43663654~43684339:-
READ	cis	rs748404	0.66	rs548704	ENSG00000249839.1	AC011330.5	-4.67	1.53e-05	0.0311	-0.65	-0.5	Lung cancer;	chr15:43499508	chr15:43663654~43684339:-
READ	cis	rs992157	0.835	rs6729058	ENSG00000261338.2	RP11-378A13.1	-4.67	1.53e-05	0.0312	-0.61	-0.5	Colorectal cancer;	chr2:218283646	chr2:218255319~218257366:+
READ	cis	rs7429990	0.901	rs9825114	ENSG00000229759.1	MRPS18AP1	-4.67	1.53e-05	0.0312	-0.54	-0.5	Educational attainment (years of education);	chr3:48096592	chr3:48256350~48256938:-
READ	cis	rs17826219	0.789	rs4794873	ENSG00000263531.1	RP13-753N3.1	4.67	1.54e-05	0.0312	0.76	0.5	Body mass index;	chr17:30421334	chr17:30863921~30864940:-
READ	cis	rs748404	0.66	rs2467741	ENSG00000249839.1	AC011330.5	-4.67	1.54e-05	0.0313	-0.65	-0.5	Lung cancer;	chr15:43450428	chr15:43663654~43684339:-
READ	cis	rs7429990	0.864	rs3888	ENSG00000229759.1	MRPS18AP1	-4.67	1.54e-05	0.0313	-0.56	-0.5	Educational attainment (years of education);	chr3:47816085	chr3:48256350~48256938:-
READ	cis	rs10540	0.584	rs10751658	ENSG00000254739.1	RP13-46H24.1	-4.67	1.55e-05	0.0314	-0.68	-0.5	Body mass index;	chr11:437401	chr11:528907~529659:+
READ	cis	rs10540	0.584	rs10751659	ENSG00000254739.1	RP13-46H24.1	-4.67	1.55e-05	0.0314	-0.68	-0.5	Body mass index;	chr11:437559	chr11:528907~529659:+
READ	cis	rs748404	0.578	rs2012467	ENSG00000249839.1	AC011330.5	-4.67	1.55e-05	0.0314	-0.65	-0.5	Lung cancer;	chr15:43398367	chr15:43663654~43684339:-
READ	cis	rs7429990	0.965	rs9854454	ENSG00000229759.1	MRPS18AP1	-4.67	1.55e-05	0.0314	-0.54	-0.5	Educational attainment (years of education);	chr3:47971307	chr3:48256350~48256938:-
READ	cis	rs7829975	0.514	rs2979151	ENSG00000173295.6	FAM86B3P	-4.66	1.56e-05	0.0315	-0.57	-0.5	Mood instability;	chr8:8400509	chr8:8228595~8244865:+
READ	cis	rs2581828	0.646	rs9878875	ENSG00000242142.1	SERBP1P3	-4.66	1.56e-05	0.0315	-0.56	-0.5	Crohn's disease;	chr3:53122851	chr3:53064283~53065091:-
READ	cis	rs17507216	0.718	rs72751657	ENSG00000278603.1	RP13-608F4.5	4.66	1.56e-05	0.0316	0.86	0.5	Excessive daytime sleepiness;	chr15:82581259	chr15:82472203~82472426:+
READ	cis	rs17507216	0.718	rs72751662	ENSG00000278603.1	RP13-608F4.5	4.66	1.56e-05	0.0316	0.86	0.5	Excessive daytime sleepiness;	chr15:82594705	chr15:82472203~82472426:+
READ	cis	rs17507216	0.718	rs72751675	ENSG00000278603.1	RP13-608F4.5	4.66	1.56e-05	0.0316	0.86	0.5	Excessive daytime sleepiness;	chr15:82630452	chr15:82472203~82472426:+
READ	cis	rs2980439	0.846	rs2980437	ENSG00000253981.4	ALG1L13P	-4.66	1.56e-05	0.0316	-0.61	-0.5	Neuroticism;	chr8:8237241	chr8:8236003~8244667:-
READ	cis	rs10463554	0.853	rs246903	ENSG00000175749.11	EIF3KP1	4.66	1.56e-05	0.0316	0.59	0.5	Parkinson's disease;	chr5:103253753	chr5:103032376~103033031:+
READ	cis	rs10463554	0.889	rs246908	ENSG00000175749.11	EIF3KP1	4.66	1.57e-05	0.0316	0.64	0.5	Parkinson's disease;	chr5:103228476	chr5:103032376~103033031:+
READ	cis	rs10463554	0.853	rs246907	ENSG00000175749.11	EIF3KP1	4.66	1.57e-05	0.0316	0.64	0.5	Parkinson's disease;	chr5:103230577	chr5:103032376~103033031:+
READ	cis	rs10463554	0.853	rs458598	ENSG00000175749.11	EIF3KP1	4.66	1.57e-05	0.0316	0.64	0.5	Parkinson's disease;	chr5:103233677	chr5:103032376~103033031:+
READ	cis	rs2739330	0.731	rs4822450	ENSG00000250470.1	AP000351.3	4.66	1.57e-05	0.0317	0.69	0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900700	chr22:23976904~23977585:-
READ	cis	rs9687846	0.61	rs34342767	ENSG00000243592.1	RPL17P22	-4.66	1.57e-05	0.0317	-0.95	-0.5	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr5:56557522	chr5:56136979~56137531:+
READ	cis	rs12468226	0.938	rs55668474	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202265559	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs16824590	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202272624	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs77018809	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202273166	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs7585867	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202287040	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs58834901	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202288169	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs1474002	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202290195	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs6753044	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0317	0.71	0.5	Urate levels;	chr2:202300710	chr2:202336739~202337200:+
READ	cis	rs55726902	0.506	rs1006476	ENSG00000276691.1	RP5-1057I20.5	4.66	1.58e-05	0.0317	0.71	0.5	Allergic disease (asthma, hay fever or eczema);	chr12:47785564	chr12:47788426~47788971:+
READ	cis	rs9425766	0.679	rs6681618	ENSG00000227373.4	RP11-160H22.5	-4.66	1.58e-05	0.0318	-0.66	-0.5	Life satisfaction;	chr1:174201203	chr1:174115300~174160004:-
READ	cis	rs12468226	0.938	rs115418918	ENSG00000272966.1	RP11-686O6.1	4.66	1.58e-05	0.0318	0.73	0.5	Urate levels;	chr2:202315145	chr2:202336739~202337200:+
READ	cis	rs9865818	0.605	rs1464510	ENSG00000228952.1	RP11-567G11.1	4.66	1.59e-05	0.0319	0.7	0.5	Allergic sensitization;	chr3:188394766	chr3:187448845~187449450:+
READ	cis	rs4774565	0.762	rs8041193	ENSG00000244879.4	GABPB1-AS1	-4.66	1.59e-05	0.0319	-0.48	-0.5	Breast cancer;	chr15:50369960	chr15:50354959~50372202:+
READ	cis	rs4774565	0.762	rs34565064	ENSG00000244879.4	GABPB1-AS1	-4.66	1.59e-05	0.0319	-0.48	-0.5	Breast cancer;	chr15:50371706	chr15:50354959~50372202:+
READ	cis	rs9322193	0.886	rs9718079	ENSG00000216906.2	RP11-350J20.9	4.66	1.59e-05	0.0319	0.65	0.5	Lung cancer;	chr6:149645947	chr6:149904243~149906418:+
READ	cis	rs5753037	0.869	rs41165	ENSG00000279159.1	RP3-394A18.1	4.66	1.6e-05	0.032	0.35	0.5	Type 1 diabetes;	chr22:30017350	chr22:29978950~30028236:-
READ	cis	rs3931020	0.53	rs12125889	ENSG00000272864.1	RP11-17E13.2	-4.66	1.6e-05	0.032	-0.61	-0.5	Resistin levels;	chr1:74776287	chr1:74698769~74699333:-
READ	cis	rs4718428	0.672	rs12530806	ENSG00000226824.5	RP4-756H11.3	-4.66	1.6e-05	0.032	-0.7	-0.5	Corneal structure;	chr7:66925737	chr7:66654538~66669855:+
READ	cis	rs2455601	0.573	rs2653573	ENSG00000254860.4	TMEM9B-AS1	4.66	1.6e-05	0.032	0.69	0.5	Schizophrenia;	chr11:8968327	chr11:8964675~8977527:+
READ	cis	rs35160687	0.865	rs10189492	ENSG00000273080.1	RP11-301O19.1	4.66	1.6e-05	0.0321	0.59	0.5	Night sleep phenotypes;	chr2:86251779	chr2:86195590~86196049:+
READ	cis	rs9895661	0.618	rs11650989	ENSG00000227694.1	AC005884.1	4.66	1.6e-05	0.0321	0.6	0.5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine);Renal function-related traits (eGRFcrea);Glomerular filtration rate;Renal function-related traits (sCR);Red blood cell count;Glomerular filtration rate (creatinine);Hematocrit;	chr17:61372275	chr17:61069871~61070341:+
READ	cis	rs6671200	1	rs34396223	ENSG00000228852.5	RP11-57H12.5	4.66	1.6e-05	0.0321	0.88	0.5	Stearic acid (18:0) levels;	chr1:95232272	chr1:95243167~95278940:-
READ	cis	rs6671200	1	rs62625008	ENSG00000228852.5	RP11-57H12.5	4.66	1.6e-05	0.0321	0.88	0.5	Stearic acid (18:0) levels;	chr1:95237026	chr1:95243167~95278940:-
READ	cis	rs6671200	0.92	rs35403759	ENSG00000228852.5	RP11-57H12.5	4.66	1.6e-05	0.0321	0.88	0.5	Stearic acid (18:0) levels;	chr1:95237334	chr1:95243167~95278940:-
READ	cis	rs5753037	0.543	rs131267	ENSG00000279159.1	RP3-394A18.1	-4.66	1.61e-05	0.0322	-0.33	-0.5	Type 1 diabetes;	chr22:29751872	chr22:29978950~30028236:-
READ	cis	rs5753037	0.543	rs131268	ENSG00000279159.1	RP3-394A18.1	-4.66	1.61e-05	0.0322	-0.33	-0.5	Type 1 diabetes;	chr22:29751949	chr22:29978950~30028236:-
READ	cis	rs2019137	1	rs2019137	ENSG00000189223.12	PAX8-AS1	4.66	1.61e-05	0.0322	0.59	0.5	Lymphocyte counts;	chr2:113216055	chr2:113211522~113276581:+
READ	cis	rs2019137	0.967	rs895412	ENSG00000189223.12	PAX8-AS1	4.66	1.61e-05	0.0322	0.59	0.5	Lymphocyte counts;	chr2:113216387	chr2:113211522~113276581:+
READ	cis	rs2581828	0.609	rs73088342	ENSG00000242142.1	SERBP1P3	-4.66	1.61e-05	0.0322	-0.56	-0.5	Crohn's disease;	chr3:53117648	chr3:53064283~53065091:-
READ	cis	rs62229266	0.659	rs2835258	ENSG00000231106.2	LINC01436	4.66	1.61e-05	0.0322	0.65	0.5	Mitral valve prolapse;	chr21:36052067	chr21:36005338~36007838:+
READ	cis	rs5753037	0.869	rs41155	ENSG00000279159.1	RP3-394A18.1	4.65	1.61e-05	0.0323	0.35	0.5	Type 1 diabetes;	chr22:30008558	chr22:29978950~30028236:-
READ	cis	rs10851478	0.59	rs12591300	ENSG00000259531.2	RP11-295H24.3	4.65	1.62e-05	0.0323	0.71	0.5	Oral cavity cancer;	chr15:49412544	chr15:49365124~49366685:-
READ	cis	rs10463554	1	rs10463554	ENSG00000175749.11	EIF3KP1	4.65	1.62e-05	0.0323	0.57	0.5	Parkinson's disease;	chr5:102983270	chr5:103032376~103033031:+
READ	cis	rs13113518	0.812	rs11932712	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55436423	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs12501746	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55437438	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs6849474	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55452295	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs2412648	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55454900	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs12512737	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55454938	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs13125984	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55455102	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs11133385	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55460485	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs11133389	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55486718	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs1522114	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55489895	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs4865001	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55490176	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs4864543	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55490228	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs6825774	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55491150	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs3805153	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55493557	chr4:55540502~55540835:-
READ	cis	rs13113518	0.756	rs7658446	ENSG00000223305.1	RN7SKP30	4.65	1.62e-05	0.0323	0.61	0.5	Height;	chr4:55495262	chr4:55540502~55540835:-
READ	cis	rs10426930	0.816	rs2620809	ENSG00000269425.1	AC007292.7	-4.65	1.62e-05	0.0323	-0.67	-0.5	Monocyte percentage of white cells;	chr19:5062477	chr19:4339577~4343491:+
READ	cis	rs2581828	0.656	rs2581800	ENSG00000242142.1	SERBP1P3	4.65	1.62e-05	0.0324	0.52	0.5	Crohn's disease;	chr3:53075336	chr3:53064283~53065091:-
READ	cis	rs17301013	0.581	rs12082139	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174589043	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs12067463	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174625437	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs10912823	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174625602	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs6677874	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174628410	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs333423	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174666557	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs333437	ENSG00000227373.4	RP11-160H22.5	4.65	1.63e-05	0.0324	0.78	0.5	Systemic lupus erythematosus;	chr1:174672224	chr1:174115300~174160004:-
READ	cis	rs2739330	0.76	rs5751761	ENSG00000225282.1	AP000350.6	-4.65	1.63e-05	0.0324	-0.52	-0.5	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901549	chr22:23926900~23929574:+
READ	cis	rs7937890	1	rs2915401	ENSG00000254418.1	RP11-21L19.1	-4.65	1.63e-05	0.0324	-0.59	-0.5	Mitochondrial DNA levels;	chr11:14353467	chr11:14262846~14273691:-
READ	cis	rs9487094	0.67	rs11755641	ENSG00000260273.1	RP11-425D10.10	4.65	1.63e-05	0.0324	0.59	0.5	Height;	chr6:109586733	chr6:109382795~109383666:+
READ	cis	rs4957798	0.648	rs10074158	ENSG00000271849.1	CTC-332L22.1	-4.65	1.63e-05	0.0325	-0.66	-0.5	Asthma;Asthma (childhood onset);	chr5:109147154	chr5:109687802~109688329:-
READ	cis	rs6460942	0.659	rs28366613	ENSG00000236048.2	AC013470.6	4.65	1.63e-05	0.0325	0.98	0.5	Coronary artery disease;	chr7:12472541	chr7:12471352~12472545:+
READ	cis	rs858239	0.539	rs10270695	ENSG00000230658.1	KLHL7-AS1	-4.65	1.63e-05	0.0325	-0.64	-0.5	Cerebrospinal fluid biomarker levels;	chr7:23149369	chr7:23101228~23105703:-
READ	cis	rs6844153	0.752	rs6815719	ENSG00000240005.4	RP11-293A21.1	-4.65	1.64e-05	0.0326	-0.6	-0.5	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26880232	chr4:26859806~26860599:-
READ	cis	rs1799949	0.929	rs799905	ENSG00000198496.9	NBR2	-4.65	1.64e-05	0.0326	-0.56	-0.5	Menopause (age at onset);	chr17:43125170	chr17:43125610~43153671:+
READ	cis	rs7264396	0.836	rs6088880	ENSG00000278367.1	RP11-42O4.2	4.65	1.64e-05	0.0326	0.62	0.5	Total cholesterol levels;	chr20:35577660	chr20:35174355~35174919:-
READ	cis	rs7264396	1	rs6088881	ENSG00000278367.1	RP11-42O4.2	4.65	1.64e-05	0.0326	0.62	0.5	Total cholesterol levels;	chr20:35577687	chr20:35174355~35174919:-
READ	cis	rs9322193	0.884	rs1108889	ENSG00000268592.3	RAET1E-AS1	4.65	1.64e-05	0.0326	0.61	0.5	Lung cancer;	chr6:149845433	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs880245	ENSG00000268592.3	RAET1E-AS1	-4.65	1.64e-05	0.0326	-0.61	-0.5	Lung cancer;	chr6:149846262	chr6:149863494~149919507:+
READ	cis	rs7937890	1	rs2915402	ENSG00000254418.1	RP11-21L19.1	-4.65	1.65e-05	0.0328	-0.59	-0.5	Mitochondrial DNA levels;	chr11:14356082	chr11:14262846~14273691:-
READ	cis	rs2929278	0.562	rs8033846	ENSG00000249839.1	AC011330.5	4.65	1.65e-05	0.0328	0.67	0.5	Schizophrenia;	chr15:43743165	chr15:43663654~43684339:-
READ	cis	rs2929278	0.589	rs7174732	ENSG00000249839.1	AC011330.5	4.65	1.65e-05	0.0328	0.67	0.5	Schizophrenia;	chr15:43746265	chr15:43663654~43684339:-
READ	cis	rs4774565	0.762	rs11634585	ENSG00000244879.4	GABPB1-AS1	4.65	1.66e-05	0.0328	0.48	0.5	Breast cancer;	chr15:50364252	chr15:50354959~50372202:+
READ	cis	rs9425766	0.566	rs56188862	ENSG00000227373.4	RP11-160H22.5	4.65	1.66e-05	0.0328	0.63	0.5	Life satisfaction;	chr1:174220131	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1793307	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174758716	chr1:174115300~174160004:-
READ	cis	rs17301013	0.62	rs1793310	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174770786	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1618408	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174777402	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1793315	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174808923	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs1894198	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174835393	chr1:174115300~174160004:-
READ	cis	rs17301013	0.659	rs1894199	ENSG00000227373.4	RP11-160H22.5	-4.65	1.66e-05	0.0328	-0.76	-0.5	Systemic lupus erythematosus;	chr1:174835545	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs459078	ENSG00000227373.4	RP11-160H22.5	4.65	1.66e-05	0.0328	0.76	0.5	Systemic lupus erythematosus;	chr1:174733772	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs162815	ENSG00000227373.4	RP11-160H22.5	4.65	1.66e-05	0.0328	0.76	0.5	Systemic lupus erythematosus;	chr1:174738792	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs913687	ENSG00000227373.4	RP11-160H22.5	4.65	1.66e-05	0.0328	0.76	0.5	Systemic lupus erythematosus;	chr1:174805993	chr1:174115300~174160004:-
READ	cis	rs79040073	0.637	rs57252806	ENSG00000259531.2	RP11-295H24.3	4.65	1.66e-05	0.0328	0.79	0.5	Lung cancer in ever smokers;	chr15:49352188	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs11633981	ENSG00000259531.2	RP11-295H24.3	4.65	1.66e-05	0.0328	0.79	0.5	Lung cancer in ever smokers;	chr15:49360903	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs11633282	ENSG00000259531.2	RP11-295H24.3	4.65	1.66e-05	0.0328	0.79	0.5	Lung cancer in ever smokers;	chr15:49372472	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs11638606	ENSG00000259531.2	RP11-295H24.3	4.65	1.66e-05	0.0328	0.79	0.5	Lung cancer in ever smokers;	chr15:49372564	chr15:49365124~49366685:-
READ	cis	rs11155671	0.53	rs9371544	ENSG00000231760.4	RP11-350J20.5	4.65	1.66e-05	0.0329	0.68	0.5	Testicular germ cell tumor;	chr6:149896224	chr6:149796151~149826294:-
READ	cis	rs77204473	0.655	rs11216183	ENSG00000254851.1	RP11-109L13.1	4.65	1.67e-05	0.033	0.9	0.5	Sum eosinophil basophil counts;Eosinophil counts;	chr11:116910829	chr11:117135528~117138582:+
READ	cis	rs9425766	0.679	rs12085290	ENSG00000227373.4	RP11-160H22.5	-4.65	1.67e-05	0.033	-0.66	-0.5	Life satisfaction;	chr1:174124699	chr1:174115300~174160004:-
READ	cis	rs2019137	0.901	rs4849176	ENSG00000189223.12	PAX8-AS1	4.64	1.67e-05	0.0331	0.59	0.5	Lymphocyte counts;	chr2:113220359	chr2:113211522~113276581:+
READ	cis	rs11155671	0.53	rs9383940	ENSG00000231760.4	RP11-350J20.5	4.64	1.68e-05	0.0331	0.69	0.5	Testicular germ cell tumor;	chr6:149904923	chr6:149796151~149826294:-
READ	cis	rs773506	0.72	rs7036028	ENSG00000233081.1	RP11-440G5.2	4.64	1.68e-05	0.0332	0.61	0.5	Type 2 diabetes nephropathy;	chr9:91195254	chr9:91426238~91427144:+
READ	cis	rs773506	0.72	rs12236714	ENSG00000233081.1	RP11-440G5.2	4.64	1.68e-05	0.0332	0.61	0.5	Type 2 diabetes nephropathy;	chr9:91199045	chr9:91426238~91427144:+
READ	cis	rs67383717	0.777	rs591486	ENSG00000175611.10	LINC00476	-4.64	1.68e-05	0.0332	-0.54	-0.5	Parkinson's disease (pesticide exposure interaction);	chr9:95887764	chr9:95759231~95875977:-
READ	cis	rs79040073	0.53	rs1055254	ENSG00000259531.2	RP11-295H24.3	4.64	1.68e-05	0.0333	0.76	0.5	Lung cancer in ever smokers;	chr15:49328003	chr15:49365124~49366685:-
READ	cis	rs9487094	0.644	rs13201430	ENSG00000260273.1	RP11-425D10.10	4.64	1.69e-05	0.0333	0.61	0.5	Height;	chr6:109634847	chr6:109382795~109383666:+
READ	cis	rs4774565	0.762	rs7164848	ENSG00000244879.4	GABPB1-AS1	4.64	1.69e-05	0.0333	0.49	0.5	Breast cancer;	chr15:50370833	chr15:50354959~50372202:+
READ	cis	rs210138	1	rs210137	ENSG00000197251.3	LINC00336	4.64	1.69e-05	0.0333	0.77	0.5	Testicular germ cell tumor;	chr6:33574701	chr6:33586106~33593338:-
READ	cis	rs7617773	0.78	rs34523942	ENSG00000229759.1	MRPS18AP1	4.64	1.69e-05	0.0334	0.6	0.5	Coronary artery disease;	chr3:48301179	chr3:48256350~48256938:-
READ	cis	rs2019137	0.936	rs3811059	ENSG00000189223.12	PAX8-AS1	4.64	1.69e-05	0.0334	0.59	0.5	Lymphocyte counts;	chr2:113204494	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs12620738	ENSG00000189223.12	PAX8-AS1	4.64	1.69e-05	0.0334	0.59	0.5	Lymphocyte counts;	chr2:113206162	chr2:113211522~113276581:+
READ	cis	rs13113518	1	rs13132420	ENSG00000223305.1	RN7SKP30	-4.64	1.69e-05	0.0334	-0.59	-0.5	Height;	chr4:55526646	chr4:55540502~55540835:-
READ	cis	rs881375	0.934	rs2159778	ENSG00000226752.6	PSMD5-AS1	-4.64	1.69e-05	0.0334	-0.61	-0.5	Rheumatoid arthritis;	chr9:120915851	chr9:120824828~120854385:+
READ	cis	rs9322193	0.847	rs880246	ENSG00000268592.3	RAET1E-AS1	4.64	1.7e-05	0.0335	0.61	0.5	Lung cancer;	chr6:149845972	chr6:149863494~149919507:+
READ	cis	rs4718428	0.672	rs4718412	ENSG00000226824.5	RP4-756H11.3	4.64	1.7e-05	0.0336	0.7	0.5	Corneal structure;	chr7:66821880	chr7:66654538~66669855:+
READ	cis	rs2564921	0.73	rs930122	ENSG00000242142.1	SERBP1P3	4.64	1.71e-05	0.0336	0.51	0.5	Height;	chr3:53085313	chr3:53064283~53065091:-
READ	cis	rs1075265	0.568	rs805416	ENSG00000233266.1	HMGB1P31	-4.64	1.73e-05	0.034	-0.58	-0.5	Chronotype;Morning vs. evening chronotype;	chr2:53898121	chr2:54051334~54051760:+
READ	cis	rs5760092	0.755	rs915589	ENSG00000250470.1	AP000351.3	-4.64	1.73e-05	0.034	-0.78	-0.5	Urinary 1,3-butadiene metabolite levels in smokers;	chr22:23918817	chr22:23976904~23977585:-
READ	cis	rs17301013	0.606	rs332798	ENSG00000227373.4	RP11-160H22.5	4.64	1.73e-05	0.034	0.77	0.5	Systemic lupus erythematosus;	chr1:174729096	chr1:174115300~174160004:-
READ	cis	rs2882667	0.522	rs7731574	ENSG00000253404.1	AC034243.1	-4.64	1.73e-05	0.034	-0.59	-0.5	Age-related hearing impairment (SNP x SNP interaction);	chr5:139118503	chr5:138744434~138753309:-
READ	cis	rs79040073	0.637	rs11632575	ENSG00000259531.2	RP11-295H24.3	4.64	1.73e-05	0.034	0.76	0.5	Lung cancer in ever smokers;	chr15:49380758	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs77296528	ENSG00000259531.2	RP11-295H24.3	4.64	1.73e-05	0.034	0.76	0.5	Lung cancer in ever smokers;	chr15:49381827	chr15:49365124~49366685:-
READ	cis	rs79040073	0.594	rs59112977	ENSG00000259531.2	RP11-295H24.3	4.64	1.73e-05	0.034	0.76	0.5	Lung cancer in ever smokers;	chr15:49382342	chr15:49365124~49366685:-
READ	cis	rs7617773	0.78	rs3197223	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48294367	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs13067450	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48295716	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs4479622	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48296683	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs34946886	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48296997	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs34589064	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48298059	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs2541	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48298128	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs13085251	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48298555	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs35297395	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48301392	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs36075665	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48301597	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs35190747	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48301800	chr3:48256350~48256938:-
READ	cis	rs7617773	0.743	rs7621785	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48302218	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs4511915	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48302368	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs13066758	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48302387	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs4392440	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48302430	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs13082859	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48303185	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs36121690	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48304021	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs35778847	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48305495	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs34749846	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48305678	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs7632297	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48306673	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs79089926	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48307074	chr3:48256350~48256938:-
READ	cis	rs7617773	0.643	rs78159520	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48307533	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs4511916	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48308876	chr3:48256350~48256938:-
READ	cis	rs7617773	0.815	rs7624450	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48308885	chr3:48256350~48256938:-
READ	cis	rs7617773	0.815	rs6793150	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48310070	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs6793239	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48310128	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs6782166	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48310193	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs4130522	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48310823	chr3:48256350~48256938:-
READ	cis	rs7617773	0.674	rs13069029	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48313534	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs13081169	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48315307	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs35411187	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48318527	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs11714176	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48319372	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs7653152	ENSG00000229759.1	MRPS18AP1	4.64	1.73e-05	0.034	0.6	0.5	Coronary artery disease;	chr3:48320607	chr3:48256350~48256938:-
READ	cis	rs7617773	0.746	rs4130995	ENSG00000229759.1	MRPS18AP1	4.63	1.74e-05	0.0341	0.57	0.5	Coronary artery disease;	chr3:48316765	chr3:48256350~48256938:-
READ	cis	rs79040073	0.637	rs11638314	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer in ever smokers;	chr15:49421747	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs61259878	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer in ever smokers;	chr15:49432564	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs78323502	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer in ever smokers;	chr15:49436634	chr15:49365124~49366685:-
READ	cis	rs79040073	0.517	rs118069527	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer in ever smokers;	chr15:49436684	chr15:49365124~49366685:-
READ	cis	rs7169304	0.559	rs117818498	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer;Lung cancer in ever smokers;Lung adenocarcinoma;	chr15:49436685	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs79404431	ENSG00000259531.2	RP11-295H24.3	4.63	1.74e-05	0.0341	0.76	0.5	Lung cancer in ever smokers;	chr15:49436689	chr15:49365124~49366685:-
READ	cis	rs4718428	0.705	rs11028	ENSG00000226824.5	RP4-756H11.3	-4.63	1.74e-05	0.0341	-0.7	-0.5	Corneal structure;	chr7:66811230	chr7:66654538~66669855:+
READ	cis	rs75920871	0.528	rs7124872	ENSG00000254851.1	RP11-109L13.1	-4.63	1.75e-05	0.0342	-0.71	-0.5	Subjective well-being;	chr11:117057235	chr11:117135528~117138582:+
READ	cis	rs75920871	0.528	rs7935913	ENSG00000254851.1	RP11-109L13.1	-4.63	1.75e-05	0.0342	-0.71	-0.5	Subjective well-being;	chr11:117073632	chr11:117135528~117138582:+
READ	cis	rs79040073	0.53	rs17476940	ENSG00000259531.2	RP11-295H24.3	-4.63	1.75e-05	0.0342	-0.72	-0.5	Lung cancer in ever smokers;	chr15:49332587	chr15:49365124~49366685:-
READ	cis	rs12468226	1	rs112306637	ENSG00000226261.1	AC064836.3	4.63	1.75e-05	0.0342	0.84	0.5	Urate levels;	chr2:202334195	chr2:202336024~202336727:-
READ	cis	rs12468226	1	rs111252524	ENSG00000226261.1	AC064836.3	4.63	1.75e-05	0.0342	0.84	0.5	Urate levels;	chr2:202334465	chr2:202336024~202336727:-
READ	cis	rs12468226	1	rs112753638	ENSG00000226261.1	AC064836.3	4.63	1.75e-05	0.0342	0.84	0.5	Urate levels;	chr2:202334496	chr2:202336024~202336727:-
READ	cis	rs12468226	0.935	rs113188021	ENSG00000226261.1	AC064836.3	4.63	1.75e-05	0.0342	0.84	0.5	Urate levels;	chr2:202336237	chr2:202336024~202336727:-
READ	cis	rs12468226	1	rs6731027	ENSG00000226261.1	AC064836.3	4.63	1.75e-05	0.0342	0.84	0.5	Urate levels;	chr2:202337443	chr2:202336024~202336727:-
READ	cis	rs6844153	0.752	rs11737218	ENSG00000240005.4	RP11-293A21.1	4.63	1.75e-05	0.0342	0.59	0.5	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26884151	chr4:26859806~26860599:-
READ	cis	rs9322193	0.962	rs1889473	ENSG00000216906.2	RP11-350J20.9	4.63	1.75e-05	0.0342	0.66	0.5	Lung cancer;	chr6:149825485	chr6:149904243~149906418:+
READ	cis	rs9322193	0.962	rs6903998	ENSG00000216906.2	RP11-350J20.9	4.63	1.75e-05	0.0342	0.66	0.5	Lung cancer;	chr6:149831357	chr6:149904243~149906418:+
READ	cis	rs9322193	0.923	rs1984111	ENSG00000216906.2	RP11-350J20.9	4.63	1.75e-05	0.0342	0.66	0.5	Lung cancer;	chr6:149831720	chr6:149904243~149906418:+
READ	cis	rs11105298	0.891	rs10858899	ENSG00000258302.2	RP11-981P6.1	4.63	1.76e-05	0.0343	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89530034	chr12:89561129~89594878:+
READ	cis	rs13113518	0.841	rs7699867	ENSG00000223305.1	RN7SKP30	4.63	1.76e-05	0.0343	0.62	0.5	Height;	chr4:55483718	chr4:55540502~55540835:-
READ	cis	rs2019137	0.936	rs902696	ENSG00000274877.1	RP11-65I12.1	-4.63	1.76e-05	0.0344	-0.55	-0.5	Lymphocyte counts;	chr2:113197302	chr2:113237595~113240825:+
READ	cis	rs5753037	0.869	rs5763646	ENSG00000279159.1	RP3-394A18.1	-4.63	1.76e-05	0.0344	-0.36	-0.5	Type 1 diabetes;	chr22:29963421	chr22:29978950~30028236:-
READ	cis	rs5753037	0.809	rs997913	ENSG00000279159.1	RP3-394A18.1	-4.63	1.76e-05	0.0344	-0.36	-0.5	Type 1 diabetes;	chr22:29978632	chr22:29978950~30028236:-
READ	cis	rs11123170	0.64	rs931472	ENSG00000189223.12	PAX8-AS1	4.63	1.76e-05	0.0344	0.71	0.5	Renal function-related traits (BUN);	chr2:113212371	chr2:113211522~113276581:+
READ	cis	rs526231	0.697	rs253759	ENSG00000175749.11	EIF3KP1	4.63	1.76e-05	0.0344	0.67	0.5	Primary biliary cholangitis;	chr5:103279974	chr5:103032376~103033031:+
READ	cis	rs117004340	0.702	rs73203996	ENSG00000242607.1	RPS3AP34	4.63	1.77e-05	0.0345	0.81	0.5	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13361475	chr8:12570350~12571130:-
READ	cis	rs117004340	0.702	rs73203998	ENSG00000242607.1	RPS3AP34	4.63	1.77e-05	0.0345	0.81	0.5	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13361890	chr8:12570350~12571130:-
READ	cis	rs117004340	0.702	rs73203999	ENSG00000242607.1	RPS3AP34	4.63	1.77e-05	0.0345	0.81	0.5	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13362585	chr8:12570350~12571130:-
READ	cis	rs117004340	0.702	rs73204001	ENSG00000242607.1	RPS3AP34	4.63	1.77e-05	0.0345	0.81	0.5	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13363111	chr8:12570350~12571130:-
READ	cis	rs11155671	0.53	rs7757984	ENSG00000268592.3	RAET1E-AS1	4.63	1.77e-05	0.0346	0.62	0.5	Testicular germ cell tumor;	chr6:149887515	chr6:149863494~149919507:+
READ	cis	rs2014572	0.967	rs8100154	ENSG00000268713.1	CTC-444N24.8	4.63	1.77e-05	0.0346	0.58	0.5	Hyperactive-impulsive symptoms;	chr19:57254064	chr19:57261354~57262738:+
READ	cis	rs11105298	0.891	rs1054807	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89519642	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858894	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89520484	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs11105310	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89524900	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10777184	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89525791	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10858896	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89526407	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs11105312	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89526956	chr12:89561129~89594878:+
READ	cis	rs11105298	0.891	rs10777185	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89527498	chr12:89561129~89594878:+
READ	cis	rs11105298	0.786	rs10777186	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89527500	chr12:89561129~89594878:+
READ	cis	rs11105298	0.786	rs10858897	ENSG00000258302.2	RP11-981P6.1	4.63	1.78e-05	0.0346	0.64	0.5	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89528255	chr12:89561129~89594878:+
READ	cis	rs916888	0.61	rs199452	ENSG00000214401.4	KANSL1-AS1	4.63	1.78e-05	0.0346	0.72	0.5	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46723974	chr17:46193576~46196723:+
READ	cis	rs7617773	0.746	rs4371540	ENSG00000229759.1	MRPS18AP1	4.63	1.78e-05	0.0346	0.63	0.5	Coronary artery disease;	chr3:48312053	chr3:48256350~48256938:-
READ	cis	rs2486288	0.656	rs8039352	ENSG00000259520.4	CTD-2651B20.3	4.63	1.78e-05	0.0346	0.59	0.49	Glomerular filtration rate;	chr15:45259592	chr15:45251580~45279251:-
READ	cis	rs67180937	0.844	rs4846770	ENSG00000272750.1	RP11-378J18.8	-4.63	1.78e-05	0.0346	-0.7	-0.49	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222622227	chr1:222658867~222661512:-
READ	cis	rs67180937	0.844	rs4846384	ENSG00000272750.1	RP11-378J18.8	-4.63	1.78e-05	0.0346	-0.7	-0.49	Coronary artery disease;Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);	chr1:222624272	chr1:222658867~222661512:-
READ	cis	rs2739330	0.734	rs2000467	ENSG00000225282.1	AP000350.6	-4.63	1.78e-05	0.0346	-0.48	-0.49	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899346	chr22:23926900~23929574:+
READ	cis	rs61160187	0.51	rs6893642	ENSG00000215032.2	GNL3LP1	4.63	1.78e-05	0.0347	0.57	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60821896	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs3936423	ENSG00000215032.2	GNL3LP1	4.63	1.78e-05	0.0347	0.57	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60823134	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs1445293	ENSG00000215032.2	GNL3LP1	4.63	1.78e-05	0.0347	0.57	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60823910	chr5:60891935~60893577:-
READ	cis	rs12049351	0.665	rs10916491	ENSG00000229367.1	HMGN2P19	4.63	1.78e-05	0.0347	0.75	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229492923	chr1:229570532~229570796:+
READ	cis	rs7617773	0.709	rs4404473	ENSG00000229759.1	MRPS18AP1	4.63	1.79e-05	0.0347	0.61	0.49	Coronary artery disease;	chr3:48312136	chr3:48256350~48256938:-
READ	cis	rs6671200	1	rs12755552	ENSG00000228852.5	RP11-57H12.5	4.63	1.79e-05	0.0348	0.88	0.49	Stearic acid (18:0) levels;	chr1:95219470	chr1:95243167~95278940:-
READ	cis	rs6095360	1	rs1983639	ENSG00000278231.1	RP5-906C1.1	-4.63	1.8e-05	0.0348	-0.74	-0.49	Intelligence (multi-trait analysis);	chr20:48955745	chr20:48821688~48849458:-
READ	cis	rs11690935	0.851	rs7581072	ENSG00000228389.1	AC068039.4	4.63	1.8e-05	0.0348	0.63	0.49	Schizophrenia;	chr2:171994938	chr2:171773482~171775844:+
READ	cis	rs17301013	0.861	rs333418	ENSG00000227373.4	RP11-160H22.5	4.62	1.8e-05	0.0349	0.63	0.49	Systemic lupus erythematosus;	chr1:174707294	chr1:174115300~174160004:-
READ	cis	rs17301013	0.828	rs332783	ENSG00000227373.4	RP11-160H22.5	4.62	1.8e-05	0.0349	0.63	0.49	Systemic lupus erythematosus;	chr1:174719260	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs170768	ENSG00000227373.4	RP11-160H22.5	4.62	1.8e-05	0.0349	0.63	0.49	Systemic lupus erythematosus;	chr1:174720787	chr1:174115300~174160004:-
READ	cis	rs62229266	0.557	rs4817760	ENSG00000231106.2	LINC01436	4.62	1.8e-05	0.0349	0.68	0.49	Mitral valve prolapse;	chr21:36023003	chr21:36005338~36007838:+
READ	cis	rs62229266	0.557	rs4817761	ENSG00000231106.2	LINC01436	4.62	1.8e-05	0.0349	0.68	0.49	Mitral valve prolapse;	chr21:36023258	chr21:36005338~36007838:+
READ	cis	rs11155671	0.53	rs9397420	ENSG00000268592.3	RAET1E-AS1	-4.62	1.8e-05	0.0349	-0.62	-0.49	Testicular germ cell tumor;	chr6:149885645	chr6:149863494~149919507:+
READ	cis	rs992157	0.767	rs2382822	ENSG00000261338.2	RP11-378A13.1	-4.62	1.8e-05	0.0349	-0.59	-0.49	Colorectal cancer;	chr2:218308604	chr2:218255319~218257366:+
READ	cis	rs13113518	0.776	rs13124436	ENSG00000223305.1	RN7SKP30	4.62	1.8e-05	0.0349	0.61	0.49	Height;	chr4:55502504	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs6843997	ENSG00000223305.1	RN7SKP30	4.62	1.8e-05	0.0349	0.61	0.49	Height;	chr4:55508982	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs12508367	ENSG00000223305.1	RN7SKP30	4.62	1.8e-05	0.0349	0.61	0.49	Height;	chr4:55509442	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs2272073	ENSG00000223305.1	RN7SKP30	4.62	1.8e-05	0.0349	0.61	0.49	Height;	chr4:55510177	chr4:55540502~55540835:-
READ	cis	rs9487094	0.961	rs11153175	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109361318	chr6:109382795~109383666:+
READ	cis	rs9487094	0.848	rs7372	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109366911	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs12193493	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109371573	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs3778475	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109375003	chr6:109382795~109383666:+
READ	cis	rs9487094	0.885	rs1358997	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109380457	chr6:109382795~109383666:+
READ	cis	rs9487094	0.885	rs3799839	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109380990	chr6:109382795~109383666:+
READ	cis	rs9487094	0.848	rs1322816	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109382524	chr6:109382795~109383666:+
READ	cis	rs9487094	0.885	rs13212766	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109384228	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs3757234	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109385087	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs1923725	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109387685	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs12524639	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109388256	chr6:109382795~109383666:+
READ	cis	rs9487094	0.885	rs12524273	ENSG00000260273.1	RP11-425D10.10	4.62	1.81e-05	0.035	0.6	0.49	Height;	chr6:109395761	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs1358998	ENSG00000260273.1	RP11-425D10.10	-4.62	1.81e-05	0.035	-0.6	-0.49	Height;	chr6:109380015	chr6:109382795~109383666:+
READ	cis	rs2929278	0.617	rs11070410	ENSG00000249839.1	AC011330.5	4.62	1.81e-05	0.0351	0.65	0.49	Schizophrenia;	chr15:43764847	chr15:43663654~43684339:-
READ	cis	rs9399135	0.773	rs949895	ENSG00000232876.1	CTA-212D2.2	-4.62	1.82e-05	0.0352	-0.64	-0.49	Red blood cell count;	chr6:135084221	chr6:135055033~135060550:+
READ	cis	rs9487094	0.813	rs12528712	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109339681	chr6:109382795~109383666:+
READ	cis	rs9487094	0.778	rs11757877	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109360679	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs61233650	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109365409	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs3799835	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109372084	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs11753645	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109373851	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs34131679	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109375848	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs13195517	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109415050	chr6:109382795~109383666:+
READ	cis	rs9487094	0.813	rs12528566	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.62	0.49	Height;	chr6:109416945	chr6:109382795~109383666:+
READ	cis	rs10129255	1	rs10129319	ENSG00000211972.2	IGHV3-66	4.62	1.83e-05	0.0353	0.48	0.49	Kawasaki disease;	chr14:106767996	chr14:106675017~106675544:-
READ	cis	rs6671200	0.92	rs7555236	ENSG00000228852.5	RP11-57H12.5	4.62	1.83e-05	0.0353	0.88	0.49	Stearic acid (18:0) levels;	chr1:95165758	chr1:95243167~95278940:-
READ	cis	rs9487094	0.67	rs34928881	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.59	0.49	Height;	chr6:109526846	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs10782163	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.59	0.49	Height;	chr6:109533040	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs10457195	ENSG00000260273.1	RP11-425D10.10	4.62	1.83e-05	0.0353	0.59	0.49	Height;	chr6:109534269	chr6:109382795~109383666:+
READ	cis	rs9487094	0.67	rs749517	ENSG00000260273.1	RP11-425D10.10	-4.62	1.83e-05	0.0353	-0.59	-0.49	Height;	chr6:109531713	chr6:109382795~109383666:+
READ	cis	rs1577917	1	rs1415753	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86043356	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs1577919	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86047578	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12203493	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86048924	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12205548	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86050052	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12665321	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86059571	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12203924	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86066694	chr6:85660950~85678736:-
READ	cis	rs1577917	0.958	rs12196175	ENSG00000203875.9	SNHG5	-4.62	1.84e-05	0.0355	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86069652	chr6:85660950~85678736:-
READ	cis	rs2014572	0.904	rs10412465	ENSG00000268713.1	CTC-444N24.8	4.62	1.84e-05	0.0355	0.58	0.49	Hyperactive-impulsive symptoms;	chr19:57242563	chr19:57261354~57262738:+
READ	cis	rs6493487	0.512	rs7170815	ENSG00000244879.4	GABPB1-AS1	4.62	1.84e-05	0.0355	0.66	0.49	Thiazide-induced adverse metabolic effects in hypertensive patients;	chr15:51077740	chr15:50354959~50372202:+
READ	cis	rs992157	0.798	rs7557709	ENSG00000261338.2	RP11-378A13.1	4.62	1.85e-05	0.0356	0.6	0.49	Colorectal cancer;	chr2:218302806	chr2:218255319~218257366:+
READ	cis	rs7429990	0.803	rs2049300	ENSG00000229759.1	MRPS18AP1	-4.62	1.85e-05	0.0357	-0.54	-0.49	Educational attainment (years of education);	chr3:47601236	chr3:48256350~48256938:-
READ	cis	rs453301	0.597	rs7001187	ENSG00000233609.3	RP11-62H7.2	-4.62	1.85e-05	0.0357	-0.59	-0.49	Joint mobility (Beighton score);	chr8:8935272	chr8:8961200~8979025:+
READ	cis	rs453301	0.631	rs13250781	ENSG00000233609.3	RP11-62H7.2	-4.62	1.85e-05	0.0357	-0.59	-0.49	Joint mobility (Beighton score);	chr8:8935833	chr8:8961200~8979025:+
READ	cis	rs453301	0.631	rs28572014	ENSG00000233609.3	RP11-62H7.2	-4.62	1.85e-05	0.0357	-0.59	-0.49	Joint mobility (Beighton score);	chr8:8936097	chr8:8961200~8979025:+
READ	cis	rs11064994	0.51	rs10774530	ENSG00000213137.3	ARF1P2	4.62	1.85e-05	0.0357	1.08	0.49	Cognitive performance;	chr12:119949157	chr12:120845110~120845647:-
READ	cis	rs9545047	1	rs9545047	ENSG00000227676.3	LINC01068	4.62	1.86e-05	0.0357	0.61	0.49	Schizophrenia;	chr13:79285321	chr13:79566727~79571436:+
READ	cis	rs11168854	0.656	rs7969967	ENSG00000258017.1	RP11-386G11.10	4.62	1.86e-05	0.0357	0.64	0.49	Body mass index;	chr12:49118234	chr12:49127782~49147869:+
READ	cis	rs2251381	0.52	rs873651	ENSG00000232118.2	BACH1-AS1	-4.62	1.86e-05	0.0358	-0.62	-0.49	Selective IgA deficiency;	chr21:29409528	chr21:29370019~29376339:-
READ	cis	rs3096299	0.658	rs34590044	ENSG00000274627.1	RP11-104N10.2	4.62	1.86e-05	0.0358	0.52	0.49	Multiple myeloma (IgH translocation);	chr16:89476749	chr16:89516797~89522217:+
READ	cis	rs79040073	0.911	rs34895054	ENSG00000259531.2	RP11-295H24.3	4.61	1.87e-05	0.0359	0.74	0.49	Lung cancer in ever smokers;	chr15:48992804	chr15:49365124~49366685:-
READ	cis	rs12468226	0.938	rs13392645	ENSG00000272966.1	RP11-686O6.1	4.61	1.87e-05	0.036	0.7	0.49	Urate levels;	chr2:202270116	chr2:202336739~202337200:+
READ	cis	rs12468226	0.938	rs7568159	ENSG00000272966.1	RP11-686O6.1	4.61	1.87e-05	0.036	0.7	0.49	Urate levels;	chr2:202286226	chr2:202336739~202337200:+
READ	cis	rs9309473	0.606	rs79234109	ENSG00000163016.8	ALMS1P	4.61	1.88e-05	0.0361	0.82	0.49	Metabolite levels;	chr2:73621227	chr2:73644919~73685576:+
READ	cis	rs7208859	0.623	rs9895785	ENSG00000263531.1	RP13-753N3.1	-4.61	1.88e-05	0.0361	-0.9	-0.49	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780690	chr17:30863921~30864940:-
READ	cis	rs4877387	1	rs4877387	ENSG00000186940.6	CHCHD2P9	4.61	1.88e-05	0.0361	0.78	0.49	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;	chr9:79064959	chr9:79391304~79391759:+
READ	cis	rs62229266	0.625	rs62230813	ENSG00000231106.2	LINC01436	4.61	1.89e-05	0.0361	0.62	0.49	Mitral valve prolapse;	chr21:36031134	chr21:36005338~36007838:+
READ	cis	rs62229266	0.633	rs34259635	ENSG00000231106.2	LINC01436	4.61	1.89e-05	0.0361	0.62	0.49	Mitral valve prolapse;	chr21:36031272	chr21:36005338~36007838:+
READ	cis	rs79040073	1	rs79040073	ENSG00000259531.2	RP11-295H24.3	4.61	1.89e-05	0.0362	0.7	0.49	Lung cancer in ever smokers;	chr15:49038657	chr15:49365124~49366685:-
READ	cis	rs2115630	1	rs6496441	ENSG00000225151.9	GOLGA2P7	4.61	1.9e-05	0.0363	0.49	0.49	P wave terminal force;	chr15:84820117	chr15:84199311~84230136:-
READ	cis	rs9399135	0.773	rs1331308	ENSG00000232876.1	CTA-212D2.2	4.61	1.9e-05	0.0364	0.64	0.49	Red blood cell count;	chr6:135083984	chr6:135055033~135060550:+
READ	cis	rs6671200	1	rs76064624	ENSG00000228852.5	RP11-57H12.5	4.61	1.9e-05	0.0364	0.88	0.49	Stearic acid (18:0) levels;	chr1:95195477	chr1:95243167~95278940:-
READ	cis	rs6671200	1	rs71654417	ENSG00000228852.5	RP11-57H12.5	4.61	1.9e-05	0.0364	0.88	0.49	Stearic acid (18:0) levels;	chr1:95195644	chr1:95243167~95278940:-
READ	cis	rs6671200	1	rs71654418	ENSG00000228852.5	RP11-57H12.5	4.61	1.9e-05	0.0364	0.88	0.49	Stearic acid (18:0) levels;	chr1:95197102	chr1:95243167~95278940:-
READ	cis	rs6671200	1	rs71654419	ENSG00000228852.5	RP11-57H12.5	4.61	1.9e-05	0.0364	0.88	0.49	Stearic acid (18:0) levels;	chr1:95198941	chr1:95243167~95278940:-
READ	cis	rs2564921	0.73	rs6781896	ENSG00000242142.1	SERBP1P3	-4.61	1.9e-05	0.0364	-0.51	-0.49	Height;	chr3:53047596	chr3:53064283~53065091:-
READ	cis	rs11123170	0.64	rs2863240	ENSG00000189223.12	PAX8-AS1	4.61	1.9e-05	0.0364	0.71	0.49	Renal function-related traits (BUN);	chr2:113212539	chr2:113211522~113276581:+
READ	cis	rs10256972	0.552	rs2960837	ENSG00000229043.2	AC091729.9	-4.61	1.91e-05	0.0364	-0.63	-0.49	Endometriosis;Longevity;	chr7:1164321	chr7:1160374~1165267:+
READ	cis	rs11105298	0.891	rs10858879	ENSG00000258302.2	RP11-981P6.1	-4.61	1.91e-05	0.0365	-0.6	-0.49	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89492801	chr12:89561129~89594878:+
READ	cis	rs5760092	0.717	rs5760101	ENSG00000273295.1	AP000350.5	4.61	1.91e-05	0.0366	0.54	0.49	Urinary 1,3-butadiene metabolite levels in smokers;	chr22:23906525	chr22:23901432~23907068:-
READ	cis	rs7429990	0.965	rs2882668	ENSG00000229759.1	MRPS18AP1	4.61	1.91e-05	0.0366	0.55	0.49	Educational attainment (years of education);	chr3:47938816	chr3:48256350~48256938:-
READ	cis	rs11811982	0.793	rs11805012	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227033982	chr1:226148003~226155071:+
READ	cis	rs11811982	0.546	rs74491441	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227038500	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs74683900	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227038559	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs11803919	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227041254	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs79773617	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227050607	chr1:226148003~226155071:+
READ	cis	rs11811982	0.655	rs11805662	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227050839	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78587644	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227063871	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs75213165	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227092819	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs74840653	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227094113	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs79655227	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227098007	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78707784	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227098699	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs114967166	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227100629	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78292385	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227107363	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78220690	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227109822	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs116389194	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227115220	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs7535648	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227118855	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs75714930	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227130975	chr1:226148003~226155071:+
READ	cis	rs11811982	0.557	rs76599385	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227131223	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs74475302	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227131371	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs11799389	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227136086	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs76897971	ENSG00000234478.1	RP11-275I14.4	4.61	1.92e-05	0.0366	1.44	0.49	Optic disc area;	chr1:227140687	chr1:226148003~226155071:+
READ	cis	rs2739330	0.76	rs1007888	ENSG00000231271.1	AP000350.8	4.61	1.92e-05	0.0366	0.64	0.49	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23949918~23954042:+
READ	cis	rs17507216	0.718	rs17158403	ENSG00000278603.1	RP13-608F4.5	4.61	1.93e-05	0.0367	0.83	0.49	Excessive daytime sleepiness;	chr15:82572478	chr15:82472203~82472426:+
READ	cis	rs2581828	0.606	rs1004807	ENSG00000242142.1	SERBP1P3	4.61	1.93e-05	0.0368	0.53	0.49	Crohn's disease;	chr3:53106587	chr3:53064283~53065091:-
READ	cis	rs62229266	0.659	rs2255734	ENSG00000231106.2	LINC01436	4.61	1.93e-05	0.0368	0.63	0.49	Mitral valve prolapse;	chr21:36039611	chr21:36005338~36007838:+
READ	cis	rs62229266	0.659	rs2835242	ENSG00000231106.2	LINC01436	4.61	1.93e-05	0.0368	0.63	0.49	Mitral valve prolapse;	chr21:36041234	chr21:36005338~36007838:+
READ	cis	rs62229266	0.659	rs2835243	ENSG00000231106.2	LINC01436	4.61	1.93e-05	0.0368	0.63	0.49	Mitral valve prolapse;	chr21:36041648	chr21:36005338~36007838:+
READ	cis	rs62229266	0.659	rs2835245	ENSG00000231106.2	LINC01436	4.61	1.93e-05	0.0368	0.63	0.49	Mitral valve prolapse;	chr21:36044410	chr21:36005338~36007838:+
READ	cis	rs9322193	0.884	rs9397036	ENSG00000268592.3	RAET1E-AS1	4.61	1.93e-05	0.0368	0.59	0.49	Lung cancer;	chr6:149851787	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs9383865	ENSG00000268592.3	RAET1E-AS1	4.61	1.93e-05	0.0368	0.59	0.49	Lung cancer;	chr6:149852043	chr6:149863494~149919507:+
READ	cis	rs2111504	0.583	rs1008425	ENSG00000267213.4	AC007773.2	4.61	1.93e-05	0.0368	0.64	0.49	Bipolar disorder;	chr19:32361239	chr19:32390050~32405560:-
READ	cis	rs9322193	0.884	rs9383864	ENSG00000268592.3	RAET1E-AS1	4.6	1.94e-05	0.0369	0.6	0.49	Lung cancer;	chr6:149851969	chr6:149863494~149919507:+
READ	cis	rs79040073	0.911	rs11638981	ENSG00000259531.2	RP11-295H24.3	4.6	1.94e-05	0.0369	0.68	0.49	Lung cancer in ever smokers;	chr15:49029332	chr15:49365124~49366685:-
READ	cis	rs17301013	0.896	rs6425287	ENSG00000227373.4	RP11-160H22.5	4.6	1.94e-05	0.0369	0.64	0.49	Systemic lupus erythematosus;	chr1:174566264	chr1:174115300~174160004:-
READ	cis	rs17301013	0.896	rs6425292	ENSG00000227373.4	RP11-160H22.5	4.6	1.94e-05	0.0369	0.64	0.49	Systemic lupus erythematosus;	chr1:174618364	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6664864	ENSG00000227373.4	RP11-160H22.5	4.6	1.94e-05	0.0369	0.64	0.49	Systemic lupus erythematosus;	chr1:174622912	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs6689170	ENSG00000227373.4	RP11-160H22.5	4.6	1.94e-05	0.0369	0.64	0.49	Systemic lupus erythematosus;	chr1:174639596	chr1:174115300~174160004:-
READ	cis	rs2486288	0.656	rs62026703	ENSG00000259520.4	CTD-2651B20.3	4.6	1.94e-05	0.037	0.61	0.49	Glomerular filtration rate;	chr15:45277731	chr15:45251580~45279251:-
READ	cis	rs2486288	0.656	rs7165039	ENSG00000259520.4	CTD-2651B20.3	4.6	1.94e-05	0.037	0.61	0.49	Glomerular filtration rate;	chr15:45278215	chr15:45251580~45279251:-
READ	cis	rs2486288	0.656	rs7166580	ENSG00000259520.4	CTD-2651B20.3	4.6	1.94e-05	0.037	0.61	0.49	Glomerular filtration rate;	chr15:45279011	chr15:45251580~45279251:-
READ	cis	rs17301013	0.897	rs1793291	ENSG00000227373.4	RP11-160H22.5	-4.6	1.95e-05	0.037	-0.63	-0.49	Systemic lupus erythematosus;	chr1:174822675	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs1894200	ENSG00000227373.4	RP11-160H22.5	-4.6	1.95e-05	0.037	-0.63	-0.49	Systemic lupus erythematosus;	chr1:174842039	chr1:174115300~174160004:-
READ	cis	rs2019137	0.868	rs6755639	ENSG00000274877.1	RP11-65I12.1	-4.6	1.95e-05	0.037	-0.54	-0.49	Lymphocyte counts;	chr2:113224233	chr2:113237595~113240825:+
READ	cis	rs5753037	0.869	rs41160	ENSG00000279159.1	RP3-394A18.1	4.6	1.95e-05	0.0371	0.35	0.49	Type 1 diabetes;	chr22:30011399	chr22:29978950~30028236:-
READ	cis	rs6671200	1	rs60929805	ENSG00000228852.5	RP11-57H12.5	4.6	1.95e-05	0.0371	0.88	0.49	Stearic acid (18:0) levels;	chr1:95180830	chr1:95243167~95278940:-
READ	cis	rs372883	0.58	rs2254038	ENSG00000232118.2	BACH1-AS1	-4.6	1.95e-05	0.0371	-0.6	-0.49	Pancreatic cancer;	chr21:29373402	chr21:29370019~29376339:-
READ	cis	rs2486288	0.656	rs11631021	ENSG00000259520.4	CTD-2651B20.3	4.6	1.96e-05	0.0373	0.61	0.49	Glomerular filtration rate;	chr15:45264631	chr15:45251580~45279251:-
READ	cis	rs62229266	0.609	rs12482541	ENSG00000231106.2	LINC01436	4.6	1.97e-05	0.0374	0.63	0.49	Mitral valve prolapse;	chr21:36047445	chr21:36005338~36007838:+
READ	cis	rs62229266	0.609	rs2835253	ENSG00000231106.2	LINC01436	4.6	1.97e-05	0.0374	0.63	0.49	Mitral valve prolapse;	chr21:36047447	chr21:36005338~36007838:+
READ	cis	rs1577917	0.874	rs11756621	ENSG00000203875.9	SNHG5	-4.6	1.97e-05	0.0374	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86030345	chr6:85660950~85678736:-
READ	cis	rs1577917	1	rs12196411	ENSG00000203875.9	SNHG5	-4.6	1.97e-05	0.0374	-0.69	-0.49	Response to antipsychotic treatment;	chr6:86070044	chr6:85660950~85678736:-
READ	cis	rs11690935	0.788	rs6715929	ENSG00000228389.1	AC068039.4	4.6	1.98e-05	0.0375	0.63	0.49	Schizophrenia;	chr2:172012600	chr2:171773482~171775844:+
READ	cis	rs862034	0.509	rs740503	ENSG00000258603.3	RP3-414A15.10	-4.6	1.98e-05	0.0375	-0.54	-0.49	Height;	chr14:74455192	chr14:73616700~73633941:-
READ	cis	rs62229266	0.659	rs7275820	ENSG00000231106.2	LINC01436	4.6	1.98e-05	0.0375	0.63	0.49	Mitral valve prolapse;	chr21:36037116	chr21:36005338~36007838:+
READ	cis	rs62229266	0.652	rs7280551	ENSG00000231106.2	LINC01436	4.6	1.98e-05	0.0375	0.63	0.49	Mitral valve prolapse;	chr21:36037311	chr21:36005338~36007838:+
READ	cis	rs992157	0.775	rs1877714	ENSG00000261338.2	RP11-378A13.1	-4.6	1.99e-05	0.0376	-0.61	-0.49	Colorectal cancer;	chr2:218270205	chr2:218255319~218257366:+
READ	cis	rs9549367	0.713	rs3024769	ENSG00000269125.1	RP11-98F14.11	4.6	1.99e-05	0.0377	0.61	0.49	Platelet distribution width;	chr13:113171287	chr13:113165002~113165183:-
READ	cis	rs12468226	0.873	rs78798541	ENSG00000272966.1	RP11-686O6.1	4.6	2e-05	0.0378	0.8	0.49	Urate levels;	chr2:202194708	chr2:202336739~202337200:+
READ	cis	rs7404843	0.789	rs222907	ENSG00000263335.1	AF001548.5	4.6	2e-05	0.0378	0.85	0.49	Testicular germ cell tumor;	chr16:15404950	chr16:15726674~15732993:+
READ	cis	rs2739330	0.76	rs5760095	ENSG00000225282.1	AP000350.6	4.6	2e-05	0.0378	0.5	0.49	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23905106	chr22:23926900~23929574:+
READ	cis	rs10129255	1	rs11621409	ENSG00000211972.2	IGHV3-66	4.6	2e-05	0.0379	0.47	0.49	Kawasaki disease;	chr14:106695603	chr14:106675017~106675544:-
READ	cis	rs12049351	0.719	rs2145394	ENSG00000229367.1	HMGN2P19	4.59	2.01e-05	0.0379	0.73	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229535217	chr1:229570532~229570796:+
READ	cis	rs4718428	0.705	rs28648401	ENSG00000226824.5	RP4-756H11.3	-4.59	2.01e-05	0.0379	-0.69	-0.49	Corneal structure;	chr7:66902145	chr7:66654538~66669855:+
READ	cis	rs4718428	0.607	rs66954441	ENSG00000226824.5	RP4-756H11.3	-4.59	2.01e-05	0.0379	-0.69	-0.49	Corneal structure;	chr7:66904222	chr7:66654538~66669855:+
READ	cis	rs9487094	0.778	rs61318425	ENSG00000260273.1	RP11-425D10.10	4.59	2.01e-05	0.0379	0.62	0.49	Height;	chr6:109427303	chr6:109382795~109383666:+
READ	cis	rs17507216	0.671	rs28582623	ENSG00000278603.1	RP13-608F4.5	4.59	2.01e-05	0.0379	0.81	0.49	Excessive daytime sleepiness;	chr15:82577381	chr15:82472203~82472426:+
READ	cis	rs1577917	0.74	rs2758842	ENSG00000203875.9	SNHG5	-4.59	2.01e-05	0.038	-0.65	-0.49	Response to antipsychotic treatment;	chr6:85599013	chr6:85660950~85678736:-
READ	cis	rs1577917	0.572	rs911927	ENSG00000203875.9	SNHG5	-4.59	2.01e-05	0.038	-0.65	-0.49	Response to antipsychotic treatment;	chr6:85618142	chr6:85660950~85678736:-
READ	cis	rs80285556	0.655	rs17311832	ENSG00000161643.11	SIGLEC16	4.59	2.01e-05	0.038	1.06	0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50022059	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs80314222	ENSG00000161643.11	SIGLEC16	4.59	2.01e-05	0.038	1.06	0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50022257	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs79602855	ENSG00000161643.11	SIGLEC16	4.59	2.01e-05	0.038	1.06	0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50022468	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs55914901	ENSG00000161643.11	SIGLEC16	4.59	2.01e-05	0.038	1.06	0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50025089	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs76812330	ENSG00000161643.11	SIGLEC16	4.59	2.01e-05	0.038	1.06	0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50028603	chr19:49969673~49975814:+
READ	cis	rs80285556	1	rs17661933	ENSG00000161643.11	SIGLEC16	-4.59	2.01e-05	0.038	-1.06	-0.49	antipsychotic drug dosage in schizophrenia or schizoaffective disorder;	chr19:50031263	chr19:49969673~49975814:+
READ	cis	rs1577917	0.958	rs28442244	ENSG00000203875.9	SNHG5	4.59	2.02e-05	0.0381	0.66	0.49	Response to antipsychotic treatment;	chr6:85991518	chr6:85660950~85678736:-
READ	cis	rs7615304	0.617	rs2054880	ENSG00000272990.1	RP11-305K5.1	-4.59	2.02e-05	0.0381	-0.68	-0.49	Interleukin-2 levels;	chr3:156782192	chr3:156523740~156524247:-
READ	cis	rs453301	0.686	rs11787026	ENSG00000233609.3	RP11-62H7.2	4.59	2.02e-05	0.0381	0.57	0.49	Joint mobility (Beighton score);	chr8:9044861	chr8:8961200~8979025:+
READ	cis	rs17301013	0.861	rs1793319	ENSG00000227373.4	RP11-160H22.5	4.59	2.02e-05	0.0381	0.63	0.49	Systemic lupus erythematosus;	chr1:174795470	chr1:174115300~174160004:-
READ	cis	rs17301013	0.861	rs7538650	ENSG00000227373.4	RP11-160H22.5	-4.59	2.02e-05	0.0381	-0.63	-0.49	Systemic lupus erythematosus;	chr1:174788821	chr1:174115300~174160004:-
READ	cis	rs7617773	0.78	rs13079728	ENSG00000229759.1	MRPS18AP1	4.59	2.02e-05	0.0381	0.62	0.49	Coronary artery disease;	chr3:48297870	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs34630841	ENSG00000229759.1	MRPS18AP1	4.59	2.02e-05	0.0381	0.62	0.49	Coronary artery disease;	chr3:48301771	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs77044321	ENSG00000229759.1	MRPS18AP1	4.59	2.02e-05	0.0381	0.62	0.49	Coronary artery disease;	chr3:48307824	chr3:48256350~48256938:-
READ	cis	rs7617773	0.743	rs13081633	ENSG00000229759.1	MRPS18AP1	4.59	2.02e-05	0.0381	0.62	0.49	Coronary artery disease;	chr3:48315791	chr3:48256350~48256938:-
READ	cis	rs7617773	0.78	rs11718350	ENSG00000229759.1	MRPS18AP1	4.59	2.02e-05	0.0381	0.62	0.49	Coronary artery disease;	chr3:48319502	chr3:48256350~48256938:-
READ	cis	rs2115630	1	rs7183401	ENSG00000225151.9	GOLGA2P7	4.59	2.03e-05	0.0382	0.49	0.49	P wave terminal force;	chr15:84828713	chr15:84199311~84230136:-
READ	cis	rs9487094	0.689	rs2884037	ENSG00000260273.1	RP11-425D10.10	4.59	2.03e-05	0.0382	0.61	0.49	Height;	chr6:109354092	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs2277113	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109454233	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs1046943	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109462738	chr6:109382795~109383666:+
READ	cis	rs9487094	0.689	rs6939548	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109464011	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs3734652	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109465777	chr6:109382795~109383666:+
READ	cis	rs9487094	0.666	rs3778478	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109470427	chr6:109382795~109383666:+
READ	cis	rs9487094	0.644	rs9791241	ENSG00000260273.1	RP11-425D10.10	4.59	2.04e-05	0.0383	0.6	0.49	Height;	chr6:109470900	chr6:109382795~109383666:+
READ	cis	rs748404	0.631	rs3809482	ENSG00000249839.1	AC011330.5	-4.59	2.04e-05	0.0383	-0.62	-0.49	Lung cancer;	chr15:43369604	chr15:43663654~43684339:-
READ	cis	rs4959270	0.874	rs4311550	ENSG00000270937.1	RP5-856G1.1	-4.59	2.04e-05	0.0384	-0.59	-0.49	Limited cutaneous systemic scleroderma;	chr6:451925	chr6:1026494~1027225:-
READ	cis	rs2302464	1	rs58978163	ENSG00000214846.4	RP11-115L11.1	4.59	2.04e-05	0.0384	1.19	0.49	Cerebrospinal fluid biomarker levels;	chr4:15726385	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs16892272	ENSG00000214846.4	RP11-115L11.1	4.59	2.04e-05	0.0384	1.19	0.49	Cerebrospinal fluid biomarker levels;	chr4:15726456	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs73123615	ENSG00000214846.4	RP11-115L11.1	4.59	2.04e-05	0.0384	1.19	0.49	Cerebrospinal fluid biomarker levels;	chr4:15726553	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs16892276	ENSG00000214846.4	RP11-115L11.1	4.59	2.04e-05	0.0384	1.19	0.49	Cerebrospinal fluid biomarker levels;	chr4:15726614	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs60913985	ENSG00000214846.4	RP11-115L11.1	4.59	2.04e-05	0.0384	1.19	0.49	Cerebrospinal fluid biomarker levels;	chr4:15726671	chr4:15730962~15731627:-
READ	cis	rs9322193	0.772	rs7738696	ENSG00000268592.3	RAET1E-AS1	4.59	2.04e-05	0.0385	0.59	0.49	Lung cancer;	chr6:149848985	chr6:149863494~149919507:+
READ	cis	rs977987	0.832	rs37597	ENSG00000261783.1	RP11-252K23.2	4.59	2.05e-05	0.0385	0.67	0.49	Dupuytren's disease;	chr16:75466377	chr16:75379818~75381260:-
READ	cis	rs9309473	0.583	rs11899517	ENSG00000163016.8	ALMS1P	4.59	2.05e-05	0.0385	0.6	0.49	Metabolite levels;	chr2:73346133	chr2:73644919~73685576:+
READ	cis	rs9309473	0.583	rs6546822	ENSG00000163016.8	ALMS1P	4.59	2.05e-05	0.0385	0.6	0.49	Metabolite levels;	chr2:73347970	chr2:73644919~73685576:+
READ	cis	rs4718428	0.96	rs6460317	ENSG00000226824.5	RP4-756H11.3	-4.59	2.05e-05	0.0385	-0.67	-0.49	Corneal structure;	chr7:66925268	chr7:66654538~66669855:+
READ	cis	rs10129255	0.913	rs28861466	ENSG00000211972.2	IGHV3-66	4.59	2.05e-05	0.0385	0.49	0.49	Kawasaki disease;	chr14:106718572	chr14:106675017~106675544:-
READ	cis	rs453301	0.686	rs3989373	ENSG00000253981.4	ALG1L13P	-4.59	2.05e-05	0.0386	-0.55	-0.49	Joint mobility (Beighton score);	chr8:9053798	chr8:8236003~8244667:-
READ	cis	rs12468226	1	rs111542497	ENSG00000272966.1	RP11-686O6.1	4.59	2.06e-05	0.0387	0.74	0.49	Urate levels;	chr2:202330369	chr2:202336739~202337200:+
READ	cis	rs77505915	0.512	rs12921808	ENSG00000261783.1	RP11-252K23.2	4.59	2.06e-05	0.0387	0.81	0.49	Migraine;	chr16:75350086	chr16:75379818~75381260:-
READ	cis	rs12049351	0.612	rs10916485	ENSG00000229367.1	HMGN2P19	4.59	2.06e-05	0.0387	0.76	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229468942	chr1:229570532~229570796:+
READ	cis	rs2613964	0.504	rs2399465	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113129145	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs2399466	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113129190	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs7617193	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113130004	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs9288972	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113131422	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs9838215	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113131616	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs9838253	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113131678	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs17317945	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113131934	chr3:113885298~113886031:+
READ	cis	rs2613964	0.504	rs12695288	ENSG00000241889.1	RP11-435F17.3	-4.58	2.09e-05	0.0391	-0.58	-0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113132668	chr3:113885298~113886031:+
READ	cis	rs117004340	0.702	rs73205711	ENSG00000242607.1	RPS3AP34	4.58	2.09e-05	0.0392	0.79	0.49	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13365040	chr8:12570350~12571130:-
READ	cis	rs117004340	0.702	rs73205714	ENSG00000242607.1	RPS3AP34	4.58	2.09e-05	0.0392	0.79	0.49	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13365728	chr8:12570350~12571130:-
READ	cis	rs117004340	0.702	rs73205715	ENSG00000242607.1	RPS3AP34	4.58	2.09e-05	0.0392	0.79	0.49	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13365750	chr8:12570350~12571130:-
READ	cis	rs12594515	0.6	rs12903858	ENSG00000273972.1	CTD-2306A12.1	-4.58	2.09e-05	0.0392	-0.55	-0.49	Weight;Waist circumference;	chr15:45679968	chr15:45702640~45703183:+
READ	cis	rs6911965	0.615	rs79554492	ENSG00000272345.1	RP1-30M3.5	-4.58	2.09e-05	0.0392	-0.74	-0.49	Hematological and biochemical traits;	chr6:24458068	chr6:24700907~24701793:-
READ	cis	rs6911965	0.615	rs7754778	ENSG00000272345.1	RP1-30M3.5	-4.58	2.09e-05	0.0392	-0.74	-0.49	Hematological and biochemical traits;	chr6:24459920	chr6:24700907~24701793:-
READ	cis	rs7615952	0.605	rs11708269	ENSG00000272840.1	RP11-379B18.6	4.58	2.09e-05	0.0392	1.29	0.49	Blood pressure (smoking interaction);	chr3:125613306	chr3:125774714~125797953:+
READ	cis	rs9545047	0.935	rs7988601	ENSG00000227676.3	LINC01068	-4.58	2.1e-05	0.0393	-0.58	-0.49	Schizophrenia;	chr13:79475648	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs6563110	ENSG00000227676.3	LINC01068	-4.58	2.1e-05	0.0393	-0.58	-0.49	Schizophrenia;	chr13:79477137	chr13:79566727~79571436:+
READ	cis	rs9545047	0.901	rs7338530	ENSG00000227676.3	LINC01068	-4.58	2.1e-05	0.0393	-0.58	-0.49	Schizophrenia;	chr13:79477715	chr13:79566727~79571436:+
READ	cis	rs4957798	0.69	rs7735111	ENSG00000271849.1	CTC-332L22.1	-4.58	2.1e-05	0.0393	-0.66	-0.49	Asthma;Asthma (childhood onset);	chr5:109148854	chr5:109687802~109688329:-
READ	cis	rs1799949	1	rs4793197	ENSG00000198496.9	NBR2	-4.58	2.1e-05	0.0394	-0.57	-0.49	Menopause (age at onset);	chr17:43079885	chr17:43125610~43153671:+
READ	cis	rs7617773	0.817	rs9819094	ENSG00000229759.1	MRPS18AP1	4.58	2.11e-05	0.0394	0.58	0.49	Coronary artery disease;	chr3:48278068	chr3:48256350~48256938:-
READ	cis	rs79040073	0.637	rs73394324	ENSG00000259531.2	RP11-295H24.3	4.58	2.11e-05	0.0394	0.79	0.49	Lung cancer in ever smokers;	chr15:49274894	chr15:49365124~49366685:-
READ	cis	rs79040073	0.599	rs73394331	ENSG00000259531.2	RP11-295H24.3	4.58	2.11e-05	0.0394	0.79	0.49	Lung cancer in ever smokers;	chr15:49278236	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73394333	ENSG00000259531.2	RP11-295H24.3	4.58	2.11e-05	0.0394	0.79	0.49	Lung cancer in ever smokers;	chr15:49278719	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs76069611	ENSG00000259531.2	RP11-295H24.3	4.58	2.11e-05	0.0394	0.79	0.49	Lung cancer in ever smokers;	chr15:49281322	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs78050772	ENSG00000259531.2	RP11-295H24.3	4.58	2.11e-05	0.0394	0.79	0.49	Lung cancer in ever smokers;	chr15:49286380	chr15:49365124~49366685:-
READ	cis	rs10463554	0.963	rs3776859	ENSG00000175749.11	EIF3KP1	4.58	2.12e-05	0.0396	0.57	0.49	Parkinson's disease;	chr5:103016330	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs17154953	ENSG00000175749.11	EIF3KP1	4.58	2.12e-05	0.0396	0.57	0.49	Parkinson's disease;	chr5:103019557	chr5:103032376~103033031:+
READ	cis	rs79040073	0.599	rs17396536	ENSG00000259531.2	RP11-295H24.3	4.58	2.13e-05	0.0397	0.79	0.49	Lung cancer in ever smokers;	chr15:49256871	chr15:49365124~49366685:-
READ	cis	rs6694545	0.607	rs4949238	ENSG00000233399.2	RP11-111I12.1	4.58	2.13e-05	0.0397	0.92	0.49	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29949749	chr1:30013952~30037612:-
READ	cis	rs6694545	0.576	rs12086315	ENSG00000233399.2	RP11-111I12.1	-4.58	2.13e-05	0.0397	-0.92	-0.49	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29948128	chr1:30013952~30037612:-
READ	cis	rs6694545	0.576	rs904303	ENSG00000233399.2	RP11-111I12.1	-4.58	2.13e-05	0.0397	-0.92	-0.49	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29949383	chr1:30013952~30037612:-
READ	cis	rs6694545	0.607	rs59131678	ENSG00000233399.2	RP11-111I12.1	-4.58	2.13e-05	0.0397	-0.92	-0.49	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29951298	chr1:30013952~30037612:-
READ	cis	rs6694545	0.607	rs57283666	ENSG00000233399.2	RP11-111I12.1	-4.58	2.13e-05	0.0397	-0.92	-0.49	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);	chr1:29951521	chr1:30013952~30037612:-
READ	cis	rs10463554	0.963	rs13340364	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103003406	chr5:103032376~103033031:+
READ	cis	rs10463554	0.892	rs13340345	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103003518	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs3776860	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103014266	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs62362546	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103015615	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs17154959	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103020587	chr5:103032376~103033031:+
READ	cis	rs10463554	0.926	rs3776858	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103021790	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs3776857	ENSG00000175749.11	EIF3KP1	4.58	2.13e-05	0.0397	0.58	0.49	Parkinson's disease;	chr5:103022456	chr5:103032376~103033031:+
READ	cis	rs2302464	1	rs57326588	ENSG00000214846.4	RP11-115L11.1	4.58	2.13e-05	0.0397	1.16	0.49	Cerebrospinal fluid biomarker levels;	chr4:15723813	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs11944132	ENSG00000214846.4	RP11-115L11.1	4.58	2.13e-05	0.0397	1.16	0.49	Cerebrospinal fluid biomarker levels;	chr4:15724291	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs73123607	ENSG00000214846.4	RP11-115L11.1	4.58	2.13e-05	0.0397	1.16	0.49	Cerebrospinal fluid biomarker levels;	chr4:15725058	chr4:15730962~15731627:-
READ	cis	rs2302464	1	rs6844968	ENSG00000214846.4	RP11-115L11.1	4.58	2.13e-05	0.0397	1.16	0.49	Cerebrospinal fluid biomarker levels;	chr4:15725641	chr4:15730962~15731627:-
READ	cis	rs6671200	1	rs35179427	ENSG00000228852.5	RP11-57H12.5	4.58	2.13e-05	0.0398	0.87	0.49	Stearic acid (18:0) levels;	chr1:95205332	chr1:95243167~95278940:-
READ	cis	rs2006933	1	rs9900311	ENSG00000237575.4	PYY2	4.58	2.13e-05	0.0398	0.71	0.49	Amyotrophic lateral sclerosis;	chr17:28268381	chr17:28226563~28228065:+
READ	cis	rs3096299	0.685	rs4785676	ENSG00000274627.1	RP11-104N10.2	4.58	2.14e-05	0.0398	0.54	0.49	Multiple myeloma (IgH translocation);	chr16:89487216	chr16:89516797~89522217:+
READ	cis	rs3096299	0.658	rs3934737	ENSG00000274627.1	RP11-104N10.2	4.58	2.14e-05	0.0398	0.54	0.49	Multiple myeloma (IgH translocation);	chr16:89493801	chr16:89516797~89522217:+
READ	cis	rs5753037	0.838	rs5763688	ENSG00000279159.1	RP3-394A18.1	4.58	2.15e-05	0.0399	0.35	0.49	Type 1 diabetes;	chr22:29997514	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs5763645	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29961812	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs5763650	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29968235	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs5763651	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29968272	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs3788420	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29980930	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs5752992	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29988055	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs5763671	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29988583	chr22:29978950~30028236:-
READ	cis	rs5753037	0.835	rs2007458	ENSG00000279159.1	RP3-394A18.1	-4.58	2.15e-05	0.0399	-0.35	-0.49	Type 1 diabetes;	chr22:29992717	chr22:29978950~30028236:-
READ	cis	rs1799949	0.965	rs8176310	ENSG00000198496.9	NBR2	-4.58	2.15e-05	0.0399	-0.56	-0.49	Menopause (age at onset);	chr17:43047896	chr17:43125610~43153671:+
READ	cis	rs1799949	0.965	rs8070179	ENSG00000198496.9	NBR2	-4.58	2.15e-05	0.0399	-0.56	-0.49	Menopause (age at onset);	chr17:43050671	chr17:43125610~43153671:+
READ	cis	rs7617773	0.744	rs2125482	ENSG00000229759.1	MRPS18AP1	4.58	2.15e-05	0.04	0.59	0.49	Coronary artery disease;	chr3:48281643	chr3:48256350~48256938:-
READ	cis	rs2795502	0.63	rs1271547	ENSG00000185904.10	LINC00839	4.57	2.16e-05	0.0401	1.01	0.49	Blood protein levels;	chr10:43012217	chr10:42475543~42495336:+
READ	cis	rs2795502	0.63	rs2914988	ENSG00000185904.10	LINC00839	4.57	2.16e-05	0.0401	1.01	0.49	Blood protein levels;	chr10:43013906	chr10:42475543~42495336:+
READ	cis	rs58804349	0.605	rs117540287	ENSG00000185904.10	LINC00839	4.57	2.16e-05	0.0401	1.01	0.49	Pediatric bone mineral content (radius);	chr10:43016592	chr10:42475543~42495336:+
READ	cis	rs6504950	1	rs12940106	ENSG00000275710.1	RP11-257O5.4	4.57	2.16e-05	0.0402	0.71	0.49	Breast cancer;	chr17:54990322	chr17:54964474~54964679:+
READ	cis	rs9302065	0.565	rs2992908	ENSG00000223298.1	RNY3P8	4.57	2.17e-05	0.0402	0.59	0.49	Blood metabolite levels;	chr13:95308346	chr13:95310830~95310955:-
READ	cis	rs210138	1	rs210138	ENSG00000197251.3	LINC00336	-4.57	2.17e-05	0.0402	-0.76	-0.49	Testicular germ cell tumor;	chr6:33574761	chr6:33586106~33593338:-
READ	cis	rs1799949	0.965	rs9911630	ENSG00000198496.9	NBR2	-4.57	2.17e-05	0.0402	-0.57	-0.49	Menopause (age at onset);	chr17:43036325	chr17:43125610~43153671:+
READ	cis	rs2581828	0.659	rs9845352	ENSG00000242142.1	SERBP1P3	-4.57	2.17e-05	0.0403	-0.55	-0.49	Crohn's disease;	chr3:53108205	chr3:53064283~53065091:-
READ	cis	rs2581828	0.659	rs9845484	ENSG00000242142.1	SERBP1P3	-4.57	2.17e-05	0.0403	-0.55	-0.49	Crohn's disease;	chr3:53108240	chr3:53064283~53065091:-
READ	cis	rs2581828	0.646	rs3796351	ENSG00000242142.1	SERBP1P3	4.57	2.18e-05	0.0403	0.55	0.49	Crohn's disease;	chr3:53122049	chr3:53064283~53065091:-
READ	cis	rs10463554	0.892	rs34816	ENSG00000175749.11	EIF3KP1	4.57	2.18e-05	0.0403	0.58	0.49	Parkinson's disease;	chr5:103098941	chr5:103032376~103033031:+
READ	cis	rs4959270	0.78	rs4339511	ENSG00000270937.1	RP5-856G1.1	4.57	2.18e-05	0.0403	0.58	0.49	Limited cutaneous systemic scleroderma;	chr6:451895	chr6:1026494~1027225:-
READ	cis	rs6545883	0.868	rs2518933	ENSG00000271707.1	ATP1B3P1	-4.57	2.18e-05	0.0404	-0.66	-0.49	Tuberculosis;	chr2:61569895	chr2:60734895~60735715:-
READ	cis	rs11155671	0.53	rs9397420	ENSG00000231760.4	RP11-350J20.5	-4.57	2.19e-05	0.0404	-0.65	-0.49	Testicular germ cell tumor;	chr6:149885645	chr6:149796151~149826294:-
READ	cis	rs2117029	1	rs10783301	ENSG00000258017.1	RP11-386G11.10	-4.57	2.19e-05	0.0405	-0.65	-0.49	Intelligence (multi-trait analysis);	chr12:49045593	chr12:49127782~49147869:+
READ	cis	rs6504950	1	rs17745344	ENSG00000275710.1	RP11-257O5.4	4.57	2.19e-05	0.0405	0.71	0.49	Breast cancer;	chr17:54970958	chr17:54964474~54964679:+
READ	cis	rs9487094	0.6	rs1885690	ENSG00000260273.1	RP11-425D10.10	4.57	2.2e-05	0.0405	0.6	0.49	Height;	chr6:109351795	chr6:109382795~109383666:+
READ	cis	rs9487094	0.744	rs13192476	ENSG00000260273.1	RP11-425D10.10	4.57	2.2e-05	0.0405	0.62	0.49	Height;	chr6:109403951	chr6:109382795~109383666:+
READ	cis	rs7429990	0.864	rs6768699	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47711258	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs6786001	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47718500	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs12495204	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47720540	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7618758	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47720993	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs6442081	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47728890	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7612219	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47739676	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs35148469	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47739873	chr3:48256350~48256938:-
READ	cis	rs7429990	0.694	rs7645846	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47740829	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs6442082	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47743991	chr3:48256350~48256938:-
READ	cis	rs7429990	0.747	rs6442083	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47744305	chr3:48256350~48256938:-
READ	cis	rs7429990	0.786	rs13064183	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47745405	chr3:48256350~48256938:-
READ	cis	rs7429990	0.833	rs6777632	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47748775	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7637372	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47750385	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13098128	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47756066	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs6442085	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47760080	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13086149	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47784158	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs3772399	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47826237	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs3915654	ENSG00000229759.1	MRPS18AP1	-4.57	2.2e-05	0.0405	-0.55	-0.49	Educational attainment (years of education);	chr3:47827132	chr3:48256350~48256938:-
READ	cis	rs2795502	0.564	rs3004259	ENSG00000185904.10	LINC00839	-4.57	2.2e-05	0.0405	-1.02	-0.49	Blood protein levels;	chr10:42990593	chr10:42475543~42495336:+
READ	cis	rs7208859	0.573	rs8070182	ENSG00000263531.1	RP13-753N3.1	4.57	2.2e-05	0.0405	0.87	0.49	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30808576	chr17:30863921~30864940:-
READ	cis	rs13113518	0.812	rs4864996	ENSG00000223305.1	RN7SKP30	4.57	2.22e-05	0.0408	0.6	0.49	Height;	chr4:55452921	chr4:55540502~55540835:-
READ	cis	rs6740660	0.935	rs67180281	ENSG00000228446.2	AC073052.1	4.57	2.23e-05	0.041	0.92	0.49	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil);	chr2:224106956	chr2:224499387~224500100:-
READ	cis	rs7615952	0.512	rs2979336	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125638626	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs4679430	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125639049	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs34651730	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125639796	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs2979334	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125639980	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs11929125	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125640599	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs11921452	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125640906	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs2922175	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125642516	chr3:125774714~125797953:+
READ	cis	rs7615952	0.512	rs2979351	ENSG00000272840.1	RP11-379B18.6	4.57	2.24e-05	0.041	0.78	0.49	Blood pressure (smoking interaction);	chr3:125644755	chr3:125774714~125797953:+
READ	cis	rs372883	0.648	rs2832297	ENSG00000232118.2	BACH1-AS1	-4.56	2.24e-05	0.041	-0.58	-0.49	Pancreatic cancer;	chr21:29370675	chr21:29370019~29376339:-
READ	cis	rs2929278	0.617	rs4617832	ENSG00000249839.1	AC011330.5	4.56	2.25e-05	0.0412	0.66	0.49	Schizophrenia;	chr15:43738381	chr15:43663654~43684339:-
READ	cis	rs2929278	0.589	rs2411284	ENSG00000249839.1	AC011330.5	4.56	2.25e-05	0.0412	0.66	0.49	Schizophrenia;	chr15:43746701	chr15:43663654~43684339:-
READ	cis	rs2929278	0.617	rs12908467	ENSG00000249839.1	AC011330.5	4.56	2.25e-05	0.0412	0.66	0.49	Schizophrenia;	chr15:43755232	chr15:43663654~43684339:-
READ	cis	rs9308062	1	rs9308062	ENSG00000273449.1	RP11-218F10.3	-4.56	2.25e-05	0.0412	-0.45	-0.49	Small cell lung carcinoma;	chr4:163517048	chr4:163529771~163530697:+
READ	cis	rs13068223	0.584	rs344018	ENSG00000243926.1	TIPARP-AS1	-4.56	2.25e-05	0.0412	-0.57	-0.49	Age-related hearing impairment (SNP x SNP interaction);	chr3:156698204	chr3:156671862~156674378:-
READ	cis	rs9309473	0.583	rs6713196	ENSG00000163016.8	ALMS1P	4.56	2.26e-05	0.0413	0.61	0.49	Metabolite levels;	chr2:73349277	chr2:73644919~73685576:+
READ	cis	rs9309473	0.607	rs12478346	ENSG00000163016.8	ALMS1P	4.56	2.26e-05	0.0413	0.61	0.49	Metabolite levels;	chr2:73357232	chr2:73644919~73685576:+
READ	cis	rs2019137	0.936	rs4849169	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113196080	chr2:113211522~113276581:+
READ	cis	rs2019137	0.836	rs4848318	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113196375	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs2241978	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113196429	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs3828188	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113196670	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs3828189	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113196919	chr2:113211522~113276581:+
READ	cis	rs2019137	0.967	rs902695	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113197497	chr2:113211522~113276581:+
READ	cis	rs2019137	0.905	rs2276561	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113198794	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs2305133	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113199244	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs12612729	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113199471	chr2:113211522~113276581:+
READ	cis	rs2019137	0.936	rs731834	ENSG00000189223.12	PAX8-AS1	4.56	2.26e-05	0.0413	0.59	0.49	Lymphocyte counts;	chr2:113199621	chr2:113211522~113276581:+
READ	cis	rs79040073	0.637	rs77408643	ENSG00000259531.2	RP11-295H24.3	4.56	2.26e-05	0.0413	0.78	0.49	Lung cancer in ever smokers;	chr15:49377226	chr15:49365124~49366685:-
READ	cis	rs79040073	0.637	rs73398223	ENSG00000259531.2	RP11-295H24.3	4.56	2.26e-05	0.0413	0.78	0.49	Lung cancer in ever smokers;	chr15:49379505	chr15:49365124~49366685:-
READ	cis	rs17301013	0.606	rs333471	ENSG00000227373.4	RP11-160H22.5	4.56	2.27e-05	0.0414	0.76	0.49	Systemic lupus erythematosus;	chr1:174705062	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs332784	ENSG00000227373.4	RP11-160H22.5	4.56	2.27e-05	0.0414	0.76	0.49	Systemic lupus erythematosus;	chr1:174719927	chr1:174115300~174160004:-
READ	cis	rs5753037	0.543	rs140126	ENSG00000279159.1	RP3-394A18.1	-4.56	2.27e-05	0.0414	-0.34	-0.49	Type 1 diabetes;	chr22:29751049	chr22:29978950~30028236:-
READ	cis	rs2581828	0.539	rs114317830	ENSG00000242142.1	SERBP1P3	-4.56	2.27e-05	0.0415	-0.54	-0.49	Crohn's disease;	chr3:53126253	chr3:53064283~53065091:-
READ	cis	rs2581828	0.539	rs114670283	ENSG00000242142.1	SERBP1P3	-4.56	2.27e-05	0.0415	-0.54	-0.49	Crohn's disease;	chr3:53126254	chr3:53064283~53065091:-
READ	cis	rs3753275	0.684	rs3866804	ENSG00000207865.1	MIR34A	-4.56	2.28e-05	0.0416	-0.84	-0.49	Educational attainment;	chr1:8838916	chr1:9151668~9151777:-
READ	cis	rs12468226	0.817	rs6722588	ENSG00000272966.1	RP11-686O6.1	-4.56	2.28e-05	0.0416	-0.81	-0.49	Urate levels;	chr2:202187163	chr2:202336739~202337200:+
READ	cis	rs17301013	0.606	rs332764	ENSG00000227373.4	RP11-160H22.5	4.56	2.29e-05	0.0417	0.77	0.49	Systemic lupus erythematosus;	chr1:174693056	chr1:174115300~174160004:-
READ	cis	rs17301013	0.606	rs332763	ENSG00000227373.4	RP11-160H22.5	4.56	2.29e-05	0.0417	0.77	0.49	Systemic lupus erythematosus;	chr1:174693482	chr1:174115300~174160004:-
READ	cis	rs17301013	0.581	rs332772	ENSG00000227373.4	RP11-160H22.5	4.56	2.29e-05	0.0417	0.77	0.49	Systemic lupus erythematosus;	chr1:174695740	chr1:174115300~174160004:-
READ	cis	rs1286150	0.812	rs12431875	ENSG00000260711.2	RP11-747H7.3	4.56	2.29e-05	0.0417	0.65	0.49	Total body bone mineral density;	chr14:90897944	chr14:91752856~91759798:-
READ	cis	rs9322193	0.884	rs7769115	ENSG00000268592.3	RAET1E-AS1	4.56	2.29e-05	0.0417	0.59	0.49	Lung cancer;	chr6:149848796	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs7744105	ENSG00000268592.3	RAET1E-AS1	4.56	2.29e-05	0.0417	0.59	0.49	Lung cancer;	chr6:149849308	chr6:149863494~149919507:+
READ	cis	rs9322193	0.884	rs7743823	ENSG00000268592.3	RAET1E-AS1	4.56	2.29e-05	0.0417	0.59	0.49	Lung cancer;	chr6:149849744	chr6:149863494~149919507:+
READ	cis	rs7937890	0.967	rs963212	ENSG00000254418.1	RP11-21L19.1	-4.56	2.29e-05	0.0417	-0.58	-0.49	Mitochondrial DNA levels;	chr11:14303186	chr11:14262846~14273691:-
READ	cis	rs7937890	1	rs2970334	ENSG00000254418.1	RP11-21L19.1	-4.56	2.29e-05	0.0417	-0.58	-0.49	Mitochondrial DNA levels;	chr11:14307809	chr11:14262846~14273691:-
READ	cis	rs9302065	0.529	rs2992904	ENSG00000223298.1	RNY3P8	4.56	2.29e-05	0.0417	0.59	0.49	Blood metabolite levels;	chr13:95305919	chr13:95310830~95310955:-
READ	cis	rs9302065	0.529	rs2993582	ENSG00000223298.1	RNY3P8	4.56	2.29e-05	0.0417	0.59	0.49	Blood metabolite levels;	chr13:95305927	chr13:95310830~95310955:-
READ	cis	rs9302065	0.565	rs2992905	ENSG00000223298.1	RNY3P8	4.56	2.29e-05	0.0417	0.59	0.49	Blood metabolite levels;	chr13:95305936	chr13:95310830~95310955:-
READ	cis	rs8078472	1	rs8078472	ENSG00000277621.1	RP11-597M12.2	-4.56	2.29e-05	0.0417	-1.08	-0.49	Joint mobility (Beighton score);	chr17:12970070	chr17:12982613~12983002:-
READ	cis	rs59482735	1	rs59482735	ENSG00000226752.6	PSMD5-AS1	-4.56	2.3e-05	0.0419	-0.71	-0.49	Prostate-specific antigen levels;	chr9:120881148	chr9:120824828~120854385:+
READ	cis	rs75920871	0.528	rs12279066	ENSG00000254851.1	RP11-109L13.1	4.56	2.31e-05	0.0419	0.72	0.49	Subjective well-being;	chr11:117043193	chr11:117135528~117138582:+
READ	cis	rs10129255	0.833	rs7156689	ENSG00000211972.2	IGHV3-66	4.56	2.31e-05	0.042	0.47	0.49	Kawasaki disease;	chr14:106816039	chr14:106675017~106675544:-
READ	cis	rs2613964	0.504	rs4682466	ENSG00000241889.1	RP11-435F17.3	4.56	2.31e-05	0.042	0.6	0.49	Pediatric bone mineral content (spine);Pediatric bone mineral density (spine);	chr3:113130841	chr3:113885298~113886031:+
READ	cis	rs4660456	0.529	rs61779237	ENSG00000237899.1	RP4-739H11.3	4.55	2.32e-05	0.0421	0.69	0.49	Platelet count;	chr1:40685300	chr1:40669089~40687588:-
READ	cis	rs4388249	0.687	rs2301016	ENSG00000271849.1	CTC-332L22.1	-4.55	2.33e-05	0.0423	-0.56	-0.49	Schizophrenia;	chr5:109807901	chr5:109687802~109688329:-
READ	cis	rs4388249	0.687	rs11745926	ENSG00000271849.1	CTC-332L22.1	-4.55	2.33e-05	0.0423	-0.56	-0.49	Schizophrenia;	chr5:109809489	chr5:109687802~109688329:-
READ	cis	rs9625935	0.518	rs713718	ENSG00000279159.1	RP3-394A18.1	4.55	2.33e-05	0.0423	0.31	0.49	Tonsillectomy;	chr22:29918103	chr22:29978950~30028236:-
READ	cis	rs9625935	0.518	rs245008	ENSG00000279159.1	RP3-394A18.1	-4.55	2.33e-05	0.0423	-0.31	-0.49	Tonsillectomy;	chr22:29919747	chr22:29978950~30028236:-
READ	cis	rs11155671	0.53	rs2342770	ENSG00000231760.4	RP11-350J20.5	4.55	2.34e-05	0.0424	0.66	0.49	Testicular germ cell tumor;	chr6:149895549	chr6:149796151~149826294:-
READ	cis	rs2564921	0.73	rs60579898	ENSG00000242142.1	SERBP1P3	-4.55	2.35e-05	0.0426	-0.5	-0.49	Height;	chr3:53069965	chr3:53064283~53065091:-
READ	cis	rs11155671	0.546	rs1999633	ENSG00000216906.2	RP11-350J20.9	4.55	2.35e-05	0.0427	0.66	0.49	Testicular germ cell tumor;	chr6:149866576	chr6:149904243~149906418:+
READ	cis	rs13113518	0.783	rs1586555	ENSG00000223305.1	RN7SKP30	4.55	2.36e-05	0.0427	0.62	0.49	Height;	chr4:55587104	chr4:55540502~55540835:-
READ	cis	rs950169	1	rs79318564	ENSG00000225151.9	GOLGA2P7	-4.55	2.36e-05	0.0428	-0.49	-0.49	Schizophrenia;	chr15:84117398	chr15:84199311~84230136:-
READ	cis	rs950169	1	rs1911155	ENSG00000225151.9	GOLGA2P7	-4.55	2.36e-05	0.0428	-0.49	-0.49	Schizophrenia;	chr15:84118883	chr15:84199311~84230136:-
READ	cis	rs2111504	0.583	rs8104714	ENSG00000267213.4	AC007773.2	4.55	2.37e-05	0.043	0.63	0.49	Bipolar disorder;	chr19:32381203	chr19:32390050~32405560:-
READ	cis	rs7617773	0.817	rs13094727	ENSG00000229759.1	MRPS18AP1	4.55	2.37e-05	0.043	0.61	0.49	Coronary artery disease;	chr3:48281999	chr3:48256350~48256938:-
READ	cis	rs2564921	0.73	rs58492539	ENSG00000242142.1	SERBP1P3	-4.55	2.38e-05	0.043	-0.5	-0.49	Height;	chr3:53052712	chr3:53064283~53065091:-
READ	cis	rs1286150	0.738	rs12433410	ENSG00000260711.2	RP11-747H7.3	4.55	2.39e-05	0.0432	0.65	0.49	Total body bone mineral density;	chr14:90896096	chr14:91752856~91759798:-
READ	cis	rs977987	0.902	rs34539062	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75459381	chr16:75379818~75381260:-
READ	cis	rs977987	0.866	rs17696831	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75459400	chr16:75379818~75381260:-
READ	cis	rs977987	0.898	rs12918797	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75459912	chr16:75379818~75381260:-
READ	cis	rs977987	0.931	rs11641430	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75461378	chr16:75379818~75381260:-
READ	cis	rs977987	0.931	rs7195161	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75461674	chr16:75379818~75381260:-
READ	cis	rs977987	0.931	rs1424013	ENSG00000261783.1	RP11-252K23.2	-4.55	2.39e-05	0.0432	-0.64	-0.49	Dupuytren's disease;	chr16:75462088	chr16:75379818~75381260:-
READ	cis	rs9487094	0.689	rs9480936	ENSG00000260273.1	RP11-425D10.10	4.55	2.39e-05	0.0432	0.6	0.49	Height;	chr6:109358227	chr6:109382795~109383666:+
READ	cis	rs7615304	0.617	rs343994	ENSG00000272990.1	RP11-305K5.1	-4.55	2.39e-05	0.0433	-0.67	-0.49	Interleukin-2 levels;	chr3:156787575	chr3:156523740~156524247:-
READ	cis	rs9487094	0.67	rs12194061	ENSG00000260273.1	RP11-425D10.10	4.55	2.39e-05	0.0433	0.59	0.49	Height;	chr6:109546439	chr6:109382795~109383666:+
READ	cis	rs6920372	0.731	rs2357124	ENSG00000260273.1	RP11-425D10.10	4.55	2.39e-05	0.0433	0.59	0.49	Height;	chr6:109551060	chr6:109382795~109383666:+
READ	cis	rs9487094	0.696	rs11153188	ENSG00000260273.1	RP11-425D10.10	4.55	2.39e-05	0.0433	0.59	0.49	Height;	chr6:109558247	chr6:109382795~109383666:+
READ	cis	rs12468226	0.873	rs59293950	ENSG00000272966.1	RP11-686O6.1	4.55	2.4e-05	0.0434	0.79	0.49	Urate levels;	chr2:202214069	chr2:202336739~202337200:+
READ	cis	rs12468226	0.873	rs12472035	ENSG00000272966.1	RP11-686O6.1	4.55	2.4e-05	0.0434	0.79	0.49	Urate levels;	chr2:202221970	chr2:202336739~202337200:+
READ	cis	rs12468226	0.873	rs12470401	ENSG00000272966.1	RP11-686O6.1	4.55	2.4e-05	0.0434	0.79	0.49	Urate levels;	chr2:202236436	chr2:202336739~202337200:+
READ	cis	rs5769707	0.568	rs2011097	ENSG00000188511.11	C22orf34	4.54	2.4e-05	0.0434	0.6	0.49	Monocyte percentage of white cells;Monocyte count;	chr22:49624421	chr22:49414524~49657542:-
READ	cis	rs35681285	0.59	rs78881437	ENSG00000235837.1	AC073333.8	4.54	2.41e-05	0.0435	1.02	0.49	Serum tamsulosin hydrochloride concentration;	chr7:16110040	chr7:16695871~16719898:-
READ	cis	rs35681285	0.59	rs75481407	ENSG00000235837.1	AC073333.8	4.54	2.41e-05	0.0435	1.02	0.49	Serum tamsulosin hydrochloride concentration;	chr7:16110042	chr7:16695871~16719898:-
READ	cis	rs1799949	0.93	rs34210004	ENSG00000198496.9	NBR2	-4.54	2.42e-05	0.0435	-0.54	-0.49	Menopause (age at onset);	chr17:43218318	chr17:43125610~43153671:+
READ	cis	rs10463554	0.963	rs28301	ENSG00000175749.11	EIF3KP1	4.54	2.42e-05	0.0436	0.57	0.49	Parkinson's disease;	chr5:103105778	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs34828	ENSG00000175749.11	EIF3KP1	4.54	2.42e-05	0.0436	0.57	0.49	Parkinson's disease;	chr5:103107209	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs34774	ENSG00000175749.11	EIF3KP1	4.54	2.42e-05	0.0436	0.57	0.49	Parkinson's disease;	chr5:103115116	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs34777	ENSG00000175749.11	EIF3KP1	4.54	2.42e-05	0.0436	0.57	0.49	Parkinson's disease;	chr5:103116554	chr5:103032376~103033031:+
READ	cis	rs10463554	0.963	rs26524	ENSG00000175749.11	EIF3KP1	4.54	2.42e-05	0.0436	0.57	0.49	Parkinson's disease;	chr5:103120600	chr5:103032376~103033031:+
READ	cis	rs7264396	1	rs6060479	ENSG00000088340.14	FER1L4	4.54	2.43e-05	0.0437	0.69	0.49	Total cholesterol levels;	chr20:35577801	chr20:35558737~35607562:-
READ	cis	rs10463554	0.963	rs27970	ENSG00000175749.11	EIF3KP1	4.54	2.43e-05	0.0437	0.57	0.49	Parkinson's disease;	chr5:103151019	chr5:103032376~103033031:+
READ	cis	rs13068223	0.663	rs12107178	ENSG00000243926.1	TIPARP-AS1	4.54	2.43e-05	0.0437	0.6	0.49	Age-related hearing impairment (SNP x SNP interaction);	chr3:156756735	chr3:156671862~156674378:-
READ	cis	rs1799949	0.965	rs2236762	ENSG00000198496.9	NBR2	-4.54	2.43e-05	0.0438	-0.57	-0.49	Menopause (age at onset);	chr17:43074658	chr17:43125610~43153671:+
READ	cis	rs2243480	1	rs316315	ENSG00000226824.5	RP4-756H11.3	4.54	2.43e-05	0.0438	0.76	0.49	Diabetic kidney disease;	chr7:66126218	chr7:66654538~66669855:+
READ	cis	rs1185460	0.546	rs592190	ENSG00000272186.1	RP11-110I1.13	4.54	2.43e-05	0.0438	0.63	0.49	Coronary artery disease;	chr11:119084604	chr11:119067374~119067698:-
READ	cis	rs1185460	0.546	rs589925	ENSG00000272186.1	RP11-110I1.13	4.54	2.43e-05	0.0438	0.63	0.49	Coronary artery disease;	chr11:119084969	chr11:119067374~119067698:-
READ	cis	rs992157	0.798	rs1017698	ENSG00000261338.2	RP11-378A13.1	-4.54	2.44e-05	0.0438	-0.58	-0.49	Colorectal cancer;	chr2:218305802	chr2:218255319~218257366:+
READ	cis	rs6504950	1	rs8082471	ENSG00000275710.1	RP11-257O5.4	4.54	2.44e-05	0.0438	0.71	0.49	Breast cancer;	chr17:54990632	chr17:54964474~54964679:+
READ	cis	rs12468226	0.872	rs1061157	ENSG00000226261.1	AC064836.3	4.54	2.44e-05	0.0438	0.87	0.49	Urate levels;	chr2:202556476	chr2:202336024~202336727:-
READ	cis	rs12049351	0.507	rs10916484	ENSG00000229367.1	HMGN2P19	4.54	2.44e-05	0.0439	0.78	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229465926	chr1:229570532~229570796:+
READ	cis	rs12049351	0.665	rs35085232	ENSG00000229367.1	HMGN2P19	4.54	2.44e-05	0.0439	0.78	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229466333	chr1:229570532~229570796:+
READ	cis	rs1577917	0.739	rs6922	ENSG00000203875.9	SNHG5	4.54	2.45e-05	0.044	0.66	0.49	Response to antipsychotic treatment;	chr6:85495605	chr6:85660950~85678736:-
READ	cis	rs1577917	0.666	rs6454471	ENSG00000203875.9	SNHG5	4.54	2.45e-05	0.044	0.66	0.49	Response to antipsychotic treatment;	chr6:85504738	chr6:85660950~85678736:-
READ	cis	rs1577917	0.665	rs4304137	ENSG00000203875.9	SNHG5	4.54	2.45e-05	0.044	0.66	0.49	Response to antipsychotic treatment;	chr6:85507730	chr6:85660950~85678736:-
READ	cis	rs4718428	0.672	rs36038499	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66824628	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs62465692	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66830758	chr7:66654538~66669855:+
READ	cis	rs4718428	0.672	rs13241598	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66835665	chr7:66654538~66669855:+
READ	cis	rs4718428	0.662	rs34577323	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66845054	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs4717328	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66887678	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs4718424	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66911108	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs4717331	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66913899	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs10267335	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66938233	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs2901311	ENSG00000226824.5	RP4-756H11.3	-4.54	2.45e-05	0.044	-0.68	-0.49	Corneal structure;	chr7:66950082	chr7:66654538~66669855:+
READ	cis	rs9545047	0.967	rs9574402	ENSG00000227676.3	LINC01068	4.54	2.46e-05	0.0441	0.59	0.49	Schizophrenia;	chr13:79298392	chr13:79566727~79571436:+
READ	cis	rs17301013	0.9	rs1754351	ENSG00000227373.4	RP11-160H22.5	-4.54	2.46e-05	0.0441	-0.65	-0.49	Systemic lupus erythematosus;	chr1:174762458	chr1:174115300~174160004:-
READ	cis	rs17301013	0.9	rs1793300	ENSG00000227373.4	RP11-160H22.5	-4.54	2.46e-05	0.0441	-0.65	-0.49	Systemic lupus erythematosus;	chr1:174768559	chr1:174115300~174160004:-
READ	cis	rs17301013	0.896	rs3118980	ENSG00000227373.4	RP11-160H22.5	-4.54	2.46e-05	0.0441	-0.65	-0.49	Systemic lupus erythematosus;	chr1:174793701	chr1:174115300~174160004:-
READ	cis	rs17301013	0.932	rs2987874	ENSG00000227373.4	RP11-160H22.5	-4.54	2.46e-05	0.0441	-0.65	-0.49	Systemic lupus erythematosus;	chr1:174801053	chr1:174115300~174160004:-
READ	cis	rs17301013	0.869	rs3133270	ENSG00000227373.4	RP11-160H22.5	-4.54	2.46e-05	0.0441	-0.65	-0.49	Systemic lupus erythematosus;	chr1:174819547	chr1:174115300~174160004:-
READ	cis	rs7397814	0.558	rs4764447	ENSG00000256673.1	RP11-599J14.2	4.54	2.46e-05	0.0441	0.58	0.49	IgG glycosylation;	chr12:9426513	chr12:9398355~9414851:-
READ	cis	rs2019137	0.936	rs902696	ENSG00000189223.12	PAX8-AS1	-4.54	2.46e-05	0.0442	-0.58	-0.49	Lymphocyte counts;	chr2:113197302	chr2:113211522~113276581:+
READ	cis	rs9545047	0.935	rs9530922	ENSG00000227676.3	LINC01068	-4.54	2.46e-05	0.0442	-0.58	-0.49	Schizophrenia;	chr13:79469002	chr13:79566727~79571436:+
READ	cis	rs9545047	0.935	rs4885633	ENSG00000227676.3	LINC01068	-4.54	2.46e-05	0.0442	-0.58	-0.49	Schizophrenia;	chr13:79469720	chr13:79566727~79571436:+
READ	cis	rs10472828	0.601	rs1389873	ENSG00000249774.1	CTD-2206G10.2	-4.54	2.46e-05	0.0442	-0.54	-0.49	Height;	chr5:32907101	chr5:31923367~31923532:+
READ	cis	rs6504950	1	rs9915183	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54969776	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9895808	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54971081	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9897447	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54971108	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9896044	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54971181	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9902687	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54971563	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs8080491	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54972508	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs6504948	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54972626	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs6504949	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54972772	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs8078550	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54976018	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9914732	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54977006	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9916642	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54977136	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9915832	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54977336	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9893306	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54977388	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9894529	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54977885	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs6504950	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54979110	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs6504951	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54979614	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9903146	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54980386	chr17:54964474~54964679:+
READ	cis	rs6504950	0.962	rs9902950	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54980403	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9903220	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54980504	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9903444	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54980532	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9903825	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54980553	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs16955471	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54981446	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs7221223	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54981646	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9891865	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54982672	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs9892173	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54982853	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs1990674	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54983714	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs10468513	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54985542	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs56348638	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54987189	chr17:54964474~54964679:+
READ	cis	rs6504950	1	rs7219874	ENSG00000275710.1	RP11-257O5.4	4.54	2.47e-05	0.0442	0.71	0.49	Breast cancer;	chr17:54988446	chr17:54964474~54964679:+
READ	cis	rs117004340	0.925	rs73203978	ENSG00000242607.1	RPS3AP34	4.54	2.47e-05	0.0442	0.92	0.49	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13356511	chr8:12570350~12571130:-
READ	cis	rs117004340	0.925	rs73203990	ENSG00000242607.1	RPS3AP34	4.54	2.47e-05	0.0442	0.92	0.49	Obstructive sleep apnea trait (apnea hypopnea index);	chr8:13358218	chr8:12570350~12571130:-
READ	cis	rs12468226	0.817	rs6722588	ENSG00000226261.1	AC064836.3	-4.54	2.47e-05	0.0442	-0.89	-0.49	Urate levels;	chr2:202187163	chr2:202336024~202336727:-
READ	cis	rs6490294	0.571	rs11066120	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:111998391	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7312472	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112000966	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs57439171	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112001483	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7316650	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112001860	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7313773	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112003884	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs12423960	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112004612	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs10849992	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112005213	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7310545	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112006156	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7296841	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112006305	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs11066127	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112008551	chr12:111927018~111929017:+
READ	cis	rs6490294	0.528	rs7980579	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112009556	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7952986	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112010358	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7132863	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112011079	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs12300496	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112012629	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs11066128	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112012950	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7316563	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112015831	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs58368428	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112024471	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7295294	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112027089	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs6489824	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112030613	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs12312538	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112051717	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7959011	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112063433	chr12:111927018~111929017:+
READ	cis	rs6490294	0.528	rs60690688	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112104179	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7965087	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112110758	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs73421065	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112121575	chr12:111927018~111929017:+
READ	cis	rs6490294	0.528	rs58047810	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112124682	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7309841	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112127249	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7294753	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112129646	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7970397	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112142267	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs6489830	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112144736	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs12422864	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112146397	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs2272308	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112163446	chr12:111927018~111929017:+
READ	cis	rs6490294	0.528	rs7970181	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112172194	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs7973898	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112178363	chr12:111927018~111929017:+
READ	cis	rs6490294	0.571	rs57168159	ENSG00000226469.1	ADAM1B	4.54	2.48e-05	0.0442	1.03	0.49	Mean platelet volume;	chr12:112189041	chr12:111927018~111929017:+
READ	cis	rs2564921	0.693	rs2581798	ENSG00000242142.1	SERBP1P3	4.54	2.48e-05	0.0442	0.5	0.49	Height;	chr3:53073584	chr3:53064283~53065091:-
READ	cis	rs10472828	0.601	rs1389872	ENSG00000249774.1	CTD-2206G10.2	4.54	2.49e-05	0.0443	0.53	0.49	Height;	chr5:32906753	chr5:31923367~31923532:+
READ	cis	rs2486288	0.656	rs11639420	ENSG00000259520.4	CTD-2651B20.3	4.54	2.49e-05	0.0444	0.57	0.49	Glomerular filtration rate;	chr15:45267070	chr15:45251580~45279251:-
READ	cis	rs2980439	0.525	rs2980508	ENSG00000253981.4	ALG1L13P	4.54	2.49e-05	0.0444	0.57	0.49	Neuroticism;	chr8:8314210	chr8:8236003~8244667:-
READ	cis	rs10472828	0.601	rs4867485	ENSG00000249774.1	CTD-2206G10.2	4.53	2.49e-05	0.0444	0.53	0.49	Height;	chr5:32904432	chr5:31923367~31923532:+
READ	cis	rs4718428	0.705	rs4718422	ENSG00000273142.1	RP11-458F8.4	-4.53	2.5e-05	0.0444	-0.55	-0.49	Corneal structure;	chr7:66894282	chr7:66902857~66906297:+
READ	cis	rs4718428	0.705	rs13231140	ENSG00000273142.1	RP11-458F8.4	-4.53	2.5e-05	0.0444	-0.55	-0.49	Corneal structure;	chr7:66896631	chr7:66902857~66906297:+
READ	cis	rs13113518	0.812	rs12505880	ENSG00000223305.1	RN7SKP30	4.53	2.5e-05	0.0445	0.59	0.49	Height;	chr4:55440988	chr4:55540502~55540835:-
READ	cis	rs7208859	0.673	rs9903862	ENSG00000263531.1	RP13-753N3.1	4.53	2.5e-05	0.0445	1.3	0.49	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30879415	chr17:30863921~30864940:-
READ	cis	rs9487094	0.961	rs9480948	ENSG00000260273.1	RP11-425D10.10	4.53	2.51e-05	0.0446	0.59	0.49	Height;	chr6:109407148	chr6:109382795~109383666:+
READ	cis	rs9487094	1	rs12197114	ENSG00000260273.1	RP11-425D10.10	4.53	2.51e-05	0.0446	0.59	0.49	Height;	chr6:109414295	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs11153177	ENSG00000260273.1	RP11-425D10.10	4.53	2.51e-05	0.0446	0.59	0.49	Height;	chr6:109416225	chr6:109382795~109383666:+
READ	cis	rs75422866	0.867	rs73104103	ENSG00000274902.1	RP1-197B17.4	4.53	2.51e-05	0.0446	1.19	0.49	Pneumonia;	chr12:47669604	chr12:47731908~47732351:+
READ	cis	rs2486288	0.656	rs7162022	ENSG00000259520.4	CTD-2651B20.3	4.53	2.52e-05	0.0448	0.6	0.49	Glomerular filtration rate;	chr15:45273055	chr15:45251580~45279251:-
READ	cis	rs4908768	0.871	rs11121221	ENSG00000230679.1	ENO1-AS1	4.53	2.53e-05	0.0449	0.59	0.49	Neuroticism (multi-trait analysis);Subjective well-being (multi-trait analysis);	chr1:8707470	chr1:8878835~8879894:+
READ	cis	rs13113518	0.783	rs6843722	ENSG00000223305.1	RN7SKP30	4.53	2.53e-05	0.0449	0.6	0.49	Height;	chr4:55465165	chr4:55540502~55540835:-
READ	cis	rs2581828	0.656	rs2253685	ENSG00000242142.1	SERBP1P3	4.53	2.53e-05	0.0449	0.53	0.49	Crohn's disease;	chr3:53085687	chr3:53064283~53065091:-
READ	cis	rs2581828	0.656	rs2253796	ENSG00000242142.1	SERBP1P3	4.53	2.53e-05	0.0449	0.53	0.49	Crohn's disease;	chr3:53086082	chr3:53064283~53065091:-
READ	cis	rs2581828	0.656	rs11130338	ENSG00000242142.1	SERBP1P3	4.53	2.53e-05	0.0449	0.53	0.49	Crohn's disease;	chr3:53086908	chr3:53064283~53065091:-
READ	cis	rs7617773	0.78	rs35297486	ENSG00000229759.1	MRPS18AP1	4.53	2.54e-05	0.045	0.61	0.49	Coronary artery disease;	chr3:48336657	chr3:48256350~48256938:-
READ	cis	rs6545883	0.868	rs2441381	ENSG00000271707.1	ATP1B3P1	-4.53	2.55e-05	0.0451	-0.65	-0.49	Tuberculosis;	chr2:61571694	chr2:60734895~60735715:-
READ	cis	rs11168854	0.656	rs7969963	ENSG00000258017.1	RP11-386G11.10	-4.53	2.55e-05	0.0452	-0.63	-0.49	Body mass index;	chr12:49118222	chr12:49127782~49147869:+
READ	cis	rs732716	0.785	rs56272533	ENSG00000267769.1	CTB-50L17.9	-4.53	2.56e-05	0.0452	-0.67	-0.49	Mean corpuscular volume;	chr19:4420045	chr19:4454014~4455286:+
READ	cis	rs1859156	0.723	rs34867390	ENSG00000271474.1	RP11-710C12.1	-4.53	2.57e-05	0.0455	-0.87	-0.49	Attention deficit hyperactivity disorder;	chr4:94861625	chr4:95549129~95552457:+
READ	cis	rs7429990	0.864	rs6806860	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47708218	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs6785669	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47715771	chr3:48256350~48256938:-
READ	cis	rs7429990	0.833	rs6442079	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47721044	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13094264	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47722723	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs4858851	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47724165	chr3:48256350~48256938:-
READ	cis	rs7429990	0.833	rs34777284	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47726585	chr3:48256350~48256938:-
READ	cis	rs7429990	0.833	rs7649393	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47727501	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7638103	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47727585	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs11130148	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47729797	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs17079785	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47743160	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs7637950	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47758204	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs13091913	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47762307	chr3:48256350~48256938:-
READ	cis	rs7429990	0.833	rs1486915	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47781053	chr3:48256350~48256938:-
READ	cis	rs7429990	0.828	rs6792350	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47797451	chr3:48256350~48256938:-
READ	cis	rs7429990	0.864	rs4858860	ENSG00000229759.1	MRPS18AP1	-4.52	2.59e-05	0.0457	-0.55	-0.49	Educational attainment (years of education);	chr3:47817344	chr3:48256350~48256938:-
READ	cis	rs17301013	0.507	rs6678209	ENSG00000227373.4	RP11-160H22.5	-4.52	2.59e-05	0.0457	-0.77	-0.49	Systemic lupus erythematosus;	chr1:174325607	chr1:174115300~174160004:-
READ	cis	rs748404	0.534	rs489509	ENSG00000249839.1	AC011330.5	-4.52	2.6e-05	0.0459	-0.61	-0.49	Lung cancer;	chr15:43294709	chr15:43663654~43684339:-
READ	cis	rs11155671	0.53	rs7757984	ENSG00000231760.4	RP11-350J20.5	4.52	2.61e-05	0.046	0.65	0.49	Testicular germ cell tumor;	chr6:149887515	chr6:149796151~149826294:-
READ	cis	rs12468226	0.873	rs79071680	ENSG00000272966.1	RP11-686O6.1	4.52	2.61e-05	0.046	0.81	0.49	Urate levels;	chr2:202191520	chr2:202336739~202337200:+
READ	cis	rs12468226	0.873	rs79860867	ENSG00000272966.1	RP11-686O6.1	4.52	2.61e-05	0.046	0.81	0.49	Urate levels;	chr2:202192397	chr2:202336739~202337200:+
READ	cis	rs2111504	0.559	rs7250813	ENSG00000267213.4	AC007773.2	4.52	2.62e-05	0.0461	0.64	0.49	Bipolar disorder;	chr19:32358815	chr19:32390050~32405560:-
READ	cis	rs11811982	0.793	rs79098346	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227032736	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs114098136	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227047809	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs11810440	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227079701	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs74782247	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227088245	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs79766410	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227101402	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs77464064	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227113909	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78061959	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227115303	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs78944317	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227120160	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs11806633	ENSG00000234478.1	RP11-275I14.4	-4.52	2.62e-05	0.0461	-1.39	-0.49	Optic disc area;	chr1:227120715	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs77168416	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227134137	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs75714085	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227138115	chr1:226148003~226155071:+
READ	cis	rs11811982	0.793	rs115332333	ENSG00000234478.1	RP11-275I14.4	4.52	2.62e-05	0.0461	1.39	0.49	Optic disc area;	chr1:227141305	chr1:226148003~226155071:+
READ	cis	rs10463554	0.927	rs34831	ENSG00000175749.11	EIF3KP1	4.52	2.62e-05	0.0461	0.6	0.49	Parkinson's disease;	chr5:103108385	chr5:103032376~103033031:+
READ	cis	rs9549367	0.713	rs9549691	ENSG00000269125.1	RP11-98F14.11	-4.52	2.63e-05	0.0462	-0.61	-0.49	Platelet distribution width;	chr13:113207292	chr13:113165002~113165183:-
READ	cis	rs9487094	0.644	rs9320288	ENSG00000260273.1	RP11-425D10.10	4.52	2.63e-05	0.0462	0.6	0.49	Height;	chr6:109446727	chr6:109382795~109383666:+
READ	cis	rs17407555	0.683	rs4697998	ENSG00000250413.1	RP11-448G15.1	-4.52	2.63e-05	0.0463	-0.65	-0.49	Schizophrenia (age at onset);	chr4:10273002	chr4:10006482~10009725:+
READ	cis	rs9487094	0.961	rs11153180	ENSG00000260273.1	RP11-425D10.10	4.52	2.64e-05	0.0464	0.59	0.49	Height;	chr6:109423238	chr6:109382795~109383666:+
READ	cis	rs9487094	0.922	rs11153181	ENSG00000260273.1	RP11-425D10.10	4.52	2.64e-05	0.0464	0.59	0.49	Height;	chr6:109428824	chr6:109382795~109383666:+
READ	cis	rs9487094	0.961	rs9487100	ENSG00000260273.1	RP11-425D10.10	4.52	2.64e-05	0.0464	0.59	0.49	Height;	chr6:109429207	chr6:109382795~109383666:+
READ	cis	rs2117029	1	rs3782357	ENSG00000258017.1	RP11-386G11.10	-4.52	2.64e-05	0.0464	-0.65	-0.49	Intelligence (multi-trait analysis);	chr12:49033869	chr12:49127782~49147869:+
READ	cis	rs13113518	0.783	rs34534635	ENSG00000223305.1	RN7SKP30	4.52	2.67e-05	0.0468	0.6	0.49	Height;	chr4:55573424	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs7690837	ENSG00000223305.1	RN7SKP30	4.52	2.67e-05	0.0468	0.6	0.49	Height;	chr4:55575856	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs12510400	ENSG00000223305.1	RN7SKP30	4.52	2.67e-05	0.0468	0.6	0.49	Height;	chr4:55577294	chr4:55540502~55540835:-
READ	cis	rs13113518	0.783	rs13111128	ENSG00000223305.1	RN7SKP30	4.52	2.67e-05	0.0468	0.6	0.49	Height;	chr4:55578154	chr4:55540502~55540835:-
READ	cis	rs7829975	0.514	rs2920991	ENSG00000173295.6	FAM86B3P	4.52	2.67e-05	0.0468	0.59	0.49	Mood instability;	chr8:8401607	chr8:8228595~8244865:+
READ	cis	rs453301	0.653	rs11784393	ENSG00000253981.4	ALG1L13P	4.52	2.67e-05	0.0468	0.64	0.49	Joint mobility (Beighton score);	chr8:9045624	chr8:8236003~8244667:-
READ	cis	rs3902035	0.964	rs1891715	ENSG00000253194.1	RP11-351A11.1	4.52	2.67e-05	0.0468	0.61	0.49	QT interval;	chr6:118683568	chr6:118934785~119031541:+
READ	cis	rs5753037	0.869	rs41159	ENSG00000279159.1	RP3-394A18.1	-4.52	2.67e-05	0.0468	-0.36	-0.49	Type 1 diabetes;	chr22:30011375	chr22:29978950~30028236:-
READ	cis	rs4963124	0.886	rs10902216	ENSG00000279672.1	CMB9-55F22.1	4.52	2.67e-05	0.0468	0.57	0.49	Proteinuria and chronic kidney disease;	chr11:739392	chr11:779617~780755:+
READ	cis	rs11105298	0.891	rs10858898	ENSG00000258302.2	RP11-981P6.1	4.51	2.68e-05	0.0469	0.63	0.49	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89528334	chr12:89561129~89594878:+
READ	cis	rs13113518	0.812	rs4865003	ENSG00000223305.1	RN7SKP30	4.51	2.68e-05	0.047	0.6	0.49	Height;	chr4:55514802	chr4:55540502~55540835:-
READ	cis	rs13113518	0.756	rs12510275	ENSG00000223305.1	RN7SKP30	4.51	2.68e-05	0.047	0.6	0.49	Height;	chr4:55516548	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs12510327	ENSG00000223305.1	RN7SKP30	4.51	2.68e-05	0.047	0.6	0.49	Height;	chr4:55516744	chr4:55540502~55540835:-
READ	cis	rs13113518	0.812	rs11939580	ENSG00000223305.1	RN7SKP30	4.51	2.68e-05	0.047	0.6	0.49	Height;	chr4:55517185	chr4:55540502~55540835:-
READ	cis	rs2115630	1	rs56074163	ENSG00000225151.9	GOLGA2P7	4.51	2.69e-05	0.047	0.49	0.49	P wave terminal force;	chr15:84808101	chr15:84199311~84230136:-
READ	cis	rs2115630	1	rs11854291	ENSG00000225151.9	GOLGA2P7	4.51	2.69e-05	0.047	0.49	0.49	P wave terminal force;	chr15:84820477	chr15:84199311~84230136:-
READ	cis	rs2564921	0.73	rs56386026	ENSG00000242142.1	SERBP1P3	-4.51	2.69e-05	0.047	-0.51	-0.49	Height;	chr3:53080524	chr3:53064283~53065091:-
READ	cis	rs7208859	0.614	rs216474	ENSG00000263531.1	RP13-753N3.1	-4.51	2.69e-05	0.0471	-0.73	-0.49	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30538073	chr17:30863921~30864940:-
READ	cis	rs10463554	0.853	rs246902	ENSG00000175749.11	EIF3KP1	4.51	2.7e-05	0.0472	0.55	0.49	Parkinson's disease;	chr5:103253553	chr5:103032376~103033031:+
READ	cis	rs17826219	0.585	rs8064302	ENSG00000263531.1	RP13-753N3.1	-4.51	2.7e-05	0.0473	-0.75	-0.49	Body mass index;	chr17:30397920	chr17:30863921~30864940:-
READ	cis	rs6911965	0.615	rs6900646	ENSG00000272345.1	RP1-30M3.5	-4.51	2.72e-05	0.0474	-0.73	-0.49	Hematological and biochemical traits;	chr6:24457338	chr6:24700907~24701793:-
READ	cis	rs1799949	0.965	rs11080034	ENSG00000198496.9	NBR2	-4.51	2.72e-05	0.0475	-0.55	-0.49	Menopause (age at onset);	chr17:43365646	chr17:43125610~43153671:+
READ	cis	rs12049351	0.665	rs1838464	ENSG00000229367.1	HMGN2P19	4.51	2.72e-05	0.0475	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229480946	chr1:229570532~229570796:+
READ	cis	rs2739330	0.76	rs5751760	ENSG00000225282.1	AP000350.6	4.51	2.72e-05	0.0475	0.5	0.49	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901386	chr22:23926900~23929574:+
READ	cis	rs13068223	0.562	rs346003	ENSG00000243926.1	TIPARP-AS1	-4.51	2.73e-05	0.0477	-0.56	-0.49	Age-related hearing impairment (SNP x SNP interaction);	chr3:156705283	chr3:156671862~156674378:-
READ	cis	rs9938149	0.736	rs6540223	ENSG00000260630.5	SNAI3-AS1	-4.51	2.74e-05	0.0477	-0.82	-0.49	Central corneal thickness;Corneal structure;	chr16:88287830	chr16:88663298~88687186:+
READ	cis	rs17507216	0.718	rs7165690	ENSG00000278603.1	RP13-608F4.5	4.51	2.74e-05	0.0479	0.85	0.49	Excessive daytime sleepiness;	chr15:82654804	chr15:82472203~82472426:+
READ	cis	rs2980439	0.818	rs2948294	ENSG00000253981.4	ALG1L13P	4.51	2.75e-05	0.0479	0.58	0.49	Neuroticism;	chr8:8237439	chr8:8236003~8244667:-
READ	cis	rs3096299	0.685	rs8050512	ENSG00000274627.1	RP11-104N10.2	4.51	2.75e-05	0.048	0.53	0.49	Multiple myeloma (IgH translocation);	chr16:89485912	chr16:89516797~89522217:+
READ	cis	rs12049351	0.774	rs1053513	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229516840	chr1:229570532~229570796:+
READ	cis	rs12049351	0.722	rs4148763	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229519213	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs12138965	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229519973	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs10799533	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229520815	chr1:229570532~229570796:+
READ	cis	rs12049351	0.665	rs10799534	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229521466	chr1:229570532~229570796:+
READ	cis	rs12049351	0.665	rs3738186	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229521483	chr1:229570532~229570796:+
READ	cis	rs12049351	0.613	rs10799535	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229522047	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs12024146	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229525144	chr1:229570532~229570796:+
READ	cis	rs12049351	0.665	rs4148761	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229526597	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs12066463	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229533540	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs2145395	ENSG00000229367.1	HMGN2P19	4.51	2.75e-05	0.048	0.71	0.49	Circulating myeloperoxidase levels (plasma);	chr1:229535234	chr1:229570532~229570796:+
READ	cis	rs61160187	0.51	rs10072745	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60787448	chr5:60891935~60893577:-
READ	cis	rs61160187	0.527	rs6449500	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60788076	chr5:60891935~60893577:-
READ	cis	rs4700393	0.967	rs921897	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Intelligence (multi-trait analysis);	chr5:60793310	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs10076679	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795124	chr5:60891935~60893577:-
READ	cis	rs61160187	0.527	rs10076742	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795219	chr5:60891935~60893577:-
READ	cis	rs61160187	0.527	rs6890201	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795365	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs6875456	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795503	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs6894750	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795729	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs6876335	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60795991	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs6449501	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60796860	chr5:60891935~60893577:-
READ	cis	rs61160187	0.51	rs4235481	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60797560	chr5:60891935~60893577:-
READ	cis	rs61160187	0.505	rs4235482	ENSG00000215032.2	GNL3LP1	4.51	2.76e-05	0.048	0.55	0.49	Educational attainment (years of education);Educational attainment (college completion);	chr5:60797785	chr5:60891935~60893577:-
READ	cis	rs7829975	0.514	rs2979151	ENSG00000253981.4	ALG1L13P	-4.51	2.77e-05	0.0482	-0.53	-0.49	Mood instability;	chr8:8400509	chr8:8236003~8244667:-
READ	cis	rs11105298	0.891	rs10858906	ENSG00000258302.2	RP11-981P6.1	4.51	2.77e-05	0.0482	0.62	0.48	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;	chr12:89540697	chr12:89561129~89594878:+
READ	cis	rs6844153	0.752	rs28520489	ENSG00000240005.4	RP11-293A21.1	-4.5	2.78e-05	0.0483	-0.59	-0.48	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);	chr4:26896082	chr4:26859806~26860599:-
READ	cis	rs10463554	0.963	rs32850	ENSG00000175749.11	EIF3KP1	4.5	2.78e-05	0.0483	0.56	0.48	Parkinson's disease;	chr5:103134325	chr5:103032376~103033031:+
READ	cis	rs2581828	0.646	rs9861233	ENSG00000242142.1	SERBP1P3	-4.5	2.79e-05	0.0484	-0.54	-0.48	Crohn's disease;	chr3:53124815	chr3:53064283~53065091:-
READ	cis	rs11690935	0.688	rs7600835	ENSG00000228389.1	AC068039.4	4.5	2.79e-05	0.0484	0.62	0.48	Schizophrenia;	chr2:171665317	chr2:171773482~171775844:+
READ	cis	rs7615952	0.558	rs7641353	ENSG00000272840.1	RP11-379B18.6	4.5	2.79e-05	0.0484	0.81	0.48	Blood pressure (smoking interaction);	chr3:125621035	chr3:125774714~125797953:+
READ	cis	rs4718428	0.705	rs12536410	ENSG00000226824.5	RP4-756H11.3	-4.5	2.8e-05	0.0485	-0.71	-0.48	Corneal structure;	chr7:66789303	chr7:66654538~66669855:+
READ	cis	rs4718428	0.705	rs68168107	ENSG00000226824.5	RP4-756H11.3	-4.5	2.8e-05	0.0485	-0.71	-0.48	Corneal structure;	chr7:66790251	chr7:66654538~66669855:+
READ	cis	rs9487051	0.768	rs371960	ENSG00000219700.1	PTCHD3P3	4.5	2.8e-05	0.0486	0.59	0.48	Reticulocyte fraction of red cells;	chr6:109203879	chr6:109288571~109290503:-
READ	cis	rs950169	0.84	rs35522895	ENSG00000225151.9	GOLGA2P7	-4.5	2.81e-05	0.0486	-0.55	-0.48	Schizophrenia;	chr15:84259297	chr15:84199311~84230136:-
READ	cis	rs7829975	0.742	rs12547493	ENSG00000253981.4	ALG1L13P	-4.5	2.81e-05	0.0486	-0.58	-0.48	Mood instability;	chr8:8804024	chr8:8236003~8244667:-
READ	cis	rs17301013	0.803	rs2187562	ENSG00000227373.4	RP11-160H22.5	4.5	2.81e-05	0.0486	0.66	0.48	Systemic lupus erythematosus;	chr1:174842513	chr1:174115300~174160004:-
READ	cis	rs748404	0.646	rs2253268	ENSG00000249839.1	AC011330.5	-4.5	2.81e-05	0.0487	-0.63	-0.48	Lung cancer;	chr15:43508770	chr15:43663654~43684339:-
READ	cis	rs35160687	0.901	rs10520415	ENSG00000273080.1	RP11-301O19.1	-4.5	2.82e-05	0.0487	-0.57	-0.48	Night sleep phenotypes;	chr2:86271615	chr2:86195590~86196049:+
READ	cis	rs35160687	0.871	rs2278105	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86239393	chr2:86195590~86196049:+
READ	cis	rs35160687	1	rs35160687	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86244991	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12620833	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86245747	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12472390	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86247960	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs13017338	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86274430	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12999029	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86275790	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12472676	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86283692	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs67903513	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86284976	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs35762338	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86286430	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs17738096	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86286770	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12714179	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86287835	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs13020869	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86296237	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12714180	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86298200	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs35281683	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86299249	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs10200186	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86300300	chr2:86195590~86196049:+
READ	cis	rs35160687	0.842	rs10200526	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86300476	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs34048420	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86302625	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs34069316	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86302669	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs11127026	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86304625	chr2:86195590~86196049:+
READ	cis	rs35160687	0.901	rs12478575	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86308191	chr2:86195590~86196049:+
READ	cis	rs35160687	0.871	rs11127028	ENSG00000273080.1	RP11-301O19.1	4.5	2.82e-05	0.0487	0.57	0.48	Night sleep phenotypes;	chr2:86310386	chr2:86195590~86196049:+
READ	cis	rs75422866	0.867	rs73102195	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47666309	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73102201	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47669269	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104104	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47671986	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104111	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47673994	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104115	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47684843	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104116	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47685023	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104138	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47692302	chr12:47731908~47732351:+
READ	cis	rs75422866	0.717	rs73104143	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47693449	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104144	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47694390	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104148	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47696732	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104152	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47699091	chr12:47731908~47732351:+
READ	cis	rs75422866	0.867	rs73104155	ENSG00000274902.1	RP1-197B17.4	4.5	2.82e-05	0.0487	1.18	0.48	Pneumonia;	chr12:47700790	chr12:47731908~47732351:+
READ	cis	rs12049351	0.774	rs35464914	ENSG00000229367.1	HMGN2P19	4.5	2.82e-05	0.0487	0.71	0.48	Circulating myeloperoxidase levels (plasma);	chr1:229554485	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs4148758	ENSG00000229367.1	HMGN2P19	4.5	2.82e-05	0.0487	0.71	0.48	Circulating myeloperoxidase levels (plasma);	chr1:229557919	chr1:229570532~229570796:+
READ	cis	rs12049351	0.774	rs4148755	ENSG00000229367.1	HMGN2P19	4.5	2.82e-05	0.0487	0.71	0.48	Circulating myeloperoxidase levels (plasma);	chr1:229559119	chr1:229570532~229570796:+
READ	cis	rs2739330	0.587	rs4820571	ENSG00000231271.1	AP000350.8	4.5	2.83e-05	0.0488	0.61	0.48	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23900786	chr22:23949918~23954042:+
READ	cis	rs2486288	0.656	rs9921035	ENSG00000259520.4	CTD-2651B20.3	4.5	2.83e-05	0.0488	0.59	0.48	Glomerular filtration rate;	chr15:45254462	chr15:45251580~45279251:-
READ	cis	rs748404	0.631	rs6493086	ENSG00000249839.1	AC011330.5	-4.5	2.83e-05	0.0488	-0.62	-0.48	Lung cancer;	chr15:43363196	chr15:43663654~43684339:-
READ	cis	rs2006771	0.81	rs2006648	ENSG00000236132.1	CTA-440B3.1	4.5	2.84e-05	0.0489	0.58	0.48	Nonsyndromic cleft lip with cleft palate;	chr22:31685943	chr22:31816379~31817491:-
READ	cis	rs2739330	0.76	rs5751760	ENSG00000250470.1	AP000351.3	4.5	2.85e-05	0.049	0.68	0.48	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23901386	chr22:23976904~23977585:-
READ	cis	rs5753037	0.869	rs4287865	ENSG00000279159.1	RP3-394A18.1	-4.5	2.85e-05	0.0491	-0.35	-0.48	Type 1 diabetes;	chr22:29911569	chr22:29978950~30028236:-
READ	cis	rs5753037	0.869	rs737939	ENSG00000279159.1	RP3-394A18.1	-4.5	2.85e-05	0.0491	-0.35	-0.48	Type 1 diabetes;	chr22:29919427	chr22:29978950~30028236:-
READ	cis	rs1577917	1	rs6923148	ENSG00000203875.9	SNHG5	4.5	2.86e-05	0.0493	0.66	0.48	Response to antipsychotic treatment;	chr6:86058068	chr6:85660950~85678736:-
READ	cis	rs74019828	0.655	rs11860708	ENSG00000260038.1	RP11-407G23.4	-4.5	2.87e-05	0.0494	-0.98	-0.48	Telomere length;	chr16:58144692	chr16:57247350~57248492:+
READ	cis	rs9487094	0.961	rs11153171	ENSG00000260273.1	RP11-425D10.10	4.5	2.87e-05	0.0494	0.6	0.48	Height;	chr6:109332622	chr6:109382795~109383666:+
READ	cis	rs2243480	1	rs1499614	ENSG00000273142.1	RP11-458F8.4	-4.5	2.87e-05	0.0494	-0.71	-0.48	Diabetic kidney disease;	chr7:66265811	chr7:66902857~66906297:+
READ	cis	rs453301	0.624	rs330049	ENSG00000253981.4	ALG1L13P	4.5	2.87e-05	0.0494	0.56	0.48	Joint mobility (Beighton score);	chr8:9229789	chr8:8236003~8244667:-
READ	cis	rs7188445	1	rs16950982	ENSG00000261390.4	RP11-345M22.2	-4.5	2.88e-05	0.0495	-0.62	-0.48	Urate levels;	chr16:79668474	chr16:79715232~79770563:-
READ	cis	rs9425766	0.679	rs57919173	ENSG00000227373.4	RP11-160H22.5	4.49	2.9e-05	0.0497	0.65	0.48	Life satisfaction;	chr1:174159856	chr1:174115300~174160004:-
READ	cis	rs748404	0.631	rs8042688	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43346327	chr15:43663654~43684339:-
READ	cis	rs748404	0.587	rs9920879	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43347572	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs7166812	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43352562	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs4296223	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43353048	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs11070399	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43354149	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs6493084	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43355429	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs12905772	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43356246	chr15:43663654~43684339:-
READ	cis	rs748404	0.676	rs4401024	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43358137	chr15:43663654~43684339:-
READ	cis	rs748404	0.631	rs1133395	ENSG00000249839.1	AC011330.5	-4.49	2.9e-05	0.0498	-0.62	-0.48	Lung cancer;	chr15:43358186	chr15:43663654~43684339:-
READ	cis	rs977987	0.931	rs8057084	ENSG00000261783.1	RP11-252K23.2	4.49	2.9e-05	0.0498	0.62	0.48	Dupuytren's disease;	chr16:75458808	chr16:75379818~75381260:-
READ	cis	rs977987	0.705	rs4888377	ENSG00000261783.1	RP11-252K23.2	-4.49	2.91e-05	0.0498	-0.69	-0.48	Dupuytren's disease;	chr16:75291788	chr16:75379818~75381260:-
READ	cis	rs8072100	0.875	rs4794047	ENSG00000228782.6	CTD-2026D20.3	-4.49	2.91e-05	0.0499	-0.6	-0.48	Very long-chain saturated fatty acid levels (fatty acid 20:0);	chr17:47685639	chr17:47450568~47492492:-
READ	cis	rs7937890	0.681	rs4756784	ENSG00000254418.1	RP11-21L19.1	-4.49	2.91e-05	0.0499	-0.59	-0.48	Mitochondrial DNA levels;	chr11:14249358	chr11:14262846~14273691:-
READ	cis	rs7937890	0.732	rs7946902	ENSG00000254418.1	RP11-21L19.1	-4.49	2.91e-05	0.0499	-0.59	-0.48	Mitochondrial DNA levels;	chr11:14251762	chr11:14262846~14273691:-
READ	trans	rs1816752	0.87	rs7981337	ENSG00000237917.1	PARP4P1	17.69	9.68e-27	4.04e-17	1.21	0.91	Obesity-related traits;	chr13:24440915	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs7981480	ENSG00000237917.1	PARP4P1	17.69	9.68e-27	4.04e-17	1.21	0.91	Obesity-related traits;	chr13:24440966	chrY:26594851~26634652:-
READ	trans	rs1816752	0.837	rs4769355	ENSG00000237917.1	PARP4P1	17.69	9.68e-27	4.04e-17	1.21	0.91	Obesity-related traits;	chr13:24441059	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs4770680	ENSG00000237917.1	PARP4P1	17.69	9.68e-27	4.04e-17	1.21	0.91	Obesity-related traits;	chr13:24441110	chrY:26594851~26634652:-
READ	trans	rs1816752	0.805	rs61614647	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24441829	chrY:26594851~26634652:-
READ	trans	rs1816752	0.774	rs55888616	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24441954	chrY:26594851~26634652:-
READ	trans	rs1816752	0.806	rs3816218	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443033	chrY:26594851~26634652:-
READ	trans	rs1816752	0.666	rs7994022	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443092	chrY:26594851~26634652:-
READ	trans	rs1816752	0.776	rs7998843	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443147	chrY:26594851~26634652:-
READ	trans	rs1816752	0.713	rs7336357	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443452	chrY:26594851~26634652:-
READ	trans	rs1816752	0.683	rs7330532	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443453	chrY:26594851~26634652:-
READ	trans	rs1816752	0.59	rs61947036	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24443544	chrY:26594851~26634652:-
READ	trans	rs1816752	0.746	rs9511270	ENSG00000237917.1	PARP4P1	17.56	1.42e-26	4.04e-17	1.22	0.91	Obesity-related traits;	chr13:24444542	chrY:26594851~26634652:-
READ	trans	rs1816752	0.712	rs6490932	ENSG00000237917.1	PARP4P1	17.48	1.84e-26	4.97e-17	1.21	0.91	Obesity-related traits;	chr13:24443313	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7995909	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24439159	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs6490927	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24439802	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs6490928	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24439921	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs6490929	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24440114	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs3825449	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24440303	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs7998797	ENSG00000237917.1	PARP4P1	17.24	3.96e-26	6.99e-17	1.21	0.9	Obesity-related traits;	chr13:24440850	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9511266	ENSG00000237917.1	PARP4P1	17.2	4.46e-26	7.15e-17	1.22	0.9	Obesity-related traits;	chr13:24438366	chrY:26594851~26634652:-
READ	trans	rs1816752	0.817	rs7985394	ENSG00000237917.1	PARP4P1	17.2	4.46e-26	7.15e-17	1.22	0.9	Obesity-related traits;	chr13:24438714	chrY:26594851~26634652:-
READ	trans	rs1816752	0.789	rs7986037	ENSG00000237917.1	PARP4P1	17.2	4.46e-26	7.15e-17	1.22	0.9	Obesity-related traits;	chr13:24438715	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9511264	ENSG00000237917.1	PARP4P1	-16.88	1.2e-25	1.43e-16	-1.18	-0.9	Obesity-related traits;	chr13:24438079	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs2033955	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24436406	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs2033954	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24436429	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9511260	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24437038	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs7320102	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24437435	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7339140	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24437764	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs9511261	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24437880	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9511262	ENSG00000237917.1	PARP4P1	16.88	1.2e-25	1.43e-16	1.18	0.9	Obesity-related traits;	chr13:24437885	chrY:26594851~26634652:-
READ	trans	rs1816752	0.776	rs9511268	ENSG00000237917.1	PARP4P1	16.82	1.49e-25	1.74e-16	1.21	0.9	Obesity-related traits;	chr13:24444182	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs1050112	ENSG00000237917.1	PARP4P1	16.5	4.19e-25	4.48e-16	1.17	0.9	Obesity-related traits;	chr13:24435159	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs13428	ENSG00000237917.1	PARP4P1	16.5	4.19e-25	4.48e-16	1.17	0.9	Obesity-related traits;	chr13:24435303	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs8000215	ENSG00000237917.1	PARP4P1	16.5	4.19e-25	4.48e-16	1.17	0.9	Obesity-related traits;	chr13:24435648	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs11839006	ENSG00000237917.1	PARP4P1	16.5	4.19e-25	4.48e-16	1.17	0.9	Obesity-related traits;	chr13:24435893	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7995492	ENSG00000237917.1	PARP4P1	16.17	1.21e-24	1.27e-15	1.19	0.89	Obesity-related traits;	chr13:24438885	chrY:26594851~26634652:-
READ	trans	rs1816752	0.837	rs7324645	ENSG00000237917.1	PARP4P1	15.14	3.71e-23	3.8e-14	1.16	0.88	Obesity-related traits;	chr13:24426717	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7991450	ENSG00000237917.1	PARP4P1	15.09	4.51e-23	3.92e-14	1.15	0.88	Obesity-related traits;	chr13:24425898	chrY:26594851~26634652:-
READ	trans	rs1816752	0.774	rs7986162	ENSG00000237917.1	PARP4P1	15.09	4.51e-23	3.92e-14	1.15	0.88	Obesity-related traits;	chr13:24425941	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs4769352	ENSG00000237917.1	PARP4P1	15.09	4.51e-23	3.92e-14	1.15	0.88	Obesity-related traits;	chr13:24426237	chrY:26594851~26634652:-
READ	trans	rs1816752	0.805	rs4769353	ENSG00000237917.1	PARP4P1	15.09	4.51e-23	3.92e-14	1.15	0.88	Obesity-related traits;	chr13:24426318	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7571	ENSG00000237917.1	PARP4P1	15.09	4.51e-23	3.92e-14	1.15	0.88	Obesity-related traits;	chr13:24426479	chrY:26594851~26634652:-
READ	trans	rs1816752	0.875	rs1050110	ENSG00000237917.1	PARP4P1	14.97	6.6e-23	5.64e-14	1.16	0.88	Obesity-related traits;	chr13:24435347	chrY:26594851~26634652:-
READ	trans	rs1816752	0.719	rs11841989	ENSG00000237917.1	PARP4P1	14.91	8.34e-23	6.8e-14	1.13	0.88	Obesity-related traits;	chr13:24423560	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs9581029	ENSG00000237917.1	PARP4P1	14.88	9.11e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24425147	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs9581025	ENSG00000237917.1	PARP4P1	14.87	9.29e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24423687	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9581026	ENSG00000237917.1	PARP4P1	14.87	9.29e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24423788	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs9581027	ENSG00000237917.1	PARP4P1	14.87	9.29e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24423790	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs9318529	ENSG00000237917.1	PARP4P1	14.87	9.29e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24424190	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs9511249	ENSG00000237917.1	PARP4P1	14.87	9.29e-23	6.8e-14	1.14	0.88	Obesity-related traits;	chr13:24425457	chrY:26594851~26634652:-
READ	trans	rs1816752	0.87	rs73469543	ENSG00000237917.1	PARP4P1	14.86	9.62e-23	6.85e-14	1.15	0.88	Obesity-related traits;	chr13:24424832	chrY:26594851~26634652:-
READ	trans	rs1816752	0.638	rs9578730	ENSG00000237917.1	PARP4P1	14.36	5.54e-22	3.84e-13	1.16	0.87	Obesity-related traits;	chr13:24425545	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs8002215	ENSG00000237917.1	PARP4P1	14.28	7.23e-22	4.76e-13	1.13	0.87	Obesity-related traits;	chr13:24416229	chrY:26594851~26634652:-
READ	trans	rs1816752	1	rs9507341	ENSG00000237917.1	PARP4P1	-14.22	8.91e-22	5.78e-13	-1.12	-0.87	Obesity-related traits;	chr13:24432440	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs7400631	ENSG00000237917.1	PARP4P1	14.22	9.02e-22	5.78e-13	1.13	0.87	Obesity-related traits;	chr13:24415927	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs7985478	ENSG00000237917.1	PARP4P1	14	1.99e-21	1.17e-12	1.13	0.86	Obesity-related traits;	chr13:24417135	chrY:26594851~26634652:-
READ	trans	rs12291225	0.679	rs11238	ENSG00000236360.2	RP11-334A14.2	-13.92	2.59e-21	1.17e-12	-1.21	-0.86	Sense of smell;	chr11:14266582	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs11369	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14266550	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs11605531	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14270048	chr1:52993201~52993702:-
READ	trans	rs12291225	0.639	rs61883858	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14273162	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs11023170	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14273363	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs11023172	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14273821	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs4757245	ENSG00000236360.2	RP11-334A14.2	13.92	2.59e-21	1.17e-12	1.21	0.86	Sense of smell;	chr11:14276326	chr1:52993201~52993702:-
READ	trans	rs1816752	0.748	rs6490912	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24408941	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs1981276	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24409361	chrY:26594851~26634652:-
READ	trans	rs1816752	0.755	rs1981277	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24409375	chrY:26594851~26634652:-
READ	trans	rs1816752	0.837	rs57052031	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24409730	chrY:26594851~26634652:-
READ	trans	rs1816752	0.712	rs9507335	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24409766	chrY:26594851~26634652:-
READ	trans	rs1816752	0.774	rs2862895	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24410328	chrY:26594851~26634652:-
READ	trans	rs1816752	0.811	rs9507337	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24410807	chrY:26594851~26634652:-
READ	trans	rs1816752	0.783	rs7317439	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24410939	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs7316961	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24411039	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs7317504	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24411287	chrY:26594851~26634652:-
READ	trans	rs1816752	0.783	rs7317712	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24411365	chrY:26594851~26634652:-
READ	trans	rs1816752	0.783	rs7139527	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24411374	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs9511240	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24411768	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs7988388	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24412675	chrY:26594851~26634652:-
READ	trans	rs1816752	0.875	rs7993132	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24412903	chrY:26594851~26634652:-
READ	trans	rs1816752	0.792	rs7330956	ENSG00000237917.1	PARP4P1	13.91	2.68e-21	1.17e-12	1.12	0.86	Obesity-related traits;	chr13:24413174	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs4769349	ENSG00000237917.1	PARP4P1	-13.87	3.06e-21	1.3e-12	-1.11	-0.86	Obesity-related traits;	chr13:24408694	chrY:26594851~26634652:-
READ	trans	rs12291225	0.679	rs4756786	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14264354	chr1:52993201~52993702:-
READ	trans	rs12291225	0.637	rs8570	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14279213	chr1:52993201~52993702:-
READ	trans	rs12291225	0.753	rs1431374	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14282429	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs10832240	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14283198	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs7934671	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14283555	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs11023178	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14288736	chr1:52993201~52993702:-
READ	trans	rs12291225	0.679	rs34238445	ENSG00000236360.2	RP11-334A14.2	13.86	3.24e-21	1.3e-12	1.21	0.86	Sense of smell;	chr11:14294369	chr1:52993201~52993702:-
READ	trans	rs1816752	0.712	rs2862898	ENSG00000237917.1	PARP4P1	13.85	3.31e-21	1.3e-12	1.11	0.86	Obesity-related traits;	chr13:24414323	chrY:26594851~26634652:-
READ	trans	rs1816752	0.652	rs2902356	ENSG00000237917.1	PARP4P1	13.85	3.31e-21	1.3e-12	1.11	0.86	Obesity-related traits;	chr13:24414333	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs4770664	ENSG00000237917.1	PARP4P1	13.85	3.31e-21	1.3e-12	1.11	0.86	Obesity-related traits;	chr13:24414695	chrY:26594851~26634652:-
READ	trans	rs1816752	0.935	rs3816219	ENSG00000237917.1	PARP4P1	13.84	3.41e-21	1.3e-12	1.17	0.86	Obesity-related traits;	chr13:24442995	chrY:26594851~26634652:-
READ	trans	rs1816752	1	rs7988810	ENSG00000237917.1	PARP4P1	13.84	3.41e-21	1.3e-12	1.17	0.86	Obesity-related traits;	chr13:24444958	chrY:26594851~26634652:-
READ	trans	rs6477998	0.603	rs10117451	ENSG00000238072.1	RP11-305M3.2	13.82	3.77e-21	1.43e-12	1.1	0.86	Hematology traits;	chr9:113273610	chr7:129410113~129410370:-
READ	trans	rs1816752	0.777	rs6490915	ENSG00000237917.1	PARP4P1	13.8	3.98e-21	1.5e-12	1.13	0.86	Obesity-related traits;	chr13:24413724	chrY:26594851~26634652:-
READ	trans	rs7949030	0.626	rs72927213	ENSG00000186676.3	EEF1GP1	13.77	4.43e-21	1.63e-12	1.13	0.86	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62583726	chr7:125033453~125035301:+
READ	trans	rs6477998	0.58	rs9299214	ENSG00000238072.1	RP11-305M3.2	13.74	4.99e-21	1.81e-12	1.1	0.86	Hematology traits;	chr9:113273416	chr7:129410113~129410370:-
READ	trans	rs1816752	0.837	rs7139748	ENSG00000237917.1	PARP4P1	13.7	5.78e-21	2.06e-12	1.11	0.86	Obesity-related traits;	chr13:24411531	chrY:26594851~26634652:-
READ	trans	rs12291225	0.645	rs3763950	ENSG00000236360.2	RP11-334A14.2	13.67	6.44e-21	2.28e-12	1.2	0.86	Sense of smell;	chr11:14256503	chr1:52993201~52993702:-
READ	trans	rs1816752	0.905	rs4770666	ENSG00000237917.1	PARP4P1	13.63	7.45e-21	2.62e-12	1.11	0.86	Obesity-related traits;	chr13:24414891	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs1348110	ENSG00000237917.1	PARP4P1	13.6	8.12e-21	2.81e-12	1.13	0.86	Obesity-related traits;	chr13:24406537	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs4770665	ENSG00000237917.1	PARP4P1	13.54	1.01e-20	3.36e-12	1.12	0.86	Obesity-related traits;	chr13:24414810	chrY:26594851~26634652:-
READ	trans	rs1816752	0.721	rs7399656	ENSG00000237917.1	PARP4P1	13.54	1.01e-20	3.36e-12	1.12	0.86	Obesity-related traits;	chr13:24415708	chrY:26594851~26634652:-
READ	trans	rs1816752	0.749	rs77832754	ENSG00000237917.1	PARP4P1	13.54	1.01e-20	3.36e-12	1.12	0.86	Obesity-related traits;	chr13:24416016	chrY:26594851~26634652:-
READ	trans	rs1816752	0.633	rs8002387	ENSG00000237917.1	PARP4P1	13.54	1.01e-20	3.36e-12	1.12	0.86	Obesity-related traits;	chr13:24416306	chrY:26594851~26634652:-
READ	trans	rs1816752	0.819	rs7400583	ENSG00000237917.1	PARP4P1	13.49	1.24e-20	4.06e-12	1.08	0.86	Obesity-related traits;	chr13:24415916	chrY:26594851~26634652:-
READ	trans	rs1816752	1	rs9511265	ENSG00000237917.1	PARP4P1	13.34	2.07e-20	6.67e-12	1.16	0.85	Obesity-related traits;	chr13:24438221	chrY:26594851~26634652:-
READ	trans	rs7949030	0.596	rs11231138	ENSG00000186676.3	EEF1GP1	13.33	2.18e-20	6.97e-12	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62548723	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs61296092	ENSG00000186676.3	EEF1GP1	13.27	2.71e-20	8.62e-12	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62553366	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs11231141	ENSG00000186676.3	EEF1GP1	13.24	2.96e-20	9.36e-12	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62558793	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs7930896	ENSG00000186676.3	EEF1GP1	13.19	3.64e-20	1.14e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62557800	chr7:125033453~125035301:+
READ	trans	rs1816752	1	rs7999554	ENSG00000237917.1	PARP4P1	13.15	4.22e-20	1.27e-11	1.13	0.85	Obesity-related traits;	chr13:24435631	chrY:26594851~26634652:-
READ	trans	rs7949030	0.626	rs11231144	ENSG00000186676.3	EEF1GP1	13.1	4.99e-20	1.47e-11	1.09	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62560566	chr7:125033453~125035301:+
READ	trans	rs7949030	0.596	rs71490394	ENSG00000186676.3	EEF1GP1	13.1	4.99e-20	1.47e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62602683	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs7943191	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561079	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs11231145	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561382	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs71490390	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561713	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs7124057	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62566624	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs1061093	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62567436	chr7:125033453~125035301:+
READ	trans	rs7949030	0.626	rs11231154	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62594821	chr7:125033453~125035301:+
READ	trans	rs7949030	0.591	rs11231156	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62598982	chr7:125033453~125035301:+
READ	trans	rs7949030	0.591	rs12049914	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62601964	chr7:125033453~125035301:+
READ	trans	rs7949030	0.591	rs35156678	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62602409	chr7:125033453~125035301:+
READ	trans	rs7949030	0.591	rs35880596	ENSG00000186676.3	EEF1GP1	13.08	5.38e-20	1.48e-11	1.1	0.85	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62602412	chr7:125033453~125035301:+
READ	trans	rs6477998	0.58	rs10981715	ENSG00000238072.1	RP11-305M3.2	13.07	5.53e-20	1.52e-11	1.11	0.85	Hematology traits;	chr9:113287218	chr7:129410113~129410370:-
READ	trans	rs12291225	0.679	rs1043237	ENSG00000236360.2	RP11-334A14.2	13.06	5.87e-20	1.59e-11	1.19	0.85	Sense of smell;	chr11:14267507	chr1:52993201~52993702:-
READ	trans	rs6477998	0.58	rs2296073	ENSG00000238072.1	RP11-305M3.2	13.03	6.42e-20	1.73e-11	1.08	0.85	Hematology traits;	chr9:113299348	chr7:129410113~129410370:-
READ	trans	rs6477998	0.58	rs7027833	ENSG00000238072.1	RP11-305M3.2	12.95	8.78e-20	2.36e-11	1.09	0.85	Hematology traits;	chr9:113301377	chr7:129410113~129410370:-
READ	trans	rs1816752	1	rs7326932	ENSG00000237917.1	PARP4P1	12.76	1.78e-19	4.61e-11	1.12	0.84	Obesity-related traits;	chr13:24430355	chrY:26594851~26634652:-
READ	trans	rs6477998	0.557	rs3750534	ENSG00000238072.1	RP11-305M3.2	12.73	1.95e-19	4.99e-11	1.09	0.84	Hematology traits;	chr9:113297844	chr7:129410113~129410370:-
READ	trans	rs6477998	0.58	rs3750532	ENSG00000238072.1	RP11-305M3.2	12.73	1.95e-19	4.99e-11	1.09	0.84	Hematology traits;	chr9:113298207	chr7:129410113~129410370:-
READ	trans	rs6477998	0.535	rs3750535	ENSG00000238072.1	RP11-305M3.2	12.71	2.12e-19	5.41e-11	1.09	0.84	Hematology traits;	chr9:113297453	chr7:129410113~129410370:-
READ	trans	rs6477998	0.58	rs10759638	ENSG00000238072.1	RP11-305M3.2	-12.65	2.61e-19	6.6e-11	-1.07	-0.84	Hematology traits;	chr9:113280212	chr7:129410113~129410370:-
READ	trans	rs1816752	1	rs9511272	ENSG00000237917.1	PARP4P1	12.6	3.16e-19	7.88e-11	1.14	0.84	Obesity-related traits;	chr13:24446495	chrY:26594851~26634652:-
READ	trans	rs1816752	0.935	rs4770676	ENSG00000237917.1	PARP4P1	12.48	4.95e-19	1.2e-10	1.1	0.84	Obesity-related traits;	chr13:24429745	chrY:26594851~26634652:-
READ	trans	rs1816752	0.837	rs9318530	ENSG00000237917.1	PARP4P1	-12.37	7.53e-19	1.78e-10	-1.1	-0.84	Obesity-related traits;	chr13:24424419	chrY:26594851~26634652:-
READ	trans	rs928391	0.681	rs12161427	ENSG00000227183.3	HDGFP1	12.36	7.84e-19	1.82e-10	1.08	0.84	Platelet count;	chr1:156736030	chrX:131646639~131646890:+
READ	trans	rs928391	0.681	rs3806417	ENSG00000227183.3	HDGFP1	12.36	7.84e-19	1.82e-10	1.08	0.84	Platelet count;	chr1:156741831	chrX:131646639~131646890:+
READ	trans	rs13177918	0.677	rs3797622	ENSG00000239528.1	RPS14P8	12.31	9.43e-19	2.18e-10	1.05	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr5:116562562~116562930:+
READ	trans	rs7949030	0.688	rs2849031	ENSG00000186676.3	EEF1GP1	-12.21	1.36e-18	3.08e-10	-1.11	-0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62598193	chr7:125033453~125035301:+
READ	trans	rs7949030	0.653	rs2849030	ENSG00000186676.3	EEF1GP1	-12.21	1.36e-18	3.08e-10	-1.11	-0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62599514	chr7:125033453~125035301:+
READ	trans	rs928391	0.681	rs4501833	ENSG00000227183.3	HDGFP1	12.2	1.42e-18	3.17e-10	1.08	0.83	Platelet count;	chr1:156746806	chrX:131646639~131646890:+
READ	trans	rs928391	0.681	rs11264533	ENSG00000227183.3	HDGFP1	12.2	1.42e-18	3.17e-10	1.08	0.83	Platelet count;	chr1:156748656	chrX:131646639~131646890:+
READ	trans	rs928391	0.681	rs12145743	ENSG00000227183.3	HDGFP1	12.19	1.5e-18	3.33e-10	1.07	0.83	Platelet count;	chr1:156730859	chrX:131646639~131646890:+
READ	trans	rs6477998	0.58	rs12343629	ENSG00000238072.1	RP11-305M3.2	12.14	1.76e-18	3.9e-10	1.07	0.83	Hematology traits;	chr9:113279301	chr7:129410113~129410370:-
READ	trans	rs13177918	0.677	rs4841	ENSG00000239528.1	RPS14P8	12.11	1.99e-18	4.35e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13183077	ENSG00000239528.1	RPS14P8	12.11	1.99e-18	4.35e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr5:116562562~116562930:+
READ	trans	rs13177918	0.557	rs12520101	ENSG00000239528.1	RPS14P8	12.06	2.42e-18	5.28e-10	1.01	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150431360	chr5:116562562~116562930:+
READ	trans	rs6477998	0.58	rs4979231	ENSG00000238072.1	RP11-305M3.2	12	3e-18	6.34e-10	1.11	0.83	Hematology traits;	chr9:113286475	chr7:129410113~129410370:-
READ	trans	rs13177918	0.677	rs13171800	ENSG00000239528.1	RPS14P8	11.91	4.24e-18	8.36e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs2070841	ENSG00000239528.1	RPS14P8	11.91	4.24e-18	8.36e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13177951	ENSG00000239528.1	RPS14P8	11.91	4.24e-18	8.36e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13177970	ENSG00000239528.1	RPS14P8	11.91	4.24e-18	8.36e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13164105	ENSG00000239528.1	RPS14P8	11.91	4.24e-18	8.36e-10	1.04	0.83	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr5:116562562~116562930:+
READ	trans	rs7949030	0.62	rs2428551	ENSG00000186676.3	EEF1GP1	11.89	4.6e-18	8.75e-10	1.09	0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62562286	chr7:125033453~125035301:+
READ	trans	rs7949030	0.688	rs11231155	ENSG00000186676.3	EEF1GP1	11.89	4.6e-18	8.75e-10	1.09	0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62598147	chr7:125033453~125035301:+
READ	trans	rs7949030	0.653	rs2516634	ENSG00000186676.3	EEF1GP1	-11.89	4.6e-18	8.75e-10	-1.09	-0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62599714	chr7:125033453~125035301:+
READ	trans	rs7949030	0.653	rs17773169	ENSG00000186676.3	EEF1GP1	11.88	4.7e-18	8.89e-10	1.08	0.83	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62551058	chr7:125033453~125035301:+
READ	trans	rs6477998	0.58	rs4979233	ENSG00000238072.1	RP11-305M3.2	11.69	9.88e-18	1.67e-09	1.07	0.82	Hematology traits;	chr9:113295501	chr7:129410113~129410370:-
READ	trans	rs13177918	0.677	rs3857421	ENSG00000239528.1	RPS14P8	-11.63	1.23e-17	2.04e-09	-1.02	-0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr5:116562562~116562930:+
READ	trans	rs13177918	0.686	rs12654827	ENSG00000239528.1	RPS14P8	11.57	1.57e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13160685	ENSG00000239528.1	RPS14P8	11.57	1.57e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13161099	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr5:116562562~116562930:+
READ	trans	rs13177918	0.629	rs13161261	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13161417	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13161156	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs13181401	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs4541646	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs3900644	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs2070844	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr5:116562562~116562930:+
READ	trans	rs13177918	0.677	rs2073472	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr5:116562562~116562930:+
READ	trans	rs13177918	0.629	rs2070842	ENSG00000239528.1	RPS14P8	11.56	1.61e-17	2.13e-09	1.02	0.82	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr5:116562562~116562930:+
READ	trans	rs1816752	0.905	rs4769348	ENSG00000237917.1	PARP4P1	11.53	1.81e-17	2.13e-09	1.11	0.82	Obesity-related traits;	chr13:24400975	chrY:26594851~26634652:-
READ	trans	rs1816752	0.905	rs8002309	ENSG00000237917.1	PARP4P1	11.53	1.81e-17	2.13e-09	1.11	0.82	Obesity-related traits;	chr13:24402217	chrY:26594851~26634652:-
READ	trans	rs7554547	0.667	rs4846072	ENSG00000261819.1	RP11-680G24.4	11.52	1.91e-17	2.22e-09	0.95	0.82	Nonsyndromic cleft lip with cleft palate;	chr1:11890334	chr16:14988259~14990160:-
READ	trans	rs7554547	0.739	rs7518827	ENSG00000261819.1	RP11-680G24.4	11.51	1.95e-17	2.26e-09	0.95	0.82	Nonsyndromic cleft lip with cleft palate;	chr1:11916688	chr16:14988259~14990160:-
READ	trans	rs7554547	0.668	rs2038028	ENSG00000261819.1	RP11-680G24.4	11.51	1.95e-17	2.26e-09	0.95	0.82	Nonsyndromic cleft lip with cleft palate;	chr1:11919499	chr16:14988259~14990160:-
READ	trans	rs1816752	0.875	rs8001187	ENSG00000237917.1	PARP4P1	11.48	2.18e-17	2.44e-09	1.1	0.82	Obesity-related traits;	chr13:24402276	chrY:26594851~26634652:-
READ	trans	rs1816752	0.783	rs9507333	ENSG00000237917.1	PARP4P1	11.48	2.18e-17	2.44e-09	1.1	0.82	Obesity-related traits;	chr13:24404172	chrY:26594851~26634652:-
READ	trans	rs6477998	0.557	rs11789755	ENSG00000238072.1	RP11-305M3.2	11.48	2.2e-17	2.46e-09	1.06	0.82	Hematology traits;	chr9:113292796	chr7:129410113~129410370:-
READ	trans	rs1816752	0.905	rs3818938	ENSG00000237917.1	PARP4P1	11.39	3.16e-17	3.21e-09	1.03	0.81	Obesity-related traits;	chr13:24454945	chrY:26594851~26634652:-
READ	trans	rs7554547	0.63	rs4845889	ENSG00000261819.1	RP11-680G24.4	11.32	4.15e-17	4.04e-09	0.95	0.81	Nonsyndromic cleft lip with cleft palate;	chr1:11911288	chr16:14988259~14990160:-
READ	trans	rs7554547	0.667	rs7525521	ENSG00000261819.1	RP11-680G24.4	11.32	4.15e-17	4.04e-09	0.95	0.81	Nonsyndromic cleft lip with cleft palate;	chr1:11915109	chr16:14988259~14990160:-
READ	trans	rs6477998	0.58	rs11552582	ENSG00000238072.1	RP11-305M3.2	11.29	4.64e-17	4.5e-09	1.04	0.81	Hematology traits;	chr9:113282718	chr7:129410113~129410370:-
READ	trans	rs7554547	0.667	rs2336377	ENSG00000261819.1	RP11-680G24.4	-11.27	4.95e-17	4.78e-09	-0.95	-0.81	Nonsyndromic cleft lip with cleft palate;	chr1:11889913	chr16:14988259~14990160:-
READ	trans	rs12709013	0.591	rs30841	ENSG00000230849.2	GOT2P2	11.23	5.77e-17	5.41e-09	1.06	0.81	Blood metabolite ratios;	chr16:58709819	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs30840	ENSG00000230849.2	GOT2P2	11.23	5.77e-17	5.41e-09	1.06	0.81	Blood metabolite ratios;	chr16:58710165	chr1:173141100~173142350:-
READ	trans	rs1816752	1	rs1816752	ENSG00000237917.1	PARP4P1	11.21	6.39e-17	5.93e-09	1.06	0.81	Obesity-related traits;	chr13:24406811	chrY:26594851~26634652:-
READ	trans	rs12709013	0.597	rs1657171	ENSG00000230849.2	GOT2P2	11.17	7.48e-17	6.82e-09	1.08	0.81	Blood metabolite ratios;	chr16:58752083	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646284	ENSG00000230849.2	GOT2P2	11.17	7.48e-17	6.82e-09	1.08	0.81	Blood metabolite ratios;	chr16:58752093	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646285	ENSG00000230849.2	GOT2P2	11.17	7.48e-17	6.82e-09	1.08	0.81	Blood metabolite ratios;	chr16:58752102	chr1:173141100~173142350:-
READ	trans	rs13177918	0.677	rs57890152	ENSG00000239528.1	RPS14P8	11.16	7.53e-17	6.85e-09	1.03	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr5:116562562~116562930:+
READ	trans	rs12709013	0.591	rs149479	ENSG00000230849.2	GOT2P2	-11.16	7.56e-17	6.86e-09	-1.06	-0.81	Blood metabolite ratios;	chr16:58703171	chr1:173141100~173142350:-
READ	trans	rs12709013	0.646	rs8046154	ENSG00000230849.2	GOT2P2	-11.13	8.47e-17	7.57e-09	-1.06	-0.81	Blood metabolite ratios;	chr16:58773978	chr1:173141100~173142350:-
READ	trans	rs12709013	0.551	rs154435	ENSG00000230849.2	GOT2P2	-11.12	9.13e-17	8.08e-09	-1.1	-0.81	Blood metabolite ratios;	chr16:58702746	chr1:173141100~173142350:-
READ	trans	rs7554547	0.756	rs6684539	ENSG00000261819.1	RP11-680G24.4	11.09	9.92e-17	8.46e-09	0.94	0.81	Nonsyndromic cleft lip with cleft palate;	chr1:11908216	chr16:14988259~14990160:-
READ	trans	rs7554547	0.765	rs6541010	ENSG00000261819.1	RP11-680G24.4	11.09	9.92e-17	8.46e-09	0.94	0.81	Nonsyndromic cleft lip with cleft palate;	chr1:11913785	chr16:14988259~14990160:-
READ	trans	rs928391	0.681	rs9427242	ENSG00000227183.3	HDGFP1	-11.08	1.06e-16	8.85e-09	-1.02	-0.81	Platelet count;	chr1:156755209	chrX:131646639~131646890:+
READ	trans	rs13177918	0.559	rs10447224	ENSG00000224114.1	RP11-343H5.4	11.07	1.11e-16	8.85e-09	1	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454802	chr1:206695837~206696269:-
READ	trans	rs13177918	0.559	rs10447225	ENSG00000224114.1	RP11-343H5.4	11.07	1.11e-16	8.85e-09	1	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454891	chr1:206695837~206696269:-
READ	trans	rs12709013	0.536	rs1646260	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58734951	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs1657178	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58735300	chr1:173141100~173142350:-
READ	trans	rs12709013	0.585	rs7188608	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58736236	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1657176	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58736833	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs4238801	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58738275	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs4575523	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58738559	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646282	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58741296	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs4784977	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58742120	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646269	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58743412	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs4538000	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58744506	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646272	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58746508	chr1:173141100~173142350:-
READ	trans	rs12709013	0.66	rs1657163	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58746688	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs72792430	ENSG00000230849.2	GOT2P2	-11.05	1.18e-16	8.85e-09	-1.08	-0.81	Blood metabolite ratios;	chr16:58746990	chr1:173141100~173142350:-
READ	trans	rs12709013	0.597	rs1616072	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58747194	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs2575374	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58747494	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1657164	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58747949	chr1:173141100~173142350:-
READ	trans	rs12709013	0.537	rs1657167	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58748955	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs8054414	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58749772	chr1:173141100~173142350:-
READ	trans	rs12709013	0.597	rs11076259	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58749860	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs12325516	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58749899	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs11076260	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58749942	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646278	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58750084	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646279	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58750235	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646280	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58750420	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1646281	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58750512	chr1:173141100~173142350:-
READ	trans	rs12709013	0.597	rs1646286	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58752651	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1624301	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58753491	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1626006	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58753691	chr1:173141100~173142350:-
READ	trans	rs12709013	0.684	rs1646287	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58753774	chr1:173141100~173142350:-
READ	trans	rs12709013	0.671	rs1369933	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58753927	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1369934	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58754124	chr1:173141100~173142350:-
READ	trans	rs12709013	0.561	rs1657174	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58755139	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs1646288	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58755576	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs1618602	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58756080	chr1:173141100~173142350:-
READ	trans	rs12709013	0.561	rs727484	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58756568	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs8049462	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58757654	chr1:173141100~173142350:-
READ	trans	rs12709013	0.66	rs257629	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58758044	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs257628	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58758924	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs257627	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58758956	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs191783	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58759994	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs257624	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58760994	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs8045466	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58765113	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs8060717	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58765574	chr1:173141100~173142350:-
READ	trans	rs12709013	0.559	rs8060721	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58765581	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs8044542	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58765620	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1865836	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58768143	chr1:173141100~173142350:-
READ	trans	rs12709013	0.621	rs6499974	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58769642	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs4499224	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58770364	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs1595180	ENSG00000230849.2	GOT2P2	11.05	1.18e-16	8.85e-09	1.08	0.81	Blood metabolite ratios;	chr16:58770545	chr1:173141100~173142350:-
READ	trans	rs12709013	0.601	rs2432621	ENSG00000230849.2	GOT2P2	11.03	1.26e-16	9.34e-09	1.1	0.81	Blood metabolite ratios;	chr16:58749676	chr1:173141100~173142350:-
READ	trans	rs12709013	0.576	rs2432622	ENSG00000230849.2	GOT2P2	11.03	1.26e-16	9.34e-09	1.1	0.81	Blood metabolite ratios;	chr16:58749681	chr1:173141100~173142350:-
READ	trans	rs13177918	0.75	rs58256223	ENSG00000239528.1	RPS14P8	11.03	1.27e-16	9.37e-09	1.01	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr5:116562562~116562930:+
READ	trans	rs13177918	0.75	rs59354956	ENSG00000239528.1	RPS14P8	11.03	1.27e-16	9.37e-09	1.01	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr5:116562562~116562930:+
READ	trans	rs12709013	0.636	rs1646268	ENSG00000230849.2	GOT2P2	11.02	1.31e-16	9.59e-09	1.07	0.8	Blood metabolite ratios;	chr16:58743292	chr1:173141100~173142350:-
READ	trans	rs12709013	0.597	rs8051078	ENSG00000230849.2	GOT2P2	11.02	1.31e-16	9.59e-09	1.07	0.8	Blood metabolite ratios;	chr16:58774200	chr1:173141100~173142350:-
READ	trans	rs12709013	0.574	rs839418	ENSG00000230849.2	GOT2P2	10.99	1.51e-16	1.1e-08	1.05	0.8	Blood metabolite ratios;	chr16:58705426	chr1:173141100~173142350:-
READ	trans	rs1816752	0.669	rs7984513	ENSG00000237917.1	PARP4P1	-10.98	1.53e-16	1.11e-08	-1.08	-0.8	Obesity-related traits;	chr13:24445117	chrY:26594851~26634652:-
READ	trans	rs12709013	0.636	rs10852565	ENSG00000230849.2	GOT2P2	10.98	1.53e-16	1.11e-08	1.09	0.8	Blood metabolite ratios;	chr16:58771277	chr1:173141100~173142350:-
READ	trans	rs6477998	0.58	rs3750533	ENSG00000238072.1	RP11-305M3.2	10.95	1.74e-16	1.24e-08	1.03	0.8	Hematology traits;	chr9:113297941	chr7:129410113~129410370:-
READ	trans	rs12709013	0.636	rs1657161	ENSG00000230849.2	GOT2P2	10.93	1.85e-16	1.32e-08	1.08	0.8	Blood metabolite ratios;	chr16:58743234	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs9937713	ENSG00000230849.2	GOT2P2	10.86	2.52e-16	1.71e-08	1.07	0.8	Blood metabolite ratios;	chr16:58771921	chr1:173141100~173142350:-
READ	trans	rs13177918	0.677	rs3797622	ENSG00000224114.1	RP11-343H5.4	10.83	2.82e-16	1.9e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13171800	ENSG00000224114.1	RP11-343H5.4	10.81	2.97e-16	1.98e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs2070841	ENSG00000224114.1	RP11-343H5.4	10.81	2.97e-16	1.98e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13177951	ENSG00000224114.1	RP11-343H5.4	10.81	2.97e-16	1.98e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13177970	ENSG00000224114.1	RP11-343H5.4	10.81	2.97e-16	1.98e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13164105	ENSG00000224114.1	RP11-343H5.4	10.81	2.97e-16	1.98e-08	1.04	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr1:206695837~206696269:-
READ	trans	rs12291225	0.546	rs12795545	ENSG00000236360.2	RP11-334A14.2	10.79	3.24e-16	2.14e-08	0.99	0.8	Sense of smell;	chr11:14334018	chr1:52993201~52993702:-
READ	trans	rs12709013	0.636	rs6499976	ENSG00000230849.2	GOT2P2	10.79	3.32e-16	2.19e-08	1.04	0.8	Blood metabolite ratios;	chr16:58770330	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs30838	ENSG00000230849.2	GOT2P2	10.61	6.63e-16	4.16e-08	1.08	0.79	Blood metabolite ratios;	chr16:58711513	chr1:173141100~173142350:-
READ	trans	rs12709013	0.569	rs30837	ENSG00000230849.2	GOT2P2	10.61	6.63e-16	4.16e-08	1.08	0.79	Blood metabolite ratios;	chr16:58711942	chr1:173141100~173142350:-
READ	trans	rs7949030	0.596	rs11231137	ENSG00000186676.3	EEF1GP1	10.6	6.95e-16	4.35e-08	1.21	0.79	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62548227	chr7:125033453~125035301:+
READ	trans	rs13177918	0.677	rs4841	ENSG00000224114.1	RP11-343H5.4	10.59	7.05e-16	4.4e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13183077	ENSG00000224114.1	RP11-343H5.4	10.59	7.05e-16	4.4e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs3857421	ENSG00000224114.1	RP11-343H5.4	-10.48	1.1e-15	6.64e-08	-1.01	-0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr1:206695837~206696269:-
READ	trans	rs7554547	0.526	rs4846078	ENSG00000261819.1	RP11-680G24.4	10.48	1.13e-15	6.8e-08	0.91	0.79	Nonsyndromic cleft lip with cleft palate;	chr1:11907299	chr16:14988259~14990160:-
READ	trans	rs13177918	0.557	rs12520101	ENSG00000224114.1	RP11-343H5.4	10.47	1.14e-15	6.87e-08	0.99	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150431360	chr1:206695837~206696269:-
READ	trans	rs7943191	0.81	rs7942991	ENSG00000186676.3	EEF1GP1	-10.46	1.18e-15	7.11e-08	-1.17	-0.79	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);Waist-to-hip ratio adjusted for body mass index;	chr11:62569731	chr7:125033453~125035301:+
READ	trans	rs941207	0.789	rs2958145	ENSG00000121089.4	NACA3P	-10.45	1.25e-15	7.48e-08	-1.03	-0.79	Platelet count;	chr12:56662290	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs2958153	ENSG00000121089.4	NACA3P	10.45	1.25e-15	7.48e-08	1.03	0.79	Platelet count;	chr12:56687733	chr4:164943290~164943937:+
READ	trans	rs12709013	0.591	rs30834	ENSG00000230849.2	GOT2P2	10.44	1.29e-15	7.68e-08	1.08	0.79	Blood metabolite ratios;	chr16:58715394	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs30842	ENSG00000230849.2	GOT2P2	-10.44	1.3e-15	7.72e-08	-1.03	-0.79	Blood metabolite ratios;	chr16:58709550	chr1:173141100~173142350:-
READ	trans	rs7121616	0.563	rs1461494	ENSG00000234176.1	HSPA8P1	10.44	1.32e-15	7.84e-08	0.93	0.79	Breast cancer;	chr11:123055777	chrX:121203182~121205014:-
READ	trans	rs7949030	0.523	rs12223627	ENSG00000186676.3	EEF1GP1	10.43	1.38e-15	8.14e-08	1.2	0.79	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62601085	chr7:125033453~125035301:+
READ	trans	rs7943191	0.805	rs12226821	ENSG00000186676.3	EEF1GP1	10.43	1.38e-15	8.14e-08	1.2	0.79	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);Waist-to-hip ratio adjusted for body mass index;	chr11:62601546	chr7:125033453~125035301:+
READ	trans	rs13177918	0.677	rs13161099	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr1:206695837~206696269:-
READ	trans	rs13177918	0.629	rs13161261	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13161417	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13161156	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13181401	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs4541646	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs3900644	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs2070844	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs2073472	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr1:206695837~206696269:-
READ	trans	rs13177918	0.629	rs2070842	ENSG00000224114.1	RP11-343H5.4	10.37	1.7e-15	9.74e-08	1.02	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr1:206695837~206696269:-
READ	trans	rs13177918	0.626	rs12186649	ENSG00000239528.1	RPS14P8	10.35	1.88e-15	1.08e-07	1	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr5:116562562~116562930:+
READ	trans	rs13177918	0.559	rs12109637	ENSG00000224114.1	RP11-343H5.4	10.34	1.93e-15	1.1e-07	0.99	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150455155	chr1:206695837~206696269:-
READ	trans	rs13177918	0.75	rs58256223	ENSG00000224114.1	RP11-343H5.4	10.27	2.55e-15	1.44e-07	1.01	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr1:206695837~206696269:-
READ	trans	rs13177918	0.75	rs59354956	ENSG00000224114.1	RP11-343H5.4	10.27	2.55e-15	1.44e-07	1.01	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr1:206695837~206696269:-
READ	trans	rs941207	0.756	rs7978685	ENSG00000121089.4	NACA3P	10.24	2.91e-15	1.63e-07	1.01	0.78	Platelet count;	chr12:56709370	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs2958149	ENSG00000121089.4	NACA3P	10.24	2.91e-15	1.63e-07	1.01	0.78	Platelet count;	chr12:56716008	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs2926743	ENSG00000121089.4	NACA3P	10.24	2.91e-15	1.63e-07	1.01	0.78	Platelet count;	chr12:56720316	chr4:164943290~164943937:+
READ	trans	rs941207	0.724	rs1979325	ENSG00000121089.4	NACA3P	10.24	2.91e-15	1.63e-07	1.01	0.78	Platelet count;	chr12:56728152	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs1465081	ENSG00000121089.4	NACA3P	-10.24	2.91e-15	1.63e-07	-1.01	-0.78	Platelet count;	chr12:56656390	chr4:164943290~164943937:+
READ	trans	rs941207	0.724	rs4788	ENSG00000121089.4	NACA3P	10.23	2.96e-15	1.65e-07	1	0.78	Platelet count;	chr12:56712876	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs10876915	ENSG00000121089.4	NACA3P	-10.23	2.96e-15	1.65e-07	-1	-0.78	Platelet count;	chr12:56655280	chr4:164943290~164943937:+
READ	trans	rs7121616	0.563	rs4936770	ENSG00000234176.1	HSPA8P1	10.23	3.01e-15	1.67e-07	0.9	0.78	Breast cancer;	chr11:123058167	chrX:121203182~121205014:-
READ	trans	rs7121616	0.576	rs4802	ENSG00000234176.1	HSPA8P1	10.22	3.09e-15	1.71e-07	0.92	0.78	Breast cancer;	chr11:123057914	chrX:121203182~121205014:-
READ	trans	rs13177918	0.686	rs12654827	ENSG00000224114.1	RP11-343H5.4	10.19	3.47e-15	1.92e-07	1	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13160685	ENSG00000224114.1	RP11-343H5.4	10.19	3.47e-15	1.92e-07	1	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr1:206695837~206696269:-
READ	trans	rs13177918	0.677	rs13171800	ENSG00000213058.3	RP4-765C7.2	10.15	4.11e-15	2.25e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs2070841	ENSG00000213058.3	RP4-765C7.2	10.15	4.11e-15	2.25e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13177951	ENSG00000213058.3	RP4-765C7.2	10.15	4.11e-15	2.25e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13177970	ENSG00000213058.3	RP4-765C7.2	10.15	4.11e-15	2.25e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13164105	ENSG00000213058.3	RP4-765C7.2	10.15	4.11e-15	2.25e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs3797622	ENSG00000213058.3	RP4-765C7.2	10.13	4.48e-15	2.45e-07	0.95	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr1:178411616~178411972:+
READ	trans	rs12291225	0.585	rs34171876	ENSG00000236360.2	RP11-334A14.2	10.1	5.11e-15	2.78e-07	0.97	0.78	Sense of smell;	chr11:14332411	chr1:52993201~52993702:-
READ	trans	rs941207	0.756	rs9634246	ENSG00000121089.4	NACA3P	-10.09	5.33e-15	2.88e-07	-1.01	-0.78	Platelet count;	chr12:56640604	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs2950394	ENSG00000121089.4	NACA3P	-10.09	5.33e-15	2.88e-07	-1.01	-0.78	Platelet count;	chr12:56644548	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs2950388	ENSG00000121089.4	NACA3P	-10.08	5.46e-15	2.94e-07	-1.01	-0.78	Platelet count;	chr12:56639569	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs7315472	ENSG00000121089.4	NACA3P	-10.08	5.46e-15	2.94e-07	-1.01	-0.78	Platelet count;	chr12:56648276	chr4:164943290~164943937:+
READ	trans	rs941207	0.756	rs67046307	ENSG00000121089.4	NACA3P	-10.08	5.46e-15	2.94e-07	-1.01	-0.78	Platelet count;	chr12:56651152	chr4:164943290~164943937:+
READ	trans	rs13253073	0.723	rs7813557	ENSG00000260318.1	COX6CP1	10.07	5.6e-15	3.01e-07	1.29	0.78	Glucose homeostasis traits;	chr8:99878665	chr16:11903923~11904137:-
READ	trans	rs13177918	0.677	rs4841	ENSG00000213058.3	RP4-765C7.2	10.07	5.76e-15	3.09e-07	0.94	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13183077	ENSG00000213058.3	RP4-765C7.2	10.07	5.76e-15	3.09e-07	0.94	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr1:178411616~178411972:+
READ	trans	rs7554547	0.722	rs7554327	ENSG00000261819.1	RP11-680G24.4	10.06	6.03e-15	3.23e-07	0.97	0.78	Nonsyndromic cleft lip with cleft palate;	chr1:11877347	chr16:14988259~14990160:-
READ	trans	rs6708331	0.517	rs6743372	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70125508	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs2028879	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70127505	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs12617812	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70132339	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs7599072	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70132874	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs12992553	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70133130	chr6:3045384~3045800:+
READ	trans	rs6708331	0.54	rs11890701	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70133325	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs11890741	ENSG00000232654.1	FAM136BP	10.03	6.62e-15	3.52e-07	1.07	0.78	Obesity-related traits;	chr2:70133374	chr6:3045384~3045800:+
READ	trans	rs7121616	0.576	rs4936767	ENSG00000234176.1	HSPA8P1	10.03	6.67e-15	3.54e-07	0.91	0.78	Breast cancer;	chr11:123047451	chrX:121203182~121205014:-
READ	trans	rs12709013	0.636	rs1646256	ENSG00000230849.2	GOT2P2	10	7.42e-15	3.92e-07	1.06	0.78	Blood metabolite ratios;	chr16:58712114	chr1:173141100~173142350:-
READ	trans	rs7554547	0.722	rs7545014	ENSG00000261819.1	RP11-680G24.4	9.94	9.57e-15	4.97e-07	0.97	0.77	Nonsyndromic cleft lip with cleft palate;	chr1:11874596	chr16:14988259~14990160:-
READ	trans	rs7121616	0.595	rs7949414	ENSG00000234176.1	HSPA8P1	9.94	9.65e-15	5.01e-07	0.96	0.77	Breast cancer;	chr11:123072787	chrX:121203182~121205014:-
READ	trans	rs941207	1	rs941207	ENSG00000121089.4	NACA3P	-9.93	9.9e-15	5.13e-07	-1.01	-0.77	Platelet count;	chr12:56629500	chr4:164943290~164943937:+
READ	trans	rs13177918	0.75	rs58256223	ENSG00000213058.3	RP4-765C7.2	9.89	1.17e-14	6.02e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr1:178411616~178411972:+
READ	trans	rs13177918	0.75	rs59354956	ENSG00000213058.3	RP4-765C7.2	9.89	1.17e-14	6.02e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr1:178411616~178411972:+
READ	trans	rs12291225	0.585	rs4757250	ENSG00000236360.2	RP11-334A14.2	9.88	1.21e-14	6.19e-07	0.96	0.77	Sense of smell;	chr11:14354137	chr1:52993201~52993702:-
READ	trans	rs7943191	0.81	rs7942154	ENSG00000186676.3	EEF1GP1	9.87	1.25e-14	6.4e-07	1.21	0.77	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);Waist-to-hip ratio adjusted for body mass index;	chr11:62569691	chr7:125033453~125035301:+
READ	trans	rs12291225	0.877	rs2303974	ENSG00000236360.2	RP11-334A14.2	9.87	1.27e-14	6.52e-07	1.04	0.77	Sense of smell;	chr11:14243433	chr1:52993201~52993702:-
READ	trans	rs13177918	0.677	rs13161099	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr1:178411616~178411972:+
READ	trans	rs13177918	0.629	rs13161261	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13161417	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13161156	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13181401	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs4541646	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs3900644	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs2070844	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs2073472	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr1:178411616~178411972:+
READ	trans	rs13177918	0.629	rs2070842	ENSG00000213058.3	RP4-765C7.2	9.85	1.36e-14	6.84e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs57890152	ENSG00000224114.1	RP11-343H5.4	9.85	1.4e-14	7.03e-07	1.01	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr1:206695837~206696269:-
READ	trans	rs13177918	0.686	rs12654827	ENSG00000213058.3	RP4-765C7.2	9.85	1.4e-14	7.03e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr1:178411616~178411972:+
READ	trans	rs13177918	0.677	rs13160685	ENSG00000213058.3	RP4-765C7.2	9.85	1.4e-14	7.03e-07	0.93	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr1:178411616~178411972:+
READ	trans	rs12709013	0.66	rs30839	ENSG00000230849.2	GOT2P2	9.83	1.51e-14	7.53e-07	1.01	0.77	Blood metabolite ratios;	chr16:58711437	chr1:173141100~173142350:-
READ	trans	rs12709013	0.636	rs30835	ENSG00000230849.2	GOT2P2	9.83	1.51e-14	7.53e-07	1.01	0.77	Blood metabolite ratios;	chr16:58714117	chr1:173141100~173142350:-
READ	trans	rs6708331	0.517	rs7579922	ENSG00000232654.1	FAM136BP	9.82	1.59e-14	7.84e-07	1.07	0.77	Obesity-related traits;	chr2:70134781	chr6:3045384~3045800:+
READ	trans	rs6708331	0.54	rs28623550	ENSG00000232654.1	FAM136BP	9.82	1.59e-14	7.84e-07	1.07	0.77	Obesity-related traits;	chr2:70139260	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs12999042	ENSG00000232654.1	FAM136BP	9.82	1.59e-14	7.84e-07	1.07	0.77	Obesity-related traits;	chr2:70139679	chr6:3045384~3045800:+
READ	trans	rs7121616	0.562	rs2061602	ENSG00000234176.1	HSPA8P1	9.75	2.07e-14	1.01e-06	0.9	0.77	Breast cancer;	chr11:123065079	chrX:121203182~121205014:-
READ	trans	rs7121616	0.562	rs7131452	ENSG00000234176.1	HSPA8P1	9.75	2.07e-14	1.01e-06	0.9	0.77	Breast cancer;	chr11:123065314	chrX:121203182~121205014:-
READ	trans	rs12709013	0.591	rs6499980	ENSG00000230849.2	GOT2P2	9.73	2.25e-14	1.09e-06	1.01	0.77	Blood metabolite ratios;	chr16:58787972	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs899375	ENSG00000230849.2	GOT2P2	9.73	2.25e-14	1.09e-06	1.01	0.77	Blood metabolite ratios;	chr16:58792325	chr1:173141100~173142350:-
READ	trans	rs7554547	0.778	rs2008113	ENSG00000261819.1	RP11-680G24.4	-9.72	2.36e-14	1.14e-06	-0.93	-0.77	Nonsyndromic cleft lip with cleft palate;	chr1:11878809	chr16:14988259~14990160:-
READ	trans	rs13177918	0.557	rs12520101	ENSG00000213058.3	RP4-765C7.2	9.72	2.36e-14	1.14e-06	0.91	0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150431360	chr1:178411616~178411972:+
READ	trans	rs13253073	0.723	rs12548344	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99868676	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs4510829	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99878982	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs1135382	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99879402	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs7812991	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99884095	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs12548840	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99885580	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs1130569	ENSG00000260318.1	COX6CP1	9.71	2.47e-14	1.18e-06	1.27	0.77	Glucose homeostasis traits;	chr8:99887565	chr16:11903923~11904137:-
READ	trans	rs1816752	0.74	rs6490924	ENSG00000237917.1	PARP4P1	-9.65	3.08e-14	1.45e-06	-1	-0.77	Obesity-related traits;	chr13:24432914	chrY:26594851~26634652:-
READ	trans	rs12291225	0.546	rs12291662	ENSG00000236360.2	RP11-334A14.2	9.64	3.17e-14	1.48e-06	0.94	0.76	Sense of smell;	chr11:14321403	chr1:52993201~52993702:-
READ	trans	rs12291225	0.545	rs11023187	ENSG00000236360.2	RP11-334A14.2	9.64	3.17e-14	1.48e-06	0.94	0.76	Sense of smell;	chr11:14324013	chr1:52993201~52993702:-
READ	trans	rs12291225	0.585	rs11023194	ENSG00000236360.2	RP11-334A14.2	9.64	3.17e-14	1.48e-06	0.94	0.76	Sense of smell;	chr11:14348223	chr1:52993201~52993702:-
READ	trans	rs12291225	0.585	rs12270374	ENSG00000236360.2	RP11-334A14.2	9.64	3.17e-14	1.48e-06	0.94	0.76	Sense of smell;	chr11:14353533	chr1:52993201~52993702:-
READ	trans	rs13253073	0.723	rs13274441	ENSG00000260318.1	COX6CP1	9.64	3.27e-14	1.53e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99861038	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs62534626	ENSG00000260318.1	COX6CP1	9.64	3.27e-14	1.53e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99866119	chr16:11903923~11904137:-
READ	trans	rs13253073	0.76	rs62534633	ENSG00000260318.1	COX6CP1	9.63	3.32e-14	1.55e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99884533	chr16:11903923~11904137:-
READ	trans	rs12709013	0.635	rs6993	ENSG00000230849.2	GOT2P2	9.62	3.5e-14	1.63e-06	0.99	0.76	Blood metabolite ratios;	chr16:58707463	chr1:173141100~173142350:-
READ	trans	rs12291225	0.585	rs11023197	ENSG00000236360.2	RP11-334A14.2	9.62	3.53e-14	1.64e-06	0.94	0.76	Sense of smell;	chr11:14359452	chr1:52993201~52993702:-
READ	trans	rs12709013	0.514	rs8062639	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58800264	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs4410065	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58800968	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs2406234	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58801840	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs2086206	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58802094	chr1:173141100~173142350:-
READ	trans	rs12709013	0.591	rs4784986	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58803007	chr1:173141100~173142350:-
READ	trans	rs12709013	0.536	rs9930758	ENSG00000230849.2	GOT2P2	9.62	3.53e-14	1.64e-06	1	0.76	Blood metabolite ratios;	chr16:58803167	chr1:173141100~173142350:-
READ	trans	rs13177918	0.677	rs3857421	ENSG00000213058.3	RP4-765C7.2	-9.61	3.58e-14	1.66e-06	-0.92	-0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr1:178411616~178411972:+
READ	trans	rs5022636	0.594	rs7489	ENSG00000180764.13	PIPSL	9.59	4.02e-14	1.85e-06	1.16	0.76	Gut microbiota (functional units);	chr1:151266575	chr10:93958191~93961540:-
READ	trans	rs12291225	0.877	rs11023160	ENSG00000236360.2	RP11-334A14.2	9.58	4.07e-14	1.88e-06	1.03	0.76	Sense of smell;	chr11:14242679	chr1:52993201~52993702:-
READ	trans	rs13177918	0.626	rs12186649	ENSG00000224114.1	RP11-343H5.4	9.58	4.1e-14	1.89e-06	1	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr1:206695837~206696269:-
READ	trans	rs6708331	0.517	rs11692018	ENSG00000232654.1	FAM136BP	9.53	5.01e-14	2.28e-06	1.05	0.76	Obesity-related traits;	chr2:70142022	chr6:3045384~3045800:+
READ	trans	rs12291225	0.585	rs10832246	ENSG00000236360.2	RP11-334A14.2	9.53	5.02e-14	2.28e-06	0.93	0.76	Sense of smell;	chr11:14359282	chr1:52993201~52993702:-
READ	trans	rs12291225	0.585	rs4517475	ENSG00000236360.2	RP11-334A14.2	9.53	5.02e-14	2.28e-06	0.93	0.76	Sense of smell;	chr11:14364599	chr1:52993201~52993702:-
READ	trans	rs12291225	0.546	rs11023199	ENSG00000236360.2	RP11-334A14.2	9.53	5.02e-14	2.28e-06	0.93	0.76	Sense of smell;	chr11:14372712	chr1:52993201~52993702:-
READ	trans	rs13253073	0.723	rs7157	ENSG00000260318.1	COX6CP1	9.52	5.13e-14	2.32e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99877449	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs12548542	ENSG00000260318.1	COX6CP1	9.52	5.13e-14	2.32e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99890167	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs7840626	ENSG00000260318.1	COX6CP1	9.52	5.16e-14	2.34e-06	1.27	0.76	Glucose homeostasis traits;	chr8:99867598	chr16:11903923~11904137:-
READ	trans	rs13177918	0.677	rs57890152	ENSG00000213058.3	RP4-765C7.2	9.51	5.45e-14	2.46e-06	0.93	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr1:178411616~178411972:+
READ	trans	rs13253073	0.723	rs7831963	ENSG00000260318.1	COX6CP1	9.49	5.96e-14	2.69e-06	1.26	0.76	Glucose homeostasis traits;	chr8:99853014	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs7832488	ENSG00000260318.1	COX6CP1	9.49	5.96e-14	2.69e-06	1.26	0.76	Glucose homeostasis traits;	chr8:99853185	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs6468695	ENSG00000260318.1	COX6CP1	9.49	5.96e-14	2.69e-06	1.26	0.76	Glucose homeostasis traits;	chr8:99857123	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs6468696	ENSG00000260318.1	COX6CP1	9.49	5.96e-14	2.69e-06	1.26	0.76	Glucose homeostasis traits;	chr8:99857130	chr16:11903923~11904137:-
READ	trans	rs12709013	0.636	rs967852	ENSG00000230849.2	GOT2P2	9.49	6.02e-14	2.71e-06	1.03	0.76	Blood metabolite ratios;	chr16:58807313	chr1:173141100~173142350:-
READ	trans	rs12709013	0.613	rs6499984	ENSG00000230849.2	GOT2P2	9.49	6.02e-14	2.71e-06	1.03	0.76	Blood metabolite ratios;	chr16:58810209	chr1:173141100~173142350:-
READ	trans	rs7554547	1	rs926270	ENSG00000261819.1	RP11-680G24.4	9.46	6.64e-14	2.94e-06	0.96	0.76	Nonsyndromic cleft lip with cleft palate;	chr1:11909729	chr16:14988259~14990160:-
READ	trans	rs7554547	1	rs926271	ENSG00000261819.1	RP11-680G24.4	9.46	6.64e-14	2.94e-06	0.96	0.76	Nonsyndromic cleft lip with cleft palate;	chr1:11909860	chr16:14988259~14990160:-
READ	trans	rs7554547	0.967	rs4845888	ENSG00000261819.1	RP11-680G24.4	9.46	6.64e-14	2.94e-06	0.96	0.76	Nonsyndromic cleft lip with cleft palate;	chr1:11910946	chr16:14988259~14990160:-
READ	trans	rs7554547	1	rs7554547	ENSG00000261819.1	RP11-680G24.4	9.46	6.64e-14	2.94e-06	0.96	0.76	Nonsyndromic cleft lip with cleft palate;	chr1:11913831	chr16:14988259~14990160:-
READ	trans	rs7554547	1	rs2336378	ENSG00000261819.1	RP11-680G24.4	9.46	6.64e-14	2.94e-06	0.96	0.76	Nonsyndromic cleft lip with cleft palate;	chr1:11915626	chr16:14988259~14990160:-
READ	trans	rs12291225	0.585	rs10832242	ENSG00000236360.2	RP11-334A14.2	-9.46	6.81e-14	3.01e-06	-0.92	-0.76	Sense of smell;	chr11:14318958	chr1:52993201~52993702:-
READ	trans	rs1816752	0.583	rs6490918	ENSG00000237917.1	PARP4P1	-9.44	7.27e-14	3.21e-06	-0.98	-0.76	Obesity-related traits;	chr13:24427977	chrY:26594851~26634652:-
READ	trans	rs8081395	0.741	rs1292056	ENSG00000187870.7	RNFT1P3	9.44	7.3e-14	3.21e-06	0.95	0.76	White blood cell count;	chr17:59881686	chr17:20743333~20754501:-
READ	trans	rs13177918	0.559	rs10447224	ENSG00000213058.3	RP4-765C7.2	9.43	7.57e-14	3.33e-06	0.88	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454802	chr1:178411616~178411972:+
READ	trans	rs13177918	0.559	rs10447225	ENSG00000213058.3	RP4-765C7.2	9.43	7.57e-14	3.33e-06	0.88	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454891	chr1:178411616~178411972:+
READ	trans	rs941207	0.855	rs2256341	ENSG00000121089.4	NACA3P	-9.43	7.64e-14	3.35e-06	-0.94	-0.76	Platelet count;	chr12:56599930	chr4:164943290~164943937:+
READ	trans	rs8081395	0.741	rs1292055	ENSG00000187870.7	RNFT1P3	9.42	8.01e-14	3.5e-06	0.95	0.76	White blood cell count;	chr17:59881707	chr17:20743333~20754501:-
READ	trans	rs12709013	0.535	rs9924136	ENSG00000230849.2	GOT2P2	9.41	8.24e-14	3.52e-06	1.05	0.76	Blood metabolite ratios;	chr16:58779573	chr1:173141100~173142350:-
READ	trans	rs12709013	0.574	rs35321124	ENSG00000230849.2	GOT2P2	9.41	8.24e-14	3.52e-06	1.05	0.76	Blood metabolite ratios;	chr16:58786561	chr1:173141100~173142350:-
READ	trans	rs13253073	0.657	rs35135010	ENSG00000260318.1	COX6CP1	9.35	1.05e-13	4.42e-06	1.26	0.75	Glucose homeostasis traits;	chr8:99864209	chr16:11903923~11904137:-
READ	trans	rs1816752	0.875	rs3783076	ENSG00000237917.1	PARP4P1	9.34	1.11e-13	4.61e-06	0.93	0.75	Obesity-related traits;	chr13:24490319	chrY:26594851~26634652:-
READ	trans	rs8081395	0.741	rs1292051	ENSG00000187870.7	RNFT1P3	9.33	1.13e-13	4.71e-06	0.95	0.75	White blood cell count;	chr17:59886562	chr17:20743333~20754501:-
READ	trans	rs3749237	0.595	rs12489092	ENSG00000197582.5	GPX1P1	9.32	1.17e-13	4.85e-06	1.01	0.75	Resting heart rate;	chr3:49513481	chrX:13378735~13379340:-
READ	trans	rs3749237	0.555	rs7637665	ENSG00000197582.5	GPX1P1	9.32	1.17e-13	4.85e-06	1.01	0.75	Resting heart rate;	chr3:49514862	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs3870338	ENSG00000197582.5	GPX1P1	9.32	1.17e-13	4.85e-06	1.01	0.75	Resting heart rate;	chr3:49519618	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs3870337	ENSG00000197582.5	GPX1P1	9.32	1.17e-13	4.85e-06	1.01	0.75	Resting heart rate;	chr3:49519662	chrX:13378735~13379340:-
READ	trans	rs13253073	0.723	rs7828241	ENSG00000260318.1	COX6CP1	9.32	1.17e-13	4.85e-06	1.25	0.75	Glucose homeostasis traits;	chr8:99880417	chr16:11903923~11904137:-
READ	trans	rs3749237	0.595	rs6784820	ENSG00000197582.5	GPX1P1	-9.32	1.17e-13	4.85e-06	-0.99	-0.75	Resting heart rate;	chr3:49413431	chrX:13378735~13379340:-
READ	trans	rs8081395	0.741	rs180532	ENSG00000187870.7	RNFT1P3	9.31	1.23e-13	5.05e-06	0.99	0.75	White blood cell count;	chr17:59925936	chr17:20743333~20754501:-
READ	trans	rs8081395	0.741	rs180530	ENSG00000187870.7	RNFT1P3	9.31	1.23e-13	5.05e-06	0.99	0.75	White blood cell count;	chr17:59926233	chr17:20743333~20754501:-
READ	trans	rs3749237	0.576	rs4241406	ENSG00000197582.5	GPX1P1	9.29	1.33e-13	5.42e-06	1.01	0.75	Resting heart rate;	chr3:49562993	chrX:13378735~13379340:-
READ	trans	rs8081395	0.741	rs180520	ENSG00000187870.7	RNFT1P3	9.28	1.36e-13	5.51e-06	0.98	0.75	White blood cell count;	chr17:59937788	chr17:20743333~20754501:-
READ	trans	rs8081395	0.741	rs180519	ENSG00000187870.7	RNFT1P3	9.28	1.36e-13	5.51e-06	0.98	0.75	White blood cell count;	chr17:59938910	chr17:20743333~20754501:-
READ	trans	rs8081395	0.711	rs11368	ENSG00000187870.7	RNFT1P3	9.28	1.36e-13	5.51e-06	0.98	0.75	White blood cell count;	chr17:59954051	chr17:20743333~20754501:-
READ	trans	rs8081395	0.737	rs4968401	ENSG00000187870.7	RNFT1P3	-9.28	1.36e-13	5.51e-06	-0.98	-0.75	White blood cell count;	chr17:59963369	chr17:20743333~20754501:-
READ	trans	rs2950393	0.895	rs2926740	ENSG00000121089.4	NACA3P	9.28	1.38e-13	5.53e-06	0.87	0.75	Platelet distribution width;	chr12:56666751	chr4:164943290~164943937:+
READ	trans	rs941207	0.526	rs7303216	ENSG00000121089.4	NACA3P	9.28	1.38e-13	5.53e-06	0.87	0.75	Platelet count;	chr12:56680909	chr4:164943290~164943937:+
READ	trans	rs941207	0.507	rs7297289	ENSG00000121089.4	NACA3P	9.28	1.38e-13	5.53e-06	0.87	0.75	Platelet count;	chr12:56682703	chr4:164943290~164943937:+
READ	trans	rs941207	0.526	rs4759028	ENSG00000121089.4	NACA3P	9.28	1.38e-13	5.53e-06	0.87	0.75	Platelet count;	chr12:56686399	chr4:164943290~164943937:+
READ	trans	rs8081395	0.707	rs1024637	ENSG00000187870.7	RNFT1P3	-9.27	1.46e-13	5.84e-06	-0.97	-0.75	White blood cell count;	chr17:59961532	chr17:20743333~20754501:-
READ	trans	rs941207	0.526	rs11171916	ENSG00000121089.4	NACA3P	-9.25	1.59e-13	6.35e-06	-0.87	-0.75	Platelet count;	chr12:56653236	chr4:164943290~164943937:+
READ	trans	rs7554547	0.871	rs11588551	ENSG00000261819.1	RP11-680G24.4	-9.25	1.59e-13	6.35e-06	-0.92	-0.75	Nonsyndromic cleft lip with cleft palate;	chr1:11881879	chr16:14988259~14990160:-
READ	trans	rs8081395	0.741	rs2645462	ENSG00000187870.7	RNFT1P3	9.24	1.61e-13	6.38e-06	0.99	0.75	White blood cell count;	chr17:59906198	chr17:20743333~20754501:-
READ	trans	rs8081395	0.711	rs1292034	ENSG00000187870.7	RNFT1P3	9.24	1.61e-13	6.38e-06	0.99	0.75	White blood cell count;	chr17:59912499	chr17:20743333~20754501:-
READ	trans	rs12709013	0.591	rs9932967	ENSG00000230849.2	GOT2P2	9.2	1.89e-13	7.39e-06	1.02	0.75	Blood metabolite ratios;	chr16:58805583	chr1:173141100~173142350:-
READ	trans	rs3749237	0.537	rs4459909	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49431784	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs11130196	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49452716	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs35701831	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49477567	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs1568661	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49483525	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855864	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49484541	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs11130199	ENSG00000197582.5	GPX1P1	9.17	2.17e-13	8.43e-06	1.01	0.75	Resting heart rate;	chr3:49501366	chrX:13378735~13379340:-
READ	trans	rs4240897	0.935	rs2236055	ENSG00000261819.1	RP11-680G24.4	9.16	2.23e-13	8.65e-06	0.9	0.75	Tuberculosis;	chr1:11982204	chr16:14988259~14990160:-
READ	trans	rs13253073	0.662	rs34513504	ENSG00000260318.1	COX6CP1	9.16	2.27e-13	8.77e-06	1.24	0.75	Glucose homeostasis traits;	chr8:99848918	chr16:11903923~11904137:-
READ	trans	rs3749237	0.595	rs1464566	ENSG00000197582.5	GPX1P1	9.16	2.27e-13	8.78e-06	1	0.75	Resting heart rate;	chr3:49421943	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855839	ENSG00000197582.5	GPX1P1	9.15	2.32e-13	8.96e-06	1	0.75	Resting heart rate;	chr3:49470414	chrX:13378735~13379340:-
READ	trans	rs1816752	0.875	rs59686377	ENSG00000237917.1	PARP4P1	9.13	2.51e-13	9.65e-06	0.96	0.75	Obesity-related traits;	chr13:24475869	chrY:26594851~26634652:-
READ	trans	rs1816752	0.875	rs17384871	ENSG00000237917.1	PARP4P1	9.13	2.51e-13	9.65e-06	0.96	0.75	Obesity-related traits;	chr13:24484959	chrY:26594851~26634652:-
READ	trans	rs7121616	0.595	rs7941144	ENSG00000234176.1	HSPA8P1	9.12	2.62e-13	1.01e-05	0.84	0.75	Breast cancer;	chr11:123079805	chrX:121203182~121205014:-
READ	trans	rs941207	0.805	rs2958139	ENSG00000121089.4	NACA3P	-9.12	2.68e-13	1.03e-05	-0.93	-0.75	Platelet count;	chr12:56610884	chr4:164943290~164943937:+
READ	trans	rs3749237	0.595	rs2878298	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49368647	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs17595772	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49372271	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs7621003	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49373971	chrX:13378735~13379340:-
READ	trans	rs3749237	0.555	rs2117939	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49377746	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4955412	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49380735	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs6797765	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49386543	chrX:13378735~13379340:-
READ	trans	rs3749237	0.557	rs7631908	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49388274	chrX:13378735~13379340:-
READ	trans	rs3749237	0.615	rs55957735	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49400725	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855877	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49411094	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs1464568	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49420833	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855873	ENSG00000197582.5	GPX1P1	9.11	2.8e-13	1.06e-05	0.99	0.75	Resting heart rate;	chr3:49421681	chrX:13378735~13379340:-
READ	trans	rs941207	0.526	rs12229457	ENSG00000121089.4	NACA3P	-9.11	2.82e-13	1.06e-05	-0.87	-0.75	Platelet count;	chr12:56639896	chr4:164943290~164943937:+
READ	trans	rs941207	0.526	rs2950393	ENSG00000121089.4	NACA3P	-9.11	2.82e-13	1.06e-05	-0.87	-0.75	Platelet count;	chr12:56642239	chr4:164943290~164943937:+
READ	trans	rs2950393	0.927	rs11171914	ENSG00000121089.4	NACA3P	-9.11	2.82e-13	1.06e-05	-0.87	-0.75	Platelet distribution width;	chr12:56649462	chr4:164943290~164943937:+
READ	trans	rs5022636	0.564	rs2275900	ENSG00000180764.13	PIPSL	9.09	3.05e-13	1.14e-05	1.12	0.75	Gut microbiota (functional units);	chr1:151265746	chr10:93958191~93961540:-
READ	trans	rs5022636	0.594	rs10888408	ENSG00000180764.13	PIPSL	9.09	3.05e-13	1.14e-05	1.12	0.75	Gut microbiota (functional units);	chr1:151267094	chr10:93958191~93961540:-
READ	trans	rs13253073	0.723	rs34830464	ENSG00000260318.1	COX6CP1	9.07	3.23e-13	1.2e-05	1.25	0.74	Glucose homeostasis traits;	chr8:99866638	chr16:11903923~11904137:-
READ	trans	rs2950393	0.895	rs2958154	ENSG00000121089.4	NACA3P	-9.07	3.27e-13	1.21e-05	-0.86	-0.74	Platelet distribution width;	chr12:56671929	chr4:164943290~164943937:+
READ	trans	rs13253073	0.723	rs7009713	ENSG00000260318.1	COX6CP1	9.07	3.32e-13	1.22e-05	1.24	0.74	Glucose homeostasis traits;	chr8:99869626	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs12546882	ENSG00000260318.1	COX6CP1	9.07	3.32e-13	1.22e-05	1.24	0.74	Glucose homeostasis traits;	chr8:99869919	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs4626565	ENSG00000260318.1	COX6CP1	9.07	3.32e-13	1.22e-05	1.24	0.74	Glucose homeostasis traits;	chr8:99878314	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs35429753	ENSG00000260318.1	COX6CP1	9.07	3.32e-13	1.22e-05	1.24	0.74	Glucose homeostasis traits;	chr8:99891015	chr16:11903923~11904137:-
READ	trans	rs13253073	0.723	rs1130474	ENSG00000260318.1	COX6CP1	9.07	3.32e-13	1.22e-05	1.24	0.74	Glucose homeostasis traits;	chr8:99892049	chr16:11903923~11904137:-
READ	trans	rs8081395	0.775	rs2645482	ENSG00000187870.7	RNFT1P3	9.06	3.39e-13	1.24e-05	0.94	0.74	White blood cell count;	chr17:59865754	chr17:20743333~20754501:-
READ	trans	rs8081395	0.805	rs2645485	ENSG00000187870.7	RNFT1P3	9.06	3.39e-13	1.24e-05	0.94	0.74	White blood cell count;	chr17:59866920	chr17:20743333~20754501:-
READ	trans	rs12709013	0.574	rs9302706	ENSG00000230849.2	GOT2P2	9.06	3.47e-13	1.26e-05	1.06	0.74	Blood metabolite ratios;	chr16:58812060	chr1:173141100~173142350:-
READ	trans	rs13177918	0.603	rs2748241	ENSG00000224114.1	RP11-343H5.4	9.04	3.71e-13	1.34e-05	0.9	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447931	chr1:206695837~206696269:-
READ	trans	rs4240897	0.935	rs4846082	ENSG00000261819.1	RP11-680G24.4	9.03	3.84e-13	1.38e-05	0.91	0.74	Tuberculosis;	chr1:11982386	chr16:14988259~14990160:-
READ	trans	rs4240897	0.835	rs4845891	ENSG00000261819.1	RP11-680G24.4	9.03	3.84e-13	1.38e-05	0.91	0.74	Tuberculosis;	chr1:11982449	chr16:14988259~14990160:-
READ	trans	rs6708331	0.517	rs9989876	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70115578	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs9989836	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70115595	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs10496178	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70115683	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs6546570	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70122901	chr6:3045384~3045800:+
READ	trans	rs6708331	0.517	rs6546572	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70146510	chr6:3045384~3045800:+
READ	trans	rs6708331	0.564	rs4632370	ENSG00000232654.1	FAM136BP	8.95	5.24e-13	1.84e-05	0.99	0.74	Obesity-related traits;	chr2:70149693	chr6:3045384~3045800:+
READ	trans	rs5022636	0.559	rs41302131	ENSG00000180764.13	PIPSL	8.93	5.74e-13	1.94e-05	1.1	0.74	Gut microbiota (functional units);	chr1:151267532	chr10:93958191~93961540:-
READ	trans	rs13253073	0.723	rs7844439	ENSG00000260318.1	COX6CP1	8.93	5.82e-13	1.97e-05	1.15	0.74	Glucose homeostasis traits;	chr8:99878567	chr16:11903923~11904137:-
READ	trans	rs12709013	0.591	rs7184377	ENSG00000230849.2	GOT2P2	8.89	6.85e-13	2.29e-05	1.03	0.74	Blood metabolite ratios;	chr16:58808765	chr1:173141100~173142350:-
READ	trans	rs8081395	0.775	rs2526355	ENSG00000187870.7	RNFT1P3	8.88	6.97e-13	2.32e-05	0.91	0.74	White blood cell count;	chr17:59875872	chr17:20743333~20754501:-
READ	trans	rs1292048	1	rs1292048	ENSG00000187870.7	RNFT1P3	8.88	6.97e-13	2.32e-05	0.91	0.74	Red cell distribution width;	chr17:59877710	chr17:20743333~20754501:-
READ	trans	rs2950393	0.857	rs1563896	ENSG00000121089.4	NACA3P	8.87	7.3e-13	2.39e-05	0.86	0.74	Platelet distribution width;	chr12:56699312	chr4:164943290~164943937:+
READ	trans	rs6708331	0.54	rs6546576	ENSG00000232654.1	FAM136BP	8.87	7.38e-13	2.42e-05	0.98	0.74	Obesity-related traits;	chr2:70174356	chr6:3045384~3045800:+
READ	trans	rs7949030	1	rs10897289	ENSG00000186676.3	EEF1GP1	8.85	8.04e-13	2.59e-05	1.11	0.74	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62632544	chr7:125033453~125035301:+
READ	trans	rs5022636	0.594	rs12048670	ENSG00000180764.13	PIPSL	8.79	1.03e-12	3.31e-05	1.18	0.73	Gut microbiota (functional units);	chr1:151272510	chr10:93958191~93961540:-
READ	trans	rs8081395	0.576	rs1292032	ENSG00000187870.7	RNFT1P3	8.75	1.2e-12	3.78e-05	0.96	0.73	White blood cell count;	chr17:59914982	chr17:20743333~20754501:-
READ	trans	rs3749237	0.595	rs11130192	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49429773	chrX:13378735~13379340:-
READ	trans	rs13096760	1	rs13096760	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Intelligence (multi-trait analysis);	chr3:49439373	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs885592	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49460450	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs10865955	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49462396	chrX:13378735~13379340:-
READ	trans	rs3749237	0.636	rs1568662	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49483830	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs3924462	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49486803	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855861	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49488529	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs4855859	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49488867	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs7643845	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49493278	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs7637999	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49497682	chrX:13378735~13379340:-
READ	trans	rs3749237	0.576	rs3877784	ENSG00000197582.5	GPX1P1	8.75	1.2e-12	3.78e-05	0.98	0.73	Resting heart rate;	chr3:49501984	chrX:13378735~13379340:-
READ	trans	rs3749237	0.615	rs11130202	ENSG00000197582.5	GPX1P1	8.74	1.26e-12	3.96e-05	0.98	0.73	Resting heart rate;	chr3:49529282	chrX:13378735~13379340:-
READ	trans	rs7949030	0.754	rs36104523	ENSG00000186676.3	EEF1GP1	-8.74	1.27e-12	3.97e-05	-1.12	-0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62628268	chr7:125033453~125035301:+
READ	trans	rs7949030	1	rs2956993	ENSG00000186676.3	EEF1GP1	-8.74	1.27e-12	3.97e-05	-1.12	-0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62638690	chr7:125033453~125035301:+
READ	trans	rs6708331	0.517	rs13017427	ENSG00000232654.1	FAM136BP	8.71	1.4e-12	4.35e-05	0.98	0.73	Obesity-related traits;	chr2:70154399	chr6:3045384~3045800:+
READ	trans	rs6708331	0.54	rs9677885	ENSG00000232654.1	FAM136BP	8.71	1.4e-12	4.35e-05	0.98	0.73	Obesity-related traits;	chr2:70154687	chr6:3045384~3045800:+
READ	trans	rs6708331	0.54	rs9679269	ENSG00000232654.1	FAM136BP	8.71	1.4e-12	4.35e-05	0.98	0.73	Obesity-related traits;	chr2:70154696	chr6:3045384~3045800:+
READ	trans	rs55665837	0.524	rs61884009	ENSG00000236360.2	RP11-334A14.2	8.71	1.42e-12	4.38e-05	0.93	0.73	Vitamin D levels;	chr11:14404916	chr1:52993201~52993702:-
READ	trans	rs3749237	0.615	rs6792911	ENSG00000197582.5	GPX1P1	8.7	1.5e-12	4.64e-05	0.97	0.73	Resting heart rate;	chr3:49392423	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs11720264	ENSG00000197582.5	GPX1P1	8.7	1.5e-12	4.64e-05	0.97	0.73	Resting heart rate;	chr3:49542914	chrX:13378735~13379340:-
READ	trans	rs3749237	0.595	rs1050088	ENSG00000197582.5	GPX1P1	-8.7	1.5e-12	4.64e-05	-0.97	-0.73	Resting heart rate;	chr3:49533449	chrX:13378735~13379340:-
READ	trans	rs5022636	0.631	rs6587562	ENSG00000180764.13	PIPSL	-8.69	1.55e-12	4.74e-05	-1.18	-0.73	Gut microbiota (functional units);	chr1:151273765	chr10:93958191~93961540:-
READ	trans	rs12291225	0.535	rs16930126	ENSG00000236360.2	RP11-334A14.2	-8.65	1.8e-12	5.42e-05	-0.92	-0.73	Sense of smell;	chr11:14383437	chr1:52993201~52993702:-
READ	trans	rs55665837	0.559	rs9667144	ENSG00000236360.2	RP11-334A14.2	-8.65	1.8e-12	5.42e-05	-0.92	-0.73	Vitamin D levels;	chr11:14399555	chr1:52993201~52993702:-
READ	trans	rs55665837	0.559	rs11023209	ENSG00000236360.2	RP11-334A14.2	8.65	1.8e-12	5.42e-05	0.92	0.73	Vitamin D levels;	chr11:14401054	chr1:52993201~52993702:-
READ	trans	rs55665837	0.559	rs11023210	ENSG00000236360.2	RP11-334A14.2	-8.65	1.8e-12	5.42e-05	-0.92	-0.73	Vitamin D levels;	chr11:14401216	chr1:52993201~52993702:-
READ	trans	rs7554547	0.871	rs6661289	ENSG00000261819.1	RP11-680G24.4	8.62	2.03e-12	6.04e-05	0.92	0.73	Nonsyndromic cleft lip with cleft palate;	chr1:11882724	chr16:14988259~14990160:-
READ	trans	rs13177918	0.626	rs12186649	ENSG00000213058.3	RP4-765C7.2	8.62	2.03e-12	6.05e-05	0.9	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr1:178411616~178411972:+
READ	trans	rs4240897	0.935	rs3766744	ENSG00000261819.1	RP11-680G24.4	8.61	2.14e-12	6.36e-05	0.88	0.73	Tuberculosis;	chr1:11983660	chr16:14988259~14990160:-
READ	trans	rs7554547	0.838	rs885770	ENSG00000261819.1	RP11-680G24.4	8.61	2.15e-12	6.37e-05	0.92	0.73	Nonsyndromic cleft lip with cleft palate;	chr1:11878699	chr16:14988259~14990160:-
READ	trans	rs13177918	0.559	rs10447224	ENSG00000239528.1	RPS14P8	8.61	2.15e-12	6.38e-05	0.88	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454802	chr5:116562562~116562930:+
READ	trans	rs13177918	0.559	rs10447225	ENSG00000239528.1	RPS14P8	8.61	2.15e-12	6.38e-05	0.88	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150454891	chr5:116562562~116562930:+
READ	trans	rs4240897	0.935	rs1474868	ENSG00000261819.1	RP11-680G24.4	-8.6	2.19e-12	6.49e-05	-0.88	-0.73	Tuberculosis;	chr1:11984107	chr16:14988259~14990160:-
READ	trans	rs12291225	0.535	rs11023203	ENSG00000236360.2	RP11-334A14.2	8.6	2.21e-12	6.52e-05	0.92	0.73	Sense of smell;	chr11:14388269	chr1:52993201~52993702:-
READ	trans	rs55665837	0.583	rs78843135	ENSG00000236360.2	RP11-334A14.2	8.6	2.21e-12	6.52e-05	0.92	0.73	Vitamin D levels;	chr11:14389708	chr1:52993201~52993702:-
READ	trans	rs12291225	0.535	rs10832248	ENSG00000236360.2	RP11-334A14.2	8.6	2.21e-12	6.52e-05	0.92	0.73	Sense of smell;	chr11:14391541	chr1:52993201~52993702:-
READ	trans	rs12291225	0.535	rs12806025	ENSG00000236360.2	RP11-334A14.2	8.6	2.21e-12	6.52e-05	0.92	0.73	Sense of smell;	chr11:14392271	chr1:52993201~52993702:-
READ	trans	rs55665837	0.524	rs2882128	ENSG00000236360.2	RP11-334A14.2	8.6	2.21e-12	6.52e-05	0.92	0.73	Vitamin D levels;	chr11:14393088	chr1:52993201~52993702:-
READ	trans	rs61990749	0.597	rs176946	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77712096	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176952	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77714393	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176955	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77714877	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs2544566	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77715395	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs2544567	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77715396	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs176962	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77719167	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176971	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77725256	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs176979	ENSG00000235400.1	RP4-641G12.4	8.6	2.24e-12	6.54e-05	1.04	0.73	Fibroblast growth factor basic levels;	chr14:77731729	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176980	ENSG00000235400.1	RP4-641G12.4	-8.52	3.08e-12	8.82e-05	-1.04	-0.72	Fibroblast growth factor basic levels;	chr14:77732106	chr1:78749073~78750659:+
READ	trans	rs941207	0.526	rs2255074	ENSG00000121089.4	NACA3P	-8.48	3.6e-12	0.000102	-0.8	-0.72	Platelet count;	chr12:56636242	chr4:164943290~164943937:+
READ	trans	rs9467773	0.62	rs2504567	ENSG00000242375.1	RP11-498P14.3	8.48	3.71e-12	0.000105	1	0.72	Intelligence (multi-trait analysis);	chr6:26662692	chr9:97195351~97197687:-
READ	trans	rs2950393	0.929	rs7973157	ENSG00000121089.4	NACA3P	-8.47	3.83e-12	0.000108	-0.77	-0.72	Platelet distribution width;	chr12:56655409	chr4:164943290~164943937:+
READ	trans	rs3749237	0.576	rs62259939	ENSG00000197582.5	GPX1P1	8.46	3.96e-12	0.000111	0.97	0.72	Resting heart rate;	chr3:49348614	chrX:13378735~13379340:-
READ	trans	rs61990749	0.597	rs9323650	ENSG00000235400.1	RP4-641G12.4	8.46	4.05e-12	0.000114	1.02	0.72	Fibroblast growth factor basic levels;	chr14:77683993	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs28534379	ENSG00000235400.1	RP4-641G12.4	-8.45	4.18e-12	0.000116	-1.05	-0.72	Fibroblast growth factor basic levels;	chr14:77705797	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176943	ENSG00000235400.1	RP4-641G12.4	-8.45	4.18e-12	0.000116	-1.05	-0.72	Fibroblast growth factor basic levels;	chr14:77709454	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs176944	ENSG00000235400.1	RP4-641G12.4	-8.45	4.18e-12	0.000116	-1.05	-0.72	Fibroblast growth factor basic levels;	chr14:77709868	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs12887282	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77734242	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs12887606	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77734277	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs6574391	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77741778	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs8003691	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77744882	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs8003979	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77744947	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs8016416	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77746757	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2032781	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77748532	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2267768	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77749671	chr1:78749073~78750659:+
READ	trans	rs61990749	0.686	rs11159288	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77750629	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs3783980	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77753464	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1549119	ENSG00000235400.1	RP4-641G12.4	8.45	4.18e-12	0.000116	1.05	0.72	Fibroblast growth factor basic levels;	chr14:77753469	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs10142722	ENSG00000235400.1	RP4-641G12.4	8.42	4.75e-12	0.000131	1.04	0.72	Fibroblast growth factor basic levels;	chr14:77809206	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs117131659	ENSG00000235400.1	RP4-641G12.4	-8.39	5.34e-12	0.000146	-1.04	-0.72	Fibroblast growth factor basic levels;	chr14:77664783	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs9788540	ENSG00000235400.1	RP4-641G12.4	-8.39	5.34e-12	0.000146	-1.04	-0.72	Fibroblast growth factor basic levels;	chr14:77665829	chr1:78749073~78750659:+
READ	trans	rs2950393	0.857	rs9989034	ENSG00000121089.4	NACA3P	8.38	5.43e-12	0.000148	0.76	0.72	Platelet distribution width;	chr12:56674508	chr4:164943290~164943937:+
READ	trans	rs2950393	0.929	rs2290893	ENSG00000121089.4	NACA3P	8.38	5.43e-12	0.000148	0.76	0.72	Platelet distribution width;	chr12:56684836	chr4:164943290~164943937:+
READ	trans	rs7949030	1	rs7949030	ENSG00000186676.3	EEF1GP1	8.35	6.24e-12	0.000169	1.1	0.72	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62627409	chr7:125033453~125035301:+
READ	trans	rs8081395	0.741	rs1292053	ENSG00000187870.7	RNFT1P3	-8.35	6.39e-12	0.000173	-0.93	-0.72	White blood cell count;	chr17:59886176	chr17:20743333~20754501:-
READ	trans	rs941207	0.507	rs1107479	ENSG00000121089.4	NACA3P	-8.34	6.43e-12	0.000174	-0.79	-0.72	Platelet count;	chr12:56636902	chr4:164943290~164943937:+
READ	trans	rs10716881	1	rs10716881	ENSG00000121089.4	NACA3P	-8.34	6.43e-12	0.000174	-0.79	-0.72	High light scatter reticulocyte count;	chr12:56644387	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs2958130	ENSG00000121089.4	NACA3P	8.32	7.18e-12	0.000193	0.76	0.72	Platelet distribution width;	chr12:56746722	chr4:164943290~164943937:+
READ	trans	rs941207	0.526	rs2950390	ENSG00000121089.4	NACA3P	8.31	7.5e-12	0.000202	0.83	0.71	Platelet count;	chr12:56661507	chr4:164943290~164943937:+
READ	trans	rs61990749	0.597	rs8016447	ENSG00000235400.1	RP4-641G12.4	8.29	7.91e-12	0.000212	1.04	0.71	Fibroblast growth factor basic levels;	chr14:77755725	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1477262	ENSG00000235400.1	RP4-641G12.4	8.28	8.3e-12	0.000222	1.04	0.71	Fibroblast growth factor basic levels;	chr14:77760310	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1978416	ENSG00000235400.1	RP4-641G12.4	8.28	8.3e-12	0.000222	1.04	0.71	Fibroblast growth factor basic levels;	chr14:77761558	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs3759728	ENSG00000235400.1	RP4-641G12.4	8.28	8.3e-12	0.000222	1.04	0.71	Fibroblast growth factor basic levels;	chr14:77763816	chr1:78749073~78750659:+
READ	trans	rs6708331	0.504	rs2169837	ENSG00000232654.1	FAM136BP	8.28	8.47e-12	0.000223	0.98	0.71	Obesity-related traits;	chr2:70324775	chr6:3045384~3045800:+
READ	trans	rs13190036	1	rs6880798	ENSG00000217325.2	PRELID1P1	8.27	8.87e-12	0.000233	1.08	0.71	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177277456	chr6:126643488~126644390:+
READ	trans	rs7121616	0.961	rs11218976	ENSG00000234176.1	HSPA8P1	8.23	1.01e-11	0.000264	0.74	0.71	Breast cancer;	chr11:123090950	chrX:121203182~121205014:-
READ	trans	rs2950393	0.895	rs2958123	ENSG00000121089.4	NACA3P	8.23	1.03e-11	0.000269	0.75	0.71	Platelet distribution width;	chr12:56668441	chr4:164943290~164943937:+
READ	trans	rs2950393	0.929	rs7980835	ENSG00000121089.4	NACA3P	8.23	1.03e-11	0.000269	0.75	0.71	Platelet distribution width;	chr12:56676847	chr4:164943290~164943937:+
READ	trans	rs2950393	0.929	rs10747769	ENSG00000121089.4	NACA3P	8.23	1.03e-11	0.000269	0.75	0.71	Platelet distribution width;	chr12:56677056	chr4:164943290~164943937:+
READ	trans	rs2950393	0.929	rs10876916	ENSG00000121089.4	NACA3P	8.23	1.03e-11	0.000269	0.75	0.71	Platelet distribution width;	chr12:56692728	chr4:164943290~164943937:+
READ	trans	rs61990749	0.597	rs11623088	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77671392	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs11624101	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77671716	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1048147	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77673645	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs13379065	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77674952	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs17106157	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77680535	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2267758	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77681086	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2267759	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77681272	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2267761	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77681506	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs7151211	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77685558	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs2364584	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77685943	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs72685264	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77686655	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs7147516	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77687637	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs10136053	ENSG00000235400.1	RP4-641G12.4	-8.19	1.2e-11	0.000301	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77688862	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs11628888	ENSG00000235400.1	RP4-641G12.4	-8.18	1.26e-11	0.000317	-0.99	-0.71	Fibroblast growth factor basic levels;	chr14:77695163	chr1:78749073~78750659:+
READ	trans	rs2950393	0.804	rs11171951	ENSG00000121089.4	NACA3P	8.17	1.32e-11	0.000331	0.76	0.71	Platelet distribution width;	chr12:56718853	chr4:164943290~164943937:+
READ	trans	rs12709013	0.591	rs30841	ENSG00000233719.3	GOT2P3	8.16	1.37e-11	0.000342	0.87	0.71	Blood metabolite ratios;	chr16:58709819	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs30840	ENSG00000233719.3	GOT2P3	8.16	1.37e-11	0.000342	0.87	0.71	Blood metabolite ratios;	chr16:58710165	chr12:9641802~9643007:+
READ	trans	rs2950393	0.794	rs1563897	ENSG00000121089.4	NACA3P	8.16	1.39e-11	0.000344	0.76	0.71	Platelet distribution width;	chr12:56699316	chr4:164943290~164943937:+
READ	trans	rs2950393	0.777	rs7966391	ENSG00000121089.4	NACA3P	8.16	1.39e-11	0.000346	0.75	0.71	Platelet distribution width;	chr12:56745272	chr4:164943290~164943937:+
READ	trans	rs61990749	0.597	rs4632066	ENSG00000235400.1	RP4-641G12.4	-8.13	1.54e-11	0.000382	-1.06	-0.71	Fibroblast growth factor basic levels;	chr14:77780939	chr1:78749073~78750659:+
READ	trans	rs13177918	0.559	rs12109637	ENSG00000213058.3	RP4-765C7.2	8.13	1.56e-11	0.000384	0.84	0.71	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150455155	chr1:178411616~178411972:+
READ	trans	rs941207	0.756	rs7313074	ENSG00000121089.4	NACA3P	-8.11	1.67e-11	0.000411	-0.94	-0.71	Platelet count;	chr12:56760705	chr4:164943290~164943937:+
READ	trans	rs12709013	0.591	rs6499980	ENSG00000233719.3	GOT2P3	8.09	1.8e-11	0.000442	0.88	0.71	Blood metabolite ratios;	chr16:58787972	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs899375	ENSG00000233719.3	GOT2P3	8.09	1.8e-11	0.000442	0.88	0.71	Blood metabolite ratios;	chr16:58792325	chr12:9641802~9643007:+
READ	trans	rs2950393	0.777	rs12828563	ENSG00000121089.4	NACA3P	8.09	1.85e-11	0.000453	0.75	0.71	Platelet distribution width;	chr12:56709378	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs1131514	ENSG00000121089.4	NACA3P	-8.08	1.89e-11	0.000464	-0.74	-0.71	Platelet distribution width;	chr12:56739356	chr4:164943290~164943937:+
READ	trans	rs941207	0.507	rs73337030	ENSG00000121089.4	NACA3P	-8.07	1.99e-11	0.000487	-0.76	-0.7	Platelet count;	chr12:56652410	chr4:164943290~164943937:+
READ	trans	rs7121616	0.92	rs7109445	ENSG00000234176.1	HSPA8P1	8.05	2.12e-11	0.000518	0.76	0.7	Breast cancer;	chr11:123094779	chrX:121203182~121205014:-
READ	trans	rs61990749	0.597	rs2112136	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77782609	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs759808	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77784502	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs4903643	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77788448	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs717683	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77789110	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs1477259	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77789795	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1477260	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77790475	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs1008988	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77794452	chr1:78749073~78750659:+
READ	trans	rs61990749	0.597	rs6574402	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77801607	chr1:78749073~78750659:+
READ	trans	rs61990749	0.5	rs8011337	ENSG00000235400.1	RP4-641G12.4	8.04	2.28e-11	0.00055	1.05	0.7	Fibroblast growth factor basic levels;	chr14:77806283	chr1:78749073~78750659:+
READ	trans	rs13177918	0.906	rs12652032	ENSG00000224114.1	RP11-343H5.4	8.03	2.32e-11	0.000558	0.99	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr1:206695837~206696269:-
READ	trans	rs13177918	1	rs13161334	ENSG00000224114.1	RP11-343H5.4	8.03	2.32e-11	0.000558	0.99	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr1:206695837~206696269:-
READ	trans	rs13177918	1	rs35007082	ENSG00000224114.1	RP11-343H5.4	8.03	2.32e-11	0.000558	0.99	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr1:206695837~206696269:-
READ	trans	rs13177918	1	rs13177918	ENSG00000224114.1	RP11-343H5.4	8.03	2.32e-11	0.000558	0.99	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr1:206695837~206696269:-
READ	trans	rs13177918	0.906	rs12652032	ENSG00000239528.1	RPS14P8	8.01	2.57e-11	0.000613	0.95	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr5:116562562~116562930:+
READ	trans	rs13177918	1	rs13161334	ENSG00000239528.1	RPS14P8	8.01	2.57e-11	0.000613	0.95	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr5:116562562~116562930:+
READ	trans	rs13177918	1	rs35007082	ENSG00000239528.1	RPS14P8	8.01	2.57e-11	0.000613	0.95	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr5:116562562~116562930:+
READ	trans	rs13177918	1	rs13177918	ENSG00000239528.1	RPS14P8	8.01	2.57e-11	0.000613	0.95	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr5:116562562~116562930:+
READ	trans	rs13358908	0.595	rs4975942	ENSG00000231752.4	EMBP1	-7.99	2.71e-11	0.000643	-0.99	-0.7	Schizophrenia;	chr5:46371833	chr1:121519112~121571892:+
READ	trans	rs13358908	0.632	rs35088345	ENSG00000231752.4	EMBP1	-7.99	2.71e-11	0.000643	-0.99	-0.7	Schizophrenia;	chr5:46372364	chr1:121519112~121571892:+
READ	trans	rs13253073	0.8	rs7015733	ENSG00000260318.1	COX6CP1	7.99	2.79e-11	0.00066	1.25	0.7	Glucose homeostasis traits;	chr8:99899353	chr16:11903923~11904137:-
READ	trans	rs9467773	0.62	rs2504571	ENSG00000242375.1	RP11-498P14.3	7.97	2.99e-11	0.000703	0.97	0.7	Intelligence (multi-trait analysis);	chr6:26643207	chr9:97195351~97197687:-
READ	trans	rs2950393	0.804	rs898609	ENSG00000121089.4	NACA3P	7.92	3.67e-11	0.00083	0.74	0.7	Platelet distribution width;	chr12:56713026	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs4902	ENSG00000121089.4	NACA3P	7.92	3.67e-11	0.00083	0.74	0.7	Platelet distribution width;	chr12:56714419	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs2926748	ENSG00000121089.4	NACA3P	7.92	3.67e-11	0.00083	0.74	0.7	Platelet distribution width;	chr12:56715628	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs2035081	ENSG00000121089.4	NACA3P	7.92	3.67e-11	0.00083	0.74	0.7	Platelet distribution width;	chr12:56732095	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs10783796	ENSG00000121089.4	NACA3P	7.92	3.67e-11	0.00083	0.74	0.7	Platelet distribution width;	chr12:56733387	chr4:164943290~164943937:+
READ	trans	rs13358908	0.652	rs8185385	ENSG00000231752.4	EMBP1	-7.92	3.69e-11	0.000834	-0.98	-0.7	Schizophrenia;	chr5:46318532	chr1:121519112~121571892:+
READ	trans	rs13177918	0.559	rs12109637	ENSG00000239528.1	RPS14P8	7.9	3.93e-11	0.000885	0.85	0.7	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150455155	chr5:116562562~116562930:+
READ	trans	rs9467773	0.62	rs2451732	ENSG00000242375.1	RP11-498P14.3	-7.9	4.08e-11	0.000911	-0.96	-0.7	Intelligence (multi-trait analysis);	chr6:26622676	chr9:97195351~97197687:-
READ	trans	rs5022636	0.594	rs11204791	ENSG00000180764.13	PIPSL	7.88	4.26e-11	0.000951	1.1	0.7	Gut microbiota (functional units);	chr1:151268066	chr10:93958191~93961540:-
READ	trans	rs61990749	0.597	rs2299930	ENSG00000235400.1	RP4-641G12.4	-7.88	4.28e-11	0.000955	-0.95	-0.7	Fibroblast growth factor basic levels;	chr14:77697379	chr1:78749073~78750659:+
READ	trans	rs7811142	0.775	rs1059129	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100328899	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs1063945	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100332824	chr7:102337316~102339115:+
READ	trans	rs7811142	0.562	rs7786844	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100336385	chr7:102337316~102339115:+
READ	trans	rs7811142	0.667	rs3873746	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100337474	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs11761253	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100341698	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs6979910	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100343007	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs11771936	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100345660	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs28495773	ENSG00000228546.2	CTA-313A17.3	7.88	4.4e-11	0.000975	1	0.7	Platelet count;	chr7:100345960	chr7:102337316~102339115:+
READ	trans	rs13190036	1	rs4976682	ENSG00000217325.2	PRELID1P1	7.85	4.82e-11	0.00106	1.02	0.7	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177299001	chr6:126643488~126644390:+
READ	trans	rs4276421	0.688	rs10038249	ENSG00000231752.4	EMBP1	7.85	4.98e-11	0.0011	0.98	0.69	P wave duration;	chr5:46160595	chr1:121519112~121571892:+
READ	trans	rs9467773	0.596	rs2451750	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26646351	chr9:97195351~97197687:-
READ	trans	rs9467773	0.596	rs2451751	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26646486	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2504600	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26648106	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2130657	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26650598	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2504565	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26656662	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2498351	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26659414	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2504566	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26660260	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494716	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26662508	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2451711	ENSG00000242375.1	RP11-498P14.3	7.84	5.05e-11	0.00111	0.97	0.69	Intelligence (multi-trait analysis);	chr6:26662882	chr9:97195351~97197687:-
READ	trans	rs7811142	0.775	rs1636980	ENSG00000228546.2	CTA-313A17.3	-7.84	5.07e-11	0.00111	-1	-0.69	Platelet count;	chr7:100341241	chr7:102337316~102339115:+
READ	trans	rs6477998	0.903	rs7041615	ENSG00000238072.1	RP11-305M3.2	7.84	5.14e-11	0.00111	0.89	0.69	Hematology traits;	chr9:113244747	chr7:129410113~129410370:-
READ	trans	rs12709013	0.646	rs8046154	ENSG00000233719.3	GOT2P3	-7.84	5.17e-11	0.00111	-0.86	-0.69	Blood metabolite ratios;	chr16:58773978	chr12:9641802~9643007:+
READ	trans	rs4276421	0.574	rs80150384	ENSG00000231752.4	EMBP1	-7.83	5.24e-11	0.00113	-0.96	-0.69	P wave duration;	chr5:46296183	chr1:121519112~121571892:+
READ	trans	rs4276421	0.609	rs4975911	ENSG00000231752.4	EMBP1	-7.83	5.24e-11	0.00113	-0.96	-0.69	P wave duration;	chr5:46297143	chr1:121519112~121571892:+
READ	trans	rs4276421	0.578	rs8185314	ENSG00000231752.4	EMBP1	-7.83	5.24e-11	0.00113	-0.96	-0.69	P wave duration;	chr5:46299648	chr1:121519112~121571892:+
READ	trans	rs9467773	0.596	rs62396201	ENSG00000242375.1	RP11-498P14.3	7.81	5.74e-11	0.00123	1	0.69	Intelligence (multi-trait analysis);	chr6:26667988	chr9:97195351~97197687:-
READ	trans	rs4276421	0.652	rs8185226	ENSG00000231752.4	EMBP1	7.8	6.14e-11	0.00131	0.97	0.69	P wave duration;	chr5:46160685	chr1:121519112~121571892:+
READ	trans	rs2950393	0.804	rs2958127	ENSG00000121089.4	NACA3P	7.79	6.21e-11	0.00132	0.74	0.69	Platelet distribution width;	chr12:56720523	chr4:164943290~164943937:+
READ	trans	rs4276421	0.695	rs8185255	ENSG00000231752.4	EMBP1	-7.79	6.32e-11	0.00134	-0.97	-0.69	P wave duration;	chr5:46263336	chr1:121519112~121571892:+
READ	trans	rs4276421	0.777	rs8185098	ENSG00000231752.4	EMBP1	7.79	6.32e-11	0.00134	0.97	0.69	P wave duration;	chr5:46125388	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs10941746	ENSG00000231752.4	EMBP1	7.79	6.32e-11	0.00134	0.97	0.69	P wave duration;	chr5:46202737	chr1:121519112~121571892:+
READ	trans	rs4276421	0.684	rs8185055	ENSG00000231752.4	EMBP1	-7.76	7.02e-11	0.00147	-0.96	-0.69	P wave duration;	chr5:46262149	chr1:121519112~121571892:+
READ	trans	rs4276421	0.587	rs4975957	ENSG00000231752.4	EMBP1	-7.76	7.02e-11	0.00147	-0.96	-0.69	P wave duration;	chr5:46265200	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs10040808	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46123599	chr1:121519112~121571892:+
READ	trans	rs4276421	0.716	rs12656601	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46124483	chr1:121519112~121571892:+
READ	trans	rs4276421	0.684	rs8175395	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46125498	chr1:121519112~121571892:+
READ	trans	rs4276421	0.716	rs13156708	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46128924	chr1:121519112~121571892:+
READ	trans	rs4276421	0.744	rs13157345	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46129304	chr1:121519112~121571892:+
READ	trans	rs4276421	0.805	rs7293302	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46131077	chr1:121519112~121571892:+
READ	trans	rs4276421	0.657	rs13186103	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46131553	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs8185376	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46165191	chr1:121519112~121571892:+
READ	trans	rs4276421	0.625	rs61187820	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46199336	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs8188050	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46201372	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs13188786	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46201856	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs10064792	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46202002	chr1:121519112~121571892:+
READ	trans	rs4276421	0.597	rs10072776	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46202178	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs7293337	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46203395	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs13168431	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46205598	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs11960110	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46210055	chr1:121519112~121571892:+
READ	trans	rs4276421	0.537	rs13166566	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46210486	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs13172097	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46211694	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs8185185	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46214358	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs8188054	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46215556	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs10061101	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46217831	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs12697543	ENSG00000231752.4	EMBP1	7.76	7.02e-11	0.00147	0.96	0.69	P wave duration;	chr5:46235824	chr1:121519112~121571892:+
READ	trans	rs13358908	0.596	rs9717195	ENSG00000231752.4	EMBP1	-7.76	7.05e-11	0.00147	-0.96	-0.69	Schizophrenia;	chr5:46302679	chr1:121519112~121571892:+
READ	trans	rs13358908	0.602	rs4975977	ENSG00000231752.4	EMBP1	-7.76	7.05e-11	0.00147	-0.96	-0.69	Schizophrenia;	chr5:46307988	chr1:121519112~121571892:+
READ	trans	rs13358908	0.715	rs8185301	ENSG00000231752.4	EMBP1	-7.76	7.05e-11	0.00147	-0.96	-0.69	Schizophrenia;	chr5:46312149	chr1:121519112~121571892:+
READ	trans	rs13358908	0.652	rs7293494	ENSG00000231752.4	EMBP1	-7.76	7.05e-11	0.00147	-0.96	-0.69	Schizophrenia;	chr5:46313550	chr1:121519112~121571892:+
READ	trans	rs13358908	0.631	rs6882540	ENSG00000231752.4	EMBP1	-7.76	7.05e-11	0.00147	-0.96	-0.69	Schizophrenia;	chr5:46345971	chr1:121519112~121571892:+
READ	trans	rs7811142	0.83	rs3087502	ENSG00000228546.2	CTA-313A17.3	7.76	7.13e-11	0.00148	0.99	0.69	Platelet count;	chr7:100357741	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs61735533	ENSG00000228546.2	CTA-313A17.3	7.76	7.13e-11	0.00148	0.99	0.69	Platelet count;	chr7:100358243	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs11761426	ENSG00000228546.2	CTA-313A17.3	7.76	7.13e-11	0.00148	0.99	0.69	Platelet count;	chr7:100359270	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs77861211	ENSG00000228546.2	CTA-313A17.3	7.76	7.13e-11	0.00148	0.99	0.69	Platelet count;	chr7:100364473	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs11769057	ENSG00000228546.2	CTA-313A17.3	7.76	7.13e-11	0.00148	0.99	0.69	Platelet count;	chr7:100367038	chr7:102337316~102339115:+
READ	trans	rs7811142	0.779	rs77370288	ENSG00000228546.2	CTA-313A17.3	7.76	7.16e-11	0.00148	0.99	0.69	Platelet count;	chr7:100350274	chr7:102337316~102339115:+
READ	trans	rs7811142	0.72	rs7795656	ENSG00000228546.2	CTA-313A17.3	7.76	7.16e-11	0.00148	0.99	0.69	Platelet count;	chr7:100352674	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs78256546	ENSG00000228546.2	CTA-313A17.3	7.76	7.16e-11	0.00148	0.99	0.69	Platelet count;	chr7:100355347	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs41280971	ENSG00000228546.2	CTA-313A17.3	7.76	7.16e-11	0.00148	0.99	0.69	Platelet count;	chr7:100356834	chr7:102337316~102339115:+
READ	trans	rs61990749	0.597	rs59848135	ENSG00000235400.1	RP4-641G12.4	-7.76	7.17e-11	0.00148	-1.07	-0.69	Fibroblast growth factor basic levels;	chr14:77662657	chr1:78749073~78750659:+
READ	trans	rs2950393	0.804	rs2926752	ENSG00000121089.4	NACA3P	7.76	7.22e-11	0.00149	0.73	0.69	Platelet distribution width;	chr12:56710144	chr4:164943290~164943937:+
READ	trans	rs2950393	0.777	rs2958148	ENSG00000121089.4	NACA3P	7.76	7.22e-11	0.00149	0.73	0.69	Platelet distribution width;	chr12:56710153	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs2290894	ENSG00000121089.4	NACA3P	7.76	7.22e-11	0.00149	0.73	0.69	Platelet distribution width;	chr12:56714911	chr4:164943290~164943937:+
READ	trans	rs2950393	0.777	rs2926747	ENSG00000121089.4	NACA3P	7.76	7.22e-11	0.00149	0.73	0.69	Platelet distribution width;	chr12:56716147	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs3214051	ENSG00000121089.4	NACA3P	7.76	7.22e-11	0.00149	0.73	0.69	Platelet distribution width;	chr12:56725452	chr4:164943290~164943937:+
READ	trans	rs13177918	0.906	rs12652032	ENSG00000213058.3	RP4-765C7.2	7.76	7.26e-11	0.00149	0.91	0.69	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr1:178411616~178411972:+
READ	trans	rs13177918	1	rs13161334	ENSG00000213058.3	RP4-765C7.2	7.76	7.26e-11	0.00149	0.91	0.69	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr1:178411616~178411972:+
READ	trans	rs13177918	1	rs35007082	ENSG00000213058.3	RP4-765C7.2	7.76	7.26e-11	0.00149	0.91	0.69	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr1:178411616~178411972:+
READ	trans	rs13177918	1	rs13177918	ENSG00000213058.3	RP4-765C7.2	7.76	7.26e-11	0.00149	0.91	0.69	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr1:178411616~178411972:+
READ	trans	rs4276421	0.684	rs10072945	ENSG00000231752.4	EMBP1	7.75	7.44e-11	0.00152	0.96	0.69	P wave duration;	chr5:46151307	chr1:121519112~121571892:+
READ	trans	rs4276421	0.716	rs13155082	ENSG00000231752.4	EMBP1	7.75	7.44e-11	0.00152	0.96	0.69	P wave duration;	chr5:46155135	chr1:121519112~121571892:+
READ	trans	rs10242455	0.702	rs73397481	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99432485	chr6:108907615~108907873:-
READ	trans	rs10242455	0.557	rs34943973	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99434894	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs45451992	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99443793	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs3823813	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99451766	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs17854665	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99452416	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs45441991	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99453364	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs45461000	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99455087	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs79285548	ENSG00000228834.1	RP11-249L21.4	7.75	7.48e-11	0.00152	1.88	0.69	Blood metabolite levels;	chr7:99460773	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs76840929	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99348235	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs116671616	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99356935	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs75156180	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99366477	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs57832867	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99368773	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs76635566	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99374103	chr6:108907615~108907873:-
READ	trans	rs10242455	0.571	rs117370443	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99377635	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs74552228	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99379423	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs17161700	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99379444	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs28377312	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99386590	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs1045012	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99386731	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs10251282	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99392613	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs28460612	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99395582	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs115279860	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99396869	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs75944999	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99398101	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs28753399	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99399636	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs28668326	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99400530	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs917152	ENSG00000228834.1	RP11-249L21.4	7.74	7.65e-11	0.00154	1.88	0.69	Blood metabolite levels;	chr7:99406874	chr6:108907615~108907873:-
READ	trans	rs7121616	1	rs7121616	ENSG00000234176.1	HSPA8P1	7.73	7.97e-11	0.0016	0.71	0.69	Breast cancer;	chr11:123095918	chrX:121203182~121205014:-
READ	trans	rs7121616	0.96	rs7122306	ENSG00000234176.1	HSPA8P1	7.73	7.97e-11	0.0016	0.71	0.69	Breast cancer;	chr11:123096254	chrX:121203182~121205014:-
READ	trans	rs13358908	0.599	rs34899679	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46372360	chr1:121519112~121571892:+
READ	trans	rs13358908	0.712	rs28873151	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46378558	chr1:121519112~121571892:+
READ	trans	rs13358908	0.621	rs28847123	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46378829	chr1:121519112~121571892:+
READ	trans	rs13358908	0.593	rs28855077	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46378855	chr1:121519112~121571892:+
READ	trans	rs13358908	0.715	rs12522625	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46389266	chr1:121519112~121571892:+
READ	trans	rs13358908	0.712	rs10941823	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46389481	chr1:121519112~121571892:+
READ	trans	rs13358908	0.622	rs12652607	ENSG00000231752.4	EMBP1	-7.73	8.01e-11	0.0016	-0.96	-0.69	Schizophrenia;	chr5:46392338	chr1:121519112~121571892:+
READ	trans	rs6477998	0.535	rs10981712	ENSG00000238072.1	RP11-305M3.2	7.73	8.18e-11	0.00163	0.97	0.69	Hematology traits;	chr9:113283846	chr7:129410113~129410370:-
READ	trans	rs10242455	0.702	rs78080383	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99466842	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73401510	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99468189	chr6:108907615~108907873:-
READ	trans	rs10242455	0.557	rs73401516	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99470728	chr6:108907615~108907873:-
READ	trans	rs10242455	0.557	rs77997620	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99472792	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs59240302	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99475368	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73711293	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99483972	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs79878591	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99485305	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73711294	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99491091	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73403247	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99491107	chr6:108907615~108907873:-
READ	trans	rs10242455	0.85	rs57367781	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99519196	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs6974831	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99533982	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73713507	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99540980	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs78218664	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99556758	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73403286	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99557242	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73403290	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99560205	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73405247	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99561551	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs78640327	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99569516	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs74416635	ENSG00000228834.1	RP11-249L21.4	7.72	8.29e-11	0.00163	1.88	0.69	Blood metabolite levels;	chr7:99582946	chr6:108907615~108907873:-
READ	trans	rs6477998	1	rs6477998	ENSG00000238072.1	RP11-305M3.2	-7.72	8.56e-11	0.00168	-0.9	-0.69	Hematology traits;	chr9:113234969	chr7:129410113~129410370:-
READ	trans	rs12709013	0.514	rs8062639	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58800264	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs4410065	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58800968	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs2406234	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58801840	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs2086206	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58802094	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs4784986	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58803007	chr12:9641802~9643007:+
READ	trans	rs12709013	0.536	rs9930758	ENSG00000233719.3	GOT2P3	7.71	8.58e-11	0.00168	0.85	0.69	Blood metabolite ratios;	chr16:58803167	chr12:9641802~9643007:+
READ	trans	rs4276421	0.657	rs10941759	ENSG00000231752.4	EMBP1	-7.71	8.63e-11	0.00169	-0.95	-0.69	P wave duration;	chr5:46266862	chr1:121519112~121571892:+
READ	trans	rs4276421	0.657	rs10941760	ENSG00000231752.4	EMBP1	-7.71	8.63e-11	0.00169	-0.95	-0.69	P wave duration;	chr5:46267360	chr1:121519112~121571892:+
READ	trans	rs61990749	0.597	rs12896026	ENSG00000235400.1	RP4-641G12.4	7.71	8.77e-11	0.00171	1.03	0.69	Fibroblast growth factor basic levels;	chr14:77778093	chr1:78749073~78750659:+
READ	trans	rs61990749	0.544	rs12435761	ENSG00000235400.1	RP4-641G12.4	7.71	8.77e-11	0.00171	1.03	0.69	Fibroblast growth factor basic levels;	chr14:77779734	chr1:78749073~78750659:+
READ	trans	rs10242455	0.557	rs2404487	ENSG00000228834.1	RP11-249L21.4	7.71	8.85e-11	0.00172	1.88	0.69	Blood metabolite levels;	chr7:99440434	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73711280	ENSG00000228834.1	RP11-249L21.4	7.71	8.85e-11	0.00172	1.88	0.69	Blood metabolite levels;	chr7:99441981	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs73397499	ENSG00000228834.1	RP11-249L21.4	7.71	8.85e-11	0.00172	1.88	0.69	Blood metabolite levels;	chr7:99442004	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs45448997	ENSG00000228834.1	RP11-249L21.4	7.71	8.85e-11	0.00172	1.88	0.69	Blood metabolite levels;	chr7:99443975	chr6:108907615~108907873:-
READ	trans	rs10242455	0.557	rs45492501	ENSG00000228834.1	RP11-249L21.4	7.71	8.85e-11	0.00172	1.88	0.69	Blood metabolite levels;	chr7:99449407	chr6:108907615~108907873:-
READ	trans	rs1816752	0.603	rs9551099	ENSG00000237917.1	PARP4P1	-7.71	8.93e-11	0.00174	-0.9	-0.69	Obesity-related traits;	chr13:24410978	chrY:26594851~26634652:-
READ	trans	rs6477998	1	rs4560868	ENSG00000238072.1	RP11-305M3.2	-7.7	9.25e-11	0.0018	-0.89	-0.69	Hematology traits;	chr9:113223219	chr7:129410113~129410370:-
READ	trans	rs4276421	0.63	rs10054134	ENSG00000231752.4	EMBP1	-7.69	9.33e-11	0.00181	-0.96	-0.69	P wave duration;	chr5:46292175	chr1:121519112~121571892:+
READ	trans	rs13177918	0.603	rs2748241	ENSG00000213058.3	RP4-765C7.2	7.68	9.85e-11	0.0019	0.78	0.69	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447931	chr1:178411616~178411972:+
READ	trans	rs12709013	0.636	rs10852565	ENSG00000233719.3	GOT2P3	7.68	9.9e-11	0.00191	0.88	0.69	Blood metabolite ratios;	chr16:58771277	chr12:9641802~9643007:+
READ	trans	rs10242455	0.702	rs112475236	ENSG00000228834.1	RP11-249L21.4	7.67	1.01e-10	0.00195	1.88	0.69	Blood metabolite levels;	chr7:99447056	chr6:108907615~108907873:-
READ	trans	rs10242455	0.557	rs45529541	ENSG00000228834.1	RP11-249L21.4	7.67	1.01e-10	0.00195	1.88	0.69	Blood metabolite levels;	chr7:99450520	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs3528	ENSG00000228834.1	RP11-249L21.4	7.67	1.01e-10	0.00195	1.88	0.69	Blood metabolite levels;	chr7:99458317	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs55927283	ENSG00000228834.1	RP11-249L21.4	7.67	1.01e-10	0.00195	1.88	0.69	Blood metabolite levels;	chr7:99459568	chr6:108907615~108907873:-
READ	trans	rs10940346	1	rs2883164	ENSG00000231752.4	EMBP1	7.67	1.05e-10	0.00199	0.94	0.69	Schizophrenia;	chr5:50397624	chr1:121519112~121571892:+
READ	trans	rs13358908	0.715	rs10053628	ENSG00000231752.4	EMBP1	-7.67	1.05e-10	0.00199	-0.94	-0.69	Schizophrenia;	chr5:46383233	chr1:121519112~121571892:+
READ	trans	rs61990749	0.597	rs1006039	ENSG00000235400.1	RP4-641G12.4	-7.65	1.1e-10	0.00206	-1.01	-0.69	Fibroblast growth factor basic levels;	chr14:77796853	chr1:78749073~78750659:+
READ	trans	rs13190036	0.901	rs28684504	ENSG00000217325.2	PRELID1P1	7.65	1.11e-10	0.00208	1.05	0.69	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177300437	chr6:126643488~126644390:+
READ	trans	rs9467773	0.62	rs2504540	ENSG00000242375.1	RP11-498P14.3	7.64	1.15e-10	0.00215	0.98	0.69	Intelligence (multi-trait analysis);	chr6:26641398	chr9:97195351~97197687:-
READ	trans	rs2950393	0.804	rs1026565	ENSG00000121089.4	NACA3P	7.64	1.16e-10	0.00216	0.71	0.69	Platelet distribution width;	chr12:56744044	chr4:164943290~164943937:+
READ	trans	rs6477998	0.9	rs7850357	ENSG00000238072.1	RP11-305M3.2	7.63	1.21e-10	0.00225	0.89	0.68	Hematology traits;	chr9:113222319	chr7:129410113~129410370:-
READ	trans	rs6477998	0.874	rs10739390	ENSG00000238072.1	RP11-305M3.2	7.63	1.21e-10	0.00225	0.89	0.68	Hematology traits;	chr9:113226209	chr7:129410113~129410370:-
READ	trans	rs10242455	0.557	rs59672032	ENSG00000228834.1	RP11-249L21.4	7.63	1.23e-10	0.00229	1.88	0.68	Blood metabolite levels;	chr7:99461074	chr6:108907615~108907873:-
READ	trans	rs10940346	0.818	rs472278	ENSG00000231752.4	EMBP1	-7.63	1.23e-10	0.00229	-0.95	-0.68	Schizophrenia;	chr5:50215972	chr1:121519112~121571892:+
READ	trans	rs12709013	0.597	rs1657171	ENSG00000233719.3	GOT2P3	7.62	1.25e-10	0.00231	0.86	0.68	Blood metabolite ratios;	chr16:58752083	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646284	ENSG00000233719.3	GOT2P3	7.62	1.25e-10	0.00231	0.86	0.68	Blood metabolite ratios;	chr16:58752093	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646285	ENSG00000233719.3	GOT2P3	7.62	1.25e-10	0.00231	0.86	0.68	Blood metabolite ratios;	chr16:58752102	chr12:9641802~9643007:+
READ	trans	rs10940346	0.902	rs4865727	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50145945	chr1:121519112~121571892:+
READ	trans	rs10940346	0.714	rs12523073	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50153697	chr1:121519112~121571892:+
READ	trans	rs10940346	0.846	rs8188203	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50161448	chr1:121519112~121571892:+
READ	trans	rs10940346	0.905	rs10053631	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50164086	chr1:121519112~121571892:+
READ	trans	rs10940346	0.728	rs10053639	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50164113	chr1:121519112~121571892:+
READ	trans	rs10940346	0.934	rs2353222	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50174249	chr1:121519112~121571892:+
READ	trans	rs10940346	0.716	rs8188088	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50215591	chr1:121519112~121571892:+
READ	trans	rs10940346	0.653	rs4371800	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50225349	chr1:121519112~121571892:+
READ	trans	rs10940346	0.584	rs496108	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50236794	chr1:121519112~121571892:+
READ	trans	rs10940346	0.744	rs498951	ENSG00000231752.4	EMBP1	-7.62	1.28e-10	0.00233	-0.95	-0.68	Schizophrenia;	chr5:50238681	chr1:121519112~121571892:+
READ	trans	rs7811142	1	rs1000215	ENSG00000228546.2	CTA-313A17.3	7.61	1.34e-10	0.00244	0.99	0.68	Platelet count;	chr7:100406920	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs6955367	ENSG00000228546.2	CTA-313A17.3	7.6	1.35e-10	0.00245	0.97	0.68	Platelet count;	chr7:100363571	chr7:102337316~102339115:+
READ	trans	rs9467773	0.549	rs9467805	ENSG00000242375.1	RP11-498P14.3	7.6	1.35e-10	0.00246	0.95	0.68	Intelligence (multi-trait analysis);	chr6:26583138	chr9:97195351~97197687:-
READ	trans	rs6477998	0.903	rs4979226	ENSG00000238072.1	RP11-305M3.2	7.6	1.36e-10	0.00247	0.89	0.68	Hematology traits;	chr9:113239516	chr7:129410113~129410370:-
READ	trans	rs6477998	0.934	rs4979223	ENSG00000238072.1	RP11-305M3.2	7.6	1.38e-10	0.0025	0.89	0.68	Hematology traits;	chr9:113219836	chr7:129410113~129410370:-
READ	trans	rs4276421	0.684	rs8185217	ENSG00000231752.4	EMBP1	7.6	1.38e-10	0.0025	0.95	0.68	P wave duration;	chr5:46169215	chr1:121519112~121571892:+
READ	trans	rs35275482	1	rs4775206	ENSG00000267213.4	AC007773.2	7.57	1.56e-10	0.00281	0.85	0.68	Gut microbiota (bacterial taxa);	chr15:59774922	chr19:32390050~32405560:-
READ	trans	rs12709013	0.636	rs967852	ENSG00000233719.3	GOT2P3	7.57	1.58e-10	0.00284	0.87	0.68	Blood metabolite ratios;	chr16:58807313	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs6499984	ENSG00000233719.3	GOT2P3	7.57	1.58e-10	0.00284	0.87	0.68	Blood metabolite ratios;	chr16:58810209	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646268	ENSG00000233719.3	GOT2P3	7.56	1.6e-10	0.00288	0.86	0.68	Blood metabolite ratios;	chr16:58743292	chr12:9641802~9643007:+
READ	trans	rs12709013	0.597	rs8051078	ENSG00000233719.3	GOT2P3	7.56	1.6e-10	0.00288	0.86	0.68	Blood metabolite ratios;	chr16:58774200	chr12:9641802~9643007:+
READ	trans	rs10940346	0.537	rs8188099	ENSG00000231752.4	EMBP1	-7.56	1.64e-10	0.00294	-0.94	-0.68	Schizophrenia;	chr5:50183445	chr1:121519112~121571892:+
READ	trans	rs7554547	0.69	rs10864544	ENSG00000261819.1	RP11-680G24.4	7.56	1.65e-10	0.00296	0.81	0.68	Nonsyndromic cleft lip with cleft palate;	chr1:11875666	chr16:14988259~14990160:-
READ	trans	rs7554547	0.69	rs9661078	ENSG00000261819.1	RP11-680G24.4	7.56	1.65e-10	0.00296	0.81	0.68	Nonsyndromic cleft lip with cleft palate;	chr1:11876267	chr16:14988259~14990160:-
READ	trans	rs7554547	0.69	rs61402980	ENSG00000261819.1	RP11-680G24.4	7.56	1.65e-10	0.00296	0.81	0.68	Nonsyndromic cleft lip with cleft palate;	chr1:11876432	chr16:14988259~14990160:-
READ	trans	rs7554547	0.69	rs7364817	ENSG00000261819.1	RP11-680G24.4	7.56	1.65e-10	0.00296	0.81	0.68	Nonsyndromic cleft lip with cleft palate;	chr1:11877060	chr16:14988259~14990160:-
READ	trans	rs7554547	0.69	rs4846065	ENSG00000261819.1	RP11-680G24.4	7.56	1.65e-10	0.00296	0.81	0.68	Nonsyndromic cleft lip with cleft palate;	chr1:11877306	chr16:14988259~14990160:-
READ	trans	rs12709013	0.551	rs154435	ENSG00000233719.3	GOT2P3	-7.53	1.81e-10	0.00321	-0.87	-0.68	Blood metabolite ratios;	chr16:58702746	chr12:9641802~9643007:+
READ	trans	rs9467773	0.596	rs3001369	ENSG00000242375.1	RP11-498P14.3	7.53	1.82e-10	0.00323	0.97	0.68	Intelligence (multi-trait analysis);	chr6:26670741	chr9:97195351~97197687:-
READ	trans	rs7811142	1	rs11771419	ENSG00000228546.2	CTA-313A17.3	7.53	1.85e-10	0.00325	0.99	0.68	Platelet count;	chr7:100390780	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11771241	ENSG00000228546.2	CTA-313A17.3	7.53	1.85e-10	0.00325	0.99	0.68	Platelet count;	chr7:100397162	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs76913697	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100405149	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs3900792	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100406954	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs68116612	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100408870	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs67471932	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100412362	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs73161759	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100412371	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs67315960	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100417501	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs111757992	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100418731	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11763414	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100419221	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs66632384	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100421281	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs28490152	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100423359	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs28660238	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100425685	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs67163493	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100426215	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs73403312	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100426530	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs67196635	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100427941	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs60257855	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100429157	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs74460138	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100429716	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs6975729	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100430564	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs6962151	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100430861	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs67483801	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100434135	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs4989959	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100434665	chr7:102337316~102339115:+
READ	trans	rs7811142	0.887	rs4074838	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100435042	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11761784	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100442347	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11764818	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100445432	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs112317829	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100445550	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs28578163	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100447131	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs67239991	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100448881	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs111493473	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100452119	chr7:102337316~102339115:+
READ	trans	rs7811142	0.945	rs6955362	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100458543	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs6975514	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100458597	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs7811142	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100467820	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs7794485	ENSG00000228546.2	CTA-313A17.3	7.53	1.86e-10	0.00325	0.99	0.68	Platelet count;	chr7:100471313	chr7:102337316~102339115:+
READ	trans	rs10940346	0.653	rs72768421	ENSG00000231752.4	EMBP1	-7.51	1.97e-10	0.00343	-0.95	-0.68	Schizophrenia;	chr5:50246898	chr1:121519112~121571892:+
READ	trans	rs13190036	0.551	rs7710269	ENSG00000217325.2	PRELID1P1	-7.49	2.13e-10	0.00354	-0.97	-0.68	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177187528	chr6:126643488~126644390:+
READ	trans	rs13190036	0.515	rs2878686	ENSG00000217325.2	PRELID1P1	-7.49	2.13e-10	0.00354	-0.97	-0.68	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177206748	chr6:126643488~126644390:+
READ	trans	rs13190036	0.551	rs9313751	ENSG00000217325.2	PRELID1P1	-7.49	2.13e-10	0.00354	-0.97	-0.68	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177217174	chr6:126643488~126644390:+
READ	trans	rs12709013	0.601	rs2432621	ENSG00000233719.3	GOT2P3	7.49	2.19e-10	0.0036	0.87	0.68	Blood metabolite ratios;	chr16:58749676	chr12:9641802~9643007:+
READ	trans	rs12709013	0.576	rs2432622	ENSG00000233719.3	GOT2P3	7.49	2.19e-10	0.0036	0.87	0.68	Blood metabolite ratios;	chr16:58749681	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs30838	ENSG00000233719.3	GOT2P3	7.49	2.2e-10	0.0036	0.87	0.68	Blood metabolite ratios;	chr16:58711513	chr12:9641802~9643007:+
READ	trans	rs12709013	0.569	rs30837	ENSG00000233719.3	GOT2P3	7.49	2.2e-10	0.0036	0.87	0.68	Blood metabolite ratios;	chr16:58711942	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs72792430	ENSG00000233719.3	GOT2P3	-7.48	2.22e-10	0.0036	-0.86	-0.68	Blood metabolite ratios;	chr16:58746990	chr12:9641802~9643007:+
READ	trans	rs12709013	0.536	rs1646260	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58734951	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs1657178	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58735300	chr12:9641802~9643007:+
READ	trans	rs12709013	0.585	rs7188608	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58736236	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1657176	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58736833	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs4238801	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58738275	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs4575523	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58738559	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646282	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58741296	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs4784977	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58742120	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646269	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58743412	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs4538000	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58744506	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646272	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58746508	chr12:9641802~9643007:+
READ	trans	rs12709013	0.66	rs1657163	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58746688	chr12:9641802~9643007:+
READ	trans	rs12709013	0.597	rs1616072	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58747194	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs2575374	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58747494	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1657164	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58747949	chr12:9641802~9643007:+
READ	trans	rs12709013	0.537	rs1657167	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58748955	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs8054414	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58749772	chr12:9641802~9643007:+
READ	trans	rs12709013	0.597	rs11076259	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58749860	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs12325516	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58749899	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs11076260	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58749942	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646278	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58750084	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646279	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58750235	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646280	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58750420	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1646281	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58750512	chr12:9641802~9643007:+
READ	trans	rs12709013	0.597	rs1646286	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58752651	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1624301	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58753491	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1626006	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58753691	chr12:9641802~9643007:+
READ	trans	rs12709013	0.684	rs1646287	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58753774	chr12:9641802~9643007:+
READ	trans	rs12709013	0.671	rs1369933	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58753927	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1369934	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58754124	chr12:9641802~9643007:+
READ	trans	rs12709013	0.561	rs1657174	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58755139	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs1646288	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58755576	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs1618602	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58756080	chr12:9641802~9643007:+
READ	trans	rs12709013	0.561	rs727484	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58756568	chr12:9641802~9643007:+
READ	trans	rs12709013	0.613	rs8049462	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58757654	chr12:9641802~9643007:+
READ	trans	rs12709013	0.66	rs257629	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58758044	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs257628	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58758924	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs257627	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58758956	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs191783	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58759994	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs257624	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58760994	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs8045466	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58765113	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs8060717	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58765574	chr12:9641802~9643007:+
READ	trans	rs12709013	0.559	rs8060721	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58765581	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs8044542	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58765620	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1865836	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58768143	chr12:9641802~9643007:+
READ	trans	rs12709013	0.621	rs6499974	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58769642	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs4499224	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58770364	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs1595180	ENSG00000233719.3	GOT2P3	7.48	2.22e-10	0.0036	0.86	0.68	Blood metabolite ratios;	chr16:58770545	chr12:9641802~9643007:+
READ	trans	rs4276421	0.657	rs8188296	ENSG00000231752.4	EMBP1	7.48	2.27e-10	0.00367	0.94	0.68	P wave duration;	chr5:46221948	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs10064681	ENSG00000231752.4	EMBP1	7.48	2.27e-10	0.00367	0.94	0.68	P wave duration;	chr5:46222829	chr1:121519112~121571892:+
READ	trans	rs4276421	0.623	rs12109835	ENSG00000231752.4	EMBP1	7.48	2.27e-10	0.00367	0.94	0.68	P wave duration;	chr5:46222967	chr1:121519112~121571892:+
READ	trans	rs941207	0.526	rs2950387	ENSG00000121089.4	NACA3P	-7.47	2.37e-10	0.00382	-0.73	-0.68	Platelet count;	chr12:56627222	chr4:164943290~164943937:+
READ	trans	rs10037055	1	rs6886255	ENSG00000217325.2	PRELID1P1	7.46	2.47e-10	0.00397	0.88	0.68	Migraine without aura;	chr5:177291360	chr6:126643488~126644390:+
READ	trans	rs7811142	0.83	rs75636500	ENSG00000228546.2	CTA-313A17.3	7.46	2.5e-10	0.004	0.98	0.68	Platelet count;	chr7:100350034	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs76798830	ENSG00000228546.2	CTA-313A17.3	7.46	2.5e-10	0.004	0.98	0.68	Platelet count;	chr7:100355205	chr7:102337316~102339115:+
READ	trans	rs7811142	0.775	rs6946768	ENSG00000228546.2	CTA-313A17.3	7.46	2.5e-10	0.004	0.98	0.68	Platelet count;	chr7:100356770	chr7:102337316~102339115:+
READ	trans	rs12709013	0.591	rs7184377	ENSG00000233719.3	GOT2P3	7.46	2.5e-10	0.004	0.89	0.68	Blood metabolite ratios;	chr16:58808765	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs30842	ENSG00000233719.3	GOT2P3	-7.45	2.5e-10	0.004	-0.84	-0.68	Blood metabolite ratios;	chr16:58709550	chr12:9641802~9643007:+
READ	trans	rs10940346	0.557	rs2168922	ENSG00000231752.4	EMBP1	-7.45	2.5e-10	0.004	-0.95	-0.68	Schizophrenia;	chr5:50151950	chr1:121519112~121571892:+
READ	trans	rs10940346	0.846	rs13356208	ENSG00000231752.4	EMBP1	-7.45	2.5e-10	0.004	-0.95	-0.68	Schizophrenia;	chr5:50197970	chr1:121519112~121571892:+
READ	trans	rs10940346	0.721	rs60147402	ENSG00000231752.4	EMBP1	-7.45	2.5e-10	0.004	-0.95	-0.68	Schizophrenia;	chr5:50230794	chr1:121519112~121571892:+
READ	trans	rs7811142	0.83	rs11765869	ENSG00000228546.2	CTA-313A17.3	7.45	2.56e-10	0.0041	0.98	0.68	Platelet count;	chr7:100367166	chr7:102337316~102339115:+
READ	trans	rs2950393	0.804	rs1466382	ENSG00000121089.4	NACA3P	-7.44	2.61e-10	0.00416	-0.71	-0.68	Platelet distribution width;	chr12:56723050	chr4:164943290~164943937:+
READ	trans	rs7811142	0.943	rs10241492	ENSG00000228546.2	CTA-313A17.3	7.44	2.62e-10	0.00419	0.99	0.68	Platelet count;	chr7:100397190	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs4472444	ENSG00000228546.2	CTA-313A17.3	7.44	2.64e-10	0.0042	0.98	0.68	Platelet count;	chr7:100473135	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs7809801	ENSG00000228546.2	CTA-313A17.3	7.44	2.64e-10	0.0042	0.98	0.68	Platelet count;	chr7:100474408	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11766752	ENSG00000228546.2	CTA-313A17.3	7.44	2.64e-10	0.0042	0.98	0.68	Platelet count;	chr7:100475669	chr7:102337316~102339115:+
READ	trans	rs61990749	0.597	rs7142390	ENSG00000235400.1	RP4-641G12.4	7.42	2.93e-10	0.00463	1.02	0.67	Fibroblast growth factor basic levels;	chr14:77766537	chr1:78749073~78750659:+
READ	trans	rs4276421	0.716	rs34186279	ENSG00000231752.4	EMBP1	7.41	2.98e-10	0.00471	0.94	0.67	P wave duration;	chr5:46221966	chr1:121519112~121571892:+
READ	trans	rs6477998	0.535	rs4979232	ENSG00000238072.1	RP11-305M3.2	-7.4	3.1e-10	0.00488	-0.94	-0.67	Hematology traits;	chr9:113286594	chr7:129410113~129410370:-
READ	trans	rs4276421	0.656	rs13180509	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46239147	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs8188149	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46242641	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs13436334	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46243759	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs10473416	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46246868	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs4975961	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46247615	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs8185100	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46250619	chr1:121519112~121571892:+
READ	trans	rs4276421	0.594	rs7293434	ENSG00000231752.4	EMBP1	7.39	3.22e-10	0.00506	0.96	0.67	P wave duration;	chr5:46257587	chr1:121519112~121571892:+
READ	trans	rs7811142	1	rs7783550	ENSG00000228546.2	CTA-313A17.3	-7.39	3.27e-10	0.00513	-0.97	-0.67	Platelet count;	chr7:100390182	chr7:102337316~102339115:+
READ	trans	rs12709013	0.636	rs1657161	ENSG00000233719.3	GOT2P3	7.39	3.32e-10	0.00519	0.85	0.67	Blood metabolite ratios;	chr16:58743234	chr12:9641802~9643007:+
READ	trans	rs3749237	0.595	rs1464567	ENSG00000197582.5	GPX1P1	-7.39	3.33e-10	0.00521	-0.87	-0.67	Resting heart rate;	chr3:49421819	chrX:13378735~13379340:-
READ	trans	rs7811142	0.83	rs7341507	ENSG00000228546.2	CTA-313A17.3	7.37	3.54e-10	0.0055	0.99	0.67	Platelet count;	chr7:100353692	chr7:102337316~102339115:+
READ	trans	rs7121616	0.531	rs10892958	ENSG00000234176.1	HSPA8P1	7.37	3.57e-10	0.00555	0.83	0.67	Breast cancer;	chr11:123061415	chrX:121203182~121205014:-
READ	trans	rs7121616	0.531	rs11218941	ENSG00000234176.1	HSPA8P1	7.37	3.57e-10	0.00555	0.83	0.67	Breast cancer;	chr11:123061701	chrX:121203182~121205014:-
READ	trans	rs12709013	0.574	rs839418	ENSG00000233719.3	GOT2P3	7.37	3.59e-10	0.00558	0.83	0.67	Blood metabolite ratios;	chr16:58705426	chr12:9641802~9643007:+
READ	trans	rs6477998	0.535	rs10817475	ENSG00000238072.1	RP11-305M3.2	7.36	3.7e-10	0.00573	0.95	0.67	Hematology traits;	chr9:113296774	chr7:129410113~129410370:-
READ	trans	rs12709013	0.636	rs9937713	ENSG00000233719.3	GOT2P3	7.36	3.7e-10	0.00573	0.84	0.67	Blood metabolite ratios;	chr16:58771921	chr12:9641802~9643007:+
READ	trans	rs12709013	0.591	rs9932967	ENSG00000233719.3	GOT2P3	7.36	3.76e-10	0.00581	0.86	0.67	Blood metabolite ratios;	chr16:58805583	chr12:9641802~9643007:+
READ	trans	rs7811142	1	rs11773661	ENSG00000228546.2	CTA-313A17.3	7.34	4.03e-10	0.00622	0.97	0.67	Platelet count;	chr7:100475446	chr7:102337316~102339115:+
READ	trans	rs7811142	0.943	rs66958101	ENSG00000228546.2	CTA-313A17.3	7.34	4.03e-10	0.00622	0.97	0.67	Platelet count;	chr7:100476397	chr7:102337316~102339115:+
READ	trans	rs5022636	0.891	rs4971027	ENSG00000180764.13	PIPSL	7.34	4.03e-10	0.00622	1.11	0.67	Gut microbiota (functional units);	chr1:151277945	chr10:93958191~93961540:-
READ	trans	rs12709013	0.591	rs149479	ENSG00000233719.3	GOT2P3	-7.34	4.08e-10	0.00628	-0.83	-0.67	Blood metabolite ratios;	chr16:58703171	chr12:9641802~9643007:+
READ	trans	rs10242455	0.702	rs114658645	ENSG00000228834.1	RP11-249L21.4	7.33	4.17e-10	0.00641	1.91	0.67	Blood metabolite levels;	chr7:99420114	chr6:108907615~108907873:-
READ	trans	rs10186876	0.767	rs9309111	ENSG00000274001.1	RP11-5G9.5	-7.31	4.56e-10	0.00698	-0.85	-0.67	Hand grip strength;	chr2:43938594	chr13:43877715~43878163:-
READ	trans	rs5022636	0.79	rs10399679	ENSG00000180764.13	PIPSL	7.3	4.65e-10	0.0071	1.1	0.67	Gut microbiota (functional units);	chr1:151278361	chr10:93958191~93961540:-
READ	trans	rs6477998	0.513	rs10981720	ENSG00000238072.1	RP11-305M3.2	7.28	5.03e-10	0.00763	0.94	0.67	Hematology traits;	chr9:113293831	chr7:129410113~129410370:-
READ	trans	rs12709013	0.591	rs30834	ENSG00000233719.3	GOT2P3	7.27	5.3e-10	0.008	0.86	0.67	Blood metabolite ratios;	chr16:58715394	chr12:9641802~9643007:+
READ	trans	rs13190036	0.551	rs11955537	ENSG00000217325.2	PRELID1P1	-7.27	5.43e-10	0.00817	-1	-0.67	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177147087	chr6:126643488~126644390:+
READ	trans	rs10037055	0.685	rs10039241	ENSG00000217325.2	PRELID1P1	-7.27	5.43e-10	0.00817	-1	-0.67	Migraine without aura;	chr5:177151071	chr6:126643488~126644390:+
READ	trans	rs10037055	0.636	rs13166688	ENSG00000217325.2	PRELID1P1	-7.27	5.43e-10	0.00817	-1	-0.67	Migraine without aura;	chr5:177156965	chr6:126643488~126644390:+
READ	trans	rs7811142	0.943	rs11769886	ENSG00000228546.2	CTA-313A17.3	7.27	5.45e-10	0.00819	0.98	0.67	Platelet count;	chr7:100400984	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs73161762	ENSG00000228546.2	CTA-313A17.3	7.27	5.45e-10	0.00819	0.98	0.67	Platelet count;	chr7:100417223	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs7783159	ENSG00000228546.2	CTA-313A17.3	7.27	5.45e-10	0.00819	0.98	0.67	Platelet count;	chr7:100419831	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11761725	ENSG00000228546.2	CTA-313A17.3	7.27	5.45e-10	0.00819	0.98	0.67	Platelet count;	chr7:100442192	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs2406255	ENSG00000228546.2	CTA-313A17.3	7.27	5.45e-10	0.00819	0.98	0.67	Platelet count;	chr7:100456067	chr7:102337316~102339115:+
READ	trans	rs3735025	0.963	rs728054	ENSG00000260145.1	RP11-322D14.2	-7.27	5.45e-10	0.0082	-0.83	-0.67	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137387618	chr16:57052505~57058497:-
READ	trans	rs35275482	1	rs35275482	ENSG00000267213.4	AC007773.2	-7.26	5.58e-10	0.00837	-0.86	-0.67	Gut microbiota (bacterial taxa);	chr15:59790699	chr19:32390050~32405560:-
READ	trans	rs7811142	1	rs7803454	ENSG00000228546.2	CTA-313A17.3	7.26	5.6e-10	0.0084	0.98	0.67	Platelet count;	chr7:100393925	chr7:102337316~102339115:+
READ	trans	rs7811142	0.887	rs35111986	ENSG00000228546.2	CTA-313A17.3	7.26	5.6e-10	0.0084	0.98	0.67	Platelet count;	chr7:100402651	chr7:102337316~102339115:+
READ	trans	rs6477998	0.868	rs10513189	ENSG00000238072.1	RP11-305M3.2	7.26	5.62e-10	0.00843	0.85	0.67	Hematology traits;	chr9:113227941	chr7:129410113~129410370:-
READ	trans	rs5022636	0.927	rs943637	ENSG00000180764.13	PIPSL	7.25	5.7e-10	0.00853	1.1	0.67	Gut microbiota (functional units);	chr1:151310543	chr10:93958191~93961540:-
READ	trans	rs5022636	1	rs4970948	ENSG00000180764.13	PIPSL	7.25	5.7e-10	0.00853	1.1	0.67	Gut microbiota (functional units);	chr1:151318767	chr10:93958191~93961540:-
READ	trans	rs5022636	0.964	rs7518924	ENSG00000180764.13	PIPSL	7.25	5.7e-10	0.00853	1.1	0.67	Gut microbiota (functional units);	chr1:151319225	chr10:93958191~93961540:-
READ	trans	rs5022636	1	rs5022636	ENSG00000180764.13	PIPSL	7.25	5.7e-10	0.00853	1.1	0.67	Gut microbiota (functional units);	chr1:151322585	chr10:93958191~93961540:-
READ	trans	rs12709013	0.636	rs6499976	ENSG00000233719.3	GOT2P3	7.25	5.77e-10	0.00864	0.82	0.67	Blood metabolite ratios;	chr16:58770330	chr12:9641802~9643007:+
READ	trans	rs7973618	1	rs7973618	ENSG00000121089.4	NACA3P	-7.25	5.82e-10	0.00871	-0.72	-0.67	Mean platelet volume;	chr12:56625659	chr4:164943290~164943937:+
READ	trans	rs7811142	0.779	rs111312383	ENSG00000228546.2	CTA-313A17.3	7.24	6.1e-10	0.00909	1.02	0.67	Platelet count;	chr7:100307702	chr7:102337316~102339115:+
READ	trans	rs7811142	0.779	rs28680963	ENSG00000228546.2	CTA-313A17.3	7.24	6.1e-10	0.00909	1.02	0.67	Platelet count;	chr7:100307852	chr7:102337316~102339115:+
READ	trans	rs7811142	0.666	rs28401739	ENSG00000228546.2	CTA-313A17.3	7.24	6.1e-10	0.00909	1.02	0.67	Platelet count;	chr7:100308061	chr7:102337316~102339115:+
READ	trans	rs5022636	0.896	rs4971032	ENSG00000180764.13	PIPSL	7.24	6.12e-10	0.0091	1.09	0.67	Gut microbiota (functional units);	chr1:151317948	chr10:93958191~93961540:-
READ	trans	rs4276421	0.623	rs8188231	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46186924	chr1:121519112~121571892:+
READ	trans	rs4276421	0.684	rs8188258	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46187284	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs10065920	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46190593	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs8188292	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46191402	chr1:121519112~121571892:+
READ	trans	rs4276421	0.684	rs10064829	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46192959	chr1:121519112~121571892:+
READ	trans	rs4276421	0.657	rs8175415	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46193360	chr1:121519112~121571892:+
READ	trans	rs4276421	0.657	rs8188010	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46194057	chr1:121519112~121571892:+
READ	trans	rs4276421	0.633	rs62370770	ENSG00000231752.4	EMBP1	7.24	6.12e-10	0.0091	0.92	0.67	P wave duration;	chr5:46195784	chr1:121519112~121571892:+
READ	trans	rs7811142	0.83	rs73401443	ENSG00000228546.2	CTA-313A17.3	7.24	6.14e-10	0.00911	0.99	0.67	Platelet count;	chr7:100379959	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs6945952	ENSG00000228546.2	CTA-313A17.3	7.24	6.14e-10	0.00911	0.99	0.67	Platelet count;	chr7:100384152	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs73401450	ENSG00000228546.2	CTA-313A17.3	7.24	6.14e-10	0.00911	0.99	0.67	Platelet count;	chr7:100384236	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs73401451	ENSG00000228546.2	CTA-313A17.3	7.24	6.14e-10	0.00911	0.99	0.67	Platelet count;	chr7:100384272	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs10085549	ENSG00000228546.2	CTA-313A17.3	7.24	6.14e-10	0.00911	0.99	0.67	Platelet count;	chr7:100385512	chr7:102337316~102339115:+
READ	trans	rs6732160	0.657	rs10171459	ENSG00000236165.1	PRADC1P1	7.23	6.27e-10	0.00927	0.73	0.66	Intelligence (multi-trait analysis);	chr2:73207600	chr3:36976316~36976840:+
READ	trans	rs13253073	0.545	rs13265660	ENSG00000260318.1	COX6CP1	7.23	6.43e-10	0.0095	1.13	0.66	Glucose homeostasis traits;	chr8:99815931	chr16:11903923~11904137:-
READ	trans	rs10242455	0.557	rs73403272	ENSG00000228834.1	RP11-249L21.4	7.22	6.6e-10	0.00974	1.66	0.66	Blood metabolite levels;	chr7:99536585	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs7794068	ENSG00000228834.1	RP11-249L21.4	7.22	6.6e-10	0.00974	1.66	0.66	Blood metabolite levels;	chr7:99549250	chr6:108907615~108907873:-
READ	trans	rs10242455	0.571	rs56167514	ENSG00000228834.1	RP11-249L21.4	7.22	6.6e-10	0.00974	1.66	0.66	Blood metabolite levels;	chr7:99563724	chr6:108907615~108907873:-
READ	trans	rs10242455	0.571	rs7805661	ENSG00000228834.1	RP11-249L21.4	7.22	6.6e-10	0.00974	1.66	0.66	Blood metabolite levels;	chr7:99573899	chr6:108907615~108907873:-
READ	trans	rs10242455	0.571	rs6955162	ENSG00000228834.1	RP11-249L21.4	7.22	6.6e-10	0.00974	1.66	0.66	Blood metabolite levels;	chr7:99586777	chr6:108907615~108907873:-
READ	trans	rs10940346	1	rs1328254	ENSG00000231752.4	EMBP1	-7.22	6.66e-10	0.00983	-0.93	-0.66	Schizophrenia;	chr5:50265025	chr1:121519112~121571892:+
READ	trans	rs35275482	0.79	rs2965329	ENSG00000267213.4	AC007773.2	7.21	6.85e-10	0.01	0.85	0.66	Gut microbiota (bacterial taxa);	chr15:59816800	chr19:32390050~32405560:-
READ	trans	rs9467773	0.62	rs1490488	ENSG00000242375.1	RP11-498P14.3	7.21	6.9e-10	0.01	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26614580	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494692	ENSG00000242375.1	RP11-498P14.3	7.21	6.9e-10	0.01	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26614995	chr9:97195351~97197687:-
READ	trans	rs2731664	0.792	rs335420	ENSG00000215571.5	GRK6P1	-7.2	7.1e-10	0.0102	-0.8	-0.66	Intelligence (multi-trait analysis);	chr5:177471618	chr13:21319156~21320866:+
READ	trans	rs7811142	0.83	rs6948685	ENSG00000228546.2	CTA-313A17.3	7.2	7.21e-10	0.0104	0.99	0.66	Platelet count;	chr7:100372565	chr7:102337316~102339115:+
READ	trans	rs7811142	0.887	rs111972532	ENSG00000228546.2	CTA-313A17.3	7.2	7.25e-10	0.0104	0.96	0.66	Platelet count;	chr7:100471465	chr7:102337316~102339115:+
READ	trans	rs8081395	0.834	rs11650106	ENSG00000187870.7	RNFT1P3	-7.19	7.28e-10	0.0105	-0.81	-0.66	White blood cell count;	chr17:59772890	chr17:20743333~20754501:-
READ	trans	rs9467773	0.595	rs7767847	ENSG00000242375.1	RP11-498P14.3	7.19	7.34e-10	0.0106	0.88	0.66	Intelligence (multi-trait analysis);	chr6:26597665	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs3800303	ENSG00000242375.1	RP11-498P14.3	7.19	7.34e-10	0.0106	0.88	0.66	Intelligence (multi-trait analysis);	chr6:26597960	chr9:97195351~97197687:-
READ	trans	rs8081395	0.836	rs2150879	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59781849	chr17:20743333~20754501:-
READ	trans	rs8081395	0.801	rs2665405	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59797931	chr17:20743333~20754501:-
READ	trans	rs8081395	0.801	rs2777895	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59802249	chr17:20743333~20754501:-
READ	trans	rs8081395	0.769	rs12449331	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59806285	chr17:20743333~20754501:-
READ	trans	rs8081395	0.801	rs12938273	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59824291	chr17:20743333~20754501:-
READ	trans	rs8081395	0.836	rs1295926	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59832012	chr17:20743333~20754501:-
READ	trans	rs8081395	0.836	rs1292061	ENSG00000187870.7	RNFT1P3	-7.19	7.52e-10	0.0108	-0.81	-0.66	White blood cell count;	chr17:59833869	chr17:20743333~20754501:-
READ	trans	rs8081395	0.801	rs2665404	ENSG00000187870.7	RNFT1P3	7.19	7.52e-10	0.0108	0.81	0.66	White blood cell count;	chr17:59798035	chr17:20743333~20754501:-
READ	trans	rs7554547	0.652	rs198383	ENSG00000261819.1	RP11-680G24.4	7.19	7.58e-10	0.0109	0.78	0.66	Nonsyndromic cleft lip with cleft palate;	chr1:11873583	chr16:14988259~14990160:-
READ	trans	rs8081395	0.899	rs2645477	ENSG00000187870.7	RNFT1P3	-7.17	7.92e-10	0.0113	-0.83	-0.66	White blood cell count;	chr17:59768263	chr17:20743333~20754501:-
READ	trans	rs8081395	0.836	rs2063353	ENSG00000187870.7	RNFT1P3	-7.17	7.92e-10	0.0113	-0.81	-0.66	White blood cell count;	chr17:59811831	chr17:20743333~20754501:-
READ	trans	rs941207	0.526	rs2242497	ENSG00000121089.4	NACA3P	-7.17	8.22e-10	0.0117	-0.72	-0.66	Platelet count;	chr12:56598846	chr4:164943290~164943937:+
READ	trans	rs6477998	1	rs7038769	ENSG00000238072.1	RP11-305M3.2	7.16	8.4e-10	0.0119	0.83	0.66	Hematology traits;	chr9:113245303	chr7:129410113~129410370:-
READ	trans	rs6477998	1	rs7022397	ENSG00000238072.1	RP11-305M3.2	7.16	8.4e-10	0.0119	0.83	0.66	Hematology traits;	chr9:113245397	chr7:129410113~129410370:-
READ	trans	rs3735025	1	rs17529963	ENSG00000260145.1	RP11-322D14.2	-7.16	8.44e-10	0.012	-0.84	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137394426	chr16:57052505~57058497:-
READ	trans	rs3735025	1	rs17530005	ENSG00000260145.1	RP11-322D14.2	-7.16	8.44e-10	0.012	-0.84	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137394538	chr16:57052505~57058497:-
READ	trans	rs7811142	0.83	rs11768967	ENSG00000228546.2	CTA-313A17.3	7.15	8.61e-10	0.0121	0.98	0.66	Platelet count;	chr7:100370021	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs7792525	ENSG00000228546.2	CTA-313A17.3	7.15	8.61e-10	0.0121	0.98	0.66	Platelet count;	chr7:100374499	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs7792959	ENSG00000228546.2	CTA-313A17.3	7.15	8.61e-10	0.0121	0.98	0.66	Platelet count;	chr7:100374780	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs6975660	ENSG00000228546.2	CTA-313A17.3	7.15	8.61e-10	0.0121	0.98	0.66	Platelet count;	chr7:100377643	chr7:102337316~102339115:+
READ	trans	rs9467773	0.62	rs2451731	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26624594	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs9295701	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26627280	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494700	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26631078	chr9:97195351~97197687:-
READ	trans	rs9467773	0.584	rs1021372	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26632216	chr9:97195351~97197687:-
READ	trans	rs9467773	0.583	rs1021373	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26632229	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2451744	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26633235	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494701	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26634204	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs1027204	ENSG00000242375.1	RP11-498P14.3	7.15	8.62e-10	0.0121	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26639385	chr9:97195351~97197687:-
READ	trans	rs10940346	1	rs2016360	ENSG00000231752.4	EMBP1	-7.15	8.68e-10	0.0122	-0.91	-0.66	Schizophrenia;	chr5:50491064	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs7378983	ENSG00000231752.4	EMBP1	-7.15	8.68e-10	0.0122	-0.91	-0.66	Schizophrenia;	chr5:50491889	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs6450164	ENSG00000231752.4	EMBP1	-7.15	8.68e-10	0.0122	-0.91	-0.66	Schizophrenia;	chr5:50502814	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs1962832	ENSG00000231752.4	EMBP1	-7.15	8.68e-10	0.0122	-0.91	-0.66	Schizophrenia;	chr5:50502962	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs7713759	ENSG00000231752.4	EMBP1	7.15	8.7e-10	0.0122	0.94	0.66	P wave duration;	chr5:46143447	chr1:121519112~121571892:+
READ	trans	rs35275482	0.834	rs17302720	ENSG00000267213.4	AC007773.2	-7.14	8.98e-10	0.0126	-0.85	-0.66	Gut microbiota (bacterial taxa);	chr15:59794050	chr19:32390050~32405560:-
READ	trans	rs2950393	0.572	rs10783794	ENSG00000121089.4	NACA3P	-7.13	9.32e-10	0.0131	-0.72	-0.66	Platelet distribution width;	chr12:56593395	chr4:164943290~164943937:+
READ	trans	rs35275482	1	rs4775207	ENSG00000267213.4	AC007773.2	-7.13	9.54e-10	0.0134	-0.83	-0.66	Gut microbiota (bacterial taxa);	chr15:59776023	chr19:32390050~32405560:-
READ	trans	rs6732160	0.631	rs7557285	ENSG00000236165.1	PRADC1P1	7.13	9.65e-10	0.0135	0.75	0.66	Intelligence (multi-trait analysis);	chr2:73215684	chr3:36976316~36976840:+
READ	trans	rs941207	0.762	rs10450	ENSG00000121089.4	NACA3P	7.12	9.76e-10	0.0136	0.76	0.66	Platelet count;	chr12:56590822	chr4:164943290~164943937:+
READ	trans	rs2731664	0.765	rs2630766	ENSG00000215571.5	GRK6P1	7.12	9.91e-10	0.0138	0.8	0.66	Intelligence (multi-trait analysis);	chr5:177447940	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs466256	ENSG00000215571.5	GRK6P1	7.12	9.91e-10	0.0138	0.8	0.66	Intelligence (multi-trait analysis);	chr5:177448955	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs2630765	ENSG00000215571.5	GRK6P1	7.12	9.91e-10	0.0138	0.8	0.66	Intelligence (multi-trait analysis);	chr5:177449824	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs2544809	ENSG00000215571.5	GRK6P1	7.12	9.91e-10	0.0138	0.8	0.66	Intelligence (multi-trait analysis);	chr5:177458498	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs2545795	ENSG00000215571.5	GRK6P1	7.12	9.91e-10	0.0138	0.8	0.66	Intelligence (multi-trait analysis);	chr5:177460105	chr13:21319156~21320866:+
READ	trans	rs10940346	1	rs492337	ENSG00000231752.4	EMBP1	-7.12	9.97e-10	0.0138	-0.93	-0.66	Schizophrenia;	chr5:50274706	chr1:121519112~121571892:+
READ	trans	rs7811142	1	rs11559117	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100478991	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs2406253	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100479650	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs4463351	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100480603	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs60844404	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100482851	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs113738841	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100483683	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11763511	ENSG00000228546.2	CTA-313A17.3	7.11	1.02e-09	0.0141	0.96	0.66	Platelet count;	chr7:100484321	chr7:102337316~102339115:+
READ	trans	rs3735025	0.963	rs2351137	ENSG00000260145.1	RP11-322D14.2	-7.11	1.03e-09	0.0142	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137386593	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs2351138	ENSG00000260145.1	RP11-322D14.2	-7.11	1.03e-09	0.0142	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137386644	chr16:57052505~57058497:-
READ	trans	rs4276421	0.684	rs11958686	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46173456	chr1:121519112~121571892:+
READ	trans	rs4276421	0.688	rs11950077	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46179798	chr1:121519112~121571892:+
READ	trans	rs4276421	0.654	rs8185114	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46181843	chr1:121519112~121571892:+
READ	trans	rs4276421	0.652	rs8188276	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46182731	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs8185101	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46183248	chr1:121519112~121571892:+
READ	trans	rs4276421	0.656	rs13188002	ENSG00000231752.4	EMBP1	7.1	1.07e-09	0.0147	0.91	0.66	P wave duration;	chr5:46184203	chr1:121519112~121571892:+
READ	trans	rs7811142	0.72	rs112622797	ENSG00000228546.2	CTA-313A17.3	7.1	1.09e-09	0.015	0.99	0.66	Platelet count;	chr7:100319793	chr7:102337316~102339115:+
READ	trans	rs6732160	0.593	rs2288630	ENSG00000236165.1	PRADC1P1	7.09	1.1e-09	0.0151	0.75	0.66	Intelligence (multi-trait analysis);	chr2:73230424	chr3:36976316~36976840:+
READ	trans	rs1045902	0.967	rs10207625	ENSG00000236165.1	PRADC1P1	7.09	1.1e-09	0.0151	0.75	0.66	Intelligence (multi-trait analysis);	chr2:73237680	chr3:36976316~36976840:+
READ	trans	rs1045902	0.967	rs1469530	ENSG00000236165.1	PRADC1P1	7.09	1.1e-09	0.0151	0.75	0.66	Intelligence (multi-trait analysis);	chr2:73237820	chr3:36976316~36976840:+
READ	trans	rs12709013	0.535	rs9924136	ENSG00000233719.3	GOT2P3	7.09	1.11e-09	0.0151	0.86	0.66	Blood metabolite ratios;	chr16:58779573	chr12:9641802~9643007:+
READ	trans	rs12709013	0.574	rs35321124	ENSG00000233719.3	GOT2P3	7.09	1.11e-09	0.0151	0.86	0.66	Blood metabolite ratios;	chr16:58786561	chr12:9641802~9643007:+
READ	trans	rs3735025	0.963	rs4518583	ENSG00000260145.1	RP11-322D14.2	-7.08	1.14e-09	0.0156	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137386398	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs4613918	ENSG00000260145.1	RP11-322D14.2	7.08	1.14e-09	0.0156	0.85	0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137386518	chr16:57052505~57058497:-
READ	trans	rs2950393	0.929	rs2958155	ENSG00000121089.4	NACA3P	7.08	1.14e-09	0.0156	0.71	0.66	Platelet distribution width;	chr12:56670761	chr4:164943290~164943937:+
READ	trans	rs10940346	1	rs56387400	ENSG00000231752.4	EMBP1	-7.08	1.15e-09	0.0157	-0.9	-0.66	Schizophrenia;	chr5:50517577	chr1:121519112~121571892:+
READ	trans	rs116095464	0.558	rs7708515	ENSG00000185986.11	SDHAP3	7.08	1.16e-09	0.0158	1.28	0.66	Breast cancer;	chr5:234874	chr5:1572222~1594620:-
READ	trans	rs5022636	0.927	rs10888410	ENSG00000180764.13	PIPSL	7.08	1.17e-09	0.0159	1.02	0.66	Gut microbiota (functional units);	chr1:151299975	chr10:93958191~93961540:-
READ	trans	rs5022636	0.964	rs1056847	ENSG00000180764.13	PIPSL	7.08	1.17e-09	0.0159	1.02	0.66	Gut microbiota (functional units);	chr1:151315696	chr10:93958191~93961540:-
READ	trans	rs3735025	0.963	rs4283969	ENSG00000260145.1	RP11-322D14.2	-7.08	1.18e-09	0.016	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137386581	chr16:57052505~57058497:-
READ	trans	rs35275482	0.92	rs2970367	ENSG00000267213.4	AC007773.2	-7.08	1.18e-09	0.0161	-0.84	-0.66	Gut microbiota (bacterial taxa);	chr15:59824454	chr19:32390050~32405560:-
READ	trans	rs7811142	1	rs1073	ENSG00000228546.2	CTA-313A17.3	7.07	1.2e-09	0.0163	1	0.66	Platelet count;	chr7:100433989	chr7:102337316~102339115:+
READ	trans	rs9467773	0.62	rs2101581	ENSG00000242375.1	RP11-498P14.3	7.07	1.2e-09	0.0163	0.93	0.66	Intelligence (multi-trait analysis);	chr6:26622541	chr9:97195351~97197687:-
READ	trans	rs3735025	1	rs4728408	ENSG00000260145.1	RP11-322D14.2	7.07	1.23e-09	0.0166	0.85	0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137387350	chr16:57052505~57058497:-
READ	trans	rs10242455	0.702	rs73397447	ENSG00000228834.1	RP11-249L21.4	7.06	1.25e-09	0.0169	1.71	0.66	Blood metabolite levels;	chr7:99413326	chr6:108907615~108907873:-
READ	trans	rs10940346	0.934	rs2353960	ENSG00000231752.4	EMBP1	-7.06	1.28e-09	0.0172	-0.91	-0.66	Schizophrenia;	chr5:50481153	chr1:121519112~121571892:+
READ	trans	rs10940346	0.935	rs4971258	ENSG00000231752.4	EMBP1	-7.06	1.28e-09	0.0172	-0.91	-0.66	Schizophrenia;	chr5:50498560	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs11948752	ENSG00000231752.4	EMBP1	-7.06	1.28e-09	0.0172	-0.91	-0.66	Schizophrenia;	chr5:50504082	chr1:121519112~121571892:+
READ	trans	rs61990749	0.571	rs4903655	ENSG00000235400.1	RP4-641G12.4	7.06	1.28e-09	0.0173	1.12	0.66	Fibroblast growth factor basic levels;	chr14:77839983	chr1:78749073~78750659:+
READ	trans	rs61990749	0.571	rs4448861	ENSG00000235400.1	RP4-641G12.4	7.06	1.28e-09	0.0173	1.12	0.66	Fibroblast growth factor basic levels;	chr14:77841392	chr1:78749073~78750659:+
READ	trans	rs6708331	0.517	rs12614547	ENSG00000232654.1	FAM136BP	7.06	1.29e-09	0.0174	0.87	0.66	Obesity-related traits;	chr2:70056839	chr6:3045384~3045800:+
READ	trans	rs3735025	1	rs1376608	ENSG00000260145.1	RP11-322D14.2	-7.05	1.3e-09	0.0175	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137390015	chr16:57052505~57058497:-
READ	trans	rs3735025	1	rs3735026	ENSG00000260145.1	RP11-322D14.2	-7.05	1.3e-09	0.0175	-0.85	-0.66	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137390093	chr16:57052505~57058497:-
READ	trans	rs10940346	1	rs555458	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50262772	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs510897	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50263017	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs507396	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50263374	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs11960661	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50266528	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs489407	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50266701	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs491470	ENSG00000231752.4	EMBP1	-7.04	1.36e-09	0.0182	-0.92	-0.66	Schizophrenia;	chr5:50266988	chr1:121519112~121571892:+
READ	trans	rs12709013	0.636	rs1646256	ENSG00000233719.3	GOT2P3	7.04	1.38e-09	0.0185	0.85	0.65	Blood metabolite ratios;	chr16:58712114	chr12:9641802~9643007:+
READ	trans	rs7554547	0.69	rs4846064	ENSG00000261819.1	RP11-680G24.4	7.04	1.39e-09	0.0186	0.76	0.65	Nonsyndromic cleft lip with cleft palate;	chr1:11874785	chr16:14988259~14990160:-
READ	trans	rs35275482	0.92	rs117773980	ENSG00000267213.4	AC007773.2	-7.03	1.41e-09	0.0188	-0.84	-0.65	Gut microbiota (bacterial taxa);	chr15:59825871	chr19:32390050~32405560:-
READ	trans	rs3735025	1	rs728055	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137387785	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs13230189	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137388513	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs7779548	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137389794	chr16:57052505~57058497:-
READ	trans	rs3735025	1	rs11766321	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137392157	chr16:57052505~57058497:-
READ	trans	rs3735025	1	rs12540417	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137392357	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs12538697	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137393294	chr16:57052505~57058497:-
READ	trans	rs3735025	1	rs13236574	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137393396	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs13222414	ENSG00000260145.1	RP11-322D14.2	-7.03	1.42e-09	0.0189	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137393444	chr16:57052505~57058497:-
READ	trans	rs9467773	0.62	rs2451738	ENSG00000242375.1	RP11-498P14.3	-7.03	1.43e-09	0.019	-0.91	-0.65	Intelligence (multi-trait analysis);	chr6:26618231	chr9:97195351~97197687:-
READ	trans	rs10242455	0.702	rs73713521	ENSG00000228834.1	RP11-249L21.4	7.02	1.52e-09	0.0201	1.9	0.65	Blood metabolite levels;	chr7:99591026	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs78680379	ENSG00000228834.1	RP11-249L21.4	7.02	1.52e-09	0.0201	1.9	0.65	Blood metabolite levels;	chr7:99600950	chr6:108907615~108907873:-
READ	trans	rs10940346	1	rs10940346	ENSG00000231752.4	EMBP1	-7	1.6e-09	0.0211	-0.91	-0.65	Schizophrenia;	chr5:50510208	chr1:121519112~121571892:+
READ	trans	rs8010715	1	rs3742500	ENSG00000248988.1	RP11-815N9.2	7	1.64e-09	0.0216	0.85	0.65	IgG glycosylation;	chr14:24142769	chr4:159007119~159007835:+
READ	trans	rs9467773	0.62	rs2504592	ENSG00000242375.1	RP11-498P14.3	6.99	1.66e-09	0.0218	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26640723	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2504599	ENSG00000242375.1	RP11-498P14.3	6.99	1.66e-09	0.0218	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26640832	chr9:97195351~97197687:-
READ	trans	rs10940346	1	rs2137132	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50353988	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs1995795	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50356233	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs6874829	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50357573	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs7721808	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50363136	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs1812994	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50364397	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs13185587	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50365409	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs3849670	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50365641	chr1:121519112~121571892:+
READ	trans	rs10940346	0.905	rs4030569	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50371779	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs4030570	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50371829	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs4030572	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50375897	chr1:121519112~121571892:+
READ	trans	rs10940346	0.875	rs10076490	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50389037	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs7712749	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50400441	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs2036901	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50401306	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs13154223	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50403152	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs2271236	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50405921	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs62365887	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50408254	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs34044167	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50410136	chr1:121519112~121571892:+
READ	trans	rs10940346	0.875	rs13159506	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50415061	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs13173678	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50422314	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs6450108	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50434427	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs28445612	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50439676	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs2353436	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50445695	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs1849200	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50448053	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs6899048	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50451256	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs2353437	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50452078	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs2102454	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50452446	chr1:121519112~121571892:+
READ	trans	rs10940346	0.875	rs13172257	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50462916	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs10074196	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50464713	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs13186891	ENSG00000231752.4	EMBP1	6.99	1.68e-09	0.0219	0.91	0.65	Schizophrenia;	chr5:50467244	chr1:121519112~121571892:+
READ	trans	rs10940346	0.967	rs6450134	ENSG00000231752.4	EMBP1	-6.99	1.68e-09	0.0219	-0.91	-0.65	Schizophrenia;	chr5:50471121	chr1:121519112~121571892:+
READ	trans	rs1816752	0.716	rs9553330	ENSG00000237917.1	PARP4P1	-6.99	1.68e-09	0.0219	-0.8	-0.65	Obesity-related traits;	chr13:24516018	chrY:26594851~26634652:-
READ	trans	rs12709013	0.729	rs1657179	ENSG00000230849.2	GOT2P2	6.99	1.69e-09	0.0219	0.85	0.65	Blood metabolite ratios;	chr16:58735115	chr1:173141100~173142350:-
READ	trans	rs12709013	0.792	rs1473206	ENSG00000230849.2	GOT2P2	6.99	1.69e-09	0.0219	0.85	0.65	Blood metabolite ratios;	chr16:58737529	chr1:173141100~173142350:-
READ	trans	rs12709013	0.792	rs1473205	ENSG00000230849.2	GOT2P2	6.99	1.69e-09	0.0219	0.85	0.65	Blood metabolite ratios;	chr16:58737547	chr1:173141100~173142350:-
READ	trans	rs12709013	0.694	rs1616798	ENSG00000230849.2	GOT2P2	6.99	1.69e-09	0.0219	0.85	0.65	Blood metabolite ratios;	chr16:58739433	chr1:173141100~173142350:-
READ	trans	rs35275482	0.92	rs2970366	ENSG00000267213.4	AC007773.2	-6.99	1.71e-09	0.0221	-0.83	-0.65	Gut microbiota (bacterial taxa);	chr15:59824618	chr19:32390050~32405560:-
READ	trans	rs35275482	0.92	rs4775212	ENSG00000267213.4	AC007773.2	-6.99	1.71e-09	0.0221	-0.83	-0.65	Gut microbiota (bacterial taxa);	chr15:59825409	chr19:32390050~32405560:-
READ	trans	rs9467773	0.62	rs2451737	ENSG00000242375.1	RP11-498P14.3	6.99	1.72e-09	0.0222	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26618813	chr9:97195351~97197687:-
READ	trans	rs9467773	0.596	rs2494693	ENSG00000242375.1	RP11-498P14.3	6.99	1.72e-09	0.0222	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26618998	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494694	ENSG00000242375.1	RP11-498P14.3	6.99	1.72e-09	0.0222	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26619100	chr9:97195351~97197687:-
READ	trans	rs9467773	0.595	rs2451736	ENSG00000242375.1	RP11-498P14.3	6.99	1.72e-09	0.0222	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26620316	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs2494696	ENSG00000242375.1	RP11-498P14.3	6.99	1.72e-09	0.0222	0.92	0.65	Intelligence (multi-trait analysis);	chr6:26620666	chr9:97195351~97197687:-
READ	trans	rs8081395	0.805	rs1295927	ENSG00000187870.7	RNFT1P3	6.98	1.73e-09	0.0224	0.83	0.65	White blood cell count;	chr17:59852174	chr17:20743333~20754501:-
READ	trans	rs10242455	0.702	rs17161726	ENSG00000228834.1	RP11-249L21.4	6.98	1.76e-09	0.0227	1.3	0.65	Blood metabolite levels;	chr7:99410772	chr6:108907615~108907873:-
READ	trans	rs916888	0.773	rs9896243	ENSG00000214425.5	LRRC37A4P	-6.98	1.76e-09	0.0227	-1.16	-0.65	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46748690	chr17:45506741~45550335:-
READ	trans	rs3735025	1	rs3735025	ENSG00000260145.1	RP11-322D14.2	-6.98	1.77e-09	0.0228	-0.85	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137390098	chr16:57052505~57058497:-
READ	trans	rs3735025	0.963	rs10954580	ENSG00000260145.1	RP11-322D14.2	-6.98	1.77e-09	0.0228	-0.85	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137391966	chr16:57052505~57058497:-
READ	trans	rs2731664	0.819	rs449351	ENSG00000215571.5	GRK6P1	6.97	1.83e-09	0.0235	0.77	0.65	Intelligence (multi-trait analysis);	chr5:177445590	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs465670	ENSG00000215571.5	GRK6P1	6.97	1.83e-09	0.0235	0.77	0.65	Intelligence (multi-trait analysis);	chr5:177450623	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs335452	ENSG00000215571.5	GRK6P1	6.97	1.83e-09	0.0235	0.77	0.65	Intelligence (multi-trait analysis);	chr5:177452670	chr13:21319156~21320866:+
READ	trans	rs2731664	0.721	rs2450333	ENSG00000215571.5	GRK6P1	6.97	1.83e-09	0.0236	0.78	0.65	Intelligence (multi-trait analysis);	chr5:177472545	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs2630763	ENSG00000215571.5	GRK6P1	6.97	1.83e-09	0.0236	0.78	0.65	Intelligence (multi-trait analysis);	chr5:177474004	chr13:21319156~21320866:+
READ	trans	rs2731664	0.756	rs335433	ENSG00000215571.5	GRK6P1	6.97	1.84e-09	0.0236	0.77	0.65	Intelligence (multi-trait analysis);	chr5:177440206	chr13:21319156~21320866:+
READ	trans	rs2950393	0.804	rs2958132	ENSG00000121089.4	NACA3P	6.97	1.86e-09	0.0238	0.68	0.65	Platelet distribution width;	chr12:56750749	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs7980317	ENSG00000121089.4	NACA3P	6.97	1.86e-09	0.0238	0.68	0.65	Platelet distribution width;	chr12:56764399	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs7967600	ENSG00000121089.4	NACA3P	6.97	1.86e-09	0.0238	0.68	0.65	Platelet distribution width;	chr12:56768208	chr4:164943290~164943937:+
READ	trans	rs2950393	0.804	rs898611	ENSG00000121089.4	NACA3P	-6.97	1.86e-09	0.0238	-0.68	-0.65	Platelet distribution width;	chr12:56769532	chr4:164943290~164943937:+
READ	trans	rs10037055	1	rs10037055	ENSG00000217325.2	PRELID1P1	-6.96	1.9e-09	0.0243	-0.83	-0.65	Migraine without aura;	chr5:177264278	chr6:126643488~126644390:+
READ	trans	rs12709013	0.574	rs9302706	ENSG00000233719.3	GOT2P3	6.96	1.93e-09	0.0246	0.88	0.65	Blood metabolite ratios;	chr16:58812060	chr12:9641802~9643007:+
READ	trans	rs3735025	0.963	rs4732253	ENSG00000260145.1	RP11-322D14.2	-6.96	1.93e-09	0.0247	-0.84	-0.65	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137387405	chr16:57052505~57058497:-
READ	trans	rs5022636	0.927	rs4522000	ENSG00000180764.13	PIPSL	6.96	1.94e-09	0.0248	1.06	0.65	Gut microbiota (functional units);	chr1:151283612	chr10:93958191~93961540:-
READ	trans	rs10940346	0.846	rs8175378	ENSG00000231752.4	EMBP1	-6.95	1.95e-09	0.0249	-0.93	-0.65	Schizophrenia;	chr5:50182876	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs4643959	ENSG00000231752.4	EMBP1	6.95	1.96e-09	0.025	0.9	0.65	Schizophrenia;	chr5:50391631	chr1:121519112~121571892:+
READ	trans	rs13253073	1	rs12544943	ENSG00000260318.1	COX6CP1	6.95	1.96e-09	0.0251	0.95	0.65	Glucose homeostasis traits;	chr8:99891662	chr16:11903923~11904137:-
READ	trans	rs116095464	0.558	rs1541822	ENSG00000185986.11	SDHAP3	-6.95	2e-09	0.0255	-1.27	-0.65	Breast cancer;	chr5:269119	chr5:1572222~1594620:-
READ	trans	rs5022636	0.74	rs11204795	ENSG00000180764.13	PIPSL	6.95	2.02e-09	0.0257	1.05	0.65	Gut microbiota (functional units);	chr1:151275522	chr10:93958191~93961540:-
READ	trans	rs1816752	0.624	rs2096093	ENSG00000237917.1	PARP4P1	-6.94	2.04e-09	0.026	-0.81	-0.65	Obesity-related traits;	chr13:24472753	chrY:26594851~26634652:-
READ	trans	rs1816752	0.608	rs4770690	ENSG00000237917.1	PARP4P1	-6.94	2.06e-09	0.0262	-0.79	-0.65	Obesity-related traits;	chr13:24467049	chrY:26594851~26634652:-
READ	trans	rs13190036	1	rs655623	ENSG00000217325.2	PRELID1P1	6.93	2.12e-09	0.0269	0.85	0.65	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177107515	chr6:126643488~126644390:+
READ	trans	rs13190036	0.551	rs28932178	ENSG00000217325.2	PRELID1P1	-6.93	2.17e-09	0.0274	-0.93	-0.65	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177210575	chr6:126643488~126644390:+
READ	trans	rs10940346	1	rs7380816	ENSG00000231752.4	EMBP1	-6.92	2.2e-09	0.0279	-0.9	-0.65	Schizophrenia;	chr5:50472059	chr1:121519112~121571892:+
READ	trans	rs35275482	0.92	rs2965333	ENSG00000267213.4	AC007773.2	-6.92	2.21e-09	0.0279	-0.84	-0.65	Gut microbiota (bacterial taxa);	chr15:59823555	chr19:32390050~32405560:-
READ	trans	rs35275482	0.79	rs1437476	ENSG00000267213.4	AC007773.2	-6.92	2.21e-09	0.0279	-0.84	-0.65	Gut microbiota (bacterial taxa);	chr15:59823728	chr19:32390050~32405560:-
READ	trans	rs35275482	0.92	rs2960813	ENSG00000267213.4	AC007773.2	-6.92	2.21e-09	0.0279	-0.84	-0.65	Gut microbiota (bacterial taxa);	chr15:59824533	chr19:32390050~32405560:-
READ	trans	rs7811142	1	rs6972167	ENSG00000228546.2	CTA-313A17.3	6.92	2.22e-09	0.028	0.91	0.65	Platelet count;	chr7:100482390	chr7:102337316~102339115:+
READ	trans	rs13253073	1	rs6468694	ENSG00000260318.1	COX6CP1	6.92	2.27e-09	0.0286	1.13	0.65	Glucose homeostasis traits;	chr8:99853608	chr16:11903923~11904137:-
READ	trans	rs13253073	1	rs6986006	ENSG00000260318.1	COX6CP1	6.92	2.27e-09	0.0286	1.13	0.65	Glucose homeostasis traits;	chr8:99857251	chr16:11903923~11904137:-
READ	trans	rs13190036	0.551	rs7732930	ENSG00000217325.2	PRELID1P1	-6.92	2.27e-09	0.0286	-0.98	-0.65	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177121593	chr6:126643488~126644390:+
READ	trans	rs9572786	0.832	rs7981995	ENSG00000262714.1	RP11-44F14.8	-6.92	2.29e-09	0.0287	-0.81	-0.65	Plateletcrit;	chr13:71758618	chr16:53386944~53389085:+
READ	trans	rs9467773	0.62	rs9461275	ENSG00000242375.1	RP11-498P14.3	6.91	2.31e-09	0.0287	0.87	0.65	Intelligence (multi-trait analysis);	chr6:26590573	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs6925087	ENSG00000242375.1	RP11-498P14.3	6.91	2.31e-09	0.0287	0.87	0.65	Intelligence (multi-trait analysis);	chr6:26592625	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs4368798	ENSG00000242375.1	RP11-498P14.3	6.91	2.31e-09	0.0287	0.87	0.65	Intelligence (multi-trait analysis);	chr6:26593243	chr9:97195351~97197687:-
READ	trans	rs9467773	0.62	rs9461276	ENSG00000242375.1	RP11-498P14.3	6.91	2.31e-09	0.0287	0.87	0.65	Intelligence (multi-trait analysis);	chr6:26594940	chr9:97195351~97197687:-
READ	trans	rs35275482	0.92	rs2917824	ENSG00000267213.4	AC007773.2	-6.91	2.31e-09	0.0287	-0.81	-0.65	Gut microbiota (bacterial taxa);	chr15:59826162	chr19:32390050~32405560:-
READ	trans	rs1816752	0.646	rs750390	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24461603	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs750389	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24461677	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs750388	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24461690	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs2902359	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24461783	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs2862902	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24461965	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs734715	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462041	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs730030	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462509	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs7992667	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462821	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs7995958	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462895	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs8002741	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462918	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs7998198	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462979	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs7998203	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24462989	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs7998600	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24463222	chrY:26594851~26634652:-
READ	trans	rs1816752	0.624	rs9511282	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24463597	chrY:26594851~26634652:-
READ	trans	rs1816752	0.583	rs9511283	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24463656	chrY:26594851~26634652:-
READ	trans	rs1816752	0.583	rs9511284	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24463660	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9507351	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24465118	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs4770688	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466007	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs4770689	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466008	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs12431171	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466380	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs12854523	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466460	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9578740	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466692	chrY:26594851~26634652:-
READ	trans	rs1816752	0.631	rs4769358	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466940	chrY:26594851~26634652:-
READ	trans	rs1816752	0.608	rs4769359	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24466966	chrY:26594851~26634652:-
READ	trans	rs1816752	0.608	rs4769360	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24467016	chrY:26594851~26634652:-
READ	trans	rs1816752	0.608	rs9511290	ENSG00000237917.1	PARP4P1	-6.91	2.31e-09	0.0287	-0.81	-0.65	Obesity-related traits;	chr13:24467189	chrY:26594851~26634652:-
READ	trans	rs2731664	0.792	rs652242	ENSG00000215571.5	GRK6P1	6.91	2.33e-09	0.0289	0.76	0.65	Intelligence (multi-trait analysis);	chr5:177446009	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs385981	ENSG00000215571.5	GRK6P1	6.91	2.33e-09	0.0289	0.76	0.65	Intelligence (multi-trait analysis);	chr5:177459538	chr13:21319156~21320866:+
READ	trans	rs2731664	0.792	rs163199	ENSG00000215571.5	GRK6P1	6.91	2.33e-09	0.0289	0.76	0.65	Intelligence (multi-trait analysis);	chr5:177463066	chr13:21319156~21320866:+
READ	trans	rs8081395	0.801	rs2645479	ENSG00000187870.7	RNFT1P3	6.91	2.34e-09	0.0289	0.83	0.65	White blood cell count;	chr17:59843171	chr17:20743333~20754501:-
READ	trans	rs2731664	0.792	rs1130857	ENSG00000215571.5	GRK6P1	6.91	2.36e-09	0.0292	0.76	0.65	Intelligence (multi-trait analysis);	chr5:177436518	chr13:21319156~21320866:+
READ	trans	rs2731664	0.756	rs2545796	ENSG00000215571.5	GRK6P1	6.91	2.36e-09	0.0292	0.76	0.65	Intelligence (multi-trait analysis);	chr5:177437268	chr13:21319156~21320866:+
READ	trans	rs10186876	0.728	rs4507144	ENSG00000274001.1	RP11-5G9.5	-6.91	2.37e-09	0.0294	-0.8	-0.65	Hand grip strength;	chr2:43937342	chr13:43877715~43878163:-
READ	trans	rs1816752	0.646	rs9511279	ENSG00000237917.1	PARP4P1	-6.9	2.4e-09	0.0296	-0.82	-0.65	Obesity-related traits;	chr13:24463348	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511280	ENSG00000237917.1	PARP4P1	-6.9	2.4e-09	0.0296	-0.82	-0.65	Obesity-related traits;	chr13:24463364	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511281	ENSG00000237917.1	PARP4P1	-6.9	2.4e-09	0.0296	-0.82	-0.65	Obesity-related traits;	chr13:24463441	chrY:26594851~26634652:-
READ	trans	rs6477998	0.676	rs10981693	ENSG00000238072.1	RP11-305M3.2	-6.9	2.4e-09	0.0297	-0.83	-0.65	Hematology traits;	chr9:113223137	chr7:129410113~129410370:-
READ	trans	rs1185460	0.546	rs474201	ENSG00000231822.1	AC019097.7	6.9	2.42e-09	0.0299	0.87	0.65	Coronary artery disease;	chr11:119087519	chr2:99102018~99102752:+
READ	trans	rs7811142	0.83	rs705866	ENSG00000228546.2	CTA-313A17.3	6.9	2.43e-09	0.0299	0.97	0.65	Platelet count;	chr7:100367662	chr7:102337316~102339115:+
READ	trans	rs7811142	0.83	rs6965458	ENSG00000228546.2	CTA-313A17.3	6.9	2.43e-09	0.0299	0.97	0.65	Platelet count;	chr7:100375779	chr7:102337316~102339115:+
READ	trans	rs13253073	1	rs10955222	ENSG00000260318.1	COX6CP1	-6.9	2.44e-09	0.03	-1.12	-0.65	Glucose homeostasis traits;	chr8:99875122	chr16:11903923~11904137:-
READ	trans	rs13253073	1	rs13252579	ENSG00000260318.1	COX6CP1	6.9	2.44e-09	0.03	1.12	0.65	Glucose homeostasis traits;	chr8:99885073	chr16:11903923~11904137:-
READ	trans	rs13253073	1	rs13253073	ENSG00000260318.1	COX6CP1	6.9	2.44e-09	0.03	1.12	0.65	Glucose homeostasis traits;	chr8:99885155	chr16:11903923~11904137:-
READ	trans	rs13253073	1	rs35935983	ENSG00000260318.1	COX6CP1	6.9	2.44e-09	0.03	1.12	0.65	Glucose homeostasis traits;	chr8:99888966	chr16:11903923~11904137:-
READ	trans	rs13253073	1	rs13259066	ENSG00000260318.1	COX6CP1	6.9	2.44e-09	0.03	1.12	0.65	Glucose homeostasis traits;	chr8:99889455	chr16:11903923~11904137:-
READ	trans	rs4276421	0.695	rs4421114	ENSG00000231752.4	EMBP1	-6.9	2.46e-09	0.0302	-0.94	-0.65	P wave duration;	chr5:46069241	chr1:121519112~121571892:+
READ	trans	rs9467773	0.62	rs2101582	ENSG00000242375.1	RP11-498P14.3	6.9	2.47e-09	0.0304	0.89	0.65	Intelligence (multi-trait analysis);	chr6:26622506	chr9:97195351~97197687:-
READ	trans	rs10895275	0.51	rs11225155	ENSG00000276434.1	RP11-391H12.8	-6.9	2.49e-09	0.0306	-0.75	-0.65	Migraine;	chr11:102172669	chr13:113339450~113339958:-
READ	trans	rs13190036	0.901	rs6556309	ENSG00000217325.2	PRELID1P1	6.89	2.53e-09	0.031	1.06	0.65	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177266834	chr6:126643488~126644390:+
READ	trans	rs13190036	1	rs13175695	ENSG00000217325.2	PRELID1P1	6.89	2.53e-09	0.031	1.06	0.65	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177272810	chr6:126643488~126644390:+
READ	trans	rs4276421	0.743	rs10060199	ENSG00000231752.4	EMBP1	6.88	2.6e-09	0.0319	0.95	0.65	P wave duration;	chr5:46064524	chr1:121519112~121571892:+
READ	trans	rs2731664	0.792	rs335466	ENSG00000215571.5	GRK6P1	6.88	2.6e-09	0.0319	0.78	0.65	Intelligence (multi-trait analysis);	chr5:177462529	chr13:21319156~21320866:+
READ	trans	rs6477998	0.966	rs7851395	ENSG00000238072.1	RP11-305M3.2	6.88	2.65e-09	0.0324	0.82	0.65	Hematology traits;	chr9:113240184	chr7:129410113~129410370:-
READ	trans	rs8175379	0.506	rs8188256	ENSG00000231752.4	EMBP1	-6.88	2.65e-09	0.0324	-0.92	-0.65	Interleukin-7 levels;	chr5:46372404	chr1:121519112~121571892:+
READ	trans	rs13177918	0.603	rs2748241	ENSG00000239528.1	RPS14P8	6.88	2.66e-09	0.0325	0.75	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447931	chr5:116562562~116562930:+
READ	trans	rs6477998	0.627	rs10114381	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113213692	chr7:129410113~129410370:-
READ	trans	rs6477998	0.651	rs10114423	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113213751	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs10817460	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113214118	chr7:129410113~129410370:-
READ	trans	rs6477998	0.603	rs7859189	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113217389	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs6477997	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113218833	chr7:129410113~129410370:-
READ	trans	rs6477998	0.627	rs3810914	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113219441	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs4978536	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113220123	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs4979225	ENSG00000238072.1	RP11-305M3.2	6.88	2.67e-09	0.0325	0.83	0.65	Hematology traits;	chr9:113225130	chr7:129410113~129410370:-
READ	trans	rs5022636	0.821	rs4246525	ENSG00000180764.13	PIPSL	6.88	2.68e-09	0.0326	1.05	0.65	Gut microbiota (functional units);	chr1:151285263	chr10:93958191~93961540:-
READ	trans	rs5022636	0.927	rs10788803	ENSG00000180764.13	PIPSL	6.88	2.68e-09	0.0326	1.05	0.65	Gut microbiota (functional units);	chr1:151291306	chr10:93958191~93961540:-
READ	trans	rs5022636	0.927	rs10888409	ENSG00000180764.13	PIPSL	6.88	2.68e-09	0.0326	1.05	0.65	Gut microbiota (functional units);	chr1:151299306	chr10:93958191~93961540:-
READ	trans	rs35275482	0.85	rs2965335	ENSG00000267213.4	AC007773.2	-6.88	2.69e-09	0.0327	-0.81	-0.65	Gut microbiota (bacterial taxa);	chr15:59831897	chr19:32390050~32405560:-
READ	trans	rs10940346	1	rs7708897	ENSG00000231752.4	EMBP1	-6.87	2.71e-09	0.033	-0.9	-0.65	Schizophrenia;	chr5:50528209	chr1:121519112~121571892:+
READ	trans	rs1816752	0.679	rs8181826	ENSG00000237917.1	PARP4P1	-6.87	2.72e-09	0.0331	-0.82	-0.65	Obesity-related traits;	chr13:24396570	chrY:26594851~26634652:-
READ	trans	rs13177918	0.871	rs11745133	ENSG00000239528.1	RPS14P8	6.87	2.74e-09	0.0333	0.81	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150457826	chr5:116562562~116562930:+
READ	trans	rs13177918	0.871	rs11745194	ENSG00000239528.1	RPS14P8	6.87	2.74e-09	0.0333	0.81	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150458065	chr5:116562562~116562930:+
READ	trans	rs13177918	0.822	rs62382255	ENSG00000239528.1	RPS14P8	6.87	2.74e-09	0.0333	0.81	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150459154	chr5:116562562~116562930:+
READ	trans	rs13177918	0.834	rs13163277	ENSG00000239528.1	RPS14P8	6.87	2.74e-09	0.0333	0.81	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150459359	chr5:116562562~116562930:+
READ	trans	rs13177918	0.798	rs12516161	ENSG00000239528.1	RPS14P8	6.87	2.74e-09	0.0333	0.81	0.65	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150461098	chr5:116562562~116562930:+
READ	trans	rs10186876	0.833	rs4953040	ENSG00000274001.1	RP11-5G9.5	-6.87	2.8e-09	0.0339	-0.79	-0.65	Hand grip strength;	chr2:43950895	chr13:43877715~43878163:-
READ	trans	rs7811142	1	rs67040465	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100485455	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs2897358	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100491017	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs60478351	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100491394	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs7787620	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100491611	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs6979335	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100492237	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs11769700	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100492426	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs73405353	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100493592	chr7:102337316~102339115:+
READ	trans	rs7811142	1	rs6953107	ENSG00000228546.2	CTA-313A17.3	6.87	2.81e-09	0.0339	0.94	0.65	Platelet count;	chr7:100498041	chr7:102337316~102339115:+
READ	trans	rs6477998	0.966	rs10759637	ENSG00000238072.1	RP11-305M3.2	6.86	2.83e-09	0.0342	0.82	0.65	Hematology traits;	chr9:113262744	chr7:129410113~129410370:-
READ	trans	rs2731664	0.792	rs2630767	ENSG00000215571.5	GRK6P1	6.86	2.85e-09	0.0344	0.78	0.65	Intelligence (multi-trait analysis);	chr5:177443699	chr13:21319156~21320866:+
READ	trans	rs10940346	0.846	rs2663076	ENSG00000231752.4	EMBP1	6.86	2.9e-09	0.0348	0.9	0.65	Schizophrenia;	chr5:50430593	chr1:121519112~121571892:+
READ	trans	rs10940346	0.934	rs303231	ENSG00000231752.4	EMBP1	6.86	2.9e-09	0.0348	0.9	0.65	Schizophrenia;	chr5:50447369	chr1:121519112~121571892:+
READ	trans	rs2731664	0.792	rs335435	ENSG00000215571.5	GRK6P1	6.86	2.9e-09	0.0348	0.78	0.65	Intelligence (multi-trait analysis);	chr5:177440942	chr13:21319156~21320866:+
READ	trans	rs6477998	1	rs10759636	ENSG00000238072.1	RP11-305M3.2	6.86	2.91e-09	0.0349	0.82	0.64	Hematology traits;	chr9:113256497	chr7:129410113~129410370:-
READ	trans	rs13253073	0.545	rs13260744	ENSG00000260318.1	COX6CP1	6.85	2.96e-09	0.0355	1.1	0.64	Glucose homeostasis traits;	chr8:99819032	chr16:11903923~11904137:-
READ	trans	rs10940346	0.935	rs2353959	ENSG00000231752.4	EMBP1	-6.85	2.97e-09	0.0355	-0.91	-0.64	Schizophrenia;	chr5:50473217	chr1:121519112~121571892:+
READ	trans	rs13190036	0.551	rs11957608	ENSG00000217325.2	PRELID1P1	-6.85	2.97e-09	0.0356	-0.97	-0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177228344	chr6:126643488~126644390:+
READ	trans	rs13253073	1	rs12541837	ENSG00000260318.1	COX6CP1	-6.85	3.05e-09	0.0364	-1.08	-0.64	Glucose homeostasis traits;	chr8:99869645	chr16:11903923~11904137:-
READ	trans	rs12709013	0.792	rs1615326	ENSG00000230849.2	GOT2P2	6.84	3.08e-09	0.0368	0.81	0.64	Blood metabolite ratios;	chr16:58747148	chr1:173141100~173142350:-
READ	trans	rs10242455	0.571	rs13438288	ENSG00000228834.1	RP11-249L21.4	6.84	3.1e-09	0.037	1.73	0.64	Blood metabolite levels;	chr7:99318791	chr6:108907615~108907873:-
READ	trans	rs10242455	0.702	rs76702117	ENSG00000228834.1	RP11-249L21.4	6.84	3.1e-09	0.037	1.73	0.64	Blood metabolite levels;	chr7:99319156	chr6:108907615~108907873:-
READ	trans	rs6477998	0.932	rs4129395	ENSG00000238072.1	RP11-305M3.2	6.84	3.15e-09	0.0375	0.82	0.64	Hematology traits;	chr9:113213109	chr7:129410113~129410370:-
READ	trans	rs6477998	0.966	rs7859354	ENSG00000238072.1	RP11-305M3.2	6.84	3.15e-09	0.0375	0.82	0.64	Hematology traits;	chr9:113214165	chr7:129410113~129410370:-
READ	trans	rs6477998	1	rs10739388	ENSG00000238072.1	RP11-305M3.2	6.84	3.15e-09	0.0375	0.82	0.64	Hematology traits;	chr9:113214895	chr7:129410113~129410370:-
READ	trans	rs76329678	1	rs76329678	ENSG00000231752.4	EMBP1	-6.84	3.15e-09	0.0375	-0.9	-0.64	Schizophrenia;	chr5:50534452	chr1:121519112~121571892:+
READ	trans	rs10940346	1	rs7380858	ENSG00000231752.4	EMBP1	-6.84	3.15e-09	0.0375	-0.9	-0.64	Schizophrenia;	chr5:50537022	chr1:121519112~121571892:+
READ	trans	rs12709013	0.755	rs1424245	ENSG00000230849.2	GOT2P2	6.84	3.15e-09	0.0375	0.83	0.64	Blood metabolite ratios;	chr16:58729926	chr1:173141100~173142350:-
READ	trans	rs3735025	0.963	rs16874961	ENSG00000260145.1	RP11-322D14.2	-6.83	3.24e-09	0.0385	-0.82	-0.64	Autism spectrum disorder or schizophrenia;Schizophrenia;	chr7:137395203	chr16:57052505~57058497:-
READ	trans	rs4276421	0.745	rs4441886	ENSG00000231752.4	EMBP1	-6.83	3.26e-09	0.0387	-0.92	-0.64	P wave duration;	chr5:46063034	chr1:121519112~121571892:+
READ	trans	rs4276421	0.901	rs10056175	ENSG00000231752.4	EMBP1	6.82	3.35e-09	0.0398	0.97	0.64	P wave duration;	chr5:45934503	chr1:121519112~121571892:+
READ	trans	rs13253073	1	rs4409375	ENSG00000260318.1	COX6CP1	6.82	3.37e-09	0.0398	1.11	0.64	Glucose homeostasis traits;	chr8:99877759	chr16:11903923~11904137:-
READ	trans	rs9467773	0.62	rs2451741	ENSG00000242375.1	RP11-498P14.3	6.82	3.39e-09	0.04	0.88	0.64	Intelligence (multi-trait analysis);	chr6:26629176	chr9:97195351~97197687:-
READ	trans	rs4276421	0.934	rs6451840	ENSG00000231752.4	EMBP1	6.82	3.42e-09	0.0404	0.96	0.64	P wave duration;	chr5:45935584	chr1:121519112~121571892:+
READ	trans	rs4276421	0.87	rs6451842	ENSG00000231752.4	EMBP1	6.82	3.42e-09	0.0404	0.96	0.64	P wave duration;	chr5:45936431	chr1:121519112~121571892:+
READ	trans	rs1816752	0.692	rs2282409	ENSG00000237917.1	PARP4P1	-6.82	3.44e-09	0.0404	-0.81	-0.64	Obesity-related traits;	chr13:24512388	chrY:26594851~26634652:-
READ	trans	rs8175379	0.509	rs4128583	ENSG00000231752.4	EMBP1	6.81	3.51e-09	0.0404	0.91	0.64	Interleukin-7 levels;	chr5:46251985	chr1:121519112~121571892:+
READ	trans	rs8175379	0.509	rs7293427	ENSG00000231752.4	EMBP1	6.81	3.51e-09	0.0404	0.91	0.64	Interleukin-7 levels;	chr5:46253335	chr1:121519112~121571892:+
READ	trans	rs8175379	0.542	rs12657764	ENSG00000231752.4	EMBP1	-6.81	3.51e-09	0.0404	-0.91	-0.64	Interleukin-7 levels;	chr5:46281165	chr1:121519112~121571892:+
READ	trans	rs4276421	0.904	rs7444405	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45915373	chr1:121519112~121571892:+
READ	trans	rs4276421	0.904	rs4274988	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45926339	chr1:121519112~121571892:+
READ	trans	rs4276421	0.935	rs7725537	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45927191	chr1:121519112~121571892:+
READ	trans	rs4276421	0.935	rs6451834	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45927208	chr1:121519112~121571892:+
READ	trans	rs4276421	0.935	rs35730142	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45927453	chr1:121519112~121571892:+
READ	trans	rs4276421	0.816	rs6451835	ENSG00000231752.4	EMBP1	6.81	3.59e-09	0.0409	0.96	0.64	P wave duration;	chr5:45928735	chr1:121519112~121571892:+
READ	trans	rs13190036	0.901	rs28563911	ENSG00000217325.2	PRELID1P1	6.8	3.67e-09	0.0419	1.04	0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177287942	chr6:126643488~126644390:+
READ	trans	rs116095464	0.558	rs7703803	ENSG00000185986.11	SDHAP3	6.8	3.7e-09	0.0421	1.25	0.64	Breast cancer;	chr5:292196	chr5:1572222~1594620:-
READ	trans	rs12709013	0.66	rs30839	ENSG00000233719.3	GOT2P3	6.8	3.71e-09	0.0422	0.79	0.64	Blood metabolite ratios;	chr16:58711437	chr12:9641802~9643007:+
READ	trans	rs12709013	0.636	rs30835	ENSG00000233719.3	GOT2P3	6.8	3.71e-09	0.0422	0.79	0.64	Blood metabolite ratios;	chr16:58714117	chr12:9641802~9643007:+
READ	trans	rs4276421	0.662	rs4367307	ENSG00000231752.4	EMBP1	-6.8	3.74e-09	0.0426	-0.92	-0.64	P wave duration;	chr5:46065857	chr1:121519112~121571892:+
READ	trans	rs1816752	0.692	rs6490944	ENSG00000237917.1	PARP4P1	-6.79	3.76e-09	0.0427	-0.81	-0.64	Obesity-related traits;	chr13:24513866	chrY:26594851~26634652:-
READ	trans	rs13190036	0.591	rs78523677	ENSG00000217325.2	PRELID1P1	-6.79	3.82e-09	0.0432	-0.97	-0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177124102	chr6:126643488~126644390:+
READ	trans	rs1816752	0.669	rs3783072	ENSG00000224976.2	PARP4P2	6.79	3.83e-09	0.0432	0.78	0.64	Obesity-related traits;	chr13:24493258	chr13:19349137~19407962:+
READ	trans	rs4276421	0.745	rs10941722	ENSG00000231752.4	EMBP1	-6.79	3.83e-09	0.0432	-0.91	-0.64	P wave duration;	chr5:46067527	chr1:121519112~121571892:+
READ	trans	rs1816752	0.669	rs2862906	ENSG00000237917.1	PARP4P1	-6.79	3.85e-09	0.0432	-0.81	-0.64	Obesity-related traits;	chr13:24494482	chrY:26594851~26634652:-
READ	trans	rs1816752	0.716	rs1539096	ENSG00000237917.1	PARP4P1	-6.79	3.85e-09	0.0432	-0.81	-0.64	Obesity-related traits;	chr13:24501721	chrY:26594851~26634652:-
READ	trans	rs2731664	0.792	rs2731662	ENSG00000215571.5	GRK6P1	-6.78	3.9e-09	0.0432	-0.76	-0.64	Intelligence (multi-trait analysis);	chr5:177445493	chr13:21319156~21320866:+
READ	trans	rs8175379	0.551	rs4975969	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46295887	chr1:121519112~121571892:+
READ	trans	rs8175379	0.522	rs8185256	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46298301	chr1:121519112~121571892:+
READ	trans	rs8175379	0.584	rs8185180	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46300291	chr1:121519112~121571892:+
READ	trans	rs13358908	0.526	rs4975974	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Schizophrenia;	chr5:46307464	chr1:121519112~121571892:+
READ	trans	rs8175379	0.501	rs12514178	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46309072	chr1:121519112~121571892:+
READ	trans	rs8175379	0.501	rs8185192	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46309722	chr1:121519112~121571892:+
READ	trans	rs8175379	0.575	rs8185283	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46337706	chr1:121519112~121571892:+
READ	trans	rs8175379	0.515	rs8185067	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Interleukin-7 levels;	chr5:46337722	chr1:121519112~121571892:+
READ	trans	rs13358908	0.503	rs10073687	ENSG00000231752.4	EMBP1	-6.78	3.91e-09	0.0432	-0.9	-0.64	Schizophrenia;	chr5:46352187	chr1:121519112~121571892:+
READ	trans	rs61990749	0.571	rs11628049	ENSG00000235400.1	RP4-641G12.4	-6.78	3.92e-09	0.0433	-1.09	-0.64	Fibroblast growth factor basic levels;	chr14:77842108	chr1:78749073~78750659:+
READ	trans	rs61990749	0.511	rs7146020	ENSG00000235400.1	RP4-641G12.4	6.78	3.96e-09	0.0437	1.04	0.64	Fibroblast growth factor basic levels;	chr14:77891976	chr1:78749073~78750659:+
READ	trans	rs2458413	0.522	rs2669449	ENSG00000276259.1	RP11-481J2.4	-6.78	4.01e-09	0.0441	-0.78	-0.64	Paget's disease;	chr8:104359945	chr16:58522970~58523842:+
READ	trans	rs12291225	0.839	rs4757244	ENSG00000236360.2	RP11-334A14.2	-6.78	4.04e-09	0.0444	-0.85	-0.64	Sense of smell;	chr11:14237109	chr1:52993201~52993702:-
READ	trans	rs13190036	0.551	rs1052432	ENSG00000217325.2	PRELID1P1	-6.77	4.09e-09	0.0451	-0.97	-0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177137188	chr6:126643488~126644390:+
READ	trans	rs13190036	1	rs28580074	ENSG00000217325.2	PRELID1P1	6.77	4.11e-09	0.0452	1.05	0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177294197	chr6:126643488~126644390:+
READ	trans	rs2731664	0.792	rs335468	ENSG00000215571.5	GRK6P1	-6.77	4.11e-09	0.0452	-0.76	-0.64	Intelligence (multi-trait analysis);	chr5:177465348	chr13:21319156~21320866:+
READ	trans	rs10186876	0.833	rs28394191	ENSG00000274001.1	RP11-5G9.5	-6.77	4.13e-09	0.0454	-0.8	-0.64	Hand grip strength;	chr2:43945305	chr13:43877715~43878163:-
READ	trans	rs5022636	0.927	rs4971030	ENSG00000180764.13	PIPSL	-6.76	4.25e-09	0.0466	-0.98	-0.64	Gut microbiota (functional units);	chr1:151308519	chr10:93958191~93961540:-
READ	trans	rs7911712	0.641	rs61852531	ENSG00000271924.1	5S_rRNA	6.76	4.28e-09	0.0469	1.19	0.64	Emphysema-related traits;	chr10:44844446	chr2:161409554~161409670:+
READ	trans	rs13177918	0.871	rs11745133	ENSG00000224114.1	RP11-343H5.4	6.76	4.4e-09	0.0479	0.83	0.64	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150457826	chr1:206695837~206696269:-
READ	trans	rs13177918	0.871	rs11745194	ENSG00000224114.1	RP11-343H5.4	6.76	4.4e-09	0.0479	0.83	0.64	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150458065	chr1:206695837~206696269:-
READ	trans	rs13177918	0.822	rs62382255	ENSG00000224114.1	RP11-343H5.4	6.76	4.4e-09	0.0479	0.83	0.64	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150459154	chr1:206695837~206696269:-
READ	trans	rs13177918	0.834	rs13163277	ENSG00000224114.1	RP11-343H5.4	6.76	4.4e-09	0.0479	0.83	0.64	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150459359	chr1:206695837~206696269:-
READ	trans	rs13177918	0.798	rs12516161	ENSG00000224114.1	RP11-343H5.4	6.76	4.4e-09	0.0479	0.83	0.64	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150461098	chr1:206695837~206696269:-
READ	trans	rs8010715	1	rs8010715	ENSG00000248988.1	RP11-815N9.2	6.76	4.4e-09	0.048	0.85	0.64	IgG glycosylation;	chr14:24139938	chr4:159007119~159007835:+
READ	trans	rs6477998	0.651	rs10121845	ENSG00000238072.1	RP11-305M3.2	6.75	4.42e-09	0.0481	0.83	0.64	Hematology traits;	chr9:113227443	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs10981698	ENSG00000238072.1	RP11-305M3.2	6.75	4.42e-09	0.0481	0.83	0.64	Hematology traits;	chr9:113233500	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs10759631	ENSG00000238072.1	RP11-305M3.2	6.75	4.42e-09	0.0481	0.83	0.64	Hematology traits;	chr9:113233764	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs10081797	ENSG00000238072.1	RP11-305M3.2	6.75	4.42e-09	0.0481	0.83	0.64	Hematology traits;	chr9:113237973	chr7:129410113~129410370:-
READ	trans	rs6477998	0.676	rs10759632	ENSG00000238072.1	RP11-305M3.2	6.75	4.42e-09	0.0481	0.83	0.64	Hematology traits;	chr9:113238703	chr7:129410113~129410370:-
READ	trans	rs116095464	0.558	rs9312957	ENSG00000185986.11	SDHAP3	6.75	4.46e-09	0.0484	1.38	0.64	Breast cancer;	chr5:202079	chr5:1572222~1594620:-
READ	trans	rs10940346	0.936	rs303219	ENSG00000231752.4	EMBP1	6.75	4.5e-09	0.0489	0.9	0.64	Schizophrenia;	chr5:50407795	chr1:121519112~121571892:+
READ	trans	rs6477998	0.676	rs10817470	ENSG00000238072.1	RP11-305M3.2	6.75	4.53e-09	0.0491	0.83	0.64	Hematology traits;	chr9:113252129	chr7:129410113~129410370:-
READ	trans	rs5022636	0.896	rs744536	ENSG00000180764.13	PIPSL	6.75	4.54e-09	0.0493	0.94	0.64	Gut microbiota (functional units);	chr1:151356318	chr10:93958191~93961540:-
READ	trans	rs1185460	0.546	rs592190	ENSG00000231822.1	AC019097.7	-6.75	4.58e-09	0.0493	-0.86	-0.64	Coronary artery disease;	chr11:119084604	chr2:99102018~99102752:+
READ	trans	rs1185460	0.546	rs589925	ENSG00000231822.1	AC019097.7	-6.75	4.58e-09	0.0493	-0.86	-0.64	Coronary artery disease;	chr11:119084969	chr2:99102018~99102752:+
READ	trans	rs13190036	1	rs6889220	ENSG00000217325.2	PRELID1P1	6.74	4.63e-09	0.0498	1.04	0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177266887	chr6:126643488~126644390:+
READ	trans	rs13190036	0.901	rs28715668	ENSG00000217325.2	PRELID1P1	6.74	4.63e-09	0.0498	1.04	0.64	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr5:177272267	chr6:126643488~126644390:+
READ	trans	rs10186876	0.833	rs7594526	ENSG00000274001.1	RP11-5G9.5	-6.74	4.65e-09	0.05	-0.8	-0.64	Hand grip strength;	chr2:43946283	chr13:43877715~43878163:-
READ	trans	rs1816752	0.646	rs9511291	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467609	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511292	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467623	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511293	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467747	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511294	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467773	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511295	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467794	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9511296	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24467962	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9634401	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468072	chrY:26594851~26634652:-
READ	trans	rs1816752	0.624	rs9634402	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468119	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9634403	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468211	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9581064	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468251	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs4770692	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468689	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs4769361	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468834	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs4770693	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468835	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs4770694	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468891	chrY:26594851~26634652:-
READ	trans	rs1816752	0.609	rs4770695	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24468895	chrY:26594851~26634652:-
READ	trans	rs1816752	0.624	rs9507354	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24469227	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs7337981	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24469245	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs7328391	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24470325	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs4480642	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24471358	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs9551108	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24471434	chrY:26594851~26634652:-
READ	trans	rs1816752	0.669	rs9553309	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24471476	chrY:26594851~26634652:-
READ	trans	rs1816752	0.603	rs4238178	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24472344	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs2862903	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24473169	chrY:26594851~26634652:-
READ	trans	rs1816752	0.646	rs7319207	ENSG00000237917.1	PARP4P1	-6.74	4.69e-09	0.05	-0.81	-0.64	Obesity-related traits;	chr13:24473220	chrY:26594851~26634652:-